data_1ai0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ai0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.412 ' CD1' HD13 ' B' ' 15' ' ' LEU . 51.4 mt -87.27 -27.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.88 -27.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.209 -0.932 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 55.01 0.65 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.22 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.37 -36.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -101.66 -32.22 10.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.339 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -68.89 -32.04 71.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 108.975 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.7 p -88.45 -16.1 33.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.416 -0.803 . . . . 0.0 109.45 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 10' ' ' ILE . 1.4 p -169.49 121.15 0.71 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.444 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 9' ' ' SER . 3.1 mt -44.61 107.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.14 154.96 21.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.299 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -71.99 167.56 19.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.23 -38.33 85.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.713 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.8 -43.07 94.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.873 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -63.84 -39.6 94.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.4 mt -77.16 -15.17 59.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -78.09 -22.51 48.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -85.35 17.39 3.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.24 -13.7 12.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.116 -0.99 . . . . 0.0 109.299 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.88 156.99 25.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.193 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.509 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.239 0.542 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.3 150.64 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.055 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 173.32 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.006 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -74.61 -32.67 62.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.174 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -69.03 -39.37 79.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.08 -23.48 35.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.475 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 42.4 t -74.57 -34.91 63.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.429 -0.794 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -16.01 80.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.89 -19.95 28.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.413 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -83.97 -15.07 49.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 12.9 mt -91.98 -49.71 6.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.756 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.0 m -46.56 -45.18 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -62.03 -42.79 99.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.54 22.67 2.49 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.173 -0.955 . . . . 0.0 109.631 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.412 HD13 ' CD1' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -115.89 -58.41 2.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.903 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -59.46 -27.86 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.197 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.03 -42.68 80.24 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.554 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -54.56 -47.99 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -61.44 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' B' ' 21' ' ' GLU . . . 103.65 40.04 2.43 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' B' ' 20' ' ' GLY . 3.0 tt0 78.86 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.434 -1.039 . . . . 0.0 109.419 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.21 -54.81 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 109.581 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.02 152.38 5.7 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -163.52 159.87 22.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -119.81 143.24 47.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.579 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 40.2 t80 -119.71 104.7 10.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.103 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -132.07 97.92 17.89 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.76 113.15 3.59 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.504 2.136 . . . . 0.0 110.637 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -168.17 158.25 10.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.438 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 46.0 mt -90.17 -28.37 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 109.316 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.49 -29.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.98 53.11 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.34 -36.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 63.3 m -101.62 -33.62 9.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.357 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -68.1 -30.51 69.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.904 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 75.0 p -89.82 -17.26 28.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.317 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' SER . . . . . 0.413 ' O ' ' C ' ' C' ' 10' ' ' ILE . 1.3 p -167.82 120.34 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' C' ' 9' ' ' SER . 3.1 mt -44.29 108.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.22 155.98 16.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 t -72.68 165.83 24.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.11 -37.63 86.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.968 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.24 -44.5 88.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.884 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . 0.46 ' HA ' ' ND2' ' C' ' 18' ' ' ASN . 27.8 mt-30 -61.6 -40.98 96.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 47.0 mt -74.62 -17.2 60.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 109.828 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.11 -18.79 52.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.011 -1.055 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' C' ' 15' ' ' GLN . 26.8 p30 -88.24 16.34 6.39 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.117 -0.99 . . . . 0.0 109.47 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -112.26 -12.95 13.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.51 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.22 152.56 25.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.552 -179.921 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.464 HG21 HD13 ' G' ' 10' ' ' ILE . 7.3 p -60.18 152.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.223 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' D' ' 7' ' ' CYS . 3.9 m-20 170.92 -38.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.377 -0.827 . . . . 0.0 109.219 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -75.36 -31.02 60.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -70.18 -40.36 74.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.143 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -81.87 -22.35 36.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.06 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.462 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 49.9 t -75.34 -34.53 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.39 -0.819 . . . . 0.0 109.674 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.08 -16.95 80.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.85 -19.6 32.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -1.041 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -85.57 -13.91 47.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.298 -0.876 . . . . 0.0 109.137 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 13.8 mt -92.04 -52.72 4.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' D' ' 11' ' ' LEU . 11.5 m -43.79 -48.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' D' ' 16' ' ' TYR . 82.3 mt-10 -58.71 -43.74 90.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.865 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.65 23.5 2.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.237 -0.914 . . . . 0.0 110.071 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.56 -59.28 2.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' D' ' 13' ' ' GLU . 16.5 p90 -58.42 -27.4 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.14 -43.1 79.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.385 -0.822 . . . . 0.0 109.586 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.21 -47.77 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -60.25 3.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' D' ' 21' ' ' GLU . . . 101.23 40.55 2.79 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' D' ' 20' ' ' GLY . 1.9 tt0 79.55 50.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.434 -1.039 . . . . 0.0 109.867 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -51.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.41 150.49 6.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 30.0 p90 -155.28 172.46 18.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.31 -1.112 . . . . 0.0 109.364 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' D' ' 25' ' ' PHE . 12.8 m-85 -129.12 139.03 52.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.277 -0.889 . . . . 0.0 109.37 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -120.97 99.42 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.577 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 32.4 m -126.48 100.61 28.7 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.401 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.85 110.93 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.569 2.179 . . . . 0.0 110.543 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -167.18 155.75 9.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.379 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . 0.452 ' CD1' HD13 ' F' ' 15' ' ' LEU . 50.5 mt -87.11 -27.37 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.5 -28.01 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -108.04 53.22 0.69 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.275 -0.891 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.78 -34.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.63 -30.28 11.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.221 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 4.8 t -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.339 -0.851 . . . . 0.0 109.306 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -87.67 -15.74 36.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' SER . . . . . 0.437 ' O ' ' C ' ' E' ' 10' ' ' ILE . 76.7 p -169.19 117.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.227 -0.92 . . . . 0.0 109.34 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' E' ' 9' ' ' SER . 3.1 mt -42.25 106.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.06 155.19 14.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.726 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 27.7 t -70.57 168.86 15.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.43 -37.13 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -64.74 -47.12 79.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -0.836 . . . . 0.0 109.475 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . 0.437 ' HA ' ' ND2' ' E' ' 18' ' ' ASN . 28.1 mt-30 -60.54 -39.66 88.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.899 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.288 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -76.99 -18.96 57.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' E' ' 15' ' ' GLN . 27.5 p30 -89.07 13.81 12.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.04 -1.038 . . . . 0.0 110.002 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -109.03 -13.38 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.04 -1.037 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 153.42 27.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.865 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.289 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.26 149.97 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 174.32 -41.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -72.89 -27.93 62.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -72.84 -40.01 66.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.039 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -82.46 -19.8 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 108.989 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.415 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 42.3 t -75.68 -38.61 58.58 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.523 -0.735 . . . . 0.0 109.472 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.04 -15.17 79.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -21.4 29.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.18 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -82.57 -18.58 40.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.9 mt -89.14 -49.86 6.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.746 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.65 -45.81 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.111 -0.993 . . . . 0.0 109.553 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -62.44 -40.61 97.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.03 25.06 2.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . 0.452 HD13 ' CD1' ' E' ' 2' ' ' ILE . 0.7 OUTLIER -117.97 -58.85 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -59.34 -27.73 66.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.297 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -68.07 -43.51 78.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.857 . . . . 0.0 109.493 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.06 -51.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 109.402 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -47.8 -62.23 1.56 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' F' ' 21' ' ' GLU . . . 103.63 40.42 2.36 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' F' ' 20' ' ' GLY . 2.2 tt0 79.65 49.51 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -1.046 . . . . 0.0 109.788 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -123.53 -46.8 2.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.04 -1.038 . . . . 0.0 109.563 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.22 153.14 7.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -162.81 175.68 11.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' F' ' 25' ' ' PHE . 2.4 p90 -132.76 158.18 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.383 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -138.25 93.78 2.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.411 -0.806 . . . . 0.0 109.103 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 28.5 m -120.34 99.34 48.22 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.492 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 108.59 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.424 2.083 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -164.64 155.73 15.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 44.3 p . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.568 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . 0.447 ' CD1' HD13 ' H' ' 15' ' ' LEU . 36.4 mt -84.48 -30.52 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.751 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.15 -30.05 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 109.63 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.7 52.45 0.73 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.175 -0.953 . . . . 0.0 109.888 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.05 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.379 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.5 -35.06 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.83 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.075 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -89.05 -17.4 29.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.361 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 9' ' ' SER . . . . . 0.43 ' O ' ' C ' ' G' ' 10' ' ' ILE . 1.9 p -168.75 119.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . 0.464 HD13 HG21 ' D' ' 2' ' ' VAL . 3.1 mt -42.82 106.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.578 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 62.6 m -60.62 153.97 22.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.373 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -68.76 170.16 10.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.79 -37.83 73.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 109.188 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.28 -44.82 90.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.431 -0.793 . . . . 0.0 109.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . 0.448 ' O ' ' ND2' ' G' ' 18' ' ' ASN . 21.4 mt-30 -61.92 -39.66 92.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.91 -15.36 59.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.203 -0.936 . . . . 0.0 109.544 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -79.32 -19.86 49.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.679 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' G' ' 15' ' ' GLN . 27.6 p30 -86.54 11.99 11.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -108.86 -10.94 15.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.855 . . . . 0.0 109.796 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.41 152.63 23.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.654 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.399 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.482 HG13 ' O ' ' K' ' 7' ' ' CYS . 7.5 p -60.06 152.56 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 3.6 m-20 170.72 -37.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -74.8 -33.81 62.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.25 -0.906 . . . . 0.0 108.855 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . 0.498 ' CB ' HD13 ' K' ' 10' ' ' ILE . 54.2 t60 -67.49 -42.2 83.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.513 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mt -79.22 -26.8 42.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.85 . . . . 0.0 109.427 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.409 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 42.4 t -72.21 -34.23 68.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.55 -21.47 79.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.73 -20.68 38.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -1.061 . . . . 0.0 109.665 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -82.34 -15.75 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.113 -0.992 . . . . 0.0 109.76 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.6 mt -92.41 -49.16 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.594 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 m -46.16 -47.11 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -61.42 -42.45 98.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.32 19.37 3.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 110.063 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . 0.447 HD13 ' CD1' ' G' ' 2' ' ' ILE . 0.7 OUTLIER -112.5 -59.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.07 -28.62 64.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 mt -67.07 -43.32 82.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.518 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -53.94 -45.81 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -57.16 12.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' H' ' 21' ' ' GLU . . . 99.73 38.88 3.53 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' H' ' 20' ' ' GLY . 2.2 tt0 80.93 50.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.26 -56.81 1.61 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.962 . . . . 0.0 109.475 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.37 153.25 5.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.67 158.27 17.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -1.153 . . . . 0.0 109.186 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 28.5 p90 -121.39 141.09 51.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.697 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -117.09 106.25 13.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 32.5 m -132.29 99.06 16.35 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.55 -0.719 . . . . 0.0 109.454 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.44 112.61 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.489 2.126 . . . . 0.0 110.47 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.61 153.18 8.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.612 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.514 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . 0.419 ' CD1' HD13 ' J' ' 15' ' ' LEU . 32.8 mt -86.37 -30.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -1.125 . . . . 0.0 109.4 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.46 -28.23 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -108.09 49.4 0.81 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.11 -0.994 . . . . 0.0 109.688 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.12 -34.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.22 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -102.97 -32.53 9.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.06 -26.63 64.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 46.8 p -93.76 -17.2 23.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.035 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 9' ' ' SER . . . . . 0.417 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.2 p -167.52 119.29 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' I' ' 9' ' ' SER . 3.1 mt -43.73 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.5 m -59.57 156.55 13.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.482 -0.761 . . . . 0.0 109.457 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -73.7 169.01 18.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.86 -38.16 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -65.56 -43.75 88.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . 0.426 ' HA ' ' ND2' ' I' ' 18' ' ' ASN . 26.9 mt-30 -62.97 -38.0 89.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.187 -0.945 . . . . 0.0 109.441 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 42.3 mt -78.84 -13.51 59.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -81.01 -21.55 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.08 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' I' ' 15' ' ' GLN . 27.3 p30 -85.09 15.8 3.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.314 -0.866 . . . . 0.0 109.739 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.64 -11.73 13.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.382 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.12 154.65 24.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.526 -179.859 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.99 151.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 171.8 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.048 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -74.08 -33.49 63.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.249 -0.907 . . . . 0.0 109.105 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . 0.431 ' NE2' HD22 ' L' ' 17' ' ' LEU . 47.2 t60 -68.38 -39.55 81.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.508 -0.745 . . . . 0.0 109.705 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 mt -82.19 -24.64 34.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 48.7 t -72.89 -37.31 67.32 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -0.817 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.88 -20.52 78.83 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 9' ' ' SER . . . . . 0.459 ' HB3' ' OH ' ' L' ' 16' ' ' TYR . 1.3 m -82.38 -19.71 38.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -1.11 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.46 -16.81 44.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.574 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.1 mt -91.08 -48.16 7.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -47.9 -46.15 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.276 -0.89 . . . . 0.0 109.981 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -62.27 -39.61 93.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.26 23.36 3.37 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.864 . . . . 0.0 109.753 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . 0.419 HD13 ' CD1' ' I' ' 2' ' ' ILE . 0.8 OUTLIER -116.32 -58.01 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.018 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -60.37 -28.44 68.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mt -66.17 -44.55 83.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.214 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -51.27 -48.58 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.282 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -50.77 69.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.08 -1.013 . . . . 0.0 108.831 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' J' ' 21' ' ' GLU . . . 108.77 -43.54 1.69 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' J' ' 20' ' ' GLY . 2.4 tt0 167.44 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -53.44 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.59 157.07 7.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 25.1 p90 -159.27 171.24 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -1.142 . . . . 0.0 109.742 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' J' ' 25' ' ' PHE . 1.7 p90 -128.0 141.26 51.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -121.75 98.76 6.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.873 . . . . 0.0 109.473 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -125.8 100.23 31.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.433 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.86 109.02 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.426 2.084 . . . . 0.0 110.621 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -164.29 156.85 17.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.553 -179.842 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . 0.452 ' CD1' HD13 ' L' ' 15' ' ' LEU . 38.0 mt -85.06 -29.23 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 39.4 t -69.24 -31.63 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.265 -0.897 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.95 51.96 0.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.262 -0.899 . . . . 0.0 109.975 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.28 -37.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.161 -0.962 . . . . 0.0 109.227 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 64.5 m -99.59 -34.67 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.305 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . 0.482 ' O ' HG13 ' H' ' 2' ' ' VAL . 1.7 m -68.07 -22.95 64.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 38.0 p -96.95 -20.42 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 108.978 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 9' ' ' SER . . . . . 0.414 ' O ' ' C ' ' K' ' 10' ' ' ILE . 33.8 p -165.27 119.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.324 -0.86 . . . . 0.0 108.959 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . 0.498 HD13 ' CB ' ' H' ' 5' ' ' HIS . 2.9 mp -42.99 107.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.749 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 68.7 m -59.13 156.3 12.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -73.27 169.36 17.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.52 -34.84 74.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 0.0 109.744 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.97 -45.11 75.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.995 . . . . 0.0 109.377 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . 0.433 ' O ' ' ND2' ' K' ' 18' ' ' ASN . 24.0 mt-30 -60.78 -40.43 92.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 42.5 mt -76.41 -15.57 59.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.94 -19.75 47.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.983 . . . . 0.0 109.558 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' K' ' 15' ' ' GLN . 27.5 p30 -87.17 14.18 8.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.887 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.42 -10.82 14.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.292 -0.88 . . . . 0.0 109.562 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.0 154.22 22.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.551 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.196 0.522 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.72 151.6 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.012 -1.055 . . . . 0.0 109.198 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 172.86 -40.24 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 108.907 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.4 -33.0 64.76 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.297 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -68.73 -39.65 80.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mt -82.23 -22.64 35.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.0 109.223 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.438 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 48.6 t -74.97 -32.65 61.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.432 -0.792 . . . . 0.0 109.821 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 -13.38 83.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -17.58 31.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.235 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -85.46 -19.19 31.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 11.9 mt -87.23 -51.55 5.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 m -46.1 -49.08 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -58.98 -42.57 90.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.39 22.79 2.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . 0.452 HD13 ' CD1' ' K' ' 2' ' ' ILE . 0.7 OUTLIER -115.67 -57.81 2.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 0.0 109.824 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.459 ' OH ' ' HB3' ' J' ' 9' ' ' SER . 18.0 p90 -60.45 -26.97 67.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.17 -0.956 . . . . 0.0 109.393 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.431 HD22 ' NE2' ' J' ' 5' ' ' HIS . 5.0 mt -68.59 -41.13 80.04 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.37 -49.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -59.48 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.533 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' L' ' 21' ' ' GLU . . . 101.07 39.14 3.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' L' ' 20' ' ' GLY . 2.7 tt0 80.38 48.08 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.489 -1.006 . . . . 0.0 109.929 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.36 -53.86 2.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.38 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.31 151.26 5.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -160.68 169.59 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -1.105 . . . . 0.0 108.949 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' L' ' 25' ' ' PHE . 2.5 p90 -129.38 147.61 51.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . 0.408 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 36.8 t80 -123.85 107.12 11.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.889 . . . . 0.0 109.166 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -133.17 98.48 15.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.305 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 110.7 3.05 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.471 2.114 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.0 158.52 17.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.418 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.658 -179.846 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.4 2.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -1.176 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 48.0 t -95.04 -36.65 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.958 -1.089 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.43 38.93 1.42 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.477 -0.764 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -156.34 -39.29 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 109.513 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.5 m -104.04 -38.96 6.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 109.636 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.454 ' O ' HG13 ' F' ' 2' ' ' VAL . 49.3 t -62.09 -24.3 67.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.602 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 p -77.65 -31.67 52.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -153.1 145.78 24.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.545 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -46.81 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -0.869 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.401 ' HB3' ' HG ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.56 163.23 7.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.615 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.17 165.23 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.294 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -36.5 77.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.843 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -68.89 -32.03 71.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -46.15 46.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 11' ' ' CYS . 64.8 mt -67.23 -17.34 64.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.053 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -26.15 62.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.069 -1.02 . . . . 0.0 109.335 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -55.08 -32.02 61.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.94 55.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.038 -1.039 . . . . 0.0 109.546 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -123.66 131.88 53.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.392 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.627 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.98 127.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.579 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 t30 179.96 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.95 -26.34 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -78.48 -39.4 38.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.08 -22.35 36.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.432 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 39.7 t -81.81 -33.07 30.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.941 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.81 -26.71 55.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.27 63.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -96.97 -21.17 17.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 59.5 mt -81.76 -33.45 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.58 -33.02 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -73.77 -38.17 64.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.152 -0.968 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.59 -58.06 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.519 ' HA ' ' HB ' ' B' ' 18' ' ' VAL . 9.4 mt -53.43 -23.01 8.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.992 . . . . 0.0 109.689 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -53.04 58.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 110.02 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -88.88 -23.27 22.8 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' B' ' 15' ' ' LEU . 83.7 t -65.44 -22.69 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 109.688 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.2 -34.62 8.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.626 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.48 -147.4 18.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -78.41 -1.43 33.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.252 -1.146 . . . . 0.0 109.701 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -65.83 -26.5 67.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 174.28 48.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -157.14 176.79 12.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 0.0 109.549 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.587 ' HB2' ' CE1' ' D' ' 25' ' ' PHE . 6.3 p90 -133.13 153.99 51.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.95 . . . . 0.0 109.585 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -130.92 109.4 10.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.383 -0.823 . . . . 0.0 109.302 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 40.3 m -159.7 105.89 1.46 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 109.34 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.42 -88.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.26 1.973 . . . . 0.0 110.233 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.29 -153.97 0.38 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.425 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 8.9 tt -103.02 0.96 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.644 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' C' ' 7' ' ' CYS . 48.2 t -92.62 -35.94 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.86 48.27 0.86 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.181 -0.949 . . . . 0.0 109.373 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -166.44 -36.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.459 -0.775 . . . . 0.0 109.097 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m -106.5 -39.69 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.394 -0.816 . . . . 0.0 109.374 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . 0.427 ' HB3' ' O ' ' C' ' 3' ' ' VAL . 47.0 t -64.14 -22.07 66.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.849 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -80.31 -31.73 38.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.587 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.28 146.68 26.21 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -48.76 101.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.571 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -58.32 160.12 5.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 169.91 13.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.6 -38.23 70.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.697 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.6 -31.14 70.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.43 -43.89 47.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 109.821 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 67.0 mt -69.73 -16.51 63.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.87 . . . . 0.0 109.812 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -23.13 61.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.634 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -58.72 -29.83 66.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -101.39 57.58 0.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -126.6 130.39 50.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.466 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.432 HG13 ' O ' ' G' ' 7' ' ' CYS . 13.0 p -64.8 128.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.587 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 179.25 -42.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.118 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.03 -25.36 60.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.779 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -80.83 -35.58 32.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -85.38 -20.33 30.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.147 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 41.8 t -84.31 -31.65 24.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.442 -0.786 . . . . 0.0 109.974 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.418 ' HA3' ' OH ' ' D' ' 26' ' ' TYR . . . -81.09 -27.02 51.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -15.23 63.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.34 -1.094 . . . . 0.0 109.364 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -97.06 -21.24 17.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.187 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 57.2 mt -83.81 -28.19 28.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -63.99 -32.06 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -75.32 -37.53 60.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.317 -0.864 . . . . 0.0 109.611 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.73 -55.12 18.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.942 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . 0.483 ' HA ' ' HB ' ' D' ' 18' ' ' VAL . 9.6 mt -55.13 -24.4 25.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.38 -53.77 40.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.005 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 35.3 mt -87.98 -24.85 23.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 110.463 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' D' ' 15' ' ' LEU . 78.9 t -63.68 -22.76 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.12 -37.65 7.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.383 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.74 -144.73 17.46 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.78 4.5 21.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -1.161 . . . . 0.0 109.593 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -72.67 -22.72 60.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.883 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.02 177.94 50.97 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -159.05 167.44 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -1.208 . . . . 0.0 109.925 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' B' ' 25' ' ' PHE . 2.3 m-85 -118.41 149.6 40.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.415 -0.803 . . . . 0.0 109.449 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.418 ' OH ' ' HA3' ' D' ' 8' ' ' GLY . 64.0 t80 -133.05 100.4 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.327 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.3 m -154.05 109.21 2.47 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.152 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.32 -87.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 110.313 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.18 -153.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.464 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.605 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 5.1 tt -102.35 0.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -1.087 . . . . 0.0 109.444 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 42.5 t -92.9 -38.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.301 -0.874 . . . . 0.0 109.66 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.81 45.29 0.99 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.885 . . . . 0.0 109.406 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -163.68 -36.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.456 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 74.9 m -107.01 -41.21 5.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . 0.446 ' O ' HG13 ' J' ' 2' ' ' VAL . 0.6 OUTLIER -62.36 -20.86 64.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -79.95 -34.16 39.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -150.8 146.72 26.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.265 -0.897 . . . . 0.0 109.335 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.32 102.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.678 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 162.04 6.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.366 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.47 167.65 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.516 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -39.04 77.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.163 -0.961 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -67.02 -31.33 71.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.34 -42.7 53.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 110.08 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 mt -70.67 -16.98 62.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.71 -26.66 63.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -54.62 -30.68 55.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -101.42 59.27 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -127.3 132.09 50.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.317 -179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.356 0.598 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 7' ' ' CYS . 11.5 p -62.29 127.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.389 -0.819 . . . . 0.0 109.911 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 t30 179.39 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.06 -27.31 57.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -79.54 -33.54 41.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.594 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -87.41 -22.67 24.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.107 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.457 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 37.3 t -82.53 -26.52 32.39 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.44 -27.08 31.12 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.55 -15.78 63.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -1.122 . . . . 0.0 109.181 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -96.27 -24.27 16.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.313 -0.867 . . . . 0.0 109.633 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 52.2 mt -79.86 -31.28 40.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.553 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -60.45 -33.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.95 -35.38 62.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 109.823 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . 0.493 ' CB ' ' CD1' ' L' ' 17' ' ' LEU . . . -67.9 -54.83 15.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.571 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . 0.496 ' HA ' ' HB ' ' F' ' 18' ' ' VAL . 12.0 mt -55.83 -22.28 24.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 109.598 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -55.02 35.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.76 -26.53 25.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.27 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' F' ' 15' ' ' LEU . 89.5 t -61.96 -23.14 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.116 -0.99 . . . . 0.0 109.753 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.97 -35.15 8.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.6 -143.19 16.5 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -82.79 2.69 32.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -1.14 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.53 -31.6 68.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.65 -177.35 31.8 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -169.88 154.03 5.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.433 -1.04 . . . . 0.0 109.136 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -112.25 157.88 20.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.68 108.51 8.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 108.918 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -158.71 109.22 1.62 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.688 . . . . 0.0 109.405 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.5 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.372 2.048 . . . . 0.0 110.213 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.91 -156.08 0.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.373 -0.829 . . . . 0.0 109.769 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 7.4 tt -100.21 1.48 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -1.159 . . . . 0.0 109.61 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -92.97 -40.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.38 47.69 1.03 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -166.78 -34.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 77.9 m -108.58 -38.11 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . 0.432 ' O ' HG13 ' D' ' 2' ' ' VAL . 53.4 t -64.46 -23.63 67.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.381 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 3.1 p -77.35 -30.84 54.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.13 146.68 25.02 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.211 -0.93 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 mt -49.06 103.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.148 -0.97 . . . . 0.0 109.289 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.18 162.63 5.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.06 164.41 15.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 109.244 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -41.3 91.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.88 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -64.62 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -44.77 50.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.086 -1.008 . . . . 0.0 109.863 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.57 -16.43 63.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -25.4 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 0.0 109.26 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -56.11 -28.84 59.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.864 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -103.19 56.52 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 128.06 47.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 109.553 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 109.446 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' H' ' 6' ' ' LEU . 14.0 p -66.3 126.3 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -179.36 -41.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.58 -25.04 60.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.588 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -80.01 -39.48 29.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.302 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . 0.447 ' CD1' HG23 ' H' ' 2' ' ' VAL . 12.8 mt -82.75 -16.41 48.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.438 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.437 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 44.4 t -88.89 -30.8 18.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.848 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.25 -28.22 45.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -67.29 -19.02 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -1.131 . . . . 0.0 109.559 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -93.48 -23.12 18.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.153 -0.967 . . . . 0.0 109.666 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 43.4 mt -81.56 -30.81 32.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -60.58 -31.71 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.061 -1.024 . . . . 0.0 109.631 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -75.94 -35.37 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.44 -54.13 27.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -0.98 . . . . 0.0 109.436 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . 0.458 ' HA ' ' HB ' ' H' ' 18' ' ' VAL . 12.6 mt -57.17 -24.52 54.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.873 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -51.47 61.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -89.22 -25.56 21.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' H' ' 15' ' ' LEU . 91.4 t -63.62 -26.24 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.034 -1.042 . . . . 0.0 109.65 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -39.15 9.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 109.544 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.95 -143.93 16.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.76 2.89 31.64 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.072 -1.252 . . . . 0.0 109.612 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -70.2 -24.88 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.14 -171.87 35.96 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -172.1 163.4 5.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -1.234 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -120.84 154.68 35.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.024 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -134.9 101.51 4.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.461 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 22.9 m -152.83 108.14 2.69 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 109.509 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.83 -87.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.343 2.029 . . . . 0.0 110.745 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.59 -154.91 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.393 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 7.9 tt -104.48 1.64 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -1.192 . . . . 0.0 109.523 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 42.4 t -93.52 -37.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.73 37.62 1.58 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.564 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -154.59 -38.82 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -104.57 -41.52 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' I' ' 3' ' ' VAL . 0.6 OUTLIER -60.34 -20.42 59.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.711 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -81.57 -33.4 31.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.23 147.72 28.03 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.32 -0.863 . . . . 0.0 108.949 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.92 101.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.34 164.63 1.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.62 168.71 11.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.008 . . . . 0.0 109.06 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.69 -42.84 77.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -63.55 -32.01 73.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 110.078 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -43.26 55.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.988 . . . . 0.0 109.949 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 mt -70.35 -16.01 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.826 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -19.57 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.18 -0.95 . . . . 0.0 109.65 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -62.21 -28.09 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.247 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -102.11 58.47 0.82 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.17 129.83 47.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.362 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.446 HG13 ' O ' ' E' ' 7' ' ' CYS . 12.3 p -65.47 127.33 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -179.95 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -75.13 -27.62 59.86 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.874 . . . . 0.0 109.619 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -76.8 -36.61 56.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 13.3 mt -84.98 -21.97 29.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.418 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 43.7 t -83.1 -27.19 30.36 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.31 -0.869 . . . . 0.0 109.644 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.41 -27.48 30.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 9' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 0.4 OUTLIER -69.82 -12.18 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -1.129 . . . . 0.0 109.477 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -99.43 -21.52 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.322 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 40.5 mt -83.37 -32.2 26.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 109.603 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -58.72 -32.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.354 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -74.3 -37.81 63.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.686 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.03 -59.65 3.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.568 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . 0.5 ' HA ' ' HB ' ' J' ' 18' ' ' VAL . 10.7 mt -51.0 -25.77 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.725 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -55.48 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.119 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 mt -85.9 -27.82 24.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 0.0 110.229 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' J' ' 15' ' ' LEU . 87.7 t -59.34 -26.33 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 109.935 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -99.47 -39.32 8.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.566 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 -145.11 17.18 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.35 1.18 33.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.21 -1.17 . . . . 0.0 109.578 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -66.98 -27.31 67.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.13 -177.55 41.36 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -170.5 165.1 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -1.089 . . . . 0.0 109.189 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -125.33 157.28 37.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.738 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -129.91 110.55 11.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.544 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 38.4 m -159.71 106.67 1.46 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.588 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.37 -88.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.397 2.065 . . . . 0.0 110.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.7 -158.03 0.31 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.248 -0.908 . . . . 0.0 109.354 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.919 -1.038 . . . . 0.0 109.347 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 7.1 tt -104.48 1.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -1.104 . . . . 0.0 109.159 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 46.5 t -93.5 -40.3 11.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 46.86 1.0 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -165.05 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.829 . . . . 0.0 109.235 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 81.7 m -107.01 -42.54 4.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 109.27 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . 0.449 ' SG ' HD13 ' L' ' 11' ' ' LEU . 0.6 OUTLIER -60.11 -22.27 62.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -79.43 -31.88 42.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.137 -0.977 . . . . 0.0 109.586 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.37 146.75 24.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.74 102.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.873 . . . . 0.0 109.542 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 161.53 7.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -85.93 165.77 16.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.275 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -41.99 83.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.05 -31.46 72.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.52 -0.738 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -42.65 46.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 109.73 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 mt -70.17 -16.47 63.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.718 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -23.49 61.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.92 . . . . 0.0 109.167 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -57.98 -28.12 64.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.299 -0.876 . . . . 0.0 109.359 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -103.66 58.29 0.74 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 7.2 t -127.08 131.86 50.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.573 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.33 0.586 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' L' ' 3' ' ' ASN . 11.6 p -64.61 128.09 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.729 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' L' ' 2' ' ' VAL . 14.6 t30 177.52 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.536 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -77.92 -25.25 48.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -79.74 -38.15 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.78 -25.1 33.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.815 . . . . 0.0 109.4 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.441 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 45.4 t -79.45 -30.09 42.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.744 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.2 -32.36 28.93 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -64.88 -12.96 54.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 109.698 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -98.44 -23.5 15.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.449 HD13 ' SG ' ' K' ' 7' ' ' CYS . 55.7 mt -81.35 -28.04 34.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.856 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.48 -30.32 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.569 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -76.67 -37.66 55.86 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.205 -0.935 . . . . 0.0 109.485 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.18 -56.73 11.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . 0.428 ' HA ' ' HB ' ' L' ' 18' ' ' VAL . 14.7 mt -54.05 -25.73 23.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.079 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.509 ' CE2' ' HA ' ' J' ' 9' ' ' SER . 0.4 OUTLIER -52.05 -53.74 38.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 109.941 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' CB ' ' F' ' 14' ' ' ALA . 35.9 mt -87.24 -27.99 22.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.657 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' L' ' 15' ' ' LEU . 88.5 t -59.77 -25.15 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.956 -1.09 . . . . 0.0 109.648 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -99.48 -41.76 7.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.391 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.95 -142.26 15.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -83.2 1.29 41.39 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.275 -1.132 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -67.5 -27.93 67.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 110.022 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 -176.33 39.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -171.38 167.02 6.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -1.124 . . . . 0.0 109.488 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' L' ' 25' ' ' PHE . 3.1 p90 -126.45 151.69 47.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.632 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -126.85 106.11 9.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.312 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 32.8 m -155.71 108.55 2.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -82.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.475 2.117 . . . . 0.0 110.843 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.65 -155.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 109.406 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 109.816 -179.61 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.5 mt -80.39 -30.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 109.518 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.58 -35.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.951 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -104.46 56.2 0.71 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.806 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.44 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 22.6 tt0 -178.58 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.582 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 9' ' ' SER . 63.7 m -102.16 -29.46 11.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.02 -41.48 59.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.236 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.2 p -81.34 -15.95 53.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.501 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -160.32 120.57 2.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 109.565 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' F' ' 2' ' ' VAL . 2.1 mp -47.87 101.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.319 -0.863 . . . . 0.0 109.455 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.44 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m -53.12 158.8 1.4 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.81 163.68 16.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.264 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -45.17 84.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 109.655 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -61.88 -33.49 74.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.549 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -67.72 -36.87 81.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.436 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.2 mt -83.91 -8.74 59.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.24 -0.912 . . . . 0.0 109.739 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.15 -27.96 38.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 15' ' ' GLN . 53.0 p30 -73.37 -11.91 60.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.432 ' N ' ' OD1' ' A' ' 18' ' ' ASN . 35.0 m-85 -98.32 -3.45 37.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 109.95 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.6 168.33 19.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.513 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.622 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.438 ' HA ' HD13 ' I' ' 10' ' ' ILE . 3.8 p -172.25 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 4.6 p30 170.73 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.875 . . . . 0.0 109.242 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -85.57 -24.29 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.822 . . . . 0.0 109.364 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.84 -39.42 35.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.319 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mt -81.01 -38.03 28.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 9.4 t -63.14 -36.33 83.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.33 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.4 -22.01 65.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 71.7 m -79.66 -8.88 59.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.399 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.79 -25.69 15.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.932 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 9.7 mt -79.43 -48.23 14.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.495 HG22 ' CD2' ' D' ' 16' ' ' TYR . 2.6 m -52.18 -34.01 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 109.958 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.47 -48.31 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.995 . . . . 0.0 109.423 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.48 11.92 6.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 -50.67 5.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.949 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 13.4 p90 -71.98 -21.49 61.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.07 -1.019 . . . . 0.0 109.549 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.469 HD21 HD21 ' H' ' 17' ' ' LEU . 46.9 tp -74.52 -35.98 63.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -76.02 -46.7 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -57.1 -41.74 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.928 . . . . 0.0 109.327 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.39 -141.14 15.39 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.07 4.55 33.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -1.173 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.6 -74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' B' ' 19' ' ' CYS . . . 141.17 165.6 10.41 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 13.5 p90 -161.45 167.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -1.206 . . . . 0.0 109.317 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.58 ' HB2' ' CE2' ' D' ' 25' ' ' PHE . 35.8 p90 -123.57 162.62 22.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.596 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -142.08 83.69 1.85 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 109.644 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.409 ' OG1' ' CZ ' ' D' ' 25' ' ' PHE . 0.2 OUTLIER -133.77 92.68 22.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.13 -57.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.777 2.318 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tttt 54.37 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.552 179.699 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 74.1 mt -79.72 -29.48 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -1.112 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.27 -38.51 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 5.7 mm-40 -103.41 60.59 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.803 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 22.2 tt0 178.3 -32.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.592 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 70.2 m -104.03 -31.45 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.392 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 9.9 t -73.22 -40.11 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.963 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 32.1 p -82.84 -16.14 48.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.93 118.42 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.744 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' L' ' 2' ' ' VAL . 2.1 mp -45.76 100.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 96.8 m -51.9 160.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.004 . . . . 0.0 109.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.16 162.69 15.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.232 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.24 84.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 109.687 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -63.5 -33.73 76.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . 0.436 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -67.15 -35.94 80.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 109.685 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.63 -9.5 58.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -79.19 -26.77 42.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.458 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' C' ' 15' ' ' GLN . 52.8 p30 -76.84 -8.01 56.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -101.4 -6.54 23.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.19 167.68 21.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.66 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . 0.404 ' ND2' HG22 ' B' ' 27' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.349 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -171.76 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.184 -0.947 . . . . 0.0 109.279 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 p30 173.42 -36.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 109.261 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.56 -25.39 38.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.168 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.98 -41.79 41.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.39 -36.81 38.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.411 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.5 t -63.37 -36.4 83.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.507 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.55 -18.66 67.94 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -81.95 -8.64 59.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -1.125 . . . . 0.0 109.705 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -96.96 -25.88 15.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.585 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 10.6 mt -77.42 -49.87 13.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.527 HG22 ' CE2' ' B' ' 16' ' ' TYR . 3.3 m -51.55 -33.19 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -68.73 -46.78 68.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.108 -0.995 . . . . 0.0 109.717 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.16 9.73 14.19 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.813 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 -52.33 4.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.726 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 15.6 p90 -70.85 -22.69 62.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.862 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 48.9 tp -72.86 -38.15 67.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.105 -0.997 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.2 -46.27 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -58.16 -44.87 88.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -139.03 14.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.43 5.42 35.14 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.338 -1.095 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -70.45 -75.33 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.535 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' D' ' 19' ' ' CYS . . . 142.4 166.47 10.99 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 17.7 p90 -156.94 162.35 39.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.949 -1.324 . . . . 0.0 110.068 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' B' ' 25' ' ' PHE . 55.4 m-85 -114.2 150.41 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -138.55 85.01 2.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.63 92.86 9.97 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 108.783 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.22 -61.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.674 2.249 . . . . 0.0 110.568 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttt 59.13 94.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.666 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 75.6 mt -83.94 -29.86 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -1.135 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 64.0 t -68.85 -37.31 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 4.6 mm-40 -104.12 61.43 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.976 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 22.9 tt0 176.94 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 109.514 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 66.2 m -102.06 -30.39 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.6 t -73.65 -43.03 60.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.271 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 31.6 p -80.19 -15.04 57.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.622 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' J' ' 1' ' ' PHE . 0.0 OUTLIER -161.14 116.9 2.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.141 -0.974 . . . . 0.0 109.46 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.432 HD12 ' HB2' ' J' ' 5' ' ' HIS . 2.2 mp -45.27 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.456 -0.777 . . . . 0.0 109.59 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' E' ' 5' ' ' GLN . 94.4 m -49.95 160.83 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.079 -1.013 . . . . 0.0 109.332 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.6 167.44 12.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.073 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.69 94.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.512 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -62.11 -35.31 78.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -35.19 79.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.017 . . . . 0.0 109.4 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.35 -4.52 59.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -84.59 -29.81 25.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.142 -0.974 . . . . 0.0 109.376 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' E' ' 19' ' ' TYR . 54.6 p30 -72.31 -10.32 59.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.888 . . . . 0.0 109.679 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' E' ' 18' ' ' ASN . 32.8 m-85 -100.21 -1.03 37.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.886 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 169.13 14.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 110.059 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.717 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.494 ' HA ' HD13 ' A' ' 10' ' ' ILE . 5.7 p -170.23 108.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.865 . . . . 0.0 109.67 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 171.56 -37.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -79.43 -26.94 41.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 0.0 109.51 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -76.18 -40.41 52.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.938 . . . . 0.0 109.84 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.61 -34.36 30.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.434 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 11.3 t -66.63 -31.44 72.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.261 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.26 -19.27 60.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -83.21 -7.45 59.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -1.091 . . . . 0.0 109.574 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -98.81 -22.22 15.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -81.64 -45.96 15.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.649 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -55.23 -33.37 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.09 -48.49 65.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.24 8.21 14.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -0.894 . . . . 0.0 110.065 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -51.52 5.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 109.858 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 13.5 p90 -71.51 -21.43 61.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 109.744 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 52.1 tp -74.8 -34.76 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.444 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.45 -42.93 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -37.73 86.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.036 . . . . 0.0 109.106 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.36 -139.76 15.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -83.54 -0.67 51.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.951 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -65.03 -73.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.284 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.16 168.65 11.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 12.3 p90 -163.61 172.69 13.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 109.422 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -130.41 162.53 28.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.275 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -138.99 93.16 2.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.034 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.08 89.45 7.81 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.483 -0.76 . . . . 0.0 109.477 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.38 -62.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.675 2.25 . . . . 0.0 110.115 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 62.22 93.18 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 109.648 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.568 179.904 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 73.6 mt -81.95 -26.69 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.13 -33.33 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 5.4 mm-40 -108.69 61.47 0.6 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 22.0 tt0 176.43 -31.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -104.36 -32.97 8.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 10.1 t -72.14 -43.5 64.57 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.124 -0.985 . . . . 0.0 109.286 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -77.36 -21.37 53.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 121.25 5.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.155 -0.965 . . . . 0.0 109.486 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -47.69 103.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.97 . . . . 0.0 109.156 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 69.1 m -53.32 162.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 109.617 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.1 163.28 14.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 109.33 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.36 84.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -61.04 -36.58 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.341 -0.849 . . . . 0.0 109.404 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' G' ' 18' ' ' ASN . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.7 mt -80.91 -11.32 59.6 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.906 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.56 -29.86 56.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.08 -1.012 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' G' ' 15' ' ' GLN . 53.4 p30 -73.16 -5.94 42.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.965 . . . . 0.0 109.613 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -102.17 -16.4 16.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.988 . . . . 0.0 109.76 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 6.9 m -66.51 172.86 3.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 108.814 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.423 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.418 ' HA ' HD13 ' K' ' 10' ' ' ILE . 4.4 p -171.05 107.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.55 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 172.54 -34.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.66 -22.13 32.23 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.304 -0.872 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -80.65 -39.79 26.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . 0.435 HD22 ' N ' ' H' ' 6' ' ' LEU . 4.3 mt -81.12 -37.09 29.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.216 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.41 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.4 t -63.15 -37.23 86.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.683 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.91 -18.73 71.85 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 58.5 m -83.06 -6.33 59.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -1.116 . . . . 0.0 109.559 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -100.47 -19.33 16.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.072 -1.017 . . . . 0.0 109.149 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.8 mt -84.23 -46.51 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' F' ' 16' ' ' TYR . 2.3 m -54.64 -33.17 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.726 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.27 -48.03 66.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.824 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.98 11.47 9.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.04 -48.63 6.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.996 -1.065 . . . . 0.0 109.724 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 13.2 p90 -73.12 -22.57 60.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.368 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.469 HD21 HD21 ' B' ' 17' ' ' LEU . 47.1 tp -73.47 -33.52 64.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.301 -0.875 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.25 -57.44 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -49.85 -38.41 35.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 0.0 109.245 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.5 -146.19 18.8 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -75.51 -3.96 37.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 110.046 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -61.59 -74.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.282 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.99 171.74 12.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 15.8 p90 -165.82 170.41 13.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -1.212 . . . . 0.0 109.678 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 13.1 p90 -128.5 156.74 42.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 109.496 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -136.35 91.21 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.386 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.67 90.09 8.88 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.97 -59.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.733 2.289 . . . . 0.0 110.533 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 57.56 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.335 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.507 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt -81.69 -28.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -1.105 . . . . 0.0 109.433 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.1 -32.26 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 5.8 mm-40 -108.15 58.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.277 -0.889 . . . . 0.0 109.545 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 25.3 tt0 177.34 -32.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -101.23 -30.44 11.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 109.44 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.4 -43.28 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.852 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -79.02 -14.31 59.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 9' ' ' SER . . . . . 0.424 ' O ' ' N ' ' I' ' 11' ' ' CYS . 0.0 OUTLIER -161.75 126.55 3.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.329 -0.857 . . . . 0.0 108.988 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' B' ' 2' ' ' VAL . 2.2 mp -56.17 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.851 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 10' ' ' ILE . 0.8 OUTLIER -43.23 161.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.272 -0.893 . . . . 0.0 109.346 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.2 169.34 11.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -46.16 91.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -59.74 -34.78 73.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.27 82.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.71 -9.45 58.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 109.581 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.16 -29.0 42.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' I' ' 19' ' ' TYR . 54.9 p30 -74.2 -9.74 58.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.683 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . 0.406 ' N ' ' OD1' ' I' ' 18' ' ' ASN . 29.5 m-85 -99.48 -3.48 33.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.579 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.26 167.66 19.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' E' ' 9' ' ' SER . 1.8 m-85 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 p -170.14 108.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.077 -1.014 . . . . 0.0 109.382 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 p30 172.81 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -85.03 -23.68 28.51 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.32 -0.862 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . 0.432 ' HB2' HD12 ' E' ' 10' ' ' ILE . 75.2 t60 -78.37 -40.69 35.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.965 . . . . 0.0 109.384 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mt -80.12 -37.69 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.32 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.413 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 10.8 t -63.17 -36.82 84.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.84 -17.57 74.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -84.06 -10.9 57.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -94.1 -23.82 17.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.601 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 9.3 mt -80.39 -47.73 13.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 109.661 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -53.06 -32.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 109.99 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.47 -48.97 59.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 109.733 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.88 12.34 6.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.27 -50.23 5.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 12.9 p90 -72.56 -20.82 61.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 46.1 tp -76.57 -31.74 57.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.59 -46.89 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 109.052 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' J' ' 23' ' ' GLY . 0.1 OUTLIER -56.21 -42.24 76.89 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 108.977 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -140.79 15.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.2 -0.34 48.95 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.234 -1.156 . . . . 0.0 109.751 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -64.67 -67.99 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.103 -0.998 . . . . 0.0 109.524 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' J' ' 19' ' ' CYS . . . 133.06 171.8 12.82 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -164.81 177.89 7.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.125 -1.221 . . . . 0.0 109.443 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.02 156.14 48.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -137.38 94.04 2.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.03 89.31 6.53 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 109.636 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.61 -60.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.565 2.176 . . . . 0.0 110.574 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . 0.402 ' O ' ' HB ' ' J' ' 30' ' ' THR . 4.3 tttt 59.24 92.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.519 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 30' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' J' ' 29' ' ' LYS . 13.6 m . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.6 -31.84 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -1.099 . . . . 0.0 109.238 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.99 -35.88 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.8 . . . . 0.0 109.757 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 7.0 mm-40 -105.23 59.3 0.68 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 23.5 tt0 179.25 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.488 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' K' ' 9' ' ' SER . 72.2 m -100.85 -35.66 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.31 -40.23 77.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 55.4 p -82.6 -17.22 45.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.011 . . . . 0.0 109.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 9' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.0 OUTLIER -159.27 119.74 3.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' H' ' 2' ' ' VAL . 2.0 mp -47.54 100.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.578 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . 0.417 ' SG ' ' HG2' ' K' ' 5' ' ' GLN . 88.8 m -52.12 159.83 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 109.435 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.57 167.21 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -43.2 99.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -0.934 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -62.68 -35.47 79.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.184 -0.947 . . . . 0.0 109.387 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' K' ' 18' ' ' ASN . 0.0 OUTLIER -65.79 -38.41 88.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -81.86 -9.72 59.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -79.19 -28.21 42.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 109.675 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' K' ' 15' ' ' GLN . 55.2 p30 -74.58 -7.6 53.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 109.75 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.41 -8.41 22.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.25 169.41 17.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.132 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.37 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.415 ' HA ' HD13 ' C' ' 10' ' ' ILE . 5.6 p -172.64 108.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.151 -0.968 . . . . 0.0 109.401 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p30 172.14 -36.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.049 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -81.03 -27.38 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.364 -0.835 . . . . 0.0 109.375 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -75.32 -38.42 60.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . 0.432 ' N ' HD21 ' L' ' 6' ' ' LEU . 4.7 mt -82.82 -38.67 22.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 109.568 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 51.7 t -62.09 -33.7 74.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.93 -19.95 62.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 74.3 m -82.83 -5.97 59.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -1.11 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -99.5 -22.0 15.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 109.161 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.5 mt -82.98 -47.68 11.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -53.19 -33.85 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.01 -1.056 . . . . 0.0 109.552 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.08 -46.61 70.53 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.24 11.01 13.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.68 -51.13 5.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 13.5 p90 -71.3 -22.9 61.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 49.8 tp -74.5 -34.61 63.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.776 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.93 -47.74 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.65 -37.86 68.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.5 -145.97 18.29 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -81.58 0.27 39.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.58 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -62.95 -73.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.32 165.01 10.16 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 11.2 p90 -160.24 169.3 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -1.087 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -129.8 152.49 49.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.192 -0.943 . . . . 0.0 109.389 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -129.9 96.62 4.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.853 . . . . 0.0 109.714 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.82 89.51 6.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.57 -62.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.597 2.198 . . . . 0.0 110.195 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt 62.09 92.89 0.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.53 179.77 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -133.22 6.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -1.108 . . . . 0.0 109.429 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.03 -8.37 5.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.264 -0.898 . . . . 0.0 109.75 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -111.77 1.61 16.72 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.199 -0.938 . . . . 0.0 109.792 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.86 13.19 2.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.178 -0.951 . . . . 0.0 109.304 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.73 -42.59 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.33 -16.34 63.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.423 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.9 p -70.89 -22.03 62.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.014 . . . . 0.0 109.414 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 p -163.69 144.12 8.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mt -52.62 113.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.4 m -84.29 -164.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 0.0 109.1 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.25 171.39 7.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -34.93 75.9 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 109.277 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -67.4 -38.87 85.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.955 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.92 -14.91 59.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 109.938 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.92 -28.87 63.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.023 . . . . 0.0 109.46 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -57.24 -19.03 18.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.57 59.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.1 t -123.13 119.76 31.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.641 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.2 t30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.343 179.783 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 m -131.06 46.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 109.875 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.53 -3.28 28.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -48.28 -38.53 19.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.31 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -93.42 -30.6 14.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.494 HD21 ' CG ' ' J' ' 10' ' ' HIS . 39.6 mt -80.95 -70.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 108.957 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.428 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.6 t -51.2 -37.82 48.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.665 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.464 ' O ' HG12 ' B' ' 12' ' ' VAL . . . -61.85 -44.28 98.07 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.422 ' HA ' HG23 ' B' ' 12' ' ' VAL . 31.0 p -67.84 -12.86 61.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 110.008 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -86.15 -24.63 26.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.119 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 5.7 mt -90.47 -33.77 15.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.553 HG22 ' CZ ' ' D' ' 16' ' ' TYR . 16.8 m -68.43 -38.54 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.522 ' N ' HG21 ' B' ' 12' ' ' VAL . 13.9 tt0 -66.04 -23.86 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.42 -12.89 26.93 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.442 ' HA ' HG22 ' B' ' 18' ' ' VAL . 6.5 mt -78.67 -28.66 45.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.582 ' CZ ' HG22 ' D' ' 12' ' ' VAL . 60.3 m-85 -48.25 -46.58 35.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -82.26 -36.26 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' B' ' 15' ' ' LEU . 69.7 t -47.04 -46.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.87 -30.72 26.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.459 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.04 -134.98 11.89 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -7.93 52.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.304 -1.115 . . . . 0.0 109.69 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -57.05 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.11 179.08 29.17 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.408 ' HZ ' ' CZ ' ' B' ' 16' ' ' TYR . 0.3 OUTLIER -166.31 168.23 15.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -1.182 . . . . 0.0 110.031 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.608 ' HB2' ' CD1' ' D' ' 25' ' ' PHE . 32.8 p90 -127.53 154.77 44.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.49 ' CD2' HG13 ' B' ' 12' ' ' VAL . 24.3 t80 -140.85 112.17 7.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 15.1 m -133.2 93.25 22.9 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 109.675 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.07 99.53 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.506 2.137 . . . . 0.0 110.389 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.33 -58.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -132.69 7.66 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.158 -1.201 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.92 -6.29 4.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.211 -0.931 . . . . 0.0 109.74 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -114.07 -0.39 14.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.128 -0.983 . . . . 0.0 109.604 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -134.65 9.46 3.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.189 -0.944 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.25 -39.85 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.705 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 t -66.93 -16.17 64.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 43.1 p -70.22 -24.53 63.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.92 . . . . 0.0 109.302 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 94.9 p -160.47 146.09 14.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.464 HD13 ' HB ' ' L' ' 2' ' ' VAL . 4.3 mt -54.55 117.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.7 m -89.45 -165.48 1.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 109.714 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -107.17 166.27 10.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -34.56 78.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.73 -37.56 79.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.859 . . . . 0.0 109.601 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.91 -38.39 86.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 109.53 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.81 -16.23 55.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 109.757 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.51 -30.3 68.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -56.42 -19.13 13.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.09 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -110.6 58.61 0.61 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.231 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 t -121.64 118.44 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . 0.559 ' ND2' ' CZ ' ' D' ' 25' ' ' PHE . 9.5 t30 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.509 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.359 0.6 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.02 44.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.244 -0.91 . . . . 0.0 109.159 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -100.15 -8.56 23.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 109.552 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -44.34 -40.46 5.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.44 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -90.74 -32.38 16.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . 0.467 HD21 ' CG ' ' H' ' 10' ' ' HIS . 29.0 mt -80.34 -71.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 8.3 t -51.37 -34.39 34.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.407 ' O ' HG12 ' D' ' 12' ' ' VAL . . . -64.33 -43.86 96.28 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.463 ' HA ' HG23 ' D' ' 12' ' ' VAL . 17.2 p -69.41 -14.94 63.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -1.162 . . . . 0.0 109.711 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.94 -24.38 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.895 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 6.7 mt -92.79 -32.79 14.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.582 HG22 ' CZ ' ' B' ' 16' ' ' TYR . 15.4 m -68.29 -38.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . 0.516 ' N ' HG21 ' D' ' 12' ' ' VAL . 15.0 tt0 -64.91 -27.06 68.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.62 -12.06 35.32 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.333 -0.854 . . . . 0.0 109.853 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . 0.447 ' HA ' HG22 ' D' ' 18' ' ' VAL . 6.5 mt -80.21 -28.82 38.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.553 ' CZ ' HG22 ' B' ' 12' ' ' VAL . 62.3 m-85 -48.38 -45.07 35.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.199 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.424 HD11 HD11 ' J' ' 17' ' ' LEU . 17.9 mt -81.89 -38.5 25.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' D' ' 15' ' ' LEU . 67.5 t -45.85 -44.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.891 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.86 -29.77 25.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.899 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.2 -131.66 10.65 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.73 -6.99 38.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.65 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -56.69 -81.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.061 -1.024 . . . . 0.0 109.467 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.78 176.74 28.28 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 25' ' ' PHE . 0.4 OUTLIER -164.07 161.31 22.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -1.208 . . . . 0.0 109.883 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' B' ' 25' ' ' PHE . 4.4 m-85 -119.11 163.16 17.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.416 -0.803 . . . . 0.0 109.284 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.568 ' CG ' HG13 ' D' ' 12' ' ' VAL . 33.0 t80 -151.16 105.69 3.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 108.896 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 24.4 m -127.19 94.43 38.89 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.594 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.98 97.28 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.555 2.17 . . . . 0.0 110.369 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -61.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.221 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.35 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.44 3.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -1.125 . . . . 0.0 109.563 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.9 -9.58 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.94 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.89 1.69 19.35 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.104 -0.997 . . . . 0.0 110.164 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -136.7 11.33 3.16 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.041 -1.037 . . . . 0.0 109.669 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' E' ' 9' ' ' SER . 0.0 OUTLIER -144.32 -40.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.55 -18.0 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 108.954 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 41.4 p -69.61 -25.1 63.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.376 -0.828 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' SER . . . . . 0.421 ' O ' ' O ' ' E' ' 6' ' ' CYS . 12.5 p -159.56 148.82 18.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.428 HG12 ' HB3' ' J' ' 5' ' ' HIS . 4.0 mt -58.7 115.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.55 -158.69 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.785 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.1 167.82 10.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . 0.47 HD13 ' HB3' ' L' ' 17' ' ' LEU . 0.1 OUTLIER -66.11 -35.78 81.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -66.05 -40.79 91.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.986 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -80.37 -15.45 56.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -0.973 . . . . 0.0 109.594 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.14 -25.79 62.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.722 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -60.42 -19.49 56.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.215 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.7 62.05 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 t -125.45 119.67 28.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.461 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 25.4 m -129.38 44.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.264 -0.898 . . . . 0.0 109.375 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -100.52 -4.68 28.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.377 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -48.6 -38.04 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -93.32 -30.92 14.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 35.2 mt -81.36 -71.1 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.085 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.487 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.5 t -50.18 -37.21 33.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.44 -0.787 . . . . 0.0 109.356 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . 0.4 ' O ' HG12 ' F' ' 12' ' ' VAL . . . -61.76 -42.97 99.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 9' ' ' SER . . . . . 0.42 ' HA ' HG23 ' F' ' 12' ' ' VAL . 58.4 p -70.85 -13.53 62.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.132 -1.216 . . . . 0.0 110.043 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -84.07 -24.38 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.985 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 6.5 mt -91.64 -33.45 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.813 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . 0.515 HG13 ' CG ' ' F' ' 26' ' ' TYR . 18.4 m -69.22 -36.26 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 109.848 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -69.11 -22.22 63.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.52 -11.03 28.1 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.71 -28.19 36.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.459 ' OH ' ' HB ' ' H' ' 12' ' ' VAL . 54.0 m-85 -48.61 -47.61 39.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 109.655 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . 0.488 HD12 ' CB ' ' L' ' 14' ' ' ALA . 12.4 mt -80.93 -38.59 27.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' F' ' 17' ' ' LEU . 70.8 t -44.62 -45.68 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.96 -30.04 26.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.36 -133.21 11.22 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.0 -12.89 29.54 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.256 -1.144 . . . . 0.0 109.538 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 23.0 mtt180 -50.72 -83.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.2 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.04 -177.46 33.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . 0.406 ' HZ ' ' CZ ' ' F' ' 16' ' ' TYR . 0.2 OUTLIER -171.45 168.86 6.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -1.134 . . . . 0.0 109.469 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -132.07 166.12 22.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . 0.515 ' CG ' HG13 ' F' ' 12' ' ' VAL . 26.2 t80 -147.42 115.44 6.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.52 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -132.66 91.53 29.72 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.32 98.51 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.191 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.0 -58.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.59 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.578 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.08 8.26 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -1.2 . . . . 0.0 109.735 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -127.2 -5.76 4.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -113.23 -1.14 14.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.021 -1.049 . . . . 0.0 109.812 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -134.4 11.58 3.8 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.083 -1.011 . . . . 0.0 109.704 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' G' ' 9' ' ' SER . 0.1 OUTLIER -143.98 -40.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 t -66.4 -18.11 65.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 60.5 p -69.17 -22.28 63.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.48 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 9' ' ' SER . . . . . 0.41 ' O ' ' O ' ' G' ' 6' ' ' CYS . 4.3 p -162.67 148.58 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.299 -0.875 . . . . 0.0 109.433 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mt -58.08 115.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.77 -165.02 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.1 167.4 10.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -35.55 81.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.732 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -67.27 -37.75 83.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.967 . . . . 0.0 109.852 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.39 -40.5 89.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -77.51 -14.14 59.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.15 -30.35 63.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.338 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -53.9 -23.45 12.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.37 64.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.97 120.89 30.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.331 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.562 -179.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.298 0.57 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 31.8 m -126.17 41.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' H' ' 4' ' ' GLN . 11.6 m120 -96.92 -9.92 27.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' H' ' 3' ' ' ASN . 50.2 tt0 -43.03 -40.14 2.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -90.98 -33.22 15.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 109.313 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 29.9 mt -78.44 -73.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 7.7 t -47.13 -41.46 17.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.815 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . 0.439 ' O ' HG12 ' H' ' 12' ' ' VAL . . . -58.84 -44.87 95.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -67.33 -14.92 63.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -1.114 . . . . 0.0 109.838 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . 0.467 ' CG ' HD21 ' D' ' 6' ' ' LEU . 5.6 m-70 -85.88 -20.36 29.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.665 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.0 mt -94.87 -35.3 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.384 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.478 HG13 ' CG ' ' H' ' 26' ' ' TYR . 15.6 m -68.1 -34.18 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -69.82 -23.08 63.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.141 -0.974 . . . . 0.0 109.219 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.09 -9.99 32.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.39 -0.819 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . 0.405 ' HA ' HG22 ' H' ' 18' ' ' VAL . 5.6 mt -82.37 -26.83 32.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.42 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.46 ' OH ' HG22 ' F' ' 12' ' ' VAL . 53.5 m-85 -50.04 -44.06 51.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.615 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.09 -36.45 21.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.27 -0.894 . . . . 0.0 109.724 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' H' ' 15' ' ' LEU . 76.5 t -46.33 -42.67 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 -29.39 21.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.79 -133.34 11.31 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -11.5 38.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -1.17 . . . . 0.0 109.738 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -53.01 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.037 . . . . 0.0 109.646 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.98 176.94 23.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.24 175.41 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 109.429 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 8.6 p90 -137.94 167.24 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.526 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . 0.478 ' CG ' HG13 ' H' ' 12' ' ' VAL . 23.4 t80 -149.57 115.48 5.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.288 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -133.84 90.82 26.33 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.227 -0.92 . . . . 0.0 109.328 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.16 101.0 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.674 2.249 . . . . 0.0 110.092 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.82 -57.58 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 109.656 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.056 -0.974 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 19.6 tt -131.08 8.05 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -128.71 -5.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.299 -0.876 . . . . 0.0 109.771 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -115.06 -0.06 13.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.172 -0.955 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -135.01 8.16 3.47 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.47 -41.43 0.41 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.75 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -64.63 -20.71 66.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 39.0 p -66.44 -23.39 66.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 7.5 p -161.65 146.32 13.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.65 114.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.56 -164.25 0.98 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -109.56 168.12 9.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -34.77 78.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -67.3 -39.56 85.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.45 -39.99 92.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.32 -14.3 59.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.852 . . . . 0.0 109.899 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.81 -27.17 62.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -58.05 -18.62 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.359 -0.838 . . . . 0.0 109.74 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -111.97 61.31 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -122.84 121.85 37.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.198 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.504 -179.759 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 11.0 t80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.271 0.557 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.33 47.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' J' ' 4' ' ' GLN . 13.2 m120 -102.57 -8.46 20.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.842 . . . . 0.0 109.33 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' J' ' 3' ' ' ASN . 50.4 tt0 -44.03 -38.38 3.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.352 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . 0.428 ' HB3' HG12 ' E' ' 10' ' ' ILE . 86.4 t60 -93.34 -33.95 13.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.94 . . . . 0.0 109.211 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 38.9 mt -78.03 -70.28 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.437 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.489 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 7.3 t -51.97 -37.51 53.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.354 -0.842 . . . . 0.0 109.477 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.76 -45.17 96.98 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 9' ' ' SER . . . . . 0.458 ' HA ' HG23 ' J' ' 12' ' ' VAL . 86.6 p -68.51 -16.08 63.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -1.211 . . . . 0.0 110.078 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . 0.494 ' CG ' HD21 ' B' ' 6' ' ' LEU . 4.7 m-70 -82.92 -20.49 35.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.043 . . . . 0.0 109.716 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 7.8 mt -95.16 -34.18 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.508 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . 0.555 HG13 ' CG ' ' J' ' 26' ' ' TYR . 19.1 m -68.19 -33.9 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.107 -0.995 . . . . 0.0 109.239 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -70.97 -23.77 62.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.605 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . 0.439 ' O ' HG22 ' J' ' 18' ' ' VAL . . . -95.55 -8.1 36.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.31 -0.869 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.8 -25.39 30.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.558 ' CZ ' HG22 ' L' ' 12' ' ' VAL . 46.3 m-85 -51.93 -44.54 63.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.456 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.424 HD11 HD11 ' D' ' 17' ' ' LEU . 13.1 mt -83.34 -39.17 21.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.618 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . 0.439 HG22 ' O ' ' J' ' 14' ' ' ALA . 69.5 t -44.75 -44.15 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.54 -30.62 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.61 -135.42 12.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -9.78 44.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.214 -1.168 . . . . 0.0 109.949 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -53.84 -76.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 0.0 109.664 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.46 176.8 22.99 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.21 171.16 11.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 109.688 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' J' ' 25' ' ' PHE . 6.1 p90 -134.39 165.07 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.47 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . 0.555 ' CG ' HG13 ' J' ' 12' ' ' VAL . 23.3 t80 -146.07 118.76 8.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.254 -0.904 . . . . 0.0 109.26 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 23.7 m -136.89 91.0 15.59 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.717 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.34 100.05 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.243 . . . . 0.0 110.413 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -59.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.256 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.495 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 20.6 tt -133.03 9.5 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -1.1 . . . . 0.0 109.473 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.71 -3.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.936 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -116.25 -2.1 12.22 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.08 -1.013 . . . . 0.0 109.446 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -133.23 11.18 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.341 -0.849 . . . . 0.0 109.408 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 -40.78 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 109.739 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -66.16 -16.76 64.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.964 . . . . 0.0 109.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -69.42 -26.29 64.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.236 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 6.4 p -158.08 149.9 21.69 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -0.913 . . . . 0.0 109.544 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.58 115.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -87.78 -164.27 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.984 . . . . 0.0 109.49 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.28 171.08 7.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.301 -0.874 . . . . 0.0 109.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -36.78 77.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.348 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -65.57 -38.66 90.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.669 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -66.05 -40.38 90.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.1 mt -78.43 -13.54 59.79 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.851 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.88 -28.29 63.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -57.97 -17.23 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -0.79 . . . . 0.0 109.659 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.82 60.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 t -123.17 120.36 32.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.393 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.464 ' HB ' HD13 ' C' ' 10' ' ' ILE . 29.0 m -127.8 45.75 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.54 -6.57 23.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -46.06 -39.69 9.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -92.26 -30.75 15.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 31.7 mt -80.73 -72.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.193 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.485 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 8.3 t -49.49 -39.95 35.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . 0.4 ' O ' HG12 ' L' ' 12' ' ' VAL . . . -59.68 -43.53 97.69 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 9' ' ' SER . . . . . 0.461 ' HA ' HG23 ' L' ' 12' ' ' VAL . 87.4 p -68.33 -18.15 64.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.16 -1.2 . . . . 0.0 109.784 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -81.56 -21.73 38.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.992 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 6.7 mt -93.75 -34.35 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . 0.558 HG22 ' CZ ' ' J' ' 16' ' ' TYR . 18.6 m -67.28 -38.57 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.01 . . . . 0.0 109.51 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . 0.534 ' N ' HG21 ' L' ' 12' ' ' VAL . 17.1 tt0 -65.72 -25.07 67.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.898 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . 0.488 ' CB ' HD12 ' F' ' 17' ' ' LEU . . . -92.57 -14.14 28.71 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . 0.465 ' HA ' HG22 ' L' ' 18' ' ' VAL . 6.7 mt -78.63 -31.31 46.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 0.0 109.401 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.477 ' OH ' ' HB ' ' J' ' 12' ' ' VAL . 44.7 m-85 -45.51 -45.38 13.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.9 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.47 ' HB3' HD13 ' E' ' 13' ' ' LEU . 13.1 mt -84.0 -35.75 23.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 109.933 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' L' ' 15' ' ' LEU . 70.3 t -47.42 -45.36 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.61 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.81 -33.52 27.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.234 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.75 -134.96 12.02 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -11.49 39.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.19 -1.182 . . . . 0.0 109.471 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -52.71 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.921 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.34 178.47 27.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.29 172.29 9.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.158 -1.201 . . . . 0.0 109.69 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -134.21 163.62 29.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . 0.488 ' CG ' HG13 ' L' ' 12' ' ' VAL . 24.4 t80 -147.38 113.34 5.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.226 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -132.56 89.91 34.67 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.767 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.16 100.6 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 110.47 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -159.63 -62.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.337 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.19 0.15 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.215 -1.167 . . . . 0.0 109.618 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 59.2 t -100.82 46.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.002 . . . . 0.0 109.681 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -171.58 -40.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.31 -7.17 26.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.126 -0.984 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.85 -18.94 3.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.482 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 0.5 OUTLIER -82.73 -18.26 41.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 109.117 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.3 p -83.72 -12.51 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.533 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.84 2.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.544 ' CD1' ' HB ' ' F' ' 2' ' ' VAL . 2.0 mp -61.57 140.85 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.2 m -103.94 -164.77 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.858 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -103.62 -174.3 2.51 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -0.935 . . . . 0.0 109.23 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.84 -37.37 64.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -68.91 -23.94 64.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.87 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -79.16 -39.36 33.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.593 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.6 mt -82.05 -11.68 58.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.52 -21.26 49.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.687 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -62.13 -18.68 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.962 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -118.33 48.02 1.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.86 110.95 13.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.208 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.644 -179.709 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.267 0.556 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.93 106.02 4.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.34 -0.85 . . . . 0.0 109.319 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -103.15 -8.2 20.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 0.0 109.246 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -48.88 -36.91 18.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.215 -0.928 . . . . 0.0 109.031 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.484 ' CB ' HG12 ' I' ' 10' ' ' ILE . 18.5 t60 -95.64 -30.38 13.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.147 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.05 -70.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.483 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.5 t -53.74 -32.16 51.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 0.0 109.767 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.94 -32.21 53.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.458 ' OG ' ' OH ' ' D' ' 16' ' ' TYR . 29.1 t -79.2 -3.34 45.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -1.23 . . . . 0.0 109.579 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.22 -14.65 20.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.336 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 14.3 mt -91.91 -43.55 9.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.563 HG22 ' CE2' ' D' ' 16' ' ' TYR . 2.7 m -56.8 -37.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.12 -36.18 81.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.332 -0.855 . . . . 0.0 109.871 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.89 11.19 39.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.081 -1.012 . . . . 0.0 109.807 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 11' ' ' LEU . 0.7 OUTLIER -96.67 -54.91 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.519 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 7.8 p90 -63.94 -18.05 63.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.954 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -78.28 -48.18 16.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -0.888 . . . . 0.0 109.45 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.05 -47.97 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.21 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.64 -57.07 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.89 -140.34 15.13 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 20' ' ' GLY . 19.4 mt-10 -45.54 -30.79 1.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.245 . . . . 0.0 109.36 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -69.35 159.81 32.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' B' ' 24' ' ' PHE . . . -100.51 -158.24 27.86 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 11.3 p90 -178.76 177.28 0.88 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -1.142 . . . . 0.0 109.228 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.55 146.39 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.683 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.482 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 28.6 t80 -122.93 87.29 2.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -117.61 105.74 47.49 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.1 -36.26 1.09 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.499 2.133 . . . . 0.0 110.538 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mttm 64.22 -87.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 109.41 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.528 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 15.4 tt -112.24 0.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' C' ' 3' ' ' VAL . 55.6 t -101.15 46.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -171.58 -45.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.72 -7.43 37.34 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.696 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.56 -17.71 4.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.163 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -86.34 -16.18 38.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 109.862 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.4 p -86.12 -10.51 54.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 109.517 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' SER . . . . . 0.462 ' HB3' HG22 ' L' ' 2' ' ' VAL . 0.1 OUTLIER -171.79 148.49 2.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 108.995 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' L' ' 5' ' ' HIS . 1.3 mp -58.25 151.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 109.382 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.7 -174.43 2.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.372 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -177.16 4.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.58 -38.86 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -66.29 -24.62 66.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -79.7 -36.87 36.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.98 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 62.4 mt -85.15 -6.83 59.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.89 -18.21 38.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -65.69 -19.77 66.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.279 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -116.98 48.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.484 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.89 108.24 10.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.494 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.572 -179.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.485 ' HB ' HD11 ' G' ' 10' ' ' ILE . 4.4 t -131.06 106.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 109.529 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -103.16 -8.78 20.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -48.82 -36.55 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -94.62 -31.31 13.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.1 mt -81.39 -71.24 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 19.5 t -49.75 -37.92 31.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.51 -35.9 68.34 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -75.25 -5.1 42.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.098 -1.236 . . . . 0.0 109.714 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -97.1 -16.27 20.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 16.9 mt -91.97 -41.87 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.818 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.03 -34.98 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 109.735 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -69.54 -34.51 74.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.36 6.83 45.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.195 -0.941 . . . . 0.0 109.84 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.9 OUTLIER -92.24 -57.27 2.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.049 -1.032 . . . . 0.0 109.494 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.563 ' CE2' HG22 ' B' ' 12' ' ' VAL . 7.6 p90 -61.2 -19.06 61.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.79 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.425 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 1.5 mt -78.03 -48.59 15.79 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -0.963 . . . . 0.0 109.574 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -54.49 -45.16 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.17 -54.42 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.09 -137.33 14.12 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.78 -29.0 4.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -1.138 . . . . 0.0 109.35 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.58 158.36 33.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.271 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.04 -161.8 27.57 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 6.5 p90 -167.33 178.26 5.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -1.224 . . . . 0.0 110.208 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -129.86 133.31 46.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -117.21 88.81 2.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.4 m -124.23 106.25 30.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.323 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.52 -32.73 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.344 2.029 . . . . 0.0 110.629 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.53 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.425 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 tt -114.46 0.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.226 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' E' ' 3' ' ' VAL . 58.3 t -101.81 45.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.285 -0.884 . . . . 0.0 109.988 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -169.96 -42.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.96 -9.15 28.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.311 -0.868 . . . . 0.0 109.722 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.34 -14.24 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 110.352 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.67 -17.41 33.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.937 -1.102 . . . . 0.0 109.316 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -86.32 -10.01 55.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.27 151.62 3.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.468 HD12 ' HB ' ' J' ' 2' ' ' VAL . 2.0 mp -63.46 138.74 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.381 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 61.7 m -102.62 -165.62 1.2 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.081 -1.012 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -104.52 -175.46 2.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.07 -38.85 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 110.031 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -68.38 -24.16 64.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.674 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -78.03 -41.38 35.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 65.1 mt -81.28 -9.62 59.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.233 -0.917 . . . . 0.0 109.993 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.35 -17.7 48.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 109.636 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -66.15 -16.91 64.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.424 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -119.27 50.6 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -130.48 110.21 11.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.543 -179.934 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.215 0.531 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.544 ' HB ' ' CD1' ' A' ' 10' ' ' ILE . 3.9 t -138.81 107.46 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.216 -0.927 . . . . 0.0 109.468 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -103.68 -5.88 22.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.741 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -50.94 -37.54 44.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.075 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . 0.401 ' CB ' HG12 ' A' ' 10' ' ' ILE . 16.3 t60 -95.21 -24.68 16.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.356 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 22.0 mt -87.83 -69.85 0.67 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 10.2 t -52.96 -35.65 59.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.36 -31.69 63.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 1.1 t -77.95 -7.83 57.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -1.216 . . . . 0.0 109.576 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -93.86 -16.87 23.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 110.091 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' F' ' 15' ' ' LEU . 10.9 mt -91.41 -41.42 10.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.24 -32.27 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.5 -33.3 66.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 109.652 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.72 6.58 43.99 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.8 OUTLIER -92.46 -54.71 3.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.682 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 7.2 p90 -63.9 -20.8 66.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.81 -49.86 16.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -52.06 -43.53 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 79.5 m -69.49 -51.8 32.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.661 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 87.78 -139.98 16.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' F' ' 20' ' ' GLY . 17.7 mt-10 -44.95 -34.34 2.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 109.365 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -67.37 159.04 30.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.811 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.25 -165.3 24.72 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -166.69 -171.13 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -1.112 . . . . 0.0 109.621 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.04 142.62 30.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -120.76 94.68 4.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -126.98 103.36 23.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 109.216 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.7 -36.41 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.393 2.062 . . . . 0.0 110.464 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 65.54 -86.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 14.8 tt -111.16 -0.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -1.136 . . . . 0.0 109.519 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' G' ' 3' ' ' VAL . 55.6 t -100.42 47.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.246 -0.908 . . . . 0.0 109.708 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -171.91 -42.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.98 . . . . 0.0 109.737 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.5 -9.69 24.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.62 -9.08 5.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.931 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.47 -13.96 27.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 109.477 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 41.0 p -88.23 -14.0 39.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.34 149.33 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . 0.485 HD11 ' HB ' ' D' ' 2' ' ' VAL . 1.8 mp -57.33 146.66 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.188 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -112.3 -168.4 1.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 110.404 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -101.78 176.28 5.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -65.71 -41.96 91.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.962 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -64.76 -25.27 67.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.281 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -78.06 -39.91 40.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.048 -1.032 . . . . 0.0 109.694 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.28 -6.09 59.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.612 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -83.75 -19.67 34.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.12 -18.87 65.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.478 -0.764 . . . . 0.0 109.408 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -118.28 51.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.381 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.94 107.62 8.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.853 . . . . 0.0 109.451 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.43 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.395 0.616 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.519 ' HB ' HD11 ' K' ' 10' ' ' ILE . 4.9 t -140.73 102.57 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.43 -0.794 . . . . 0.0 109.279 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' H' ' 4' ' ' GLN . 23.6 m-80 -100.33 -11.65 20.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' H' ' 3' ' ' ASN . 2.3 tt0 -44.76 -37.11 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.836 . . . . 0.0 109.168 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . 0.427 ' O ' ' HB3' ' H' ' 9' ' ' SER . 13.7 t60 -95.09 -29.48 14.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.813 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.9 mt -84.22 -69.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.5 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.469 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 1.4 t -52.88 -34.86 56.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 109.151 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.88 -32.8 60.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 9' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' H' ' 5' ' ' HIS . 1.4 t -77.66 -5.87 51.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -1.178 . . . . 0.0 109.867 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.13 -14.87 21.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.965 . . . . 0.0 109.882 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.1 mt -91.85 -42.59 9.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.642 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 m -58.03 -35.32 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.872 . . . . 0.0 109.805 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.26 -35.84 76.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.52 8.99 44.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.287 -0.883 . . . . 0.0 109.828 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.7 OUTLIER -95.56 -55.71 2.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 8.5 p90 -62.31 -22.08 65.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.404 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 1.6 mt -74.0 -49.8 22.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.26 -44.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -52.7 49.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.963 -1.086 . . . . 0.0 109.023 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.86 -137.51 14.27 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.98 -28.41 3.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -72.64 156.55 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.92 . . . . 0.0 109.19 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.51 -163.06 29.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -171.48 -171.54 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.338 -1.095 . . . . 0.0 109.196 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 3.2 p90 -146.64 146.94 30.57 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -122.23 92.4 3.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -122.5 104.99 36.51 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.367 -0.833 . . . . 0.0 109.262 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' H' ' 29' ' ' LYS . 35.9 Cg_endo -78.18 -39.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 0.0 109.977 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.6 OUTLIER 69.91 -85.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.423 -179.673 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 12.6 tt -110.51 0.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -1.151 . . . . 0.0 109.553 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.64 48.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.248 -0.907 . . . . 0.0 109.762 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -172.62 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.842 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.03 -11.94 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 110.009 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -126.78 -13.87 5.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.06 -15.36 41.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -87.81 -17.44 31.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.27 153.44 13.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . 0.484 HG12 ' CB ' ' B' ' 5' ' ' HIS . 1.9 mp -64.59 140.78 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.987 . . . . 0.0 109.374 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 62.8 m -103.26 -163.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.44 -173.91 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp -73.28 -39.58 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.258 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -67.68 -22.67 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.41 -0.806 . . . . 0.0 109.735 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -81.0 -36.62 30.42 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.57 -9.52 57.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.55 -19.64 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 0.0 109.904 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -64.17 -20.1 65.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -115.87 48.77 1.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.523 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -128.47 109.33 11.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.377 179.82 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.468 ' HB ' HD12 ' E' ' 10' ' ' ILE . 4.6 t -136.01 103.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.816 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -101.31 -10.68 20.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.555 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -47.18 -35.08 6.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -96.77 -29.09 13.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.28 -69.05 0.67 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.08 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 1.4 t -53.56 -33.05 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.367 -0.833 . . . . 0.0 109.367 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.61 54.97 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -77.6 -2.49 36.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.007 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -97.95 -15.45 20.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 14.2 mt -92.49 -42.38 9.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.578 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -58.32 -34.28 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.65 -33.02 70.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.91 6.59 43.71 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.195 -0.941 . . . . 0.0 109.704 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' J' ' 11' ' ' LEU . 0.8 OUTLIER -92.62 -55.91 3.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.511 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 10.0 p90 -63.08 -18.6 63.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.15 -50.62 11.62 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.101 -1.0 . . . . 0.0 109.103 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.65 -46.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.32 -53.28 38.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 -137.93 14.78 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -47.33 -29.87 2.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.78 153.58 41.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.59 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.68 30.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -163.5 -170.72 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -1.103 . . . . 0.0 109.573 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . 0.445 ' CD1' ' O ' ' J' ' 25' ' ' PHE . 36.0 p90 -144.01 143.93 31.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.597 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -121.55 90.64 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.39 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -122.16 103.65 38.95 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.97 -36.76 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.425 2.083 . . . . 0.0 110.496 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 65.52 -86.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.333 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.487 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 15.8 tt -111.53 1.62 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -1.14 . . . . 0.0 109.649 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 48.5 t -102.38 46.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -171.41 -42.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 109.623 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.15 33.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 109.918 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -129.71 -23.17 2.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.07 -1.019 . . . . 0.0 110.183 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' L' ' 7' ' ' CYS . 0.5 OUTLIER -79.87 -12.35 59.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.048 -1.032 . . . . 0.0 109.593 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -90.22 -9.62 47.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.09 152.77 2.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . 0.519 HD11 ' HB ' ' H' ' 2' ' ' VAL . 1.8 mp -65.65 135.27 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.994 . . . . 0.0 109.265 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -97.29 -164.02 1.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 109.594 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.21 -173.16 2.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -74.34 -40.5 62.12 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.165 -0.959 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -66.58 -26.52 67.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.06 -37.78 57.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.876 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 55.2 mt -85.6 -6.26 59.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.899 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.1 -19.47 36.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.991 . . . . 0.0 109.274 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -64.57 -16.98 63.51 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.359 -0.838 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -119.58 47.73 1.66 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . 0.418 ' O ' ' OXT' ' K' ' 21' ' ' ASN . 0.1 OUTLIER -128.08 108.5 10.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.534 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . 0.418 ' OXT' ' O ' ' K' ' 20' ' ' CYS . 6.4 t-20 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.502 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' C' ' 9' ' ' SER . 6.9 t -136.76 107.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 109.662 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -102.95 -8.21 20.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.732 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -47.84 -34.55 8.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . 0.541 ' CB ' HG12 ' C' ' 10' ' ' ILE . 19.2 t60 -98.75 -29.33 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 mt -82.44 -69.75 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.107 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 11.8 t -53.88 -33.92 57.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.24 -33.41 56.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 9' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' L' ' 5' ' ' HIS . 2.0 t -77.34 -4.57 45.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -1.104 . . . . 0.0 109.637 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -98.16 -14.42 20.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.194 -0.941 . . . . 0.0 109.541 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 15.6 mt -91.98 -44.12 9.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.37 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -56.57 -35.1 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.932 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -69.57 -35.57 75.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 109.699 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.69 8.7 44.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' L' ' 11' ' ' LEU . 0.7 OUTLIER -94.63 -52.73 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.773 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 12.7 p90 -66.3 -18.87 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.003 -1.061 . . . . 0.0 109.366 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.63 -48.18 17.49 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.94 -46.76 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.16 -55.22 27.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.223 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.4 -138.53 14.34 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -48.49 -29.4 4.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 0.0 109.31 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -72.04 156.04 39.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 109.438 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.55 -165.25 29.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -167.23 -176.88 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -1.13 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -137.55 146.54 44.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -124.07 85.56 2.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 105.1 50.15 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 109.534 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.86 -32.13 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 110.319 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mttm 61.77 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.349 -179.634 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -122.47 -24.88 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -1.158 . . . . 0.0 109.492 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.25 -14.98 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.226 -0.921 . . . . 0.0 109.54 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.84 45.52 2.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -166.28 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.845 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.54 -24.7 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -14.6 59.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.426 ' O ' ' HB3' ' A' ' 9' ' ' SER . 33.0 p -97.56 3.1 50.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 109.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 8' ' ' THR . 80.9 p -179.46 137.58 0.13 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.161 -0.962 . . . . 0.0 109.688 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -54.73 147.14 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.845 . . . . 0.0 109.472 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -121.14 174.09 6.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -101.23 -177.16 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 4.4 mp -75.16 -24.87 57.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.502 -0.749 . . . . 0.0 109.654 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.98 -43.03 65.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.673 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -70.77 -42.45 70.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.647 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.74 -23.27 61.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 9.3 mt-10 -76.75 -22.46 53.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -57.74 -23.67 53.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 20' ' ' CYS . 75.2 m-85 -84.21 -104.74 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.285 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 53.41 168.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.902 -1.123 . . . . 0.0 109.791 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.03 -0.985 . . . . 0.0 109.517 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' I' ' 9' ' ' SER . 17.0 m -79.07 83.49 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -124.78 -26.07 3.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.981 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -38.76 69.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 109.5 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.533 ' CB ' HG12 ' I' ' 10' ' ' ILE . 12.8 t60 -88.56 -29.44 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.907 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.455 HD13 HG22 ' B' ' 2' ' ' VAL . 28.0 mt -87.93 -72.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 38.5 t -45.78 -34.91 3.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.61 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.78 -40.58 52.4 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.6 p -74.75 0.97 13.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -1.181 . . . . 0.0 109.97 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.47 -23.21 16.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 109.3 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.86 -36.14 17.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.407 -0.808 . . . . 0.0 109.526 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 20.7 m -48.99 -46.65 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.407 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.07 -31.97 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.3 21.99 6.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.113 -0.992 . . . . 0.0 109.424 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.92 -60.84 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.471 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.4 p90 -64.12 -33.15 75.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.449 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.469 HD23 ' CB ' ' H' ' 14' ' ' ALA . 43.0 tp -63.84 -42.52 97.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.24 -61.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.605 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.42 -70.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.0 132.77 0.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 53.81 41.23 32.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -1.162 . . . . 0.0 109.795 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.409 ' HD3' ' SG ' ' A' ' 20' ' ' CYS . 1.8 ttt180 -143.19 -62.25 0.41 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.63 157.64 11.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 8.0 p90 -160.23 172.95 16.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -1.14 . . . . 0.0 109.289 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 8.0 p90 -130.31 146.95 51.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -132.47 99.82 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.715 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.69 91.39 18.14 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 109.416 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 84.22 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.501 2.134 . . . . 0.0 110.306 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -127.84 34.92 4.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.381 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.3 -23.53 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.766 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.2 -12.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -137.98 35.98 2.36 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 109.232 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -155.64 -35.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.08 -23.84 10.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.559 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -12.16 59.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.532 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -99.72 2.47 44.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 109.78 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -178.91 138.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.28 147.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.54 178.06 4.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -104.98 -176.02 2.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 5.3 mp -76.19 -26.36 56.08 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -69.86 -43.58 71.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.862 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -70.97 -42.66 69.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 109.675 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.4 -25.68 63.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.964 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 9.2 mt-10 -74.3 -23.9 59.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.993 -1.067 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -55.66 -26.33 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' C' ' 20' ' ' CYS . 70.9 m-85 -83.25 -109.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.399 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' C' ' 19' ' ' TYR . 4.4 m 54.38 168.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 109.244 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 C--N 1.303 -1.437 0 O-C-N 121.057 -1.027 . . . . 0.0 109.515 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.0 t80 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.527 ' CG1' ' HA ' ' G' ' 9' ' ' SER . 16.0 m -81.76 84.08 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -123.82 -23.77 4.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -40.59 82.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.429 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . 0.454 ' CB ' HG12 ' G' ' 10' ' ' ILE . 11.8 t60 -87.68 -25.84 23.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.453 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . 0.432 HD13 HG22 ' D' ' 2' ' ' VAL . 29.1 mt -92.05 -72.37 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 39.4 t -45.43 -35.56 3.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -0.855 . . . . 0.0 109.71 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.85 -39.45 54.85 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 59.7 p -73.88 -2.19 22.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 109.76 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.787 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.07 -35.46 16.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 18.4 m -50.21 -46.19 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 1.3 pt-20 -67.04 -30.95 71.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.56 17.48 13.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.165 -0.96 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.84 -61.04 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.833 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.486 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 6.3 p90 -63.24 -32.55 73.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.57 -37.47 86.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -57.55 -62.83 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 109.586 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -66.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.51 135.2 0.11 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 51.84 44.23 29.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -1.064 . . . . 0.0 109.555 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -146.18 -60.82 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.792 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.32 157.03 11.82 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 10.6 p90 -161.38 171.15 18.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.108 -1.231 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . 0.567 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 39.2 m-85 -125.83 154.19 42.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -140.75 95.83 2.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.565 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 85.0 m -133.58 91.4 26.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.47 83.86 2.08 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.634 2.223 . . . . 0.0 110.702 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -128.26 36.98 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 109.63 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.557 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 76.4 mt -120.89 -22.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -1.13 . . . . 0.0 109.643 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.89 -14.05 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.69 41.73 2.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -161.33 -35.99 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.27 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.0 -24.74 10.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.769 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -13.24 60.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.316 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 66.6 p -96.87 -1.67 45.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.758 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -175.36 142.7 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.54 145.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -116.87 179.44 4.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 -174.33 2.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.406 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -77.03 -27.22 54.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.176 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -69.13 -44.06 73.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.75 -39.99 76.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 110.33 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.9 mt -73.88 -24.43 59.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.943 . . . . 0.0 110.042 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.57 -26.16 59.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.063 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -53.42 -25.53 16.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' E' ' 20' ' ' CYS . 70.6 m-85 -83.29 -104.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.107 -0.996 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' E' ' 19' ' ' TYR . 0.9 OUTLIER 52.55 171.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.949 -1.094 . . . . 0.0 109.495 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 120.97 -1.081 . . . . 0.0 109.554 -179.879 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.46 HG22 HD13 ' F' ' 6' ' ' LEU . 17.9 m -79.48 83.42 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -123.44 -26.14 4.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.058 -1.026 . . . . 0.0 109.775 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.97 70.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.487 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -85.59 -28.92 24.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . 0.46 HD13 HG22 ' F' ' 2' ' ' VAL . 27.0 mt -88.71 -72.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.956 . . . . 0.0 109.743 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -45.25 -36.52 4.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.811 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.94 -39.05 59.78 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 97.3 p -75.49 0.59 16.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 0.0 109.736 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -97.82 -21.96 16.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.32 -34.7 16.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.211 -0.931 . . . . 0.0 109.417 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 m -49.37 -46.88 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 109.312 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 1.9 pt-20 -66.66 -33.03 74.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.547 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -91.74 17.48 8.91 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.266 -0.896 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.68 -61.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 110.117 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.474 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 6.5 p90 -63.37 -33.02 74.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.035 . . . . 0.0 109.633 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.9 -42.1 95.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -52.48 -62.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.418 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.6 -71.13 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.536 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.37 135.71 0.37 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 50.93 43.18 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -1.132 . . . . 0.0 109.603 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.03 -66.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.365 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.77 160.22 10.82 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 13.8 p90 -168.85 163.61 11.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -1.067 . . . . 0.0 109.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -126.34 147.94 49.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 109.532 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -127.87 104.63 7.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.448 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 86.9 m -138.78 89.16 13.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.681 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.97 85.82 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.57 2.18 . . . . 0.0 110.564 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -130.51 37.52 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.286 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.88 -24.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -78.36 -12.38 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.69 34.09 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.228 -0.92 . . . . 0.0 109.696 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -152.64 -37.15 0.11 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.0 -24.62 10.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -15.02 61.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.319 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 45.9 p -98.46 -2.24 39.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.62 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 9' ' ' SER . . . . . 0.527 ' HA ' ' CG1' ' D' ' 2' ' ' VAL . 93.6 p -171.79 135.97 0.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.088 -1.008 . . . . 0.0 109.752 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . 0.454 HG12 ' CB ' ' D' ' 5' ' ' HIS . 2.5 mp -55.01 143.99 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.229 -0.919 . . . . 0.0 108.806 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 m -115.84 177.58 4.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.954 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -104.45 178.19 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.43 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.6 -26.36 62.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.267 -0.896 . . . . 0.0 109.745 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -70.6 -40.9 72.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -72.57 -39.44 67.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.249 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.96 -22.14 58.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.852 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -76.44 -24.46 53.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 109.323 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.46 -25.44 36.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.837 . . . . 0.0 109.813 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' G' ' 20' ' ' CYS . 73.9 m-85 -83.65 -103.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' G' ' 19' ' ' TYR . 0.9 OUTLIER 51.19 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.105 . . . . 0.0 109.658 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.554 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 12.1 t80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.462 ' O ' HG22 ' H' ' 2' ' ' VAL . 16.2 m -79.61 81.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -121.87 -28.5 4.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.647 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -39.72 66.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.928 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -89.52 -21.73 22.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 109.736 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 mt -95.8 -70.7 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.5 t -46.52 -35.64 5.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.46 -39.16 57.31 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -77.0 2.92 13.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -1.182 . . . . 0.0 109.663 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -98.94 -23.39 15.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.413 HD22 ' N ' ' H' ' 11' ' ' LEU . 5.1 mt -87.98 -35.09 17.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -49.5 -46.37 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.489 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 3.0 pt-20 -67.85 -30.92 70.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.317 -0.864 . . . . 0.0 109.418 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . 0.469 ' CB ' HD23 ' B' ' 17' ' ' LEU . . . -95.02 21.63 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.341 -0.85 . . . . 0.0 109.635 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 -60.06 1.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.639 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 7.4 p90 -64.58 -32.6 74.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.385 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 43.8 tp -65.05 -42.52 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.383 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -51.98 -65.83 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.224 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 58.6 m -64.33 -73.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.3 136.65 0.84 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 49.87 46.06 24.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.169 -1.195 . . . . 0.0 109.333 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -147.6 -58.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.403 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.06 158.39 14.29 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 9.8 p90 -163.34 174.7 11.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -1.154 . . . . 0.0 109.428 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 15.0 p90 -129.93 157.86 41.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -144.04 91.91 2.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 84.9 m -129.19 90.52 44.82 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.75 86.32 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.433 2.089 . . . . 0.0 110.154 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -130.06 35.24 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.912 . . . . 0.0 109.595 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.546 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.15 -26.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -1.166 . . . . 0.0 109.358 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 p -75.85 -12.86 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -138.25 43.82 2.16 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -163.04 -37.45 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.213 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 2.1 t -109.6 -27.05 9.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 109.151 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -72.01 -17.16 62.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 37.1 p -96.38 1.63 51.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 9' ' ' SER . . . . . 0.528 ' HA ' ' CG1' ' B' ' 2' ' ' VAL . 85.8 p -177.24 141.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.543 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . 0.533 HG12 ' CB ' ' B' ' 5' ' ' HIS . 2.7 mp -60.77 139.93 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.355 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 m -110.04 -174.72 2.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.182 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -110.63 -175.98 2.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.175 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 3.3 mp -75.42 -24.27 57.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.562 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.57 -43.48 63.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.89 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -70.04 -44.58 68.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -68.63 -26.06 65.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.979 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 9.0 mt-10 -74.46 -22.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.032 . . . . 0.0 109.731 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.93 -23.2 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.704 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' I' ' 20' ' ' CYS . 71.3 m-85 -83.87 -109.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 0.0 109.114 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' I' ' 19' ' ' TYR . 0.9 OUTLIER 55.61 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.66 -1.275 . . . . 0.0 109.651 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.528 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 m -81.48 83.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 109.568 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.6 -32.2 3.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.75 -39.29 37.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.102 -0.999 . . . . 0.0 109.882 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -88.44 -27.82 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' J' ' 7' ' ' CYS . 33.7 mt -90.96 -71.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' J' ' 6' ' ' LEU . 6.4 t -45.01 -38.89 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.05 -39.83 84.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 9' ' ' SER . . . . . 0.417 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 79.2 p -75.86 1.46 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.157 -1.202 . . . . 0.0 109.78 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -97.25 -23.41 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mt -88.43 -36.24 16.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . 0.406 HG22 ' N ' ' J' ' 13' ' ' GLU . 23.5 m -48.09 -45.64 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.444 -0.785 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . 0.406 ' N ' HG22 ' J' ' 12' ' ' VAL . 0.8 OUTLIER -68.45 -32.17 72.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.63 21.56 6.25 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -0.876 . . . . 0.0 109.438 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.05 -60.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.656 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.461 ' OH ' ' HB2' ' L' ' 9' ' ' SER . 7.8 p90 -64.66 -32.54 74.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.102 -0.999 . . . . 0.0 109.371 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.1 -40.8 95.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.31 -61.19 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -69.6 -69.51 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.3 133.88 0.17 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 53.62 43.5 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -1.109 . . . . 0.0 109.578 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -145.38 -59.0 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.29 155.37 12.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . 0.455 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 6.9 p90 -158.88 -179.64 8.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -1.18 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.31 158.86 43.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -144.44 94.89 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.485 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -132.35 91.51 31.03 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.46 -0.775 . . . . 0.0 109.287 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.09 86.62 1.66 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.679 2.253 . . . . 0.0 110.149 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -130.82 36.67 3.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.405 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.07 -24.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.53 -7.71 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -142.14 34.17 1.53 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.604 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -153.35 -36.49 0.1 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.41 -26.12 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.208 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -73.28 -13.25 61.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.415 -0.803 . . . . 0.0 109.633 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 43.5 p -99.75 0.26 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.598 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p -176.31 145.64 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.902 . . . . 0.0 109.306 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.14 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.97 . . . . 0.0 109.393 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 33.7 m -108.8 -176.05 2.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.516 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -109.89 -177.5 3.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 109.16 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 3.3 mp -74.49 -25.64 59.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 0.0 109.74 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -71.24 -42.97 68.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.301 -0.875 . . . . 0.0 109.943 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -70.49 -43.53 69.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.878 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.27 -24.08 62.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 8.3 mt-10 -75.41 -24.09 57.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -56.94 -23.81 48.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' K' ' 20' ' ' CYS . 73.0 m-85 -85.07 -112.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' K' ' 19' ' ' TYR . 6.1 m 55.46 168.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.733 -1.229 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.381 179.974 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.446 HG22 HD13 ' L' ' 6' ' ' LEU . 22.3 m -77.1 84.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 109.813 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -125.4 -27.1 3.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -37.3 66.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.562 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -91.13 -25.26 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . 0.446 HD13 HG22 ' L' ' 2' ' ' VAL . 27.3 mt -92.72 -69.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.351 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -48.23 -34.94 11.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.263 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.19 -39.1 58.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 9' ' ' SER . . . . . 0.461 ' HB2' ' OH ' ' J' ' 16' ' ' TYR . 89.1 p -76.42 1.17 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -1.136 . . . . 0.0 109.717 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -98.28 -24.08 15.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.364 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mt -86.72 -33.68 19.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -51.83 -45.76 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 1.7 pt-20 -67.07 -33.24 75.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -92.11 19.63 6.68 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.7 -61.69 1.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.473 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 7.5 p90 -62.57 -32.96 74.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.6 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 49.7 tp -65.05 -37.31 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.846 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.6 -59.06 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -67.38 0.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.085 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.46 134.3 0.1 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 53.27 42.41 32.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -1.175 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -145.32 -60.16 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.018 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.45 162.24 14.83 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 12.2 p90 -165.51 172.09 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -1.2 . . . . 0.0 109.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -127.49 154.18 45.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.447 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -140.43 99.31 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -136.46 91.76 15.95 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 109.578 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.18 84.41 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.74 2.293 . . . . 0.0 110.663 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -128.8 38.49 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.429 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.75 3.53 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -1.15 . . . . 0.0 109.721 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.52 -11.21 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.86 43.63 2.07 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.301 -0.874 . . . . 0.0 109.356 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.25 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.043 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.4 m -115.15 26.48 10.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.6 t -117.64 -24.2 7.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.066 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -109.0 8.52 26.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.93 120.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mp -49.11 134.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -94.42 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.121 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -110.03 172.18 7.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -27.25 67.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 109.665 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.71 -46.29 69.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -33.13 68.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.99 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.79 -8.09 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -89.69 -23.1 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.57 -8.0 54.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -93.44 4.93 53.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.499 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 156.68 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.349 0.595 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.415 ' O ' ' CG1' ' B' ' 2' ' ' VAL . 7.5 p -70.88 91.04 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.885 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.98 -45.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 0.0 109.143 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.36 -32.05 58.4 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.317 -0.864 . . . . 0.0 109.14 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -70.53 -43.2 70.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 mt -74.24 -32.69 63.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.288 -0.883 . . . . 0.0 108.886 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.09 -31.43 68.99 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.466 -0.771 . . . . 0.0 109.274 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.09 -26.94 61.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.14 -10.35 59.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.25 -1.147 . . . . 0.0 109.456 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -89.59 -24.6 21.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.086 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -87.59 -43.81 11.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.0 m -47.31 -42.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.35 -39.09 85.72 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 109.752 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.38 25.59 2.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.183 -0.948 . . . . 0.0 109.555 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.06 -49.21 2.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.399 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.494 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 18.3 p90 -79.39 -25.82 42.08 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.448 HD21 HD21 ' H' ' 17' ' ' LEU . 28.0 tp -74.76 -35.9 62.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.5 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -58.12 -60.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.64 -64.48 0.85 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.579 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.46 -129.29 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.46 82.74 3.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -1.183 . . . . 0.0 109.662 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -148.44 -68.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.48 149.71 7.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.402 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 17.3 p90 -158.69 173.27 16.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -1.141 . . . . 0.0 109.312 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.566 ' HB3' ' CD2' ' D' ' 25' ' ' PHE . 23.9 p90 -129.01 146.06 51.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -124.8 102.7 7.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.458 -0.776 . . . . 0.0 109.025 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -140.72 106.01 6.37 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.922 . . . . 0.0 109.866 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.61 78.41 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.524 2.149 . . . . 0.0 110.278 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -174.29 2.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.634 -179.877 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.39 0.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -1.122 . . . . 0.0 109.258 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -85.38 -14.14 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.229 -0.919 . . . . 0.0 109.805 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.9 42.49 2.01 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.187 -0.946 . . . . 0.0 109.673 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -168.52 -34.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.229 -0.919 . . . . 0.0 109.534 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -120.89 19.7 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 109.151 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -20.31 11.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.504 -0.748 . . . . 0.0 109.205 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -111.53 7.04 20.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' L' ' 1' ' ' PHE . 85.6 p -175.87 120.12 0.17 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.901 . . . . 0.0 109.188 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mp -48.63 133.98 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.58 -169.75 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.343 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -107.43 172.84 6.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.29 -27.07 66.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.52 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -69.37 -42.92 74.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -29.23 55.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.31 -7.15 59.52 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.8 -23.66 21.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.493 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -74.53 -4.35 36.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.938 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -97.38 4.11 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.988 . . . . 0.0 109.36 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.17 155.49 18.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.469 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' G' ' 10' ' ' ILE . 4.7 p -69.61 94.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.93 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -79.36 -33.79 42.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 109.036 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -68.26 -41.07 81.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 108.919 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.63 -34.56 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.3 -28.25 67.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.456 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.23 -27.91 50.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -78.45 -8.1 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 109.211 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -93.65 -20.23 20.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.967 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mt -93.18 -44.29 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 20.2 m -45.89 -42.32 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.425 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -68.12 -43.98 77.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.316 -0.865 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.8 24.83 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.915 . . . . 0.0 109.862 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -50.53 2.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.017 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.514 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 12.0 p90 -77.92 -24.42 48.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.854 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' J' ' 14' ' ' ALA . 35.3 tp -76.86 -36.07 57.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.58 -61.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -66.16 -66.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.743 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.9 -129.41 8.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.57 82.35 3.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -1.159 . . . . 0.0 109.552 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -148.48 -69.9 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.587 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.61 143.08 5.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.422 ' N ' ' CD1' ' D' ' 24' ' ' PHE . 10.9 p90 -150.13 166.58 29.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.292 -1.122 . . . . 0.0 109.289 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . 0.566 ' CD2' ' HB3' ' B' ' 25' ' ' PHE . 11.7 m-85 -117.43 143.87 45.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.042 -1.036 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -127.04 104.84 8.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.084 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -148.83 105.37 3.42 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.28 83.68 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.397 2.065 . . . . 0.0 110.46 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.86 -179.88 2.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.441 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.393 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 tt -120.41 0.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -1.144 . . . . 0.0 109.762 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.38 -8.97 11.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.76 37.63 3.73 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.142 -0.974 . . . . 0.0 109.339 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -163.06 -42.2 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 90.3 m -113.85 26.27 10.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.228 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 51.1 t -117.24 -23.99 7.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -0.839 . . . . 0.0 109.188 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -109.93 10.97 24.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.19 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' SER . . . . . 0.475 ' HA ' ' HB3' ' J' ' 1' ' ' PHE . 2.2 p -178.81 119.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.41 132.51 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.744 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m -93.27 -169.91 2.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.6 175.45 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -24.59 63.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -71.88 -44.34 63.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -29.74 61.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.438 -0.789 . . . . 0.0 109.889 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -80.87 -10.35 59.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.922 . . . . 0.0 109.819 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -86.27 -25.44 25.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -70.66 -10.01 58.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.9 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -92.38 5.93 48.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 109.98 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.41 156.71 17.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.746 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.602 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.21 88.73 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.911 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.74 -44.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.91 . . . . 0.0 109.055 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.51 -30.77 53.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -70.46 -45.14 66.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.326 -0.859 . . . . 0.0 109.043 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.48 -30.71 63.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.327 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.1 t -72.36 -29.55 63.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.753 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.73 -25.94 59.59 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -84.23 -2.61 57.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 109.653 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . 0.467 ' ND1' HD21 ' J' ' 6' ' ' LEU . 2.6 m-70 -97.89 -19.16 18.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 15.2 mt -92.22 -43.67 9.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.527 -0.733 . . . . 0.0 109.271 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 22.8 m -48.26 -42.1 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' H' ' 13' ' ' GLU . 4.7 mt-10 -67.19 -43.07 83.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.749 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.92 21.79 2.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.283 -0.886 . . . . 0.0 109.875 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.25 -51.91 2.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 13.4 p90 -76.37 -25.48 54.68 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.189 -0.944 . . . . 0.0 109.654 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.21 -35.54 59.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.96 . . . . 0.0 109.769 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.49 -59.23 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.686 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 17.9 m -68.44 -66.72 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.078 -1.014 . . . . 0.0 109.301 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.03 -126.07 7.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.44 78.38 5.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -1.092 . . . . 0.0 109.688 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -145.14 -71.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 109.851 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.99 138.84 4.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 14.4 p90 -145.94 173.18 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.349 -1.089 . . . . 0.0 109.019 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -125.27 145.52 49.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.032 . . . . 0.0 109.789 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -127.98 104.08 7.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.245 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -147.33 107.1 3.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.9 78.39 3.42 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.539 2.159 . . . . 0.0 110.693 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.52 179.49 5.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.551 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt -119.29 -1.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -1.091 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' H' ' 28' ' ' PRO . 33.8 m -84.42 -14.4 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.257 -0.902 . . . . 0.0 110.109 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.34 37.47 3.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.069 -1.019 . . . . 0.0 110.018 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -162.05 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.338 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -115.51 21.71 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -23.05 10.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.014 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 11.0 t -108.66 8.77 27.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -177.79 119.2 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.13 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' D' ' 2' ' ' VAL . 3.3 mp -47.96 137.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.372 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 77.9 m -98.22 -168.34 1.64 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.61 169.26 8.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.949 . . . . 0.0 109.285 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -25.63 68.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -70.65 -42.75 70.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -28.16 57.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.42 -4.66 58.7 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.073 -1.017 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -93.29 -21.57 19.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.14 -0.975 . . . . 0.0 109.377 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.07 -9.63 58.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -92.31 1.4 57.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.15 157.82 16.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.002 . . . . 0.0 109.733 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.701 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.4 HG11 ' O ' ' H' ' 2' ' ' VAL . 5.6 p -68.77 91.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.79 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.169 -0.957 . . . . 0.0 109.432 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -77.33 -33.12 55.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -68.2 -40.7 82.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.248 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . 0.483 HD21 ' ND1' ' L' ' 10' ' ' HIS . 13.8 mt -77.37 -31.83 54.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 108.959 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.11 -28.02 65.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.488 -0.757 . . . . 0.0 109.338 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.98 -29.84 45.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 70.4 m -77.24 -8.35 57.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -1.179 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -93.39 -23.46 18.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' H' ' 12' ' ' VAL . 12.1 mt -88.93 -44.51 10.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' H' ' 11' ' ' LEU . 26.3 m -45.79 -44.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' F' ' 13' ' ' GLU . 5.3 mt-10 -65.95 -43.86 86.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.784 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.92 21.11 2.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 110.03 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.45 -51.93 2.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 109.684 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 12.4 p90 -76.21 -26.03 55.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.448 HD21 HD21 ' B' ' 17' ' ' LEU . 32.2 tp -75.56 -34.93 60.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.44 -60.45 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.954 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 m -67.55 -63.62 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.69 -130.23 9.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -76.92 81.94 3.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -1.105 . . . . 0.0 109.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -146.94 -68.27 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.03 142.33 5.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 18.7 p90 -152.13 174.76 13.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.132 . . . . 0.0 109.511 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.3 162.42 26.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -143.83 92.44 2.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.84 . . . . 0.0 109.588 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -133.76 107.27 11.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' G' ' 3' ' ' VAL . 34.5 Cg_endo -76.13 78.25 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.362 2.041 . . . . 0.0 109.959 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.8 -179.22 4.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.697 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.32 179.728 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -119.13 0.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 109.901 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.98 -16.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.055 -1.028 . . . . 0.0 110.075 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.75 42.88 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -169.96 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -116.91 19.51 14.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.297 -0.877 . . . . 0.0 109.211 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -24.76 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.315 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -105.28 9.38 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.633 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 9' ' ' SER . . . . . 0.438 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.9 p 179.67 118.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' I' ' 9' ' ' SER . 3.0 mp -43.5 149.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.859 . . . . 0.0 109.21 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -171.76 1.91 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.79 167.55 9.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.158 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -27.81 69.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.33 -43.26 77.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.85 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -27.17 56.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.811 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -84.15 -7.12 59.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 109.864 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.78 -24.85 21.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -71.15 -10.83 60.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -91.45 3.16 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 0.0 109.909 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 159.25 15.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 109.378 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . 0.475 ' HB3' ' HA ' ' E' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.261 0.553 . . . . 0.0 109.713 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 6.0 p -70.65 91.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.55 -42.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.146 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.17 -33.41 44.02 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.004 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -69.06 -40.06 78.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . 0.467 HD21 ' ND1' ' F' ' 10' ' ' HIS . 9.5 mt -78.49 -29.79 46.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.324 -0.86 . . . . 0.0 109.105 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -72.72 -27.71 62.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.333 -0.854 . . . . 0.0 109.465 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.84 -27.0 52.17 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -79.68 -7.57 58.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.568 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -94.5 -20.87 19.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.15 -43.69 9.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 109.677 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 26.1 m -46.95 -44.21 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.08 -44.25 89.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.601 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . 0.467 ' HA ' HD22 ' D' ' 17' ' ' LEU . . . -87.6 24.85 1.59 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.47 -46.34 3.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 109.507 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 14.3 p90 -82.64 -23.25 34.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.98 -37.85 54.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.283 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.0 t -55.7 -61.62 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 m -66.89 -64.77 0.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.55 -129.33 8.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -77.91 85.31 4.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -1.179 . . . . 0.0 109.368 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -150.88 -75.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.07 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.32 141.21 4.42 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . 0.463 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 15.5 p90 -149.05 165.69 30.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.79 136.44 54.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -117.37 104.91 11.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.536 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -146.18 108.19 4.23 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 109.438 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.85 79.57 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 110.994 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.89 179.6 5.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 109.337 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.324 179.923 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.6 tt -121.17 1.05 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.51 -12.9 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.89 40.38 2.47 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.688 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -164.93 -42.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.244 -0.91 . . . . 0.0 109.299 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 93.9 m -114.14 23.47 12.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -112.77 -26.94 8.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 109.238 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -105.48 9.4 33.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.01 118.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.804 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 mp -45.32 135.66 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.298 -0.877 . . . . 0.0 109.597 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -98.1 -167.73 1.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.46 171.71 7.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.482 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -28.06 69.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 109.678 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -69.1 -42.34 76.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.825 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -28.82 56.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.62 -7.28 59.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 109.809 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.59 -25.12 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.678 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -72.38 -7.62 50.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -93.55 0.33 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.87 158.99 15.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.419 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' C' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.406 HG11 ' O ' ' L' ' 2' ' ' VAL . 5.1 p -70.83 89.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -175.95 -44.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -78.29 -31.88 49.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -70.63 -39.17 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.127 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 13.4 mt -78.21 -31.93 49.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 108.863 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.01 -29.99 67.19 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.12 -27.26 58.43 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -80.37 -6.24 57.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -1.127 . . . . 0.0 109.616 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . 0.483 ' ND1' HD21 ' H' ' 6' ' ' LEU . 4.3 m-70 -95.14 -20.63 19.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.031 -1.043 . . . . 0.0 109.633 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' L' ' 12' ' ' VAL . 11.2 mt -92.68 -44.67 8.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.943 . . . . 0.0 109.515 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' L' ' 11' ' ' LEU . 23.4 m -45.04 -43.71 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.18 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -66.76 -44.83 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.554 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.69 23.53 1.66 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.3 -0.875 . . . . 0.0 109.936 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.62 -49.66 2.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.668 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.526 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 14.4 p90 -79.06 -24.36 43.6 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.162 -0.962 . . . . 0.0 109.663 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 tp -76.99 -33.58 57.58 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.75 -59.3 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 12.3 m -69.05 -66.08 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.568 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.98 -129.95 9.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.17 80.88 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -147.62 -68.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.092 -1.005 . . . . 0.0 109.43 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.59 131.26 3.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' L' ' 24' ' ' PHE . 9.8 p90 -135.08 -173.21 3.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 109.317 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -138.2 142.74 39.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.82 108.61 11.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.625 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -150.5 106.64 3.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.848 . . . . 0.0 109.451 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.09 79.37 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.508 2.139 . . . . 0.0 110.449 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 -179.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.537 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -97.74 -27.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.4 t -73.84 -44.11 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.64 52.12 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.843 . . . . 0.0 110.151 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -175.38 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.085 -1.01 . . . . 0.0 109.694 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.0 11.05 17.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.8 t -105.57 -23.05 12.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.9 p -67.17 -13.94 62.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.472 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.5 p -175.25 156.52 2.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.505 ' CD1' ' HB ' ' F' ' 2' ' ' VAL . 2.1 mp -62.84 130.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.255 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.32 -167.02 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.504 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.72 176.78 4.94 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -42.31 89.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.2 -0.938 . . . . 0.0 109.771 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -66.7 -35.85 81.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.962 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -36.67 77.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 109.437 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.65 -18.45 51.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 109.827 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.09 -14.48 47.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.481 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.6 -16.31 15.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.892 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.74 87.27 1.84 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.31 133.07 7.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.461 -0.774 . . . . 0.0 109.485 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.418 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.511 ' CG2' ' HA ' ' I' ' 9' ' ' SER . 70.4 t -91.02 -7.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.248 -0.908 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 4' ' ' GLN . 11.3 p30 45.08 -172.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.443 -0.785 . . . . 0.0 109.604 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' B' ' 3' ' ' ASN . 9.4 tt0 83.53 -59.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -89.08 -24.13 22.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.191 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -96.78 -50.26 4.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.135 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -57.2 -38.04 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.98 -29.46 60.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.496 ' OG ' ' CE1' ' D' ' 16' ' ' TYR . 1.2 m -67.38 -9.08 38.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.151 . . . . 0.0 109.424 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -96.25 -36.1 11.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.023 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.49 -41.44 69.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' B' ' 9' ' ' SER . 9.7 m -48.11 -37.7 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -72.25 -46.12 57.32 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.954 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.12 13.25 4.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 0.0 109.863 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.32 -53.29 3.39 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.003 -1.061 . . . . 0.0 109.537 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 11.3 p90 -73.12 -30.2 63.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.315 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 0.1 OUTLIER -61.93 -52.92 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.384 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.41 ' O ' HG11 ' B' ' 18' ' ' VAL . 98.3 t -67.41 -30.75 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.199 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 20' ' ' GLY . 1.3 m -115.45 54.74 0.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.016 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' B' ' 22' ' ' ARG . . . -58.72 -119.73 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' B' ' 22' ' ' ARG . 25.8 mt-10 -39.52 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.975 . . . . 0.0 109.933 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' B' ' 20' ' ' GLY . 2.9 mtt180 165.37 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.657 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 172.48 27.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' D' ' 26' ' ' TYR . 50.9 p90 -170.81 162.74 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.441 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -117.72 141.5 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 0.0 109.493 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.86 111.44 17.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.709 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -140.86 98.58 6.92 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.92 87.73 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.5 2.133 . . . . 0.0 110.662 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -136.1 -123.38 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.98 . . . . 0.0 109.294 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 120.741 -1.225 . . . . 0.0 109.351 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -100.3 -29.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -1.165 . . . . 0.0 109.457 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.81 -40.95 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 52.54 1.97 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.332 -0.855 . . . . 0.0 110.077 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -175.64 -34.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.82 11.58 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 t -105.66 -24.4 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 60.1 p -67.74 -11.94 59.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.575 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -174.81 155.5 2.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.624 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.558 ' CD1' ' HB ' ' L' ' 2' ' ' VAL . 1.6 mp -63.7 130.95 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 108.984 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -97.15 -167.61 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -107.12 178.8 4.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -42.29 78.65 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.288 -0.882 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -67.04 -34.82 78.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.918 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -32.5 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 11.6 mt -83.31 -21.55 33.19 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -13.59 57.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.524 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.96 -15.57 13.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.02 87.94 1.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.57 133.97 7.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.429 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.475 ' HB ' ' CD1' ' G' ' 10' ' ' ILE . 55.8 t -89.58 -9.23 10.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.422 -0.798 . . . . 0.0 109.574 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' D' ' 4' ' ' GLN . 8.6 p30 45.9 -174.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' D' ' 3' ' ' ASN . 10.2 tt0 84.07 -60.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . 0.427 ' HB3' HG12 ' G' ' 10' ' ' ILE . 32.4 t60 -88.02 -21.99 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.123 -0.986 . . . . 0.0 109.006 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.41 -51.28 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.839 . . . . 0.0 109.188 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 t -57.31 -37.79 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.35 59.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.454 ' HA ' HG23 ' D' ' 12' ' ' VAL . 0.4 OUTLIER -64.68 -11.13 32.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -1.105 . . . . 0.0 109.559 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -93.09 -35.28 13.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 15.1 mt -73.52 -39.52 64.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.454 HG23 ' HA ' ' D' ' 9' ' ' SER . 13.3 m -48.15 -35.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -75.63 -44.45 42.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 9.71 11.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.02 -56.77 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.711 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.538 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 9.1 p90 -71.6 -28.75 64.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.027 . . . . 0.0 109.541 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 0.1 OUTLIER -63.15 -52.99 60.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.186 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.1 t -66.27 -33.47 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 108.866 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' D' ' 20' ' ' GLY . 1.3 m -111.66 55.96 0.66 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 109.085 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' D' ' 22' ' ' ARG . . . -59.32 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' D' ' 22' ' ' ARG . 23.3 mt-10 -40.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.463 -1.022 . . . . 0.0 110.055 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . 0.483 ' CB ' ' O ' ' D' ' 21' ' ' GLU . 4.2 mtt180 165.07 -53.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 171.61 24.55 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -169.45 172.31 7.17 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -122.16 157.89 30.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.516 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 79.6 t80 -136.64 100.45 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.47 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -133.83 97.41 15.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.81 86.19 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.447 2.098 . . . . 0.0 110.62 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -134.16 -124.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.886 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -101.69 -25.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -1.138 . . . . 0.0 109.135 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 90.6 t -77.71 -41.47 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.493 -0.754 . . . . 0.0 109.503 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.04 50.75 1.83 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.806 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.58 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.796 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 10.95 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.024 . . . . 0.0 109.504 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 33.2 t -105.07 -23.27 12.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 77.1 p -67.01 -14.73 63.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' SER . . . . . 0.487 ' HA ' ' CG2' ' J' ' 2' ' ' VAL . 5.8 p -174.15 155.85 2.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.139 -0.975 . . . . 0.0 109.819 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.466 HG12 ' CB ' ' J' ' 5' ' ' HIS . 2.1 mp -62.0 126.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.481 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -94.54 -170.09 2.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -106.91 176.7 5.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -41.04 95.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -68.74 -35.75 77.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 109.9 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -36.63 77.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 18.9 mt -79.01 -21.28 47.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.905 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -13.44 56.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.953 . . . . 0.0 109.321 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.72 -16.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.525 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.1 88.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.65 135.45 8.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.395 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.505 ' HB ' ' CD1' ' A' ' 10' ' ' ILE . 54.8 t -90.91 -7.45 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' F' ' 4' ' ' GLN . 9.4 p30 45.81 -174.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.77 . . . . 0.0 109.657 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . 0.567 ' CB ' ' O ' ' F' ' 3' ' ' ASN . 9.5 tt0 84.19 -60.54 0.11 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.641 -0.662 . . . . 0.0 109.589 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -87.89 -23.84 23.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mt -97.37 -49.47 4.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 40.1 t -59.01 -37.37 76.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -30.09 58.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 9' ' ' SER . . . . . 0.455 ' HA ' HG23 ' F' ' 12' ' ' VAL . 0.5 OUTLIER -66.21 -15.21 62.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.325 -1.103 . . . . 0.0 109.428 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -89.18 -36.45 15.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 mt -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.036 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' F' ' 9' ' ' SER . 12.2 m -49.86 -34.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.105 -0.997 . . . . 0.0 109.633 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -76.22 -44.84 35.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.978 . . . . 0.0 109.408 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.09 10.32 6.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.06 -57.2 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.085 -1.009 . . . . 0.0 109.831 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 10.9 p90 -69.53 -30.54 68.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.378 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 0.1 OUTLIER -62.57 -53.43 54.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.64 -32.56 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' F' ' 20' ' ' GLY . 1.3 m -114.21 53.72 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' F' ' 22' ' ' ARG . . . -57.85 -118.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' F' ' 22' ' ' ARG . 25.4 mt-10 -40.53 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -1.012 . . . . 0.0 109.952 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' F' ' 20' ' ' GLY . 4.3 mtt180 164.56 -49.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.73 27.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -166.92 174.93 8.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -1.125 . . . . 0.0 109.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -128.41 152.58 48.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -130.89 106.98 8.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -139.25 98.36 8.3 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.97 86.03 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.416 2.077 . . . . 0.0 110.554 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -154.48 135.6 13.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 30' ' ' THR . . . . . 0.495 ' C ' ' O ' ' F' ' 29' ' ' LYS . 71.5 p . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt -98.23 -25.58 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -1.156 . . . . 0.0 109.125 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.15 -42.94 37.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.461 -0.775 . . . . 0.0 109.417 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 51.64 2.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.336 -0.853 . . . . 0.0 109.684 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.98 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 109.723 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 9.65 19.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.692 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -103.64 -23.15 13.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.95 . . . . 0.0 109.818 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 74.5 p -66.92 -14.97 63.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -173.18 160.26 4.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . 0.475 ' CD1' ' HB ' ' D' ' 2' ' ' VAL . 1.6 mp -66.34 128.46 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.095 -1.003 . . . . 0.0 109.368 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -94.21 -167.97 1.77 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.37 179.37 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.465 -0.772 . . . . 0.0 109.305 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.44 -41.32 80.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -68.68 -34.65 76.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -36.4 80.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.84 -21.28 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.243 -0.911 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -83.63 -9.02 59.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.634 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.97 -16.49 59.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.135 -0.978 . . . . 0.0 109.237 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.77 90.91 2.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -165.16 131.6 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.9 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.314 0.578 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.512 ' HB ' ' CD1' ' K' ' 10' ' ' ILE . 54.3 t -92.95 -6.71 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' H' ' 4' ' ' GLN . 9.9 p30 44.92 -173.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.52 -0.738 . . . . 0.0 110.031 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' H' ' 3' ' ' ASN . 9.0 tt0 83.78 -60.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.754 -0.591 . . . . 0.0 109.677 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -87.95 -23.78 23.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.25 -0.906 . . . . 0.0 109.06 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.3 -50.14 4.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.209 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.0 -40.23 80.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.07 -29.97 66.05 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 9' ' ' SER . . . . . 0.465 ' HA ' HG23 ' H' ' 12' ' ' VAL . 0.5 OUTLIER -65.67 -12.66 55.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.131 . . . . 0.0 109.492 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -93.58 -34.03 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -0.846 . . . . 0.0 109.665 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 14.0 mt -74.44 -39.25 62.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 0.0 109.707 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' H' ' 9' ' ' SER . 7.8 m -48.21 -37.57 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.129 -0.982 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.24 -46.26 51.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.09 7.81 10.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.384 -0.823 . . . . 0.0 109.634 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -93.36 -55.99 3.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.0 110.096 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.553 ' CE1' HD21 ' H' ' 17' ' ' LEU . 14.0 p90 -70.45 -31.23 68.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.624 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.553 HD21 ' CE1' ' H' ' 16' ' ' TYR . 0.1 OUTLIER -60.82 -53.76 53.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.509 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . 0.435 ' O ' HG11 ' H' ' 18' ' ' VAL . 93.3 t -67.19 -30.65 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 109.748 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.21 46.66 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . -66.69 170.27 32.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' H' ' 20' ' ' GLY . 33.8 mt-10 35.5 71.4 0.12 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.661 -0.905 . . . . 0.0 110.078 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 175.32 -48.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.18 -0.95 . . . . 0.0 109.34 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.47 169.74 27.9 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -168.0 169.29 11.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -122.78 145.39 48.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 109.547 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.91 105.57 9.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -137.48 98.97 9.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.415 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.84 86.68 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.538 2.159 . . . . 0.0 110.778 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -135.91 -129.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 109.055 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.578 -1.327 . . . . 0.0 109.519 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 tt -99.02 -26.68 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 87.8 t -75.96 -40.59 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.64 53.61 2.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -176.28 -32.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.36 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 12.3 15.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.011 . . . . 0.0 109.86 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.73 -19.56 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -70.09 -13.48 62.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.031 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 9' ' ' SER . . . . . 0.511 ' HA ' ' CG2' ' B' ' 2' ' ' VAL . 52.5 p -174.39 156.89 2.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.478 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . 0.485 ' CD1' ' HB ' ' B' ' 2' ' ' VAL . 1.8 mp -63.32 128.23 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.248 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -93.23 -165.59 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 3.7 m -110.37 -177.22 3.18 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.248 -0.908 . . . . 0.0 109.042 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -41.21 68.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -68.16 -35.14 77.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -35.79 76.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.9 mt -81.19 -19.7 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.99 -10.78 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.92 -17.61 52.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.288 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.57 89.29 2.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 0.0 109.53 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.54 134.21 6.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.234 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.377 0.608 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.487 ' CG2' ' HA ' ' E' ' 9' ' ' SER . 53.1 t -91.65 -7.34 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' J' ' 4' ' ' GLN . 9.1 p30 45.51 -174.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 0.0 110.011 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' J' ' 3' ' ' ASN . 8.9 tt0 83.61 -61.48 0.11 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.705 -0.622 . . . . 0.0 109.823 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . 0.466 ' CB ' HG12 ' E' ' 10' ' ' ILE . 36.5 t60 -86.83 -21.23 26.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.162 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.02 -52.33 3.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.103 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.4 t -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.11 -32.33 63.18 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 9' ' ' SER . . . . . 0.451 ' HA ' HG23 ' J' ' 12' ' ' VAL . 1.2 m -67.34 -10.55 52.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -1.187 . . . . 0.0 109.543 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -93.7 -34.24 13.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.176 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.91 -41.74 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.455 -0.778 . . . . 0.0 109.711 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' J' ' 9' ' ' SER . 15.3 m -45.88 -38.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.803 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.94 -44.17 61.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.017 -1.052 . . . . 0.0 109.829 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . 0.452 ' HB3' HD13 ' D' ' 17' ' ' LEU . . . -84.68 13.92 5.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.37 -54.86 2.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 11.8 p90 -72.62 -29.54 63.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 0.1 OUTLIER -63.79 -52.14 61.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 109.171 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.97 -32.2 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.406 -0.809 . . . . 0.0 109.221 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' J' ' 20' ' ' GLY . 1.1 m -113.72 54.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.078 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . -57.85 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' J' ' 22' ' ' ARG . 26.0 mt-10 -40.76 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -1.15 . . . . 0.0 110.024 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' J' ' 20' ' ' GLY . 3.6 mtt180 165.58 -47.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.848 . . . . 0.0 109.338 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.8 169.42 33.85 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -164.44 172.95 12.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -1.163 . . . . 0.0 109.784 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -122.53 151.75 41.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.166 -0.959 . . . . 0.0 109.251 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -133.59 108.17 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -142.41 96.46 6.34 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.69 93.96 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.353 2.035 . . . . 0.0 110.593 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -141.03 -119.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.353 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 120.659 -1.275 . . . . 0.0 109.652 -179.768 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 tt -98.17 -27.6 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.163 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 94.9 t -74.72 -41.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.443 -0.786 . . . . 0.0 109.682 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.0 OUTLIER -91.98 56.96 3.02 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.937 -1.102 . . . . 0.0 109.489 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 1.3 tt0 179.94 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 10.85 15.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -107.23 -19.81 13.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 0.0 108.948 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -68.97 -14.23 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 109.009 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 78.1 p -175.25 156.06 2.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.815 . . . . 0.0 109.31 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . 0.512 ' CD1' ' HB ' ' H' ' 2' ' ' VAL . 1.4 mp -63.18 129.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -95.02 -170.71 2.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.855 . . . . 0.0 109.455 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.85 177.33 4.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.401 -0.812 . . . . 0.0 109.144 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -42.89 88.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.543 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -65.97 -37.57 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.102 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -35.36 73.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.75 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.769 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.28 -12.11 55.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -18.39 44.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.327 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.55 91.06 2.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.4 137.13 5.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.506 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.42 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.42 0.629 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' C' ' 10' ' ' ILE . 55.6 t -89.35 -7.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.443 -0.786 . . . . 0.0 109.929 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' L' ' 4' ' ' GLN . 10.8 p30 45.22 -173.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' L' ' 3' ' ' ASN . 9.1 tt0 83.84 -59.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.674 -0.641 . . . . 0.0 109.502 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . 0.439 ' CB ' HG12 ' C' ' 10' ' ' ILE . 33.8 t60 -89.14 -20.34 24.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 mt -101.63 -49.33 4.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -0.793 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -59.03 -32.92 70.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 108.826 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.03 -34.05 34.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 9' ' ' SER . . . . . 0.476 ' HA ' HG23 ' L' ' 12' ' ' VAL . 0.4 OUTLIER -64.58 -11.14 31.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -1.119 . . . . 0.0 109.272 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -93.76 -32.18 14.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.01 -39.33 50.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.476 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' L' ' 9' ' ' SER . 13.4 m -47.82 -36.03 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.561 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.94 -44.51 48.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 109.293 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.93 15.03 4.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.334 -0.854 . . . . 0.0 109.687 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.42 -53.74 3.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.041 -1.037 . . . . 0.0 109.533 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.555 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 9.4 p90 -73.98 -27.1 60.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 0.1 OUTLIER -66.14 -50.1 65.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.267 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . 0.439 ' O ' HG11 ' L' ' 18' ' ' VAL . 85.1 t -70.04 -29.04 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.1 49.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.575 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . -70.45 167.91 49.34 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' L' ' 20' ' ' GLY . 31.1 mt-10 39.09 71.39 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.505 -0.997 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 173.21 -43.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.826 . . . . 0.0 108.93 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.48 174.23 35.48 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.12 172.33 7.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -1.138 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' L' ' 25' ' ' PHE . 17.8 p90 -125.0 145.31 49.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -127.84 109.15 11.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -0.928 . . . . 0.0 109.358 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 9.8 m -142.55 98.22 5.93 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 0.0 109.201 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . 0.408 ' HB3' ' CG2' ' K' ' 3' ' ' VAL . 36.4 Cg_endo -78.66 93.9 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.369 2.046 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -139.77 -115.18 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 109.523 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 109.544 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 2' ' ' ILE . 49.7 mt -99.42 25.29 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -1.16 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 60.0 t -114.56 -47.43 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -95.47 47.45 1.12 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -168.23 -35.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.336 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 9' ' ' SER . 99.1 m -108.11 -32.31 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.655 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -69.4 -19.18 63.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 0.0 109.697 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -105.75 -7.31 18.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 5.1 p -168.08 132.35 1.7 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.426 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 11' ' ' CYS . 2.5 mp -52.49 138.4 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.419 ' N ' HG21 ' A' ' 10' ' ' ILE . 86.7 m -104.39 149.6 25.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.24 158.17 29.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -29.51 58.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.782 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -64.97 -43.47 92.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.477 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -73.87 -23.55 59.62 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.42 0.4 53.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.238 -0.914 . . . . 0.0 109.967 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -90.86 -26.08 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.735 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -83.01 -7.67 59.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.932 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -90.85 15.61 10.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.65 160.16 15.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.484 -179.891 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 11.2 p90 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.417 HG11 ' O ' ' B' ' 2' ' ' VAL . 2.5 p -60.96 123.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.27 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 175.55 -36.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.163 -0.96 . . . . 0.0 108.935 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -80.34 -42.32 23.16 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.369 -0.832 . . . . 0.0 109.276 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -58.89 -23.55 61.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -101.5 -24.45 14.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 51.1 t -75.26 -17.24 60.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.414 ' O ' HG12 ' B' ' 12' ' ' VAL . . . -91.41 -21.87 33.53 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.465 ' HA ' HG23 ' B' ' 12' ' ' VAL . 24.4 p -81.01 -18.76 45.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -1.14 . . . . 0.0 109.302 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -85.56 -18.86 32.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 9.9 mt -93.69 -34.71 13.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' B' ' 9' ' ' SER . 34.0 m -60.58 -36.02 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 110.037 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -27.91 61.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.931 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.33 17.56 17.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.163 -0.96 . . . . 0.0 109.864 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -114.98 -56.52 2.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.836 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -64.26 -23.65 67.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.478 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.459 HD23 ' CB ' ' H' ' 14' ' ' ALA . 19.7 tp -74.5 -40.25 61.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.2 -0.937 . . . . 0.0 109.306 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 71.4 t -54.69 -72.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.907 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.61 -42.6 88.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.08 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.34 -97.68 0.78 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.72 -56.54 20.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -1.143 . . . . 0.0 109.514 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -53.28 154.83 3.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.72 -167.69 27.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -170.01 169.18 8.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -1.13 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.648 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 42.1 p90 -127.78 148.66 50.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.474 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' B' ' 28' ' ' PRO . 30.5 t80 -128.29 113.57 15.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.81 92.11 13.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.482 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' B' ' 26' ' ' TYR . 36.1 Cg_endo -78.96 81.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.909 2.406 . . . . 0.0 110.515 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -133.14 112.25 11.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.089 -1.007 . . . . 0.0 109.946 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.242 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' C' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' C' ' 1' ' ' GLY . 20.4 mt 71.21 -1.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -1.231 . . . . 0.0 110.196 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 61.7 t -106.24 -49.03 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.971 -1.08 . . . . 0.0 108.917 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 44.84 1.03 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.431 -0.793 . . . . 0.0 109.239 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -165.57 -35.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 93.1 m -108.27 -30.31 8.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.3 OUTLIER -71.47 -19.09 62.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 109.388 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 -6.55 19.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.726 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 2.6 p -169.16 130.36 1.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.087 -1.008 . . . . 0.0 109.411 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' L' ' 5' ' ' HIS . 2.5 mp -50.44 138.08 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.647 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -104.37 149.02 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.054 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.67 159.04 29.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . 0.42 HD22 HG12 ' D' ' 18' ' ' VAL . 0.3 OUTLIER -55.14 -30.75 60.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.2 -42.2 96.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.979 . . . . 0.0 109.702 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -74.69 -23.4 58.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 72.1 mt -96.37 4.67 52.07 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -95.24 -25.85 16.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.269 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -82.78 -9.03 59.53 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -91.58 19.23 6.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.641 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.27 158.46 17.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 109.342 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.1 p90 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.443 HG11 ' O ' ' D' ' 2' ' ' VAL . 2.5 p -59.68 122.7 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.782 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.22 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.21 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -82.1 -39.44 23.35 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.244 -0.91 . . . . 0.0 109.131 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -62.17 -22.02 65.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.0 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -102.41 -24.39 13.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.808 . . . . 0.0 109.06 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 42.2 t -74.21 -23.22 59.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.408 ' O ' HG12 ' D' ' 12' ' ' VAL . . . -87.29 -20.26 52.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.457 ' HA ' HG23 ' D' ' 12' ' ' VAL . 57.6 p -81.45 -15.24 55.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.254 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.68 -21.16 22.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.807 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 9.2 mt -90.83 -33.25 15.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.151 -0.968 . . . . 0.0 109.754 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.457 HG23 ' HA ' ' D' ' 9' ' ' SER . 35.5 m -61.85 -35.6 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.38 -26.94 60.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.021 . . . . 0.0 109.812 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . 0.43 ' HB3' HD23 ' J' ' 17' ' ' LEU . . . -98.65 19.57 14.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.133 -0.979 . . . . 0.0 109.699 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mt -117.43 -54.75 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.55 -22.8 66.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.97 . . . . 0.0 109.595 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.442 HD23 ' CB ' ' J' ' 14' ' ' ALA . 22.9 tp -77.62 -33.83 53.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.845 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . 0.42 HG12 HD22 ' C' ' 13' ' ' LEU . 66.9 t -60.6 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 109.885 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -63.35 -42.75 98.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.59 -96.93 0.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.75 -54.73 41.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -1.121 . . . . 0.0 109.61 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -56.2 156.5 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.894 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.34 -167.54 26.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -168.13 158.14 10.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -1.113 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . 0.648 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 19.2 m-85 -113.22 142.99 45.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 109.528 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -125.31 117.0 22.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -0.995 . . . . 0.0 109.465 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.2 92.56 6.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.748 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -79.16 81.61 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.717 2.278 . . . . 0.0 110.39 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -133.68 112.25 11.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . 0.465 ' CG2' ' O ' ' E' ' 2' ' ' ILE . 53.2 mt -99.83 22.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -1.115 . . . . 0.0 109.389 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 49.0 t -113.12 -47.42 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.22 -0.925 . . . . 0.0 109.735 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.71 47.88 1.12 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.136 -0.977 . . . . 0.0 109.478 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -169.99 -32.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' E' ' 9' ' ' SER . 99.9 m -111.59 -30.48 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.39 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -72.46 -17.08 61.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.955 . . . . 0.0 109.321 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -107.3 -7.56 16.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' E' ' 6' ' ' CYS . 3.5 p -168.18 134.07 1.91 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.339 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.436 HG21 ' N ' ' E' ' 11' ' ' CYS . 2.5 mp -53.73 137.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.131 -0.98 . . . . 0.0 109.736 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . 0.436 ' N ' HG21 ' E' ' 10' ' ' ILE . 88.0 m -103.3 151.23 22.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.198 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.58 158.25 28.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . 0.408 HD22 HG12 ' F' ' 18' ' ' VAL . 0.3 OUTLIER -56.01 -29.91 61.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.221 -0.925 . . . . 0.0 109.106 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.62 -45.88 85.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.42 -23.05 61.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -0.872 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.35 -0.62 49.19 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -0.939 . . . . 0.0 110.05 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -89.31 -24.8 21.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.705 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.67 -7.04 59.38 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.109 -0.995 . . . . 0.0 109.889 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.11 20.14 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.138 -0.976 . . . . 0.0 109.17 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.8 158.28 18.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.372 -0.83 . . . . 0.0 109.335 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.595 -179.829 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.6 p90 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.435 HG11 ' O ' ' F' ' 2' ' ' VAL . 2.4 p -61.04 124.45 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.32 -35.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -80.15 -43.35 21.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.363 -0.836 . . . . 0.0 108.915 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -58.09 -23.03 53.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.664 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mt -101.46 -27.27 13.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 108.997 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.476 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 46.8 t -72.65 -20.22 61.29 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.597 -0.689 . . . . 0.0 109.511 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.83 -22.55 38.76 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 9' ' ' SER . . . . . 0.458 ' HA ' HG23 ' F' ' 12' ' ' VAL . 27.6 p -80.66 -17.04 52.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -1.123 . . . . 0.0 109.42 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . 0.469 ' ND1' HD21 ' J' ' 6' ' ' LEU . 14.5 m-70 -87.54 -18.18 30.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 9.8 mt -94.58 -32.67 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' F' ' 9' ' ' SER . 36.0 m -62.83 -35.04 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.856 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -26.59 59.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.53 18.38 16.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -116.15 -55.89 2.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.065 -1.022 . . . . 0.0 109.617 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -64.27 -23.12 67.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.694 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 26.9 tp -77.86 -33.85 52.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . 0.408 HG12 HD22 ' E' ' 13' ' ' LEU . 66.6 t -60.49 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 109.78 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.21 -44.09 97.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.15 -0.969 . . . . 0.0 109.7 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.93 -96.82 0.88 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.56 -55.71 30.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -1.114 . . . . 0.0 109.575 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -55.12 156.55 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 0.0 109.592 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -166.85 28.57 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.62 161.84 6.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -1.093 . . . . 0.0 108.981 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -122.29 151.18 41.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.026 -1.046 . . . . 0.0 109.589 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . 0.434 ' CE2' ' HG3' ' F' ' 28' ' ' PRO . 33.8 t80 -129.66 118.17 21.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.33 91.27 7.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 109.352 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . 0.434 ' HG3' ' CE2' ' F' ' 26' ' ' TYR . 35.6 Cg_endo -78.52 82.19 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.646 2.231 . . . . 0.0 110.359 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.67 110.81 10.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 109.534 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . 0.456 ' CG2' ' O ' ' G' ' 2' ' ' ILE . 46.3 mt -99.13 23.34 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.45 -48.76 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.87 46.12 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -167.37 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' G' ' 9' ' ' SER . 85.6 m -110.07 -27.79 9.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 22.7 t -72.04 -22.48 61.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 15.0 t -103.27 -6.16 22.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.455 -0.778 . . . . 0.0 109.695 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 9' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' G' ' 6' ' ' CYS . 2.2 p -169.32 132.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . 0.434 HG21 ' N ' ' G' ' 11' ' ' CYS . 2.5 mp -52.22 137.4 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.365 -0.834 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . 0.434 ' N ' HG21 ' G' ' 10' ' ' ILE . 83.5 m -104.01 150.35 24.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.257 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.39 159.9 30.06 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . 0.476 HD22 HG12 ' H' ' 18' ' ' VAL . 0.3 OUTLIER -57.34 -31.82 66.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.075 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -61.6 -46.57 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.418 -0.801 . . . . 0.0 109.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -72.33 -20.98 61.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 76.0 mt -96.85 -2.62 43.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.103 -0.998 . . . . 0.0 109.792 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -89.02 -24.74 22.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -82.91 -8.26 59.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 0.0 109.837 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -90.91 12.97 17.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.456 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.01 163.0 12.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.611 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.568 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.462 HG11 ' O ' ' H' ' 2' ' ' VAL . 2.6 p -59.08 121.18 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.22 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.93 -43.67 29.21 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.181 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -57.14 -23.72 49.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.553 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mt -100.86 -26.08 13.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 109.223 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.453 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 15.4 t -73.74 -20.22 60.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.469 -0.769 . . . . 0.0 109.706 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.77 -20.2 48.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 9' ' ' SER . . . . . 0.454 ' HA ' HG23 ' H' ' 12' ' ' VAL . 87.9 p -82.04 -16.3 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -1.059 . . . . 0.0 109.508 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -89.6 -16.21 31.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 8.0 mt -96.61 -33.42 11.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.473 -0.767 . . . . 0.0 109.547 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.454 HG23 ' HA ' ' H' ' 9' ' ' SER . 35.2 m -62.96 -29.98 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -25.87 43.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.454 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . 0.459 ' CB ' HD23 ' B' ' 17' ' ' LEU . . . -100.7 22.46 11.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mt -120.15 -54.19 2.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.523 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.58 -24.2 66.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.612 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 20.7 tp -77.22 -36.5 54.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.195 -0.94 . . . . 0.0 109.583 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . 0.476 HG12 HD22 ' G' ' 13' ' ' LEU . 64.9 t -57.32 -67.41 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.932 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 43.7 m -66.97 -39.99 87.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.985 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.26 -103.37 1.07 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -50.9 -63.55 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -1.221 . . . . 0.0 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -49.08 154.35 0.79 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.361 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.42 -170.57 28.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.57 170.45 15.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 109.525 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -128.34 150.4 50.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . 0.428 ' CE2' ' HG3' ' H' ' 28' ' ' PRO . 31.8 t80 -131.99 118.55 19.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.55 89.86 7.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.583 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' H' ' 26' ' ' TYR . 34.4 Cg_endo -76.47 82.64 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.72 2.28 . . . . 0.0 110.487 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.18 111.78 9.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.368 -0.833 . . . . 0.0 109.194 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.553 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' I' ' 6' ' ' CYS . 49.6 mt -98.02 24.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -1.194 . . . . 0.0 109.314 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 57.3 t -113.46 -47.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.972 . . . . 0.0 109.57 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.01 50.49 1.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.229 -0.919 . . . . 0.0 109.33 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -172.32 -34.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.475 -0.765 . . . . 0.0 109.252 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . 0.43 ' HB2' HG21 ' I' ' 2' ' ' ILE . 51.3 m -109.06 -32.61 7.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.867 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' I' ' 3' ' ' VAL . 0.5 OUTLIER -71.17 -19.49 62.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.047 . . . . 0.0 109.482 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -103.77 -6.82 21.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 p -169.51 135.66 1.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.194 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . 0.502 HG21 ' N ' ' I' ' 11' ' ' CYS . 2.4 mp -54.84 145.29 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.346 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . 0.502 ' N ' HG21 ' I' ' 10' ' ' ILE . 0.1 OUTLIER -112.46 150.06 31.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.012 -1.055 . . . . 0.0 109.545 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.57 155.58 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . 0.431 HD22 HG12 ' J' ' 18' ' ' VAL . 0.3 OUTLIER -52.77 -30.15 31.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.739 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -63.88 -45.6 88.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -72.03 -23.97 61.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 75.8 mt -94.88 -0.81 53.69 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -91.13 -23.66 20.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.998 . . . . 0.0 109.81 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -83.84 -9.03 59.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 109.676 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.54 15.6 10.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.12 156.59 17.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 109.67 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.215 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 9.6 p90 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.401 ' O ' HG11 ' J' ' 2' ' ' VAL . 2.4 p -60.41 121.05 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.72 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.382 -0.824 . . . . 0.0 108.868 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -79.26 -40.72 29.84 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.432 -0.793 . . . . 0.0 109.5 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -61.8 -21.65 64.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 109.381 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . 0.469 HD21 ' ND1' ' F' ' 10' ' ' HIS . 8.8 mt -103.14 -22.25 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.319 -0.863 . . . . 0.0 108.928 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 46.1 t -77.64 -14.91 59.51 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.405 -0.809 . . . . 0.0 109.099 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . 0.433 ' O ' HG12 ' J' ' 12' ' ' VAL . . . -94.26 -19.2 33.78 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 9' ' ' SER . . . . . 0.458 ' HA ' HG23 ' J' ' 12' ' ' VAL . 38.4 p -83.41 -18.04 40.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.203 . . . . 0.0 109.179 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -86.02 -20.93 28.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.377 -0.827 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 9.8 mt -92.07 -33.55 14.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.954 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' J' ' 9' ' ' SER . 32.5 m -62.2 -36.23 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.739 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.76 -27.11 61.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.957 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . 0.442 ' CB ' HD23 ' D' ' 17' ' ' LEU . . . -99.09 18.35 17.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 109.74 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -116.04 -54.15 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.984 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.19 -23.96 66.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' D' ' 14' ' ' ALA . 24.1 tp -76.7 -35.19 58.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.664 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . 0.431 HG12 HD22 ' I' ' 13' ' ' LEU . 78.6 t -58.53 -68.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.688 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.08 -44.15 97.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.647 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.92 -94.94 0.8 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.02 -57.83 10.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 109.519 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -53.23 158.68 1.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.255 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.81 -172.42 25.54 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -163.33 158.24 21.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.246 . . . . 0.0 109.714 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -116.15 147.04 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.535 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -131.08 113.07 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.618 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.0 92.35 12.61 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.585 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.74 81.88 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.6 2.2 . . . . 0.0 110.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.3 110.12 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.451 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' K' ' 2' ' ' ILE . 43.7 mt -97.84 26.67 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -1.195 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 54.5 t -115.18 -49.61 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 109.429 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.02 48.1 1.24 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -169.1 -35.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.684 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' K' ' 9' ' ' SER . 77.5 m -110.0 -27.34 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.99 . . . . 0.0 109.327 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 33.6 t -73.82 -19.04 60.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -106.83 -6.04 17.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 9' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 2.1 p -167.67 135.43 2.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 109.181 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . 0.451 HG21 ' N ' ' K' ' 11' ' ' CYS . 2.3 mp -55.89 139.81 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 109.362 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . 0.451 ' N ' HG21 ' K' ' 10' ' ' ILE . 99.7 m -105.17 147.23 28.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.723 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.17 156.9 36.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.875 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . 0.434 HD22 HG12 ' L' ' 18' ' ' VAL . 0.2 OUTLIER -54.82 -32.69 60.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 109.501 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -61.36 -44.96 96.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -72.65 -22.22 60.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.816 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.98 2.02 51.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.241 -0.912 . . . . 0.0 109.739 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -93.31 -24.73 18.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.396 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -83.14 -9.49 59.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -90.15 15.81 9.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.5 161.99 13.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.446 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.632 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' L' ' 1' ' ' PHE . 10.0 p90 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.42 ' O ' HG11 ' L' ' 2' ' ' VAL . 2.5 p -61.13 124.4 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.366 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.93 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -80.75 -40.87 24.44 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . 0.411 ' HB2' HD12 ' C' ' 10' ' ' ILE . 41.7 t60 -61.31 -20.65 63.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.356 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.06 -25.03 13.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.475 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 35.2 t -74.96 -19.72 59.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.566 -0.709 . . . . 0.0 109.381 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.59 -20.97 42.11 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p -80.6 -18.48 48.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -87.32 -18.65 29.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.582 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.7 mt -94.0 -30.11 14.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.821 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 35.3 m -66.61 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -74.34 -25.67 59.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.02 19.69 16.95 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.122 -0.986 . . . . 0.0 109.698 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -117.21 -54.16 2.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -65.93 -23.68 66.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -78.82 -30.37 45.28 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.262 -0.898 . . . . 0.0 109.885 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . 0.434 HG12 HD22 ' K' ' 13' ' ' LEU . 59.5 t -62.52 -68.67 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.23 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.2 -44.47 96.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -96.79 0.94 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.73 -59.38 5.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.272 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -51.36 157.89 0.93 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.327 -0.858 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.14 -166.99 25.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -171.79 155.78 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -1.107 . . . . 0.0 109.3 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' L' ' 25' ' ' PHE . 18.1 p90 -113.88 152.47 30.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.0 109.302 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -132.51 116.64 17.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 109.247 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.57 91.54 7.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.261 -0.9 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.67 80.23 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.542 2.161 . . . . 0.0 110.202 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.26 111.7 11.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' A' ' 2' ' ' ILE . 4.5 tt -118.61 18.52 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -1.166 . . . . 0.0 109.263 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 t -121.45 -7.0 9.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.35 -0.844 . . . . 0.0 109.189 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.88 -9.78 19.6 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.356 -0.84 . . . . 0.0 109.612 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -130.96 12.82 5.23 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.307 -0.87 . . . . 0.0 109.644 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -47.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.364 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.93 -15.64 59.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.3 p -97.74 -34.23 10.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 109.494 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 0.0 109.384 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.3 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.935 . . . . 0.0 109.266 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.3 m -95.81 172.51 7.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.85 167.31 10.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.22 91.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.334 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -64.67 -33.67 76.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.84 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -50.62 70.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.24 -20.13 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.12 -21.62 61.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -64.73 -25.04 67.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -100.53 -25.63 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.85 119.18 8.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.599 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.535 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' I' ' 8' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.36 142.08 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.635 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 168.94 -39.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -76.19 -36.75 58.52 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.1 -37.79 86.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.185 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.5 mt -84.55 -23.53 29.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 108.973 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.413 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 38.7 t -69.31 -36.23 76.79 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.93 -21.48 65.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.407 ' O ' HG21 ' B' ' 12' ' ' VAL . 61.3 p -77.03 -17.13 59.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.486 -1.008 . . . . 0.0 109.494 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -88.07 -24.51 23.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 10.9 mt -81.14 -39.24 25.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.407 HG21 ' O ' ' B' ' 9' ' ' SER . 13.1 m -49.99 -40.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -70.07 -40.97 74.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.005 . . . . 0.0 109.24 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.64 27.36 1.77 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.75 -48.29 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.312 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.588 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 11.6 p90 -74.38 -17.59 60.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.925 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.588 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 8.3 mt -78.81 -19.47 52.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.408 -0.808 . . . . 0.0 109.483 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.3 -50.64 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.87 -69.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.372 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.29 -106.29 3.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -62.42 -36.36 82.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -1.134 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -68.5 171.56 7.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.012 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -115.05 178.51 17.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.89 159.55 44.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -1.183 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.581 ' O ' ' CD1' ' B' ' 25' ' ' PHE . 21.5 p90 -113.45 139.42 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -123.13 114.35 20.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.458 HG21 ' HA3' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -128.36 87.67 54.6 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.486 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.28 79.01 3.42 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.588 2.192 . . . . 0.0 110.509 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -132.04 161.42 33.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.202 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.645 -179.811 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' C' ' 2' ' ' ILE . 5.1 tt -116.61 13.84 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -116.61 -5.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.9 -4.49 22.1 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.276 -0.89 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.98 5.04 3.85 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.061 -1.025 . . . . 0.0 110.222 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.06 -42.29 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.043 . . . . 0.0 109.192 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.03 -16.01 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 71.4 p -96.59 -37.64 10.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.333 -0.854 . . . . 0.0 109.291 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 7.9 m -138.86 144.2 39.1 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.536 HG12 ' CG ' ' L' ' 5' ' ' HIS . 2.6 mp -53.48 138.25 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 m -102.36 159.76 15.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 109.622 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 170.98 11.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.845 . . . . 0.0 110.329 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -48.93 71.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 109.253 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -61.49 -33.43 73.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 109.241 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -47.75 81.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.725 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mt -71.97 -19.88 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.224 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.47 -22.75 61.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -63.68 -24.66 67.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.534 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -100.92 -27.24 13.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.519 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -58.5 119.6 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.105 -0.997 . . . . 0.0 109.475 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.6 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.463 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 7.6 p -61.52 144.41 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 0.6 OUTLIER 165.45 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.019 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.07 -34.77 43.34 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -64.18 -37.69 88.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.384 -0.822 . . . . 0.0 108.928 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -82.39 -30.79 30.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 108.938 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.438 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.2 t -63.51 -35.48 80.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.47 -0.769 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.37 -22.34 65.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.56 ' CB ' ' CZ ' ' B' ' 16' ' ' TYR . 90.7 p -79.43 -17.79 53.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.221 -1.164 . . . . 0.0 109.149 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -83.37 -27.93 29.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 109.342 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 11.1 mt -78.76 -45.05 21.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.46 HG21 ' O ' ' D' ' 9' ' ' SER . 12.8 m -43.02 -45.3 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -66.08 -40.53 90.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . 0.434 ' HB3' HD23 ' J' ' 17' ' ' LEU . . . -90.29 23.98 2.71 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 109.795 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.33 -48.34 2.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.564 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 9.5 p90 -73.72 -18.66 60.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.237 -0.914 . . . . 0.0 109.311 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 8.6 mt -77.51 -20.35 54.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.817 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.62 -50.21 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 45.1 m -74.77 -68.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.93 -109.72 3.87 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.59 -37.94 76.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.124 . . . . 0.0 109.316 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -68.42 161.09 28.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.812 . . . . 0.0 109.545 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . 0.458 ' HA3' HG21 ' B' ' 27' ' ' THR . . . -104.52 -175.06 25.01 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -158.19 157.66 33.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -1.219 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -111.78 142.62 43.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.331 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.472 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 39.3 t80 -127.76 115.92 19.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 89.99 47.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.63 74.42 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.733 2.289 . . . . 0.0 110.503 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -127.02 159.55 33.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.486 179.894 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . 0.433 HD13 ' CD2' ' E' ' 19' ' ' TYR . 6.4 tt -118.0 16.32 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.272 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 t -118.47 -10.13 11.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.514 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -100.06 -10.2 21.8 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.343 -0.848 . . . . 0.0 109.851 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -129.03 15.28 6.28 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.35 -50.52 0.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -13.91 25.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.696 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 65.2 p -98.74 -34.26 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.042 -1.036 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.3 m -142.72 145.05 32.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.05 139.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -0.983 . . . . 0.0 109.752 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -97.67 171.42 8.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.775 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.23 167.03 10.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 109.367 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -47.72 85.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.265 -0.897 . . . . 0.0 109.141 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -63.76 -34.18 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 0.0 109.606 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -49.53 76.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.77 -18.65 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 0.0 109.682 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.71 -24.24 60.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -61.53 -25.41 67.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.873 . . . . 0.0 109.786 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.433 ' CD2' HD13 ' E' ' 2' ' ' ILE . 24.0 m-85 -100.59 -27.05 13.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.589 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.27 118.53 5.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.584 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.458 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.231 0.539 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 7.6 p -63.91 145.12 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 0.6 OUTLIER 165.21 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.861 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.54 -37.54 42.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.311 -0.868 . . . . 0.0 109.102 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.47 -36.42 82.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 mt -84.51 -28.68 26.56 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 44.0 t -66.0 -33.27 75.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.676 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.34 -20.21 62.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 9' ' ' SER . . . . . 0.464 ' O ' HG21 ' F' ' 12' ' ' VAL . 5.6 p -80.08 -18.02 51.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.047 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -84.13 -26.71 28.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.106 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -78.6 -45.8 20.82 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.342 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . 0.464 HG21 ' O ' ' F' ' 9' ' ' SER . 13.0 m -42.95 -44.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.398 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -65.9 -41.31 91.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 0.0 109.941 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.81 25.74 2.28 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 0.0 109.888 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.53 -48.23 2.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.566 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.4 p90 -74.0 -17.62 60.97 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 8.4 mt -79.8 -19.53 48.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.874 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.78 -51.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.055 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.1 -69.3 0.43 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.43 -109.17 3.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -58.77 -41.6 86.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.326 -1.102 . . . . 0.0 109.342 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -63.71 163.37 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 0.0 109.733 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.11 -175.86 23.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -161.66 163.51 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.5 p90 -119.85 156.02 31.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -134.48 105.23 6.45 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.63 87.65 21.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . 0.481 ' HD2' ' CA ' ' H' ' 23' ' ' GLY . 35.1 Cg_endo -78.47 73.77 5.71 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.771 2.314 . . . . 0.0 110.713 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -125.88 165.14 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.519 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . 0.456 ' O ' ' CG1' ' G' ' 2' ' ' ILE . 5.3 tt -113.16 13.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -1.135 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -115.53 -7.51 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 109.723 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -102.49 -11.31 18.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -128.59 16.76 6.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.108 -0.995 . . . . 0.0 109.479 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.54 -50.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.436 -0.79 . . . . 0.0 109.255 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.3 -15.66 37.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.428 -0.795 . . . . 0.0 109.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 71.2 p -97.39 -39.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 m -136.29 139.77 42.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -50.62 137.8 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 97.1 m -94.97 172.09 8.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.514 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.26 170.73 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 108.932 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -45.96 85.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.165 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.41 -33.28 75.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -49.6 74.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mt -70.47 -19.79 62.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.85 -22.44 61.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -63.53 -29.48 70.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.033 -1.042 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . 0.407 ' CD2' HD13 ' G' ' 2' ' ' ILE . 29.4 m-85 -94.53 -31.87 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.975 . . . . 0.0 109.506 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 121.9 9.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.566 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.3 p -62.63 144.09 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 0.5 OUTLIER 166.09 -42.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.192 -0.942 . . . . 0.0 108.964 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.49 -36.61 60.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.228 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.86 -37.48 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -83.3 -28.08 29.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.092 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.429 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 16.8 t -66.55 -33.5 75.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.681 . . . . 0.0 109.233 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.65 56.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 9' ' ' SER . . . . . 0.403 ' O ' HG21 ' H' ' 12' ' ' VAL . 3.5 p -75.45 -18.0 60.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -1.081 . . . . 0.0 109.571 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -84.52 -24.76 29.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.823 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 11.0 mt -82.54 -42.33 18.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' H' ' 11' ' ' LEU . 12.0 m -45.68 -43.02 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.333 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -66.66 -42.91 85.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.4 26.39 1.46 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.887 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.42 -47.25 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.045 . . . . 0.0 109.37 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.576 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 8.9 p90 -74.92 -16.68 60.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.576 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 7.9 mt -80.33 -19.92 45.42 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.489 -0.757 . . . . 0.0 109.397 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.1 t -79.41 -52.29 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.265 -0.897 . . . . 0.0 109.428 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.36 -65.7 0.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.2 -105.66 3.26 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.71 -39.73 92.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -1.204 . . . . 0.0 109.405 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.94 165.9 12.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . 0.481 ' CA ' ' HD2' ' F' ' 28' ' ' PRO . . . -109.97 -176.75 21.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -159.05 153.51 24.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.409 -1.054 . . . . 0.0 109.347 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . 0.466 ' O ' ' CD1' ' H' ' 25' ' ' PHE . 37.5 p90 -110.79 141.33 44.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.263 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.99 118.88 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.93 . . . . 0.0 109.447 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.5 87.69 49.42 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.611 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.94 77.79 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.644 2.23 . . . . 0.0 110.678 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -129.13 160.44 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.545 179.915 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . 0.465 ' O ' ' CG1' ' I' ' 2' ' ' ILE . 4.2 tt -122.14 15.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -1.207 . . . . 0.0 109.38 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 t -118.73 -3.13 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.299 -0.875 . . . . 0.0 109.311 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.71 -6.14 17.0 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -130.92 2.04 4.35 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 109.79 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 50.9 m -127.15 -39.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -69.46 -13.62 62.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.99 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 8' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' B' ' 1' ' ' PHE . 67.3 p -102.19 -20.72 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.605 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -153.64 138.09 16.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 109.358 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -50.18 138.08 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 109.014 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.0 m -102.26 161.1 13.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 170.92 10.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.341 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -49.41 72.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.542 -0.724 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -60.42 -35.07 74.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.18 -48.69 78.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.577 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.39 -15.36 61.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.266 -0.896 . . . . 0.0 109.736 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -61.59 -29.91 70.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -96.21 -30.3 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.705 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.16 118.86 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.495 179.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.262 0.554 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 7.3 p -64.21 145.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 0.6 OUTLIER 165.3 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -77.99 -38.1 45.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.217 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.32 -35.29 78.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -0.853 . . . . 0.0 108.916 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -85.33 -27.46 25.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.432 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 12.9 t -67.23 -33.95 76.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.793 . . . . 0.0 109.42 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.91 -22.67 60.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 93.3 p -77.28 -16.99 58.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -1.026 . . . . 0.0 109.322 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -88.02 -21.65 24.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.892 . . . . 0.0 109.665 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.8 mt -84.02 -38.97 20.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 m -49.67 -40.61 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.43 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -69.44 -40.52 77.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . 0.501 ' CB ' HD23 ' D' ' 17' ' ' LEU . . . -91.2 27.81 1.8 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.381 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.56 -46.41 2.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.583 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 12.6 p90 -76.22 -16.22 59.87 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.056 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.583 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 7.9 mt -80.83 -17.37 51.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.499 -0.75 . . . . 0.0 109.792 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -82.69 -49.42 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -63.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 109.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.74 -105.95 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -61.05 -39.12 88.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -66.63 157.51 32.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.936 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -175.87 29.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -161.1 157.9 26.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.058 -1.26 . . . . 0.0 109.726 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -115.97 142.68 46.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.76 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -122.67 119.25 30.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.406 -0.809 . . . . 0.0 109.121 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 87.38 53.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.72 77.84 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.628 2.218 . . . . 0.0 110.679 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -128.93 160.54 32.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.342 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' K' ' 2' ' ' ILE . 6.2 tt -117.66 17.22 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.316 -1.108 . . . . 0.0 109.718 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 t -119.94 -8.42 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.63 -10.37 21.0 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.279 -0.888 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -130.94 16.44 5.18 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.56 -47.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.314 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -16.09 56.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.196 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 66.9 p -96.04 -41.33 8.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.823 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 75.3 m -134.35 144.41 48.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.142 -0.974 . . . . 0.0 109.721 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.43 137.22 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.29 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.83 169.38 10.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 109.887 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.03 167.49 10.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.38 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -46.44 90.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.387 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.61 -35.0 79.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -49.06 78.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 109.598 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.23 -18.34 62.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.931 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.45 -23.12 60.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 109.188 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.576 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -99.33 -27.82 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.08 120.94 8.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.486 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' C' ' 8' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.264 0.554 . . . . 0.0 109.587 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 7.3 p -63.14 143.86 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.013 -1.055 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 0.6 OUTLIER 167.27 -39.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.017 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -77.07 -39.89 48.16 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.374 -0.829 . . . . 0.0 108.81 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . 0.536 ' CG ' HG12 ' C' ' 10' ' ' ILE . 86.3 t60 -60.67 -36.61 79.16 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mt -84.01 -29.34 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.439 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 40.7 t -66.12 -32.68 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.578 -0.701 . . . . 0.0 109.595 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.44 -26.7 53.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 9' ' ' SER . . . . . 0.454 ' O ' HG21 ' L' ' 12' ' ' VAL . 59.9 p -74.01 -19.74 60.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.48 -1.012 . . . . 0.0 109.329 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -83.78 -23.28 31.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 0.0 109.564 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 10.5 mt -82.55 -42.65 18.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 109.566 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . 0.454 HG21 ' O ' ' L' ' 9' ' ' SER . 13.9 m -46.49 -40.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -70.36 -40.21 74.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.89 21.46 3.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 109.666 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -49.28 2.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.553 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 11.5 p90 -73.05 -17.3 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.962 . . . . 0.0 109.695 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.553 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 8.4 mt -79.01 -19.51 51.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.684 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.49 -50.79 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 57.1 m -73.83 -68.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.35 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.82 -108.38 3.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.93 -38.22 85.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -1.169 . . . . 0.0 109.217 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -67.44 160.53 27.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.433 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.62 -175.46 24.91 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -155.33 170.5 21.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -125.57 136.71 53.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.968 -1.083 . . . . 0.0 109.315 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -120.16 117.08 26.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.74 87.16 50.35 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.483 -0.761 . . . . 0.0 109.307 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.99 79.14 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.593 2.196 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -130.07 161.39 31.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 0.0 109.312 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.414 179.872 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.412 ' CD1' HD13 ' B' ' 15' ' ' LEU . 51.4 mt -87.27 -27.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.88 -27.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.209 -0.932 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 55.01 0.65 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.22 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.37 -36.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -101.66 -32.22 10.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.339 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -68.89 -32.04 71.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 108.975 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.7 p -88.45 -16.1 33.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.416 -0.803 . . . . 0.0 109.45 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 10' ' ' ILE . 1.4 p -169.49 121.15 0.71 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.444 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 9' ' ' SER . 3.1 mt -44.61 107.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.14 154.96 21.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.299 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -71.99 167.56 19.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.23 -38.33 85.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.713 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.8 -43.07 94.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.873 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -63.84 -39.6 94.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.4 mt -77.16 -15.17 59.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -78.09 -22.51 48.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -85.35 17.39 3.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.24 -13.7 12.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.116 -0.99 . . . . 0.0 109.299 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.88 156.99 25.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.193 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.509 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.239 0.542 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.3 150.64 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.055 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 173.32 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.006 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -74.61 -32.67 62.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.174 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -69.03 -39.37 79.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.08 -23.48 35.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.475 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 42.4 t -74.57 -34.91 63.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.429 -0.794 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -16.01 80.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.89 -19.95 28.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.413 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -83.97 -15.07 49.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 12.9 mt -91.98 -49.71 6.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.756 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.0 m -46.56 -45.18 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -62.03 -42.79 99.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.483 ' CB ' ' H5 ' ' B' ' 32' ' ' IPH . . . -88.54 22.67 2.49 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.173 -0.955 . . . . 0.0 109.631 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.412 HD13 ' CD1' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -115.89 -58.41 2.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.903 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -59.46 -27.86 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.197 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.03 -42.68 80.24 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.554 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -54.56 -47.99 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -61.44 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' B' ' 21' ' ' GLU . . . 103.65 40.04 2.43 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' B' ' 20' ' ' GLY . 3.0 tt0 78.86 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.434 -1.039 . . . . 0.0 109.419 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.21 -54.81 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 109.581 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.02 152.38 5.7 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -163.52 159.87 22.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -119.81 143.24 47.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.579 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 40.2 t80 -119.71 104.7 10.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.103 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -132.07 97.92 17.89 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.76 113.15 3.59 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.504 2.136 . . . . 0.0 110.637 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -168.17 158.25 10.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.438 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 46.0 mt -90.17 -28.37 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 109.316 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.49 -29.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.98 53.11 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.34 -36.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 63.3 m -101.62 -33.62 9.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.357 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -68.1 -30.51 69.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.904 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 75.0 p -89.82 -17.26 28.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.317 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' SER . . . . . 0.413 ' O ' ' C ' ' C' ' 10' ' ' ILE . 1.3 p -167.82 120.34 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' C' ' 9' ' ' SER . 3.1 mt -44.29 108.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.22 155.98 16.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 t -72.68 165.83 24.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.11 -37.63 86.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.968 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.24 -44.5 88.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.884 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . 0.46 ' HA ' ' ND2' ' C' ' 18' ' ' ASN . 27.8 mt-30 -61.6 -40.98 96.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 47.0 mt -74.62 -17.2 60.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 109.828 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.11 -18.79 52.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.011 -1.055 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' C' ' 15' ' ' GLN . 26.8 p30 -88.24 16.34 6.39 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.117 -0.99 . . . . 0.0 109.47 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -112.26 -12.95 13.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.51 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.22 152.56 25.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.552 -179.921 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.464 HG21 HD13 ' G' ' 10' ' ' ILE . 7.3 p -60.18 152.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.223 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' D' ' 7' ' ' CYS . 3.9 m-20 170.92 -38.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.377 -0.827 . . . . 0.0 109.219 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -75.36 -31.02 60.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -70.18 -40.36 74.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.143 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -81.87 -22.35 36.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.06 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.462 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 49.9 t -75.34 -34.53 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.39 -0.819 . . . . 0.0 109.674 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.08 -16.95 80.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.85 -19.6 32.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -1.041 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -85.57 -13.91 47.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.298 -0.876 . . . . 0.0 109.137 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 13.8 mt -92.04 -52.72 4.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' D' ' 11' ' ' LEU . 11.5 m -43.79 -48.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' D' ' 16' ' ' TYR . 82.3 mt-10 -58.71 -43.74 90.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.865 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.459 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -88.65 23.5 2.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.237 -0.914 . . . . 0.0 110.071 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.56 -59.28 2.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' D' ' 13' ' ' GLU . 16.5 p90 -58.42 -27.4 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.14 -43.1 79.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.385 -0.822 . . . . 0.0 109.586 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.21 -47.77 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -60.25 3.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' D' ' 21' ' ' GLU . . . 101.23 40.55 2.79 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' D' ' 20' ' ' GLY . 1.9 tt0 79.55 50.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.434 -1.039 . . . . 0.0 109.867 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -51.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.41 150.49 6.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 30.0 p90 -155.28 172.46 18.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.31 -1.112 . . . . 0.0 109.364 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' D' ' 25' ' ' PHE . 12.8 m-85 -129.12 139.03 52.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.277 -0.889 . . . . 0.0 109.37 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -120.97 99.42 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.577 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 32.4 m -126.48 100.61 28.7 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.401 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.85 110.93 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.569 2.179 . . . . 0.0 110.543 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -167.18 155.75 9.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.379 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.452 ' CD1' HD13 ' F' ' 15' ' ' LEU . 50.5 mt -87.11 -27.37 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.5 -28.01 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -108.04 53.22 0.69 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.275 -0.891 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.78 -34.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.63 -30.28 11.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.221 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 4.8 t -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.339 -0.851 . . . . 0.0 109.306 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -87.67 -15.74 36.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' SER . . . . . 0.437 ' O ' ' C ' ' E' ' 10' ' ' ILE . 76.7 p -169.19 117.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.227 -0.92 . . . . 0.0 109.34 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' E' ' 9' ' ' SER . 3.1 mt -42.25 106.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.06 155.19 14.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.726 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 27.7 t -70.57 168.86 15.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.43 -37.13 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -64.74 -47.12 79.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -0.836 . . . . 0.0 109.475 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . 0.437 ' HA ' ' ND2' ' E' ' 18' ' ' ASN . 28.1 mt-30 -60.54 -39.66 88.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.899 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.288 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -76.99 -18.96 57.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' E' ' 15' ' ' GLN . 27.5 p30 -89.07 13.81 12.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.04 -1.038 . . . . 0.0 110.002 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -109.03 -13.38 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.04 -1.037 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 153.42 27.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.865 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.289 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.26 149.97 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 174.32 -41.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -72.89 -27.93 62.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -72.84 -40.01 66.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.039 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -82.46 -19.8 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 108.989 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.415 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 42.3 t -75.68 -38.61 58.58 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.523 -0.735 . . . . 0.0 109.472 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.04 -15.17 79.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -21.4 29.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.18 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -82.57 -18.58 40.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.9 mt -89.14 -49.86 6.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.746 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.65 -45.81 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.111 -0.993 . . . . 0.0 109.553 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -62.44 -40.61 97.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.514 ' CB ' ' H5 ' ' E' ' 22' ' ' IPH . . . -91.03 25.06 2.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . 0.452 HD13 ' CD1' ' E' ' 2' ' ' ILE . 0.7 OUTLIER -117.97 -58.85 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -59.34 -27.73 66.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.297 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -68.07 -43.51 78.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.857 . . . . 0.0 109.493 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.06 -51.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 109.402 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -47.8 -62.23 1.56 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' F' ' 21' ' ' GLU . . . 103.63 40.42 2.36 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' F' ' 20' ' ' GLY . 2.2 tt0 79.65 49.51 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -1.046 . . . . 0.0 109.788 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -123.53 -46.8 2.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.04 -1.038 . . . . 0.0 109.563 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.22 153.14 7.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -162.81 175.68 11.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' F' ' 25' ' ' PHE . 2.4 p90 -132.76 158.18 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.383 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -138.25 93.78 2.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.411 -0.806 . . . . 0.0 109.103 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 28.5 m -120.34 99.34 48.22 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.492 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 108.59 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.424 2.083 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -164.64 155.73 15.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 44.3 p . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.568 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . 0.447 ' CD1' HD13 ' H' ' 15' ' ' LEU . 36.4 mt -84.48 -30.52 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.751 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.15 -30.05 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 109.63 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.7 52.45 0.73 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.175 -0.953 . . . . 0.0 109.888 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.05 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.379 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.5 -35.06 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.83 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.075 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -89.05 -17.4 29.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.361 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 9' ' ' SER . . . . . 0.43 ' O ' ' C ' ' G' ' 10' ' ' ILE . 1.9 p -168.75 119.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.464 HD13 HG21 ' D' ' 2' ' ' VAL . 3.1 mt -42.82 106.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.578 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 62.6 m -60.62 153.97 22.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.373 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -68.76 170.16 10.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.79 -37.83 73.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 109.188 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.28 -44.82 90.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.431 -0.793 . . . . 0.0 109.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . 0.448 ' O ' ' ND2' ' G' ' 18' ' ' ASN . 21.4 mt-30 -61.92 -39.66 92.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.91 -15.36 59.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.203 -0.936 . . . . 0.0 109.544 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -79.32 -19.86 49.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.679 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' G' ' 15' ' ' GLN . 27.6 p30 -86.54 11.99 11.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -108.86 -10.94 15.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.855 . . . . 0.0 109.796 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.41 152.63 23.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.654 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.399 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.482 HG13 ' O ' ' K' ' 7' ' ' CYS . 7.5 p -60.06 152.56 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 3.6 m-20 170.72 -37.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -74.8 -33.81 62.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.25 -0.906 . . . . 0.0 108.855 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . 0.498 ' CB ' HD13 ' K' ' 10' ' ' ILE . 54.2 t60 -67.49 -42.2 83.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.513 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mt -79.22 -26.8 42.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.85 . . . . 0.0 109.427 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.409 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 42.4 t -72.21 -34.23 68.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.55 -21.47 79.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.73 -20.68 38.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -1.061 . . . . 0.0 109.665 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -82.34 -15.75 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.113 -0.992 . . . . 0.0 109.76 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.6 mt -92.41 -49.16 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.594 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 m -46.16 -47.11 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -61.42 -42.45 98.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.475 ' CB ' ' H5 ' ' G' ' 22' ' ' IPH . . . -88.32 19.37 3.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 110.063 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . 0.447 HD13 ' CD1' ' G' ' 2' ' ' ILE . 0.7 OUTLIER -112.5 -59.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.07 -28.62 64.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 mt -67.07 -43.32 82.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.518 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -53.94 -45.81 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -57.16 12.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' H' ' 21' ' ' GLU . . . 99.73 38.88 3.53 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' H' ' 20' ' ' GLY . 2.2 tt0 80.93 50.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.26 -56.81 1.61 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.962 . . . . 0.0 109.475 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.37 153.25 5.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.67 158.27 17.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -1.153 . . . . 0.0 109.186 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 28.5 p90 -121.39 141.09 51.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.697 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -117.09 106.25 13.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 32.5 m -132.29 99.06 16.35 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.55 -0.719 . . . . 0.0 109.454 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.44 112.61 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.489 2.126 . . . . 0.0 110.47 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.61 153.18 8.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.612 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.514 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . 0.419 ' CD1' HD13 ' J' ' 15' ' ' LEU . 32.8 mt -86.37 -30.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -1.125 . . . . 0.0 109.4 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.46 -28.23 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -108.09 49.4 0.81 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.11 -0.994 . . . . 0.0 109.688 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.12 -34.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.22 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -102.97 -32.53 9.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.06 -26.63 64.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 46.8 p -93.76 -17.2 23.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.035 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 9' ' ' SER . . . . . 0.417 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.2 p -167.52 119.29 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' I' ' 9' ' ' SER . 3.1 mt -43.73 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.5 m -59.57 156.55 13.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.482 -0.761 . . . . 0.0 109.457 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -73.7 169.01 18.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.86 -38.16 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -65.56 -43.75 88.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . 0.426 ' HA ' ' ND2' ' I' ' 18' ' ' ASN . 26.9 mt-30 -62.97 -38.0 89.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.187 -0.945 . . . . 0.0 109.441 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 42.3 mt -78.84 -13.51 59.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -81.01 -21.55 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.08 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' I' ' 15' ' ' GLN . 27.3 p30 -85.09 15.8 3.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.314 -0.866 . . . . 0.0 109.739 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.64 -11.73 13.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.382 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.12 154.65 24.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.526 -179.859 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.99 151.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 171.8 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.048 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -74.08 -33.49 63.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.249 -0.907 . . . . 0.0 109.105 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . 0.431 ' NE2' HD22 ' L' ' 17' ' ' LEU . 47.2 t60 -68.38 -39.55 81.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.508 -0.745 . . . . 0.0 109.705 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 mt -82.19 -24.64 34.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 48.7 t -72.89 -37.31 67.32 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -0.817 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.88 -20.52 78.83 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 9' ' ' SER . . . . . 0.459 ' HB3' ' OH ' ' L' ' 16' ' ' TYR . 1.3 m -82.38 -19.71 38.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -1.11 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.46 -16.81 44.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.574 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.1 mt -91.08 -48.16 7.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -47.9 -46.15 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.276 -0.89 . . . . 0.0 109.981 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -62.27 -39.61 93.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.481 ' CB ' ' H5 ' ' J' ' 32' ' ' IPH . . . -91.26 23.36 3.37 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.864 . . . . 0.0 109.753 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . 0.419 HD13 ' CD1' ' I' ' 2' ' ' ILE . 0.8 OUTLIER -116.32 -58.01 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.018 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -60.37 -28.44 68.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mt -66.17 -44.55 83.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.214 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -51.27 -48.58 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.282 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -50.77 69.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.08 -1.013 . . . . 0.0 108.831 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' J' ' 21' ' ' GLU . . . 108.77 -43.54 1.69 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' J' ' 20' ' ' GLY . 2.4 tt0 167.44 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -53.44 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.59 157.07 7.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 25.1 p90 -159.27 171.24 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -1.142 . . . . 0.0 109.742 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' J' ' 25' ' ' PHE . 1.7 p90 -128.0 141.26 51.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -121.75 98.76 6.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.873 . . . . 0.0 109.473 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -125.8 100.23 31.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.433 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.86 109.02 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.426 2.084 . . . . 0.0 110.621 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -164.29 156.85 17.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.553 -179.842 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . 0.452 ' CD1' HD13 ' L' ' 15' ' ' LEU . 38.0 mt -85.06 -29.23 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 39.4 t -69.24 -31.63 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.265 -0.897 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.95 51.96 0.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.262 -0.899 . . . . 0.0 109.975 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.28 -37.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.161 -0.962 . . . . 0.0 109.227 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 64.5 m -99.59 -34.67 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.305 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . 0.482 ' O ' HG13 ' H' ' 2' ' ' VAL . 1.7 m -68.07 -22.95 64.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 38.0 p -96.95 -20.42 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 108.978 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 9' ' ' SER . . . . . 0.414 ' O ' ' C ' ' K' ' 10' ' ' ILE . 33.8 p -165.27 119.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.324 -0.86 . . . . 0.0 108.959 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . 0.498 HD13 ' CB ' ' H' ' 5' ' ' HIS . 2.9 mp -42.99 107.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.749 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 68.7 m -59.13 156.3 12.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -73.27 169.36 17.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.52 -34.84 74.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 0.0 109.744 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.97 -45.11 75.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.995 . . . . 0.0 109.377 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . 0.433 ' O ' ' ND2' ' K' ' 18' ' ' ASN . 24.0 mt-30 -60.78 -40.43 92.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 42.5 mt -76.41 -15.57 59.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.94 -19.75 47.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.983 . . . . 0.0 109.558 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' K' ' 15' ' ' GLN . 27.5 p30 -87.17 14.18 8.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.887 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.42 -10.82 14.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.292 -0.88 . . . . 0.0 109.562 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.0 154.22 22.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.551 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.196 0.522 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.72 151.6 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.012 -1.055 . . . . 0.0 109.198 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 172.86 -40.24 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 108.907 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.4 -33.0 64.76 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.297 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -68.73 -39.65 80.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mt -82.23 -22.64 35.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.0 109.223 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.438 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 48.6 t -74.97 -32.65 61.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.432 -0.792 . . . . 0.0 109.821 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 -13.38 83.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -17.58 31.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.235 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -85.46 -19.19 31.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 11.9 mt -87.23 -51.55 5.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 m -46.1 -49.08 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -58.98 -42.57 90.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.461 ' CB ' ' H5 ' ' L' ' 32' ' ' IPH . . . -89.39 22.79 2.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . 0.452 HD13 ' CD1' ' K' ' 2' ' ' ILE . 0.7 OUTLIER -115.67 -57.81 2.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 0.0 109.824 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.459 ' OH ' ' HB3' ' J' ' 9' ' ' SER . 18.0 p90 -60.45 -26.97 67.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.17 -0.956 . . . . 0.0 109.393 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.431 HD22 ' NE2' ' J' ' 5' ' ' HIS . 5.0 mt -68.59 -41.13 80.04 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.37 -49.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -59.48 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.533 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' L' ' 21' ' ' GLU . . . 101.07 39.14 3.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' L' ' 20' ' ' GLY . 2.7 tt0 80.38 48.08 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.489 -1.006 . . . . 0.0 109.929 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.36 -53.86 2.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.38 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.31 151.26 5.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -160.68 169.59 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -1.105 . . . . 0.0 108.949 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' L' ' 25' ' ' PHE . 2.5 p90 -129.38 147.61 51.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . 0.408 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 36.8 t80 -123.85 107.12 11.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.889 . . . . 0.0 109.166 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -133.17 98.48 15.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.305 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 110.7 3.05 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.471 2.114 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.0 158.52 17.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.418 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.658 -179.846 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . 0.483 ' H5 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.459 ' H5 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' IPH . . . . . 0.514 ' H5 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 22' ' ' IPH . . . . . 0.475 ' H5 ' ' CB ' ' H' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . 0.481 ' H5 ' ' CB ' ' J' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . 0.461 ' H5 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.4 2.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -1.176 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 48.0 t -95.04 -36.65 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.958 -1.089 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.43 38.93 1.42 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.477 -0.764 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -156.34 -39.29 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 109.513 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.5 m -104.04 -38.96 6.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 109.636 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.454 ' O ' HG13 ' F' ' 2' ' ' VAL . 49.3 t -62.09 -24.3 67.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.602 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 p -77.65 -31.67 52.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -153.1 145.78 24.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.545 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -46.81 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -0.869 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.401 ' HB3' ' HG ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.56 163.23 7.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.615 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.17 165.23 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.294 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -36.5 77.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.843 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -68.89 -32.03 71.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -46.15 46.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 11' ' ' CYS . 64.8 mt -67.23 -17.34 64.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.053 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -26.15 62.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.069 -1.02 . . . . 0.0 109.335 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -55.08 -32.02 61.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.94 55.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.038 -1.039 . . . . 0.0 109.546 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -123.66 131.88 53.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.392 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.627 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.98 127.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.579 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 t30 179.96 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.95 -26.34 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -78.48 -39.4 38.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.08 -22.35 36.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.432 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 39.7 t -81.81 -33.07 30.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.941 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.81 -26.71 55.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.27 63.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -96.97 -21.17 17.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 59.5 mt -81.76 -33.45 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.58 -33.02 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -73.77 -38.17 64.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.152 -0.968 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.59 -58.06 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.519 ' HA ' ' HB ' ' B' ' 18' ' ' VAL . 9.4 mt -53.43 -23.01 8.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.992 . . . . 0.0 109.689 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -53.04 58.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 110.02 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -88.88 -23.27 22.8 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' B' ' 15' ' ' LEU . 83.7 t -65.44 -22.69 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 109.688 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.2 -34.62 8.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.626 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.48 -147.4 18.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -78.41 -1.43 33.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.252 -1.146 . . . . 0.0 109.701 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -65.83 -26.5 67.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 174.28 48.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -157.14 176.79 12.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 0.0 109.549 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.587 ' HB2' ' CE1' ' D' ' 25' ' ' PHE . 6.3 p90 -133.13 153.99 51.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.95 . . . . 0.0 109.585 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -130.92 109.4 10.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.383 -0.823 . . . . 0.0 109.302 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 40.3 m -159.7 105.89 1.46 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 109.34 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.42 -88.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.26 1.973 . . . . 0.0 110.233 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.29 -153.97 0.38 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.425 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 8.9 tt -103.02 0.96 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.644 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' C' ' 7' ' ' CYS . 48.2 t -92.62 -35.94 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.86 48.27 0.86 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.181 -0.949 . . . . 0.0 109.373 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -166.44 -36.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.459 -0.775 . . . . 0.0 109.097 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m -106.5 -39.69 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.394 -0.816 . . . . 0.0 109.374 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . 0.427 ' HB3' ' O ' ' C' ' 3' ' ' VAL . 47.0 t -64.14 -22.07 66.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.849 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -80.31 -31.73 38.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.587 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.28 146.68 26.21 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -48.76 101.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.571 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -58.32 160.12 5.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 169.91 13.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.6 -38.23 70.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.697 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.6 -31.14 70.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.43 -43.89 47.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 109.821 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 67.0 mt -69.73 -16.51 63.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.87 . . . . 0.0 109.812 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -23.13 61.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.634 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -58.72 -29.83 66.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -101.39 57.58 0.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -126.6 130.39 50.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.466 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.432 HG13 ' O ' ' G' ' 7' ' ' CYS . 13.0 p -64.8 128.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.587 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 179.25 -42.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.118 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.03 -25.36 60.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.779 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -80.83 -35.58 32.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -85.38 -20.33 30.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.147 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 41.8 t -84.31 -31.65 24.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.442 -0.786 . . . . 0.0 109.974 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.418 ' HA3' ' OH ' ' D' ' 26' ' ' TYR . . . -81.09 -27.02 51.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -15.23 63.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.34 -1.094 . . . . 0.0 109.364 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -97.06 -21.24 17.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.187 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 57.2 mt -83.81 -28.19 28.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -63.99 -32.06 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -75.32 -37.53 60.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.317 -0.864 . . . . 0.0 109.611 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.73 -55.12 18.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.942 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . 0.483 ' HA ' ' HB ' ' D' ' 18' ' ' VAL . 9.6 mt -55.13 -24.4 25.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.38 -53.77 40.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.005 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 35.3 mt -87.98 -24.85 23.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 110.463 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' D' ' 15' ' ' LEU . 78.9 t -63.68 -22.76 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.12 -37.65 7.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.383 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.74 -144.73 17.46 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.78 4.5 21.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -1.161 . . . . 0.0 109.593 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -72.67 -22.72 60.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.883 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.02 177.94 50.97 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -159.05 167.44 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -1.208 . . . . 0.0 109.925 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' B' ' 25' ' ' PHE . 2.3 m-85 -118.41 149.6 40.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.415 -0.803 . . . . 0.0 109.449 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.418 ' OH ' ' HA3' ' D' ' 8' ' ' GLY . 64.0 t80 -133.05 100.4 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.327 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.3 m -154.05 109.21 2.47 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.152 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.32 -87.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 110.313 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.18 -153.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.464 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.605 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 5.1 tt -102.35 0.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -1.087 . . . . 0.0 109.444 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 42.5 t -92.9 -38.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.301 -0.874 . . . . 0.0 109.66 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.81 45.29 0.99 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.885 . . . . 0.0 109.406 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -163.68 -36.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.456 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 74.9 m -107.01 -41.21 5.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . 0.446 ' O ' HG13 ' J' ' 2' ' ' VAL . 0.6 OUTLIER -62.36 -20.86 64.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -79.95 -34.16 39.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -150.8 146.72 26.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.265 -0.897 . . . . 0.0 109.335 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.409 ' HA ' ' H2 ' ' E' ' 22' ' ' IPH . 2.7 mt -47.32 102.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.678 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 162.04 6.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.366 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.47 167.65 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.516 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -39.04 77.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.163 -0.961 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -67.02 -31.33 71.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.34 -42.7 53.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 110.08 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 mt -70.67 -16.98 62.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.71 -26.66 63.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -54.62 -30.68 55.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -101.42 59.27 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -127.3 132.09 50.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.317 -179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.356 0.598 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 7' ' ' CYS . 11.5 p -62.29 127.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.389 -0.819 . . . . 0.0 109.911 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 t30 179.39 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.06 -27.31 57.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -79.54 -33.54 41.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.594 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -87.41 -22.67 24.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.107 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.457 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 37.3 t -82.53 -26.52 32.39 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.44 -27.08 31.12 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.55 -15.78 63.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -1.122 . . . . 0.0 109.181 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -96.27 -24.27 16.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.313 -0.867 . . . . 0.0 109.633 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 52.2 mt -79.86 -31.28 40.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.553 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -60.45 -33.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.95 -35.38 62.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 109.823 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.493 ' CB ' ' CD1' ' L' ' 17' ' ' LEU . . . -67.9 -54.83 15.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.571 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . 0.496 ' HA ' ' HB ' ' F' ' 18' ' ' VAL . 12.0 mt -55.83 -22.28 24.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 109.598 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -55.02 35.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.76 -26.53 25.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.27 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' F' ' 15' ' ' LEU . 89.5 t -61.96 -23.14 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.116 -0.99 . . . . 0.0 109.753 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.97 -35.15 8.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.6 -143.19 16.5 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -82.79 2.69 32.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -1.14 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.53 -31.6 68.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.65 -177.35 31.8 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -169.88 154.03 5.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.433 -1.04 . . . . 0.0 109.136 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -112.25 157.88 20.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.68 108.51 8.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 108.918 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -158.71 109.22 1.62 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.688 . . . . 0.0 109.405 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.5 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.372 2.048 . . . . 0.0 110.213 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.91 -156.08 0.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.373 -0.829 . . . . 0.0 109.769 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 7.4 tt -100.21 1.48 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -1.159 . . . . 0.0 109.61 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -92.97 -40.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.38 47.69 1.03 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -166.78 -34.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 77.9 m -108.58 -38.11 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . 0.432 ' O ' HG13 ' D' ' 2' ' ' VAL . 53.4 t -64.46 -23.63 67.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.381 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 3.1 p -77.35 -30.84 54.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.13 146.68 25.02 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.211 -0.93 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 mt -49.06 103.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.148 -0.97 . . . . 0.0 109.289 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.18 162.63 5.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.06 164.41 15.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 109.244 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -41.3 91.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.88 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -64.62 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -44.77 50.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.086 -1.008 . . . . 0.0 109.863 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.57 -16.43 63.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -25.4 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 0.0 109.26 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -56.11 -28.84 59.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.864 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -103.19 56.52 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 128.06 47.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 109.553 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 109.446 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' H' ' 6' ' ' LEU . 14.0 p -66.3 126.3 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -179.36 -41.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.58 -25.04 60.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.588 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -80.01 -39.48 29.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.302 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . 0.447 ' CD1' HG23 ' H' ' 2' ' ' VAL . 12.8 mt -82.75 -16.41 48.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.438 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.437 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 44.4 t -88.89 -30.8 18.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.848 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.25 -28.22 45.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -67.29 -19.02 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -1.131 . . . . 0.0 109.559 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -93.48 -23.12 18.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.153 -0.967 . . . . 0.0 109.666 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 43.4 mt -81.56 -30.81 32.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -60.58 -31.71 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.061 -1.024 . . . . 0.0 109.631 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -75.94 -35.37 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.44 -54.13 27.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -0.98 . . . . 0.0 109.436 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . 0.458 ' HA ' ' HB ' ' H' ' 18' ' ' VAL . 12.6 mt -57.17 -24.52 54.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.873 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -51.47 61.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -89.22 -25.56 21.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' H' ' 15' ' ' LEU . 91.4 t -63.62 -26.24 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.034 -1.042 . . . . 0.0 109.65 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -39.15 9.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 109.544 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.95 -143.93 16.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.76 2.89 31.64 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.072 -1.252 . . . . 0.0 109.612 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -70.2 -24.88 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.14 -171.87 35.96 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -172.1 163.4 5.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -1.234 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -120.84 154.68 35.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.024 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -134.9 101.51 4.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.461 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 22.9 m -152.83 108.14 2.69 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 109.509 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.83 -87.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.343 2.029 . . . . 0.0 110.745 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.59 -154.91 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.393 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 7.9 tt -104.48 1.64 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -1.192 . . . . 0.0 109.523 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 42.4 t -93.52 -37.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.73 37.62 1.58 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.564 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -154.59 -38.82 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -104.57 -41.52 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' I' ' 3' ' ' VAL . 0.6 OUTLIER -60.34 -20.42 59.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.711 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -81.57 -33.4 31.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.23 147.72 28.03 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.32 -0.863 . . . . 0.0 108.949 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.92 101.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.34 164.63 1.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.62 168.71 11.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.008 . . . . 0.0 109.06 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.69 -42.84 77.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -63.55 -32.01 73.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 110.078 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -43.26 55.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.988 . . . . 0.0 109.949 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 mt -70.35 -16.01 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.826 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -19.57 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.18 -0.95 . . . . 0.0 109.65 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -62.21 -28.09 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.247 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -102.11 58.47 0.82 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.17 129.83 47.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.362 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.446 HG13 ' O ' ' E' ' 7' ' ' CYS . 12.3 p -65.47 127.33 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -179.95 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -75.13 -27.62 59.86 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.874 . . . . 0.0 109.619 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -76.8 -36.61 56.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 13.3 mt -84.98 -21.97 29.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.418 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 43.7 t -83.1 -27.19 30.36 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.31 -0.869 . . . . 0.0 109.644 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.41 -27.48 30.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 9' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 0.4 OUTLIER -69.82 -12.18 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -1.129 . . . . 0.0 109.477 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -99.43 -21.52 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.322 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 40.5 mt -83.37 -32.2 26.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 109.603 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -58.72 -32.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.354 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -74.3 -37.81 63.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.686 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.03 -59.65 3.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.568 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . 0.5 ' HA ' ' HB ' ' J' ' 18' ' ' VAL . 10.7 mt -51.0 -25.77 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.725 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -55.48 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.119 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 mt -85.9 -27.82 24.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 0.0 110.229 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' J' ' 15' ' ' LEU . 87.7 t -59.34 -26.33 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 109.935 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -99.47 -39.32 8.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.566 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 -145.11 17.18 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.35 1.18 33.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.21 -1.17 . . . . 0.0 109.578 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -66.98 -27.31 67.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.13 -177.55 41.36 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -170.5 165.1 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -1.089 . . . . 0.0 109.189 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -125.33 157.28 37.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.738 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -129.91 110.55 11.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.544 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 38.4 m -159.71 106.67 1.46 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.588 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.37 -88.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.397 2.065 . . . . 0.0 110.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.7 -158.03 0.31 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.248 -0.908 . . . . 0.0 109.354 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.919 -1.038 . . . . 0.0 109.347 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 7.1 tt -104.48 1.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -1.104 . . . . 0.0 109.159 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 46.5 t -93.5 -40.3 11.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 46.86 1.0 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -165.05 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.829 . . . . 0.0 109.235 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 81.7 m -107.01 -42.54 4.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 109.27 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . 0.449 ' SG ' HD13 ' L' ' 11' ' ' LEU . 0.6 OUTLIER -60.11 -22.27 62.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -79.43 -31.88 42.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.137 -0.977 . . . . 0.0 109.586 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.37 146.75 24.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.74 102.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.873 . . . . 0.0 109.542 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 161.53 7.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -85.93 165.77 16.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.275 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -41.99 83.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.05 -31.46 72.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.52 -0.738 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -42.65 46.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 109.73 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 mt -70.17 -16.47 63.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.718 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -23.49 61.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.92 . . . . 0.0 109.167 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -57.98 -28.12 64.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.299 -0.876 . . . . 0.0 109.359 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -103.66 58.29 0.74 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 7.2 t -127.08 131.86 50.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.573 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.33 0.586 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' L' ' 3' ' ' ASN . 11.6 p -64.61 128.09 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.729 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' L' ' 2' ' ' VAL . 14.6 t30 177.52 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.536 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -77.92 -25.25 48.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -79.74 -38.15 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.78 -25.1 33.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.815 . . . . 0.0 109.4 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.441 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 45.4 t -79.45 -30.09 42.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.744 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.2 -32.36 28.93 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -64.88 -12.96 54.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 109.698 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -98.44 -23.5 15.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.449 HD13 ' SG ' ' K' ' 7' ' ' CYS . 55.7 mt -81.35 -28.04 34.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.856 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.48 -30.32 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.569 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -76.67 -37.66 55.86 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.205 -0.935 . . . . 0.0 109.485 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.18 -56.73 11.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . 0.428 ' HA ' ' HB ' ' L' ' 18' ' ' VAL . 14.7 mt -54.05 -25.73 23.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.079 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.509 ' CE2' ' HA ' ' J' ' 9' ' ' SER . 0.4 OUTLIER -52.05 -53.74 38.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 109.941 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' CB ' ' F' ' 14' ' ' ALA . 35.9 mt -87.24 -27.99 22.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.657 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' L' ' 15' ' ' LEU . 88.5 t -59.77 -25.15 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.956 -1.09 . . . . 0.0 109.648 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -99.48 -41.76 7.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.391 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.95 -142.26 15.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -83.2 1.29 41.39 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.275 -1.132 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -67.5 -27.93 67.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 110.022 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 -176.33 39.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -171.38 167.02 6.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -1.124 . . . . 0.0 109.488 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' L' ' 25' ' ' PHE . 3.1 p90 -126.45 151.69 47.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.632 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -126.85 106.11 9.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.312 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 32.8 m -155.71 108.55 2.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -82.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.475 2.117 . . . . 0.0 110.843 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.65 -155.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 109.406 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 109.816 -179.61 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' IPH . . . . . 0.409 ' H2 ' ' HA ' ' E' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 22' ' ' IPH . . . . . 0.401 ' H6 ' HG22 ' D' ' 2' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.5 mt -80.39 -30.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 109.518 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.58 -35.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.951 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -104.46 56.2 0.71 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.806 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.44 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 22.6 tt0 -178.58 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.582 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 9' ' ' SER . 63.7 m -102.16 -29.46 11.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.02 -41.48 59.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.236 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.2 p -81.34 -15.95 53.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.501 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -160.32 120.57 2.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 109.565 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' F' ' 2' ' ' VAL . 2.1 mp -47.87 101.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.319 -0.863 . . . . 0.0 109.455 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.44 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m -53.12 158.8 1.4 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.81 163.68 16.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.264 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -45.17 84.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 109.655 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -61.88 -33.49 74.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.549 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -67.72 -36.87 81.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.436 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.2 mt -83.91 -8.74 59.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.24 -0.912 . . . . 0.0 109.739 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.15 -27.96 38.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 15' ' ' GLN . 53.0 p30 -73.37 -11.91 60.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.432 ' N ' ' OD1' ' A' ' 18' ' ' ASN . 35.0 m-85 -98.32 -3.45 37.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 109.95 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.6 168.33 19.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.513 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.622 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.438 ' HA ' HD13 ' I' ' 10' ' ' ILE . 3.8 p -172.25 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 4.6 p30 170.73 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.875 . . . . 0.0 109.242 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -85.57 -24.29 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.822 . . . . 0.0 109.364 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.84 -39.42 35.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.319 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mt -81.01 -38.03 28.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 9.4 t -63.14 -36.33 83.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.33 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.4 -22.01 65.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 71.7 m -79.66 -8.88 59.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.399 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.79 -25.69 15.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.932 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 9.7 mt -79.43 -48.23 14.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.495 HG22 ' CD2' ' D' ' 16' ' ' TYR . 2.6 m -52.18 -34.01 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 109.958 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.47 -48.31 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.995 . . . . 0.0 109.423 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.444 ' CB ' ' H3 ' ' B' ' 32' ' ' IPH . . . -83.48 11.92 6.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 -50.67 5.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.949 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 13.4 p90 -71.98 -21.49 61.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.07 -1.019 . . . . 0.0 109.549 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.469 HD21 HD21 ' H' ' 17' ' ' LEU . 46.9 tp -74.52 -35.98 63.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -76.02 -46.7 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -57.1 -41.74 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.928 . . . . 0.0 109.327 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.39 -141.14 15.39 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.07 4.55 33.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -1.173 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.6 -74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' B' ' 19' ' ' CYS . . . 141.17 165.6 10.41 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 13.5 p90 -161.45 167.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -1.206 . . . . 0.0 109.317 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.58 ' HB2' ' CE2' ' D' ' 25' ' ' PHE . 35.8 p90 -123.57 162.62 22.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.596 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -142.08 83.69 1.85 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 109.644 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.409 ' OG1' ' CZ ' ' D' ' 25' ' ' PHE . 0.2 OUTLIER -133.77 92.68 22.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.13 -57.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.777 2.318 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tttt 54.37 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.552 179.699 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 74.1 mt -79.72 -29.48 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -1.112 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.27 -38.51 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 5.7 mm-40 -103.41 60.59 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.803 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 22.2 tt0 178.3 -32.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.592 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 70.2 m -104.03 -31.45 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.392 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 9.9 t -73.22 -40.11 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.963 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 32.1 p -82.84 -16.14 48.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.93 118.42 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.744 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' L' ' 2' ' ' VAL . 2.1 mp -45.76 100.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 96.8 m -51.9 160.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.004 . . . . 0.0 109.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.16 162.69 15.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.232 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.24 84.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 109.687 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -63.5 -33.73 76.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . 0.436 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -67.15 -35.94 80.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 109.685 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.63 -9.5 58.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -79.19 -26.77 42.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.458 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' C' ' 15' ' ' GLN . 52.8 p30 -76.84 -8.01 56.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -101.4 -6.54 23.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.19 167.68 21.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.66 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . 0.404 ' ND2' HG22 ' B' ' 27' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.349 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -171.76 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.184 -0.947 . . . . 0.0 109.279 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 p30 173.42 -36.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 109.261 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.56 -25.39 38.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.168 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.98 -41.79 41.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.39 -36.81 38.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.411 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.5 t -63.37 -36.4 83.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.507 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.55 -18.66 67.94 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -81.95 -8.64 59.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -1.125 . . . . 0.0 109.705 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -96.96 -25.88 15.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.585 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 10.6 mt -77.42 -49.87 13.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.527 HG22 ' CE2' ' B' ' 16' ' ' TYR . 3.3 m -51.55 -33.19 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -68.73 -46.78 68.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.108 -0.995 . . . . 0.0 109.717 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.414 ' CB ' ' H3 ' ' D' ' 32' ' ' IPH . . . -85.16 9.73 14.19 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.813 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 -52.33 4.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.726 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 15.6 p90 -70.85 -22.69 62.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.862 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 48.9 tp -72.86 -38.15 67.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.105 -0.997 . . . . 0.0 109.63 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.2 -46.27 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -58.16 -44.87 88.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -139.03 14.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.43 5.42 35.14 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.338 -1.095 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -70.45 -75.33 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.535 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' D' ' 19' ' ' CYS . . . 142.4 166.47 10.99 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 17.7 p90 -156.94 162.35 39.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.949 -1.324 . . . . 0.0 110.068 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' B' ' 25' ' ' PHE . 55.4 m-85 -114.2 150.41 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -138.55 85.01 2.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.63 92.86 9.97 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 108.783 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.22 -61.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.674 2.249 . . . . 0.0 110.568 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttt 59.13 94.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.666 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 75.6 mt -83.94 -29.86 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -1.135 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 64.0 t -68.85 -37.31 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 4.6 mm-40 -104.12 61.43 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.976 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 22.9 tt0 176.94 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 109.514 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 66.2 m -102.06 -30.39 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.6 t -73.65 -43.03 60.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.271 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 31.6 p -80.19 -15.04 57.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.622 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' J' ' 1' ' ' PHE . 0.0 OUTLIER -161.14 116.9 2.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.141 -0.974 . . . . 0.0 109.46 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.432 HD12 ' HB2' ' J' ' 5' ' ' HIS . 2.2 mp -45.27 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.456 -0.777 . . . . 0.0 109.59 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' E' ' 5' ' ' GLN . 94.4 m -49.95 160.83 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.079 -1.013 . . . . 0.0 109.332 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.6 167.44 12.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.073 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.69 94.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.512 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -62.11 -35.31 78.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -35.19 79.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.017 . . . . 0.0 109.4 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.35 -4.52 59.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -84.59 -29.81 25.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.142 -0.974 . . . . 0.0 109.376 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' E' ' 19' ' ' TYR . 54.6 p30 -72.31 -10.32 59.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.888 . . . . 0.0 109.679 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' E' ' 18' ' ' ASN . 32.8 m-85 -100.21 -1.03 37.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.886 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 169.13 14.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 110.059 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.717 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.494 ' HA ' HD13 ' A' ' 10' ' ' ILE . 5.7 p -170.23 108.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.865 . . . . 0.0 109.67 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 171.56 -37.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -79.43 -26.94 41.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 0.0 109.51 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -76.18 -40.41 52.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.938 . . . . 0.0 109.84 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.61 -34.36 30.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.434 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 11.3 t -66.63 -31.44 72.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.261 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.26 -19.27 60.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -83.21 -7.45 59.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -1.091 . . . . 0.0 109.574 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -98.81 -22.22 15.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -81.64 -45.96 15.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.649 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -55.23 -33.37 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.09 -48.49 65.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.481 ' CB ' ' H3 ' ' E' ' 22' ' ' IPH . . . -83.24 8.21 14.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -0.894 . . . . 0.0 110.065 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -51.52 5.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 109.858 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 13.5 p90 -71.51 -21.43 61.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 109.744 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 52.1 tp -74.8 -34.76 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.444 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.45 -42.93 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -37.73 86.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.036 . . . . 0.0 109.106 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.36 -139.76 15.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -83.54 -0.67 51.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.951 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -65.03 -73.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.284 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.16 168.65 11.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 12.3 p90 -163.61 172.69 13.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 109.422 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -130.41 162.53 28.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.275 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -138.99 93.16 2.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.034 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.08 89.45 7.81 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.483 -0.76 . . . . 0.0 109.477 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.38 -62.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.675 2.25 . . . . 0.0 110.115 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 62.22 93.18 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 109.648 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.568 179.904 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 73.6 mt -81.95 -26.69 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.13 -33.33 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 5.4 mm-40 -108.69 61.47 0.6 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 22.0 tt0 176.43 -31.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -104.36 -32.97 8.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 10.1 t -72.14 -43.5 64.57 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.124 -0.985 . . . . 0.0 109.286 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -77.36 -21.37 53.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 121.25 5.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.155 -0.965 . . . . 0.0 109.486 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.448 HG21 ' O1 ' ' G' ' 22' ' ' IPH . 2.1 mp -47.69 103.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.97 . . . . 0.0 109.156 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 69.1 m -53.32 162.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 109.617 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.1 163.28 14.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 109.33 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.36 84.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -61.04 -36.58 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.341 -0.849 . . . . 0.0 109.404 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' G' ' 18' ' ' ASN . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.7 mt -80.91 -11.32 59.6 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.906 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.56 -29.86 56.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.08 -1.012 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' G' ' 15' ' ' GLN . 53.4 p30 -73.16 -5.94 42.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.965 . . . . 0.0 109.613 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -102.17 -16.4 16.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.988 . . . . 0.0 109.76 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 6.9 m -66.51 172.86 3.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 108.814 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.423 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.418 ' HA ' HD13 ' K' ' 10' ' ' ILE . 4.4 p -171.05 107.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.55 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 172.54 -34.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.66 -22.13 32.23 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.304 -0.872 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -80.65 -39.79 26.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . 0.435 HD22 ' N ' ' H' ' 6' ' ' LEU . 4.3 mt -81.12 -37.09 29.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.216 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.41 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.4 t -63.15 -37.23 86.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.683 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.91 -18.73 71.85 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 58.5 m -83.06 -6.33 59.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -1.116 . . . . 0.0 109.559 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -100.47 -19.33 16.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.072 -1.017 . . . . 0.0 109.149 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.8 mt -84.23 -46.51 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' F' ' 16' ' ' TYR . 2.3 m -54.64 -33.17 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.726 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.27 -48.03 66.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.824 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.98 11.47 9.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.04 -48.63 6.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.996 -1.065 . . . . 0.0 109.724 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 13.2 p90 -73.12 -22.57 60.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.368 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.469 HD21 HD21 ' B' ' 17' ' ' LEU . 47.1 tp -73.47 -33.52 64.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.301 -0.875 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.25 -57.44 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -49.85 -38.41 35.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 0.0 109.245 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.5 -146.19 18.8 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -75.51 -3.96 37.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 110.046 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -61.59 -74.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.282 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.99 171.74 12.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 15.8 p90 -165.82 170.41 13.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -1.212 . . . . 0.0 109.678 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 13.1 p90 -128.5 156.74 42.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 109.496 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -136.35 91.21 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.386 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.67 90.09 8.88 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.97 -59.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.733 2.289 . . . . 0.0 110.533 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 57.56 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.335 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.507 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt -81.69 -28.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -1.105 . . . . 0.0 109.433 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.1 -32.26 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 5.8 mm-40 -108.15 58.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.277 -0.889 . . . . 0.0 109.545 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 25.3 tt0 177.34 -32.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -101.23 -30.44 11.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 109.44 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.4 -43.28 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.852 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -79.02 -14.31 59.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 9' ' ' SER . . . . . 0.424 ' O ' ' N ' ' I' ' 11' ' ' CYS . 0.0 OUTLIER -161.75 126.55 3.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.329 -0.857 . . . . 0.0 108.988 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' B' ' 2' ' ' VAL . 2.2 mp -56.17 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.851 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 10' ' ' ILE . 0.8 OUTLIER -43.23 161.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.272 -0.893 . . . . 0.0 109.346 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.2 169.34 11.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -46.16 91.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -59.74 -34.78 73.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.27 82.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.71 -9.45 58.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 109.581 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.16 -29.0 42.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' I' ' 19' ' ' TYR . 54.9 p30 -74.2 -9.74 58.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.683 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . 0.406 ' N ' ' OD1' ' I' ' 18' ' ' ASN . 29.5 m-85 -99.48 -3.48 33.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.579 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.26 167.66 19.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' E' ' 9' ' ' SER . 1.8 m-85 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 p -170.14 108.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.077 -1.014 . . . . 0.0 109.382 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 p30 172.81 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -85.03 -23.68 28.51 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.32 -0.862 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . 0.432 ' HB2' HD12 ' E' ' 10' ' ' ILE . 75.2 t60 -78.37 -40.69 35.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.965 . . . . 0.0 109.384 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 mt -80.12 -37.69 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.32 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.413 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 10.8 t -63.17 -36.82 84.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.84 -17.57 74.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -84.06 -10.9 57.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -94.1 -23.82 17.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.601 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 9.3 mt -80.39 -47.73 13.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 109.661 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -53.06 -32.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 109.99 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.47 -48.97 59.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 109.733 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.88 12.34 6.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.27 -50.23 5.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 12.9 p90 -72.56 -20.82 61.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 46.1 tp -76.57 -31.74 57.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.59 -46.89 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 109.052 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' J' ' 23' ' ' GLY . 0.1 OUTLIER -56.21 -42.24 76.89 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 108.977 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -140.79 15.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.2 -0.34 48.95 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.234 -1.156 . . . . 0.0 109.751 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -64.67 -67.99 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.103 -0.998 . . . . 0.0 109.524 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' J' ' 19' ' ' CYS . . . 133.06 171.8 12.82 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -164.81 177.89 7.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.125 -1.221 . . . . 0.0 109.443 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.02 156.14 48.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -137.38 94.04 2.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.03 89.31 6.53 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 109.636 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.61 -60.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.565 2.176 . . . . 0.0 110.574 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . 0.402 ' O ' ' HB ' ' J' ' 30' ' ' THR . 4.3 tttt 59.24 92.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.519 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 30' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' J' ' 29' ' ' LYS . 13.6 m . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.6 -31.84 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -1.099 . . . . 0.0 109.238 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.99 -35.88 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.8 . . . . 0.0 109.757 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 7.0 mm-40 -105.23 59.3 0.68 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 23.5 tt0 179.25 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.488 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' K' ' 9' ' ' SER . 72.2 m -100.85 -35.66 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.31 -40.23 77.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 55.4 p -82.6 -17.22 45.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.011 . . . . 0.0 109.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 9' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.0 OUTLIER -159.27 119.74 3.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . 0.421 HG21 ' O1 ' ' L' ' 32' ' ' IPH . 2.0 mp -47.54 100.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.578 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . 0.417 ' SG ' ' HG2' ' K' ' 5' ' ' GLN . 88.8 m -52.12 159.83 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 109.435 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.57 167.21 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -43.2 99.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -0.934 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -62.68 -35.47 79.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.184 -0.947 . . . . 0.0 109.387 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' K' ' 18' ' ' ASN . 0.0 OUTLIER -65.79 -38.41 88.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -81.86 -9.72 59.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -79.19 -28.21 42.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 109.675 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' K' ' 15' ' ' GLN . 55.2 p30 -74.58 -7.6 53.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 109.75 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.41 -8.41 22.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.25 169.41 17.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.132 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.37 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.415 ' HA ' HD13 ' C' ' 10' ' ' ILE . 5.6 p -172.64 108.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.151 -0.968 . . . . 0.0 109.401 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p30 172.14 -36.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.049 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -81.03 -27.38 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.364 -0.835 . . . . 0.0 109.375 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -75.32 -38.42 60.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . 0.432 ' N ' HD21 ' L' ' 6' ' ' LEU . 4.7 mt -82.82 -38.67 22.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 109.568 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 51.7 t -62.09 -33.7 74.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.93 -19.95 62.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 74.3 m -82.83 -5.97 59.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -1.11 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -99.5 -22.0 15.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 109.161 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.5 mt -82.98 -47.68 11.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -53.19 -33.85 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.01 -1.056 . . . . 0.0 109.552 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.08 -46.61 70.53 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.464 ' CB ' ' H3 ' ' L' ' 32' ' ' IPH . . . -86.24 11.01 13.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.68 -51.13 5.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 13.5 p90 -71.3 -22.9 61.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 49.8 tp -74.5 -34.61 63.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.776 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.93 -47.74 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.65 -37.86 68.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.5 -145.97 18.29 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -81.58 0.27 39.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.58 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -62.95 -73.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.32 165.01 10.16 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 11.2 p90 -160.24 169.3 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -1.087 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -129.8 152.49 49.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.192 -0.943 . . . . 0.0 109.389 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -129.9 96.62 4.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.853 . . . . 0.0 109.714 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.82 89.51 6.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.57 -62.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.597 2.198 . . . . 0.0 110.195 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt 62.09 92.89 0.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.53 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . 0.453 ' O1 ' HG21 ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.414 ' H3 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' IPH . . . . . 0.481 ' H3 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 22' ' ' IPH . . . . . 0.448 ' O1 ' HG21 ' G' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . 0.464 ' H3 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -133.22 6.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -1.108 . . . . 0.0 109.429 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.03 -8.37 5.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.264 -0.898 . . . . 0.0 109.75 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -111.77 1.61 16.72 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.199 -0.938 . . . . 0.0 109.792 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.86 13.19 2.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.178 -0.951 . . . . 0.0 109.304 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.73 -42.59 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.33 -16.34 63.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.423 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.9 p -70.89 -22.03 62.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.014 . . . . 0.0 109.414 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 p -163.69 144.12 8.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mt -52.62 113.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.4 m -84.29 -164.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 0.0 109.1 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.25 171.39 7.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -34.93 75.9 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 109.277 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -67.4 -38.87 85.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.955 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.92 -14.91 59.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 109.938 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.92 -28.87 63.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.023 . . . . 0.0 109.46 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -57.24 -19.03 18.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.57 59.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.1 t -123.13 119.76 31.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.641 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.2 t30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.343 179.783 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 m -131.06 46.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 109.875 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.53 -3.28 28.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -48.28 -38.53 19.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.31 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -93.42 -30.6 14.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.494 HD21 ' CG ' ' J' ' 10' ' ' HIS . 39.6 mt -80.95 -70.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 108.957 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.428 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.6 t -51.2 -37.82 48.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.665 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.464 ' O ' HG12 ' B' ' 12' ' ' VAL . . . -61.85 -44.28 98.07 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.422 ' HA ' HG23 ' B' ' 12' ' ' VAL . 31.0 p -67.84 -12.86 61.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 110.008 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -86.15 -24.63 26.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.119 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 5.7 mt -90.47 -33.77 15.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.553 HG22 ' CZ ' ' D' ' 16' ' ' TYR . 16.8 m -68.43 -38.54 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.522 ' N ' HG21 ' B' ' 12' ' ' VAL . 13.9 tt0 -66.04 -23.86 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.42 -12.89 26.93 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.442 ' HA ' HG22 ' B' ' 18' ' ' VAL . 6.5 mt -78.67 -28.66 45.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.582 ' CZ ' HG22 ' D' ' 12' ' ' VAL . 60.3 m-85 -48.25 -46.58 35.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -82.26 -36.26 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' B' ' 15' ' ' LEU . 69.7 t -47.04 -46.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.87 -30.72 26.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.459 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.04 -134.98 11.89 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -7.93 52.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.304 -1.115 . . . . 0.0 109.69 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -57.05 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.11 179.08 29.17 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.408 ' HZ ' ' CZ ' ' B' ' 16' ' ' TYR . 0.3 OUTLIER -166.31 168.23 15.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -1.182 . . . . 0.0 110.031 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.608 ' HB2' ' CD1' ' D' ' 25' ' ' PHE . 32.8 p90 -127.53 154.77 44.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.49 ' CD2' HG13 ' B' ' 12' ' ' VAL . 24.3 t80 -140.85 112.17 7.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 15.1 m -133.2 93.25 22.9 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 109.675 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.07 99.53 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.506 2.137 . . . . 0.0 110.389 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.33 -58.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -132.69 7.66 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.158 -1.201 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.92 -6.29 4.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.211 -0.931 . . . . 0.0 109.74 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -114.07 -0.39 14.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.128 -0.983 . . . . 0.0 109.604 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -134.65 9.46 3.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.189 -0.944 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.25 -39.85 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.705 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 t -66.93 -16.17 64.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 43.1 p -70.22 -24.53 63.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.92 . . . . 0.0 109.302 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 94.9 p -160.47 146.09 14.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.464 HD13 ' HB ' ' L' ' 2' ' ' VAL . 4.3 mt -54.55 117.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.7 m -89.45 -165.48 1.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 109.714 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -107.17 166.27 10.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -34.56 78.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.73 -37.56 79.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.859 . . . . 0.0 109.601 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.91 -38.39 86.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 109.53 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.81 -16.23 55.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 109.757 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.51 -30.3 68.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -56.42 -19.13 13.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.09 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -110.6 58.61 0.61 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.231 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 t -121.64 118.44 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . 0.559 ' ND2' ' CZ ' ' D' ' 25' ' ' PHE . 9.5 t30 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.509 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.359 0.6 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.02 44.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.244 -0.91 . . . . 0.0 109.159 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -100.15 -8.56 23.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 109.552 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -44.34 -40.46 5.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.44 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -90.74 -32.38 16.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.467 HD21 ' CG ' ' H' ' 10' ' ' HIS . 29.0 mt -80.34 -71.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 8.3 t -51.37 -34.39 34.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.407 ' O ' HG12 ' D' ' 12' ' ' VAL . . . -64.33 -43.86 96.28 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.463 ' HA ' HG23 ' D' ' 12' ' ' VAL . 17.2 p -69.41 -14.94 63.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -1.162 . . . . 0.0 109.711 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.94 -24.38 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.895 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 6.7 mt -92.79 -32.79 14.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.582 HG22 ' CZ ' ' B' ' 16' ' ' TYR . 15.4 m -68.29 -38.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . 0.516 ' N ' HG21 ' D' ' 12' ' ' VAL . 15.0 tt0 -64.91 -27.06 68.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.62 -12.06 35.32 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.333 -0.854 . . . . 0.0 109.853 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . 0.447 ' HA ' HG22 ' D' ' 18' ' ' VAL . 6.5 mt -80.21 -28.82 38.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.553 ' CZ ' HG22 ' B' ' 12' ' ' VAL . 62.3 m-85 -48.38 -45.07 35.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.199 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.424 HD11 HD11 ' J' ' 17' ' ' LEU . 17.9 mt -81.89 -38.5 25.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' D' ' 15' ' ' LEU . 67.5 t -45.85 -44.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.891 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.86 -29.77 25.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.899 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.2 -131.66 10.65 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.73 -6.99 38.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.65 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -56.69 -81.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.061 -1.024 . . . . 0.0 109.467 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.78 176.74 28.28 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 25' ' ' PHE . 0.4 OUTLIER -164.07 161.31 22.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -1.208 . . . . 0.0 109.883 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' B' ' 25' ' ' PHE . 4.4 m-85 -119.11 163.16 17.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.416 -0.803 . . . . 0.0 109.284 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.568 ' CG ' HG13 ' D' ' 12' ' ' VAL . 33.0 t80 -151.16 105.69 3.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 108.896 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 24.4 m -127.19 94.43 38.89 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.594 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.98 97.28 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.555 2.17 . . . . 0.0 110.369 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -61.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.221 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.35 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.44 3.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -1.125 . . . . 0.0 109.563 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.9 -9.58 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.94 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.89 1.69 19.35 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.104 -0.997 . . . . 0.0 110.164 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -136.7 11.33 3.16 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.041 -1.037 . . . . 0.0 109.669 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' E' ' 9' ' ' SER . 0.0 OUTLIER -144.32 -40.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.55 -18.0 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 108.954 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 41.4 p -69.61 -25.1 63.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.376 -0.828 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' SER . . . . . 0.421 ' O ' ' O ' ' E' ' 6' ' ' CYS . 12.5 p -159.56 148.82 18.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.428 HG12 ' HB3' ' J' ' 5' ' ' HIS . 4.0 mt -58.7 115.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.55 -158.69 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.785 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.1 167.82 10.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . 0.47 HD13 ' HB3' ' L' ' 17' ' ' LEU . 0.1 OUTLIER -66.11 -35.78 81.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -66.05 -40.79 91.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.986 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -80.37 -15.45 56.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -0.973 . . . . 0.0 109.594 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.14 -25.79 62.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.722 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -60.42 -19.49 56.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.215 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.7 62.05 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 t -125.45 119.67 28.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.461 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 25.4 m -129.38 44.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.264 -0.898 . . . . 0.0 109.375 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -100.52 -4.68 28.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.377 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -48.6 -38.04 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -93.32 -30.92 14.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 35.2 mt -81.36 -71.1 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.085 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.487 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.5 t -50.18 -37.21 33.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.44 -0.787 . . . . 0.0 109.356 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . 0.4 ' O ' HG12 ' F' ' 12' ' ' VAL . . . -61.76 -42.97 99.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 9' ' ' SER . . . . . 0.42 ' HA ' HG23 ' F' ' 12' ' ' VAL . 58.4 p -70.85 -13.53 62.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.132 -1.216 . . . . 0.0 110.043 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -84.07 -24.38 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.985 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 6.5 mt -91.64 -33.45 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.813 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . 0.515 HG13 ' CG ' ' F' ' 26' ' ' TYR . 18.4 m -69.22 -36.26 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 109.848 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -69.11 -22.22 63.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.52 -11.03 28.1 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.71 -28.19 36.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.459 ' OH ' ' HB ' ' H' ' 12' ' ' VAL . 54.0 m-85 -48.61 -47.61 39.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 109.655 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . 0.488 HD12 ' CB ' ' L' ' 14' ' ' ALA . 12.4 mt -80.93 -38.59 27.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' F' ' 17' ' ' LEU . 70.8 t -44.62 -45.68 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.96 -30.04 26.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.36 -133.21 11.22 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.0 -12.89 29.54 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.256 -1.144 . . . . 0.0 109.538 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 23.0 mtt180 -50.72 -83.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.2 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.04 -177.46 33.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . 0.406 ' HZ ' ' CZ ' ' F' ' 16' ' ' TYR . 0.2 OUTLIER -171.45 168.86 6.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -1.134 . . . . 0.0 109.469 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -132.07 166.12 22.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . 0.515 ' CG ' HG13 ' F' ' 12' ' ' VAL . 26.2 t80 -147.42 115.44 6.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.52 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -132.66 91.53 29.72 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.32 98.51 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.191 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.0 -58.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.59 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.578 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.08 8.26 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -1.2 . . . . 0.0 109.735 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -127.2 -5.76 4.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -113.23 -1.14 14.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.021 -1.049 . . . . 0.0 109.812 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -134.4 11.58 3.8 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.083 -1.011 . . . . 0.0 109.704 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' G' ' 9' ' ' SER . 0.1 OUTLIER -143.98 -40.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 t -66.4 -18.11 65.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 60.5 p -69.17 -22.28 63.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.48 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 9' ' ' SER . . . . . 0.41 ' O ' ' O ' ' G' ' 6' ' ' CYS . 4.3 p -162.67 148.58 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.299 -0.875 . . . . 0.0 109.433 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mt -58.08 115.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.77 -165.02 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.1 167.4 10.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -35.55 81.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.732 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -67.27 -37.75 83.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.967 . . . . 0.0 109.852 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.39 -40.5 89.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -77.51 -14.14 59.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.15 -30.35 63.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.338 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -53.9 -23.45 12.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.37 64.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.97 120.89 30.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.331 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.562 -179.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.298 0.57 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 31.8 m -126.17 41.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' H' ' 4' ' ' GLN . 11.6 m120 -96.92 -9.92 27.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' H' ' 3' ' ' ASN . 50.2 tt0 -43.03 -40.14 2.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -90.98 -33.22 15.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 109.313 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 29.9 mt -78.44 -73.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 7.7 t -47.13 -41.46 17.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.815 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . 0.439 ' O ' HG12 ' H' ' 12' ' ' VAL . . . -58.84 -44.87 95.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -67.33 -14.92 63.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -1.114 . . . . 0.0 109.838 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . 0.467 ' CG ' HD21 ' D' ' 6' ' ' LEU . 5.6 m-70 -85.88 -20.36 29.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.665 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.0 mt -94.87 -35.3 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.384 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.478 HG13 ' CG ' ' H' ' 26' ' ' TYR . 15.6 m -68.1 -34.18 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -69.82 -23.08 63.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.141 -0.974 . . . . 0.0 109.219 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.09 -9.99 32.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.39 -0.819 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . 0.405 ' HA ' HG22 ' H' ' 18' ' ' VAL . 5.6 mt -82.37 -26.83 32.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.42 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.46 ' OH ' HG22 ' F' ' 12' ' ' VAL . 53.5 m-85 -50.04 -44.06 51.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.615 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.09 -36.45 21.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.27 -0.894 . . . . 0.0 109.724 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' H' ' 15' ' ' LEU . 76.5 t -46.33 -42.67 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 -29.39 21.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.79 -133.34 11.31 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -11.5 38.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -1.17 . . . . 0.0 109.738 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -53.01 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.037 . . . . 0.0 109.646 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.98 176.94 23.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.24 175.41 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 109.429 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 8.6 p90 -137.94 167.24 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.526 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . 0.478 ' CG ' HG13 ' H' ' 12' ' ' VAL . 23.4 t80 -149.57 115.48 5.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.288 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -133.84 90.82 26.33 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.227 -0.92 . . . . 0.0 109.328 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.16 101.0 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.674 2.249 . . . . 0.0 110.092 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.82 -57.58 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 109.656 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.056 -0.974 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 19.6 tt -131.08 8.05 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -128.71 -5.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.299 -0.876 . . . . 0.0 109.771 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -115.06 -0.06 13.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.172 -0.955 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -135.01 8.16 3.47 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.47 -41.43 0.41 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.75 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -64.63 -20.71 66.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 39.0 p -66.44 -23.39 66.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 7.5 p -161.65 146.32 13.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.65 114.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.56 -164.25 0.98 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -109.56 168.12 9.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -34.77 78.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -67.3 -39.56 85.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.45 -39.99 92.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.32 -14.3 59.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.852 . . . . 0.0 109.899 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.81 -27.17 62.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -58.05 -18.62 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.359 -0.838 . . . . 0.0 109.74 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -111.97 61.31 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -122.84 121.85 37.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.198 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.504 -179.759 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 11.0 t80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.271 0.557 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.33 47.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' J' ' 4' ' ' GLN . 13.2 m120 -102.57 -8.46 20.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.842 . . . . 0.0 109.33 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' J' ' 3' ' ' ASN . 50.4 tt0 -44.03 -38.38 3.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.352 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . 0.428 ' HB3' HG12 ' E' ' 10' ' ' ILE . 86.4 t60 -93.34 -33.95 13.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.94 . . . . 0.0 109.211 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 38.9 mt -78.03 -70.28 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.437 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.489 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 7.3 t -51.97 -37.51 53.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.354 -0.842 . . . . 0.0 109.477 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.76 -45.17 96.98 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 9' ' ' SER . . . . . 0.458 ' HA ' HG23 ' J' ' 12' ' ' VAL . 86.6 p -68.51 -16.08 63.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -1.211 . . . . 0.0 110.078 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . 0.494 ' CG ' HD21 ' B' ' 6' ' ' LEU . 4.7 m-70 -82.92 -20.49 35.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.043 . . . . 0.0 109.716 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 7.8 mt -95.16 -34.18 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.508 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . 0.555 HG13 ' CG ' ' J' ' 26' ' ' TYR . 19.1 m -68.19 -33.9 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.107 -0.995 . . . . 0.0 109.239 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -70.97 -23.77 62.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.605 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.439 ' O ' HG22 ' J' ' 18' ' ' VAL . . . -95.55 -8.1 36.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.31 -0.869 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.8 -25.39 30.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.558 ' CZ ' HG22 ' L' ' 12' ' ' VAL . 46.3 m-85 -51.93 -44.54 63.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.456 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.424 HD11 HD11 ' D' ' 17' ' ' LEU . 13.1 mt -83.34 -39.17 21.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.618 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . 0.439 HG22 ' O ' ' J' ' 14' ' ' ALA . 69.5 t -44.75 -44.15 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.54 -30.62 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.61 -135.42 12.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -9.78 44.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.214 -1.168 . . . . 0.0 109.949 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -53.84 -76.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 0.0 109.664 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.46 176.8 22.99 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.21 171.16 11.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 109.688 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' J' ' 25' ' ' PHE . 6.1 p90 -134.39 165.07 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.47 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . 0.555 ' CG ' HG13 ' J' ' 12' ' ' VAL . 23.3 t80 -146.07 118.76 8.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.254 -0.904 . . . . 0.0 109.26 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 23.7 m -136.89 91.0 15.59 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.717 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.34 100.05 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.243 . . . . 0.0 110.413 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -59.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.256 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.495 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 20.6 tt -133.03 9.5 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -1.1 . . . . 0.0 109.473 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.71 -3.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.936 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -116.25 -2.1 12.22 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.08 -1.013 . . . . 0.0 109.446 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -133.23 11.18 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.341 -0.849 . . . . 0.0 109.408 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 -40.78 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 109.739 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -66.16 -16.76 64.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.964 . . . . 0.0 109.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -69.42 -26.29 64.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.236 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 6.4 p -158.08 149.9 21.69 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -0.913 . . . . 0.0 109.544 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.58 115.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -87.78 -164.27 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.984 . . . . 0.0 109.49 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.28 171.08 7.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.301 -0.874 . . . . 0.0 109.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -36.78 77.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.348 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -65.57 -38.66 90.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.669 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -66.05 -40.38 90.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.1 mt -78.43 -13.54 59.79 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.851 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.88 -28.29 63.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -57.97 -17.23 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -0.79 . . . . 0.0 109.659 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.82 60.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 t -123.17 120.36 32.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.393 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.464 ' HB ' HD13 ' C' ' 10' ' ' ILE . 29.0 m -127.8 45.75 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.54 -6.57 23.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -46.06 -39.69 9.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -92.26 -30.75 15.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . 0.462 HD22 ' H3 ' ' D' ' 32' ' ' IPH . 31.7 mt -80.73 -72.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.193 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.485 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 8.3 t -49.49 -39.95 35.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . 0.4 ' O ' HG12 ' L' ' 12' ' ' VAL . . . -59.68 -43.53 97.69 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 9' ' ' SER . . . . . 0.461 ' HA ' HG23 ' L' ' 12' ' ' VAL . 87.4 p -68.33 -18.15 64.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.16 -1.2 . . . . 0.0 109.784 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -81.56 -21.73 38.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.992 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 6.7 mt -93.75 -34.35 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . 0.558 HG22 ' CZ ' ' J' ' 16' ' ' TYR . 18.6 m -67.28 -38.57 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.01 . . . . 0.0 109.51 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . 0.534 ' N ' HG21 ' L' ' 12' ' ' VAL . 17.1 tt0 -65.72 -25.07 67.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.898 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.488 ' CB ' HD12 ' F' ' 17' ' ' LEU . . . -92.57 -14.14 28.71 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . 0.465 ' HA ' HG22 ' L' ' 18' ' ' VAL . 6.7 mt -78.63 -31.31 46.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 0.0 109.401 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.477 ' OH ' ' HB ' ' J' ' 12' ' ' VAL . 44.7 m-85 -45.51 -45.38 13.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.9 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.47 ' HB3' HD13 ' E' ' 13' ' ' LEU . 13.1 mt -84.0 -35.75 23.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 109.933 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' L' ' 15' ' ' LEU . 70.3 t -47.42 -45.36 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.61 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.81 -33.52 27.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.234 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.75 -134.96 12.02 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -11.49 39.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.19 -1.182 . . . . 0.0 109.471 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -52.71 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.921 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.34 178.47 27.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.29 172.29 9.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.158 -1.201 . . . . 0.0 109.69 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -134.21 163.62 29.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . 0.488 ' CG ' HG13 ' L' ' 12' ' ' VAL . 24.4 t80 -147.38 113.34 5.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.226 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -132.56 89.91 34.67 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.767 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.16 100.6 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 110.47 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -159.63 -62.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.337 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.462 ' H3 ' HD22 ' L' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 31' ' ' IPH . . . . . 0.407 ' C2 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.19 0.15 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.215 -1.167 . . . . 0.0 109.618 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 59.2 t -100.82 46.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.002 . . . . 0.0 109.681 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -171.58 -40.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.31 -7.17 26.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.126 -0.984 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.85 -18.94 3.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.482 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 0.5 OUTLIER -82.73 -18.26 41.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 109.117 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.3 p -83.72 -12.51 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.533 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.84 2.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.544 ' CD1' ' HB ' ' F' ' 2' ' ' VAL . 2.0 mp -61.57 140.85 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.2 m -103.94 -164.77 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.858 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -103.62 -174.3 2.51 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -0.935 . . . . 0.0 109.23 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.84 -37.37 64.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -68.91 -23.94 64.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.87 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -79.16 -39.36 33.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.593 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.6 mt -82.05 -11.68 58.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.52 -21.26 49.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.687 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -62.13 -18.68 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.962 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -118.33 48.02 1.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.86 110.95 13.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.208 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.644 -179.709 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.267 0.556 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.93 106.02 4.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.34 -0.85 . . . . 0.0 109.319 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -103.15 -8.2 20.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 0.0 109.246 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -48.88 -36.91 18.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.215 -0.928 . . . . 0.0 109.031 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.484 ' CB ' HG12 ' I' ' 10' ' ' ILE . 18.5 t60 -95.64 -30.38 13.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.147 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.05 -70.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.483 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.5 t -53.74 -32.16 51.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 0.0 109.767 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.94 -32.21 53.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.458 ' OG ' ' OH ' ' D' ' 16' ' ' TYR . 29.1 t -79.2 -3.34 45.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -1.23 . . . . 0.0 109.579 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.22 -14.65 20.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.336 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 14.3 mt -91.91 -43.55 9.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.563 HG22 ' CE2' ' D' ' 16' ' ' TYR . 2.7 m -56.8 -37.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.12 -36.18 81.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.332 -0.855 . . . . 0.0 109.871 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.89 11.19 39.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.081 -1.012 . . . . 0.0 109.807 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 11' ' ' LEU . 0.7 OUTLIER -96.67 -54.91 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.519 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 7.8 p90 -63.94 -18.05 63.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.954 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -78.28 -48.18 16.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -0.888 . . . . 0.0 109.45 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.05 -47.97 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.21 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.64 -57.07 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.89 -140.34 15.13 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 20' ' ' GLY . 19.4 mt-10 -45.54 -30.79 1.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.245 . . . . 0.0 109.36 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -69.35 159.81 32.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' B' ' 24' ' ' PHE . . . -100.51 -158.24 27.86 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 11.3 p90 -178.76 177.28 0.88 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -1.142 . . . . 0.0 109.228 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.55 146.39 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.683 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.482 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 28.6 t80 -122.93 87.29 2.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -117.61 105.74 47.49 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.1 -36.26 1.09 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.499 2.133 . . . . 0.0 110.538 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mttm 64.22 -87.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 109.41 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.528 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 15.4 tt -112.24 0.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' C' ' 3' ' ' VAL . 55.6 t -101.15 46.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -171.58 -45.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.72 -7.43 37.34 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.696 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.56 -17.71 4.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.163 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -86.34 -16.18 38.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 109.862 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.4 p -86.12 -10.51 54.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 109.517 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' SER . . . . . 0.462 ' HB3' HG22 ' L' ' 2' ' ' VAL . 0.1 OUTLIER -171.79 148.49 2.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 108.995 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' L' ' 5' ' ' HIS . 1.3 mp -58.25 151.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 109.382 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.7 -174.43 2.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.372 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -177.16 4.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.58 -38.86 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -66.29 -24.62 66.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -79.7 -36.87 36.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.98 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 62.4 mt -85.15 -6.83 59.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.89 -18.21 38.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -65.69 -19.77 66.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.279 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -116.98 48.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.484 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.89 108.24 10.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.494 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.572 -179.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.485 ' HB ' HD11 ' G' ' 10' ' ' ILE . 4.4 t -131.06 106.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 109.529 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -103.16 -8.78 20.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -48.82 -36.55 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -94.62 -31.31 13.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.1 mt -81.39 -71.24 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 19.5 t -49.75 -37.92 31.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.51 -35.9 68.34 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -75.25 -5.1 42.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.098 -1.236 . . . . 0.0 109.714 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -97.1 -16.27 20.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 16.9 mt -91.97 -41.87 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.818 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.03 -34.98 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 109.735 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -69.54 -34.51 74.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.36 6.83 45.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.195 -0.941 . . . . 0.0 109.84 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.9 OUTLIER -92.24 -57.27 2.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.049 -1.032 . . . . 0.0 109.494 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.563 ' CE2' HG22 ' B' ' 12' ' ' VAL . 7.6 p90 -61.2 -19.06 61.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.79 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.425 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 1.5 mt -78.03 -48.59 15.79 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -0.963 . . . . 0.0 109.574 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -54.49 -45.16 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.17 -54.42 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.09 -137.33 14.12 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.78 -29.0 4.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -1.138 . . . . 0.0 109.35 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.58 158.36 33.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.271 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.04 -161.8 27.57 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 6.5 p90 -167.33 178.26 5.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -1.224 . . . . 0.0 110.208 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -129.86 133.31 46.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -117.21 88.81 2.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.4 m -124.23 106.25 30.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.323 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.52 -32.73 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.344 2.029 . . . . 0.0 110.629 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.53 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.425 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 tt -114.46 0.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.226 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' E' ' 3' ' ' VAL . 58.3 t -101.81 45.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.285 -0.884 . . . . 0.0 109.988 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -169.96 -42.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.96 -9.15 28.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.311 -0.868 . . . . 0.0 109.722 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.34 -14.24 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 110.352 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.67 -17.41 33.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.937 -1.102 . . . . 0.0 109.316 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -86.32 -10.01 55.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.27 151.62 3.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.468 HD12 ' HB ' ' J' ' 2' ' ' VAL . 2.0 mp -63.46 138.74 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.381 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 61.7 m -102.62 -165.62 1.2 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.081 -1.012 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -104.52 -175.46 2.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.07 -38.85 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 110.031 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -68.38 -24.16 64.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.674 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -78.03 -41.38 35.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 65.1 mt -81.28 -9.62 59.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.233 -0.917 . . . . 0.0 109.993 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.35 -17.7 48.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 109.636 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -66.15 -16.91 64.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.424 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -119.27 50.6 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -130.48 110.21 11.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.543 -179.934 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.215 0.531 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.544 ' HB ' ' CD1' ' A' ' 10' ' ' ILE . 3.9 t -138.81 107.46 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.216 -0.927 . . . . 0.0 109.468 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -103.68 -5.88 22.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.741 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -50.94 -37.54 44.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.075 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . 0.401 ' CB ' HG12 ' A' ' 10' ' ' ILE . 16.3 t60 -95.21 -24.68 16.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.356 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 22.0 mt -87.83 -69.85 0.67 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 10.2 t -52.96 -35.65 59.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.36 -31.69 63.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 1.1 t -77.95 -7.83 57.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -1.216 . . . . 0.0 109.576 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -93.86 -16.87 23.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 110.091 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' F' ' 15' ' ' LEU . 10.9 mt -91.41 -41.42 10.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.24 -32.27 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.5 -33.3 66.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 109.652 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.72 6.58 43.99 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.8 OUTLIER -92.46 -54.71 3.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.682 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 7.2 p90 -63.9 -20.8 66.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.81 -49.86 16.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -52.06 -43.53 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 79.5 m -69.49 -51.8 32.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.661 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 87.78 -139.98 16.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' F' ' 20' ' ' GLY . 17.7 mt-10 -44.95 -34.34 2.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 109.365 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -67.37 159.04 30.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.811 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.25 -165.3 24.72 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -166.69 -171.13 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -1.112 . . . . 0.0 109.621 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.04 142.62 30.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -120.76 94.68 4.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -126.98 103.36 23.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 109.216 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.7 -36.41 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.393 2.062 . . . . 0.0 110.464 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 65.54 -86.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 14.8 tt -111.16 -0.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -1.136 . . . . 0.0 109.519 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' G' ' 3' ' ' VAL . 55.6 t -100.42 47.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.246 -0.908 . . . . 0.0 109.708 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -171.91 -42.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.98 . . . . 0.0 109.737 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.5 -9.69 24.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.62 -9.08 5.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.931 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.47 -13.96 27.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 109.477 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 41.0 p -88.23 -14.0 39.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.34 149.33 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.485 HD11 ' HB ' ' D' ' 2' ' ' VAL . 1.8 mp -57.33 146.66 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.188 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -112.3 -168.4 1.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 110.404 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -101.78 176.28 5.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -65.71 -41.96 91.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.962 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -64.76 -25.27 67.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.281 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -78.06 -39.91 40.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.048 -1.032 . . . . 0.0 109.694 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.28 -6.09 59.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.612 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -83.75 -19.67 34.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.12 -18.87 65.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.478 -0.764 . . . . 0.0 109.408 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -118.28 51.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.381 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.94 107.62 8.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.853 . . . . 0.0 109.451 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.43 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.395 0.616 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.519 ' HB ' HD11 ' K' ' 10' ' ' ILE . 4.9 t -140.73 102.57 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.43 -0.794 . . . . 0.0 109.279 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' H' ' 4' ' ' GLN . 23.6 m-80 -100.33 -11.65 20.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' H' ' 3' ' ' ASN . 2.3 tt0 -44.76 -37.11 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.836 . . . . 0.0 109.168 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . 0.427 ' O ' ' HB3' ' H' ' 9' ' ' SER . 13.7 t60 -95.09 -29.48 14.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.813 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.9 mt -84.22 -69.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.5 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.469 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 1.4 t -52.88 -34.86 56.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 109.151 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.88 -32.8 60.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 9' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' H' ' 5' ' ' HIS . 1.4 t -77.66 -5.87 51.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -1.178 . . . . 0.0 109.867 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.13 -14.87 21.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.965 . . . . 0.0 109.882 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.1 mt -91.85 -42.59 9.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.642 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 m -58.03 -35.32 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.872 . . . . 0.0 109.805 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.26 -35.84 76.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.52 8.99 44.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.287 -0.883 . . . . 0.0 109.828 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.7 OUTLIER -95.56 -55.71 2.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 8.5 p90 -62.31 -22.08 65.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.404 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 1.6 mt -74.0 -49.8 22.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.26 -44.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -52.7 49.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.963 -1.086 . . . . 0.0 109.023 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.86 -137.51 14.27 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.98 -28.41 3.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -72.64 156.55 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.92 . . . . 0.0 109.19 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.51 -163.06 29.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -171.48 -171.54 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.338 -1.095 . . . . 0.0 109.196 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 3.2 p90 -146.64 146.94 30.57 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -122.23 92.4 3.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -122.5 104.99 36.51 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.367 -0.833 . . . . 0.0 109.262 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' H' ' 29' ' ' LYS . 35.9 Cg_endo -78.18 -39.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 0.0 109.977 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.6 OUTLIER 69.91 -85.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.423 -179.673 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 12.6 tt -110.51 0.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -1.151 . . . . 0.0 109.553 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.64 48.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.248 -0.907 . . . . 0.0 109.762 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -172.62 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.842 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.03 -11.94 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 110.009 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -126.78 -13.87 5.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.06 -15.36 41.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -87.81 -17.44 31.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.27 153.44 13.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . 0.484 HG12 ' CB ' ' B' ' 5' ' ' HIS . 1.9 mp -64.59 140.78 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.987 . . . . 0.0 109.374 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 62.8 m -103.26 -163.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.44 -173.91 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp -73.28 -39.58 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.258 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -67.68 -22.67 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.41 -0.806 . . . . 0.0 109.735 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -81.0 -36.62 30.42 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.57 -9.52 57.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.55 -19.64 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 0.0 109.904 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -64.17 -20.1 65.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -115.87 48.77 1.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.523 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -128.47 109.33 11.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.377 179.82 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.468 ' HB ' HD12 ' E' ' 10' ' ' ILE . 4.6 t -136.01 103.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.816 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -101.31 -10.68 20.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.555 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -47.18 -35.08 6.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -96.77 -29.09 13.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.28 -69.05 0.67 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.08 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 1.4 t -53.56 -33.05 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.367 -0.833 . . . . 0.0 109.367 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.61 54.97 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -77.6 -2.49 36.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.007 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -97.95 -15.45 20.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 14.2 mt -92.49 -42.38 9.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.578 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -58.32 -34.28 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.65 -33.02 70.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.91 6.59 43.71 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.195 -0.941 . . . . 0.0 109.704 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' J' ' 11' ' ' LEU . 0.8 OUTLIER -92.62 -55.91 3.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.511 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 10.0 p90 -63.08 -18.6 63.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.15 -50.62 11.62 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.101 -1.0 . . . . 0.0 109.103 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.65 -46.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.32 -53.28 38.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 -137.93 14.78 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -47.33 -29.87 2.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.78 153.58 41.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.59 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.68 30.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -163.5 -170.72 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -1.103 . . . . 0.0 109.573 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . 0.445 ' CD1' ' O ' ' J' ' 25' ' ' PHE . 36.0 p90 -144.01 143.93 31.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.597 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -121.55 90.64 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.39 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -122.16 103.65 38.95 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.97 -36.76 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.425 2.083 . . . . 0.0 110.496 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 65.52 -86.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.333 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.487 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 15.8 tt -111.53 1.62 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -1.14 . . . . 0.0 109.649 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 48.5 t -102.38 46.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -171.41 -42.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 109.623 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.15 33.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 109.918 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -129.71 -23.17 2.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.07 -1.019 . . . . 0.0 110.183 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' L' ' 7' ' ' CYS . 0.5 OUTLIER -79.87 -12.35 59.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.048 -1.032 . . . . 0.0 109.593 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -90.22 -9.62 47.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.09 152.77 2.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . 0.519 HD11 ' HB ' ' H' ' 2' ' ' VAL . 1.8 mp -65.65 135.27 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.994 . . . . 0.0 109.265 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -97.29 -164.02 1.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 109.594 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.21 -173.16 2.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -74.34 -40.5 62.12 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.165 -0.959 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -66.58 -26.52 67.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.06 -37.78 57.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.876 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 55.2 mt -85.6 -6.26 59.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.899 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.1 -19.47 36.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.991 . . . . 0.0 109.274 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -64.57 -16.98 63.51 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.359 -0.838 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -119.58 47.73 1.66 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . 0.418 ' O ' ' OXT' ' K' ' 21' ' ' ASN . 0.1 OUTLIER -128.08 108.5 10.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.534 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . 0.418 ' OXT' ' O ' ' K' ' 20' ' ' CYS . 6.4 t-20 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.502 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' C' ' 9' ' ' SER . 6.9 t -136.76 107.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 109.662 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -102.95 -8.21 20.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.732 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -47.84 -34.55 8.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . 0.541 ' CB ' HG12 ' C' ' 10' ' ' ILE . 19.2 t60 -98.75 -29.33 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 mt -82.44 -69.75 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.107 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 11.8 t -53.88 -33.92 57.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.24 -33.41 56.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 9' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' L' ' 5' ' ' HIS . 2.0 t -77.34 -4.57 45.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -1.104 . . . . 0.0 109.637 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -98.16 -14.42 20.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.194 -0.941 . . . . 0.0 109.541 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 15.6 mt -91.98 -44.12 9.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.37 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -56.57 -35.1 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.932 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -69.57 -35.57 75.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 109.699 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.69 8.7 44.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' L' ' 11' ' ' LEU . 0.7 OUTLIER -94.63 -52.73 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.773 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 12.7 p90 -66.3 -18.87 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.003 -1.061 . . . . 0.0 109.366 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.63 -48.18 17.49 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.94 -46.76 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.16 -55.22 27.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.223 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.4 -138.53 14.34 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -48.49 -29.4 4.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 0.0 109.31 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -72.04 156.04 39.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 109.438 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.55 -165.25 29.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -167.23 -176.88 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -1.13 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -137.55 146.54 44.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -124.07 85.56 2.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 105.1 50.15 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 109.534 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.86 -32.13 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 110.319 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mttm 61.77 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.349 -179.634 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 80.9 mt -122.47 -24.88 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -1.158 . . . . 0.0 109.492 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.25 -14.98 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.226 -0.921 . . . . 0.0 109.54 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.84 45.52 2.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -166.28 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.845 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.54 -24.7 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -14.6 59.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.426 ' O ' ' HB3' ' A' ' 9' ' ' SER . 33.0 p -97.56 3.1 50.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 109.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 8' ' ' THR . 80.9 p -179.46 137.58 0.13 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.161 -0.962 . . . . 0.0 109.688 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -54.73 147.14 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.845 . . . . 0.0 109.472 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -121.14 174.09 6.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -101.23 -177.16 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 4.4 mp -75.16 -24.87 57.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.502 -0.749 . . . . 0.0 109.654 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.98 -43.03 65.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.673 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -70.77 -42.45 70.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.647 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.74 -23.27 61.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 9.3 mt-10 -76.75 -22.46 53.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -57.74 -23.67 53.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 20' ' ' CYS . 75.2 m-85 -84.21 -104.74 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.285 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 53.41 168.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.902 -1.123 . . . . 0.0 109.791 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.03 -0.985 . . . . 0.0 109.517 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' I' ' 9' ' ' SER . 17.0 m -79.07 83.49 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -124.78 -26.07 3.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.981 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -38.76 69.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 109.5 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.533 ' CB ' HG12 ' I' ' 10' ' ' ILE . 12.8 t60 -88.56 -29.44 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.907 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.455 HD13 HG22 ' B' ' 2' ' ' VAL . 28.0 mt -87.93 -72.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 38.5 t -45.78 -34.91 3.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.61 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.78 -40.58 52.4 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.6 p -74.75 0.97 13.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -1.181 . . . . 0.0 109.97 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.47 -23.21 16.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 109.3 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.86 -36.14 17.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.407 -0.808 . . . . 0.0 109.526 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 20.7 m -48.99 -46.65 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.407 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.07 -31.97 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.3 21.99 6.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.113 -0.992 . . . . 0.0 109.424 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.92 -60.84 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.471 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.4 p90 -64.12 -33.15 75.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.449 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.469 HD23 ' CB ' ' H' ' 14' ' ' ALA . 43.0 tp -63.84 -42.52 97.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.24 -61.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.605 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.42 -70.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.0 132.77 0.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 53.81 41.23 32.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -1.162 . . . . 0.0 109.795 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.409 ' HD3' ' SG ' ' A' ' 20' ' ' CYS . 1.8 ttt180 -143.19 -62.25 0.41 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.63 157.64 11.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 8.0 p90 -160.23 172.95 16.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -1.14 . . . . 0.0 109.289 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 8.0 p90 -130.31 146.95 51.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -132.47 99.82 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.715 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.69 91.39 18.14 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 109.416 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 84.22 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.501 2.134 . . . . 0.0 110.306 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -127.84 34.92 4.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.381 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.3 -23.53 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.766 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.2 -12.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -137.98 35.98 2.36 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 109.232 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -155.64 -35.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.08 -23.84 10.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.559 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -12.16 59.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.532 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -99.72 2.47 44.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 109.78 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -178.91 138.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.28 147.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.54 178.06 4.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -104.98 -176.02 2.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 5.3 mp -76.19 -26.36 56.08 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -69.86 -43.58 71.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.862 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -70.97 -42.66 69.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 109.675 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.4 -25.68 63.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.964 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 9.2 mt-10 -74.3 -23.9 59.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.993 -1.067 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -55.66 -26.33 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' C' ' 20' ' ' CYS . 70.9 m-85 -83.25 -109.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.399 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' C' ' 19' ' ' TYR . 4.4 m 54.38 168.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 109.244 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 C--N 1.303 -1.437 0 O-C-N 121.057 -1.027 . . . . 0.0 109.515 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.0 t80 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.527 ' CG1' ' HA ' ' G' ' 9' ' ' SER . 16.0 m -81.76 84.08 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -123.82 -23.77 4.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -40.59 82.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.429 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . 0.454 ' CB ' HG12 ' G' ' 10' ' ' ILE . 11.8 t60 -87.68 -25.84 23.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.453 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.432 HD13 HG22 ' D' ' 2' ' ' VAL . 29.1 mt -92.05 -72.37 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 39.4 t -45.43 -35.56 3.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -0.855 . . . . 0.0 109.71 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.85 -39.45 54.85 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 59.7 p -73.88 -2.19 22.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 109.76 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.787 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.07 -35.46 16.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 18.4 m -50.21 -46.19 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 1.3 pt-20 -67.04 -30.95 71.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.56 17.48 13.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.165 -0.96 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.84 -61.04 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.833 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.486 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 6.3 p90 -63.24 -32.55 73.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.57 -37.47 86.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -57.55 -62.83 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 109.586 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -66.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.51 135.2 0.11 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 51.84 44.23 29.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -1.064 . . . . 0.0 109.555 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -146.18 -60.82 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.792 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.32 157.03 11.82 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 10.6 p90 -161.38 171.15 18.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.108 -1.231 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . 0.567 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 39.2 m-85 -125.83 154.19 42.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -140.75 95.83 2.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.565 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 85.0 m -133.58 91.4 26.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.47 83.86 2.08 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.634 2.223 . . . . 0.0 110.702 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -128.26 36.98 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 109.63 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.557 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 76.4 mt -120.89 -22.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -1.13 . . . . 0.0 109.643 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.89 -14.05 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.69 41.73 2.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -161.33 -35.99 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.27 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.0 -24.74 10.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.769 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -13.24 60.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.316 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 66.6 p -96.87 -1.67 45.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.758 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -175.36 142.7 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.54 145.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -116.87 179.44 4.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 -174.33 2.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.406 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -77.03 -27.22 54.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.176 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -69.13 -44.06 73.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.75 -39.99 76.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 110.33 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.9 mt -73.88 -24.43 59.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.943 . . . . 0.0 110.042 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.57 -26.16 59.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.063 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -53.42 -25.53 16.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' E' ' 20' ' ' CYS . 70.6 m-85 -83.29 -104.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.107 -0.996 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' E' ' 19' ' ' TYR . 0.9 OUTLIER 52.55 171.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.949 -1.094 . . . . 0.0 109.495 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 120.97 -1.081 . . . . 0.0 109.554 -179.879 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.46 HG22 HD13 ' F' ' 6' ' ' LEU . 17.9 m -79.48 83.42 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -123.44 -26.14 4.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.058 -1.026 . . . . 0.0 109.775 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.97 70.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.487 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -85.59 -28.92 24.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . 0.46 HD13 HG22 ' F' ' 2' ' ' VAL . 27.0 mt -88.71 -72.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.956 . . . . 0.0 109.743 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -45.25 -36.52 4.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.811 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.94 -39.05 59.78 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 97.3 p -75.49 0.59 16.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 0.0 109.736 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -97.82 -21.96 16.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.32 -34.7 16.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.211 -0.931 . . . . 0.0 109.417 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 m -49.37 -46.88 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 109.312 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 1.9 pt-20 -66.66 -33.03 74.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.547 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -91.74 17.48 8.91 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.266 -0.896 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.68 -61.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 110.117 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.474 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 6.5 p90 -63.37 -33.02 74.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.035 . . . . 0.0 109.633 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 41.9 tp -64.9 -42.1 95.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -52.48 -62.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.418 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.6 -71.13 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.536 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.37 135.71 0.37 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 50.93 43.18 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -1.132 . . . . 0.0 109.603 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.03 -66.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.365 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.77 160.22 10.82 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . 0.474 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 13.8 p90 -168.85 163.61 11.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -1.067 . . . . 0.0 109.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -126.34 147.94 49.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 109.532 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -127.87 104.63 7.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.448 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 86.9 m -138.78 89.16 13.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.681 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.97 85.82 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.57 2.18 . . . . 0.0 110.564 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -130.51 37.52 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.286 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.88 -24.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -78.36 -12.38 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.69 34.09 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.228 -0.92 . . . . 0.0 109.696 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -152.64 -37.15 0.11 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.0 -24.62 10.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -15.02 61.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.319 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 45.9 p -98.46 -2.24 39.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.62 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 9' ' ' SER . . . . . 0.527 ' HA ' ' CG1' ' D' ' 2' ' ' VAL . 93.6 p -171.79 135.97 0.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.088 -1.008 . . . . 0.0 109.752 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.454 HG12 ' CB ' ' D' ' 5' ' ' HIS . 2.5 mp -55.01 143.99 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.229 -0.919 . . . . 0.0 108.806 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 m -115.84 177.58 4.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.954 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -104.45 178.19 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.43 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.6 -26.36 62.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.267 -0.896 . . . . 0.0 109.745 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -70.6 -40.9 72.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -72.57 -39.44 67.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.249 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.96 -22.14 58.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.852 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -76.44 -24.46 53.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 109.323 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.46 -25.44 36.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.837 . . . . 0.0 109.813 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' G' ' 20' ' ' CYS . 73.9 m-85 -83.65 -103.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' G' ' 19' ' ' TYR . 0.9 OUTLIER 51.19 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.105 . . . . 0.0 109.658 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.554 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 12.1 t80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.462 ' O ' HG22 ' H' ' 2' ' ' VAL . 16.2 m -79.61 81.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -121.87 -28.5 4.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.647 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -39.72 66.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.928 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -89.52 -21.73 22.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 109.736 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 mt -95.8 -70.7 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.5 t -46.52 -35.64 5.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.46 -39.16 57.31 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -77.0 2.92 13.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -1.182 . . . . 0.0 109.663 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -98.94 -23.39 15.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.413 HD22 ' N ' ' H' ' 11' ' ' LEU . 5.1 mt -87.98 -35.09 17.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -49.5 -46.37 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.489 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 3.0 pt-20 -67.85 -30.92 70.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.317 -0.864 . . . . 0.0 109.418 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.469 ' CB ' HD23 ' B' ' 17' ' ' LEU . . . -95.02 21.63 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.341 -0.85 . . . . 0.0 109.635 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 -60.06 1.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.639 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 7.4 p90 -64.58 -32.6 74.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.385 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 43.8 tp -65.05 -42.52 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.383 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -51.98 -65.83 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.224 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 58.6 m -64.33 -73.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.3 136.65 0.84 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 49.87 46.06 24.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.169 -1.195 . . . . 0.0 109.333 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -147.6 -58.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.403 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.06 158.39 14.29 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 9.8 p90 -163.34 174.7 11.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -1.154 . . . . 0.0 109.428 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 15.0 p90 -129.93 157.86 41.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -144.04 91.91 2.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 84.9 m -129.19 90.52 44.82 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.75 86.32 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.433 2.089 . . . . 0.0 110.154 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -130.06 35.24 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.912 . . . . 0.0 109.595 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.546 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.15 -26.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -1.166 . . . . 0.0 109.358 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 p -75.85 -12.86 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -138.25 43.82 2.16 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -163.04 -37.45 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.213 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . 0.473 ' SG ' ' O1 ' ' J' ' 32' ' ' IPH . 2.1 t -109.6 -27.05 9.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 109.151 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -72.01 -17.16 62.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 37.1 p -96.38 1.63 51.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 9' ' ' SER . . . . . 0.528 ' HA ' ' CG1' ' B' ' 2' ' ' VAL . 85.8 p -177.24 141.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.543 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . 0.533 HG12 ' CB ' ' B' ' 5' ' ' HIS . 2.7 mp -60.77 139.93 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.355 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 m -110.04 -174.72 2.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.182 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -110.63 -175.98 2.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.175 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 3.3 mp -75.42 -24.27 57.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.562 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.57 -43.48 63.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.89 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -70.04 -44.58 68.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -68.63 -26.06 65.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.979 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 9.0 mt-10 -74.46 -22.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.032 . . . . 0.0 109.731 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.93 -23.2 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.704 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' I' ' 20' ' ' CYS . 71.3 m-85 -83.87 -109.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 0.0 109.114 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' I' ' 19' ' ' TYR . 0.9 OUTLIER 55.61 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.66 -1.275 . . . . 0.0 109.651 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.528 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 m -81.48 83.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 109.568 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.6 -32.2 3.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.75 -39.29 37.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.102 -0.999 . . . . 0.0 109.882 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -88.44 -27.82 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' J' ' 7' ' ' CYS . 33.7 mt -90.96 -71.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' J' ' 6' ' ' LEU . 6.4 t -45.01 -38.89 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.05 -39.83 84.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 9' ' ' SER . . . . . 0.417 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 79.2 p -75.86 1.46 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.157 -1.202 . . . . 0.0 109.78 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -97.25 -23.41 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.553 ' CD2' ' C6 ' ' J' ' 32' ' ' IPH . 3.4 mt -88.43 -36.24 16.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . 0.406 HG22 ' N ' ' J' ' 13' ' ' GLU . 23.5 m -48.09 -45.64 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.444 -0.785 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . 0.406 ' N ' HG22 ' J' ' 12' ' ' VAL . 0.8 OUTLIER -68.45 -32.17 72.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.63 21.56 6.25 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -0.876 . . . . 0.0 109.438 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.05 -60.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.656 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.461 ' OH ' ' HB2' ' L' ' 9' ' ' SER . 7.8 p90 -64.66 -32.54 74.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.102 -0.999 . . . . 0.0 109.371 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.1 -40.8 95.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.31 -61.19 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -69.6 -69.51 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.3 133.88 0.17 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 53.62 43.5 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -1.109 . . . . 0.0 109.578 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -145.38 -59.0 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.29 155.37 12.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . 0.455 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 6.9 p90 -158.88 -179.64 8.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -1.18 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.31 158.86 43.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -144.44 94.89 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.485 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -132.35 91.51 31.03 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.46 -0.775 . . . . 0.0 109.287 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.09 86.62 1.66 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.679 2.253 . . . . 0.0 110.149 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -130.82 36.67 3.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.405 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.07 -24.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.53 -7.71 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -142.14 34.17 1.53 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.604 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -153.35 -36.49 0.1 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . 0.433 ' SG ' ' O1 ' ' L' ' 32' ' ' IPH . 2.4 t -110.41 -26.12 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.208 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -73.28 -13.25 61.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.415 -0.803 . . . . 0.0 109.633 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 43.5 p -99.75 0.26 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.598 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p -176.31 145.64 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.902 . . . . 0.0 109.306 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.14 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.97 . . . . 0.0 109.393 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 33.7 m -108.8 -176.05 2.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.516 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -109.89 -177.5 3.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 109.16 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 3.3 mp -74.49 -25.64 59.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 0.0 109.74 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -71.24 -42.97 68.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.301 -0.875 . . . . 0.0 109.943 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -70.49 -43.53 69.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.878 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.27 -24.08 62.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 8.3 mt-10 -75.41 -24.09 57.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -56.94 -23.81 48.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' K' ' 20' ' ' CYS . 73.0 m-85 -85.07 -112.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' K' ' 19' ' ' TYR . 6.1 m 55.46 168.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.733 -1.229 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.381 179.974 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.446 HG22 HD13 ' L' ' 6' ' ' LEU . 22.3 m -77.1 84.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 109.813 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -125.4 -27.1 3.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -37.3 66.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.562 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -91.13 -25.26 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . 0.446 HD13 HG22 ' L' ' 2' ' ' VAL . 27.3 mt -92.72 -69.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.351 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -48.23 -34.94 11.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.263 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.19 -39.1 58.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 9' ' ' SER . . . . . 0.461 ' HB2' ' OH ' ' J' ' 16' ' ' TYR . 89.1 p -76.42 1.17 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -1.136 . . . . 0.0 109.717 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -98.28 -24.08 15.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.364 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mt -86.72 -33.68 19.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -51.83 -45.76 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 1.7 pt-20 -67.07 -33.24 75.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -92.11 19.63 6.68 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.7 -61.69 1.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.473 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 7.5 p90 -62.57 -32.96 74.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.6 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 49.7 tp -65.05 -37.31 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.846 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.6 -59.06 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -67.38 0.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.085 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.46 134.3 0.1 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 53.27 42.41 32.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -1.175 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -145.32 -60.16 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.018 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.45 162.24 14.83 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 12.2 p90 -165.51 172.09 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -1.2 . . . . 0.0 109.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -127.49 154.18 45.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.447 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -140.43 99.31 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -136.46 91.76 15.95 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 109.578 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.18 84.41 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.74 2.293 . . . . 0.0 110.663 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -128.8 38.49 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.429 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . 0.553 ' C6 ' ' CD2' ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . 0.433 ' O1 ' ' SG ' ' K' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.75 3.53 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -1.15 . . . . 0.0 109.721 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.52 -11.21 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.86 43.63 2.07 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.301 -0.874 . . . . 0.0 109.356 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.25 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.043 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.4 m -115.15 26.48 10.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.6 t -117.64 -24.2 7.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.066 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -109.0 8.52 26.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.93 120.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mp -49.11 134.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -94.42 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.121 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -110.03 172.18 7.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -27.25 67.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 109.665 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.71 -46.29 69.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -33.13 68.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.99 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.79 -8.09 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -89.69 -23.1 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.57 -8.0 54.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -93.44 4.93 53.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.499 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 156.68 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.349 0.595 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.415 ' O ' ' CG1' ' B' ' 2' ' ' VAL . 7.5 p -70.88 91.04 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.885 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.98 -45.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 0.0 109.143 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.36 -32.05 58.4 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.317 -0.864 . . . . 0.0 109.14 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -70.53 -43.2 70.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 mt -74.24 -32.69 63.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.288 -0.883 . . . . 0.0 108.886 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.09 -31.43 68.99 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.466 -0.771 . . . . 0.0 109.274 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.09 -26.94 61.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.14 -10.35 59.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.25 -1.147 . . . . 0.0 109.456 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -89.59 -24.6 21.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.086 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -87.59 -43.81 11.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.0 m -47.31 -42.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.35 -39.09 85.72 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 109.752 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.495 ' CB ' ' H5 ' ' B' ' 32' ' ' IPH . . . -92.38 25.59 2.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.183 -0.948 . . . . 0.0 109.555 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.06 -49.21 2.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.399 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.494 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 18.3 p90 -79.39 -25.82 42.08 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.448 HD21 HD21 ' H' ' 17' ' ' LEU . 28.0 tp -74.76 -35.9 62.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.5 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -58.12 -60.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.64 -64.48 0.85 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.579 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.46 -129.29 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.46 82.74 3.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -1.183 . . . . 0.0 109.662 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -148.44 -68.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.48 149.71 7.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.402 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 17.3 p90 -158.69 173.27 16.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -1.141 . . . . 0.0 109.312 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.566 ' HB3' ' CD2' ' D' ' 25' ' ' PHE . 23.9 p90 -129.01 146.06 51.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -124.8 102.7 7.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.458 -0.776 . . . . 0.0 109.025 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -140.72 106.01 6.37 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.922 . . . . 0.0 109.866 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.61 78.41 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.524 2.149 . . . . 0.0 110.278 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -174.29 2.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.634 -179.877 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.39 0.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -1.122 . . . . 0.0 109.258 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -85.38 -14.14 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.229 -0.919 . . . . 0.0 109.805 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.9 42.49 2.01 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.187 -0.946 . . . . 0.0 109.673 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -168.52 -34.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.229 -0.919 . . . . 0.0 109.534 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -120.89 19.7 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 109.151 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -20.31 11.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.504 -0.748 . . . . 0.0 109.205 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -111.53 7.04 20.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' L' ' 1' ' ' PHE . 85.6 p -175.87 120.12 0.17 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.901 . . . . 0.0 109.188 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mp -48.63 133.98 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.58 -169.75 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.343 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -107.43 172.84 6.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.29 -27.07 66.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.52 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -69.37 -42.92 74.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -29.23 55.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.31 -7.15 59.52 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.8 -23.66 21.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.493 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -74.53 -4.35 36.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.938 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -97.38 4.11 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.988 . . . . 0.0 109.36 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.17 155.49 18.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.469 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' G' ' 10' ' ' ILE . 4.7 p -69.61 94.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.93 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -79.36 -33.79 42.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 109.036 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -68.26 -41.07 81.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 108.919 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.63 -34.56 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.3 -28.25 67.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.456 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.23 -27.91 50.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -78.45 -8.1 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 109.211 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -93.65 -20.23 20.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.967 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mt -93.18 -44.29 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 20.2 m -45.89 -42.32 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.425 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -68.12 -43.98 77.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.316 -0.865 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.429 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -87.8 24.83 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.915 . . . . 0.0 109.862 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -50.53 2.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.017 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.514 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 12.0 p90 -77.92 -24.42 48.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.854 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' J' ' 14' ' ' ALA . 35.3 tp -76.86 -36.07 57.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.58 -61.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -66.16 -66.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.743 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.9 -129.41 8.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.57 82.35 3.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -1.159 . . . . 0.0 109.552 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -148.48 -69.9 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.587 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.61 143.08 5.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.422 ' N ' ' CD1' ' D' ' 24' ' ' PHE . 10.9 p90 -150.13 166.58 29.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.292 -1.122 . . . . 0.0 109.289 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . 0.566 ' CD2' ' HB3' ' B' ' 25' ' ' PHE . 11.7 m-85 -117.43 143.87 45.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.042 -1.036 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -127.04 104.84 8.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.084 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -148.83 105.37 3.42 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.28 83.68 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.397 2.065 . . . . 0.0 110.46 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.86 -179.88 2.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.441 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.393 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 tt -120.41 0.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -1.144 . . . . 0.0 109.762 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.38 -8.97 11.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.76 37.63 3.73 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.142 -0.974 . . . . 0.0 109.339 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -163.06 -42.2 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 90.3 m -113.85 26.27 10.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.228 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 51.1 t -117.24 -23.99 7.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -0.839 . . . . 0.0 109.188 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -109.93 10.97 24.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.19 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' SER . . . . . 0.475 ' HA ' ' HB3' ' J' ' 1' ' ' PHE . 2.2 p -178.81 119.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.41 132.51 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.744 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m -93.27 -169.91 2.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.6 175.45 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -24.59 63.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -71.88 -44.34 63.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -29.74 61.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.438 -0.789 . . . . 0.0 109.889 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -80.87 -10.35 59.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.922 . . . . 0.0 109.819 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -86.27 -25.44 25.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -70.66 -10.01 58.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.9 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -92.38 5.93 48.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 109.98 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.41 156.71 17.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.746 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.602 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.21 88.73 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.911 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.74 -44.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.91 . . . . 0.0 109.055 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.51 -30.77 53.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -70.46 -45.14 66.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.326 -0.859 . . . . 0.0 109.043 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.48 -30.71 63.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.327 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.1 t -72.36 -29.55 63.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.753 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.73 -25.94 59.59 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -84.23 -2.61 57.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 109.653 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . 0.467 ' ND1' HD21 ' J' ' 6' ' ' LEU . 2.6 m-70 -97.89 -19.16 18.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 15.2 mt -92.22 -43.67 9.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.527 -0.733 . . . . 0.0 109.271 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 22.8 m -48.26 -42.1 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' H' ' 13' ' ' GLU . 4.7 mt-10 -67.19 -43.07 83.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.749 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.489 ' CB ' ' H5 ' ' E' ' 31' ' ' IPH . . . -87.92 21.79 2.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.283 -0.886 . . . . 0.0 109.875 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.25 -51.91 2.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 13.4 p90 -76.37 -25.48 54.68 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.189 -0.944 . . . . 0.0 109.654 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.21 -35.54 59.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.96 . . . . 0.0 109.769 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.49 -59.23 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.686 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 17.9 m -68.44 -66.72 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.078 -1.014 . . . . 0.0 109.301 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.03 -126.07 7.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.44 78.38 5.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -1.092 . . . . 0.0 109.688 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -145.14 -71.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 109.851 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.99 138.84 4.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 14.4 p90 -145.94 173.18 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.349 -1.089 . . . . 0.0 109.019 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -125.27 145.52 49.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.032 . . . . 0.0 109.789 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -127.98 104.08 7.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.245 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -147.33 107.1 3.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.9 78.39 3.42 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.539 2.159 . . . . 0.0 110.693 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.52 179.49 5.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.551 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt -119.29 -1.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -1.091 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' H' ' 28' ' ' PRO . 33.8 m -84.42 -14.4 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.257 -0.902 . . . . 0.0 110.109 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.34 37.47 3.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.069 -1.019 . . . . 0.0 110.018 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -162.05 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.338 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -115.51 21.71 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -23.05 10.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.014 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 11.0 t -108.66 8.77 27.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -177.79 119.2 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.13 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' D' ' 2' ' ' VAL . 3.3 mp -47.96 137.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.372 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 77.9 m -98.22 -168.34 1.64 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.61 169.26 8.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.949 . . . . 0.0 109.285 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -25.63 68.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -70.65 -42.75 70.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -28.16 57.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.42 -4.66 58.7 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.073 -1.017 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -93.29 -21.57 19.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.14 -0.975 . . . . 0.0 109.377 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.07 -9.63 58.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -92.31 1.4 57.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.15 157.82 16.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.002 . . . . 0.0 109.733 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.701 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.4 HG11 ' O ' ' H' ' 2' ' ' VAL . 5.6 p -68.77 91.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.79 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.169 -0.957 . . . . 0.0 109.432 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -77.33 -33.12 55.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -68.2 -40.7 82.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.248 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . 0.483 HD21 ' ND1' ' L' ' 10' ' ' HIS . 13.8 mt -77.37 -31.83 54.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 108.959 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.11 -28.02 65.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.488 -0.757 . . . . 0.0 109.338 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.98 -29.84 45.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 70.4 m -77.24 -8.35 57.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -1.179 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -93.39 -23.46 18.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' H' ' 12' ' ' VAL . 12.1 mt -88.93 -44.51 10.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' H' ' 11' ' ' LEU . 26.3 m -45.79 -44.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' F' ' 13' ' ' GLU . 5.3 mt-10 -65.95 -43.86 86.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.784 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.479 ' CB ' ' H5 ' ' G' ' 22' ' ' IPH . . . -86.92 21.11 2.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 110.03 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.45 -51.93 2.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 109.684 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 12.4 p90 -76.21 -26.03 55.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.448 HD21 HD21 ' B' ' 17' ' ' LEU . 32.2 tp -75.56 -34.93 60.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.44 -60.45 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.954 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 m -67.55 -63.62 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.69 -130.23 9.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -76.92 81.94 3.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -1.105 . . . . 0.0 109.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -146.94 -68.27 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.03 142.33 5.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 18.7 p90 -152.13 174.76 13.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.132 . . . . 0.0 109.511 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.3 162.42 26.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -143.83 92.44 2.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.84 . . . . 0.0 109.588 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -133.76 107.27 11.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' G' ' 3' ' ' VAL . 34.5 Cg_endo -76.13 78.25 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.362 2.041 . . . . 0.0 109.959 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.8 -179.22 4.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.697 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.32 179.728 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -119.13 0.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 109.901 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.98 -16.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.055 -1.028 . . . . 0.0 110.075 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.75 42.88 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -169.96 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -116.91 19.51 14.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.297 -0.877 . . . . 0.0 109.211 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -24.76 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.315 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -105.28 9.38 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.633 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 9' ' ' SER . . . . . 0.438 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.9 p 179.67 118.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' I' ' 9' ' ' SER . 3.0 mp -43.5 149.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.859 . . . . 0.0 109.21 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -171.76 1.91 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.79 167.55 9.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.158 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.39 -27.81 69.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.33 -43.26 77.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.85 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -27.17 56.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.811 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -84.15 -7.12 59.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 109.864 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.78 -24.85 21.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -71.15 -10.83 60.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -91.45 3.16 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 0.0 109.909 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 159.25 15.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 109.378 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . 0.475 ' HB3' ' HA ' ' E' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.261 0.553 . . . . 0.0 109.713 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 6.0 p -70.65 91.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.55 -42.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.146 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.17 -33.41 44.02 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.004 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -69.06 -40.06 78.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . 0.467 HD21 ' ND1' ' F' ' 10' ' ' HIS . 9.5 mt -78.49 -29.79 46.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.324 -0.86 . . . . 0.0 109.105 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -72.72 -27.71 62.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.333 -0.854 . . . . 0.0 109.465 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.84 -27.0 52.17 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -79.68 -7.57 58.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.568 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -94.5 -20.87 19.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.15 -43.69 9.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 109.677 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 26.1 m -46.95 -44.21 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.08 -44.25 89.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.601 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.501 ' CB ' ' H5 ' ' J' ' 32' ' ' IPH . . . -87.6 24.85 1.59 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.47 -46.34 3.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 109.507 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 14.3 p90 -82.64 -23.25 34.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.98 -37.85 54.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.283 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.0 t -55.7 -61.62 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 m -66.89 -64.77 0.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.55 -129.33 8.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -77.91 85.31 4.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -1.179 . . . . 0.0 109.368 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -150.88 -75.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.07 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.32 141.21 4.42 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . 0.463 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 15.5 p90 -149.05 165.69 30.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.79 136.44 54.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -117.37 104.91 11.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.536 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -146.18 108.19 4.23 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 109.438 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.85 79.57 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 110.994 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.89 179.6 5.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 109.337 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.324 179.923 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.6 tt -121.17 1.05 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.51 -12.9 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.89 40.38 2.47 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.688 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -164.93 -42.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.244 -0.91 . . . . 0.0 109.299 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 93.9 m -114.14 23.47 12.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -112.77 -26.94 8.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 109.238 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -105.48 9.4 33.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.01 118.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.804 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 mp -45.32 135.66 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.298 -0.877 . . . . 0.0 109.597 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -98.1 -167.73 1.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.46 171.71 7.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.482 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -28.06 69.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 109.678 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -69.1 -42.34 76.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.825 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -28.82 56.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.62 -7.28 59.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 109.809 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.59 -25.12 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.678 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -72.38 -7.62 50.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -93.55 0.33 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.87 158.99 15.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.419 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' C' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.406 HG11 ' O ' ' L' ' 2' ' ' VAL . 5.1 p -70.83 89.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -175.95 -44.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -78.29 -31.88 49.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -70.63 -39.17 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.127 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 13.4 mt -78.21 -31.93 49.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 108.863 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.01 -29.99 67.19 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.12 -27.26 58.43 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -80.37 -6.24 57.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -1.127 . . . . 0.0 109.616 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . 0.483 ' ND1' HD21 ' H' ' 6' ' ' LEU . 4.3 m-70 -95.14 -20.63 19.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.031 -1.043 . . . . 0.0 109.633 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' L' ' 12' ' ' VAL . 11.2 mt -92.68 -44.67 8.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.943 . . . . 0.0 109.515 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' L' ' 11' ' ' LEU . 23.4 m -45.04 -43.71 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.18 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -66.76 -44.83 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.554 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.455 ' CB ' ' H5 ' ' L' ' 32' ' ' IPH . . . -86.69 23.53 1.66 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.3 -0.875 . . . . 0.0 109.936 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.62 -49.66 2.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.668 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.526 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 14.4 p90 -79.06 -24.36 43.6 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.162 -0.962 . . . . 0.0 109.663 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 tp -76.99 -33.58 57.58 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.75 -59.3 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 12.3 m -69.05 -66.08 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.568 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.98 -129.95 9.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.17 80.88 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -147.62 -68.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.092 -1.005 . . . . 0.0 109.43 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.59 131.26 3.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' L' ' 24' ' ' PHE . 9.8 p90 -135.08 -173.21 3.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 109.317 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -138.2 142.74 39.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.82 108.61 11.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.625 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -150.5 106.64 3.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.848 . . . . 0.0 109.451 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.09 79.37 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.508 2.139 . . . . 0.0 110.449 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 -179.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.537 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . 0.495 ' H5 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.429 ' H5 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 31' ' ' IPH . . . . . 0.489 ' H5 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 22' ' ' IPH . . . . . 0.479 ' H5 ' ' CB ' ' H' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . 0.501 ' H5 ' ' CB ' ' J' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . 0.455 ' H5 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -97.74 -27.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.4 t -73.84 -44.11 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.64 52.12 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.843 . . . . 0.0 110.151 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -175.38 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.085 -1.01 . . . . 0.0 109.694 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.0 11.05 17.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.8 t -105.57 -23.05 12.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.9 p -67.17 -13.94 62.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.472 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.5 p -175.25 156.52 2.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.505 ' CD1' ' HB ' ' F' ' 2' ' ' VAL . 2.1 mp -62.84 130.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.255 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.32 -167.02 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.504 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.72 176.78 4.94 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -42.31 89.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.2 -0.938 . . . . 0.0 109.771 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -66.7 -35.85 81.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.962 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -36.67 77.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 109.437 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.65 -18.45 51.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 109.827 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.09 -14.48 47.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.481 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.6 -16.31 15.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.892 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.74 87.27 1.84 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.31 133.07 7.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.461 -0.774 . . . . 0.0 109.485 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.418 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.511 ' CG2' ' HA ' ' I' ' 9' ' ' SER . 70.4 t -91.02 -7.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.248 -0.908 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 4' ' ' GLN . 11.3 p30 45.08 -172.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.443 -0.785 . . . . 0.0 109.604 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' B' ' 3' ' ' ASN . 9.4 tt0 83.53 -59.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -89.08 -24.13 22.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.191 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -96.78 -50.26 4.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.135 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -57.2 -38.04 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.98 -29.46 60.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.496 ' OG ' ' CE1' ' D' ' 16' ' ' TYR . 1.2 m -67.38 -9.08 38.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.151 . . . . 0.0 109.424 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -96.25 -36.1 11.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.023 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.49 -41.44 69.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' B' ' 9' ' ' SER . 9.7 m -48.11 -37.7 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -72.25 -46.12 57.32 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.954 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.12 13.25 4.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 0.0 109.863 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.32 -53.29 3.39 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.003 -1.061 . . . . 0.0 109.537 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 11.3 p90 -73.12 -30.2 63.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.315 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 0.1 OUTLIER -61.93 -52.92 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.384 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.41 ' O ' HG11 ' B' ' 18' ' ' VAL . 98.3 t -67.41 -30.75 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.199 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 20' ' ' GLY . 1.3 m -115.45 54.74 0.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.016 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' B' ' 22' ' ' ARG . . . -58.72 -119.73 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' B' ' 22' ' ' ARG . 25.8 mt-10 -39.52 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.975 . . . . 0.0 109.933 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' B' ' 20' ' ' GLY . 2.9 mtt180 165.37 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.657 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 172.48 27.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' D' ' 26' ' ' TYR . 50.9 p90 -170.81 162.74 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.441 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -117.72 141.5 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 0.0 109.493 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.86 111.44 17.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.709 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -140.86 98.58 6.92 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.92 87.73 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.5 2.133 . . . . 0.0 110.662 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -136.1 -123.38 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.98 . . . . 0.0 109.294 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 120.741 -1.225 . . . . 0.0 109.351 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -100.3 -29.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -1.165 . . . . 0.0 109.457 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.81 -40.95 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 52.54 1.97 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.332 -0.855 . . . . 0.0 110.077 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -175.64 -34.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.82 11.58 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 t -105.66 -24.4 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 60.1 p -67.74 -11.94 59.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.575 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -174.81 155.5 2.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.624 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.558 ' CD1' ' HB ' ' L' ' 2' ' ' VAL . 1.6 mp -63.7 130.95 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 108.984 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -97.15 -167.61 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -107.12 178.8 4.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -42.29 78.65 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.288 -0.882 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -67.04 -34.82 78.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.918 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -32.5 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 11.6 mt -83.31 -21.55 33.19 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -13.59 57.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.524 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.96 -15.57 13.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.02 87.94 1.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.57 133.97 7.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.429 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.475 ' HB ' ' CD1' ' G' ' 10' ' ' ILE . 55.8 t -89.58 -9.23 10.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.422 -0.798 . . . . 0.0 109.574 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' D' ' 4' ' ' GLN . 8.6 p30 45.9 -174.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' D' ' 3' ' ' ASN . 10.2 tt0 84.07 -60.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . 0.427 ' HB3' HG12 ' G' ' 10' ' ' ILE . 32.4 t60 -88.02 -21.99 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.123 -0.986 . . . . 0.0 109.006 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.41 -51.28 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.839 . . . . 0.0 109.188 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 t -57.31 -37.79 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.35 59.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.454 ' HA ' HG23 ' D' ' 12' ' ' VAL . 0.4 OUTLIER -64.68 -11.13 32.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -1.105 . . . . 0.0 109.559 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -93.09 -35.28 13.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 15.1 mt -73.52 -39.52 64.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.454 HG23 ' HA ' ' D' ' 9' ' ' SER . 13.3 m -48.15 -35.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -75.63 -44.45 42.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 9.71 11.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.02 -56.77 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.711 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.538 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 9.1 p90 -71.6 -28.75 64.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.027 . . . . 0.0 109.541 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 0.1 OUTLIER -63.15 -52.99 60.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.186 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.1 t -66.27 -33.47 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 108.866 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' D' ' 20' ' ' GLY . 1.3 m -111.66 55.96 0.66 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 109.085 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' D' ' 22' ' ' ARG . . . -59.32 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' D' ' 22' ' ' ARG . 23.3 mt-10 -40.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.463 -1.022 . . . . 0.0 110.055 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . 0.483 ' CB ' ' O ' ' D' ' 21' ' ' GLU . 4.2 mtt180 165.07 -53.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 171.61 24.55 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -169.45 172.31 7.17 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -122.16 157.89 30.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.516 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 79.6 t80 -136.64 100.45 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.47 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -133.83 97.41 15.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.81 86.19 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.447 2.098 . . . . 0.0 110.62 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -134.16 -124.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.886 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -101.69 -25.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -1.138 . . . . 0.0 109.135 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 90.6 t -77.71 -41.47 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.493 -0.754 . . . . 0.0 109.503 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.04 50.75 1.83 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.806 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.58 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.796 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 10.95 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.024 . . . . 0.0 109.504 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 33.2 t -105.07 -23.27 12.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 77.1 p -67.01 -14.73 63.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' SER . . . . . 0.487 ' HA ' ' CG2' ' J' ' 2' ' ' VAL . 5.8 p -174.15 155.85 2.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.139 -0.975 . . . . 0.0 109.819 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.466 HG12 ' CB ' ' J' ' 5' ' ' HIS . 2.1 mp -62.0 126.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.481 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -94.54 -170.09 2.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -106.91 176.7 5.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -41.04 95.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -68.74 -35.75 77.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 109.9 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -36.63 77.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 18.9 mt -79.01 -21.28 47.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.905 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -13.44 56.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.953 . . . . 0.0 109.321 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.72 -16.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.525 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.1 88.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.65 135.45 8.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.395 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.505 ' HB ' ' CD1' ' A' ' 10' ' ' ILE . 54.8 t -90.91 -7.45 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' F' ' 4' ' ' GLN . 9.4 p30 45.81 -174.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.77 . . . . 0.0 109.657 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . 0.567 ' CB ' ' O ' ' F' ' 3' ' ' ASN . 9.5 tt0 84.19 -60.54 0.11 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.641 -0.662 . . . . 0.0 109.589 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -87.89 -23.84 23.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mt -97.37 -49.47 4.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 40.1 t -59.01 -37.37 76.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -30.09 58.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 9' ' ' SER . . . . . 0.455 ' HA ' HG23 ' F' ' 12' ' ' VAL . 0.5 OUTLIER -66.21 -15.21 62.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.325 -1.103 . . . . 0.0 109.428 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -89.18 -36.45 15.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 mt -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.036 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' F' ' 9' ' ' SER . 12.2 m -49.86 -34.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.105 -0.997 . . . . 0.0 109.633 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -76.22 -44.84 35.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.978 . . . . 0.0 109.408 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.09 10.32 6.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.06 -57.2 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.085 -1.009 . . . . 0.0 109.831 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 10.9 p90 -69.53 -30.54 68.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.378 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 0.1 OUTLIER -62.57 -53.43 54.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.64 -32.56 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' F' ' 20' ' ' GLY . 1.3 m -114.21 53.72 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' F' ' 22' ' ' ARG . . . -57.85 -118.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' F' ' 22' ' ' ARG . 25.4 mt-10 -40.53 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -1.012 . . . . 0.0 109.952 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' F' ' 20' ' ' GLY . 4.3 mtt180 164.56 -49.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.73 27.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -166.92 174.93 8.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -1.125 . . . . 0.0 109.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -128.41 152.58 48.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -130.89 106.98 8.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -139.25 98.36 8.3 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.97 86.03 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.416 2.077 . . . . 0.0 110.554 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -154.48 135.6 13.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 30' ' ' THR . . . . . 0.495 ' C ' ' O ' ' F' ' 29' ' ' LYS . 71.5 p . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt -98.23 -25.58 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -1.156 . . . . 0.0 109.125 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.15 -42.94 37.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.461 -0.775 . . . . 0.0 109.417 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 51.64 2.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.336 -0.853 . . . . 0.0 109.684 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.98 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 109.723 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 9.65 19.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.692 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -103.64 -23.15 13.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.95 . . . . 0.0 109.818 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 74.5 p -66.92 -14.97 63.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -173.18 160.26 4.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.475 ' CD1' ' HB ' ' D' ' 2' ' ' VAL . 1.6 mp -66.34 128.46 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.095 -1.003 . . . . 0.0 109.368 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -94.21 -167.97 1.77 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.37 179.37 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.465 -0.772 . . . . 0.0 109.305 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.44 -41.32 80.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -68.68 -34.65 76.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -36.4 80.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.84 -21.28 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.243 -0.911 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -83.63 -9.02 59.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.634 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.97 -16.49 59.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.135 -0.978 . . . . 0.0 109.237 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.77 90.91 2.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -165.16 131.6 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.9 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.314 0.578 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.512 ' HB ' ' CD1' ' K' ' 10' ' ' ILE . 54.3 t -92.95 -6.71 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' H' ' 4' ' ' GLN . 9.9 p30 44.92 -173.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.52 -0.738 . . . . 0.0 110.031 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' H' ' 3' ' ' ASN . 9.0 tt0 83.78 -60.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.754 -0.591 . . . . 0.0 109.677 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -87.95 -23.78 23.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.25 -0.906 . . . . 0.0 109.06 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.3 -50.14 4.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.209 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.0 -40.23 80.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.07 -29.97 66.05 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 9' ' ' SER . . . . . 0.465 ' HA ' HG23 ' H' ' 12' ' ' VAL . 0.5 OUTLIER -65.67 -12.66 55.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.131 . . . . 0.0 109.492 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -93.58 -34.03 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -0.846 . . . . 0.0 109.665 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 14.0 mt -74.44 -39.25 62.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 0.0 109.707 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' H' ' 9' ' ' SER . 7.8 m -48.21 -37.57 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.129 -0.982 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.24 -46.26 51.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.09 7.81 10.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.384 -0.823 . . . . 0.0 109.634 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -93.36 -55.99 3.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.0 110.096 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.553 ' CE1' HD21 ' H' ' 17' ' ' LEU . 14.0 p90 -70.45 -31.23 68.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.624 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.553 HD21 ' CE1' ' H' ' 16' ' ' TYR . 0.1 OUTLIER -60.82 -53.76 53.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.509 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.435 ' O ' HG11 ' H' ' 18' ' ' VAL . 93.3 t -67.19 -30.65 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 109.748 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.21 46.66 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . -66.69 170.27 32.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' H' ' 20' ' ' GLY . 33.8 mt-10 35.5 71.4 0.12 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.661 -0.905 . . . . 0.0 110.078 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 175.32 -48.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.18 -0.95 . . . . 0.0 109.34 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.47 169.74 27.9 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -168.0 169.29 11.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -122.78 145.39 48.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 109.547 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.91 105.57 9.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -137.48 98.97 9.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.415 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.84 86.68 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.538 2.159 . . . . 0.0 110.778 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -135.91 -129.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 109.055 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.578 -1.327 . . . . 0.0 109.519 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 tt -99.02 -26.68 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 87.8 t -75.96 -40.59 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.64 53.61 2.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -176.28 -32.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.36 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 12.3 15.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.011 . . . . 0.0 109.86 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.73 -19.56 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -70.09 -13.48 62.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.031 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 9' ' ' SER . . . . . 0.511 ' HA ' ' CG2' ' B' ' 2' ' ' VAL . 52.5 p -174.39 156.89 2.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.478 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . 0.485 ' CD1' ' HB ' ' B' ' 2' ' ' VAL . 1.8 mp -63.32 128.23 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.248 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -93.23 -165.59 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 3.7 m -110.37 -177.22 3.18 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.248 -0.908 . . . . 0.0 109.042 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -41.21 68.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -68.16 -35.14 77.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -35.79 76.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.9 mt -81.19 -19.7 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.99 -10.78 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.92 -17.61 52.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.288 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.57 89.29 2.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 0.0 109.53 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.54 134.21 6.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.234 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.377 0.608 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.487 ' CG2' ' HA ' ' E' ' 9' ' ' SER . 53.1 t -91.65 -7.34 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' J' ' 4' ' ' GLN . 9.1 p30 45.51 -174.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 0.0 110.011 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' J' ' 3' ' ' ASN . 8.9 tt0 83.61 -61.48 0.11 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.705 -0.622 . . . . 0.0 109.823 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . 0.466 ' CB ' HG12 ' E' ' 10' ' ' ILE . 36.5 t60 -86.83 -21.23 26.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.162 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.02 -52.33 3.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.103 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.4 t -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.11 -32.33 63.18 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 9' ' ' SER . . . . . 0.451 ' HA ' HG23 ' J' ' 12' ' ' VAL . 1.2 m -67.34 -10.55 52.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -1.187 . . . . 0.0 109.543 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -93.7 -34.24 13.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.176 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.91 -41.74 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.455 -0.778 . . . . 0.0 109.711 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' J' ' 9' ' ' SER . 15.3 m -45.88 -38.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.803 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.94 -44.17 61.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.017 -1.052 . . . . 0.0 109.829 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.452 ' HB3' HD13 ' D' ' 17' ' ' LEU . . . -84.68 13.92 5.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.37 -54.86 2.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 11.8 p90 -72.62 -29.54 63.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 0.1 OUTLIER -63.79 -52.14 61.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 109.171 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.97 -32.2 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.406 -0.809 . . . . 0.0 109.221 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' J' ' 20' ' ' GLY . 1.1 m -113.72 54.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.078 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . -57.85 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' J' ' 22' ' ' ARG . 26.0 mt-10 -40.76 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -1.15 . . . . 0.0 110.024 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' J' ' 20' ' ' GLY . 3.6 mtt180 165.58 -47.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.848 . . . . 0.0 109.338 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.8 169.42 33.85 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -164.44 172.95 12.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -1.163 . . . . 0.0 109.784 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -122.53 151.75 41.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.166 -0.959 . . . . 0.0 109.251 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -133.59 108.17 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -142.41 96.46 6.34 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.69 93.96 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.353 2.035 . . . . 0.0 110.593 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -141.03 -119.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.353 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 120.659 -1.275 . . . . 0.0 109.652 -179.768 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 tt -98.17 -27.6 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.163 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 94.9 t -74.72 -41.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.443 -0.786 . . . . 0.0 109.682 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.0 OUTLIER -91.98 56.96 3.02 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.937 -1.102 . . . . 0.0 109.489 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 1.3 tt0 179.94 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 10.85 15.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -107.23 -19.81 13.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 0.0 108.948 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -68.97 -14.23 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 109.009 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 78.1 p -175.25 156.06 2.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.815 . . . . 0.0 109.31 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . 0.512 ' CD1' ' HB ' ' H' ' 2' ' ' VAL . 1.4 mp -63.18 129.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -95.02 -170.71 2.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.855 . . . . 0.0 109.455 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.85 177.33 4.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.401 -0.812 . . . . 0.0 109.144 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -42.89 88.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.543 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -65.97 -37.57 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.102 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -35.36 73.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.75 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.769 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.28 -12.11 55.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -18.39 44.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.327 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.55 91.06 2.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.4 137.13 5.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.506 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.42 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.42 0.629 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' C' ' 10' ' ' ILE . 55.6 t -89.35 -7.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.443 -0.786 . . . . 0.0 109.929 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' L' ' 4' ' ' GLN . 10.8 p30 45.22 -173.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' L' ' 3' ' ' ASN . 9.1 tt0 83.84 -59.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.674 -0.641 . . . . 0.0 109.502 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . 0.439 ' CB ' HG12 ' C' ' 10' ' ' ILE . 33.8 t60 -89.14 -20.34 24.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 mt -101.63 -49.33 4.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -0.793 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -59.03 -32.92 70.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 108.826 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.03 -34.05 34.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 9' ' ' SER . . . . . 0.476 ' HA ' HG23 ' L' ' 12' ' ' VAL . 0.4 OUTLIER -64.58 -11.14 31.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -1.119 . . . . 0.0 109.272 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -93.76 -32.18 14.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.01 -39.33 50.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.476 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' L' ' 9' ' ' SER . 13.4 m -47.82 -36.03 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.561 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.94 -44.51 48.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 109.293 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.93 15.03 4.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.334 -0.854 . . . . 0.0 109.687 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.42 -53.74 3.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.041 -1.037 . . . . 0.0 109.533 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.555 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 9.4 p90 -73.98 -27.1 60.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 0.1 OUTLIER -66.14 -50.1 65.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.267 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . 0.439 ' O ' HG11 ' L' ' 18' ' ' VAL . 85.1 t -70.04 -29.04 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.1 49.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.575 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . -70.45 167.91 49.34 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' L' ' 20' ' ' GLY . 31.1 mt-10 39.09 71.39 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.505 -0.997 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 173.21 -43.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.826 . . . . 0.0 108.93 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.48 174.23 35.48 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.12 172.33 7.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -1.138 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' L' ' 25' ' ' PHE . 17.8 p90 -125.0 145.31 49.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -127.84 109.15 11.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -0.928 . . . . 0.0 109.358 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 9.8 m -142.55 98.22 5.93 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 0.0 109.201 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . 0.408 ' HB3' ' CG2' ' K' ' 3' ' ' VAL . 36.4 Cg_endo -78.66 93.9 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.369 2.046 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -139.77 -115.18 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 109.523 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 109.544 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 2' ' ' ILE . 49.7 mt -99.42 25.29 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -1.16 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 60.0 t -114.56 -47.43 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -95.47 47.45 1.12 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -168.23 -35.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.336 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 9' ' ' SER . 99.1 m -108.11 -32.31 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.655 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -69.4 -19.18 63.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 0.0 109.697 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -105.75 -7.31 18.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 5.1 p -168.08 132.35 1.7 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.426 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' HA ' ' O1 ' ' B' ' 32' ' ' IPH . 2.5 mp -52.49 138.4 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.419 ' N ' HG21 ' A' ' 10' ' ' ILE . 86.7 m -104.39 149.6 25.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.24 158.17 29.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -29.51 58.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.782 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -64.97 -43.47 92.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.477 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -73.87 -23.55 59.62 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.42 0.4 53.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.238 -0.914 . . . . 0.0 109.967 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -90.86 -26.08 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.735 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -83.01 -7.67 59.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.932 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -90.85 15.61 10.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.65 160.16 15.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.484 -179.891 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 11.2 p90 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.417 HG11 ' O ' ' B' ' 2' ' ' VAL . 2.5 p -60.96 123.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.27 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 175.55 -36.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.163 -0.96 . . . . 0.0 108.935 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -80.34 -42.32 23.16 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.369 -0.832 . . . . 0.0 109.276 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -58.89 -23.55 61.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -101.5 -24.45 14.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 51.1 t -75.26 -17.24 60.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.414 ' O ' HG12 ' B' ' 12' ' ' VAL . . . -91.41 -21.87 33.53 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.465 ' HA ' HG23 ' B' ' 12' ' ' VAL . 24.4 p -81.01 -18.76 45.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -1.14 . . . . 0.0 109.302 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -85.56 -18.86 32.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.624 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.487 ' CD2' ' C6 ' ' B' ' 32' ' ' IPH . 9.9 mt -93.69 -34.71 13.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' B' ' 9' ' ' SER . 34.0 m -60.58 -36.02 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 110.037 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -27.91 61.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.931 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.33 17.56 17.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.163 -0.96 . . . . 0.0 109.864 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -114.98 -56.52 2.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.836 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -64.26 -23.65 67.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.478 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.459 HD23 ' CB ' ' H' ' 14' ' ' ALA . 19.7 tp -74.5 -40.25 61.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.2 -0.937 . . . . 0.0 109.306 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 71.4 t -54.69 -72.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.907 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.61 -42.6 88.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.08 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.34 -97.68 0.78 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.72 -56.54 20.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -1.143 . . . . 0.0 109.514 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -53.28 154.83 3.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.72 -167.69 27.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -170.01 169.18 8.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -1.13 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.648 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 42.1 p90 -127.78 148.66 50.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.474 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' B' ' 28' ' ' PRO . 30.5 t80 -128.29 113.57 15.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.81 92.11 13.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.482 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' B' ' 26' ' ' TYR . 36.1 Cg_endo -78.96 81.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.909 2.406 . . . . 0.0 110.515 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -133.14 112.25 11.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.089 -1.007 . . . . 0.0 109.946 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.242 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' C' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' C' ' 1' ' ' GLY . 20.4 mt 71.21 -1.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -1.231 . . . . 0.0 110.196 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 61.7 t -106.24 -49.03 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.971 -1.08 . . . . 0.0 108.917 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 44.84 1.03 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.431 -0.793 . . . . 0.0 109.239 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -165.57 -35.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 93.1 m -108.27 -30.31 8.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.3 OUTLIER -71.47 -19.09 62.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 109.388 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 -6.55 19.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.726 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 2.6 p -169.16 130.36 1.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.087 -1.008 . . . . 0.0 109.411 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.458 ' HA ' ' O1 ' ' D' ' 32' ' ' IPH . 2.5 mp -50.44 138.08 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.647 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -104.37 149.02 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.054 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.67 159.04 29.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . 0.42 HD22 HG12 ' D' ' 18' ' ' VAL . 0.3 OUTLIER -55.14 -30.75 60.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.2 -42.2 96.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.979 . . . . 0.0 109.702 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -74.69 -23.4 58.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 72.1 mt -96.37 4.67 52.07 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -95.24 -25.85 16.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.269 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -82.78 -9.03 59.53 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -91.58 19.23 6.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.641 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.27 158.46 17.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 109.342 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.1 p90 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.443 HG11 ' O ' ' D' ' 2' ' ' VAL . 2.5 p -59.68 122.7 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.782 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.22 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.21 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -82.1 -39.44 23.35 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.244 -0.91 . . . . 0.0 109.131 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -62.17 -22.02 65.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.0 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -102.41 -24.39 13.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.808 . . . . 0.0 109.06 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 42.2 t -74.21 -23.22 59.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.408 ' O ' HG12 ' D' ' 12' ' ' VAL . . . -87.29 -20.26 52.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.457 ' HA ' HG23 ' D' ' 12' ' ' VAL . 57.6 p -81.45 -15.24 55.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.254 . . . . 0.0 109.434 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.68 -21.16 22.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.807 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 9.2 mt -90.83 -33.25 15.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.151 -0.968 . . . . 0.0 109.754 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.457 HG23 ' HA ' ' D' ' 9' ' ' SER . 35.5 m -61.85 -35.6 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.38 -26.94 60.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.021 . . . . 0.0 109.812 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.43 ' HB3' HD23 ' J' ' 17' ' ' LEU . . . -98.65 19.57 14.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.133 -0.979 . . . . 0.0 109.699 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mt -117.43 -54.75 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.55 -22.8 66.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.97 . . . . 0.0 109.595 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.442 HD23 ' CB ' ' J' ' 14' ' ' ALA . 22.9 tp -77.62 -33.83 53.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.845 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . 0.42 HG12 HD22 ' C' ' 13' ' ' LEU . 66.9 t -60.6 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 109.885 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -63.35 -42.75 98.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.59 -96.93 0.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.75 -54.73 41.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -1.121 . . . . 0.0 109.61 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -56.2 156.5 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.894 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.34 -167.54 26.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -168.13 158.14 10.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -1.113 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . 0.648 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 19.2 m-85 -113.22 142.99 45.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 109.528 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -125.31 117.0 22.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -0.995 . . . . 0.0 109.465 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.2 92.56 6.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.748 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -79.16 81.61 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.717 2.278 . . . . 0.0 110.39 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -133.68 112.25 11.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.465 ' CG2' ' O ' ' E' ' 2' ' ' ILE . 53.2 mt -99.83 22.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -1.115 . . . . 0.0 109.389 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 49.0 t -113.12 -47.42 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.22 -0.925 . . . . 0.0 109.735 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.71 47.88 1.12 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.136 -0.977 . . . . 0.0 109.478 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -169.99 -32.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' E' ' 9' ' ' SER . 99.9 m -111.59 -30.48 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.39 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -72.46 -17.08 61.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.955 . . . . 0.0 109.321 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -107.3 -7.56 16.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' E' ' 6' ' ' CYS . 3.5 p -168.18 134.07 1.91 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.339 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.458 ' HA ' ' O1 ' ' E' ' 31' ' ' IPH . 2.5 mp -53.73 137.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.131 -0.98 . . . . 0.0 109.736 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . 0.436 ' N ' HG21 ' E' ' 10' ' ' ILE . 88.0 m -103.3 151.23 22.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.198 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.58 158.25 28.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . 0.408 HD22 HG12 ' F' ' 18' ' ' VAL . 0.3 OUTLIER -56.01 -29.91 61.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.221 -0.925 . . . . 0.0 109.106 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.62 -45.88 85.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.42 -23.05 61.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -0.872 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.35 -0.62 49.19 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -0.939 . . . . 0.0 110.05 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -89.31 -24.8 21.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.705 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.67 -7.04 59.38 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.109 -0.995 . . . . 0.0 109.889 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.11 20.14 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.138 -0.976 . . . . 0.0 109.17 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.8 158.28 18.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.372 -0.83 . . . . 0.0 109.335 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.595 -179.829 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.6 p90 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.435 HG11 ' O ' ' F' ' 2' ' ' VAL . 2.4 p -61.04 124.45 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.32 -35.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -80.15 -43.35 21.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.363 -0.836 . . . . 0.0 108.915 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -58.09 -23.03 53.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.664 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mt -101.46 -27.27 13.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 108.997 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.476 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 46.8 t -72.65 -20.22 61.29 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.597 -0.689 . . . . 0.0 109.511 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.83 -22.55 38.76 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 9' ' ' SER . . . . . 0.458 ' HA ' HG23 ' F' ' 12' ' ' VAL . 27.6 p -80.66 -17.04 52.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -1.123 . . . . 0.0 109.42 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . 0.469 ' ND1' HD21 ' J' ' 6' ' ' LEU . 14.5 m-70 -87.54 -18.18 30.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 9.8 mt -94.58 -32.67 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' F' ' 9' ' ' SER . 36.0 m -62.83 -35.04 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.856 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -26.59 59.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.53 18.38 16.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -116.15 -55.89 2.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.065 -1.022 . . . . 0.0 109.617 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -64.27 -23.12 67.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.694 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 26.9 tp -77.86 -33.85 52.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.408 HG12 HD22 ' E' ' 13' ' ' LEU . 66.6 t -60.49 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 109.78 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.21 -44.09 97.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.15 -0.969 . . . . 0.0 109.7 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.93 -96.82 0.88 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.56 -55.71 30.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -1.114 . . . . 0.0 109.575 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -55.12 156.55 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 0.0 109.592 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -166.85 28.57 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.62 161.84 6.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -1.093 . . . . 0.0 108.981 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -122.29 151.18 41.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.026 -1.046 . . . . 0.0 109.589 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . 0.434 ' CE2' ' HG3' ' F' ' 28' ' ' PRO . 33.8 t80 -129.66 118.17 21.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.33 91.27 7.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 109.352 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . 0.434 ' HG3' ' CE2' ' F' ' 26' ' ' TYR . 35.6 Cg_endo -78.52 82.19 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.646 2.231 . . . . 0.0 110.359 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.67 110.81 10.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 109.534 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . 0.456 ' CG2' ' O ' ' G' ' 2' ' ' ILE . 46.3 mt -99.13 23.34 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.45 -48.76 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.87 46.12 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -167.37 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' G' ' 9' ' ' SER . 85.6 m -110.07 -27.79 9.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 22.7 t -72.04 -22.48 61.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 15.0 t -103.27 -6.16 22.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.455 -0.778 . . . . 0.0 109.695 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 9' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' G' ' 6' ' ' CYS . 2.2 p -169.32 132.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.434 HG21 ' N ' ' G' ' 11' ' ' CYS . 2.5 mp -52.22 137.4 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.365 -0.834 . . . . 0.0 109.526 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . 0.434 ' N ' HG21 ' G' ' 10' ' ' ILE . 83.5 m -104.01 150.35 24.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.257 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.39 159.9 30.06 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . 0.476 HD22 HG12 ' H' ' 18' ' ' VAL . 0.3 OUTLIER -57.34 -31.82 66.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.075 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -61.6 -46.57 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.418 -0.801 . . . . 0.0 109.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -72.33 -20.98 61.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 76.0 mt -96.85 -2.62 43.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.103 -0.998 . . . . 0.0 109.792 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -89.02 -24.74 22.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -82.91 -8.26 59.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 0.0 109.837 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -90.91 12.97 17.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.456 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.01 163.0 12.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.611 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.568 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.462 HG11 ' O ' ' H' ' 2' ' ' VAL . 2.6 p -59.08 121.18 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.22 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.93 -43.67 29.21 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.181 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -57.14 -23.72 49.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.553 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mt -100.86 -26.08 13.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 109.223 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.453 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 15.4 t -73.74 -20.22 60.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.469 -0.769 . . . . 0.0 109.706 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.77 -20.2 48.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 9' ' ' SER . . . . . 0.454 ' HA ' HG23 ' H' ' 12' ' ' VAL . 87.9 p -82.04 -16.3 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -1.059 . . . . 0.0 109.508 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -89.6 -16.21 31.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.548 ' CD2' ' C6 ' ' G' ' 31' ' ' IPH . 8.0 mt -96.61 -33.42 11.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.473 -0.767 . . . . 0.0 109.547 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.454 HG23 ' HA ' ' H' ' 9' ' ' SER . 35.2 m -62.96 -29.98 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -25.87 43.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.454 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.459 ' CB ' HD23 ' B' ' 17' ' ' LEU . . . -100.7 22.46 11.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mt -120.15 -54.19 2.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.523 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.58 -24.2 66.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.612 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 20.7 tp -77.22 -36.5 54.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.195 -0.94 . . . . 0.0 109.583 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.476 HG12 HD22 ' G' ' 13' ' ' LEU . 64.9 t -57.32 -67.41 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.932 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 43.7 m -66.97 -39.99 87.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.985 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.26 -103.37 1.07 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -50.9 -63.55 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -1.221 . . . . 0.0 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -49.08 154.35 0.79 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.361 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.42 -170.57 28.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.57 170.45 15.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 109.525 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -128.34 150.4 50.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . 0.428 ' CE2' ' HG3' ' H' ' 28' ' ' PRO . 31.8 t80 -131.99 118.55 19.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.55 89.86 7.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.583 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' H' ' 26' ' ' TYR . 34.4 Cg_endo -76.47 82.64 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.72 2.28 . . . . 0.0 110.487 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.18 111.78 9.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.368 -0.833 . . . . 0.0 109.194 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.553 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' I' ' 6' ' ' CYS . 49.6 mt -98.02 24.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -1.194 . . . . 0.0 109.314 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 57.3 t -113.46 -47.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.972 . . . . 0.0 109.57 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.01 50.49 1.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.229 -0.919 . . . . 0.0 109.33 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -172.32 -34.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.475 -0.765 . . . . 0.0 109.252 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . 0.43 ' HB2' HG21 ' I' ' 2' ' ' ILE . 51.3 m -109.06 -32.61 7.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.867 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' I' ' 3' ' ' VAL . 0.5 OUTLIER -71.17 -19.49 62.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.047 . . . . 0.0 109.482 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -103.77 -6.82 21.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 p -169.51 135.66 1.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.194 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . 0.502 HG21 ' N ' ' I' ' 11' ' ' CYS . 2.4 mp -54.84 145.29 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.346 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . 0.502 ' N ' HG21 ' I' ' 10' ' ' ILE . 0.1 OUTLIER -112.46 150.06 31.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.012 -1.055 . . . . 0.0 109.545 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.57 155.58 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . 0.431 HD22 HG12 ' J' ' 18' ' ' VAL . 0.3 OUTLIER -52.77 -30.15 31.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.739 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -63.88 -45.6 88.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -72.03 -23.97 61.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 75.8 mt -94.88 -0.81 53.69 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -91.13 -23.66 20.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.998 . . . . 0.0 109.81 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -83.84 -9.03 59.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 109.676 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.54 15.6 10.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.12 156.59 17.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 109.67 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.215 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 9.6 p90 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.401 ' O ' HG11 ' J' ' 2' ' ' VAL . 2.4 p -60.41 121.05 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.72 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.382 -0.824 . . . . 0.0 108.868 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -79.26 -40.72 29.84 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.432 -0.793 . . . . 0.0 109.5 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -61.8 -21.65 64.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 109.381 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . 0.469 HD21 ' ND1' ' F' ' 10' ' ' HIS . 8.8 mt -103.14 -22.25 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.319 -0.863 . . . . 0.0 108.928 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 46.1 t -77.64 -14.91 59.51 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.405 -0.809 . . . . 0.0 109.099 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . 0.433 ' O ' HG12 ' J' ' 12' ' ' VAL . . . -94.26 -19.2 33.78 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 9' ' ' SER . . . . . 0.458 ' HA ' HG23 ' J' ' 12' ' ' VAL . 38.4 p -83.41 -18.04 40.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.203 . . . . 0.0 109.179 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -86.02 -20.93 28.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.377 -0.827 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.453 ' CD2' ' C6 ' ' J' ' 32' ' ' IPH . 9.8 mt -92.07 -33.55 14.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.954 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' J' ' 9' ' ' SER . 32.5 m -62.2 -36.23 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.739 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.76 -27.11 61.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.957 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.442 ' CB ' HD23 ' D' ' 17' ' ' LEU . . . -99.09 18.35 17.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 109.74 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -116.04 -54.15 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.984 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.19 -23.96 66.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' D' ' 14' ' ' ALA . 24.1 tp -76.7 -35.19 58.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.664 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . 0.431 HG12 HD22 ' I' ' 13' ' ' LEU . 78.6 t -58.53 -68.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.688 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.08 -44.15 97.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.647 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.92 -94.94 0.8 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.02 -57.83 10.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 109.519 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -53.23 158.68 1.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.255 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.81 -172.42 25.54 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -163.33 158.24 21.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.246 . . . . 0.0 109.714 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -116.15 147.04 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.535 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -131.08 113.07 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.618 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.0 92.35 12.61 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.585 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.74 81.88 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.6 2.2 . . . . 0.0 110.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.3 110.12 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.451 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' K' ' 2' ' ' ILE . 43.7 mt -97.84 26.67 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -1.195 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 54.5 t -115.18 -49.61 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 109.429 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.02 48.1 1.24 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -169.1 -35.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.684 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' K' ' 9' ' ' SER . 77.5 m -110.0 -27.34 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.99 . . . . 0.0 109.327 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 33.6 t -73.82 -19.04 60.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -106.83 -6.04 17.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 9' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 2.1 p -167.67 135.43 2.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 109.181 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . 0.451 HG21 ' N ' ' K' ' 11' ' ' CYS . 2.3 mp -55.89 139.81 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 109.362 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . 0.451 ' N ' HG21 ' K' ' 10' ' ' ILE . 99.7 m -105.17 147.23 28.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.723 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.17 156.9 36.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.875 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . 0.434 HD22 HG12 ' L' ' 18' ' ' VAL . 0.2 OUTLIER -54.82 -32.69 60.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 109.501 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -61.36 -44.96 96.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -72.65 -22.22 60.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.816 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.98 2.02 51.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.241 -0.912 . . . . 0.0 109.739 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -93.31 -24.73 18.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.396 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -83.14 -9.49 59.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -90.15 15.81 9.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.5 161.99 13.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.446 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.632 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' L' ' 1' ' ' PHE . 10.0 p90 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.42 ' O ' HG11 ' L' ' 2' ' ' VAL . 2.5 p -61.13 124.4 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.366 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.93 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -80.75 -40.87 24.44 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . 0.411 ' HB2' HD12 ' C' ' 10' ' ' ILE . 41.7 t60 -61.31 -20.65 63.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.356 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.06 -25.03 13.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.475 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 35.2 t -74.96 -19.72 59.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.566 -0.709 . . . . 0.0 109.381 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.59 -20.97 42.11 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p -80.6 -18.48 48.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -87.32 -18.65 29.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.582 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.7 mt -94.0 -30.11 14.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.821 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 35.3 m -66.61 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -74.34 -25.67 59.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.02 19.69 16.95 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.122 -0.986 . . . . 0.0 109.698 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -117.21 -54.16 2.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -65.93 -23.68 66.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -78.82 -30.37 45.28 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.262 -0.898 . . . . 0.0 109.885 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . 0.434 HG12 HD22 ' K' ' 13' ' ' LEU . 59.5 t -62.52 -68.67 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.23 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.2 -44.47 96.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -96.79 0.94 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.73 -59.38 5.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.272 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -51.36 157.89 0.93 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.327 -0.858 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.14 -166.99 25.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -171.79 155.78 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -1.107 . . . . 0.0 109.3 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' L' ' 25' ' ' PHE . 18.1 p90 -113.88 152.47 30.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.0 109.302 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -132.51 116.64 17.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 109.247 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.57 91.54 7.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.261 -0.9 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.67 80.23 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.542 2.161 . . . . 0.0 110.202 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.26 111.7 11.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . 0.487 ' C6 ' ' CD2' ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.458 ' O1 ' ' HA ' ' C' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 31' ' ' IPH . . . . . 0.458 ' O1 ' ' HA ' ' E' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 31' ' ' IPH . . . . . 0.548 ' C6 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . 0.453 ' C6 ' ' CD2' ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . 0.427 ' C6 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' J' J ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' A' ' 2' ' ' ILE . 4.5 tt -118.61 18.52 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -1.166 . . . . 0.0 109.263 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 t -121.45 -7.0 9.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.35 -0.844 . . . . 0.0 109.189 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.88 -9.78 19.6 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.356 -0.84 . . . . 0.0 109.612 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -130.96 12.82 5.23 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.307 -0.87 . . . . 0.0 109.644 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -47.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.364 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.93 -15.64 59.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.3 p -97.74 -34.23 10.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 109.494 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 0.0 109.384 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.3 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.935 . . . . 0.0 109.266 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.3 m -95.81 172.51 7.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.85 167.31 10.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.22 91.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.334 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -64.67 -33.67 76.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.84 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -50.62 70.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.24 -20.13 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.12 -21.62 61.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -64.73 -25.04 67.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -100.53 -25.63 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.85 119.18 8.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.599 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.535 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' I' ' 8' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.36 142.08 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.635 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 168.94 -39.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -76.19 -36.75 58.52 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.1 -37.79 86.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.185 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.484 HD23 ' H5 ' ' J' ' 32' ' ' IPH . 9.5 mt -84.55 -23.53 29.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 108.973 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.413 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 38.7 t -69.31 -36.23 76.79 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.93 -21.48 65.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.407 ' O ' HG21 ' B' ' 12' ' ' VAL . 61.3 p -77.03 -17.13 59.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.486 -1.008 . . . . 0.0 109.494 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -88.07 -24.51 23.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 10.9 mt -81.14 -39.24 25.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.407 HG21 ' O ' ' B' ' 9' ' ' SER . 13.1 m -49.99 -40.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -70.07 -40.97 74.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.005 . . . . 0.0 109.24 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.64 27.36 1.77 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.75 -48.29 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.312 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.588 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 11.6 p90 -74.38 -17.59 60.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.925 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.588 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 8.3 mt -78.81 -19.47 52.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.408 -0.808 . . . . 0.0 109.483 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.3 -50.64 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.87 -69.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.372 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.29 -106.29 3.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -62.42 -36.36 82.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -1.134 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -68.5 171.56 7.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.012 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -115.05 178.51 17.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.89 159.55 44.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -1.183 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.581 ' O ' ' CD1' ' B' ' 25' ' ' PHE . 21.5 p90 -113.45 139.42 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -123.13 114.35 20.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.458 HG21 ' HA3' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -128.36 87.67 54.6 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.486 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.28 79.01 3.42 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.588 2.192 . . . . 0.0 110.509 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -132.04 161.42 33.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.202 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.645 -179.811 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' C' ' 2' ' ' ILE . 5.1 tt -116.61 13.84 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -116.61 -5.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.9 -4.49 22.1 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.276 -0.89 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.98 5.04 3.85 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.061 -1.025 . . . . 0.0 110.222 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.06 -42.29 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.043 . . . . 0.0 109.192 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.03 -16.01 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 71.4 p -96.59 -37.64 10.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.333 -0.854 . . . . 0.0 109.291 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 7.9 m -138.86 144.2 39.1 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.536 HG12 ' CG ' ' L' ' 5' ' ' HIS . 2.6 mp -53.48 138.25 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 m -102.36 159.76 15.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 109.622 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 170.98 11.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.845 . . . . 0.0 110.329 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -48.93 71.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 109.253 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -61.49 -33.43 73.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 109.241 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -47.75 81.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.725 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mt -71.97 -19.88 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.224 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.47 -22.75 61.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -63.68 -24.66 67.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.534 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -100.92 -27.24 13.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.519 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -58.5 119.6 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.105 -0.997 . . . . 0.0 109.475 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.6 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.463 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 7.6 p -61.52 144.41 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 0.6 OUTLIER 165.45 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.019 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.07 -34.77 43.34 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -64.18 -37.69 88.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.384 -0.822 . . . . 0.0 108.928 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -82.39 -30.79 30.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 108.938 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.438 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.2 t -63.51 -35.48 80.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.47 -0.769 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.37 -22.34 65.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.56 ' CB ' ' CZ ' ' B' ' 16' ' ' TYR . 90.7 p -79.43 -17.79 53.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.221 -1.164 . . . . 0.0 109.149 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -83.37 -27.93 29.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 109.342 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 11.1 mt -78.76 -45.05 21.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.46 HG21 ' O ' ' D' ' 9' ' ' SER . 12.8 m -43.02 -45.3 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -66.08 -40.53 90.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.434 ' HB3' HD23 ' J' ' 17' ' ' LEU . . . -90.29 23.98 2.71 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 109.795 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.33 -48.34 2.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.564 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 9.5 p90 -73.72 -18.66 60.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.237 -0.914 . . . . 0.0 109.311 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 8.6 mt -77.51 -20.35 54.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.817 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.62 -50.21 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 45.1 m -74.77 -68.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.93 -109.72 3.87 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.59 -37.94 76.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.124 . . . . 0.0 109.316 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -68.42 161.09 28.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.812 . . . . 0.0 109.545 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . 0.458 ' HA3' HG21 ' B' ' 27' ' ' THR . . . -104.52 -175.06 25.01 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -158.19 157.66 33.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -1.219 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -111.78 142.62 43.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.331 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.472 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 39.3 t80 -127.76 115.92 19.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 89.99 47.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.63 74.42 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.733 2.289 . . . . 0.0 110.503 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -127.02 159.55 33.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.486 179.894 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.433 HD13 ' CD2' ' E' ' 19' ' ' TYR . 6.4 tt -118.0 16.32 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.272 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 t -118.47 -10.13 11.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.514 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -100.06 -10.2 21.8 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.343 -0.848 . . . . 0.0 109.851 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -129.03 15.28 6.28 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.35 -50.52 0.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -13.91 25.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.696 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 65.2 p -98.74 -34.26 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.042 -1.036 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.3 m -142.72 145.05 32.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.05 139.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -0.983 . . . . 0.0 109.752 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -97.67 171.42 8.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.775 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.23 167.03 10.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 109.367 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -47.72 85.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.265 -0.897 . . . . 0.0 109.141 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -63.76 -34.18 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 0.0 109.606 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -49.53 76.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.77 -18.65 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 0.0 109.682 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.71 -24.24 60.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -61.53 -25.41 67.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.873 . . . . 0.0 109.786 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.433 ' CD2' HD13 ' E' ' 2' ' ' ILE . 24.0 m-85 -100.59 -27.05 13.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.589 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.27 118.53 5.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.584 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.458 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.231 0.539 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 7.6 p -63.91 145.12 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 0.6 OUTLIER 165.21 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.861 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.54 -37.54 42.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.311 -0.868 . . . . 0.0 109.102 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.47 -36.42 82.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 mt -84.51 -28.68 26.56 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 44.0 t -66.0 -33.27 75.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.676 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.34 -20.21 62.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 9' ' ' SER . . . . . 0.464 ' O ' HG21 ' F' ' 12' ' ' VAL . 5.6 p -80.08 -18.02 51.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.047 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -84.13 -26.71 28.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.106 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -78.6 -45.8 20.82 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.342 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . 0.464 HG21 ' O ' ' F' ' 9' ' ' SER . 13.0 m -42.95 -44.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.398 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -65.9 -41.31 91.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 0.0 109.941 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.81 25.74 2.28 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 0.0 109.888 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.53 -48.23 2.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.566 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.4 p90 -74.0 -17.62 60.97 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 8.4 mt -79.8 -19.53 48.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.874 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.78 -51.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.055 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.1 -69.3 0.43 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.43 -109.17 3.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -58.77 -41.6 86.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.326 -1.102 . . . . 0.0 109.342 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -63.71 163.37 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 0.0 109.733 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.11 -175.86 23.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -161.66 163.51 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.5 p90 -119.85 156.02 31.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -134.48 105.23 6.45 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.63 87.65 21.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . 0.481 ' HD2' ' CA ' ' H' ' 23' ' ' GLY . 35.1 Cg_endo -78.47 73.77 5.71 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.771 2.314 . . . . 0.0 110.713 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -125.88 165.14 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.519 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . 0.456 ' O ' ' CG1' ' G' ' 2' ' ' ILE . 5.3 tt -113.16 13.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -1.135 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -115.53 -7.51 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 109.723 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -102.49 -11.31 18.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -128.59 16.76 6.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.108 -0.995 . . . . 0.0 109.479 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.54 -50.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.436 -0.79 . . . . 0.0 109.255 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.3 -15.66 37.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.428 -0.795 . . . . 0.0 109.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 71.2 p -97.39 -39.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 m -136.29 139.77 42.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -50.62 137.8 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 97.1 m -94.97 172.09 8.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.514 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.26 170.73 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 108.932 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -45.96 85.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.165 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.41 -33.28 75.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -49.6 74.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mt -70.47 -19.79 62.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.85 -22.44 61.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -63.53 -29.48 70.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.033 -1.042 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . 0.407 ' CD2' HD13 ' G' ' 2' ' ' ILE . 29.4 m-85 -94.53 -31.87 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.975 . . . . 0.0 109.506 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 121.9 9.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.566 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.3 p -62.63 144.09 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 0.5 OUTLIER 166.09 -42.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.192 -0.942 . . . . 0.0 108.964 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.49 -36.61 60.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.228 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.86 -37.48 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -83.3 -28.08 29.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.092 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.429 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 16.8 t -66.55 -33.5 75.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.681 . . . . 0.0 109.233 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.65 56.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 9' ' ' SER . . . . . 0.403 ' O ' HG21 ' H' ' 12' ' ' VAL . 3.5 p -75.45 -18.0 60.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -1.081 . . . . 0.0 109.571 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -84.52 -24.76 29.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.823 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 11.0 mt -82.54 -42.33 18.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' H' ' 11' ' ' LEU . 12.0 m -45.68 -43.02 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.333 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -66.66 -42.91 85.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.4 26.39 1.46 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.887 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.42 -47.25 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.045 . . . . 0.0 109.37 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.576 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 8.9 p90 -74.92 -16.68 60.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.576 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 7.9 mt -80.33 -19.92 45.42 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.489 -0.757 . . . . 0.0 109.397 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.1 t -79.41 -52.29 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.265 -0.897 . . . . 0.0 109.428 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.36 -65.7 0.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.2 -105.66 3.26 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.71 -39.73 92.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -1.204 . . . . 0.0 109.405 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.94 165.9 12.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . 0.481 ' CA ' ' HD2' ' F' ' 28' ' ' PRO . . . -109.97 -176.75 21.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -159.05 153.51 24.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.409 -1.054 . . . . 0.0 109.347 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . 0.466 ' O ' ' CD1' ' H' ' 25' ' ' PHE . 37.5 p90 -110.79 141.33 44.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.263 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.99 118.88 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.93 . . . . 0.0 109.447 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.5 87.69 49.42 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.611 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.94 77.79 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.644 2.23 . . . . 0.0 110.678 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -129.13 160.44 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.545 179.915 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . 0.465 ' O ' ' CG1' ' I' ' 2' ' ' ILE . 4.2 tt -122.14 15.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -1.207 . . . . 0.0 109.38 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 t -118.73 -3.13 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.299 -0.875 . . . . 0.0 109.311 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.71 -6.14 17.0 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -130.92 2.04 4.35 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 109.79 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 50.9 m -127.15 -39.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -69.46 -13.62 62.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.99 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 8' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' B' ' 1' ' ' PHE . 67.3 p -102.19 -20.72 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.605 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -153.64 138.09 16.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 109.358 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -50.18 138.08 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 109.014 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.0 m -102.26 161.1 13.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 170.92 10.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.341 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -49.41 72.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.542 -0.724 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -60.42 -35.07 74.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.18 -48.69 78.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.577 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.39 -15.36 61.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.266 -0.896 . . . . 0.0 109.736 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -61.59 -29.91 70.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -96.21 -30.3 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.705 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.16 118.86 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.495 179.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.262 0.554 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 7.3 p -64.21 145.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 0.6 OUTLIER 165.3 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -77.99 -38.1 45.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.217 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.32 -35.29 78.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -0.853 . . . . 0.0 108.916 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . 0.469 HD23 ' H5 ' ' E' ' 31' ' ' IPH . 11.3 mt -85.33 -27.46 25.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.432 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 12.9 t -67.23 -33.95 76.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.793 . . . . 0.0 109.42 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.91 -22.67 60.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 93.3 p -77.28 -16.99 58.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -1.026 . . . . 0.0 109.322 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -88.02 -21.65 24.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.892 . . . . 0.0 109.665 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.8 mt -84.02 -38.97 20.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 m -49.67 -40.61 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.43 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -69.44 -40.52 77.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.501 ' CB ' HD23 ' D' ' 17' ' ' LEU . . . -91.2 27.81 1.8 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.381 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.56 -46.41 2.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.583 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 12.6 p90 -76.22 -16.22 59.87 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.056 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.583 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 7.9 mt -80.83 -17.37 51.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.499 -0.75 . . . . 0.0 109.792 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -82.69 -49.42 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -63.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 109.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.74 -105.95 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -61.05 -39.12 88.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -66.63 157.51 32.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.936 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -175.87 29.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -161.1 157.9 26.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.058 -1.26 . . . . 0.0 109.726 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -115.97 142.68 46.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.76 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -122.67 119.25 30.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.406 -0.809 . . . . 0.0 109.121 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 87.38 53.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.72 77.84 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.628 2.218 . . . . 0.0 110.679 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -128.93 160.54 32.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.342 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' K' ' 2' ' ' ILE . 6.2 tt -117.66 17.22 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.316 -1.108 . . . . 0.0 109.718 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 t -119.94 -8.42 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.63 -10.37 21.0 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.279 -0.888 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -130.94 16.44 5.18 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.56 -47.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.314 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -16.09 56.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.196 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 66.9 p -96.04 -41.33 8.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.823 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 75.3 m -134.35 144.41 48.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.142 -0.974 . . . . 0.0 109.721 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.43 137.22 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.29 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.83 169.38 10.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 109.887 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.03 167.49 10.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.38 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -46.44 90.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.387 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.61 -35.0 79.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -49.06 78.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 109.598 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.23 -18.34 62.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.931 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.45 -23.12 60.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 109.188 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.576 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -99.33 -27.82 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.08 120.94 8.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.486 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' C' ' 8' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.264 0.554 . . . . 0.0 109.587 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 7.3 p -63.14 143.86 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.013 -1.055 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 0.6 OUTLIER 167.27 -39.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.017 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -77.07 -39.89 48.16 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.374 -0.829 . . . . 0.0 108.81 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . 0.536 ' CG ' HG12 ' C' ' 10' ' ' ILE . 86.3 t60 -60.67 -36.61 79.16 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . 0.444 HD23 ' H5 ' ' D' ' 32' ' ' IPH . 10.8 mt -84.01 -29.34 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.439 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 40.7 t -66.12 -32.68 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.578 -0.701 . . . . 0.0 109.595 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.44 -26.7 53.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 9' ' ' SER . . . . . 0.454 ' O ' HG21 ' L' ' 12' ' ' VAL . 59.9 p -74.01 -19.74 60.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.48 -1.012 . . . . 0.0 109.329 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -83.78 -23.28 31.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 0.0 109.564 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 10.5 mt -82.55 -42.65 18.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 109.566 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . 0.454 HG21 ' O ' ' L' ' 9' ' ' SER . 13.9 m -46.49 -40.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -70.36 -40.21 74.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.89 21.46 3.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 109.666 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -49.28 2.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.553 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 11.5 p90 -73.05 -17.3 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.962 . . . . 0.0 109.695 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.553 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 8.4 mt -79.01 -19.51 51.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.684 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.49 -50.79 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 57.1 m -73.83 -68.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.35 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.82 -108.38 3.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.93 -38.22 85.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -1.169 . . . . 0.0 109.217 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -67.44 160.53 27.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.433 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.62 -175.46 24.91 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -155.33 170.5 21.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -125.57 136.71 53.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.968 -1.083 . . . . 0.0 109.315 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -120.16 117.08 26.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.74 87.16 50.35 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.483 -0.761 . . . . 0.0 109.307 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.99 79.14 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.593 2.196 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -130.07 161.39 31.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 0.0 109.312 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.414 179.872 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.444 ' H5 ' HD23 ' L' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 31' ' ' IPH . . . . . 0.469 ' H5 ' HD23 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . 0.484 ' H5 ' HD23 ' B' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.483 HD13 HD11 ' B' ' 15' ' ' LEU . 51.4 mt -87.27 -27.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.88 -27.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.209 -0.932 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 55.01 0.65 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.22 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.37 -36.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -101.66 -32.22 10.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.339 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.454 ' O ' HG12 ' F' ' 2' ' ' VAL . 1.7 m -68.89 -32.04 71.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 108.975 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.7 p -88.45 -16.1 33.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.416 -0.803 . . . . 0.0 109.45 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 10' ' ' ILE . 1.4 p -169.49 121.15 0.71 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.444 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 9' ' ' SER . 3.1 mt -44.61 107.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.14 154.96 21.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.299 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -71.99 167.56 19.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.23 -38.33 85.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.713 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.8 -43.07 94.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.873 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -63.84 -39.6 94.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.4 mt -77.16 -15.17 59.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -78.09 -22.51 48.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -85.35 17.39 3.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.24 -13.7 12.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.116 -0.99 . . . . 0.0 109.299 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.88 156.99 25.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.193 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.509 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.239 0.542 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.3 150.64 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.055 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 173.32 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.006 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -74.61 -32.67 62.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.174 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -69.03 -39.37 79.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.08 -23.48 35.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.484 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 42.4 t -74.57 -34.91 63.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.429 -0.794 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -16.01 80.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.89 -19.95 28.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.413 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.736 ' CG ' HD22 ' F' ' 6' ' ' LEU . 10.9 m-70 -83.97 -15.07 49.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 12.9 mt -91.98 -49.71 6.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.756 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.454 HG23 ' N ' ' B' ' 13' ' ' GLU . 9.0 m -46.56 -45.18 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.454 ' N ' HG23 ' B' ' 12' ' ' VAL . 67.4 mt-10 -62.03 -42.79 99.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.54 22.67 2.49 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.173 -0.955 . . . . 0.0 109.631 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.483 HD11 HD13 ' A' ' 2' ' ' ILE . 0.7 OUTLIER -115.89 -58.41 2.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.903 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -59.46 -27.86 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.197 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.03 -42.68 80.24 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.554 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -54.56 -47.99 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -61.44 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' B' ' 21' ' ' GLU . . . 103.65 40.04 2.43 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' B' ' 20' ' ' GLY . 3.0 tt0 78.86 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.434 -1.039 . . . . 0.0 109.419 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.21 -54.81 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 109.581 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.02 152.38 5.7 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -163.52 159.87 22.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -119.81 143.24 47.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.601 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 40.2 t80 -119.71 104.7 10.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.103 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -132.07 97.92 17.89 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.76 113.15 3.59 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.504 2.136 . . . . 0.0 110.637 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -168.17 158.25 10.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.438 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 2' ' ' ILE . . . . . 0.488 HD13 HD11 ' D' ' 15' ' ' LEU . 46.0 mt -90.17 -28.37 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 109.316 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.49 -29.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.98 53.11 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -174.34 -36.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 6' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' C' ' 9' ' ' SER . 63.3 m -101.62 -33.62 9.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.357 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -68.1 -30.51 69.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.904 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 75.0 p -89.82 -17.26 28.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.317 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 9' ' ' SER . . . . . 0.413 ' O ' ' C ' ' C' ' 10' ' ' ILE . 1.3 p -167.82 120.34 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' C' ' 9' ' ' SER . 3.1 mt -44.29 108.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.22 155.98 16.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 t -72.68 165.83 24.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.11 -37.63 86.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.968 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.24 -44.5 88.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.884 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' GLN . . . . . 0.464 ' HA ' ' ND2' ' C' ' 18' ' ' ASN . 27.8 mt-30 -61.6 -40.98 96.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 47.0 mt -74.62 -17.2 60.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 109.828 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.11 -18.79 52.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.011 -1.055 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' C' ' 15' ' ' GLN . 26.8 p30 -88.24 16.34 6.39 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.117 -0.99 . . . . 0.0 109.47 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -112.26 -12.95 13.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.51 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.22 152.56 25.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.552 -179.921 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.63 HG23 HD11 ' G' ' 10' ' ' ILE . 7.3 p -60.18 152.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.223 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' D' ' 7' ' ' CYS . 3.9 m-20 170.92 -38.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.377 -0.827 . . . . 0.0 109.219 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -75.36 -31.02 60.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -70.18 -40.36 74.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.143 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -81.87 -22.35 36.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.06 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 49.9 t -75.34 -34.53 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.39 -0.819 . . . . 0.0 109.674 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.08 -16.95 80.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.85 -19.6 32.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -1.041 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 10' ' ' HIS . . . . . 0.704 ' CG ' HD22 ' L' ' 6' ' ' LEU . 15.5 m-70 -85.57 -13.91 47.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.298 -0.876 . . . . 0.0 109.137 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 13.8 mt -92.04 -52.72 4.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.527 HG23 ' N ' ' D' ' 13' ' ' GLU . 11.5 m -43.79 -48.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.527 ' N ' HG23 ' D' ' 12' ' ' VAL . 82.3 mt-10 -58.71 -43.74 90.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.865 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.65 23.5 2.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.237 -0.914 . . . . 0.0 110.071 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.488 HD11 HD13 ' C' ' 2' ' ' ILE . 0.8 OUTLIER -115.56 -59.28 2.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' D' ' 13' ' ' GLU . 16.5 p90 -58.42 -27.4 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' D' ' 17' ' ' LEU . 4.9 mt -68.14 -43.1 79.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.385 -0.822 . . . . 0.0 109.586 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.21 -47.77 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -60.25 3.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' D' ' 21' ' ' GLU . . . 101.23 40.55 2.79 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' D' ' 20' ' ' GLY . 1.9 tt0 79.55 50.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.434 -1.039 . . . . 0.0 109.867 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -51.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.41 150.49 6.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 30.0 p90 -155.28 172.46 18.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.31 -1.112 . . . . 0.0 109.364 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 25' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' D' ' 25' ' ' PHE . 12.8 m-85 -129.12 139.03 52.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.277 -0.889 . . . . 0.0 109.37 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -120.97 99.42 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.577 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 32.4 m -126.48 100.61 28.7 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.401 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.85 110.93 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.569 2.179 . . . . 0.0 110.543 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -167.18 155.75 9.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.379 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.517 HD13 HD11 ' F' ' 15' ' ' LEU . 50.5 mt -87.11 -27.37 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.5 -28.01 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -108.04 53.22 0.69 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.275 -0.891 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -174.78 -34.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 6' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' E' ' 2' ' ' ILE . 64.3 m -102.63 -30.28 11.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.221 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 4.8 t -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.339 -0.851 . . . . 0.0 109.306 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -87.67 -15.74 36.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 9' ' ' SER . . . . . 0.437 ' O ' ' C ' ' E' ' 10' ' ' ILE . 76.7 p -169.19 117.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.227 -0.92 . . . . 0.0 109.34 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.509 HD11 HG23 ' J' ' 2' ' ' VAL . 3.1 mt -42.25 106.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.06 155.19 14.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.726 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 27.7 t -70.57 168.86 15.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.43 -37.13 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -64.74 -47.12 79.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -0.836 . . . . 0.0 109.475 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 15' ' ' GLN . . . . . 0.445 ' HA ' ' ND2' ' E' ' 18' ' ' ASN . 28.1 mt-30 -60.54 -39.66 88.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.899 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.288 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -76.99 -18.96 57.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 18' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' E' ' 15' ' ' GLN . 27.5 p30 -89.07 13.81 12.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.04 -1.038 . . . . 0.0 110.002 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -109.03 -13.38 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.04 -1.037 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 153.42 27.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.865 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.289 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 7' ' ' CYS . 10.0 p -58.26 149.97 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 174.32 -41.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -72.89 -27.93 62.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -72.84 -40.01 66.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.039 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 6' ' ' LEU . . . . . 0.736 HD22 ' CG ' ' B' ' 10' ' ' HIS . 6.6 mt -82.46 -19.8 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 108.989 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.422 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 42.3 t -75.68 -38.61 58.58 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.523 -0.735 . . . . 0.0 109.472 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.04 -15.17 79.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -21.4 29.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.18 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -82.57 -18.58 40.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.9 mt -89.14 -49.86 6.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.746 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.489 HG23 ' N ' ' F' ' 13' ' ' GLU . 12.4 m -46.65 -45.81 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.111 -0.993 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 13' ' ' GLU . . . . . 0.489 ' N ' HG23 ' F' ' 12' ' ' VAL . 79.4 mt-10 -62.44 -40.61 97.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.03 25.06 2.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.517 HD11 HD13 ' E' ' 2' ' ' ILE . 0.7 OUTLIER -117.97 -58.85 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -59.34 -27.73 66.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.297 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' F' ' 17' ' ' LEU . 5.3 mt -68.07 -43.51 78.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.857 . . . . 0.0 109.493 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.06 -51.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 109.402 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -47.8 -62.23 1.56 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' F' ' 21' ' ' GLU . . . 103.63 40.42 2.36 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' F' ' 20' ' ' GLY . 2.2 tt0 79.65 49.51 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -1.046 . . . . 0.0 109.788 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -123.53 -46.8 2.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.04 -1.038 . . . . 0.0 109.563 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.22 153.14 7.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -162.81 175.68 11.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 25' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 2.4 p90 -132.76 158.18 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.383 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -138.25 93.78 2.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.411 -0.806 . . . . 0.0 109.103 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 28.5 m -120.34 99.34 48.22 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.492 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 108.59 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.424 2.083 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -164.64 155.73 15.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 44.3 p . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.568 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' G' G ' 2' ' ' ILE . . . . . 0.503 HD13 HD11 ' H' ' 15' ' ' LEU . 36.4 mt -84.48 -30.52 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.751 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.15 -30.05 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 109.63 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.7 52.45 0.73 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.175 -0.953 . . . . 0.0 109.888 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -173.05 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.379 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.5 -35.06 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.83 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.075 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -89.05 -17.4 29.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.361 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 9' ' ' SER . . . . . 0.43 ' O ' ' C ' ' G' ' 10' ' ' ILE . 1.9 p -168.75 119.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 10' ' ' ILE . . . . . 0.63 HD11 HG23 ' D' ' 2' ' ' VAL . 3.1 mt -42.82 106.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.578 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 62.6 m -60.62 153.97 22.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.373 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -68.76 170.16 10.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 13' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' G' ' 13' ' ' LEU . 1.3 mm? -70.79 -37.83 73.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 109.188 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.28 -44.82 90.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.431 -0.793 . . . . 0.0 109.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 15' ' ' GLN . . . . . 0.452 ' HA ' ' ND2' ' G' ' 18' ' ' ASN . 21.4 mt-30 -61.92 -39.66 92.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.91 -15.36 59.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.203 -0.936 . . . . 0.0 109.544 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -79.32 -19.86 49.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.679 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 18' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' G' ' 15' ' ' GLN . 27.6 p30 -86.54 11.99 11.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -108.86 -10.94 15.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.855 . . . . 0.0 109.796 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.41 152.63 23.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.654 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.399 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.408 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.5 p -60.06 152.56 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 3.6 m-20 170.72 -37.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -74.8 -33.81 62.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.25 -0.906 . . . . 0.0 108.855 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 5' ' ' HIS . . . . . 0.6 ' CB ' HD11 ' K' ' 10' ' ' ILE . 54.2 t60 -67.49 -42.2 83.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.513 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mt -79.22 -26.8 42.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.85 . . . . 0.0 109.427 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 42.4 t -72.21 -34.23 68.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.55 -21.47 79.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.73 -20.68 38.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -1.061 . . . . 0.0 109.665 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -82.34 -15.75 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.113 -0.992 . . . . 0.0 109.76 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.433 HD13 HG22 ' G' ' 2' ' ' ILE . 9.6 mt -92.41 -49.16 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.594 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.497 HG23 ' N ' ' H' ' 13' ' ' GLU . 10.8 m -46.16 -47.11 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 13' ' ' GLU . . . . . 0.497 ' N ' HG23 ' H' ' 12' ' ' VAL . 78.3 mt-10 -61.42 -42.45 98.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.32 19.37 3.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 110.063 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 15' ' ' LEU . . . . . 0.503 HD11 HD13 ' G' ' 2' ' ' ILE . 0.7 OUTLIER -112.5 -59.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.07 -28.62 64.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' H' ' 17' ' ' LEU . 5.4 mt -67.07 -43.32 82.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.518 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -53.94 -45.81 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -57.16 12.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 20' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' H' ' 21' ' ' GLU . . . 99.73 38.88 3.53 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 21' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' H' ' 20' ' ' GLY . 2.2 tt0 80.93 50.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.26 -56.81 1.61 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.962 . . . . 0.0 109.475 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.37 153.25 5.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.67 158.27 17.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -1.153 . . . . 0.0 109.186 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 28.5 p90 -121.39 141.09 51.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.697 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -117.09 106.25 13.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 32.5 m -132.29 99.06 16.35 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.55 -0.719 . . . . 0.0 109.454 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.44 112.61 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.489 2.126 . . . . 0.0 110.47 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.61 153.18 8.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.612 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.514 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.494 HD13 HD11 ' J' ' 15' ' ' LEU . 32.8 mt -86.37 -30.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -1.125 . . . . 0.0 109.4 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.46 -28.23 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -108.09 49.4 0.81 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.11 -0.994 . . . . 0.0 109.688 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -170.12 -34.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.22 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -102.97 -32.53 9.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.06 -26.63 64.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 46.8 p -93.76 -17.2 23.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.035 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 9' ' ' SER . . . . . 0.417 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.2 p -167.52 119.29 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' I' ' 9' ' ' SER . 3.1 mt -43.73 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.5 m -59.57 156.55 13.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.482 -0.761 . . . . 0.0 109.457 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -73.7 169.01 18.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.86 -38.16 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -65.56 -43.75 88.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 15' ' ' GLN . . . . . 0.433 ' HA ' ' ND2' ' I' ' 18' ' ' ASN . 26.9 mt-30 -62.97 -38.0 89.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.187 -0.945 . . . . 0.0 109.441 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 42.3 mt -78.84 -13.51 59.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -81.01 -21.55 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.08 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 18' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' I' ' 15' ' ' GLN . 27.3 p30 -85.09 15.8 3.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.314 -0.866 . . . . 0.0 109.739 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.64 -11.73 13.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.382 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.12 154.65 24.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.526 -179.859 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.509 HG23 HD11 ' E' ' 10' ' ' ILE . 11.2 p -59.99 151.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 171.8 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.048 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -74.08 -33.49 63.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.249 -0.907 . . . . 0.0 109.105 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 t60 -68.38 -39.55 81.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.508 -0.745 . . . . 0.0 109.705 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 mt -82.19 -24.64 34.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.465 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 48.7 t -72.89 -37.31 67.32 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -0.817 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.88 -20.52 78.83 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 9' ' ' SER . . . . . 0.461 ' HB3' ' OH ' ' L' ' 16' ' ' TYR . 1.3 m -82.38 -19.71 38.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -1.11 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.46 -16.81 44.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.574 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.1 mt -91.08 -48.16 7.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.481 HG23 ' N ' ' J' ' 13' ' ' GLU . 11.7 m -47.9 -46.15 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.276 -0.89 . . . . 0.0 109.981 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.481 ' N ' HG23 ' J' ' 12' ' ' VAL . 60.9 mt-10 -62.27 -39.61 93.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.26 23.36 3.37 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.864 . . . . 0.0 109.753 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 15' ' ' LEU . . . . . 0.494 HD11 HD13 ' I' ' 2' ' ' ILE . 0.8 OUTLIER -116.32 -58.01 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.018 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -60.37 -28.44 68.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' J' ' 17' ' ' LEU . 5.5 mt -66.17 -44.55 83.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.214 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -51.27 -48.58 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.282 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -50.77 69.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.08 -1.013 . . . . 0.0 108.831 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 20' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' J' ' 21' ' ' GLU . . . 108.77 -43.54 1.69 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 21' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' J' ' 20' ' ' GLY . 2.4 tt0 167.44 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -53.44 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.59 157.07 7.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 24' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 25.1 p90 -159.27 171.24 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -1.142 . . . . 0.0 109.742 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 25' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 1.7 p90 -128.0 141.26 51.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -121.75 98.76 6.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.873 . . . . 0.0 109.473 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -125.8 100.23 31.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.433 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.86 109.02 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.426 2.084 . . . . 0.0 110.621 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -164.29 156.85 17.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.553 -179.842 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' K' K ' 2' ' ' ILE . . . . . 0.508 HD13 HD11 ' L' ' 15' ' ' LEU . 38.0 mt -85.06 -29.23 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 39.4 t -69.24 -31.63 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.265 -0.897 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.95 51.96 0.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.262 -0.899 . . . . 0.0 109.975 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.28 -37.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.161 -0.962 . . . . 0.0 109.227 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 64.5 m -99.59 -34.67 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.305 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 7' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 1.7 m -68.07 -22.95 64.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 38.0 p -96.95 -20.42 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 108.978 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 9' ' ' SER . . . . . 0.414 ' O ' ' C ' ' K' ' 10' ' ' ILE . 33.8 p -165.27 119.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.324 -0.86 . . . . 0.0 108.959 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 10' ' ' ILE . . . . . 0.6 HD11 ' CB ' ' H' ' 5' ' ' HIS . 2.9 mp -42.99 107.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.749 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 68.7 m -59.13 156.3 12.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -73.27 169.36 17.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.52 -34.84 74.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 0.0 109.744 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.97 -45.11 75.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.995 . . . . 0.0 109.377 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 15' ' ' GLN . . . . . 0.441 ' HA ' ' ND2' ' K' ' 18' ' ' ASN . 24.0 mt-30 -60.78 -40.43 92.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 42.5 mt -76.41 -15.57 59.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.94 -19.75 47.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.983 . . . . 0.0 109.558 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 18' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' K' ' 15' ' ' GLN . 27.5 p30 -87.17 14.18 8.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.887 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.42 -10.82 14.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.292 -0.88 . . . . 0.0 109.562 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.0 154.22 22.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.551 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.196 0.522 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.72 151.6 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.012 -1.055 . . . . 0.0 109.198 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 172.86 -40.24 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 108.907 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.4 -33.0 64.76 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.297 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -68.73 -39.65 80.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 6' ' ' LEU . . . . . 0.704 HD22 ' CG ' ' D' ' 10' ' ' HIS . 7.9 mt -82.23 -22.64 35.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.0 109.223 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 48.6 t -74.97 -32.65 61.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.432 -0.792 . . . . 0.0 109.821 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 -13.38 83.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -17.58 31.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.235 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -85.46 -19.19 31.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 11.9 mt -87.23 -51.55 5.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.51 HG23 ' N ' ' L' ' 13' ' ' GLU . 8.4 m -46.1 -49.08 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.641 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 13' ' ' GLU . . . . . 0.51 ' N ' HG23 ' L' ' 12' ' ' VAL . 62.3 mt-10 -58.98 -42.57 90.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.39 22.79 2.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 15' ' ' LEU . . . . . 0.508 HD11 HD13 ' K' ' 2' ' ' ILE . 0.7 OUTLIER -115.67 -57.81 2.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 0.0 109.824 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.461 ' OH ' ' HB3' ' J' ' 9' ' ' SER . 18.0 p90 -60.45 -26.97 67.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.17 -0.956 . . . . 0.0 109.393 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' L' ' 17' ' ' LEU . 5.0 mt -68.59 -41.13 80.04 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.37 -49.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -59.48 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.533 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' L' ' 21' ' ' GLU . . . 101.07 39.14 3.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' L' ' 20' ' ' GLY . 2.7 tt0 80.38 48.08 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.489 -1.006 . . . . 0.0 109.929 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.36 -53.86 2.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.38 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.31 151.26 5.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -160.68 169.59 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -1.105 . . . . 0.0 108.949 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 25' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 2.5 p90 -129.38 147.61 51.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 26' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 36.8 t80 -123.85 107.12 11.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.889 . . . . 0.0 109.166 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -133.17 98.48 15.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.305 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 110.7 3.05 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.471 2.114 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.0 158.52 17.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.418 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.658 -179.846 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.4 2.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -1.176 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 48.0 t -95.04 -36.65 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.958 -1.089 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.43 38.93 1.42 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.477 -0.764 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -156.34 -39.29 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 109.513 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.5 m -104.04 -38.96 6.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 109.636 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 49.3 t -62.09 -24.3 67.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.602 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 p -77.65 -31.67 52.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -153.1 145.78 24.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.545 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -46.81 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -0.869 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.428 ' HB3' ' HG ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.56 163.23 7.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.615 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.17 165.23 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.294 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -36.5 77.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.843 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -68.89 -32.03 71.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -46.15 46.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' A' ' 11' ' ' CYS . 64.8 mt -67.23 -17.34 64.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.053 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -26.15 62.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.069 -1.02 . . . . 0.0 109.335 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -55.08 -32.02 61.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.94 55.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.038 -1.039 . . . . 0.0 109.546 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -123.66 131.88 53.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.392 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.627 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.474 ' O ' HG13 ' B' ' 2' ' ' VAL . 11.1 p -66.98 127.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.579 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 t30 179.96 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.95 -26.34 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -78.48 -39.4 38.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.08 -22.35 36.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 39.7 t -81.81 -33.07 30.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.941 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.81 -26.71 55.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.27 63.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -96.97 -21.17 17.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 59.5 mt -81.76 -33.45 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.58 -33.02 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -73.77 -38.17 64.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.152 -0.968 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -64.59 -58.06 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.543 ' HA ' ' HB ' ' B' ' 18' ' ' VAL . 9.4 mt -53.43 -23.01 8.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.992 . . . . 0.0 109.689 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -53.04 58.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 110.02 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -88.88 -23.27 22.8 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' B' ' 15' ' ' LEU . 83.7 t -65.44 -22.69 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 109.688 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.2 -34.62 8.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.626 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.48 -147.4 18.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -78.41 -1.43 33.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.252 -1.146 . . . . 0.0 109.701 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -65.83 -26.5 67.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 174.28 48.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -157.14 176.79 12.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 0.0 109.549 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.61 ' HB2' ' CE1' ' D' ' 25' ' ' PHE . 6.3 p90 -133.13 153.99 51.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.95 . . . . 0.0 109.585 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -130.92 109.4 10.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.383 -0.823 . . . . 0.0 109.302 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 40.3 m -159.7 105.89 1.46 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 109.34 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.42 -88.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.26 1.973 . . . . 0.0 110.233 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.29 -153.97 0.38 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.425 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 2' ' ' ILE . . . . . 0.443 HD12 ' CD2' ' C' ' 19' ' ' TYR . 8.9 tt -103.02 0.96 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.644 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 3' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' C' ' 7' ' ' CYS . 48.2 t -92.62 -35.94 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.86 48.27 0.86 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.181 -0.949 . . . . 0.0 109.373 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -166.44 -36.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.459 -0.775 . . . . 0.0 109.097 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m -106.5 -39.69 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.394 -0.816 . . . . 0.0 109.374 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' C' ' 3' ' ' VAL . 47.0 t -64.14 -22.07 66.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.849 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -80.31 -31.73 38.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.587 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.28 146.68 26.21 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -48.76 101.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.571 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' CYS . . . . . 0.402 ' HB3' ' HG ' ' C' ' 16' ' ' LEU . 0.3 OUTLIER -58.32 160.12 5.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 169.91 13.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.6 -38.23 70.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.697 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.6 -31.14 70.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.43 -43.89 47.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 109.821 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' C' ' 11' ' ' CYS . 67.0 mt -69.73 -16.51 63.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.87 . . . . 0.0 109.812 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -23.13 61.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.634 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -58.72 -29.83 66.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.443 ' CD2' HD12 ' C' ' 2' ' ' ILE . 10.6 m-85 -101.39 57.58 0.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -126.6 130.39 50.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.466 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.485 ' O ' HG13 ' D' ' 2' ' ' VAL . 13.0 p -64.8 128.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.587 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 179.25 -42.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.118 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.03 -25.36 60.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.779 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -80.83 -35.58 32.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -85.38 -20.33 30.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.147 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.472 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 41.8 t -84.31 -31.65 24.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.442 -0.786 . . . . 0.0 109.974 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.443 ' HA3' ' OH ' ' D' ' 26' ' ' TYR . . . -81.09 -27.02 51.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -15.23 63.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.34 -1.094 . . . . 0.0 109.364 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -97.06 -21.24 17.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.187 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 57.2 mt -83.81 -28.19 28.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -63.99 -32.06 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -75.32 -37.53 60.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.317 -0.864 . . . . 0.0 109.611 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -65.73 -55.12 18.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.942 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.503 ' HA ' ' HB ' ' D' ' 18' ' ' VAL . 9.6 mt -55.13 -24.4 25.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.38 -53.77 40.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.005 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 35.3 mt -87.98 -24.85 23.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 110.463 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' D' ' 15' ' ' LEU . 78.9 t -63.68 -22.76 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.12 -37.65 7.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.383 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.74 -144.73 17.46 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.78 4.5 21.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -1.161 . . . . 0.0 109.593 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -72.67 -22.72 60.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.883 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.02 177.94 50.97 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -159.05 167.44 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -1.208 . . . . 0.0 109.925 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' B' ' 25' ' ' PHE . 2.3 m-85 -118.41 149.6 40.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.415 -0.803 . . . . 0.0 109.449 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.443 ' OH ' ' HA3' ' D' ' 8' ' ' GLY . 64.0 t80 -133.05 100.4 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.327 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.3 m -154.05 109.21 2.47 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.152 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.32 -87.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 110.313 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.18 -153.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.464 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.605 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' E' ' 19' ' ' TYR . 5.1 tt -102.35 0.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -1.087 . . . . 0.0 109.444 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 3' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 42.5 t -92.9 -38.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.301 -0.874 . . . . 0.0 109.66 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.81 45.29 0.99 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.885 . . . . 0.0 109.406 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -163.68 -36.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.456 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 74.9 m -107.01 -41.21 5.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 7' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' F' ' 11' ' ' LEU . 0.6 OUTLIER -62.36 -20.86 64.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -79.95 -34.16 39.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -150.8 146.72 26.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.265 -0.897 . . . . 0.0 109.335 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.32 102.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.678 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 162.04 6.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.366 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.47 167.65 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.516 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -39.04 77.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.163 -0.961 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -67.02 -31.33 71.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.34 -42.7 53.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 110.08 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 mt -70.67 -16.98 62.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.71 -26.66 63.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -54.62 -30.68 55.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.431 ' CD2' HD12 ' E' ' 2' ' ' ILE . 10.6 m-85 -101.42 59.27 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -127.3 132.09 50.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.317 -179.955 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.356 0.598 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.476 ' O ' HG13 ' F' ' 2' ' ' VAL . 11.5 p -62.29 127.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.389 -0.819 . . . . 0.0 109.911 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 t30 179.39 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.06 -27.31 57.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -79.54 -33.54 41.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.594 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -87.41 -22.67 24.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.107 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 37.3 t -82.53 -26.52 32.39 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.44 -27.08 31.12 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.55 -15.78 63.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -1.122 . . . . 0.0 109.181 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -96.27 -24.27 16.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.313 -0.867 . . . . 0.0 109.633 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.581 HD11 ' SG ' ' E' ' 7' ' ' CYS . 52.2 mt -79.86 -31.28 40.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.553 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.407 HG22 ' H ' ' F' ' 12' ' ' VAL . 4.1 m -60.45 -33.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.95 -35.38 62.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 109.823 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.548 ' CB ' HD13 ' L' ' 17' ' ' LEU . . . -67.9 -54.83 15.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.571 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.519 ' HA ' ' HB ' ' F' ' 18' ' ' VAL . 12.0 mt -55.83 -22.28 24.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 109.598 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -55.02 35.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.482 HD21 ' NE2' ' H' ' 5' ' ' HIS . 42.2 mt -85.76 -26.53 25.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.27 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 18' ' ' VAL . . . . . 0.541 HG23 ' O ' ' F' ' 14' ' ' ALA . 89.5 t -61.96 -23.14 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.116 -0.99 . . . . 0.0 109.753 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.97 -35.15 8.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.6 -143.19 16.5 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -82.79 2.69 32.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -1.14 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.53 -31.6 68.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.65 -177.35 31.8 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -169.88 154.03 5.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.433 -1.04 . . . . 0.0 109.136 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -112.25 157.88 20.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.68 108.51 8.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 108.918 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -158.71 109.22 1.62 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.688 . . . . 0.0 109.405 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.5 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.372 2.048 . . . . 0.0 110.213 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.91 -156.08 0.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.373 -0.829 . . . . 0.0 109.769 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' G' G ' 2' ' ' ILE . . . . . 0.418 HD12 ' CD2' ' G' ' 19' ' ' TYR . 7.4 tt -100.21 1.48 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -1.159 . . . . 0.0 109.61 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -92.97 -40.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.38 47.69 1.03 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -166.78 -34.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 77.9 m -108.58 -38.11 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.46 -23.63 67.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.381 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 3.1 p -77.35 -30.84 54.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.13 146.68 25.02 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.211 -0.93 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 mt -49.06 103.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.148 -0.97 . . . . 0.0 109.289 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.18 162.63 5.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.06 164.41 15.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 109.244 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -41.3 91.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.88 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -64.62 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -44.77 50.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.086 -1.008 . . . . 0.0 109.863 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.57 -16.43 63.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -25.4 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 0.0 109.26 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -56.11 -28.84 59.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.864 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 19' ' ' TYR . . . . . 0.418 ' CD2' HD12 ' G' ' 2' ' ' ILE . 10.2 m-85 -103.19 56.52 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 128.06 47.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 109.553 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 109.446 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.538 ' O ' HG13 ' H' ' 2' ' ' VAL . 14.0 p -66.3 126.3 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -179.36 -41.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.58 -25.04 60.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.588 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 5' ' ' HIS . . . . . 0.482 ' NE2' HD21 ' F' ' 17' ' ' LEU . 37.1 t60 -80.01 -39.48 29.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.302 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -82.75 -16.41 48.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.438 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 44.4 t -88.89 -30.8 18.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.848 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.25 -28.22 45.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -67.29 -19.02 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -1.131 . . . . 0.0 109.559 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -93.48 -23.12 18.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.153 -0.967 . . . . 0.0 109.666 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 43.4 mt -81.56 -30.81 32.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.404 ' H ' HG22 ' H' ' 12' ' ' VAL . 3.6 m -60.58 -31.71 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.061 -1.024 . . . . 0.0 109.631 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -75.94 -35.37 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 14' ' ' ALA . . . . . 0.567 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -66.44 -54.13 27.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -0.98 . . . . 0.0 109.436 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 15' ' ' LEU . . . . . 0.478 ' HA ' ' HB ' ' H' ' 18' ' ' VAL . 12.6 mt -57.17 -24.52 54.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.873 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -51.47 61.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -89.22 -25.56 21.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 18' ' ' VAL . . . . . 0.567 HG23 ' O ' ' H' ' 14' ' ' ALA . 91.4 t -63.62 -26.24 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.034 -1.042 . . . . 0.0 109.65 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -39.15 9.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 109.544 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.95 -143.93 16.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.76 2.89 31.64 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.072 -1.252 . . . . 0.0 109.612 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -70.2 -24.88 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.14 -171.87 35.96 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -172.1 163.4 5.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -1.234 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -120.84 154.68 35.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.024 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -134.9 101.51 4.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.461 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 22.9 m -152.83 108.14 2.69 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 109.509 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.83 -87.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.343 2.029 . . . . 0.0 110.745 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.59 -154.91 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.393 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' I' ' 19' ' ' TYR . 7.9 tt -104.48 1.64 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -1.192 . . . . 0.0 109.523 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 3' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 42.4 t -93.52 -37.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.73 37.62 1.58 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.564 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -154.59 -38.82 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -104.57 -41.52 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 7' ' ' CYS . . . . . 0.527 ' SG ' HD11 ' J' ' 11' ' ' LEU . 0.6 OUTLIER -60.34 -20.42 59.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.711 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -81.57 -33.4 31.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.23 147.72 28.03 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.32 -0.863 . . . . 0.0 108.949 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.92 101.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.34 164.63 1.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.62 168.71 11.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.008 . . . . 0.0 109.06 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.69 -42.84 77.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -63.55 -32.01 73.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 110.078 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -43.26 55.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.988 . . . . 0.0 109.949 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 mt -70.35 -16.01 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.826 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -19.57 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.18 -0.95 . . . . 0.0 109.65 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -62.21 -28.09 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.247 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 19' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' I' ' 2' ' ' ILE . 11.5 m-85 -102.11 58.47 0.82 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.17 129.83 47.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.362 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.514 ' O ' HG13 ' J' ' 2' ' ' VAL . 12.3 p -65.47 127.33 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -179.95 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -75.13 -27.62 59.86 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.874 . . . . 0.0 109.619 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -76.8 -36.61 56.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 13.3 mt -84.98 -21.97 29.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.418 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.422 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 43.7 t -83.1 -27.19 30.36 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.31 -0.869 . . . . 0.0 109.644 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.41 -27.48 30.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 9' ' ' SER . . . . . 0.515 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 0.4 OUTLIER -69.82 -12.18 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -1.129 . . . . 0.0 109.477 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -99.43 -21.52 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.322 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.527 HD11 ' SG ' ' I' ' 7' ' ' CYS . 40.5 mt -83.37 -32.2 26.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 109.603 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.418 HG22 ' H ' ' J' ' 12' ' ' VAL . 6.2 m -58.72 -32.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.354 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -74.3 -37.81 63.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.686 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 14' ' ' ALA . . . . . 0.417 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -65.03 -59.65 3.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.568 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 15' ' ' LEU . . . . . 0.521 ' HA ' ' HB ' ' J' ' 18' ' ' VAL . 10.7 mt -51.0 -25.77 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.725 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -55.48 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.119 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 mt -85.9 -27.82 24.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 0.0 110.229 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 18' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' J' ' 15' ' ' LEU . 87.7 t -59.34 -26.33 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 109.935 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -99.47 -39.32 8.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.566 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 -145.11 17.18 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.35 1.18 33.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.21 -1.17 . . . . 0.0 109.578 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -66.98 -27.31 67.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.13 -177.55 41.36 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -170.5 165.1 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -1.089 . . . . 0.0 109.189 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -125.33 157.28 37.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.738 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -129.91 110.55 11.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.544 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 38.4 m -159.71 106.67 1.46 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.588 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.37 -88.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.397 2.065 . . . . 0.0 110.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.7 -158.03 0.31 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.248 -0.908 . . . . 0.0 109.354 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.919 -1.038 . . . . 0.0 109.347 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' K' K ' 2' ' ' ILE . . . . . 0.441 HD12 ' CD2' ' K' ' 19' ' ' TYR . 7.1 tt -104.48 1.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -1.104 . . . . 0.0 109.159 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 46.5 t -93.5 -40.3 11.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 46.86 1.0 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -165.05 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.829 . . . . 0.0 109.235 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 81.7 m -107.01 -42.54 4.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 109.27 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 7' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' L' ' 11' ' ' LEU . 0.6 OUTLIER -60.11 -22.27 62.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -79.43 -31.88 42.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.137 -0.977 . . . . 0.0 109.586 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.37 146.75 24.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.74 102.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.873 . . . . 0.0 109.542 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 161.53 7.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -85.93 165.77 16.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.275 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -41.99 83.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.05 -31.46 72.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.52 -0.738 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -42.65 46.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 109.73 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 mt -70.17 -16.47 63.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.718 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -23.49 61.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.92 . . . . 0.0 109.167 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -57.98 -28.12 64.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.299 -0.876 . . . . 0.0 109.359 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 19' ' ' TYR . . . . . 0.441 ' CD2' HD12 ' K' ' 2' ' ' ILE . 11.0 m-85 -103.66 58.29 0.74 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 7.2 t -127.08 131.86 50.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.573 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.33 0.586 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.461 ' O ' HG13 ' L' ' 2' ' ' VAL . 11.6 p -64.61 128.09 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.729 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 14.6 t30 177.52 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.536 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -77.92 -25.25 48.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -79.74 -38.15 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.78 -25.1 33.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.815 . . . . 0.0 109.4 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.451 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 45.4 t -79.45 -30.09 42.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.744 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.2 -32.36 28.93 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -64.88 -12.96 54.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 109.698 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -98.44 -23.5 15.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.546 HD11 ' SG ' ' K' ' 7' ' ' CYS . 55.7 mt -81.35 -28.04 34.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.856 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.48 -30.32 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.569 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -76.67 -37.66 55.86 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.205 -0.935 . . . . 0.0 109.485 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 14' ' ' ALA . . . . . 0.429 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -65.18 -56.73 11.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 15' ' ' LEU . . . . . 0.454 ' HA ' ' HB ' ' L' ' 18' ' ' VAL . 14.7 mt -54.05 -25.73 23.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.079 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' J' ' 9' ' ' SER . 0.4 OUTLIER -52.05 -53.74 38.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 109.941 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.548 HD13 ' CB ' ' F' ' 14' ' ' ALA . 35.9 mt -87.24 -27.99 22.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.657 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 18' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' L' ' 15' ' ' LEU . 88.5 t -59.77 -25.15 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.956 -1.09 . . . . 0.0 109.648 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -99.48 -41.76 7.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.391 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.95 -142.26 15.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -83.2 1.29 41.39 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.275 -1.132 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -67.5 -27.93 67.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 110.022 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 -176.33 39.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -171.38 167.02 6.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -1.124 . . . . 0.0 109.488 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 25' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 3.1 p90 -126.45 151.69 47.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.632 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -126.85 106.11 9.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.312 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 32.8 m -155.71 108.55 2.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -82.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.475 2.117 . . . . 0.0 110.843 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.65 -155.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 109.406 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 109.816 -179.61 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.5 mt -80.39 -30.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 109.518 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.58 -35.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.951 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -104.46 56.2 0.71 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.806 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.436 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 22.6 tt0 -178.58 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.582 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' SER . 63.7 m -102.16 -29.46 11.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.02 -41.48 59.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.236 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.2 p -81.34 -15.95 53.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.501 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -160.32 120.57 2.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 109.565 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.554 HD12 ' O ' ' F' ' 1' ' ' PHE . 2.1 mp -47.87 101.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.319 -0.863 . . . . 0.0 109.455 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m -53.12 158.8 1.4 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.81 163.68 16.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.264 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -45.17 84.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 109.655 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -61.88 -33.49 74.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.549 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -67.72 -36.87 81.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.436 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.2 mt -83.91 -8.74 59.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.24 -0.912 . . . . 0.0 109.739 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.15 -27.96 38.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 15' ' ' GLN . 53.0 p30 -73.37 -11.91 60.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.432 ' N ' ' OD1' ' A' ' 18' ' ' ASN . 35.0 m-85 -98.32 -3.45 37.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 109.95 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.6 168.33 19.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.513 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.622 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.55 ' O ' HG13 ' B' ' 2' ' ' VAL . 3.8 p -172.25 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 4.6 p30 170.73 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.875 . . . . 0.0 109.242 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -85.57 -24.29 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.822 . . . . 0.0 109.364 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.84 -39.42 35.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.319 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mt -81.01 -38.03 28.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 9.4 t -63.14 -36.33 83.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.33 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.436 ' O ' HG22 ' B' ' 12' ' ' VAL . . . -79.4 -22.01 65.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 71.7 m -79.66 -8.88 59.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.399 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.79 -25.69 15.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.932 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 9.7 mt -79.43 -48.23 14.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.443 ' H ' HG22 ' B' ' 12' ' ' VAL . 2.6 m -52.18 -34.01 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 109.958 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.47 -48.31 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.995 . . . . 0.0 109.423 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.48 11.92 6.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 -50.67 5.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.949 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 13.4 p90 -71.98 -21.49 61.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.07 -1.019 . . . . 0.0 109.549 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.948 HD23 HD23 ' H' ' 17' ' ' LEU . 46.9 tp -74.52 -35.98 63.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -76.02 -46.7 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -57.1 -41.74 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.928 . . . . 0.0 109.327 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.39 -141.14 15.39 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.07 4.55 33.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -1.173 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.6 -74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' B' ' 19' ' ' CYS . . . 141.17 165.6 10.41 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 13.5 p90 -161.45 167.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -1.206 . . . . 0.0 109.317 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.605 ' HB2' ' CD2' ' D' ' 25' ' ' PHE . 35.8 p90 -123.57 162.62 22.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.596 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -142.08 83.69 1.85 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 109.644 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.404 ' OG1' ' CZ ' ' D' ' 25' ' ' PHE . 0.2 OUTLIER -133.77 92.68 22.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.13 -57.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.777 2.318 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tttt 54.37 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.552 179.699 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 74.1 mt -79.72 -29.48 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -1.112 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.27 -38.51 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 4' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 5.7 mm-40 -103.41 60.59 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.803 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 5' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 22.2 tt0 178.3 -32.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.592 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 70.2 m -104.03 -31.45 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.392 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 9.9 t -73.22 -40.11 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.963 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 32.1 p -82.84 -16.14 48.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.93 118.42 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.744 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -45.76 100.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 96.8 m -51.9 160.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.004 . . . . 0.0 109.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.16 162.69 15.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.232 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.24 84.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 109.687 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -63.5 -33.73 76.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' GLN . . . . . 0.436 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -67.15 -35.94 80.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 109.685 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.63 -9.5 58.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -79.19 -26.77 42.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.458 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' C' ' 15' ' ' GLN . 52.8 p30 -76.84 -8.01 56.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -101.4 -6.54 23.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.19 167.68 21.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.66 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.349 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.487 ' O ' HG13 ' D' ' 2' ' ' VAL . 2.5 p -171.76 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.184 -0.947 . . . . 0.0 109.279 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 p30 173.42 -36.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 109.261 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.56 -25.39 38.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.168 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.98 -41.79 41.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.453 ' N ' HD23 ' D' ' 6' ' ' LEU . 4.3 mt -79.39 -36.81 38.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.418 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.5 t -63.37 -36.4 83.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.507 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.55 -18.66 67.94 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -81.95 -8.64 59.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -1.125 . . . . 0.0 109.705 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -96.96 -25.88 15.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.585 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 10.6 mt -77.42 -49.87 13.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -51.55 -33.19 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -68.73 -46.78 68.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.108 -0.995 . . . . 0.0 109.717 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.16 9.73 14.19 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.813 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 -52.33 4.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.726 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 15.6 p90 -70.85 -22.69 62.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.862 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.509 HD23 HD23 ' J' ' 17' ' ' LEU . 48.9 tp -72.86 -38.15 67.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.105 -0.997 . . . . 0.0 109.63 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.2 -46.27 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -58.16 -44.87 88.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -139.03 14.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.43 5.42 35.14 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.338 -1.095 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -70.45 -75.33 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.535 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' D' ' 19' ' ' CYS . . . 142.4 166.47 10.99 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 17.7 p90 -156.94 162.35 39.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.949 -1.324 . . . . 0.0 110.068 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 25' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' B' ' 25' ' ' PHE . 55.4 m-85 -114.2 150.41 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -138.55 85.01 2.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.63 92.86 9.97 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 108.783 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.22 -61.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.674 2.249 . . . . 0.0 110.568 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttt 59.13 94.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.666 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 75.6 mt -83.94 -29.86 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -1.135 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 64.0 t -68.85 -37.31 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 4' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 4.6 mm-40 -104.12 61.43 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.976 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 22.9 tt0 176.94 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 109.514 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 66.2 m -102.06 -30.39 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.6 t -73.65 -43.03 60.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.271 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 31.6 p -80.19 -15.04 57.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.622 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 9' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' J' ' 1' ' ' PHE . 0.0 OUTLIER -161.14 116.9 2.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.141 -0.974 . . . . 0.0 109.46 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mp -45.27 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.456 -0.777 . . . . 0.0 109.59 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 11' ' ' CYS . . . . . 0.427 ' SG ' ' HG2' ' E' ' 5' ' ' GLN . 94.4 m -49.95 160.83 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.079 -1.013 . . . . 0.0 109.332 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.6 167.44 12.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.073 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.69 94.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.512 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -62.11 -35.31 78.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -35.19 79.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.017 . . . . 0.0 109.4 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.35 -4.52 59.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -84.59 -29.81 25.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.142 -0.974 . . . . 0.0 109.376 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 18' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' E' ' 19' ' ' TYR . 54.6 p30 -72.31 -10.32 59.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.888 . . . . 0.0 109.679 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' E' ' 18' ' ' ASN . 32.8 m-85 -100.21 -1.03 37.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.886 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 169.13 14.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 110.059 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.717 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 1' ' ' PHE . . . . . 0.554 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.8 m-85 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.577 ' O ' HG13 ' F' ' 2' ' ' VAL . 5.7 p -170.23 108.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.865 . . . . 0.0 109.67 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 171.56 -37.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -79.43 -26.94 41.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 0.0 109.51 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -76.18 -40.41 52.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.938 . . . . 0.0 109.84 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.61 -34.36 30.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.441 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 11.3 t -66.63 -31.44 72.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.261 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.431 ' O ' HG22 ' F' ' 12' ' ' VAL . . . -84.26 -19.27 60.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -83.21 -7.45 59.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -1.091 . . . . 0.0 109.574 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -98.81 -22.22 15.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -81.64 -45.96 15.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.649 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.431 HG22 ' O ' ' F' ' 8' ' ' GLY . 2.4 m -55.23 -33.37 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.09 -48.49 65.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.24 8.21 14.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -0.894 . . . . 0.0 110.065 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -51.52 5.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 109.858 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.531 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 13.5 p90 -71.51 -21.43 61.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 109.744 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.485 HD23 HD23 ' L' ' 17' ' ' LEU . 52.1 tp -74.8 -34.76 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.444 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.45 -42.93 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -37.73 86.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.036 . . . . 0.0 109.106 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.36 -139.76 15.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -83.54 -0.67 51.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.951 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -65.03 -73.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.284 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.16 168.65 11.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 24' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 12.3 p90 -163.61 172.69 13.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 109.422 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -130.41 162.53 28.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.275 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -138.99 93.16 2.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.034 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.08 89.45 7.81 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.483 -0.76 . . . . 0.0 109.477 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.38 -62.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.675 2.25 . . . . 0.0 110.115 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 62.22 93.18 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 109.648 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.568 179.904 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' G' G ' 2' ' ' ILE . . . . . 0.41 HD13 HD11 ' H' ' 15' ' ' LEU . 73.6 mt -81.95 -26.69 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.13 -33.33 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 4' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 5.4 mm-40 -108.69 61.47 0.6 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 22.0 tt0 176.43 -31.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -104.36 -32.97 8.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 10.1 t -72.14 -43.5 64.57 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.124 -0.985 . . . . 0.0 109.286 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -77.36 -21.37 53.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 121.25 5.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.155 -0.965 . . . . 0.0 109.486 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -47.69 103.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.97 . . . . 0.0 109.156 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 69.1 m -53.32 162.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 109.617 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.1 163.28 14.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 109.33 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.36 84.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -61.04 -36.58 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.341 -0.849 . . . . 0.0 109.404 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' G' ' 18' ' ' ASN . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.7 mt -80.91 -11.32 59.6 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.906 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.56 -29.86 56.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.08 -1.012 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' G' ' 15' ' ' GLN . 53.4 p30 -73.16 -5.94 42.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.965 . . . . 0.0 109.613 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -102.17 -16.4 16.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.988 . . . . 0.0 109.76 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 6.9 m -66.51 172.86 3.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 108.814 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.423 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.585 ' O ' HG13 ' H' ' 2' ' ' VAL . 4.4 p -171.05 107.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.55 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 172.54 -34.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.66 -22.13 32.23 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.304 -0.872 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -80.65 -39.79 26.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 6' ' ' LEU . . . . . 0.44 HD23 ' N ' ' H' ' 6' ' ' LEU . 4.3 mt -81.12 -37.09 29.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.216 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.4 t -63.15 -37.23 86.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.683 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 8' ' ' GLY . . . . . 0.448 ' O ' HG22 ' H' ' 12' ' ' VAL . . . -79.91 -18.73 71.85 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 58.5 m -83.06 -6.33 59.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -1.116 . . . . 0.0 109.559 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -100.47 -19.33 16.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.072 -1.017 . . . . 0.0 109.149 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.8 mt -84.23 -46.51 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.448 HG22 ' O ' ' H' ' 8' ' ' GLY . 2.3 m -54.64 -33.17 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.726 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.27 -48.03 66.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.824 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.98 11.47 9.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -93.04 -48.63 6.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.996 -1.065 . . . . 0.0 109.724 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 13.2 p90 -73.12 -22.57 60.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.368 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.948 HD23 HD23 ' B' ' 17' ' ' LEU . 47.1 tp -73.47 -33.52 64.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.301 -0.875 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.25 -57.44 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -49.85 -38.41 35.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 0.0 109.245 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.5 -146.19 18.8 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -75.51 -3.96 37.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 110.046 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -61.59 -74.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.282 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.99 171.74 12.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 24' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 15.8 p90 -165.82 170.41 13.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -1.212 . . . . 0.0 109.678 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 13.1 p90 -128.5 156.74 42.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 109.496 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -136.35 91.21 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.386 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.67 90.09 8.88 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.97 -59.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.733 2.289 . . . . 0.0 110.533 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 57.56 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.335 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.507 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt -81.69 -28.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -1.105 . . . . 0.0 109.433 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.1 -32.26 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 4' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 5.8 mm-40 -108.15 58.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.277 -0.889 . . . . 0.0 109.545 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 25.3 tt0 177.34 -32.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -101.23 -30.44 11.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 109.44 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.4 -43.28 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.852 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -79.02 -14.31 59.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 9' ' ' SER . . . . . 0.424 ' O ' ' N ' ' I' ' 11' ' ' CYS . 0.0 OUTLIER -161.75 126.55 3.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.329 -0.857 . . . . 0.0 108.988 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' I' ' 11' ' ' CYS . 2.2 mp -56.17 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.851 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 11' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 10' ' ' ILE . 0.8 OUTLIER -43.23 161.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.272 -0.893 . . . . 0.0 109.346 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.2 169.34 11.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -46.16 91.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -59.74 -34.78 73.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.27 82.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.71 -9.45 58.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 109.581 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.16 -29.0 42.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 18' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' I' ' 19' ' ' TYR . 54.9 p30 -74.2 -9.74 58.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.683 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 19' ' ' TYR . . . . . 0.406 ' N ' ' OD1' ' I' ' 18' ' ' ASN . 29.5 m-85 -99.48 -3.48 33.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.579 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.26 167.66 19.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 1' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' E' ' 9' ' ' SER . 1.8 m-85 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.521 ' O ' HG13 ' J' ' 2' ' ' VAL . 3.2 p -170.14 108.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.077 -1.014 . . . . 0.0 109.382 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 p30 172.81 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -85.03 -23.68 28.51 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.32 -0.862 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -78.37 -40.69 35.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.965 . . . . 0.0 109.384 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 6' ' ' LEU . . . . . 0.414 ' N ' HD23 ' J' ' 6' ' ' LEU . 5.6 mt -80.12 -37.69 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.32 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.421 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 10.8 t -63.17 -36.82 84.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.435 ' O ' HG22 ' J' ' 12' ' ' VAL . . . -79.84 -17.57 74.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -84.06 -10.9 57.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -94.1 -23.82 17.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.601 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 9.3 mt -80.39 -47.73 13.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 109.661 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.442 ' H ' HG22 ' J' ' 12' ' ' VAL . 2.6 m -53.06 -32.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 109.99 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.47 -48.97 59.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 109.733 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.88 12.34 6.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.27 -50.23 5.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 12.9 p90 -72.56 -20.82 61.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.509 HD23 HD23 ' D' ' 17' ' ' LEU . 46.1 tp -76.57 -31.74 57.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.59 -46.89 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 109.052 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' J' ' 23' ' ' GLY . 0.1 OUTLIER -56.21 -42.24 76.89 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 108.977 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -140.79 15.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.2 -0.34 48.95 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.234 -1.156 . . . . 0.0 109.751 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -64.67 -67.99 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.103 -0.998 . . . . 0.0 109.524 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 23' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' J' ' 19' ' ' CYS . . . 133.06 171.8 12.82 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 24' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 13.1 p90 -164.81 177.89 7.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.125 -1.221 . . . . 0.0 109.443 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.02 156.14 48.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -137.38 94.04 2.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.03 89.31 6.53 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 109.636 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.61 -60.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.565 2.176 . . . . 0.0 110.574 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' J' ' 30' ' ' THR . 4.3 tttt 59.24 92.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.519 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 30' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' J' ' 29' ' ' LYS . 13.6 m . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.6 -31.84 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -1.099 . . . . 0.0 109.238 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.99 -35.88 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.8 . . . . 0.0 109.757 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 4' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 7.0 mm-40 -105.23 59.3 0.68 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 5' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 23.5 tt0 179.25 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.488 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 6' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' K' ' 9' ' ' SER . 72.2 m -100.85 -35.66 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.31 -40.23 77.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 55.4 p -82.6 -17.22 45.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.011 . . . . 0.0 109.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 9' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.0 OUTLIER -159.27 119.74 3.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 mp -47.54 100.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.578 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' HG2' ' K' ' 5' ' ' GLN . 88.8 m -52.12 159.83 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 109.435 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.57 167.21 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -43.2 99.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -0.934 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -62.68 -35.47 79.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.184 -0.947 . . . . 0.0 109.387 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 15' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' K' ' 18' ' ' ASN . 0.0 OUTLIER -65.79 -38.41 88.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -81.86 -9.72 59.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -79.19 -28.21 42.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 109.675 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 18' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' K' ' 15' ' ' GLN . 55.2 p30 -74.58 -7.6 53.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 109.75 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.41 -8.41 22.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.25 169.41 17.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.132 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.37 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.569 ' O ' HG13 ' L' ' 2' ' ' VAL . 5.6 p -172.64 108.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.151 -0.968 . . . . 0.0 109.401 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p30 172.14 -36.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.049 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -81.03 -27.38 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.364 -0.835 . . . . 0.0 109.375 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -75.32 -38.42 60.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 6' ' ' LEU . . . . . 0.437 ' N ' HD23 ' L' ' 6' ' ' LEU . 4.7 mt -82.82 -38.67 22.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 109.568 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 51.7 t -62.09 -33.7 74.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.93 -19.95 62.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 74.3 m -82.83 -5.97 59.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -1.11 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -99.5 -22.0 15.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 109.161 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.5 mt -82.98 -47.68 11.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -53.19 -33.85 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.01 -1.056 . . . . 0.0 109.552 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.08 -46.61 70.53 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.24 11.01 13.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.68 -51.13 5.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 13.5 p90 -71.3 -22.9 61.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.485 HD23 HD23 ' F' ' 17' ' ' LEU . 49.8 tp -74.5 -34.61 63.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.776 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.93 -47.74 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.65 -37.86 68.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.5 -145.97 18.29 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -81.58 0.27 39.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.58 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -62.95 -73.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.32 165.01 10.16 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 24' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 11.2 p90 -160.24 169.3 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -1.087 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -129.8 152.49 49.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.192 -0.943 . . . . 0.0 109.389 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -129.9 96.62 4.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.853 . . . . 0.0 109.714 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.82 89.51 6.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.57 -62.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.597 2.198 . . . . 0.0 110.195 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt 62.09 92.89 0.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.53 179.77 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.435 HG23 HG13 ' A' ' 3' ' ' VAL . 20.7 tt -133.22 6.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -1.108 . . . . 0.0 109.429 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 HG23 ' A' ' 2' ' ' ILE . 16.4 m -126.03 -8.37 5.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.264 -0.898 . . . . 0.0 109.75 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -111.77 1.61 16.72 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.199 -0.938 . . . . 0.0 109.792 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.86 13.19 2.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.178 -0.951 . . . . 0.0 109.304 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.73 -42.59 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.33 -16.34 63.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.423 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.9 p -70.89 -22.03 62.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.014 . . . . 0.0 109.414 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 p -163.69 144.12 8.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mt -52.62 113.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.4 m -84.29 -164.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 0.0 109.1 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.25 171.39 7.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -34.93 75.9 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 109.277 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -67.4 -38.87 85.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.955 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.92 -14.91 59.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 109.938 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.92 -28.87 63.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.023 . . . . 0.0 109.46 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -57.24 -19.03 18.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.57 59.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.1 t -123.13 119.76 31.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.641 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.2 t30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.343 179.783 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' I' ' 9' ' ' SER . 25.8 m -131.06 46.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 109.875 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.53 -3.28 28.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -48.28 -38.53 19.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.31 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -93.42 -30.6 14.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.589 HD22 ' CG ' ' J' ' 10' ' ' HIS . 39.6 mt -80.95 -70.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 108.957 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.6 t -51.2 -37.82 48.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.665 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.438 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -61.85 -44.28 98.07 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 31.0 p -67.84 -12.86 61.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 110.008 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -86.15 -24.63 26.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.119 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 5.7 mt -90.47 -33.77 15.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.516 HG21 ' CZ ' ' D' ' 16' ' ' TYR . 16.8 m -68.43 -38.54 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.472 ' N ' HG23 ' B' ' 12' ' ' VAL . 13.9 tt0 -66.04 -23.86 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.78 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -94.42 -12.89 26.93 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mt -78.67 -28.66 45.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.547 ' CZ ' HG21 ' D' ' 12' ' ' VAL . 60.3 m-85 -48.25 -46.58 35.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -82.26 -36.26 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.78 HG23 ' O ' ' B' ' 14' ' ' ALA . 69.7 t -47.04 -46.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.87 -30.72 26.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.459 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.04 -134.98 11.89 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -7.93 52.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.304 -1.115 . . . . 0.0 109.69 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -57.05 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.11 179.08 29.17 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.408 ' HZ ' ' CZ ' ' B' ' 16' ' ' TYR . 0.3 OUTLIER -166.31 168.23 15.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -1.182 . . . . 0.0 110.031 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.631 ' HB2' ' CD1' ' D' ' 25' ' ' PHE . 32.8 p90 -127.53 154.77 44.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.437 ' CD2' HG11 ' B' ' 12' ' ' VAL . 24.3 t80 -140.85 112.17 7.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 15.1 m -133.2 93.25 22.9 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 109.675 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.07 99.53 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.506 2.137 . . . . 0.0 110.389 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.33 -58.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -132.69 7.66 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.158 -1.201 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.92 -6.29 4.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.211 -0.931 . . . . 0.0 109.74 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -114.07 -0.39 14.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.128 -0.983 . . . . 0.0 109.604 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -134.65 9.46 3.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.189 -0.944 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.25 -39.85 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.705 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 t -66.93 -16.17 64.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 43.1 p -70.22 -24.53 63.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.92 . . . . 0.0 109.302 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' SER . . . . . 0.404 ' HA ' HG11 ' L' ' 2' ' ' VAL . 94.9 p -160.47 146.09 14.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.502 HD11 ' O ' ' L' ' 2' ' ' VAL . 4.3 mt -54.55 117.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.7 m -89.45 -165.48 1.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 109.714 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -107.17 166.27 10.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -34.56 78.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.73 -37.56 79.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.859 . . . . 0.0 109.601 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.91 -38.39 86.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 109.53 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.81 -16.23 55.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 109.757 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.51 -30.3 68.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -56.42 -19.13 13.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.09 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -110.6 58.61 0.61 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.231 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 t -121.64 118.44 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ASN . . . . . 0.559 ' ND2' ' CZ ' ' D' ' 25' ' ' PHE . 9.5 t30 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.509 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.359 0.6 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' G' ' 9' ' ' SER . 30.9 m -132.02 44.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.244 -0.91 . . . . 0.0 109.159 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -100.15 -8.56 23.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 109.552 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -44.34 -40.46 5.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.44 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -90.74 -32.38 16.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.504 HD22 ' CG ' ' H' ' 10' ' ' HIS . 29.0 mt -80.34 -71.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.477 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 8.3 t -51.37 -34.39 34.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.501 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -64.33 -43.86 96.28 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 9' ' ' SER . . . . . 0.428 ' HA ' HG22 ' D' ' 12' ' ' VAL . 17.2 p -69.41 -14.94 63.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -1.162 . . . . 0.0 109.711 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.94 -24.38 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.895 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 6.7 mt -92.79 -32.79 14.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.547 HG21 ' CZ ' ' B' ' 16' ' ' TYR . 15.4 m -68.29 -38.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.475 ' N ' HG23 ' D' ' 12' ' ' VAL . 15.0 tt0 -64.91 -27.06 68.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 14' ' ' ALA . . . . . 0.705 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -91.62 -12.06 35.32 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.333 -0.854 . . . . 0.0 109.853 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.21 -28.82 38.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.516 ' CZ ' HG21 ' B' ' 12' ' ' VAL . 62.3 m-85 -48.38 -45.07 35.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.199 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 mt -81.89 -38.5 25.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.705 HG23 ' O ' ' D' ' 14' ' ' ALA . 67.5 t -45.85 -44.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.891 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.86 -29.77 25.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.899 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.2 -131.66 10.65 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.73 -6.99 38.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.65 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -56.69 -81.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.061 -1.024 . . . . 0.0 109.467 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.78 176.74 28.28 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 25' ' ' PHE . 0.4 OUTLIER -164.07 161.31 22.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -1.208 . . . . 0.0 109.883 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 25' ' ' PHE . . . . . 0.631 ' CD1' ' HB2' ' B' ' 25' ' ' PHE . 4.4 m-85 -119.11 163.16 17.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.416 -0.803 . . . . 0.0 109.284 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.43 ' CD2' HG11 ' D' ' 12' ' ' VAL . 33.0 t80 -151.16 105.69 3.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 108.896 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 24.4 m -127.19 94.43 38.89 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.594 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.98 97.28 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.555 2.17 . . . . 0.0 110.369 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -61.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.221 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.35 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.44 3.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -1.125 . . . . 0.0 109.563 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.9 -9.58 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.94 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.89 1.69 19.35 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.104 -0.997 . . . . 0.0 110.164 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -136.7 11.33 3.16 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.041 -1.037 . . . . 0.0 109.669 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 6' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' E' ' 9' ' ' SER . 0.0 OUTLIER -144.32 -40.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.55 -18.0 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 108.954 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 41.4 p -69.61 -25.1 63.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.376 -0.828 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 9' ' ' SER . . . . . 0.421 ' O ' ' O ' ' E' ' 6' ' ' CYS . 12.5 p -159.56 148.82 18.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.438 HG12 ' HB3' ' J' ' 5' ' ' HIS . 4.0 mt -58.7 115.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.55 -158.69 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.785 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.1 167.82 10.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 13' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' L' ' 17' ' ' LEU . 0.1 OUTLIER -66.11 -35.78 81.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -66.05 -40.79 91.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.986 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -80.37 -15.45 56.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -0.973 . . . . 0.0 109.594 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.14 -25.79 62.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.722 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -60.42 -19.49 56.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.215 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.7 62.05 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 t -125.45 119.67 28.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.461 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.424 ' O ' HG23 ' F' ' 2' ' ' VAL . 25.4 m -129.38 44.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.264 -0.898 . . . . 0.0 109.375 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -100.52 -4.68 28.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.377 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -48.6 -38.04 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -93.32 -30.92 14.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 35.2 mt -81.36 -71.1 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.085 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.495 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.5 t -50.18 -37.21 33.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.44 -0.787 . . . . 0.0 109.356 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.483 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -61.76 -42.97 99.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 9' ' ' SER . . . . . 0.469 ' HA ' HG22 ' F' ' 12' ' ' VAL . 58.4 p -70.85 -13.53 62.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.132 -1.216 . . . . 0.0 110.043 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -84.07 -24.38 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.985 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 6.5 mt -91.64 -33.45 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.813 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.557 HG21 ' CZ ' ' H' ' 16' ' ' TYR . 18.4 m -69.22 -36.26 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 109.848 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 13' ' ' GLU . . . . . 0.419 ' N ' HG23 ' F' ' 12' ' ' VAL . 16.0 tt0 -69.11 -22.22 63.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.769 ' O ' HG23 ' F' ' 18' ' ' VAL . . . -95.52 -11.03 28.1 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.71 -28.19 36.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.499 ' CZ ' HG21 ' H' ' 12' ' ' VAL . 54.0 m-85 -48.61 -47.61 39.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 109.655 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' F' ' 18' ' ' VAL . 12.4 mt -80.93 -38.59 27.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 18' ' ' VAL . . . . . 0.769 HG23 ' O ' ' F' ' 14' ' ' ALA . 70.8 t -44.62 -45.68 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.96 -30.04 26.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.36 -133.21 11.22 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.0 -12.89 29.54 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.256 -1.144 . . . . 0.0 109.538 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 23.0 mtt180 -50.72 -83.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.2 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.04 -177.46 33.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 24' ' ' PHE . . . . . 0.408 ' HZ ' ' CZ ' ' F' ' 16' ' ' TYR . 0.2 OUTLIER -171.45 168.86 6.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -1.134 . . . . 0.0 109.469 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -132.07 166.12 22.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -147.42 115.44 6.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.52 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -132.66 91.53 29.72 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.32 98.51 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.191 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.0 -58.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.59 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.578 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.08 8.26 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -1.2 . . . . 0.0 109.735 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -127.2 -5.76 4.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -113.23 -1.14 14.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.021 -1.049 . . . . 0.0 109.812 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -134.4 11.58 3.8 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.083 -1.011 . . . . 0.0 109.704 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 6' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' G' ' 9' ' ' SER . 0.1 OUTLIER -143.98 -40.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 t -66.4 -18.11 65.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 60.5 p -69.17 -22.28 63.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.48 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 9' ' ' SER . . . . . 0.659 ' HA ' HG11 ' D' ' 2' ' ' VAL . 4.3 p -162.67 148.58 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.299 -0.875 . . . . 0.0 109.433 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mt -58.08 115.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.77 -165.02 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.1 167.4 10.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -35.55 81.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.732 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -67.27 -37.75 83.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.967 . . . . 0.0 109.852 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.39 -40.5 89.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -77.51 -14.14 59.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.15 -30.35 63.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.338 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -53.9 -23.45 12.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.37 64.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.97 120.89 30.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.331 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.562 -179.946 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.298 0.57 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 31.8 m -126.17 41.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' H' ' 4' ' ' GLN . 11.6 m120 -96.92 -9.92 27.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 4' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' H' ' 3' ' ' ASN . 50.2 tt0 -43.03 -40.14 2.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -90.98 -33.22 15.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 109.313 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 29.9 mt -78.44 -73.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 7.7 t -47.13 -41.46 17.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.815 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 8' ' ' GLY . . . . . 0.441 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -58.84 -44.87 95.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 9' ' ' SER . . . . . 0.411 ' HA ' HG22 ' H' ' 12' ' ' VAL . 24.3 p -67.33 -14.92 63.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -1.114 . . . . 0.0 109.838 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 10' ' ' HIS . . . . . 0.504 ' CG ' HD22 ' D' ' 6' ' ' LEU . 5.6 m-70 -85.88 -20.36 29.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.665 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.0 mt -94.87 -35.3 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.384 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.499 HG21 ' CZ ' ' F' ' 16' ' ' TYR . 15.6 m -68.1 -34.18 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -69.82 -23.08 63.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.141 -0.974 . . . . 0.0 109.219 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 14' ' ' ALA . . . . . 0.756 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -95.09 -9.99 32.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.39 -0.819 . . . . 0.0 109.538 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -82.37 -26.83 32.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.557 ' CZ ' HG21 ' F' ' 12' ' ' VAL . 53.5 m-85 -50.04 -44.06 51.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.615 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.09 -36.45 21.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.27 -0.894 . . . . 0.0 109.724 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 18' ' ' VAL . . . . . 0.756 HG23 ' O ' ' H' ' 14' ' ' ALA . 76.5 t -46.33 -42.67 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 -29.39 21.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.79 -133.34 11.31 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -11.5 38.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -1.17 . . . . 0.0 109.738 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -53.01 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.037 . . . . 0.0 109.646 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.98 176.94 23.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.24 175.41 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 109.429 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 8.6 p90 -137.94 167.24 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.526 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -149.57 115.48 5.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.288 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -133.84 90.82 26.33 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.227 -0.92 . . . . 0.0 109.328 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.16 101.0 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.674 2.249 . . . . 0.0 110.092 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.82 -57.58 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 109.656 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.056 -0.974 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.439 HG23 HG13 ' I' ' 3' ' ' VAL . 19.6 tt -131.08 8.05 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 0.0 109.501 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 3' ' ' VAL . . . . . 0.439 HG13 HG23 ' I' ' 2' ' ' ILE . 15.9 m -128.71 -5.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.299 -0.876 . . . . 0.0 109.771 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -115.06 -0.06 13.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.172 -0.955 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -135.01 8.16 3.47 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.47 -41.43 0.41 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.75 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -64.63 -20.71 66.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 8' ' ' THR . . . . . 0.425 ' O ' HG11 ' B' ' 2' ' ' VAL . 39.0 p -66.44 -23.39 66.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 9' ' ' SER . . . . . 0.604 ' HA ' HG11 ' B' ' 2' ' ' VAL . 7.5 p -161.65 146.32 13.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.65 114.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.56 -164.25 0.98 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -109.56 168.12 9.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -34.77 78.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -67.3 -39.56 85.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.45 -39.99 92.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.32 -14.3 59.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.852 . . . . 0.0 109.899 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.81 -27.17 62.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -58.05 -18.62 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.359 -0.838 . . . . 0.0 109.74 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -111.97 61.31 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -122.84 121.85 37.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.198 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.504 -179.759 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 11.0 t80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.271 0.557 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.42 HG23 ' O ' ' J' ' 2' ' ' VAL . 31.0 m -133.33 47.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 3' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' J' ' 4' ' ' GLN . 13.2 m120 -102.57 -8.46 20.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.842 . . . . 0.0 109.33 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 4' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' J' ' 3' ' ' ASN . 50.4 tt0 -44.03 -38.38 3.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.352 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 5' ' ' HIS . . . . . 0.438 ' HB3' HG12 ' E' ' 10' ' ' ILE . 86.4 t60 -93.34 -33.95 13.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.94 . . . . 0.0 109.211 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 38.9 mt -78.03 -70.28 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.437 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.499 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 7.3 t -51.97 -37.51 53.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.354 -0.842 . . . . 0.0 109.477 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.439 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -60.76 -45.17 96.98 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 9' ' ' SER . . . . . 0.493 ' HA ' HG22 ' J' ' 12' ' ' VAL . 86.6 p -68.51 -16.08 63.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -1.211 . . . . 0.0 110.078 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 10' ' ' HIS . . . . . 0.589 ' CG ' HD22 ' B' ' 6' ' ' LEU . 4.7 m-70 -82.92 -20.49 35.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.043 . . . . 0.0 109.716 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 7.8 mt -95.16 -34.18 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.508 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.504 HG21 ' CZ ' ' L' ' 16' ' ' TYR . 19.1 m -68.19 -33.9 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.107 -0.995 . . . . 0.0 109.239 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -70.97 -23.77 62.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.605 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 14' ' ' ALA . . . . . 0.81 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -95.55 -8.1 36.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.31 -0.869 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.8 -25.39 30.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.505 ' CZ ' HG21 ' L' ' 12' ' ' VAL . 46.3 m-85 -51.93 -44.54 63.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.456 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.34 -39.17 21.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.618 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 18' ' ' VAL . . . . . 0.81 HG23 ' O ' ' J' ' 14' ' ' ALA . 69.5 t -44.75 -44.15 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.54 -30.62 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.61 -135.42 12.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -9.78 44.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.214 -1.168 . . . . 0.0 109.949 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -53.84 -76.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 0.0 109.664 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.46 176.8 22.99 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.21 171.16 11.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 109.688 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 25' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 6.1 p90 -134.39 165.07 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.47 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 26' ' ' TYR . . . . . 0.411 ' CD2' HG11 ' J' ' 12' ' ' VAL . 23.3 t80 -146.07 118.76 8.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.254 -0.904 . . . . 0.0 109.26 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 23.7 m -136.89 91.0 15.59 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.717 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.34 100.05 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.243 . . . . 0.0 110.413 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -59.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.256 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.495 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' K' K ' 2' ' ' ILE . . . . . 0.428 HG23 HG13 ' K' ' 3' ' ' VAL . 20.6 tt -133.03 9.5 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -1.1 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.428 HG13 HG23 ' K' ' 2' ' ' ILE . 15.6 m -129.71 -3.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.936 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -116.25 -2.1 12.22 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.08 -1.013 . . . . 0.0 109.446 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -133.23 11.18 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.341 -0.849 . . . . 0.0 109.408 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 -40.78 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 109.739 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -66.16 -16.76 64.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.964 . . . . 0.0 109.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -69.42 -26.29 64.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.236 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 6.4 p -158.08 149.9 21.69 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -0.913 . . . . 0.0 109.544 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.58 115.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -87.78 -164.27 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.984 . . . . 0.0 109.49 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.28 171.08 7.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.301 -0.874 . . . . 0.0 109.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -36.78 77.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.348 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -65.57 -38.66 90.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.669 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -66.05 -40.38 90.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.1 mt -78.43 -13.54 59.79 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.851 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.88 -28.29 63.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -57.97 -17.23 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -0.79 . . . . 0.0 109.659 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.82 60.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 t -123.17 120.36 32.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.393 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.502 ' O ' HD11 ' C' ' 10' ' ' ILE . 29.0 m -127.8 45.75 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.54 -6.57 23.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -46.06 -39.69 9.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -92.26 -30.75 15.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 31.7 mt -80.73 -72.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.193 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.496 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 8.3 t -49.49 -39.95 35.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.416 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -59.68 -43.53 97.69 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 87.4 p -68.33 -18.15 64.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.16 -1.2 . . . . 0.0 109.784 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -81.56 -21.73 38.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.992 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 6.7 mt -93.75 -34.35 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.505 HG21 ' CZ ' ' J' ' 16' ' ' TYR . 18.6 m -67.28 -38.57 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.01 . . . . 0.0 109.51 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 13' ' ' GLU . . . . . 0.449 ' N ' HG23 ' L' ' 12' ' ' VAL . 17.1 tt0 -65.72 -25.07 67.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.898 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 14' ' ' ALA . . . . . 0.752 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -92.57 -14.14 28.71 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 6.7 mt -78.63 -31.31 46.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 0.0 109.401 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.504 ' CZ ' HG21 ' J' ' 12' ' ' VAL . 44.7 m-85 -45.51 -45.38 13.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.9 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' E' ' 13' ' ' LEU . 13.1 mt -84.0 -35.75 23.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 109.933 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 18' ' ' VAL . . . . . 0.752 HG23 ' O ' ' L' ' 14' ' ' ALA . 70.3 t -47.42 -45.36 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.61 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.81 -33.52 27.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.234 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.75 -134.96 12.02 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -11.49 39.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.19 -1.182 . . . . 0.0 109.471 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -52.71 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.921 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.34 178.47 27.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.29 172.29 9.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.158 -1.201 . . . . 0.0 109.69 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -134.21 163.62 29.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -147.38 113.34 5.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.226 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -132.56 89.91 34.67 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.767 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.16 100.6 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 110.47 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -159.63 -62.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.337 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.426 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.3 tt -109.19 0.15 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.215 -1.167 . . . . 0.0 109.618 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 3' ' ' VAL . 59.2 t -100.82 46.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.002 . . . . 0.0 109.681 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -171.58 -40.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.31 -7.17 26.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.126 -0.984 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.85 -18.94 3.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.482 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 0.5 OUTLIER -82.73 -18.26 41.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 109.117 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.3 p -83.72 -12.51 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.533 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.84 2.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.552 ' CD1' ' HB ' ' F' ' 2' ' ' VAL . 2.0 mp -61.57 140.85 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.2 m -103.94 -164.77 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.858 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -103.62 -174.3 2.51 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -0.935 . . . . 0.0 109.23 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.84 -37.37 64.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -68.91 -23.94 64.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.87 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -79.16 -39.36 33.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.593 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.6 mt -82.05 -11.68 58.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.52 -21.26 49.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.687 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -62.13 -18.68 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.962 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.426 ' CD2' HD12 ' A' ' 2' ' ' ILE . 2.8 m-85 -118.33 48.02 1.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.86 110.95 13.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.208 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.267 0.556 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.93 106.02 4.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.34 -0.85 . . . . 0.0 109.319 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.414 ' HB3' ' CB ' ' B' ' 7' ' ' CYS . 22.7 m-80 -103.15 -8.2 20.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 0.0 109.246 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -48.88 -36.91 18.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.215 -0.928 . . . . 0.0 109.031 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.503 ' HB3' HG12 ' I' ' 10' ' ' ILE . 18.5 t60 -95.64 -30.38 13.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.147 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.05 -70.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.492 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.5 t -53.74 -32.16 51.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 0.0 109.767 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.94 -32.21 53.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -79.2 -3.34 45.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -1.23 . . . . 0.0 109.579 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.22 -14.65 20.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.336 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 14.3 mt -91.91 -43.55 9.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.429 ' H ' HG22 ' B' ' 12' ' ' VAL . 2.7 m -56.8 -37.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.12 -36.18 81.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.332 -0.855 . . . . 0.0 109.871 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.89 11.19 39.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.081 -1.012 . . . . 0.0 109.807 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' B' ' 11' ' ' LEU . 0.7 OUTLIER -96.67 -54.91 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 7.8 p90 -63.94 -18.05 63.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.954 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -78.28 -48.18 16.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -0.888 . . . . 0.0 109.45 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.05 -47.97 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.21 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.64 -57.07 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.89 -140.34 15.13 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 20' ' ' GLY . 19.4 mt-10 -45.54 -30.79 1.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.245 . . . . 0.0 109.36 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -69.35 159.81 32.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' B' ' 24' ' ' PHE . . . -100.51 -158.24 27.86 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 11.3 p90 -178.76 177.28 0.88 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -1.142 . . . . 0.0 109.228 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.55 146.39 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.683 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.506 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 28.6 t80 -122.93 87.29 2.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -117.61 105.74 47.49 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.526 ' HB3' HG21 ' A' ' 3' ' ' VAL . 36.3 Cg_endo -78.1 -36.26 1.09 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.499 2.133 . . . . 0.0 110.538 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mttm 64.22 -87.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 109.41 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.528 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 2' ' ' ILE . . . . . 0.531 HD12 ' CD2' ' C' ' 19' ' ' TYR . 15.4 tt -112.24 0.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 3' ' ' VAL . . . . . 0.651 HG12 ' O ' ' C' ' 3' ' ' VAL . 55.6 t -101.15 46.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -171.58 -45.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.72 -7.43 37.34 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.696 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 6' ' ' CYS . . . . . 0.442 ' HB2' HG13 ' C' ' 2' ' ' ILE . 0.5 OUTLIER -127.56 -17.71 4.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.163 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -86.34 -16.18 38.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 109.862 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.4 p -86.12 -10.51 54.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 109.517 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.79 148.49 2.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 108.995 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' L' ' 5' ' ' HIS . 1.3 mp -58.25 151.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 109.382 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.7 -174.43 2.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.372 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -177.16 4.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.58 -38.86 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -66.29 -24.62 66.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -79.7 -36.87 36.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.98 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 62.4 mt -85.15 -6.83 59.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.89 -18.21 38.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -65.69 -19.77 66.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.279 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.531 ' CD2' HD12 ' C' ' 2' ' ' ILE . 2.5 m-85 -116.98 48.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.484 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.89 108.24 10.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.494 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.572 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.479 ' HB ' HD13 ' G' ' 10' ' ' ILE . 4.4 t -131.06 106.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 109.529 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -103.16 -8.78 20.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -48.82 -36.55 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -94.62 -31.31 13.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.1 mt -81.39 -71.24 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.484 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 19.5 t -49.75 -37.92 31.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.51 -35.9 68.34 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -75.25 -5.1 42.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.098 -1.236 . . . . 0.0 109.714 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -97.1 -16.27 20.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 16.9 mt -91.97 -41.87 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.818 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.03 -34.98 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 109.735 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -69.54 -34.51 74.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.36 6.83 45.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.195 -0.941 . . . . 0.0 109.84 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.9 OUTLIER -92.24 -57.27 2.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.049 -1.032 . . . . 0.0 109.494 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.524 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 7.6 p90 -61.2 -19.06 61.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.79 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.434 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 1.5 mt -78.03 -48.59 15.79 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -0.963 . . . . 0.0 109.574 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -54.49 -45.16 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.17 -54.42 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.09 -137.33 14.12 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.78 -29.0 4.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -1.138 . . . . 0.0 109.35 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.58 158.36 33.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.271 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.04 -161.8 27.57 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 6.5 p90 -167.33 178.26 5.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -1.224 . . . . 0.0 110.208 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -129.86 133.31 46.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -117.21 88.81 2.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.4 m -124.23 106.25 30.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.323 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.0 Cg_endo -78.52 -32.73 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.344 2.029 . . . . 0.0 110.629 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.53 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.425 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.456 HD12 ' CD2' ' E' ' 19' ' ' TYR . 14.4 tt -114.46 0.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.226 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 3' ' ' VAL . . . . . 0.646 ' O ' HG12 ' E' ' 3' ' ' VAL . 58.3 t -101.81 45.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.285 -0.884 . . . . 0.0 109.988 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -169.96 -42.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.96 -9.15 28.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.311 -0.868 . . . . 0.0 109.722 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.34 -14.24 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 110.352 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.67 -17.41 33.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.937 -1.102 . . . . 0.0 109.316 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -86.32 -10.01 55.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.27 151.62 3.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.498 HD13 ' HB ' ' J' ' 2' ' ' VAL . 2.0 mp -63.46 138.74 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.381 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 61.7 m -102.62 -165.62 1.2 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.081 -1.012 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -104.52 -175.46 2.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.07 -38.85 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 110.031 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -68.38 -24.16 64.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.674 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -78.03 -41.38 35.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 65.1 mt -81.28 -9.62 59.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.233 -0.917 . . . . 0.0 109.993 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.35 -17.7 48.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 109.636 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -66.15 -16.91 64.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.424 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' E' ' 2' ' ' ILE . 3.0 m-85 -119.27 50.6 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -130.48 110.21 11.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.543 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.215 0.531 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.552 ' HB ' ' CD1' ' A' ' 10' ' ' ILE . 3.9 t -138.81 107.46 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.216 -0.927 . . . . 0.0 109.468 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -103.68 -5.88 22.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.741 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -50.94 -37.54 44.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.075 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 5' ' ' HIS . . . . . 0.411 ' CB ' HG12 ' A' ' 10' ' ' ILE . 16.3 t60 -95.21 -24.68 16.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.356 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 22.0 mt -87.83 -69.85 0.67 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 10.2 t -52.96 -35.65 59.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.36 -31.69 63.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 9' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' F' ' 5' ' ' HIS . 1.1 t -77.95 -7.83 57.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -1.216 . . . . 0.0 109.576 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -93.86 -16.87 23.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 110.091 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 10.9 mt -91.41 -41.42 10.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.24 -32.27 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.5 -33.3 66.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 109.652 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' F' ' 18' ' ' VAL . . . -100.72 6.58 43.99 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.8 OUTLIER -92.46 -54.71 3.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.682 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 7.2 p90 -63.9 -20.8 66.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.81 -49.86 16.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' F' ' 14' ' ' ALA . 75.5 t -52.06 -43.53 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 79.5 m -69.49 -51.8 32.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.661 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 20' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 87.78 -139.98 16.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 21' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' F' ' 20' ' ' GLY . 17.7 mt-10 -44.95 -34.34 2.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 109.365 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -67.37 159.04 30.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.811 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.25 -165.3 24.72 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -166.69 -171.13 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -1.112 . . . . 0.0 109.621 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.04 142.62 30.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -120.76 94.68 4.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -126.98 103.36 23.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 109.216 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 28' ' ' PRO . . . . . 0.581 ' HB3' HG21 ' E' ' 3' ' ' VAL . 35.0 Cg_endo -76.7 -36.41 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.393 2.062 . . . . 0.0 110.464 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 65.54 -86.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' G' G ' 2' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' G' ' 19' ' ' TYR . 14.8 tt -111.16 -0.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -1.136 . . . . 0.0 109.519 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 3' ' ' VAL . . . . . 0.631 ' O ' HG12 ' G' ' 3' ' ' VAL . 55.6 t -100.42 47.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.246 -0.908 . . . . 0.0 109.708 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -171.91 -42.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.98 . . . . 0.0 109.737 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.5 -9.69 24.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 6' ' ' CYS . . . . . 0.44 ' HB2' HG13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -127.62 -9.08 5.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.931 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.47 -13.96 27.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 109.477 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 41.0 p -88.23 -14.0 39.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.34 149.33 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 10' ' ' ILE . . . . . 0.479 HD13 ' HB ' ' D' ' 2' ' ' VAL . 1.8 mp -57.33 146.66 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.188 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -112.3 -168.4 1.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 110.404 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -101.78 176.28 5.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -65.71 -41.96 91.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.962 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -64.76 -25.27 67.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.281 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -78.06 -39.91 40.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.048 -1.032 . . . . 0.0 109.694 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.28 -6.09 59.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.612 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -83.75 -19.67 34.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.12 -18.87 65.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.478 -0.764 . . . . 0.0 109.408 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 19' ' ' TYR . . . . . 0.506 ' CD2' HD12 ' G' ' 2' ' ' ILE . 2.0 m-85 -118.28 51.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.381 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.94 107.62 8.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.853 . . . . 0.0 109.451 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.43 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.395 0.616 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.649 ' HB ' HD13 ' K' ' 10' ' ' ILE . 4.9 t -140.73 102.57 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.43 -0.794 . . . . 0.0 109.279 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' H' ' 4' ' ' GLN . 23.6 m-80 -100.33 -11.65 20.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 4' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' H' ' 3' ' ' ASN . 2.3 tt0 -44.76 -37.11 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.836 . . . . 0.0 109.168 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 5' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' H' ' 9' ' ' SER . 13.7 t60 -95.09 -29.48 14.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.813 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.9 mt -84.22 -69.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.5 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.477 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 1.4 t -52.88 -34.86 56.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 109.151 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.88 -32.8 60.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 9' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' H' ' 5' ' ' HIS . 1.4 t -77.66 -5.87 51.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -1.178 . . . . 0.0 109.867 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.13 -14.87 21.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.965 . . . . 0.0 109.882 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.1 mt -91.85 -42.59 9.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.642 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.453 ' H ' HG22 ' H' ' 12' ' ' VAL . 2.7 m -58.03 -35.32 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.872 . . . . 0.0 109.805 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.26 -35.84 76.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.52 8.99 44.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.287 -0.883 . . . . 0.0 109.828 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 15' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.7 OUTLIER -95.56 -55.71 2.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 8.5 p90 -62.31 -22.08 65.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.414 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 1.6 mt -74.0 -49.8 22.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.26 -44.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -52.7 49.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.963 -1.086 . . . . 0.0 109.023 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.86 -137.51 14.27 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.98 -28.41 3.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -72.64 156.55 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.92 . . . . 0.0 109.19 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.51 -163.06 29.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -171.48 -171.54 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.338 -1.095 . . . . 0.0 109.196 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 25' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 3.2 p90 -146.64 146.94 30.57 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -122.23 92.4 3.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -122.5 104.99 36.51 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.367 -0.833 . . . . 0.0 109.262 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 28' ' ' PRO . . . . . 0.596 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.9 Cg_endo -78.18 -39.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 0.0 109.977 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.6 OUTLIER 69.91 -85.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.423 -179.673 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' I' ' 19' ' ' TYR . 12.6 tt -110.51 0.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -1.151 . . . . 0.0 109.553 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 3' ' ' VAL . . . . . 0.592 ' O ' HG12 ' I' ' 3' ' ' VAL . 46.8 t -101.64 48.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.248 -0.907 . . . . 0.0 109.762 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -172.62 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.842 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.03 -11.94 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 110.009 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -126.78 -13.87 5.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.06 -15.36 41.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -87.81 -17.44 31.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.27 153.44 13.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' B' ' 5' ' ' HIS . 1.9 mp -64.59 140.78 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.987 . . . . 0.0 109.374 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 62.8 m -103.26 -163.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.44 -173.91 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp -73.28 -39.58 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.258 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -67.68 -22.67 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.41 -0.806 . . . . 0.0 109.735 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -81.0 -36.62 30.42 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.57 -9.52 57.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.55 -19.64 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 0.0 109.904 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -64.17 -20.1 65.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 19' ' ' TYR . . . . . 0.495 ' CE2' HD12 ' I' ' 2' ' ' ILE . 2.3 m-85 -115.87 48.77 1.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.523 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -128.47 109.33 11.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.377 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' E' ' 10' ' ' ILE . 4.6 t -136.01 103.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.816 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -101.31 -10.68 20.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.555 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -47.18 -35.08 6.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -96.77 -29.09 13.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.28 -69.05 0.67 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.08 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 1.4 t -53.56 -33.05 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.367 -0.833 . . . . 0.0 109.367 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.61 54.97 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -77.6 -2.49 36.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.007 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -97.95 -15.45 20.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 14.2 mt -92.49 -42.38 9.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.578 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -58.32 -34.28 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.65 -33.02 70.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.91 6.59 43.71 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.195 -0.941 . . . . 0.0 109.704 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 15' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' J' ' 11' ' ' LEU . 0.8 OUTLIER -92.62 -55.91 3.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 10.0 p90 -63.08 -18.6 63.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.15 -50.62 11.62 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.101 -1.0 . . . . 0.0 109.103 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.65 -46.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.32 -53.28 38.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 -137.93 14.78 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -47.33 -29.87 2.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.78 153.58 41.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.59 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.68 30.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -163.5 -170.72 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -1.103 . . . . 0.0 109.573 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 25' ' ' PHE . . . . . 0.445 ' CD1' ' O ' ' J' ' 25' ' ' PHE . 36.0 p90 -144.01 143.93 31.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.597 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -121.55 90.64 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.39 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -122.16 103.65 38.95 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 28' ' ' PRO . . . . . 0.538 ' HB3' HG21 ' I' ' 3' ' ' VAL . 35.3 Cg_endo -76.97 -36.76 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.425 2.083 . . . . 0.0 110.496 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 65.52 -86.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.333 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.487 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' K' K ' 2' ' ' ILE . . . . . 0.484 HD12 ' CD2' ' K' ' 19' ' ' TYR . 15.8 tt -111.53 1.62 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -1.14 . . . . 0.0 109.649 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.621 HG12 ' O ' ' K' ' 3' ' ' VAL . 48.5 t -102.38 46.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -171.41 -42.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 109.623 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.15 33.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 109.918 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -129.71 -23.17 2.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.07 -1.019 . . . . 0.0 110.183 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 7' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' L' ' 7' ' ' CYS . 0.5 OUTLIER -79.87 -12.35 59.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.048 -1.032 . . . . 0.0 109.593 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -90.22 -9.62 47.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.09 152.77 2.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 10' ' ' ILE . . . . . 0.649 HD13 ' HB ' ' H' ' 2' ' ' VAL . 1.8 mp -65.65 135.27 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.994 . . . . 0.0 109.265 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -97.29 -164.02 1.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 109.594 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.21 -173.16 2.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -74.34 -40.5 62.12 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.165 -0.959 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -66.58 -26.52 67.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.06 -37.78 57.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.876 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 55.2 mt -85.6 -6.26 59.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.899 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.1 -19.47 36.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.991 . . . . 0.0 109.274 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -64.57 -16.98 63.51 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.359 -0.838 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 19' ' ' TYR . . . . . 0.484 ' CD2' HD12 ' K' ' 2' ' ' ILE . 2.4 m-85 -119.58 47.73 1.66 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 20' ' ' CYS . . . . . 0.418 ' O ' ' OXT' ' K' ' 21' ' ' ASN . 0.1 OUTLIER -128.08 108.5 10.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.534 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 21' ' ' ASN . . . . . 0.418 ' OXT' ' O ' ' K' ' 20' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.502 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 t -136.76 107.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 109.662 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -102.95 -8.21 20.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.732 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -47.84 -34.55 8.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 5' ' ' HIS . . . . . 0.543 ' CB ' HG12 ' C' ' 10' ' ' ILE . 19.2 t60 -98.75 -29.33 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 mt -82.44 -69.75 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.107 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.478 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 11.8 t -53.88 -33.92 57.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.24 -33.41 56.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 9' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' L' ' 5' ' ' HIS . 2.0 t -77.34 -4.57 45.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -1.104 . . . . 0.0 109.637 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -98.16 -14.42 20.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.194 -0.941 . . . . 0.0 109.541 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 15.6 mt -91.98 -44.12 9.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.37 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.419 ' H ' HG22 ' L' ' 12' ' ' VAL . 2.6 m -56.57 -35.1 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.932 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -69.57 -35.57 75.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 109.699 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.69 8.7 44.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 15' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' L' ' 11' ' ' LEU . 0.7 OUTLIER -94.63 -52.73 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.773 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 12.7 p90 -66.3 -18.87 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.003 -1.061 . . . . 0.0 109.366 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.63 -48.18 17.49 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.94 -46.76 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.16 -55.22 27.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.223 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.4 -138.53 14.34 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -48.49 -29.4 4.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 0.0 109.31 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -72.04 156.04 39.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 109.438 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.55 -165.25 29.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -167.23 -176.88 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -1.13 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -137.55 146.54 44.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -124.07 85.56 2.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 105.1 50.15 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 109.534 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 28' ' ' PRO . . . . . 0.6 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.4 Cg_endo -78.86 -32.13 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 110.319 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mttm 61.77 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.349 -179.634 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.403 HD13 HD11 ' B' ' 15' ' ' LEU . 80.9 mt -122.47 -24.88 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -1.158 . . . . 0.0 109.492 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.25 -14.98 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.226 -0.921 . . . . 0.0 109.54 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.84 45.52 2.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -166.28 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.845 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.54 -24.7 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -14.6 59.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 9' ' ' SER . 33.0 p -97.56 3.1 50.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 109.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' THR . 80.9 p -179.46 137.58 0.13 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.161 -0.962 . . . . 0.0 109.688 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -54.73 147.14 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.845 . . . . 0.0 109.472 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -121.14 174.09 6.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -101.23 -177.16 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 4.4 mp -75.16 -24.87 57.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.502 -0.749 . . . . 0.0 109.654 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.98 -43.03 65.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.673 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -70.77 -42.45 70.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.647 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.74 -23.27 61.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 9.3 mt-10 -76.75 -22.46 53.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -57.74 -23.67 53.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 20' ' ' CYS . 75.2 m-85 -84.21 -104.74 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.285 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 53.41 168.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.902 -1.123 . . . . 0.0 109.791 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.03 -0.985 . . . . 0.0 109.517 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.542 HG23 ' O ' ' B' ' 2' ' ' VAL . 17.0 m -79.07 83.49 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -124.78 -26.07 3.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.981 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -38.76 69.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 109.5 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.537 ' CB ' HG12 ' I' ' 10' ' ' ILE . 12.8 t60 -88.56 -29.44 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.907 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 mt -87.93 -72.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 38.5 t -45.78 -34.91 3.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.61 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.78 -40.58 52.4 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.6 p -74.75 0.97 13.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -1.181 . . . . 0.0 109.97 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.47 -23.21 16.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 109.3 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.536 HD23 ' N ' ' B' ' 11' ' ' LEU . 4.6 mt -87.86 -36.14 17.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.407 -0.808 . . . . 0.0 109.526 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.546 HG23 ' N ' ' B' ' 13' ' ' GLU . 20.7 m -48.99 -46.65 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.407 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.546 ' N ' HG23 ' B' ' 12' ' ' VAL . 0.8 OUTLIER -67.07 -31.97 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.3 21.99 6.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.113 -0.992 . . . . 0.0 109.424 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -115.92 -60.84 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.533 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.492 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.4 p90 -64.12 -33.15 75.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.449 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.791 HD23 HD23 ' H' ' 17' ' ' LEU . 43.0 tp -63.84 -42.52 97.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.24 -61.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.605 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.42 -70.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.0 132.77 0.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 53.81 41.23 32.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -1.162 . . . . 0.0 109.795 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.429 ' HD3' ' SG ' ' A' ' 20' ' ' CYS . 1.8 ttt180 -143.19 -62.25 0.41 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.63 157.64 11.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 8.0 p90 -160.23 172.95 16.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -1.14 . . . . 0.0 109.289 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 8.0 p90 -130.31 146.95 51.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -132.47 99.82 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.715 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.69 91.39 18.14 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 109.416 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 84.22 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.501 2.134 . . . . 0.0 110.306 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -127.84 34.92 4.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.381 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 2' ' ' ILE . . . . . 0.479 HG23 ' HB2' ' C' ' 6' ' ' CYS . 78.8 mt -122.3 -23.53 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.766 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.2 -12.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -137.98 35.98 2.36 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 109.232 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -155.64 -35.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 6' ' ' CYS . . . . . 0.479 ' HB2' HG23 ' C' ' 2' ' ' ILE . 0.9 OUTLIER -111.08 -23.84 10.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.559 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -12.16 59.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.532 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -99.72 2.47 44.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 109.78 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -178.91 138.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.28 147.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.54 178.06 4.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -104.98 -176.02 2.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 5.3 mp -76.19 -26.36 56.08 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -69.86 -43.58 71.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.862 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -70.97 -42.66 69.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 109.675 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.4 -25.68 63.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.964 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 9.2 mt-10 -74.3 -23.9 59.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.993 -1.067 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -55.66 -26.33 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' C' ' 20' ' ' CYS . 70.9 m-85 -83.25 -109.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.399 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' C' ' 19' ' ' TYR . 4.4 m 54.38 168.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 109.244 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 C--N 1.303 -1.437 0 O-C-N 121.057 -1.027 . . . . 0.0 109.515 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.0 t80 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.54 ' CG1' ' HA ' ' G' ' 9' ' ' SER . 16.0 m -81.76 84.08 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -123.82 -23.77 4.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -40.59 82.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.429 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 5' ' ' HIS . . . . . 0.46 ' CB ' HG12 ' G' ' 10' ' ' ILE . 11.8 t60 -87.68 -25.84 23.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.453 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 29.1 mt -92.05 -72.37 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 39.4 t -45.43 -35.56 3.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -0.855 . . . . 0.0 109.71 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.85 -39.45 54.85 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 9' ' ' SER . . . . . 0.412 ' HB2' ' CZ ' ' B' ' 16' ' ' TYR . 59.7 p -73.88 -2.19 22.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.787 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.52 HD23 ' N ' ' D' ' 11' ' ' LEU . 5.2 mt -89.07 -35.46 16.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.52 HG23 ' N ' ' D' ' 13' ' ' GLU . 18.4 m -50.21 -46.19 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.52 ' N ' HG23 ' D' ' 12' ' ' VAL . 1.3 pt-20 -67.04 -30.95 71.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 14' ' ' ALA . . . . . 0.414 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.56 17.48 13.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.165 -0.96 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.84 -61.04 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.833 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.506 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 6.3 p90 -63.24 -32.55 73.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.682 HD23 HD23 ' J' ' 17' ' ' LEU . 46.0 tp -65.57 -37.47 86.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -57.55 -62.83 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 109.586 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -66.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.51 135.2 0.11 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 51.84 44.23 29.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -1.064 . . . . 0.0 109.555 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -146.18 -60.82 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.792 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.32 157.03 11.82 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 10.6 p90 -161.38 171.15 18.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.108 -1.231 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' PHE . . . . . 0.567 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 39.2 m-85 -125.83 154.19 42.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -140.75 95.83 2.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.565 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 85.0 m -133.58 91.4 26.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.47 83.86 2.08 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.634 2.223 . . . . 0.0 110.702 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -128.26 36.98 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 109.63 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.557 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.441 HD13 HD11 ' F' ' 15' ' ' LEU . 76.4 mt -120.89 -22.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -1.13 . . . . 0.0 109.643 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.89 -14.05 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.69 41.73 2.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -161.33 -35.99 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.27 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.0 -24.74 10.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.769 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -13.24 60.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.316 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 66.6 p -96.87 -1.67 45.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.758 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -175.36 142.7 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.54 145.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -116.87 179.44 4.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 -174.33 2.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.406 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -77.03 -27.22 54.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.176 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -69.13 -44.06 73.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.75 -39.99 76.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 110.33 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.9 mt -73.88 -24.43 59.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.943 . . . . 0.0 110.042 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.57 -26.16 59.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.063 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -53.42 -25.53 16.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' E' ' 20' ' ' CYS . 70.6 m-85 -83.29 -104.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.107 -0.996 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 20' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' E' ' 19' ' ' TYR . 0.9 OUTLIER 52.55 171.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.949 -1.094 . . . . 0.0 109.495 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 120.97 -1.081 . . . . 0.0 109.554 -179.879 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.543 ' O ' HG23 ' F' ' 2' ' ' VAL . 17.9 m -79.48 83.42 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -123.44 -26.14 4.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.058 -1.026 . . . . 0.0 109.775 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.97 70.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.487 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -85.59 -28.92 24.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 27.0 mt -88.71 -72.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.956 . . . . 0.0 109.743 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -45.25 -36.52 4.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.811 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.94 -39.05 59.78 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 97.3 p -75.49 0.59 16.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 0.0 109.736 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -97.82 -21.96 16.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.508 ' N ' HD23 ' F' ' 11' ' ' LEU . 5.3 mt -89.32 -34.7 16.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.211 -0.931 . . . . 0.0 109.417 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.567 HG23 ' N ' ' F' ' 13' ' ' GLU . 22.5 m -49.37 -46.88 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 109.312 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 13' ' ' GLU . . . . . 0.567 ' N ' HG23 ' F' ' 12' ' ' VAL . 1.9 pt-20 -66.66 -33.03 74.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.547 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' L' ' 17' ' ' LEU . . . -91.74 17.48 8.91 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.266 -0.896 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.441 HD11 HD13 ' E' ' 2' ' ' ILE . 0.8 OUTLIER -112.68 -61.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 110.117 -179.579 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 6.5 p90 -63.37 -33.02 74.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.035 . . . . 0.0 109.633 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.933 HD23 HD23 ' L' ' 17' ' ' LEU . 41.9 tp -64.9 -42.1 95.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -52.48 -62.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.418 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.6 -71.13 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.536 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.37 135.71 0.37 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 50.93 43.18 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -1.132 . . . . 0.0 109.603 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.03 -66.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.365 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.77 160.22 10.82 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 24' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 13.8 p90 -168.85 163.61 11.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -1.067 . . . . 0.0 109.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -126.34 147.94 49.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 109.532 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -127.87 104.63 7.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.448 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 86.9 m -138.78 89.16 13.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.681 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.97 85.82 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.57 2.18 . . . . 0.0 110.564 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -130.51 37.52 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.286 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.88 -24.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -78.36 -12.38 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.69 34.09 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.228 -0.92 . . . . 0.0 109.696 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -152.64 -37.15 0.11 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.0 -24.62 10.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -15.02 61.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.319 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 45.9 p -98.46 -2.24 39.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.62 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 9' ' ' SER . . . . . 0.54 ' HA ' ' CG1' ' D' ' 2' ' ' VAL . 93.6 p -171.79 135.97 0.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.088 -1.008 . . . . 0.0 109.752 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 10' ' ' ILE . . . . . 0.46 HG12 ' CB ' ' D' ' 5' ' ' HIS . 2.5 mp -55.01 143.99 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.229 -0.919 . . . . 0.0 108.806 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 m -115.84 177.58 4.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.954 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -104.45 178.19 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.43 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.6 -26.36 62.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.267 -0.896 . . . . 0.0 109.745 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -70.6 -40.9 72.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -72.57 -39.44 67.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.249 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.96 -22.14 58.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.852 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -76.44 -24.46 53.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 109.323 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.46 -25.44 36.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.837 . . . . 0.0 109.813 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 19' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' G' ' 20' ' ' CYS . 73.9 m-85 -83.65 -103.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 20' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' G' ' 19' ' ' TYR . 0.9 OUTLIER 51.19 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.105 . . . . 0.0 109.658 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.554 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 12.1 t80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.471 ' O ' HG23 ' H' ' 2' ' ' VAL . 16.2 m -79.61 81.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -121.87 -28.5 4.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.647 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -39.72 66.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.928 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -89.52 -21.73 22.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 109.736 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 6' ' ' LEU . . . . . 0.416 HD22 ' ND1' ' L' ' 10' ' ' HIS . 31.0 mt -95.8 -70.7 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.5 t -46.52 -35.64 5.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.46 -39.16 57.31 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -77.0 2.92 13.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -1.182 . . . . 0.0 109.663 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -98.94 -23.39 15.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.523 ' N ' HD23 ' H' ' 11' ' ' LEU . 5.1 mt -87.98 -35.09 17.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.534 HG23 ' N ' ' H' ' 13' ' ' GLU . 18.6 m -49.5 -46.37 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.489 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 13' ' ' GLU . . . . . 0.534 ' N ' HG23 ' H' ' 12' ' ' VAL . 3.0 pt-20 -67.85 -30.92 70.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.317 -0.864 . . . . 0.0 109.418 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 14' ' ' ALA . . . . . 0.689 ' HA ' HD21 ' B' ' 17' ' ' LEU . . . -95.02 21.63 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.341 -0.85 . . . . 0.0 109.635 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 -60.06 1.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.639 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.467 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 7.4 p90 -64.58 -32.6 74.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.385 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.791 HD23 HD23 ' B' ' 17' ' ' LEU . 43.8 tp -65.05 -42.52 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.383 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -51.98 -65.83 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.224 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 58.6 m -64.33 -73.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.3 136.65 0.84 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 49.87 46.06 24.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.169 -1.195 . . . . 0.0 109.333 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -147.6 -58.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.403 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.06 158.39 14.29 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 24' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 9.8 p90 -163.34 174.7 11.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -1.154 . . . . 0.0 109.428 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 25' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 15.0 p90 -129.93 157.86 41.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -144.04 91.91 2.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 84.9 m -129.19 90.52 44.82 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.75 86.32 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.433 2.089 . . . . 0.0 110.154 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -130.06 35.24 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.912 . . . . 0.0 109.595 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.546 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.418 HD13 HD11 ' J' ' 15' ' ' LEU . 85.3 mt -122.15 -26.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -1.166 . . . . 0.0 109.358 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 p -75.85 -12.86 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -138.25 43.82 2.16 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -163.04 -37.45 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.213 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 2.1 t -109.6 -27.05 9.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 109.151 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -72.01 -17.16 62.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 37.1 p -96.38 1.63 51.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 9' ' ' SER . . . . . 0.538 ' HA ' ' CG1' ' B' ' 2' ' ' VAL . 85.8 p -177.24 141.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.543 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' B' ' 5' ' ' HIS . 2.7 mp -60.77 139.93 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.355 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 m -110.04 -174.72 2.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.182 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -110.63 -175.98 2.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.175 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 3.3 mp -75.42 -24.27 57.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.562 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.57 -43.48 63.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.89 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -70.04 -44.58 68.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -68.63 -26.06 65.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.979 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 9.0 mt-10 -74.46 -22.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.032 . . . . 0.0 109.731 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.93 -23.2 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.704 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 19' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' I' ' 20' ' ' CYS . 71.3 m-85 -83.87 -109.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 0.0 109.114 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 20' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' I' ' 19' ' ' TYR . 0.9 OUTLIER 55.61 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.66 -1.275 . . . . 0.0 109.651 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.528 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.54 HG23 ' O ' ' J' ' 2' ' ' VAL . 16.9 m -81.48 83.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 109.568 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.6 -32.2 3.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.75 -39.29 37.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.102 -0.999 . . . . 0.0 109.882 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -88.44 -27.82 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 6' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' J' ' 7' ' ' CYS . 33.7 mt -90.96 -71.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' J' ' 6' ' ' LEU . 6.4 t -45.01 -38.89 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.05 -39.83 84.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 9' ' ' SER . . . . . 0.439 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 79.2 p -75.86 1.46 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.157 -1.202 . . . . 0.0 109.78 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -97.25 -23.41 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.553 HD23 ' N ' ' J' ' 11' ' ' LEU . 3.4 mt -88.43 -36.24 16.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.54 HG23 ' N ' ' J' ' 13' ' ' GLU . 23.5 m -48.09 -45.64 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.444 -0.785 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.54 ' N ' HG23 ' J' ' 12' ' ' VAL . 0.8 OUTLIER -68.45 -32.17 72.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.63 21.56 6.25 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -0.876 . . . . 0.0 109.438 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 15' ' ' LEU . . . . . 0.418 HD11 HD13 ' I' ' 2' ' ' ILE . 0.8 OUTLIER -116.05 -60.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.656 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' L' ' 9' ' ' SER . 7.8 p90 -64.66 -32.54 74.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.102 -0.999 . . . . 0.0 109.371 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.682 HD23 HD23 ' D' ' 17' ' ' LEU . 52.8 tp -65.1 -40.8 95.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.31 -61.19 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -69.6 -69.51 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.3 133.88 0.17 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 53.62 43.5 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -1.109 . . . . 0.0 109.578 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -145.38 -59.0 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.29 155.37 12.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 24' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 6.9 p90 -158.88 -179.64 8.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -1.18 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.31 158.86 43.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -144.44 94.89 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.485 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -132.35 91.51 31.03 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.46 -0.775 . . . . 0.0 109.287 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.09 86.62 1.66 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.679 2.253 . . . . 0.0 110.149 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -130.82 36.67 3.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.405 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.07 -24.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.46 HG22 ' O ' ' K' ' 3' ' ' VAL . 14.9 p -78.53 -7.71 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -142.14 34.17 1.53 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.604 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -153.35 -36.49 0.1 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.41 -26.12 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.208 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -73.28 -13.25 61.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.415 -0.803 . . . . 0.0 109.633 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 43.5 p -99.75 0.26 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.598 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p -176.31 145.64 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.902 . . . . 0.0 109.306 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.14 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.97 . . . . 0.0 109.393 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 33.7 m -108.8 -176.05 2.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.516 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -109.89 -177.5 3.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 109.16 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 13' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 3.3 mp -74.49 -25.64 59.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 0.0 109.74 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -71.24 -42.97 68.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.301 -0.875 . . . . 0.0 109.943 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -70.49 -43.53 69.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.878 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.27 -24.08 62.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 17' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 8.3 mt-10 -75.41 -24.09 57.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -56.94 -23.81 48.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 19' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' K' ' 20' ' ' CYS . 73.0 m-85 -85.07 -112.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 20' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' K' ' 19' ' ' TYR . 6.1 m 55.46 168.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.733 -1.229 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.381 179.974 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.595 HG23 ' O ' ' L' ' 2' ' ' VAL . 22.3 m -77.1 84.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 109.813 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -125.4 -27.1 3.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -37.3 66.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.562 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -91.13 -25.26 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -92.72 -69.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.351 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 4.9 t -48.23 -34.94 11.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.19 -39.1 58.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 9' ' ' SER . . . . . 0.494 ' HB2' ' OH ' ' J' ' 16' ' ' TYR . 89.1 p -76.42 1.17 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -1.136 . . . . 0.0 109.717 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 10' ' ' HIS . . . . . 0.416 ' ND1' HD22 ' H' ' 6' ' ' LEU . 3.1 m-70 -98.28 -24.08 15.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.364 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.492 HD23 ' N ' ' L' ' 11' ' ' LEU . 6.4 mt -86.72 -33.68 19.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.52 HG23 ' N ' ' L' ' 13' ' ' GLU . 19.0 m -51.83 -45.76 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 13' ' ' GLU . . . . . 0.52 ' N ' HG23 ' L' ' 12' ' ' VAL . 1.7 pt-20 -67.07 -33.24 75.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 14' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -92.11 19.63 6.68 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.7 -61.69 1.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 7.5 p90 -62.57 -32.96 74.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.6 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.933 HD23 HD23 ' F' ' 17' ' ' LEU . 49.7 tp -65.05 -37.31 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.846 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.6 -59.06 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -67.38 0.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.085 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.46 134.3 0.1 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 53.27 42.41 32.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -1.175 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -145.32 -60.16 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.018 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.45 162.24 14.83 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 24' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 12.2 p90 -165.51 172.09 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -1.2 . . . . 0.0 109.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -127.49 154.18 45.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.447 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -140.43 99.31 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -136.46 91.76 15.95 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 109.578 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.18 84.41 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.74 2.293 . . . . 0.0 110.663 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -128.8 38.49 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.429 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.75 3.53 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -1.15 . . . . 0.0 109.721 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 35.9 m -89.52 -11.21 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.86 43.63 2.07 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.301 -0.874 . . . . 0.0 109.356 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.25 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.043 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.4 m -115.15 26.48 10.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 45.6 t -117.64 -24.2 7.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.066 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -109.0 8.52 26.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.93 120.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mp -49.11 134.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -94.42 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.121 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -110.03 172.18 7.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -27.25 67.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 109.665 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.71 -46.29 69.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -33.13 68.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.99 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.79 -8.09 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -89.69 -23.1 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.57 -8.0 54.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -93.44 4.93 53.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.499 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 156.68 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.349 0.595 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.667 ' O ' HG13 ' B' ' 2' ' ' VAL . 7.5 p -70.88 91.04 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.885 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.98 -45.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 0.0 109.143 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.36 -32.05 58.4 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.317 -0.864 . . . . 0.0 109.14 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -70.53 -43.2 70.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 mt -74.24 -32.69 63.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.288 -0.883 . . . . 0.0 108.886 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.09 -31.43 68.99 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.466 -0.771 . . . . 0.0 109.274 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.09 -26.94 61.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.14 -10.35 59.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.25 -1.147 . . . . 0.0 109.456 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -89.59 -24.6 21.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.086 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -87.59 -43.81 11.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.48 HG23 ' N ' ' B' ' 13' ' ' GLU . 29.0 m -47.31 -42.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.48 ' N ' HG23 ' B' ' 12' ' ' VAL . 5.0 mt-10 -67.35 -39.09 85.72 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 109.752 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.38 25.59 2.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.183 -0.948 . . . . 0.0 109.555 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.06 -49.21 2.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.399 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 18.3 p90 -79.39 -25.82 42.08 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.925 HD23 HD23 ' H' ' 17' ' ' LEU . 28.0 tp -74.76 -35.9 62.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.5 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -58.12 -60.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.64 -64.48 0.85 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.579 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.46 -129.29 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.46 82.74 3.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -1.183 . . . . 0.0 109.662 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -148.44 -68.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.48 149.71 7.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 17.3 p90 -158.69 173.27 16.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -1.141 . . . . 0.0 109.312 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.593 ' HB3' ' CD2' ' D' ' 25' ' ' PHE . 23.9 p90 -129.01 146.06 51.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -124.8 102.7 7.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.458 -0.776 . . . . 0.0 109.025 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -140.72 106.01 6.37 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.922 . . . . 0.0 109.866 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.61 78.41 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.524 2.149 . . . . 0.0 110.278 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -174.29 2.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.634 -179.877 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.39 0.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -1.122 . . . . 0.0 109.258 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 3' ' ' VAL . . . . . 0.418 ' H ' HG22 ' C' ' 3' ' ' VAL . 28.6 m -85.38 -14.14 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.229 -0.919 . . . . 0.0 109.805 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.9 42.49 2.01 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.187 -0.946 . . . . 0.0 109.673 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -168.52 -34.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.229 -0.919 . . . . 0.0 109.534 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -120.89 19.7 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 109.151 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -20.31 11.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.504 -0.748 . . . . 0.0 109.205 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -111.53 7.04 20.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 9' ' ' SER . . . . . 0.484 ' HA ' ' HB3' ' L' ' 1' ' ' PHE . 85.6 p -175.87 120.12 0.17 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.901 . . . . 0.0 109.188 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.414 ' H ' HD12 ' C' ' 10' ' ' ILE . 2.9 mp -48.63 133.98 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.294 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.58 -169.75 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.343 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -107.43 172.84 6.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.29 -27.07 66.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.52 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -69.37 -42.92 74.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -29.23 55.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.31 -7.15 59.52 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.8 -23.66 21.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.493 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -74.53 -4.35 36.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.938 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -97.38 4.11 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.988 . . . . 0.0 109.36 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.17 155.49 18.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.469 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.597 ' O ' HG13 ' D' ' 2' ' ' VAL . 4.7 p -69.61 94.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.93 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -79.36 -33.79 42.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 109.036 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -68.26 -41.07 81.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 108.919 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.63 -34.56 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.3 -28.25 67.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.456 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.23 -27.91 50.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -78.45 -8.1 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 109.211 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -93.65 -20.23 20.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.967 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mt -93.18 -44.29 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.486 HG23 ' N ' ' D' ' 13' ' ' GLU . 20.2 m -45.89 -42.32 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.425 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.486 ' N ' HG23 ' D' ' 12' ' ' VAL . 4.3 mt-10 -68.12 -43.98 77.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.316 -0.865 . . . . 0.0 109.665 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.8 24.83 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.915 . . . . 0.0 109.862 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -50.53 2.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.017 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 12.0 p90 -77.92 -24.42 48.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.854 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.532 HD21 ' CB ' ' J' ' 14' ' ' ALA . 35.3 tp -76.86 -36.07 57.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.58 -61.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -66.16 -66.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.743 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.9 -129.41 8.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.57 82.35 3.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -1.159 . . . . 0.0 109.552 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -148.48 -69.9 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.587 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.61 143.08 5.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 10.9 p90 -150.13 166.58 29.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.292 -1.122 . . . . 0.0 109.289 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 25' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' B' ' 25' ' ' PHE . 11.7 m-85 -117.43 143.87 45.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.042 -1.036 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -127.04 104.84 8.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.084 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -148.83 105.37 3.42 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.28 83.68 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.397 2.065 . . . . 0.0 110.46 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.86 -179.88 2.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.441 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.393 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 tt -120.41 0.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -1.144 . . . . 0.0 109.762 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.38 -8.97 11.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.76 37.63 3.73 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.142 -0.974 . . . . 0.0 109.339 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -163.06 -42.2 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 90.3 m -113.85 26.27 10.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.228 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 51.1 t -117.24 -23.99 7.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -0.839 . . . . 0.0 109.188 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -109.93 10.97 24.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.19 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 9' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' J' ' 1' ' ' PHE . 2.2 p -178.81 119.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.41 132.51 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.744 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m -93.27 -169.91 2.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.6 175.45 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -24.59 63.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -71.88 -44.34 63.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -29.74 61.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.438 -0.789 . . . . 0.0 109.889 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -80.87 -10.35 59.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.922 . . . . 0.0 109.819 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -86.27 -25.44 25.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -70.66 -10.01 58.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.9 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -92.38 5.93 48.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 109.98 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.41 156.71 17.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.746 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.602 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.643 ' O ' HG13 ' F' ' 2' ' ' VAL . 5.9 p -74.21 88.73 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.911 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.74 -44.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.91 . . . . 0.0 109.055 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.51 -30.77 53.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -70.46 -45.14 66.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.326 -0.859 . . . . 0.0 109.043 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.48 -30.71 63.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.327 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.414 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.1 t -72.36 -29.55 63.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.753 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.73 -25.94 59.59 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -84.23 -2.61 57.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 109.653 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 10' ' ' HIS . . . . . 0.603 ' ND1' HD22 ' J' ' 6' ' ' LEU . 2.6 m-70 -97.89 -19.16 18.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 15.2 mt -92.22 -43.67 9.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.527 -0.733 . . . . 0.0 109.271 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.477 HG23 ' N ' ' F' ' 13' ' ' GLU . 22.8 m -48.26 -42.1 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 13' ' ' GLU . . . . . 0.477 ' N ' HG23 ' F' ' 12' ' ' VAL . 4.7 mt-10 -67.19 -43.07 83.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.749 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.92 21.79 2.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.283 -0.886 . . . . 0.0 109.875 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.25 -51.91 2.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 13.4 p90 -76.37 -25.48 54.68 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.189 -0.944 . . . . 0.0 109.654 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.519 HD23 HD23 ' L' ' 17' ' ' LEU . 31.9 tp -76.21 -35.54 59.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.96 . . . . 0.0 109.769 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.49 -59.23 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.686 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 17.9 m -68.44 -66.72 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.078 -1.014 . . . . 0.0 109.301 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.03 -126.07 7.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.44 78.38 5.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -1.092 . . . . 0.0 109.688 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -145.14 -71.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 109.851 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.99 138.84 4.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 24' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 14.4 p90 -145.94 173.18 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.349 -1.089 . . . . 0.0 109.019 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -125.27 145.52 49.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.032 . . . . 0.0 109.789 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -127.98 104.08 7.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.245 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -147.33 107.1 3.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.9 78.39 3.42 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.539 2.159 . . . . 0.0 110.693 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.52 179.49 5.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.551 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt -119.29 -1.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -1.091 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.42 -14.4 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.257 -0.902 . . . . 0.0 110.109 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.34 37.47 3.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.069 -1.019 . . . . 0.0 110.018 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -162.05 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.338 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -115.51 21.71 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -23.05 10.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.014 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 11.0 t -108.66 8.77 27.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -177.79 119.2 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.13 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 10' ' ' ILE . . . . . 0.498 ' H ' HD12 ' G' ' 10' ' ' ILE . 3.3 mp -47.96 137.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.372 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 77.9 m -98.22 -168.34 1.64 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.61 169.26 8.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.949 . . . . 0.0 109.285 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 13' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' G' ' 13' ' ' LEU . 0.3 OUTLIER -64.38 -25.63 68.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -70.65 -42.75 70.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -28.16 57.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.42 -4.66 58.7 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.073 -1.017 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -93.29 -21.57 19.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.14 -0.975 . . . . 0.0 109.377 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.07 -9.63 58.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -92.31 1.4 57.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.15 157.82 16.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.002 . . . . 0.0 109.733 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.701 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.621 ' O ' HG13 ' H' ' 2' ' ' VAL . 5.6 p -68.77 91.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.79 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.169 -0.957 . . . . 0.0 109.432 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -77.33 -33.12 55.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -68.2 -40.7 82.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.248 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 6' ' ' LEU . . . . . 0.474 HD22 ' ND1' ' L' ' 10' ' ' HIS . 13.8 mt -77.37 -31.83 54.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 108.959 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.11 -28.02 65.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.488 -0.757 . . . . 0.0 109.338 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.98 -29.84 45.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 70.4 m -77.24 -8.35 57.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -1.179 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -93.39 -23.46 18.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' H' ' 12' ' ' VAL . 12.1 mt -88.93 -44.51 10.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.525 HG23 ' N ' ' H' ' 13' ' ' GLU . 26.3 m -45.79 -44.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 13' ' ' GLU . . . . . 0.525 ' N ' HG23 ' H' ' 12' ' ' VAL . 5.3 mt-10 -65.95 -43.86 86.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.784 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 14' ' ' ALA . . . . . 0.574 ' HA ' HD21 ' B' ' 17' ' ' LEU . . . -86.92 21.11 2.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 110.03 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.45 -51.93 2.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 109.684 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 12.4 p90 -76.21 -26.03 55.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.925 HD23 HD23 ' B' ' 17' ' ' LEU . 32.2 tp -75.56 -34.93 60.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.44 -60.45 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.954 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 m -67.55 -63.62 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.69 -130.23 9.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -76.92 81.94 3.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -1.105 . . . . 0.0 109.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -146.94 -68.27 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.03 142.33 5.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 24' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 18.7 p90 -152.13 174.76 13.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.132 . . . . 0.0 109.511 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.3 162.42 26.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -143.83 92.44 2.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.84 . . . . 0.0 109.588 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -133.76 107.27 11.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.13 78.25 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.362 2.041 . . . . 0.0 109.959 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.8 -179.22 4.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.697 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.32 179.728 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -119.13 0.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 109.901 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.98 -16.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.055 -1.028 . . . . 0.0 110.075 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.75 42.88 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -169.96 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -116.91 19.51 14.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.297 -0.877 . . . . 0.0 109.211 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -24.76 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.315 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -105.28 9.38 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.633 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 9' ' ' SER . . . . . 0.438 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.9 p 179.67 118.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.453 ' H ' HD12 ' I' ' 10' ' ' ILE . 3.0 mp -43.5 149.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.859 . . . . 0.0 109.21 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -171.76 1.91 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.79 167.55 9.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.158 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 13' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' I' ' 13' ' ' LEU . 0.3 OUTLIER -63.39 -27.81 69.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.33 -43.26 77.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.85 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -27.17 56.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.811 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -84.15 -7.12 59.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 109.864 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.78 -24.85 21.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -71.15 -10.83 60.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -91.45 3.16 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 0.0 109.909 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 159.25 15.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 109.378 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 1' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' E' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.261 0.553 . . . . 0.0 109.713 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.624 ' O ' HG13 ' J' ' 2' ' ' VAL . 6.0 p -70.65 91.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.55 -42.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.146 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.17 -33.41 44.02 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.004 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -69.06 -40.06 78.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 6' ' ' LEU . . . . . 0.603 HD22 ' ND1' ' F' ' 10' ' ' HIS . 9.5 mt -78.49 -29.79 46.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.324 -0.86 . . . . 0.0 109.105 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -72.72 -27.71 62.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.333 -0.854 . . . . 0.0 109.465 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.84 -27.0 52.17 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -79.68 -7.57 58.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.568 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -94.5 -20.87 19.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.15 -43.69 9.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 109.677 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.504 HG23 ' N ' ' J' ' 13' ' ' GLU . 26.1 m -46.95 -44.21 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.504 ' N ' HG23 ' J' ' 12' ' ' VAL . 3.9 mt-10 -65.08 -44.25 89.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.601 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 14' ' ' ALA . . . . . 0.532 ' CB ' HD21 ' D' ' 17' ' ' LEU . . . -87.6 24.85 1.59 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.47 -46.34 3.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 109.507 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 14.3 p90 -82.64 -23.25 34.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.98 -37.85 54.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.283 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.0 t -55.7 -61.62 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 m -66.89 -64.77 0.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.55 -129.33 8.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -77.91 85.31 4.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -1.179 . . . . 0.0 109.368 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -150.88 -75.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.07 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.32 141.21 4.42 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 24' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 15.5 p90 -149.05 165.69 30.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.79 136.44 54.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -117.37 104.91 11.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.536 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -146.18 108.19 4.23 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 109.438 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.85 79.57 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 110.994 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.89 179.6 5.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 109.337 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.324 179.923 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.6 tt -121.17 1.05 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 30.9 m -86.51 -12.9 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.89 40.38 2.47 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.688 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -164.93 -42.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.244 -0.91 . . . . 0.0 109.299 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 93.9 m -114.14 23.47 12.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 7' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 40.9 t -112.77 -26.94 8.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 109.238 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -105.48 9.4 33.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.01 118.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.804 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 10' ' ' ILE . . . . . 0.475 HD12 ' H ' ' K' ' 10' ' ' ILE . 3.1 mp -45.32 135.66 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.298 -0.877 . . . . 0.0 109.597 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -98.1 -167.73 1.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.46 171.71 7.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.482 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 13' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' K' ' 13' ' ' LEU . 0.3 OUTLIER -65.24 -28.06 69.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 109.678 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -69.1 -42.34 76.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.825 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -28.82 56.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.62 -7.28 59.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 109.809 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.59 -25.12 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.678 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -72.38 -7.62 50.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -93.55 0.33 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.87 158.99 15.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.419 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 1' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' C' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.624 ' O ' HG13 ' L' ' 2' ' ' VAL . 5.1 p -70.83 89.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -175.95 -44.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -78.29 -31.88 49.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -70.63 -39.17 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.127 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 13.4 mt -78.21 -31.93 49.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 108.863 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.01 -29.99 67.19 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.12 -27.26 58.43 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -80.37 -6.24 57.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -1.127 . . . . 0.0 109.616 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 10' ' ' HIS . . . . . 0.474 ' ND1' HD22 ' H' ' 6' ' ' LEU . 4.3 m-70 -95.14 -20.63 19.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.031 -1.043 . . . . 0.0 109.633 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' L' ' 12' ' ' VAL . 11.2 mt -92.68 -44.67 8.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.943 . . . . 0.0 109.515 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.51 HG23 ' N ' ' L' ' 13' ' ' GLU . 23.4 m -45.04 -43.71 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.18 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 13' ' ' GLU . . . . . 0.51 ' N ' HG23 ' L' ' 12' ' ' VAL . 4.7 mt-10 -66.76 -44.83 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.554 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.69 23.53 1.66 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.3 -0.875 . . . . 0.0 109.936 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.62 -49.66 2.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.668 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.526 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 14.4 p90 -79.06 -24.36 43.6 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.162 -0.962 . . . . 0.0 109.663 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.519 HD23 HD23 ' F' ' 17' ' ' LEU . 38.7 tp -76.99 -33.58 57.58 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.75 -59.3 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 12.3 m -69.05 -66.08 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.568 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.98 -129.95 9.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.17 80.88 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -147.62 -68.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.092 -1.005 . . . . 0.0 109.43 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.59 131.26 3.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 24' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 9.8 p90 -135.08 -173.21 3.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 109.317 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -138.2 142.74 39.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.82 108.61 11.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.625 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -150.5 106.64 3.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.848 . . . . 0.0 109.451 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.09 79.37 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.508 2.139 . . . . 0.0 110.449 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 -179.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.537 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -97.74 -27.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' B' ' 28' ' ' PRO . 94.4 t -73.84 -44.11 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.64 52.12 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.843 . . . . 0.0 110.151 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -175.38 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.085 -1.01 . . . . 0.0 109.694 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.0 11.05 17.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.8 t -105.57 -23.05 12.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.9 p -67.17 -13.94 62.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.472 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.5 p -175.25 156.52 2.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' F' ' 2' ' ' VAL . 2.1 mp -62.84 130.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.255 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.32 -167.02 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.504 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.72 176.78 4.94 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -42.31 89.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.2 -0.938 . . . . 0.0 109.771 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -66.7 -35.85 81.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.962 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -36.67 77.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 109.437 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.65 -18.45 51.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 109.827 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.09 -14.48 47.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.481 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.6 -16.31 15.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.892 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.74 87.27 1.84 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.31 133.07 7.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.461 -0.774 . . . . 0.0 109.485 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.418 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.548 ' HB ' HD12 ' I' ' 10' ' ' ILE . 70.4 t -91.02 -7.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.248 -0.908 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 4' ' ' GLN . 11.3 p30 45.08 -172.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.443 -0.785 . . . . 0.0 109.604 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' B' ' 3' ' ' ASN . 9.4 tt0 83.53 -59.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -89.08 -24.13 22.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.191 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -96.78 -50.26 4.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.135 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -57.2 -38.04 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.98 -29.46 60.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.489 ' OG ' ' CE1' ' D' ' 16' ' ' TYR . 1.2 m -67.38 -9.08 38.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.151 . . . . 0.0 109.424 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -96.25 -36.1 11.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.023 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.49 -41.44 69.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 m -48.11 -37.7 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -72.25 -46.12 57.32 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.954 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.12 13.25 4.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 0.0 109.863 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.32 -53.29 3.39 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.003 -1.061 . . . . 0.0 109.537 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 11.3 p90 -73.12 -30.2 63.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.315 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 0.1 OUTLIER -61.93 -52.92 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.384 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.41 -30.75 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.199 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 20' ' ' GLY . 1.3 m -115.45 54.74 0.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.016 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' B' ' 22' ' ' ARG . . . -58.72 -119.73 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' B' ' 22' ' ' ARG . 25.8 mt-10 -39.52 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.975 . . . . 0.0 109.933 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' B' ' 20' ' ' GLY . 2.9 mtt180 165.37 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.657 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 172.48 27.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' D' ' 26' ' ' TYR . 50.9 p90 -170.81 162.74 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.441 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -117.72 141.5 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 0.0 109.493 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.86 111.44 17.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.709 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -140.86 98.58 6.92 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.635 ' HB3' HG21 ' A' ' 3' ' ' VAL . 35.7 Cg_endo -77.92 87.73 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.5 2.133 . . . . 0.0 110.662 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -136.1 -123.38 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.98 . . . . 0.0 109.294 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 120.741 -1.225 . . . . 0.0 109.351 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -100.3 -29.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -1.165 . . . . 0.0 109.457 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 3' ' ' VAL . . . . . 0.603 HG21 ' HB3' ' D' ' 28' ' ' PRO . 79.2 t -72.81 -40.95 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 52.54 1.97 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.332 -0.855 . . . . 0.0 110.077 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -175.64 -34.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.82 11.58 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 t -105.66 -24.4 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 60.1 p -67.74 -11.94 59.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.575 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -174.81 155.5 2.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.624 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.673 HD12 ' HB ' ' L' ' 2' ' ' VAL . 1.6 mp -63.7 130.95 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 108.984 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -97.15 -167.61 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -107.12 178.8 4.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -42.29 78.65 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.288 -0.882 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -67.04 -34.82 78.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.918 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -32.5 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 11.6 mt -83.31 -21.55 33.19 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -13.59 57.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.524 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.96 -15.57 13.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.02 87.94 1.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.57 133.97 7.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.429 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' G' ' 10' ' ' ILE . 55.8 t -89.58 -9.23 10.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.422 -0.798 . . . . 0.0 109.574 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' D' ' 4' ' ' GLN . 8.6 p30 45.9 -174.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' D' ' 3' ' ' ASN . 10.2 tt0 84.07 -60.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 5' ' ' HIS . . . . . 0.454 ' HB3' HG12 ' G' ' 10' ' ' ILE . 32.4 t60 -88.02 -21.99 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.123 -0.986 . . . . 0.0 109.006 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.41 -51.28 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.839 . . . . 0.0 109.188 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 t -57.31 -37.79 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.35 59.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.68 -11.13 32.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -1.105 . . . . 0.0 109.559 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -93.09 -35.28 13.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 15.1 mt -73.52 -39.52 64.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 m -48.15 -35.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -75.63 -44.45 42.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 9.71 11.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.02 -56.77 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.711 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 9.1 p90 -71.6 -28.75 64.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.027 . . . . 0.0 109.541 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 0.1 OUTLIER -63.15 -52.99 60.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.186 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.1 t -66.27 -33.47 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 108.866 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' D' ' 20' ' ' GLY . 1.3 m -111.66 55.96 0.66 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 109.085 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' D' ' 22' ' ' ARG . . . -59.32 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' D' ' 22' ' ' ARG . 23.3 mt-10 -40.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.463 -1.022 . . . . 0.0 110.055 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' ARG . . . . . 0.483 ' CB ' ' O ' ' D' ' 21' ' ' GLU . 4.2 mtt180 165.07 -53.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 171.61 24.55 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -169.45 172.31 7.17 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -122.16 157.89 30.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.516 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.44 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 79.6 t80 -136.64 100.45 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.47 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -133.83 97.41 15.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' PRO . . . . . 0.603 ' HB3' HG21 ' C' ' 3' ' ' VAL . 34.7 Cg_endo -76.81 86.19 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.447 2.098 . . . . 0.0 110.62 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -134.16 -124.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.886 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.405 HD13 HD11 ' F' ' 15' ' ' LEU . 20.7 tt -101.69 -25.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -1.138 . . . . 0.0 109.135 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 3' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' F' ' 28' ' ' PRO . 90.6 t -77.71 -41.47 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.493 -0.754 . . . . 0.0 109.503 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.04 50.75 1.83 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.806 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.58 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.796 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 10.95 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.024 . . . . 0.0 109.504 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 7' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 33.2 t -105.07 -23.27 12.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 77.1 p -67.01 -14.73 63.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 9' ' ' SER . . . . . 0.502 ' HA ' HG21 ' J' ' 2' ' ' VAL . 5.8 p -174.15 155.85 2.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.139 -0.975 . . . . 0.0 109.819 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.567 HD12 ' HB ' ' J' ' 2' ' ' VAL . 2.1 mp -62.0 126.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.481 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -94.54 -170.09 2.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -106.91 176.7 5.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -41.04 95.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -68.74 -35.75 77.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 109.9 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -36.63 77.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 18.9 mt -79.01 -21.28 47.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.905 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -13.44 56.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.953 . . . . 0.0 109.321 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.72 -16.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.525 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.1 88.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.65 135.45 8.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.395 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.642 ' HB ' HD12 ' A' ' 10' ' ' ILE . 54.8 t -90.91 -7.45 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 3' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' F' ' 4' ' ' GLN . 9.4 p30 45.81 -174.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.77 . . . . 0.0 109.657 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 4' ' ' GLN . . . . . 0.567 ' CB ' ' O ' ' F' ' 3' ' ' ASN . 9.5 tt0 84.19 -60.54 0.11 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.641 -0.662 . . . . 0.0 109.589 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -87.89 -23.84 23.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mt -97.37 -49.47 4.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 40.1 t -59.01 -37.37 76.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -30.09 58.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.21 -15.21 62.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.325 -1.103 . . . . 0.0 109.428 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -89.18 -36.45 15.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 mt -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.036 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 m -49.86 -34.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.105 -0.997 . . . . 0.0 109.633 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -76.22 -44.84 35.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.978 . . . . 0.0 109.408 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.09 10.32 6.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.405 HD11 HD13 ' E' ' 2' ' ' ILE . 1.4 mt -96.06 -57.2 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.085 -1.009 . . . . 0.0 109.831 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 10.9 p90 -69.53 -30.54 68.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.378 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 0.1 OUTLIER -62.57 -53.43 54.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.64 -32.56 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' F' ' 20' ' ' GLY . 1.3 m -114.21 53.72 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 20' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' F' ' 22' ' ' ARG . . . -57.85 -118.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 21' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' F' ' 22' ' ' ARG . 25.4 mt-10 -40.53 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -1.012 . . . . 0.0 109.952 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 22' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' F' ' 20' ' ' GLY . 4.3 mtt180 164.56 -49.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.73 27.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -166.92 174.93 8.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -1.125 . . . . 0.0 109.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -128.41 152.58 48.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -130.89 106.98 8.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -139.25 98.36 8.3 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 28' ' ' PRO . . . . . 0.485 ' HB3' HG21 ' E' ' 3' ' ' VAL . 33.0 Cg_endo -74.97 86.03 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.416 2.077 . . . . 0.0 110.554 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 29' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -154.48 135.6 13.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 30' ' ' THR . . . . . 0.495 ' C ' ' O ' ' F' ' 29' ' ' LYS . 71.5 p . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt -98.23 -25.58 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -1.156 . . . . 0.0 109.125 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 3' ' ' VAL . . . . . 0.588 HG21 ' HB3' ' H' ' 28' ' ' PRO . 61.4 t -76.15 -42.94 37.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.461 -0.775 . . . . 0.0 109.417 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 51.64 2.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.336 -0.853 . . . . 0.0 109.684 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.98 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 109.723 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 9.65 19.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.692 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -103.64 -23.15 13.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.95 . . . . 0.0 109.818 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 74.5 p -66.92 -14.97 63.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -173.18 160.26 4.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 10' ' ' ILE . . . . . 0.556 HD12 ' HB ' ' D' ' 2' ' ' VAL . 1.6 mp -66.34 128.46 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.095 -1.003 . . . . 0.0 109.368 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -94.21 -167.97 1.77 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.37 179.37 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.465 -0.772 . . . . 0.0 109.305 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.44 -41.32 80.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -68.68 -34.65 76.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -36.4 80.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.84 -21.28 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.243 -0.911 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -83.63 -9.02 59.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.634 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.97 -16.49 59.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.135 -0.978 . . . . 0.0 109.237 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.77 90.91 2.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -165.16 131.6 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.9 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.314 0.578 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.632 ' HB ' HD12 ' K' ' 10' ' ' ILE . 54.3 t -92.95 -6.71 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' H' ' 4' ' ' GLN . 9.9 p30 44.92 -173.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.52 -0.738 . . . . 0.0 110.031 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 4' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' H' ' 3' ' ' ASN . 9.0 tt0 83.78 -60.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.754 -0.591 . . . . 0.0 109.677 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -87.95 -23.78 23.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.25 -0.906 . . . . 0.0 109.06 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.3 -50.14 4.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.209 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.0 -40.23 80.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.07 -29.97 66.05 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -12.66 55.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.131 . . . . 0.0 109.492 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -93.58 -34.03 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -0.846 . . . . 0.0 109.665 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 14.0 mt -74.44 -39.25 62.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 0.0 109.707 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 m -48.21 -37.57 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.129 -0.982 . . . . 0.0 109.387 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.24 -46.26 51.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.09 7.81 10.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.384 -0.823 . . . . 0.0 109.634 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -93.36 -55.99 3.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.0 110.096 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' H' ' 17' ' ' LEU . 14.0 p90 -70.45 -31.23 68.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.624 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' H' ' 16' ' ' TYR . 0.1 OUTLIER -60.82 -53.76 53.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.509 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.19 -30.65 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 109.748 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.21 46.66 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 20' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . -66.69 170.27 32.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 21' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' H' ' 20' ' ' GLY . 33.8 mt-10 35.5 71.4 0.12 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.661 -0.905 . . . . 0.0 110.078 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 175.32 -48.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.18 -0.95 . . . . 0.0 109.34 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.47 169.74 27.9 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -168.0 169.29 11.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -122.78 145.39 48.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 109.547 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.91 105.57 9.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -137.48 98.97 9.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.415 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 28' ' ' PRO . . . . . 0.588 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.5 Cg_endo -77.84 86.68 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.538 2.159 . . . . 0.0 110.778 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -135.91 -129.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 109.055 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.578 -1.327 . . . . 0.0 109.519 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 tt -99.02 -26.68 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 3' ' ' VAL . . . . . 0.558 HG21 ' HB3' ' J' ' 28' ' ' PRO . 87.8 t -75.96 -40.59 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.64 53.61 2.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -176.28 -32.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.36 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 12.3 15.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.011 . . . . 0.0 109.86 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.73 -19.56 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -70.09 -13.48 62.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.031 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 9' ' ' SER . . . . . 0.519 ' HA ' ' CG2' ' B' ' 2' ' ' VAL . 52.5 p -174.39 156.89 2.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.478 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.548 HD12 ' HB ' ' B' ' 2' ' ' VAL . 1.8 mp -63.32 128.23 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.248 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -93.23 -165.59 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 3.7 m -110.37 -177.22 3.18 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.248 -0.908 . . . . 0.0 109.042 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -41.21 68.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -68.16 -35.14 77.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -35.79 76.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.9 mt -81.19 -19.7 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.99 -10.78 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.92 -17.61 52.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.288 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.57 89.29 2.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 0.0 109.53 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.54 134.21 6.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.234 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.377 0.608 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.567 ' HB ' HD12 ' E' ' 10' ' ' ILE . 53.1 t -91.65 -7.34 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' J' ' 4' ' ' GLN . 9.1 p30 45.51 -174.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 0.0 110.011 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' J' ' 3' ' ' ASN . 8.9 tt0 83.61 -61.48 0.11 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.705 -0.622 . . . . 0.0 109.823 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 5' ' ' HIS . . . . . 0.478 ' CB ' HG12 ' E' ' 10' ' ' ILE . 36.5 t60 -86.83 -21.23 26.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.162 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.02 -52.33 3.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.103 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.4 t -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.11 -32.33 63.18 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -67.34 -10.55 52.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -1.187 . . . . 0.0 109.543 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -93.7 -34.24 13.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.176 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.91 -41.74 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.455 -0.778 . . . . 0.0 109.711 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 15.3 m -45.88 -38.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.803 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.94 -44.17 61.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.017 -1.052 . . . . 0.0 109.829 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 14' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' D' ' 17' ' ' LEU . . . -84.68 13.92 5.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.37 -54.86 2.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.8 p90 -72.62 -29.54 63.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 0.1 OUTLIER -63.79 -52.14 61.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 109.171 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.97 -32.2 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.406 -0.809 . . . . 0.0 109.221 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' J' ' 20' ' ' GLY . 1.1 m -113.72 54.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.078 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . -57.85 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 21' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' J' ' 22' ' ' ARG . 26.0 mt-10 -40.76 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -1.15 . . . . 0.0 110.024 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' J' ' 20' ' ' GLY . 3.6 mtt180 165.58 -47.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.848 . . . . 0.0 109.338 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.8 169.42 33.85 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -164.44 172.95 12.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -1.163 . . . . 0.0 109.784 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -122.53 151.75 41.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.166 -0.959 . . . . 0.0 109.251 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -133.59 108.17 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -142.41 96.46 6.34 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 28' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' I' ' 3' ' ' VAL . 34.4 Cg_endo -76.69 93.96 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.353 2.035 . . . . 0.0 110.593 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -141.03 -119.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.353 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 120.659 -1.275 . . . . 0.0 109.652 -179.768 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 tt -98.17 -27.6 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.163 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' L' ' 28' ' ' PRO . 94.9 t -74.72 -41.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.443 -0.786 . . . . 0.0 109.682 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 4' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.0 OUTLIER -91.98 56.96 3.02 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.937 -1.102 . . . . 0.0 109.489 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 5' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 1.3 tt0 179.94 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 10.85 15.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 7' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -107.23 -19.81 13.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 0.0 108.948 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -68.97 -14.23 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 109.009 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 78.1 p -175.25 156.06 2.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.815 . . . . 0.0 109.31 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 10' ' ' ILE . . . . . 0.632 HD12 ' HB ' ' H' ' 2' ' ' VAL . 1.4 mp -63.18 129.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -95.02 -170.71 2.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.855 . . . . 0.0 109.455 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.85 177.33 4.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.401 -0.812 . . . . 0.0 109.144 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -42.89 88.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.543 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -65.97 -37.57 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.102 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -35.36 73.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.75 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.769 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.28 -12.11 55.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -18.39 44.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.327 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.55 91.06 2.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.4 137.13 5.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.506 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.42 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.42 0.629 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.673 ' HB ' HD12 ' C' ' 10' ' ' ILE . 55.6 t -89.35 -7.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.443 -0.786 . . . . 0.0 109.929 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 3' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' L' ' 4' ' ' GLN . 10.8 p30 45.22 -173.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 4' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' L' ' 3' ' ' ASN . 9.1 tt0 83.84 -59.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.674 -0.641 . . . . 0.0 109.502 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 5' ' ' HIS . . . . . 0.452 ' HB3' HG12 ' C' ' 10' ' ' ILE . 33.8 t60 -89.14 -20.34 24.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 mt -101.63 -49.33 4.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -0.793 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -59.03 -32.92 70.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 108.826 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.03 -34.05 34.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -11.14 31.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -1.119 . . . . 0.0 109.272 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -93.76 -32.18 14.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.01 -39.33 50.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.476 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -47.82 -36.03 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.561 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.94 -44.51 48.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 109.293 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.93 15.03 4.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.334 -0.854 . . . . 0.0 109.687 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.42 -53.74 3.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.041 -1.037 . . . . 0.0 109.533 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.555 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 9.4 p90 -73.98 -27.1 60.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 0.1 OUTLIER -66.14 -50.1 65.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.267 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -70.04 -29.04 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.1 49.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.575 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 20' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . -70.45 167.91 49.34 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 21' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' L' ' 20' ' ' GLY . 31.1 mt-10 39.09 71.39 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.505 -0.997 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 173.21 -43.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.826 . . . . 0.0 108.93 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.48 174.23 35.48 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.12 172.33 7.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -1.138 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 17.8 p90 -125.0 145.31 49.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -127.84 109.15 11.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -0.928 . . . . 0.0 109.358 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 9.8 m -142.55 98.22 5.93 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 0.0 109.201 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 28' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.4 Cg_endo -78.66 93.9 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.369 2.046 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -139.77 -115.18 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 109.523 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 109.544 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 2' ' ' ILE . 49.7 mt -99.42 25.29 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -1.16 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 60.0 t -114.56 -47.43 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -95.47 47.45 1.12 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -168.23 -35.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.336 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 9' ' ' SER . 99.1 m -108.11 -32.31 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.655 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -69.4 -19.18 63.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 0.0 109.697 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -105.75 -7.31 18.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 5.1 p -168.08 132.35 1.7 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.426 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -52.49 138.4 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.7 m -104.39 149.6 25.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.24 158.17 29.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -29.51 58.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.782 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -64.97 -43.47 92.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.477 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -73.87 -23.55 59.62 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.42 0.4 53.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.238 -0.914 . . . . 0.0 109.967 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -90.86 -26.08 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.735 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -83.01 -7.67 59.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.932 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -90.85 15.61 10.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.65 160.16 15.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.484 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 11.2 p90 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.414 ' H ' HG12 ' B' ' 2' ' ' VAL . 2.5 p -60.96 123.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.27 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.55 -36.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.163 -0.96 . . . . 0.0 108.935 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -80.34 -42.32 23.16 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.369 -0.832 . . . . 0.0 109.276 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -58.89 -23.55 61.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -101.5 -24.45 14.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 51.1 t -75.26 -17.24 60.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.75 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -91.41 -21.87 33.53 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -81.01 -18.76 45.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -1.14 . . . . 0.0 109.302 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.445 ' ND1' HD22 ' F' ' 6' ' ' LEU . 20.1 m-70 -85.56 -18.86 32.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.624 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 9.9 mt -93.69 -34.71 13.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.75 HG13 ' O ' ' B' ' 8' ' ' GLY . 34.0 m -60.58 -36.02 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 110.037 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.401 ' N ' HG23 ' B' ' 12' ' ' VAL . 0.8 OUTLIER -73.63 -27.91 61.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.931 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.33 17.56 17.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.163 -0.96 . . . . 0.0 109.864 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 2' ' ' ILE . 1.7 mt -114.98 -56.52 2.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.836 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -64.26 -23.65 67.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.478 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 19.7 tp -74.5 -40.25 61.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.2 -0.937 . . . . 0.0 109.306 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 71.4 t -54.69 -72.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.907 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.61 -42.6 88.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.08 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.34 -97.68 0.78 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.72 -56.54 20.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -1.143 . . . . 0.0 109.514 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -53.28 154.83 3.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.72 -167.69 27.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -170.01 169.18 8.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -1.13 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.648 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 42.1 p90 -127.78 148.66 50.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.474 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' B' ' 28' ' ' PRO . 30.5 t80 -128.29 113.57 15.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.81 92.11 13.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.482 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' B' ' 26' ' ' TYR . 36.1 Cg_endo -78.96 81.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.909 2.406 . . . . 0.0 110.515 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -133.14 112.25 11.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.089 -1.007 . . . . 0.0 109.946 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.242 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 1' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' C' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 2' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' C' ' 1' ' ' GLY . 20.4 mt 71.21 -1.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -1.231 . . . . 0.0 110.196 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 3' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 61.7 t -106.24 -49.03 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.971 -1.08 . . . . 0.0 108.917 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 44.84 1.03 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.431 -0.793 . . . . 0.0 109.239 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -165.57 -35.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 6' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' C' ' 9' ' ' SER . 93.1 m -108.27 -30.31 8.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 7' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.3 OUTLIER -71.47 -19.09 62.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 109.388 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 -6.55 19.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.726 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 6' ' ' CYS . 2.6 p -169.16 130.36 1.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.087 -1.008 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -50.44 138.08 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.647 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -104.37 149.02 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.054 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.67 159.04 29.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.14 -30.75 60.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.2 -42.2 96.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.979 . . . . 0.0 109.702 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -74.69 -23.4 58.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 72.1 mt -96.37 4.67 52.07 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -95.24 -25.85 16.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.269 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -82.78 -9.03 59.53 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -91.58 19.23 6.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.641 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.27 158.46 17.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 109.342 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.1 p90 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.413 ' H ' HG12 ' D' ' 2' ' ' VAL . 2.5 p -59.68 122.7 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.782 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' D' ' 7' ' ' CYS . 0.5 OUTLIER 175.22 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.21 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -82.1 -39.44 23.35 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.244 -0.91 . . . . 0.0 109.131 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -62.17 -22.02 65.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.0 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -102.41 -24.39 13.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.808 . . . . 0.0 109.06 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 42.2 t -74.21 -23.22 59.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.683 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -87.29 -20.26 52.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 57.6 p -81.45 -15.24 55.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.254 . . . . 0.0 109.434 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.68 -21.16 22.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.807 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 9.2 mt -90.83 -33.25 15.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.151 -0.968 . . . . 0.0 109.754 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.683 HG13 ' O ' ' D' ' 8' ' ' GLY . 35.5 m -61.85 -35.6 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.38 -26.94 60.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.021 . . . . 0.0 109.812 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.65 19.57 14.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.133 -0.979 . . . . 0.0 109.699 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' C' ' 2' ' ' ILE . 1.6 mt -117.43 -54.75 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.55 -22.8 66.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.97 . . . . 0.0 109.595 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.678 HD21 ' CB ' ' J' ' 14' ' ' ALA . 22.9 tp -77.62 -33.83 53.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.845 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 66.9 t -60.6 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 109.885 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -63.35 -42.75 98.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.59 -96.93 0.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.75 -54.73 41.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -1.121 . . . . 0.0 109.61 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -56.2 156.5 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.894 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.34 -167.54 26.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -168.13 158.14 10.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -1.113 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' PHE . . . . . 0.648 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 19.2 m-85 -113.22 142.99 45.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 109.528 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -125.31 117.0 22.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -0.995 . . . . 0.0 109.465 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.2 92.56 6.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.748 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -79.16 81.61 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.717 2.278 . . . . 0.0 110.39 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -133.68 112.25 11.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.713 HG22 ' O ' ' E' ' 2' ' ' ILE . 53.2 mt -99.83 22.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -1.115 . . . . 0.0 109.389 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 3' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 49.0 t -113.12 -47.42 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.22 -0.925 . . . . 0.0 109.735 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.71 47.88 1.12 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.136 -0.977 . . . . 0.0 109.478 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -169.99 -32.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 6' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' E' ' 9' ' ' SER . 99.9 m -111.59 -30.48 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.39 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 7' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -72.46 -17.08 61.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.955 . . . . 0.0 109.321 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -107.3 -7.56 16.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 9' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' E' ' 6' ' ' CYS . 3.5 p -168.18 134.07 1.91 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.339 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -53.73 137.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.131 -0.98 . . . . 0.0 109.736 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 88.0 m -103.3 151.23 22.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.198 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.58 158.25 28.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.01 -29.91 61.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.221 -0.925 . . . . 0.0 109.106 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.62 -45.88 85.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.42 -23.05 61.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -0.872 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.35 -0.62 49.19 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -0.939 . . . . 0.0 110.05 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -89.31 -24.8 21.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.705 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.67 -7.04 59.38 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.109 -0.995 . . . . 0.0 109.889 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.11 20.14 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.138 -0.976 . . . . 0.0 109.17 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.8 158.28 18.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.372 -0.83 . . . . 0.0 109.335 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.595 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.6 p90 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.04 124.45 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 174.32 -35.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -80.15 -43.35 21.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.363 -0.836 . . . . 0.0 108.915 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -58.09 -23.03 53.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.664 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 6' ' ' LEU . . . . . 0.445 HD22 ' ND1' ' B' ' 10' ' ' HIS . 10.4 mt -101.46 -27.27 13.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 108.997 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.485 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 46.8 t -72.65 -20.22 61.29 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.597 -0.689 . . . . 0.0 109.511 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.678 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -88.83 -22.55 38.76 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 27.6 p -80.66 -17.04 52.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -1.123 . . . . 0.0 109.42 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 10' ' ' HIS . . . . . 0.716 ' ND1' HD22 ' J' ' 6' ' ' LEU . 14.5 m-70 -87.54 -18.18 30.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 9.8 mt -94.58 -32.67 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.678 HG13 ' O ' ' F' ' 8' ' ' GLY . 36.0 m -62.83 -35.04 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.856 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -26.59 59.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.53 18.38 16.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.549 HD11 HD13 ' E' ' 2' ' ' ILE . 1.7 mt -116.15 -55.89 2.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.065 -1.022 . . . . 0.0 109.617 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -64.27 -23.12 67.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.694 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 26.9 tp -77.86 -33.85 52.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.49 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 109.78 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.21 -44.09 97.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.15 -0.969 . . . . 0.0 109.7 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.93 -96.82 0.88 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.56 -55.71 30.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -1.114 . . . . 0.0 109.575 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -55.12 156.55 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 0.0 109.592 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -166.85 28.57 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.62 161.84 6.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -1.093 . . . . 0.0 108.981 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -122.29 151.18 41.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.026 -1.046 . . . . 0.0 109.589 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 26' ' ' TYR . . . . . 0.422 ' CE2' ' HG3' ' F' ' 28' ' ' PRO . 33.8 t80 -129.66 118.17 21.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.512 HG23 ' HA3' ' H' ' 23' ' ' GLY . 0.3 OUTLIER -142.33 91.27 7.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 109.352 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 28' ' ' PRO . . . . . 0.422 ' HG3' ' CE2' ' F' ' 26' ' ' TYR . 35.6 Cg_endo -78.52 82.19 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.646 2.231 . . . . 0.0 110.359 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.67 110.81 10.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 109.534 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' G' G ' 2' ' ' ILE . . . . . 0.698 HG22 ' O ' ' G' ' 2' ' ' ILE . 46.3 mt -99.13 23.34 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 3' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' G' ' 7' ' ' CYS . 58.0 t -112.45 -48.76 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.87 46.12 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -167.37 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 6' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' G' ' 9' ' ' SER . 85.6 m -110.07 -27.79 9.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 7' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' G' ' 3' ' ' VAL . 22.7 t -72.04 -22.48 61.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 15.0 t -103.27 -6.16 22.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.455 -0.778 . . . . 0.0 109.695 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 9' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' G' ' 6' ' ' CYS . 2.2 p -169.32 132.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -52.22 137.4 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.365 -0.834 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 83.5 m -104.01 150.35 24.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.257 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.39 159.9 30.06 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -31.82 66.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.075 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -61.6 -46.57 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.418 -0.801 . . . . 0.0 109.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -72.33 -20.98 61.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 76.0 mt -96.85 -2.62 43.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.103 -0.998 . . . . 0.0 109.792 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -89.02 -24.74 22.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -82.91 -8.26 59.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 0.0 109.837 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -90.91 12.97 17.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.456 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.01 163.0 12.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.611 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.568 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.423 ' O ' HG13 ' H' ' 2' ' ' VAL . 2.6 p -59.08 121.18 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.22 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.93 -43.67 29.21 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.181 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -57.14 -23.72 49.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.553 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 6' ' ' LEU . . . . . 0.553 HD22 ' ND1' ' L' ' 10' ' ' HIS . 10.8 mt -100.86 -26.08 13.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 109.223 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.457 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 15.4 t -73.74 -20.22 60.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.469 -0.769 . . . . 0.0 109.706 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 8' ' ' GLY . . . . . 0.709 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -88.77 -20.2 48.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 87.9 p -82.04 -16.3 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -1.059 . . . . 0.0 109.508 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -89.6 -16.21 31.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 8.0 mt -96.61 -33.42 11.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.473 -0.767 . . . . 0.0 109.547 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.709 HG13 ' O ' ' H' ' 8' ' ' GLY . 35.2 m -62.96 -29.98 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -25.87 43.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.454 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.7 22.46 11.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 15' ' ' LEU . . . . . 0.61 HD11 HD13 ' G' ' 2' ' ' ILE . 1.9 mt -120.15 -54.19 2.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.523 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.58 -24.2 66.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.612 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 20.7 tp -77.22 -36.5 54.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.195 -0.94 . . . . 0.0 109.583 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.32 -67.41 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.932 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 19' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' H' ' 22' ' ' ARG . 43.7 m -66.97 -39.99 87.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.985 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.26 -103.37 1.07 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -50.9 -63.55 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -1.221 . . . . 0.0 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 22' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' H' ' 19' ' ' CYS . 6.9 mtt-85 -49.08 154.35 0.79 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.361 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.512 ' HA3' HG23 ' F' ' 27' ' ' THR . . . -101.42 -170.57 28.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.57 170.45 15.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 109.525 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -128.34 150.4 50.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 26' ' ' TYR . . . . . 0.418 ' CE2' ' HG3' ' H' ' 28' ' ' PRO . 31.8 t80 -131.99 118.55 19.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.55 89.86 7.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.583 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 28' ' ' PRO . . . . . 0.418 ' HG3' ' CE2' ' H' ' 26' ' ' TYR . 34.4 Cg_endo -76.47 82.64 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.72 2.28 . . . . 0.0 110.487 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.18 111.78 9.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.368 -0.833 . . . . 0.0 109.194 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.553 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.694 HG22 ' O ' ' I' ' 2' ' ' ILE . 49.6 mt -98.02 24.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -1.194 . . . . 0.0 109.314 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 3' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 57.3 t -113.46 -47.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.972 . . . . 0.0 109.57 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.01 50.49 1.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.229 -0.919 . . . . 0.0 109.33 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -172.32 -34.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.475 -0.765 . . . . 0.0 109.252 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 51.3 m -109.06 -32.61 7.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.867 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 7' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' I' ' 3' ' ' VAL . 0.5 OUTLIER -71.17 -19.49 62.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.047 . . . . 0.0 109.482 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -103.77 -6.82 21.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 p -169.51 135.66 1.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.194 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.84 145.29 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.346 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 11' ' ' CYS . . . . . 0.45 ' SG ' HD11 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -112.46 150.06 31.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.012 -1.055 . . . . 0.0 109.545 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.57 155.58 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.77 -30.15 31.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.739 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -63.88 -45.6 88.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -72.03 -23.97 61.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 16' ' ' LEU . . . . . 0.45 HD11 ' SG ' ' I' ' 11' ' ' CYS . 75.8 mt -94.88 -0.81 53.69 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -91.13 -23.66 20.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.998 . . . . 0.0 109.81 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -83.84 -9.03 59.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 109.676 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.54 15.6 10.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.12 156.59 17.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 109.67 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.215 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 9.6 p90 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.41 121.05 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.72 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.382 -0.824 . . . . 0.0 108.868 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -79.26 -40.72 29.84 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.432 -0.793 . . . . 0.0 109.5 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -61.8 -21.65 64.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 109.381 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 6' ' ' LEU . . . . . 0.716 HD22 ' ND1' ' F' ' 10' ' ' HIS . 8.8 mt -103.14 -22.25 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.319 -0.863 . . . . 0.0 108.928 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 46.1 t -77.64 -14.91 59.51 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.405 -0.809 . . . . 0.0 109.099 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.699 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -94.26 -19.2 33.78 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 38.4 p -83.41 -18.04 40.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.203 . . . . 0.0 109.179 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -86.02 -20.93 28.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.377 -0.827 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 9.8 mt -92.07 -33.55 14.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.954 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.699 HG13 ' O ' ' J' ' 8' ' ' GLY . 32.5 m -62.2 -36.23 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.739 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.419 ' N ' HG23 ' J' ' 12' ' ' VAL . 1.0 OUTLIER -72.76 -27.11 61.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.957 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 14' ' ' ALA . . . . . 0.678 ' CB ' HD21 ' D' ' 17' ' ' LEU . . . -99.09 18.35 17.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 109.74 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 15' ' ' LEU . . . . . 0.595 HD11 HD13 ' I' ' 2' ' ' ILE . 1.4 mt -116.04 -54.15 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.984 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.19 -23.96 66.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.7 -35.19 58.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.664 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.53 -68.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.688 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.08 -44.15 97.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.647 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.92 -94.94 0.8 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.02 -57.83 10.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 109.519 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -53.23 158.68 1.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.255 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.81 -172.42 25.54 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -163.33 158.24 21.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.246 . . . . 0.0 109.714 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 25' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' L' ' 25' ' ' PHE . 42.5 p90 -116.15 147.04 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.535 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -131.08 113.07 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.618 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 27' ' ' THR . . . . . 0.718 HG23 ' HA3' ' L' ' 23' ' ' GLY . 0.3 OUTLIER -138.0 92.35 12.61 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.585 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.74 81.88 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.6 2.2 . . . . 0.0 110.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.3 110.12 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.451 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' K' K ' 2' ' ' ILE . . . . . 0.715 ' O ' HG22 ' K' ' 2' ' ' ILE . 43.7 mt -97.84 26.67 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -1.195 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 54.5 t -115.18 -49.61 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 109.429 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.02 48.1 1.24 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -169.1 -35.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.684 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 6' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' K' ' 9' ' ' SER . 77.5 m -110.0 -27.34 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.99 . . . . 0.0 109.327 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 7' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 33.6 t -73.82 -19.04 60.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -106.83 -6.04 17.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 9' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 2.1 p -167.67 135.43 2.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 109.181 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -55.89 139.81 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 109.362 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 99.7 m -105.17 147.23 28.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.723 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.17 156.9 36.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.875 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -32.69 60.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 109.501 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -61.36 -44.96 96.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -72.65 -22.22 60.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.816 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.98 2.02 51.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.241 -0.912 . . . . 0.0 109.739 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -93.31 -24.73 18.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.396 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -83.14 -9.49 59.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -90.15 15.81 9.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.5 161.99 13.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.446 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.632 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 10.0 p90 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.13 124.4 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.366 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.93 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -80.75 -40.87 24.44 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -61.31 -20.65 63.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.356 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.06 -25.03 13.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.483 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 35.2 t -74.96 -19.72 59.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.566 -0.709 . . . . 0.0 109.381 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.683 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -89.59 -20.97 42.11 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p -80.6 -18.48 48.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 10' ' ' HIS . . . . . 0.553 ' ND1' HD22 ' H' ' 6' ' ' LEU . 21.5 m-70 -87.32 -18.65 29.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.582 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.7 mt -94.0 -30.11 14.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.821 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.683 HG13 ' O ' ' L' ' 8' ' ' GLY . 35.3 m -66.61 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -74.34 -25.67 59.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.02 19.69 16.95 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.122 -0.986 . . . . 0.0 109.698 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 15' ' ' LEU . . . . . 0.584 HD11 HD13 ' K' ' 2' ' ' ILE . 1.4 mt -117.21 -54.16 2.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -65.93 -23.68 66.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -78.82 -30.37 45.28 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.262 -0.898 . . . . 0.0 109.885 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.52 -68.67 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.23 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.2 -44.47 96.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -96.79 0.94 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.73 -59.38 5.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.272 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -51.36 157.89 0.93 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.327 -0.858 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' J' ' 27' ' ' THR . . . -103.14 -166.99 25.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -171.79 155.78 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -1.107 . . . . 0.0 109.3 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 25' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' L' ' 25' ' ' PHE . 18.1 p90 -113.88 152.47 30.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.0 109.302 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -132.51 116.64 17.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 109.247 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.57 91.54 7.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.261 -0.9 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.67 80.23 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.542 2.161 . . . . 0.0 110.202 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.26 111.7 11.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' A' ' 2' ' ' ILE . 4.5 tt -118.61 18.52 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -1.166 . . . . 0.0 109.263 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 t -121.45 -7.0 9.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.35 -0.844 . . . . 0.0 109.189 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.88 -9.78 19.6 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.356 -0.84 . . . . 0.0 109.612 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -130.96 12.82 5.23 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.307 -0.87 . . . . 0.0 109.644 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -47.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.364 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.93 -15.64 59.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.3 p -97.74 -34.23 10.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 109.494 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 0.0 109.384 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.3 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.935 . . . . 0.0 109.266 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.3 m -95.81 172.51 7.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.85 167.31 10.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.22 91.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.334 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -64.67 -33.67 76.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.84 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -50.62 70.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.24 -20.13 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.12 -21.62 61.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -64.73 -25.04 67.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.457 ' CD2' HD12 ' A' ' 2' ' ' ILE . 40.4 m-85 -100.53 -25.63 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.53 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.85 119.18 8.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.599 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.535 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' I' ' 8' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.489 ' O ' ' ND2' ' B' ' 3' ' ' ASN . 4.7 p -59.36 142.08 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.635 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' B' ' 2' ' ' VAL . 0.6 OUTLIER 168.94 -39.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -76.19 -36.75 58.52 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.409 ' HB2' HD11 ' I' ' 10' ' ' ILE . 85.3 t60 -62.1 -37.79 86.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.185 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' J' ' 10' ' ' HIS . 9.5 mt -84.55 -23.53 29.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 108.973 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.423 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 38.7 t -69.31 -36.23 76.79 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.93 -21.48 65.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 61.3 p -77.03 -17.13 59.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.486 -1.008 . . . . 0.0 109.494 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -88.07 -24.51 23.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 10.9 mt -81.14 -39.24 25.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 m -49.99 -40.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -70.07 -40.97 74.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.005 . . . . 0.0 109.24 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.64 27.36 1.77 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.75 -48.29 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.312 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.599 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 11.6 p90 -74.38 -17.59 60.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.925 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.599 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 8.3 mt -78.81 -19.47 52.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.408 -0.808 . . . . 0.0 109.483 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.3 -50.64 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.87 -69.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.372 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.29 -106.29 3.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -62.42 -36.36 82.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -1.134 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -68.5 171.56 7.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.012 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -115.05 178.51 17.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.89 159.55 44.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -1.183 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.581 ' CD1' ' O ' ' B' ' 25' ' ' PHE . 21.5 p90 -113.45 139.42 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -123.13 114.35 20.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.36 87.67 54.6 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.28 79.01 3.42 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.588 2.192 . . . . 0.0 110.509 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -132.04 161.42 33.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.202 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.645 -179.811 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 2' ' ' ILE . . . . . 0.479 HD12 ' CD2' ' C' ' 19' ' ' TYR . 5.1 tt -116.61 13.84 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -116.61 -5.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.9 -4.49 22.1 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.276 -0.89 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.98 5.04 3.85 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.061 -1.025 . . . . 0.0 110.222 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.06 -42.29 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.043 . . . . 0.0 109.192 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.03 -16.01 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.535 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 71.4 p -96.59 -37.64 10.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.333 -0.854 . . . . 0.0 109.291 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 7.9 m -138.86 144.2 39.1 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' L' ' 5' ' ' HIS . 2.6 mp -53.48 138.25 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 m -102.36 159.76 15.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 109.622 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 170.98 11.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.845 . . . . 0.0 110.329 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -48.93 71.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 109.253 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -61.49 -33.43 73.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 109.241 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -47.75 81.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.725 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mt -71.97 -19.88 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.224 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.47 -22.75 61.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -63.68 -24.66 67.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.534 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.479 ' CD2' HD12 ' C' ' 2' ' ' ILE . 27.5 m-85 -100.92 -27.24 13.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.519 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -58.5 119.6 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.105 -0.997 . . . . 0.0 109.475 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.6 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.539 ' O ' ' ND2' ' D' ' 3' ' ' ASN . 7.6 p -61.52 144.41 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' D' ' 2' ' ' VAL . 0.7 OUTLIER 165.45 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.019 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.07 -34.77 43.34 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -64.18 -37.69 88.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.384 -0.822 . . . . 0.0 108.928 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -82.39 -30.79 30.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 108.938 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.2 t -63.51 -35.48 80.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.47 -0.769 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.37 -22.34 65.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 9' ' ' SER . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 16' ' ' TYR . 90.7 p -79.43 -17.79 53.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.221 -1.164 . . . . 0.0 109.149 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -83.37 -27.93 29.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 109.342 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 11.1 mt -78.76 -45.05 21.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.464 HG23 ' N ' ' D' ' 13' ' ' GLU . 12.8 m -43.02 -45.3 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.464 ' N ' HG23 ' D' ' 12' ' ' VAL . 11.8 mt-10 -66.08 -40.53 90.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.29 23.98 2.71 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 109.795 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.33 -48.34 2.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 9.5 p90 -73.72 -18.66 60.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.237 -0.914 . . . . 0.0 109.311 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 8.6 mt -77.51 -20.35 54.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.817 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.62 -50.21 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 45.1 m -74.77 -68.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.93 -109.72 3.87 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.59 -37.94 76.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.124 . . . . 0.0 109.316 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -68.42 161.09 28.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.812 . . . . 0.0 109.545 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.52 -175.06 25.01 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -158.19 157.66 33.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -1.219 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -111.78 142.62 43.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.331 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.49 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 39.3 t80 -127.76 115.92 19.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 89.99 47.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 28' ' ' PRO . . . . . 0.413 ' HD2' ' CA ' ' B' ' 23' ' ' GLY . 35.8 Cg_endo -78.63 74.42 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.733 2.289 . . . . 0.0 110.503 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -127.02 159.55 33.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.486 179.894 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.475 HD12 ' CD2' ' E' ' 19' ' ' TYR . 6.4 tt -118.0 16.32 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.272 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 t -118.47 -10.13 11.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.514 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -100.06 -10.2 21.8 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.343 -0.848 . . . . 0.0 109.851 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.03 15.28 6.28 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.35 -50.52 0.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -13.91 25.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.696 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 65.2 p -98.74 -34.26 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.042 -1.036 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.3 m -142.72 145.05 32.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.05 139.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -0.983 . . . . 0.0 109.752 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -97.67 171.42 8.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.775 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.23 167.03 10.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 109.367 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -47.72 85.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.265 -0.897 . . . . 0.0 109.141 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -63.76 -34.18 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 0.0 109.606 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -49.53 76.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.77 -18.65 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 0.0 109.682 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.71 -24.24 60.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -61.53 -25.41 67.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.873 . . . . 0.0 109.786 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.475 ' CD2' HD12 ' E' ' 2' ' ' ILE . 24.0 m-85 -100.59 -27.05 13.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.589 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.27 118.53 5.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.584 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.458 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.231 0.539 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.507 ' O ' ' ND2' ' F' ' 3' ' ' ASN . 7.6 p -63.91 145.12 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 3' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' F' ' 2' ' ' VAL . 0.8 OUTLIER 165.21 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.861 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.54 -37.54 42.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.311 -0.868 . . . . 0.0 109.102 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.47 -36.42 82.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 mt -84.51 -28.68 26.56 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 44.0 t -66.0 -33.27 75.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.676 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.34 -20.21 62.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 9' ' ' SER . . . . . 0.435 ' O ' ' CG2' ' F' ' 12' ' ' VAL . 5.6 p -80.08 -18.02 51.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.047 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -84.13 -26.71 28.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.106 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -78.6 -45.8 20.82 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.342 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.473 HG23 ' N ' ' F' ' 13' ' ' GLU . 13.0 m -42.95 -44.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.398 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 13' ' ' GLU . . . . . 0.473 ' N ' HG23 ' F' ' 12' ' ' VAL . 14.5 mt-10 -65.9 -41.31 91.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 0.0 109.941 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.81 25.74 2.28 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 0.0 109.888 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.53 -48.23 2.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.4 p90 -74.0 -17.62 60.97 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 8.4 mt -79.8 -19.53 48.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.874 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.78 -51.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.055 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.1 -69.3 0.43 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.43 -109.17 3.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -58.77 -41.6 86.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.326 -1.102 . . . . 0.0 109.342 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -63.71 163.37 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 0.0 109.733 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.11 -175.86 23.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -161.66 163.51 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 25' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.5 p90 -119.85 156.02 31.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 26' ' ' TYR . . . . . 0.431 ' O ' ' HD3' ' F' ' 28' ' ' PRO . 31.4 t80 -134.48 105.23 6.45 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.63 87.65 21.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 28' ' ' PRO . . . . . 0.501 ' HD2' ' CA ' ' H' ' 23' ' ' GLY . 35.1 Cg_endo -78.47 73.77 5.71 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.771 2.314 . . . . 0.0 110.713 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -125.88 165.14 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.519 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' G' G ' 2' ' ' ILE . . . . . 0.494 HD12 ' CD2' ' G' ' 19' ' ' TYR . 5.3 tt -113.16 13.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -1.135 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -115.53 -7.51 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 109.723 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -102.49 -11.31 18.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.59 16.76 6.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.108 -0.995 . . . . 0.0 109.479 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.54 -50.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.436 -0.79 . . . . 0.0 109.255 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.3 -15.66 37.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.428 -0.795 . . . . 0.0 109.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 71.2 p -97.39 -39.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 m -136.29 139.77 42.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -50.62 137.8 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 97.1 m -94.97 172.09 8.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.514 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 12' ' ' SER . . . . . 0.4 ' O ' HD12 ' G' ' 16' ' ' LEU . 0.3 OUTLIER -101.26 170.73 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 108.932 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -45.96 85.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.165 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.41 -33.28 75.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -49.6 74.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 16' ' ' LEU . . . . . 0.4 HD12 ' O ' ' G' ' 12' ' ' SER . 2.1 mt -70.47 -19.79 62.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.553 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.85 -22.44 61.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -63.53 -29.48 70.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.033 -1.042 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 19' ' ' TYR . . . . . 0.494 ' CD2' HD12 ' G' ' 2' ' ' ILE . 29.4 m-85 -94.53 -31.87 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.975 . . . . 0.0 109.506 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 121.9 9.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.566 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.498 ' O ' ' ND2' ' H' ' 3' ' ' ASN . 7.3 p -62.63 144.09 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' H' ' 2' ' ' VAL . 0.9 OUTLIER 166.09 -42.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.192 -0.942 . . . . 0.0 108.964 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.49 -36.61 60.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.228 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.86 -37.48 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -83.3 -28.08 29.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.092 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 16.8 t -66.55 -33.5 75.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.681 . . . . 0.0 109.233 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.65 56.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 3.5 p -75.45 -18.0 60.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -1.081 . . . . 0.0 109.571 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -84.52 -24.76 29.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.823 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 11.0 mt -82.54 -42.33 18.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.426 HG23 ' N ' ' H' ' 13' ' ' GLU . 12.0 m -45.68 -43.02 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.333 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 13' ' ' GLU . . . . . 0.426 ' N ' HG23 ' H' ' 12' ' ' VAL . 12.7 mt-10 -66.66 -42.91 85.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.4 26.39 1.46 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.887 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.42 -47.25 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.045 . . . . 0.0 109.37 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.587 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 8.9 p90 -74.92 -16.68 60.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 7.9 mt -80.33 -19.92 45.42 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.489 -0.757 . . . . 0.0 109.397 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.1 t -79.41 -52.29 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.265 -0.897 . . . . 0.0 109.428 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.36 -65.7 0.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.2 -105.66 3.26 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.71 -39.73 92.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -1.204 . . . . 0.0 109.405 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.94 165.9 12.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.501 ' CA ' ' HD2' ' F' ' 28' ' ' PRO . . . -109.97 -176.75 21.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -159.05 153.51 24.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.409 -1.054 . . . . 0.0 109.347 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' H' ' 25' ' ' PHE . 37.5 p90 -110.79 141.33 44.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.263 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.99 118.88 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.93 . . . . 0.0 109.447 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.5 87.69 49.42 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.611 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.94 77.79 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.644 2.23 . . . . 0.0 110.678 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -129.13 160.44 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.545 179.915 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.467 HD12 ' CD2' ' I' ' 19' ' ' TYR . 4.2 tt -122.14 15.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -1.207 . . . . 0.0 109.38 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 t -118.73 -3.13 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.299 -0.875 . . . . 0.0 109.311 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.71 -6.14 17.0 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.92 2.04 4.35 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 109.79 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 50.9 m -127.15 -39.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -69.46 -13.62 62.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.99 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 8' ' ' THR . . . . . 0.508 ' O ' ' HB3' ' B' ' 1' ' ' PHE . 67.3 p -102.19 -20.72 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.605 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -153.64 138.09 16.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 109.358 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 5' ' ' HIS . 2.3 mp -50.18 138.08 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 109.014 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.0 m -102.26 161.1 13.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 12' ' ' SER . . . . . 0.422 ' O ' HD12 ' I' ' 16' ' ' LEU . 0.3 OUTLIER -89.55 170.92 10.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.341 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -49.41 72.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.542 -0.724 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -60.42 -35.07 74.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.18 -48.69 78.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.577 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 16' ' ' LEU . . . . . 0.422 HD12 ' O ' ' I' ' 12' ' ' SER . 2.1 mt -72.39 -15.36 61.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.266 -0.896 . . . . 0.0 109.736 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -61.59 -29.91 70.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 19' ' ' TYR . . . . . 0.467 ' CD2' HD12 ' I' ' 2' ' ' ILE . 28.3 m-85 -96.21 -30.3 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.705 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.16 118.86 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.495 179.902 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.262 0.554 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.517 ' O ' ' ND2' ' J' ' 3' ' ' ASN . 7.3 p -64.21 145.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 3' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' J' ' 2' ' ' VAL . 0.7 OUTLIER 165.3 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -77.99 -38.1 45.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.217 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.32 -35.29 78.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -0.853 . . . . 0.0 108.916 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -85.33 -27.46 25.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 12.9 t -67.23 -33.95 76.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.793 . . . . 0.0 109.42 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.91 -22.67 60.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 93.3 p -77.28 -16.99 58.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -1.026 . . . . 0.0 109.322 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 10' ' ' HIS . . . . . 0.489 ' CG ' HD22 ' B' ' 6' ' ' LEU . 10.3 m-70 -88.02 -21.65 24.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.892 . . . . 0.0 109.665 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.8 mt -84.02 -38.97 20.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.409 HG23 ' N ' ' J' ' 13' ' ' GLU . 11.8 m -49.67 -40.61 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.409 ' N ' HG23 ' J' ' 12' ' ' VAL . 11.8 mt-10 -69.44 -40.52 77.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.2 27.81 1.8 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.381 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.56 -46.41 2.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.594 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 12.6 p90 -76.22 -16.22 59.87 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.056 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 7.9 mt -80.83 -17.37 51.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.499 -0.75 . . . . 0.0 109.792 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -82.69 -49.42 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -63.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 109.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.74 -105.95 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -61.05 -39.12 88.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -66.63 157.51 32.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.936 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -175.87 29.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -161.1 157.9 26.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.058 -1.26 . . . . 0.0 109.726 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -115.97 142.68 46.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.76 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -122.67 119.25 30.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.406 -0.809 . . . . 0.0 109.121 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 87.38 53.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.72 77.84 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.628 2.218 . . . . 0.0 110.679 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -128.93 160.54 32.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.342 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' K' K ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' K' ' 2' ' ' ILE . 6.2 tt -117.66 17.22 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.316 -1.108 . . . . 0.0 109.718 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 t -119.94 -8.42 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.63 -10.37 21.0 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.279 -0.888 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.94 16.44 5.18 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.56 -47.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.314 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -16.09 56.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.196 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 66.9 p -96.04 -41.33 8.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.823 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 75.3 m -134.35 144.41 48.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.142 -0.974 . . . . 0.0 109.721 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.43 137.22 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.29 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.83 169.38 10.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 109.887 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.03 167.49 10.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.38 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -46.44 90.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.387 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.61 -35.0 79.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -49.06 78.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 109.598 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.23 -18.34 62.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.931 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.45 -23.12 60.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 109.188 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.576 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 19' ' ' TYR . . . . . 0.431 ' CD2' HD12 ' K' ' 2' ' ' ILE . 24.1 m-85 -99.33 -27.82 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.08 120.94 8.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.486 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' L' L ' 1' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' C' ' 8' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.264 0.554 . . . . 0.0 109.587 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.467 ' O ' ' ND2' ' L' ' 3' ' ' ASN . 7.3 p -63.14 143.86 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.013 -1.055 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 3' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' L' ' 2' ' ' VAL . 0.7 OUTLIER 167.27 -39.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.017 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -77.07 -39.89 48.16 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.374 -0.829 . . . . 0.0 108.81 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 5' ' ' HIS . . . . . 0.666 ' HB2' HD11 ' C' ' 10' ' ' ILE . 86.3 t60 -60.67 -36.61 79.16 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mt -84.01 -29.34 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.448 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 40.7 t -66.12 -32.68 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.578 -0.701 . . . . 0.0 109.595 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.44 -26.7 53.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 9' ' ' SER . . . . . 0.41 ' O ' HG22 ' L' ' 12' ' ' VAL . 59.9 p -74.01 -19.74 60.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.48 -1.012 . . . . 0.0 109.329 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -83.78 -23.28 31.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 0.0 109.564 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 10.5 mt -82.55 -42.65 18.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 109.566 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.41 HG22 ' O ' ' L' ' 9' ' ' SER . 13.9 m -46.49 -40.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -70.36 -40.21 74.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.89 21.46 3.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 109.666 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -49.28 2.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.561 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 11.5 p90 -73.05 -17.3 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.962 . . . . 0.0 109.695 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 8.4 mt -79.01 -19.51 51.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.684 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.49 -50.79 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 57.1 m -73.83 -68.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.35 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.82 -108.38 3.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.93 -38.22 85.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -1.169 . . . . 0.0 109.217 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -67.44 160.53 27.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.433 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.62 -175.46 24.91 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -155.33 170.5 21.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -125.57 136.71 53.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.968 -1.083 . . . . 0.0 109.315 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -120.16 117.08 26.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.74 87.16 50.35 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.483 -0.761 . . . . 0.0 109.307 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.99 79.14 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.593 2.196 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -130.07 161.39 31.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 0.0 109.312 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.414 179.872 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.483 HD13 HD11 ' B' ' 15' ' ' LEU . 51.4 mt -87.27 -27.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.88 -27.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.209 -0.932 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 55.01 0.65 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.22 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.37 -36.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -101.66 -32.22 10.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.339 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.454 ' O ' HG12 ' F' ' 2' ' ' VAL . 1.7 m -68.89 -32.04 71.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 108.975 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.7 p -88.45 -16.1 33.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.416 -0.803 . . . . 0.0 109.45 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 10' ' ' ILE . 1.4 p -169.49 121.15 0.71 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.444 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 9' ' ' SER . 3.1 mt -44.61 107.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.14 154.96 21.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.299 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -71.99 167.56 19.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.23 -38.33 85.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.713 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.8 -43.07 94.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.873 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -63.84 -39.6 94.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.4 mt -77.16 -15.17 59.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -78.09 -22.51 48.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -85.35 17.39 3.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.24 -13.7 12.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.116 -0.99 . . . . 0.0 109.299 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.88 156.99 25.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.193 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.509 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.239 0.542 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.3 150.64 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.055 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 173.32 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.006 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -74.61 -32.67 62.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.174 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -69.03 -39.37 79.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.08 -23.48 35.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.484 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 42.4 t -74.57 -34.91 63.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.429 -0.794 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -16.01 80.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.89 -19.95 28.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.413 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.736 ' CG ' HD22 ' F' ' 6' ' ' LEU . 10.9 m-70 -83.97 -15.07 49.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 12.9 mt -91.98 -49.71 6.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.756 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.454 HG23 ' N ' ' B' ' 13' ' ' GLU . 9.0 m -46.56 -45.18 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.454 ' N ' HG23 ' B' ' 12' ' ' VAL . 67.4 mt-10 -62.03 -42.79 99.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.49 ' CB ' ' H5 ' ' B' ' 32' ' ' IPH . . . -88.54 22.67 2.49 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.173 -0.955 . . . . 0.0 109.631 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.483 HD11 HD13 ' A' ' 2' ' ' ILE . 0.7 OUTLIER -115.89 -58.41 2.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.903 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -59.46 -27.86 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.197 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.03 -42.68 80.24 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.554 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -54.56 -47.99 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -61.44 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' B' ' 21' ' ' GLU . . . 103.65 40.04 2.43 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' B' ' 20' ' ' GLY . 3.0 tt0 78.86 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.434 -1.039 . . . . 0.0 109.419 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.21 -54.81 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 109.581 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.02 152.38 5.7 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -163.52 159.87 22.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -119.81 143.24 47.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.601 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 40.2 t80 -119.71 104.7 10.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.103 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -132.07 97.92 17.89 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.76 113.15 3.59 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.504 2.136 . . . . 0.0 110.637 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -168.17 158.25 10.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.438 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.488 HD13 HD11 ' D' ' 15' ' ' LEU . 46.0 mt -90.17 -28.37 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 109.316 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.49 -29.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.98 53.11 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -174.34 -36.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' C' ' 9' ' ' SER . 63.3 m -101.62 -33.62 9.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.357 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -68.1 -30.51 69.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.904 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 75.0 p -89.82 -17.26 28.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.317 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' SER . . . . . 0.413 ' O ' ' C ' ' C' ' 10' ' ' ILE . 1.3 p -167.82 120.34 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' C' ' 9' ' ' SER . 3.1 mt -44.29 108.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.22 155.98 16.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 t -72.68 165.83 24.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.11 -37.63 86.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.968 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.24 -44.5 88.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.884 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' GLN . . . . . 0.464 ' HA ' ' ND2' ' C' ' 18' ' ' ASN . 27.8 mt-30 -61.6 -40.98 96.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 47.0 mt -74.62 -17.2 60.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 109.828 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.11 -18.79 52.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.011 -1.055 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' C' ' 15' ' ' GLN . 26.8 p30 -88.24 16.34 6.39 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.117 -0.99 . . . . 0.0 109.47 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -112.26 -12.95 13.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.51 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.22 152.56 25.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.552 -179.921 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.63 HG23 HD11 ' G' ' 10' ' ' ILE . 7.3 p -60.18 152.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.223 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' D' ' 7' ' ' CYS . 3.9 m-20 170.92 -38.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.377 -0.827 . . . . 0.0 109.219 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -75.36 -31.02 60.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -70.18 -40.36 74.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.143 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -81.87 -22.35 36.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.06 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 49.9 t -75.34 -34.53 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.39 -0.819 . . . . 0.0 109.674 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.08 -16.95 80.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.85 -19.6 32.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -1.041 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' HIS . . . . . 0.704 ' CG ' HD22 ' L' ' 6' ' ' LEU . 15.5 m-70 -85.57 -13.91 47.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.298 -0.876 . . . . 0.0 109.137 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 13.8 mt -92.04 -52.72 4.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.527 HG23 ' N ' ' D' ' 13' ' ' GLU . 11.5 m -43.79 -48.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.527 ' N ' HG23 ' D' ' 12' ' ' VAL . 82.3 mt-10 -58.71 -43.74 90.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.865 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.467 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -88.65 23.5 2.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.237 -0.914 . . . . 0.0 110.071 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.488 HD11 HD13 ' C' ' 2' ' ' ILE . 0.8 OUTLIER -115.56 -59.28 2.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' D' ' 13' ' ' GLU . 16.5 p90 -58.42 -27.4 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' D' ' 17' ' ' LEU . 4.9 mt -68.14 -43.1 79.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.385 -0.822 . . . . 0.0 109.586 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.21 -47.77 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -60.25 3.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' D' ' 21' ' ' GLU . . . 101.23 40.55 2.79 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' D' ' 20' ' ' GLY . 1.9 tt0 79.55 50.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.434 -1.039 . . . . 0.0 109.867 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -51.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.41 150.49 6.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 30.0 p90 -155.28 172.46 18.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.31 -1.112 . . . . 0.0 109.364 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' D' ' 25' ' ' PHE . 12.8 m-85 -129.12 139.03 52.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.277 -0.889 . . . . 0.0 109.37 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -120.97 99.42 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.577 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 32.4 m -126.48 100.61 28.7 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.401 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.85 110.93 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.569 2.179 . . . . 0.0 110.543 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -167.18 155.75 9.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.379 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.517 HD13 HD11 ' F' ' 15' ' ' LEU . 50.5 mt -87.11 -27.37 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.5 -28.01 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -108.04 53.22 0.69 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.275 -0.891 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -174.78 -34.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 6' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' E' ' 2' ' ' ILE . 64.3 m -102.63 -30.28 11.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.221 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 4.8 t -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.339 -0.851 . . . . 0.0 109.306 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -87.67 -15.74 36.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 9' ' ' SER . . . . . 0.437 ' O ' ' C ' ' E' ' 10' ' ' ILE . 76.7 p -169.19 117.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.227 -0.92 . . . . 0.0 109.34 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.509 HD11 HG23 ' J' ' 2' ' ' VAL . 3.1 mt -42.25 106.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.06 155.19 14.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.726 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 27.7 t -70.57 168.86 15.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.43 -37.13 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -64.74 -47.12 79.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -0.836 . . . . 0.0 109.475 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' GLN . . . . . 0.445 ' HA ' ' ND2' ' E' ' 18' ' ' ASN . 28.1 mt-30 -60.54 -39.66 88.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.899 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.288 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -76.99 -18.96 57.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' E' ' 15' ' ' GLN . 27.5 p30 -89.07 13.81 12.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.04 -1.038 . . . . 0.0 110.002 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -109.03 -13.38 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.04 -1.037 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 153.42 27.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.865 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.289 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 7' ' ' CYS . 10.0 p -58.26 149.97 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 174.32 -41.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -72.89 -27.93 62.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -72.84 -40.01 66.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.039 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.736 HD22 ' CG ' ' B' ' 10' ' ' HIS . 6.6 mt -82.46 -19.8 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 108.989 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.422 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 42.3 t -75.68 -38.61 58.58 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.523 -0.735 . . . . 0.0 109.472 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.04 -15.17 79.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -21.4 29.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.18 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -82.57 -18.58 40.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.9 mt -89.14 -49.86 6.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.746 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.489 HG23 ' N ' ' F' ' 13' ' ' GLU . 12.4 m -46.65 -45.81 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.111 -0.993 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.489 ' N ' HG23 ' F' ' 12' ' ' VAL . 79.4 mt-10 -62.44 -40.61 97.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.523 ' CB ' ' H5 ' ' E' ' 22' ' ' IPH . . . -91.03 25.06 2.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.517 HD11 HD13 ' E' ' 2' ' ' ILE . 0.7 OUTLIER -117.97 -58.85 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -59.34 -27.73 66.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.297 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' F' ' 17' ' ' LEU . 5.3 mt -68.07 -43.51 78.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.857 . . . . 0.0 109.493 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.06 -51.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 109.402 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -47.8 -62.23 1.56 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' F' ' 21' ' ' GLU . . . 103.63 40.42 2.36 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' F' ' 20' ' ' GLY . 2.2 tt0 79.65 49.51 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -1.046 . . . . 0.0 109.788 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -123.53 -46.8 2.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.04 -1.038 . . . . 0.0 109.563 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.22 153.14 7.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -162.81 175.68 11.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 25' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 2.4 p90 -132.76 158.18 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.383 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -138.25 93.78 2.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.411 -0.806 . . . . 0.0 109.103 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 28.5 m -120.34 99.34 48.22 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.492 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 108.59 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.424 2.083 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -164.64 155.73 15.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 44.3 p . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.568 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.503 HD13 HD11 ' H' ' 15' ' ' LEU . 36.4 mt -84.48 -30.52 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.751 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.15 -30.05 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 109.63 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.7 52.45 0.73 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.175 -0.953 . . . . 0.0 109.888 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -173.05 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.379 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.5 -35.06 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.83 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.075 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -89.05 -17.4 29.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.361 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 9' ' ' SER . . . . . 0.43 ' O ' ' C ' ' G' ' 10' ' ' ILE . 1.9 p -168.75 119.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.63 HD11 HG23 ' D' ' 2' ' ' VAL . 3.1 mt -42.82 106.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.578 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 62.6 m -60.62 153.97 22.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.373 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -68.76 170.16 10.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 13' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' G' ' 13' ' ' LEU . 1.3 mm? -70.79 -37.83 73.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 109.188 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.28 -44.82 90.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.431 -0.793 . . . . 0.0 109.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 15' ' ' GLN . . . . . 0.452 ' HA ' ' ND2' ' G' ' 18' ' ' ASN . 21.4 mt-30 -61.92 -39.66 92.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.91 -15.36 59.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.203 -0.936 . . . . 0.0 109.544 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -79.32 -19.86 49.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.679 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 18' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' G' ' 15' ' ' GLN . 27.6 p30 -86.54 11.99 11.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -108.86 -10.94 15.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.855 . . . . 0.0 109.796 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.41 152.63 23.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.654 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.399 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.408 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.5 p -60.06 152.56 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 3.6 m-20 170.72 -37.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -74.8 -33.81 62.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.25 -0.906 . . . . 0.0 108.855 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 5' ' ' HIS . . . . . 0.6 ' CB ' HD11 ' K' ' 10' ' ' ILE . 54.2 t60 -67.49 -42.2 83.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.513 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mt -79.22 -26.8 42.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.85 . . . . 0.0 109.427 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 42.4 t -72.21 -34.23 68.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.55 -21.47 79.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.73 -20.68 38.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -1.061 . . . . 0.0 109.665 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -82.34 -15.75 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.113 -0.992 . . . . 0.0 109.76 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.433 HD13 HG22 ' G' ' 2' ' ' ILE . 9.6 mt -92.41 -49.16 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.594 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.497 HG23 ' N ' ' H' ' 13' ' ' GLU . 10.8 m -46.16 -47.11 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 13' ' ' GLU . . . . . 0.497 ' N ' HG23 ' H' ' 12' ' ' VAL . 78.3 mt-10 -61.42 -42.45 98.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.482 ' CB ' ' H5 ' ' G' ' 22' ' ' IPH . . . -88.32 19.37 3.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 110.063 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 15' ' ' LEU . . . . . 0.503 HD11 HD13 ' G' ' 2' ' ' ILE . 0.7 OUTLIER -112.5 -59.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.07 -28.62 64.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' H' ' 17' ' ' LEU . 5.4 mt -67.07 -43.32 82.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.518 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -53.94 -45.81 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -57.16 12.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 20' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' H' ' 21' ' ' GLU . . . 99.73 38.88 3.53 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 21' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' H' ' 20' ' ' GLY . 2.2 tt0 80.93 50.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.26 -56.81 1.61 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.962 . . . . 0.0 109.475 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.37 153.25 5.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.67 158.27 17.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -1.153 . . . . 0.0 109.186 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 28.5 p90 -121.39 141.09 51.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.697 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -117.09 106.25 13.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 32.5 m -132.29 99.06 16.35 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.55 -0.719 . . . . 0.0 109.454 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.44 112.61 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.489 2.126 . . . . 0.0 110.47 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.61 153.18 8.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.612 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.514 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.494 HD13 HD11 ' J' ' 15' ' ' LEU . 32.8 mt -86.37 -30.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -1.125 . . . . 0.0 109.4 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.46 -28.23 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -108.09 49.4 0.81 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.11 -0.994 . . . . 0.0 109.688 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -170.12 -34.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.22 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -102.97 -32.53 9.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.06 -26.63 64.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 46.8 p -93.76 -17.2 23.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.035 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 9' ' ' SER . . . . . 0.417 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.2 p -167.52 119.29 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' I' ' 9' ' ' SER . 3.1 mt -43.73 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.5 m -59.57 156.55 13.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.482 -0.761 . . . . 0.0 109.457 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -73.7 169.01 18.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.86 -38.16 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -65.56 -43.75 88.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 15' ' ' GLN . . . . . 0.433 ' HA ' ' ND2' ' I' ' 18' ' ' ASN . 26.9 mt-30 -62.97 -38.0 89.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.187 -0.945 . . . . 0.0 109.441 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 42.3 mt -78.84 -13.51 59.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -81.01 -21.55 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.08 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 18' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' I' ' 15' ' ' GLN . 27.3 p30 -85.09 15.8 3.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.314 -0.866 . . . . 0.0 109.739 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.64 -11.73 13.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.382 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.12 154.65 24.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.526 -179.859 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.509 HG23 HD11 ' E' ' 10' ' ' ILE . 11.2 p -59.99 151.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 171.8 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.048 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -74.08 -33.49 63.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.249 -0.907 . . . . 0.0 109.105 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 t60 -68.38 -39.55 81.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.508 -0.745 . . . . 0.0 109.705 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 mt -82.19 -24.64 34.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.465 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 48.7 t -72.89 -37.31 67.32 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -0.817 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.88 -20.52 78.83 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 9' ' ' SER . . . . . 0.461 ' HB3' ' OH ' ' L' ' 16' ' ' TYR . 1.3 m -82.38 -19.71 38.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -1.11 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.46 -16.81 44.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.574 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.1 mt -91.08 -48.16 7.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.481 HG23 ' N ' ' J' ' 13' ' ' GLU . 11.7 m -47.9 -46.15 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.276 -0.89 . . . . 0.0 109.981 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.481 ' N ' HG23 ' J' ' 12' ' ' VAL . 60.9 mt-10 -62.27 -39.61 93.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.489 ' CB ' ' H5 ' ' J' ' 32' ' ' IPH . . . -91.26 23.36 3.37 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.864 . . . . 0.0 109.753 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 15' ' ' LEU . . . . . 0.494 HD11 HD13 ' I' ' 2' ' ' ILE . 0.8 OUTLIER -116.32 -58.01 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.018 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -60.37 -28.44 68.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' J' ' 17' ' ' LEU . 5.5 mt -66.17 -44.55 83.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.214 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -51.27 -48.58 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.282 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -50.77 69.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.08 -1.013 . . . . 0.0 108.831 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 20' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' J' ' 21' ' ' GLU . . . 108.77 -43.54 1.69 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 21' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' J' ' 20' ' ' GLY . 2.4 tt0 167.44 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -53.44 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.59 157.07 7.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 25.1 p90 -159.27 171.24 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -1.142 . . . . 0.0 109.742 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 25' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 1.7 p90 -128.0 141.26 51.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -121.75 98.76 6.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.873 . . . . 0.0 109.473 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -125.8 100.23 31.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.433 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.86 109.02 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.426 2.084 . . . . 0.0 110.621 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -164.29 156.85 17.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.553 -179.842 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.508 HD13 HD11 ' L' ' 15' ' ' LEU . 38.0 mt -85.06 -29.23 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 39.4 t -69.24 -31.63 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.265 -0.897 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.95 51.96 0.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.262 -0.899 . . . . 0.0 109.975 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.28 -37.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.161 -0.962 . . . . 0.0 109.227 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 64.5 m -99.59 -34.67 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.305 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 7' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 1.7 m -68.07 -22.95 64.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 38.0 p -96.95 -20.42 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 108.978 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 9' ' ' SER . . . . . 0.414 ' O ' ' C ' ' K' ' 10' ' ' ILE . 33.8 p -165.27 119.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.324 -0.86 . . . . 0.0 108.959 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.6 HD11 ' CB ' ' H' ' 5' ' ' HIS . 2.9 mp -42.99 107.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.749 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 68.7 m -59.13 156.3 12.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -73.27 169.36 17.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.52 -34.84 74.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 0.0 109.744 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.97 -45.11 75.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.995 . . . . 0.0 109.377 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 15' ' ' GLN . . . . . 0.441 ' HA ' ' ND2' ' K' ' 18' ' ' ASN . 24.0 mt-30 -60.78 -40.43 92.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 42.5 mt -76.41 -15.57 59.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.94 -19.75 47.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.983 . . . . 0.0 109.558 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 18' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' K' ' 15' ' ' GLN . 27.5 p30 -87.17 14.18 8.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.887 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.42 -10.82 14.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.292 -0.88 . . . . 0.0 109.562 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.0 154.22 22.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.551 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.196 0.522 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.72 151.6 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.012 -1.055 . . . . 0.0 109.198 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 172.86 -40.24 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 108.907 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.4 -33.0 64.76 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.297 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -68.73 -39.65 80.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 6' ' ' LEU . . . . . 0.704 HD22 ' CG ' ' D' ' 10' ' ' HIS . 7.9 mt -82.23 -22.64 35.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.0 109.223 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 48.6 t -74.97 -32.65 61.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.432 -0.792 . . . . 0.0 109.821 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 -13.38 83.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -17.58 31.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.235 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -85.46 -19.19 31.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 11.9 mt -87.23 -51.55 5.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.51 HG23 ' N ' ' L' ' 13' ' ' GLU . 8.4 m -46.1 -49.08 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.641 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.51 ' N ' HG23 ' L' ' 12' ' ' VAL . 62.3 mt-10 -58.98 -42.57 90.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.469 ' CB ' ' H5 ' ' L' ' 32' ' ' IPH . . . -89.39 22.79 2.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.508 HD11 HD13 ' K' ' 2' ' ' ILE . 0.7 OUTLIER -115.67 -57.81 2.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 0.0 109.824 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.461 ' OH ' ' HB3' ' J' ' 9' ' ' SER . 18.0 p90 -60.45 -26.97 67.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.17 -0.956 . . . . 0.0 109.393 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' L' ' 17' ' ' LEU . 5.0 mt -68.59 -41.13 80.04 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.37 -49.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -59.48 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.533 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' L' ' 21' ' ' GLU . . . 101.07 39.14 3.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' L' ' 20' ' ' GLY . 2.7 tt0 80.38 48.08 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.489 -1.006 . . . . 0.0 109.929 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.36 -53.86 2.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.38 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.31 151.26 5.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -160.68 169.59 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -1.105 . . . . 0.0 108.949 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 25' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 2.5 p90 -129.38 147.61 51.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 26' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 36.8 t80 -123.85 107.12 11.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.889 . . . . 0.0 109.166 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -133.17 98.48 15.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.305 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 110.7 3.05 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.471 2.114 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.0 158.52 17.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.418 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.658 -179.846 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.49 ' H5 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.467 ' H5 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 22' ' ' IPH . . . . . 0.523 ' H5 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 22' ' ' IPH . . . . . 0.482 ' H5 ' ' CB ' ' H' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 32' ' ' IPH . . . . . 0.489 ' H5 ' ' CB ' ' J' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 32' ' ' IPH . . . . . 0.469 ' H5 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.4 2.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -1.176 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 48.0 t -95.04 -36.65 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.958 -1.089 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.43 38.93 1.42 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.477 -0.764 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -156.34 -39.29 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 109.513 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.5 m -104.04 -38.96 6.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 109.636 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 49.3 t -62.09 -24.3 67.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.602 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 p -77.65 -31.67 52.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -153.1 145.78 24.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.545 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -46.81 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -0.869 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.428 ' HB3' ' HG ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.56 163.23 7.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.615 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.17 165.23 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.294 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -36.5 77.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.843 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -68.89 -32.03 71.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -46.15 46.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' A' ' 11' ' ' CYS . 64.8 mt -67.23 -17.34 64.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.053 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -26.15 62.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.069 -1.02 . . . . 0.0 109.335 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -55.08 -32.02 61.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.94 55.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.038 -1.039 . . . . 0.0 109.546 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -123.66 131.88 53.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.392 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.627 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.474 ' O ' HG13 ' B' ' 2' ' ' VAL . 11.1 p -66.98 127.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.579 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 t30 179.96 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.95 -26.34 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -78.48 -39.4 38.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.08 -22.35 36.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 39.7 t -81.81 -33.07 30.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.941 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.81 -26.71 55.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.27 63.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -96.97 -21.17 17.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 59.5 mt -81.76 -33.45 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.58 -33.02 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -73.77 -38.17 64.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.152 -0.968 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -64.59 -58.06 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.543 ' HA ' ' HB ' ' B' ' 18' ' ' VAL . 9.4 mt -53.43 -23.01 8.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.992 . . . . 0.0 109.689 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -53.04 58.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 110.02 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -88.88 -23.27 22.8 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' B' ' 15' ' ' LEU . 83.7 t -65.44 -22.69 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 109.688 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.2 -34.62 8.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.626 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.48 -147.4 18.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -78.41 -1.43 33.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.252 -1.146 . . . . 0.0 109.701 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -65.83 -26.5 67.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 174.28 48.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -157.14 176.79 12.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 0.0 109.549 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.61 ' HB2' ' CE1' ' D' ' 25' ' ' PHE . 6.3 p90 -133.13 153.99 51.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.95 . . . . 0.0 109.585 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -130.92 109.4 10.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.383 -0.823 . . . . 0.0 109.302 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 40.3 m -159.7 105.89 1.46 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 109.34 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.42 -88.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.26 1.973 . . . . 0.0 110.233 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.29 -153.97 0.38 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.425 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.443 HD12 ' CD2' ' C' ' 19' ' ' TYR . 8.9 tt -103.02 0.96 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.644 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' C' ' 7' ' ' CYS . 48.2 t -92.62 -35.94 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.86 48.27 0.86 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.181 -0.949 . . . . 0.0 109.373 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -166.44 -36.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.459 -0.775 . . . . 0.0 109.097 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m -106.5 -39.69 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.394 -0.816 . . . . 0.0 109.374 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' C' ' 3' ' ' VAL . 47.0 t -64.14 -22.07 66.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.849 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -80.31 -31.73 38.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.587 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.28 146.68 26.21 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -48.76 101.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.571 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' CYS . . . . . 0.402 ' HB3' ' HG ' ' C' ' 16' ' ' LEU . 0.3 OUTLIER -58.32 160.12 5.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 169.91 13.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.6 -38.23 70.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.697 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.6 -31.14 70.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.43 -43.89 47.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 109.821 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' C' ' 11' ' ' CYS . 67.0 mt -69.73 -16.51 63.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.87 . . . . 0.0 109.812 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -23.13 61.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.634 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -58.72 -29.83 66.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.443 ' CD2' HD12 ' C' ' 2' ' ' ILE . 10.6 m-85 -101.39 57.58 0.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -126.6 130.39 50.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.466 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.485 ' O ' HG13 ' D' ' 2' ' ' VAL . 13.0 p -64.8 128.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.587 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 179.25 -42.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.118 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.03 -25.36 60.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.779 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -80.83 -35.58 32.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -85.38 -20.33 30.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.147 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.472 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 41.8 t -84.31 -31.65 24.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.442 -0.786 . . . . 0.0 109.974 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.443 ' HA3' ' OH ' ' D' ' 26' ' ' TYR . . . -81.09 -27.02 51.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -15.23 63.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.34 -1.094 . . . . 0.0 109.364 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -97.06 -21.24 17.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.187 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 57.2 mt -83.81 -28.19 28.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -63.99 -32.06 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -75.32 -37.53 60.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.317 -0.864 . . . . 0.0 109.611 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -65.73 -55.12 18.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.942 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.503 ' HA ' ' HB ' ' D' ' 18' ' ' VAL . 9.6 mt -55.13 -24.4 25.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.38 -53.77 40.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.005 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 35.3 mt -87.98 -24.85 23.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 110.463 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' D' ' 15' ' ' LEU . 78.9 t -63.68 -22.76 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.12 -37.65 7.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.383 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.74 -144.73 17.46 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.78 4.5 21.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -1.161 . . . . 0.0 109.593 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -72.67 -22.72 60.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.883 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.02 177.94 50.97 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -159.05 167.44 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -1.208 . . . . 0.0 109.925 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' B' ' 25' ' ' PHE . 2.3 m-85 -118.41 149.6 40.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.415 -0.803 . . . . 0.0 109.449 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.443 ' OH ' ' HA3' ' D' ' 8' ' ' GLY . 64.0 t80 -133.05 100.4 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.327 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.3 m -154.05 109.21 2.47 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.152 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.32 -87.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 110.313 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.18 -153.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.464 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.605 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' E' ' 19' ' ' TYR . 5.1 tt -102.35 0.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -1.087 . . . . 0.0 109.444 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 3' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 42.5 t -92.9 -38.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.301 -0.874 . . . . 0.0 109.66 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.81 45.29 0.99 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.885 . . . . 0.0 109.406 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -163.68 -36.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.456 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 74.9 m -107.01 -41.21 5.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 7' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' F' ' 11' ' ' LEU . 0.6 OUTLIER -62.36 -20.86 64.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -79.95 -34.16 39.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -150.8 146.72 26.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.265 -0.897 . . . . 0.0 109.335 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.423 ' HA ' ' H2 ' ' E' ' 22' ' ' IPH . 2.7 mt -47.32 102.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.678 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 162.04 6.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.366 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.47 167.65 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.516 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -39.04 77.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.163 -0.961 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -67.02 -31.33 71.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.34 -42.7 53.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 110.08 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 mt -70.67 -16.98 62.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.71 -26.66 63.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -54.62 -30.68 55.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.431 ' CD2' HD12 ' E' ' 2' ' ' ILE . 10.6 m-85 -101.42 59.27 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -127.3 132.09 50.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.317 -179.955 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.356 0.598 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.476 ' O ' HG13 ' F' ' 2' ' ' VAL . 11.5 p -62.29 127.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.389 -0.819 . . . . 0.0 109.911 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 t30 179.39 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.06 -27.31 57.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -79.54 -33.54 41.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.594 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -87.41 -22.67 24.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.107 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 37.3 t -82.53 -26.52 32.39 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.44 -27.08 31.12 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.55 -15.78 63.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -1.122 . . . . 0.0 109.181 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -96.27 -24.27 16.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.313 -0.867 . . . . 0.0 109.633 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.581 HD11 ' SG ' ' E' ' 7' ' ' CYS . 52.2 mt -79.86 -31.28 40.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.553 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.407 HG22 ' H ' ' F' ' 12' ' ' VAL . 4.1 m -60.45 -33.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.95 -35.38 62.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 109.823 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.548 ' CB ' HD13 ' L' ' 17' ' ' LEU . . . -67.9 -54.83 15.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.571 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.519 ' HA ' ' HB ' ' F' ' 18' ' ' VAL . 12.0 mt -55.83 -22.28 24.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 109.598 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -55.02 35.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.482 HD21 ' NE2' ' H' ' 5' ' ' HIS . 42.2 mt -85.76 -26.53 25.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.27 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.541 HG23 ' O ' ' F' ' 14' ' ' ALA . 89.5 t -61.96 -23.14 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.116 -0.99 . . . . 0.0 109.753 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.97 -35.15 8.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.6 -143.19 16.5 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -82.79 2.69 32.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -1.14 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.53 -31.6 68.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.65 -177.35 31.8 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -169.88 154.03 5.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.433 -1.04 . . . . 0.0 109.136 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -112.25 157.88 20.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.68 108.51 8.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 108.918 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -158.71 109.22 1.62 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.688 . . . . 0.0 109.405 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.5 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.372 2.048 . . . . 0.0 110.213 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.91 -156.08 0.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.373 -0.829 . . . . 0.0 109.769 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.418 HD12 ' CD2' ' G' ' 19' ' ' TYR . 7.4 tt -100.21 1.48 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -1.159 . . . . 0.0 109.61 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -92.97 -40.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.38 47.69 1.03 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -166.78 -34.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 77.9 m -108.58 -38.11 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.46 -23.63 67.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.381 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 3.1 p -77.35 -30.84 54.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.13 146.68 25.02 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.211 -0.93 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 mt -49.06 103.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.148 -0.97 . . . . 0.0 109.289 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.18 162.63 5.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.06 164.41 15.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 109.244 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -41.3 91.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.88 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -64.62 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -44.77 50.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.086 -1.008 . . . . 0.0 109.863 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.57 -16.43 63.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -25.4 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 0.0 109.26 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -56.11 -28.84 59.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.864 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 19' ' ' TYR . . . . . 0.418 ' CD2' HD12 ' G' ' 2' ' ' ILE . 10.2 m-85 -103.19 56.52 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 128.06 47.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 109.553 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 109.446 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.538 ' O ' HG13 ' H' ' 2' ' ' VAL . 14.0 p -66.3 126.3 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -179.36 -41.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.58 -25.04 60.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.588 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 5' ' ' HIS . . . . . 0.482 ' NE2' HD21 ' F' ' 17' ' ' LEU . 37.1 t60 -80.01 -39.48 29.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.302 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -82.75 -16.41 48.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.438 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 44.4 t -88.89 -30.8 18.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.848 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.25 -28.22 45.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -67.29 -19.02 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -1.131 . . . . 0.0 109.559 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -93.48 -23.12 18.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.153 -0.967 . . . . 0.0 109.666 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 43.4 mt -81.56 -30.81 32.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.404 ' H ' HG22 ' H' ' 12' ' ' VAL . 3.6 m -60.58 -31.71 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.061 -1.024 . . . . 0.0 109.631 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -75.94 -35.37 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.567 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -66.44 -54.13 27.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -0.98 . . . . 0.0 109.436 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 15' ' ' LEU . . . . . 0.478 ' HA ' ' HB ' ' H' ' 18' ' ' VAL . 12.6 mt -57.17 -24.52 54.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.873 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -51.47 61.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -89.22 -25.56 21.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.567 HG23 ' O ' ' H' ' 14' ' ' ALA . 91.4 t -63.62 -26.24 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.034 -1.042 . . . . 0.0 109.65 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -39.15 9.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 109.544 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.95 -143.93 16.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.76 2.89 31.64 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.072 -1.252 . . . . 0.0 109.612 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -70.2 -24.88 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.14 -171.87 35.96 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -172.1 163.4 5.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -1.234 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -120.84 154.68 35.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.024 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -134.9 101.51 4.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.461 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 22.9 m -152.83 108.14 2.69 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 109.509 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.83 -87.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.343 2.029 . . . . 0.0 110.745 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.59 -154.91 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.393 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' I' ' 19' ' ' TYR . 7.9 tt -104.48 1.64 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -1.192 . . . . 0.0 109.523 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 3' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 42.4 t -93.52 -37.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.73 37.62 1.58 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.564 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -154.59 -38.82 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -104.57 -41.52 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 7' ' ' CYS . . . . . 0.527 ' SG ' HD11 ' J' ' 11' ' ' LEU . 0.6 OUTLIER -60.34 -20.42 59.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.711 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -81.57 -33.4 31.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.23 147.72 28.03 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.32 -0.863 . . . . 0.0 108.949 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.92 101.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.34 164.63 1.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.62 168.71 11.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.008 . . . . 0.0 109.06 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.69 -42.84 77.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -63.55 -32.01 73.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 110.078 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -43.26 55.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.988 . . . . 0.0 109.949 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 mt -70.35 -16.01 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.826 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -19.57 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.18 -0.95 . . . . 0.0 109.65 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -62.21 -28.09 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.247 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 19' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' I' ' 2' ' ' ILE . 11.5 m-85 -102.11 58.47 0.82 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.17 129.83 47.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.362 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.514 ' O ' HG13 ' J' ' 2' ' ' VAL . 12.3 p -65.47 127.33 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -179.95 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -75.13 -27.62 59.86 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.874 . . . . 0.0 109.619 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -76.8 -36.61 56.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 6' ' ' LEU . . . . . 0.401 HD21 ' C6 ' ' E' ' 22' ' ' IPH . 13.3 mt -84.98 -21.97 29.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.418 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.422 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 43.7 t -83.1 -27.19 30.36 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.31 -0.869 . . . . 0.0 109.644 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.41 -27.48 30.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 9' ' ' SER . . . . . 0.515 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 0.4 OUTLIER -69.82 -12.18 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -1.129 . . . . 0.0 109.477 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -99.43 -21.52 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.322 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.527 HD11 ' SG ' ' I' ' 7' ' ' CYS . 40.5 mt -83.37 -32.2 26.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 109.603 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.418 HG22 ' H ' ' J' ' 12' ' ' VAL . 6.2 m -58.72 -32.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.354 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -74.3 -37.81 63.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.686 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.417 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -65.03 -59.65 3.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.568 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 15' ' ' LEU . . . . . 0.521 ' HA ' ' HB ' ' J' ' 18' ' ' VAL . 10.7 mt -51.0 -25.77 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.725 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -55.48 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.119 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 mt -85.9 -27.82 24.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 0.0 110.229 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 18' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' J' ' 15' ' ' LEU . 87.7 t -59.34 -26.33 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 109.935 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -99.47 -39.32 8.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.566 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 -145.11 17.18 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.35 1.18 33.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.21 -1.17 . . . . 0.0 109.578 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -66.98 -27.31 67.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.13 -177.55 41.36 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -170.5 165.1 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -1.089 . . . . 0.0 109.189 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -125.33 157.28 37.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.738 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -129.91 110.55 11.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.544 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 38.4 m -159.71 106.67 1.46 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.588 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.37 -88.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.397 2.065 . . . . 0.0 110.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.7 -158.03 0.31 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.248 -0.908 . . . . 0.0 109.354 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.919 -1.038 . . . . 0.0 109.347 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.441 HD12 ' CD2' ' K' ' 19' ' ' TYR . 7.1 tt -104.48 1.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -1.104 . . . . 0.0 109.159 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 46.5 t -93.5 -40.3 11.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 46.86 1.0 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -165.05 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.829 . . . . 0.0 109.235 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 81.7 m -107.01 -42.54 4.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 109.27 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 7' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' L' ' 11' ' ' LEU . 0.6 OUTLIER -60.11 -22.27 62.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -79.43 -31.88 42.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.137 -0.977 . . . . 0.0 109.586 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.37 146.75 24.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.74 102.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.873 . . . . 0.0 109.542 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 161.53 7.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -85.93 165.77 16.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.275 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -41.99 83.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.05 -31.46 72.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.52 -0.738 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -42.65 46.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 109.73 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 mt -70.17 -16.47 63.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.718 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -23.49 61.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.92 . . . . 0.0 109.167 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -57.98 -28.12 64.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.299 -0.876 . . . . 0.0 109.359 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 19' ' ' TYR . . . . . 0.441 ' CD2' HD12 ' K' ' 2' ' ' ILE . 11.0 m-85 -103.66 58.29 0.74 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 7.2 t -127.08 131.86 50.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.573 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.33 0.586 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.461 ' O ' HG13 ' L' ' 2' ' ' VAL . 11.6 p -64.61 128.09 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.729 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 14.6 t30 177.52 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.536 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -77.92 -25.25 48.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -79.74 -38.15 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.78 -25.1 33.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.815 . . . . 0.0 109.4 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.451 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 45.4 t -79.45 -30.09 42.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.744 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.2 -32.36 28.93 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -64.88 -12.96 54.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 109.698 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -98.44 -23.5 15.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.546 HD11 ' SG ' ' K' ' 7' ' ' CYS . 55.7 mt -81.35 -28.04 34.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.856 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.48 -30.32 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.569 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -76.67 -37.66 55.86 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.205 -0.935 . . . . 0.0 109.485 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.429 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -65.18 -56.73 11.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.454 ' HA ' ' HB ' ' L' ' 18' ' ' VAL . 14.7 mt -54.05 -25.73 23.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.079 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' J' ' 9' ' ' SER . 0.4 OUTLIER -52.05 -53.74 38.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 109.941 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.548 HD13 ' CB ' ' F' ' 14' ' ' ALA . 35.9 mt -87.24 -27.99 22.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.657 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 18' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' L' ' 15' ' ' LEU . 88.5 t -59.77 -25.15 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.956 -1.09 . . . . 0.0 109.648 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -99.48 -41.76 7.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.391 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.95 -142.26 15.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -83.2 1.29 41.39 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.275 -1.132 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -67.5 -27.93 67.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 110.022 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 -176.33 39.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -171.38 167.02 6.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -1.124 . . . . 0.0 109.488 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 25' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 3.1 p90 -126.45 151.69 47.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.632 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -126.85 106.11 9.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.312 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 32.8 m -155.71 108.55 2.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -82.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.475 2.117 . . . . 0.0 110.843 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.65 -155.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 109.406 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 109.816 -179.61 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 22' ' ' IPH . . . . . 0.423 ' H2 ' ' HA ' ' E' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.5 mt -80.39 -30.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 109.518 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.58 -35.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.951 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -104.46 56.2 0.71 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.806 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.436 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 22.6 tt0 -178.58 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.582 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' SER . 63.7 m -102.16 -29.46 11.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.02 -41.48 59.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.236 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.2 p -81.34 -15.95 53.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.501 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -160.32 120.57 2.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 109.565 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.554 HD12 ' O ' ' F' ' 1' ' ' PHE . 2.1 mp -47.87 101.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.319 -0.863 . . . . 0.0 109.455 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m -53.12 158.8 1.4 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.81 163.68 16.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.264 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -45.17 84.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 109.655 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -61.88 -33.49 74.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.549 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -67.72 -36.87 81.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.436 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.2 mt -83.91 -8.74 59.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.24 -0.912 . . . . 0.0 109.739 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.15 -27.96 38.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 15' ' ' GLN . 53.0 p30 -73.37 -11.91 60.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.432 ' N ' ' OD1' ' A' ' 18' ' ' ASN . 35.0 m-85 -98.32 -3.45 37.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 109.95 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.6 168.33 19.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.513 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.622 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.55 ' O ' HG13 ' B' ' 2' ' ' VAL . 3.8 p -172.25 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 4.6 p30 170.73 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.875 . . . . 0.0 109.242 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -85.57 -24.29 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.822 . . . . 0.0 109.364 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.84 -39.42 35.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.319 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mt -81.01 -38.03 28.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 9.4 t -63.14 -36.33 83.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.33 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.436 ' O ' HG22 ' B' ' 12' ' ' VAL . . . -79.4 -22.01 65.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 71.7 m -79.66 -8.88 59.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.399 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.79 -25.69 15.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.932 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 9.7 mt -79.43 -48.23 14.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.443 ' H ' HG22 ' B' ' 12' ' ' VAL . 2.6 m -52.18 -34.01 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 109.958 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.47 -48.31 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.995 . . . . 0.0 109.423 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.452 ' CB ' ' H3 ' ' B' ' 32' ' ' IPH . . . -83.48 11.92 6.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 -50.67 5.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.949 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 13.4 p90 -71.98 -21.49 61.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.07 -1.019 . . . . 0.0 109.549 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.948 HD23 HD23 ' H' ' 17' ' ' LEU . 46.9 tp -74.52 -35.98 63.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -76.02 -46.7 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -57.1 -41.74 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.928 . . . . 0.0 109.327 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.39 -141.14 15.39 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.07 4.55 33.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -1.173 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.6 -74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' B' ' 19' ' ' CYS . . . 141.17 165.6 10.41 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 13.5 p90 -161.45 167.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -1.206 . . . . 0.0 109.317 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.605 ' HB2' ' CD2' ' D' ' 25' ' ' PHE . 35.8 p90 -123.57 162.62 22.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.596 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -142.08 83.69 1.85 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 109.644 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.404 ' OG1' ' CZ ' ' D' ' 25' ' ' PHE . 0.2 OUTLIER -133.77 92.68 22.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.13 -57.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.777 2.318 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tttt 54.37 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.552 179.699 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 74.1 mt -79.72 -29.48 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -1.112 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.27 -38.51 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 5.7 mm-40 -103.41 60.59 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.803 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 22.2 tt0 178.3 -32.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.592 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 70.2 m -104.03 -31.45 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.392 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 9.9 t -73.22 -40.11 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.963 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 32.1 p -82.84 -16.14 48.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.93 118.42 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.744 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -45.76 100.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 96.8 m -51.9 160.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.004 . . . . 0.0 109.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.16 162.69 15.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.232 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.24 84.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 109.687 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -63.5 -33.73 76.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' GLN . . . . . 0.436 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -67.15 -35.94 80.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 109.685 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.63 -9.5 58.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -79.19 -26.77 42.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.458 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' C' ' 15' ' ' GLN . 52.8 p30 -76.84 -8.01 56.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -101.4 -6.54 23.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.19 167.68 21.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.66 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.349 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.487 ' O ' HG13 ' D' ' 2' ' ' VAL . 2.5 p -171.76 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.184 -0.947 . . . . 0.0 109.279 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 p30 173.42 -36.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 109.261 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.56 -25.39 38.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.168 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.98 -41.79 41.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.453 ' N ' HD23 ' D' ' 6' ' ' LEU . 4.3 mt -79.39 -36.81 38.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.418 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.5 t -63.37 -36.4 83.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.507 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.55 -18.66 67.94 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -81.95 -8.64 59.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -1.125 . . . . 0.0 109.705 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -96.96 -25.88 15.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.585 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 10.6 mt -77.42 -49.87 13.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -51.55 -33.19 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -68.73 -46.78 68.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.108 -0.995 . . . . 0.0 109.717 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.424 ' CB ' ' H3 ' ' D' ' 32' ' ' IPH . . . -85.16 9.73 14.19 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.813 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 -52.33 4.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.726 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 15.6 p90 -70.85 -22.69 62.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.862 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.509 HD23 HD23 ' J' ' 17' ' ' LEU . 48.9 tp -72.86 -38.15 67.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.105 -0.997 . . . . 0.0 109.63 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.2 -46.27 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -58.16 -44.87 88.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -139.03 14.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.43 5.42 35.14 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.338 -1.095 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -70.45 -75.33 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.535 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' D' ' 19' ' ' CYS . . . 142.4 166.47 10.99 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 17.7 p90 -156.94 162.35 39.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.949 -1.324 . . . . 0.0 110.068 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 25' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' B' ' 25' ' ' PHE . 55.4 m-85 -114.2 150.41 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -138.55 85.01 2.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.63 92.86 9.97 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 108.783 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.22 -61.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.674 2.249 . . . . 0.0 110.568 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttt 59.13 94.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.666 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 75.6 mt -83.94 -29.86 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -1.135 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 64.0 t -68.85 -37.31 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 4' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 4.6 mm-40 -104.12 61.43 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.976 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 22.9 tt0 176.94 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 109.514 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 66.2 m -102.06 -30.39 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.6 t -73.65 -43.03 60.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.271 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 31.6 p -80.19 -15.04 57.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.622 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 9' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' J' ' 1' ' ' PHE . 0.0 OUTLIER -161.14 116.9 2.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.141 -0.974 . . . . 0.0 109.46 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mp -45.27 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.456 -0.777 . . . . 0.0 109.59 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 11' ' ' CYS . . . . . 0.427 ' SG ' ' HG2' ' E' ' 5' ' ' GLN . 94.4 m -49.95 160.83 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.079 -1.013 . . . . 0.0 109.332 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.6 167.44 12.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.073 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.69 94.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.512 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -62.11 -35.31 78.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -35.19 79.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.017 . . . . 0.0 109.4 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.35 -4.52 59.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -84.59 -29.81 25.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.142 -0.974 . . . . 0.0 109.376 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 18' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' E' ' 19' ' ' TYR . 54.6 p30 -72.31 -10.32 59.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.888 . . . . 0.0 109.679 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' E' ' 18' ' ' ASN . 32.8 m-85 -100.21 -1.03 37.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.886 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 169.13 14.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 110.059 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.717 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 1' ' ' PHE . . . . . 0.554 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.8 m-85 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.577 ' O ' HG13 ' F' ' 2' ' ' VAL . 5.7 p -170.23 108.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.865 . . . . 0.0 109.67 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 171.56 -37.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -79.43 -26.94 41.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 0.0 109.51 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -76.18 -40.41 52.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.938 . . . . 0.0 109.84 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.61 -34.36 30.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.441 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 11.3 t -66.63 -31.44 72.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.261 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.431 ' O ' HG22 ' F' ' 12' ' ' VAL . . . -84.26 -19.27 60.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -83.21 -7.45 59.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -1.091 . . . . 0.0 109.574 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -98.81 -22.22 15.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -81.64 -45.96 15.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.649 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.431 HG22 ' O ' ' F' ' 8' ' ' GLY . 2.4 m -55.23 -33.37 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.09 -48.49 65.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.49 ' CB ' ' H3 ' ' E' ' 22' ' ' IPH . . . -83.24 8.21 14.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -0.894 . . . . 0.0 110.065 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -51.52 5.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 109.858 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.531 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 13.5 p90 -71.51 -21.43 61.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 109.744 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.485 HD23 HD23 ' L' ' 17' ' ' LEU . 52.1 tp -74.8 -34.76 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.444 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.45 -42.93 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -37.73 86.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.036 . . . . 0.0 109.106 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.36 -139.76 15.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -83.54 -0.67 51.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.951 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -65.03 -73.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.284 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.16 168.65 11.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 24' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 12.3 p90 -163.61 172.69 13.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 109.422 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -130.41 162.53 28.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.275 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -138.99 93.16 2.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.034 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.08 89.45 7.81 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.483 -0.76 . . . . 0.0 109.477 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.38 -62.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.675 2.25 . . . . 0.0 110.115 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 62.22 93.18 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 109.648 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.568 179.904 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.41 HD13 HD11 ' H' ' 15' ' ' LEU . 73.6 mt -81.95 -26.69 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.13 -33.33 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 4' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 5.4 mm-40 -108.69 61.47 0.6 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 22.0 tt0 176.43 -31.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -104.36 -32.97 8.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 10.1 t -72.14 -43.5 64.57 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.124 -0.985 . . . . 0.0 109.286 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -77.36 -21.37 53.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 121.25 5.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.155 -0.965 . . . . 0.0 109.486 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -47.69 103.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.97 . . . . 0.0 109.156 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 69.1 m -53.32 162.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 109.617 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.1 163.28 14.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 109.33 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.36 84.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -61.04 -36.58 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.341 -0.849 . . . . 0.0 109.404 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' G' ' 18' ' ' ASN . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.7 mt -80.91 -11.32 59.6 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.906 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.56 -29.86 56.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.08 -1.012 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' G' ' 15' ' ' GLN . 53.4 p30 -73.16 -5.94 42.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.965 . . . . 0.0 109.613 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -102.17 -16.4 16.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.988 . . . . 0.0 109.76 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 6.9 m -66.51 172.86 3.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 108.814 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.423 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.585 ' O ' HG13 ' H' ' 2' ' ' VAL . 4.4 p -171.05 107.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.55 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 172.54 -34.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.66 -22.13 32.23 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.304 -0.872 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -80.65 -39.79 26.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 6' ' ' LEU . . . . . 0.44 HD23 ' N ' ' H' ' 6' ' ' LEU . 4.3 mt -81.12 -37.09 29.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.216 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.4 t -63.15 -37.23 86.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.683 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 8' ' ' GLY . . . . . 0.448 ' O ' HG22 ' H' ' 12' ' ' VAL . . . -79.91 -18.73 71.85 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 58.5 m -83.06 -6.33 59.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -1.116 . . . . 0.0 109.559 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -100.47 -19.33 16.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.072 -1.017 . . . . 0.0 109.149 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.8 mt -84.23 -46.51 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.448 HG22 ' O ' ' H' ' 8' ' ' GLY . 2.3 m -54.64 -33.17 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.726 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.27 -48.03 66.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.824 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.98 11.47 9.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -93.04 -48.63 6.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.996 -1.065 . . . . 0.0 109.724 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 13.2 p90 -73.12 -22.57 60.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.368 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.948 HD23 HD23 ' B' ' 17' ' ' LEU . 47.1 tp -73.47 -33.52 64.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.301 -0.875 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.25 -57.44 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -49.85 -38.41 35.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 0.0 109.245 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.5 -146.19 18.8 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -75.51 -3.96 37.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 110.046 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -61.59 -74.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.282 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.99 171.74 12.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 24' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 15.8 p90 -165.82 170.41 13.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -1.212 . . . . 0.0 109.678 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 13.1 p90 -128.5 156.74 42.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 109.496 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -136.35 91.21 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.386 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.67 90.09 8.88 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.97 -59.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.733 2.289 . . . . 0.0 110.533 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 57.56 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.335 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.507 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt -81.69 -28.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -1.105 . . . . 0.0 109.433 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.1 -32.26 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 4' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 5.8 mm-40 -108.15 58.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.277 -0.889 . . . . 0.0 109.545 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 25.3 tt0 177.34 -32.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -101.23 -30.44 11.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 109.44 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.4 -43.28 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.852 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -79.02 -14.31 59.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 9' ' ' SER . . . . . 0.424 ' O ' ' N ' ' I' ' 11' ' ' CYS . 0.0 OUTLIER -161.75 126.55 3.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.329 -0.857 . . . . 0.0 108.988 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' I' ' 11' ' ' CYS . 2.2 mp -56.17 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.851 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 11' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 10' ' ' ILE . 0.8 OUTLIER -43.23 161.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.272 -0.893 . . . . 0.0 109.346 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.2 169.34 11.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -46.16 91.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -59.74 -34.78 73.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.27 82.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.71 -9.45 58.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 109.581 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.16 -29.0 42.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 18' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' I' ' 19' ' ' TYR . 54.9 p30 -74.2 -9.74 58.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.683 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 19' ' ' TYR . . . . . 0.406 ' N ' ' OD1' ' I' ' 18' ' ' ASN . 29.5 m-85 -99.48 -3.48 33.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.579 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.26 167.66 19.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 1' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' E' ' 9' ' ' SER . 1.8 m-85 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.521 ' O ' HG13 ' J' ' 2' ' ' VAL . 3.2 p -170.14 108.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.077 -1.014 . . . . 0.0 109.382 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 p30 172.81 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -85.03 -23.68 28.51 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.32 -0.862 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -78.37 -40.69 35.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.965 . . . . 0.0 109.384 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 6' ' ' LEU . . . . . 0.414 ' N ' HD23 ' J' ' 6' ' ' LEU . 5.6 mt -80.12 -37.69 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.32 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.421 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 10.8 t -63.17 -36.82 84.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.435 ' O ' HG22 ' J' ' 12' ' ' VAL . . . -79.84 -17.57 74.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -84.06 -10.9 57.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -94.1 -23.82 17.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.601 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 9.3 mt -80.39 -47.73 13.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 109.661 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.442 ' H ' HG22 ' J' ' 12' ' ' VAL . 2.6 m -53.06 -32.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 109.99 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.47 -48.97 59.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 109.733 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.88 12.34 6.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.27 -50.23 5.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 12.9 p90 -72.56 -20.82 61.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.509 HD23 HD23 ' D' ' 17' ' ' LEU . 46.1 tp -76.57 -31.74 57.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.59 -46.89 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 109.052 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' J' ' 23' ' ' GLY . 0.1 OUTLIER -56.21 -42.24 76.89 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 108.977 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -140.79 15.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.2 -0.34 48.95 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.234 -1.156 . . . . 0.0 109.751 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -64.67 -67.99 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.103 -0.998 . . . . 0.0 109.524 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' J' ' 19' ' ' CYS . . . 133.06 171.8 12.82 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 13.1 p90 -164.81 177.89 7.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.125 -1.221 . . . . 0.0 109.443 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.02 156.14 48.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -137.38 94.04 2.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.03 89.31 6.53 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 109.636 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.61 -60.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.565 2.176 . . . . 0.0 110.574 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' J' ' 30' ' ' THR . 4.3 tttt 59.24 92.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.519 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 30' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' J' ' 29' ' ' LYS . 13.6 m . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.6 -31.84 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -1.099 . . . . 0.0 109.238 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.99 -35.88 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.8 . . . . 0.0 109.757 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 4' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 7.0 mm-40 -105.23 59.3 0.68 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 5' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 23.5 tt0 179.25 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.488 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 6' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' K' ' 9' ' ' SER . 72.2 m -100.85 -35.66 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.31 -40.23 77.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 55.4 p -82.6 -17.22 45.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.011 . . . . 0.0 109.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 9' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.0 OUTLIER -159.27 119.74 3.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 mp -47.54 100.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.578 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' HG2' ' K' ' 5' ' ' GLN . 88.8 m -52.12 159.83 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 109.435 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.57 167.21 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -43.2 99.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -0.934 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -62.68 -35.47 79.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.184 -0.947 . . . . 0.0 109.387 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 15' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' K' ' 18' ' ' ASN . 0.0 OUTLIER -65.79 -38.41 88.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -81.86 -9.72 59.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -79.19 -28.21 42.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 109.675 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 18' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' K' ' 15' ' ' GLN . 55.2 p30 -74.58 -7.6 53.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 109.75 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.41 -8.41 22.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.25 169.41 17.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.132 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.37 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.569 ' O ' HG13 ' L' ' 2' ' ' VAL . 5.6 p -172.64 108.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.151 -0.968 . . . . 0.0 109.401 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p30 172.14 -36.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.049 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -81.03 -27.38 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.364 -0.835 . . . . 0.0 109.375 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -75.32 -38.42 60.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 6' ' ' LEU . . . . . 0.437 ' N ' HD23 ' L' ' 6' ' ' LEU . 4.7 mt -82.82 -38.67 22.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 109.568 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 51.7 t -62.09 -33.7 74.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.93 -19.95 62.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 74.3 m -82.83 -5.97 59.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -1.11 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -99.5 -22.0 15.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 109.161 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.5 mt -82.98 -47.68 11.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -53.19 -33.85 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.01 -1.056 . . . . 0.0 109.552 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.08 -46.61 70.53 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.472 ' CB ' ' H3 ' ' L' ' 32' ' ' IPH . . . -86.24 11.01 13.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.68 -51.13 5.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 13.5 p90 -71.3 -22.9 61.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.485 HD23 HD23 ' F' ' 17' ' ' LEU . 49.8 tp -74.5 -34.61 63.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.776 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.93 -47.74 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.65 -37.86 68.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.5 -145.97 18.29 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -81.58 0.27 39.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.58 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -62.95 -73.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.32 165.01 10.16 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 24' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 11.2 p90 -160.24 169.3 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -1.087 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -129.8 152.49 49.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.192 -0.943 . . . . 0.0 109.389 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -129.9 96.62 4.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.853 . . . . 0.0 109.714 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.82 89.51 6.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.57 -62.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.597 2.198 . . . . 0.0 110.195 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt 62.09 92.89 0.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.53 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.452 ' H3 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.424 ' H3 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 22' ' ' IPH . . . . . 0.49 ' H3 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' L' L ' 32' ' ' IPH . . . . . 0.472 ' H3 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.435 HG23 HG13 ' A' ' 3' ' ' VAL . 20.7 tt -133.22 6.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -1.108 . . . . 0.0 109.429 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 HG23 ' A' ' 2' ' ' ILE . 16.4 m -126.03 -8.37 5.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.264 -0.898 . . . . 0.0 109.75 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -111.77 1.61 16.72 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.199 -0.938 . . . . 0.0 109.792 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.86 13.19 2.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.178 -0.951 . . . . 0.0 109.304 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.73 -42.59 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.33 -16.34 63.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.423 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.9 p -70.89 -22.03 62.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.014 . . . . 0.0 109.414 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 p -163.69 144.12 8.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mt -52.62 113.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.4 m -84.29 -164.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 0.0 109.1 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.25 171.39 7.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -34.93 75.9 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 109.277 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -67.4 -38.87 85.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.955 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.92 -14.91 59.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 109.938 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.92 -28.87 63.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.023 . . . . 0.0 109.46 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -57.24 -19.03 18.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.57 59.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.1 t -123.13 119.76 31.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.641 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.2 t30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.343 179.783 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' I' ' 9' ' ' SER . 25.8 m -131.06 46.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 109.875 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.53 -3.28 28.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -48.28 -38.53 19.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.31 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -93.42 -30.6 14.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.589 HD22 ' CG ' ' J' ' 10' ' ' HIS . 39.6 mt -80.95 -70.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 108.957 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.6 t -51.2 -37.82 48.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.665 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.438 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -61.85 -44.28 98.07 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 31.0 p -67.84 -12.86 61.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 110.008 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -86.15 -24.63 26.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.119 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.531 HD22 ' C1 ' ' B' ' 32' ' ' IPH . 5.7 mt -90.47 -33.77 15.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.516 HG21 ' CZ ' ' D' ' 16' ' ' TYR . 16.8 m -68.43 -38.54 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.472 ' N ' HG23 ' B' ' 12' ' ' VAL . 13.9 tt0 -66.04 -23.86 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.78 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -94.42 -12.89 26.93 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mt -78.67 -28.66 45.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.547 ' CZ ' HG21 ' D' ' 12' ' ' VAL . 60.3 m-85 -48.25 -46.58 35.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -82.26 -36.26 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.78 HG23 ' O ' ' B' ' 14' ' ' ALA . 69.7 t -47.04 -46.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.87 -30.72 26.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.459 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.04 -134.98 11.89 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -7.93 52.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.304 -1.115 . . . . 0.0 109.69 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -57.05 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.11 179.08 29.17 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.408 ' HZ ' ' CZ ' ' B' ' 16' ' ' TYR . 0.3 OUTLIER -166.31 168.23 15.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -1.182 . . . . 0.0 110.031 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.631 ' HB2' ' CD1' ' D' ' 25' ' ' PHE . 32.8 p90 -127.53 154.77 44.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.437 ' CD2' HG11 ' B' ' 12' ' ' VAL . 24.3 t80 -140.85 112.17 7.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 15.1 m -133.2 93.25 22.9 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 109.675 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.07 99.53 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.506 2.137 . . . . 0.0 110.389 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.33 -58.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -132.69 7.66 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.158 -1.201 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.92 -6.29 4.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.211 -0.931 . . . . 0.0 109.74 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -114.07 -0.39 14.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.128 -0.983 . . . . 0.0 109.604 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -134.65 9.46 3.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.189 -0.944 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.25 -39.85 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.705 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 t -66.93 -16.17 64.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 43.1 p -70.22 -24.53 63.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.92 . . . . 0.0 109.302 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' SER . . . . . 0.404 ' HA ' HG11 ' L' ' 2' ' ' VAL . 94.9 p -160.47 146.09 14.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.502 HD11 ' O ' ' L' ' 2' ' ' VAL . 4.3 mt -54.55 117.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.7 m -89.45 -165.48 1.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 109.714 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -107.17 166.27 10.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -34.56 78.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.73 -37.56 79.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.859 . . . . 0.0 109.601 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.91 -38.39 86.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 109.53 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.81 -16.23 55.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 109.757 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.51 -30.3 68.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -56.42 -19.13 13.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.09 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -110.6 58.61 0.61 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.231 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 t -121.64 118.44 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ASN . . . . . 0.559 ' ND2' ' CZ ' ' D' ' 25' ' ' PHE . 9.5 t30 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.509 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.359 0.6 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' G' ' 9' ' ' SER . 30.9 m -132.02 44.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.244 -0.91 . . . . 0.0 109.159 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -100.15 -8.56 23.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 109.552 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -44.34 -40.46 5.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.44 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -90.74 -32.38 16.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.504 HD22 ' CG ' ' H' ' 10' ' ' HIS . 29.0 mt -80.34 -71.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.477 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 8.3 t -51.37 -34.39 34.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.501 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -64.33 -43.86 96.28 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 9' ' ' SER . . . . . 0.428 ' HA ' HG22 ' D' ' 12' ' ' VAL . 17.2 p -69.41 -14.94 63.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -1.162 . . . . 0.0 109.711 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.94 -24.38 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.895 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.573 HD22 ' C1 ' ' D' ' 32' ' ' IPH . 6.7 mt -92.79 -32.79 14.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.547 HG21 ' CZ ' ' B' ' 16' ' ' TYR . 15.4 m -68.29 -38.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.475 ' N ' HG23 ' D' ' 12' ' ' VAL . 15.0 tt0 -64.91 -27.06 68.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.705 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -91.62 -12.06 35.32 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.333 -0.854 . . . . 0.0 109.853 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.21 -28.82 38.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.516 ' CZ ' HG21 ' B' ' 12' ' ' VAL . 62.3 m-85 -48.38 -45.07 35.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.199 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 mt -81.89 -38.5 25.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.705 HG23 ' O ' ' D' ' 14' ' ' ALA . 67.5 t -45.85 -44.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.891 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.86 -29.77 25.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.899 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.2 -131.66 10.65 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.73 -6.99 38.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.65 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -56.69 -81.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.061 -1.024 . . . . 0.0 109.467 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.78 176.74 28.28 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 25' ' ' PHE . 0.4 OUTLIER -164.07 161.31 22.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -1.208 . . . . 0.0 109.883 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 25' ' ' PHE . . . . . 0.631 ' CD1' ' HB2' ' B' ' 25' ' ' PHE . 4.4 m-85 -119.11 163.16 17.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.416 -0.803 . . . . 0.0 109.284 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.43 ' CD2' HG11 ' D' ' 12' ' ' VAL . 33.0 t80 -151.16 105.69 3.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 108.896 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 24.4 m -127.19 94.43 38.89 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.594 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.98 97.28 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.555 2.17 . . . . 0.0 110.369 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -61.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.221 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.35 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.44 3.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -1.125 . . . . 0.0 109.563 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.9 -9.58 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.94 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.89 1.69 19.35 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.104 -0.997 . . . . 0.0 110.164 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -136.7 11.33 3.16 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.041 -1.037 . . . . 0.0 109.669 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 6' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' E' ' 9' ' ' SER . 0.0 OUTLIER -144.32 -40.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.55 -18.0 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 108.954 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 41.4 p -69.61 -25.1 63.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.376 -0.828 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 9' ' ' SER . . . . . 0.421 ' O ' ' O ' ' E' ' 6' ' ' CYS . 12.5 p -159.56 148.82 18.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.438 HG12 ' HB3' ' J' ' 5' ' ' HIS . 4.0 mt -58.7 115.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.55 -158.69 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.785 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.1 167.82 10.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 13' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' L' ' 17' ' ' LEU . 0.1 OUTLIER -66.11 -35.78 81.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -66.05 -40.79 91.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.986 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -80.37 -15.45 56.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -0.973 . . . . 0.0 109.594 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.14 -25.79 62.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.722 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -60.42 -19.49 56.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.215 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.7 62.05 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 t -125.45 119.67 28.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.461 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.424 ' O ' HG23 ' F' ' 2' ' ' VAL . 25.4 m -129.38 44.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.264 -0.898 . . . . 0.0 109.375 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -100.52 -4.68 28.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.377 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -48.6 -38.04 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -93.32 -30.92 14.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.584 HD21 ' H3 ' ' B' ' 32' ' ' IPH . 35.2 mt -81.36 -71.1 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.085 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.495 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.5 t -50.18 -37.21 33.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.44 -0.787 . . . . 0.0 109.356 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.483 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -61.76 -42.97 99.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 9' ' ' SER . . . . . 0.469 ' HA ' HG22 ' F' ' 12' ' ' VAL . 58.4 p -70.85 -13.53 62.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.132 -1.216 . . . . 0.0 110.043 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -84.07 -24.38 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.985 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.499 HD22 ' C1 ' ' E' ' 31' ' ' IPH . 6.5 mt -91.64 -33.45 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.813 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.557 HG21 ' CZ ' ' H' ' 16' ' ' TYR . 18.4 m -69.22 -36.26 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 109.848 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.419 ' N ' HG23 ' F' ' 12' ' ' VAL . 16.0 tt0 -69.11 -22.22 63.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.769 ' O ' HG23 ' F' ' 18' ' ' VAL . . . -95.52 -11.03 28.1 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.71 -28.19 36.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.499 ' CZ ' HG21 ' H' ' 12' ' ' VAL . 54.0 m-85 -48.61 -47.61 39.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 109.655 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' F' ' 18' ' ' VAL . 12.4 mt -80.93 -38.59 27.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.769 HG23 ' O ' ' F' ' 14' ' ' ALA . 70.8 t -44.62 -45.68 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.96 -30.04 26.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.36 -133.21 11.22 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.0 -12.89 29.54 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.256 -1.144 . . . . 0.0 109.538 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 23.0 mtt180 -50.72 -83.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.2 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.04 -177.46 33.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 24' ' ' PHE . . . . . 0.408 ' HZ ' ' CZ ' ' F' ' 16' ' ' TYR . 0.2 OUTLIER -171.45 168.86 6.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -1.134 . . . . 0.0 109.469 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -132.07 166.12 22.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -147.42 115.44 6.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.52 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -132.66 91.53 29.72 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.32 98.51 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.191 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.0 -58.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.59 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.578 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.08 8.26 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -1.2 . . . . 0.0 109.735 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -127.2 -5.76 4.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -113.23 -1.14 14.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.021 -1.049 . . . . 0.0 109.812 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -134.4 11.58 3.8 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.083 -1.011 . . . . 0.0 109.704 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 6' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' G' ' 9' ' ' SER . 0.1 OUTLIER -143.98 -40.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 t -66.4 -18.11 65.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 60.5 p -69.17 -22.28 63.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.48 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 9' ' ' SER . . . . . 0.659 ' HA ' HG11 ' D' ' 2' ' ' VAL . 4.3 p -162.67 148.58 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.299 -0.875 . . . . 0.0 109.433 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mt -58.08 115.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.77 -165.02 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.1 167.4 10.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -35.55 81.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.732 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -67.27 -37.75 83.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.967 . . . . 0.0 109.852 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.39 -40.5 89.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -77.51 -14.14 59.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.15 -30.35 63.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.338 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -53.9 -23.45 12.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.37 64.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.97 120.89 30.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.331 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.562 -179.946 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.298 0.57 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 31.8 m -126.17 41.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' H' ' 4' ' ' GLN . 11.6 m120 -96.92 -9.92 27.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 4' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' H' ' 3' ' ' ASN . 50.2 tt0 -43.03 -40.14 2.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -90.98 -33.22 15.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 109.313 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 29.9 mt -78.44 -73.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 7.7 t -47.13 -41.46 17.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.815 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 8' ' ' GLY . . . . . 0.441 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -58.84 -44.87 95.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 9' ' ' SER . . . . . 0.411 ' HA ' HG22 ' H' ' 12' ' ' VAL . 24.3 p -67.33 -14.92 63.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -1.114 . . . . 0.0 109.838 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 10' ' ' HIS . . . . . 0.504 ' CG ' HD22 ' D' ' 6' ' ' LEU . 5.6 m-70 -85.88 -20.36 29.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.665 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.572 HD22 ' C1 ' ' G' ' 31' ' ' IPH . 9.0 mt -94.87 -35.3 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.384 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.499 HG21 ' CZ ' ' F' ' 16' ' ' TYR . 15.6 m -68.1 -34.18 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -69.82 -23.08 63.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.141 -0.974 . . . . 0.0 109.219 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.756 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -95.09 -9.99 32.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.39 -0.819 . . . . 0.0 109.538 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -82.37 -26.83 32.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.557 ' CZ ' HG21 ' F' ' 12' ' ' VAL . 53.5 m-85 -50.04 -44.06 51.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.615 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.09 -36.45 21.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.27 -0.894 . . . . 0.0 109.724 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.756 HG23 ' O ' ' H' ' 14' ' ' ALA . 76.5 t -46.33 -42.67 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 -29.39 21.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.79 -133.34 11.31 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -11.5 38.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -1.17 . . . . 0.0 109.738 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -53.01 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.037 . . . . 0.0 109.646 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.98 176.94 23.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.24 175.41 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 109.429 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 8.6 p90 -137.94 167.24 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.526 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -149.57 115.48 5.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.288 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -133.84 90.82 26.33 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.227 -0.92 . . . . 0.0 109.328 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.16 101.0 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.674 2.249 . . . . 0.0 110.092 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.82 -57.58 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 109.656 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.056 -0.974 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.439 HG23 HG13 ' I' ' 3' ' ' VAL . 19.6 tt -131.08 8.05 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 0.0 109.501 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 3' ' ' VAL . . . . . 0.439 HG13 HG23 ' I' ' 2' ' ' ILE . 15.9 m -128.71 -5.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.299 -0.876 . . . . 0.0 109.771 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -115.06 -0.06 13.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.172 -0.955 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -135.01 8.16 3.47 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.47 -41.43 0.41 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.75 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -64.63 -20.71 66.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 8' ' ' THR . . . . . 0.425 ' O ' HG11 ' B' ' 2' ' ' VAL . 39.0 p -66.44 -23.39 66.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 9' ' ' SER . . . . . 0.604 ' HA ' HG11 ' B' ' 2' ' ' VAL . 7.5 p -161.65 146.32 13.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.65 114.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.56 -164.25 0.98 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -109.56 168.12 9.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -34.77 78.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -67.3 -39.56 85.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.45 -39.99 92.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.32 -14.3 59.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.852 . . . . 0.0 109.899 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.81 -27.17 62.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -58.05 -18.62 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.359 -0.838 . . . . 0.0 109.74 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -111.97 61.31 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -122.84 121.85 37.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.198 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.504 -179.759 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 11.0 t80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.271 0.557 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.42 HG23 ' O ' ' J' ' 2' ' ' VAL . 31.0 m -133.33 47.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 3' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' J' ' 4' ' ' GLN . 13.2 m120 -102.57 -8.46 20.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.842 . . . . 0.0 109.33 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 4' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' J' ' 3' ' ' ASN . 50.4 tt0 -44.03 -38.38 3.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.352 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 5' ' ' HIS . . . . . 0.438 ' HB3' HG12 ' E' ' 10' ' ' ILE . 86.4 t60 -93.34 -33.95 13.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.94 . . . . 0.0 109.211 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 6' ' ' LEU . . . . . 0.509 HD21 ' H3 ' ' E' ' 31' ' ' IPH . 38.9 mt -78.03 -70.28 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.437 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.499 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 7.3 t -51.97 -37.51 53.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.354 -0.842 . . . . 0.0 109.477 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.439 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -60.76 -45.17 96.98 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 9' ' ' SER . . . . . 0.493 ' HA ' HG22 ' J' ' 12' ' ' VAL . 86.6 p -68.51 -16.08 63.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -1.211 . . . . 0.0 110.078 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 10' ' ' HIS . . . . . 0.589 ' CG ' HD22 ' B' ' 6' ' ' LEU . 4.7 m-70 -82.92 -20.49 35.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.043 . . . . 0.0 109.716 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.547 HD22 ' C1 ' ' J' ' 32' ' ' IPH . 7.8 mt -95.16 -34.18 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.508 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.504 HG21 ' CZ ' ' L' ' 16' ' ' TYR . 19.1 m -68.19 -33.9 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.107 -0.995 . . . . 0.0 109.239 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -70.97 -23.77 62.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.605 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.81 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -95.55 -8.1 36.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.31 -0.869 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.8 -25.39 30.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.505 ' CZ ' HG21 ' L' ' 12' ' ' VAL . 46.3 m-85 -51.93 -44.54 63.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.456 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.34 -39.17 21.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.618 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 18' ' ' VAL . . . . . 0.81 HG23 ' O ' ' J' ' 14' ' ' ALA . 69.5 t -44.75 -44.15 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.54 -30.62 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.61 -135.42 12.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -9.78 44.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.214 -1.168 . . . . 0.0 109.949 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -53.84 -76.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 0.0 109.664 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.46 176.8 22.99 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.21 171.16 11.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 109.688 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 25' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 6.1 p90 -134.39 165.07 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.47 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 26' ' ' TYR . . . . . 0.411 ' CD2' HG11 ' J' ' 12' ' ' VAL . 23.3 t80 -146.07 118.76 8.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.254 -0.904 . . . . 0.0 109.26 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 23.7 m -136.89 91.0 15.59 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.717 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.34 100.05 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.243 . . . . 0.0 110.413 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -59.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.256 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.495 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.428 HG23 HG13 ' K' ' 3' ' ' VAL . 20.6 tt -133.03 9.5 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -1.1 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.428 HG13 HG23 ' K' ' 2' ' ' ILE . 15.6 m -129.71 -3.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.936 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -116.25 -2.1 12.22 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.08 -1.013 . . . . 0.0 109.446 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -133.23 11.18 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.341 -0.849 . . . . 0.0 109.408 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 -40.78 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 109.739 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -66.16 -16.76 64.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.964 . . . . 0.0 109.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -69.42 -26.29 64.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.236 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 6.4 p -158.08 149.9 21.69 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -0.913 . . . . 0.0 109.544 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.58 115.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -87.78 -164.27 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.984 . . . . 0.0 109.49 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.28 171.08 7.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.301 -0.874 . . . . 0.0 109.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -36.78 77.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.348 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -65.57 -38.66 90.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.669 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -66.05 -40.38 90.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.1 mt -78.43 -13.54 59.79 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.851 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.88 -28.29 63.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -57.97 -17.23 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -0.79 . . . . 0.0 109.659 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.82 60.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 t -123.17 120.36 32.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.393 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.502 ' O ' HD11 ' C' ' 10' ' ' ILE . 29.0 m -127.8 45.75 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.54 -6.57 23.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -46.06 -39.69 9.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -92.26 -30.75 15.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 6' ' ' LEU . . . . . 0.622 HD21 ' H3 ' ' D' ' 32' ' ' IPH . 31.7 mt -80.73 -72.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.193 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.496 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 8.3 t -49.49 -39.95 35.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.416 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -59.68 -43.53 97.69 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 87.4 p -68.33 -18.15 64.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.16 -1.2 . . . . 0.0 109.784 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -81.56 -21.73 38.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.992 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.511 HD22 ' C1 ' ' L' ' 32' ' ' IPH . 6.7 mt -93.75 -34.35 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.505 HG21 ' CZ ' ' J' ' 16' ' ' TYR . 18.6 m -67.28 -38.57 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.01 . . . . 0.0 109.51 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.449 ' N ' HG23 ' L' ' 12' ' ' VAL . 17.1 tt0 -65.72 -25.07 67.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.898 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.752 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -92.57 -14.14 28.71 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 6.7 mt -78.63 -31.31 46.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 0.0 109.401 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.504 ' CZ ' HG21 ' J' ' 12' ' ' VAL . 44.7 m-85 -45.51 -45.38 13.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.9 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' E' ' 13' ' ' LEU . 13.1 mt -84.0 -35.75 23.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 109.933 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 18' ' ' VAL . . . . . 0.752 HG23 ' O ' ' L' ' 14' ' ' ALA . 70.3 t -47.42 -45.36 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.61 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.81 -33.52 27.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.234 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.75 -134.96 12.02 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -11.49 39.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.19 -1.182 . . . . 0.0 109.471 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -52.71 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.921 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.34 178.47 27.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.29 172.29 9.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.158 -1.201 . . . . 0.0 109.69 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -134.21 163.62 29.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -147.38 113.34 5.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.226 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -132.56 89.91 34.67 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.767 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.16 100.6 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 110.47 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -159.63 -62.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.337 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.584 ' H3 ' HD21 ' F' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.622 ' H3 ' HD21 ' L' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 31' ' ' IPH . . . . . 0.509 ' H3 ' HD21 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 31' ' ' IPH . . . . . 0.572 ' C1 ' HD22 ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' J' J ' 32' ' ' IPH . . . . . 0.547 ' C1 ' HD22 ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 32' ' ' IPH . . . . . 0.511 ' C1 ' HD22 ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.426 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.3 tt -109.19 0.15 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.215 -1.167 . . . . 0.0 109.618 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 3' ' ' VAL . 59.2 t -100.82 46.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.002 . . . . 0.0 109.681 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -171.58 -40.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.31 -7.17 26.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.126 -0.984 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.85 -18.94 3.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.482 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 0.5 OUTLIER -82.73 -18.26 41.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 109.117 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.3 p -83.72 -12.51 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.533 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.84 2.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.552 ' CD1' ' HB ' ' F' ' 2' ' ' VAL . 2.0 mp -61.57 140.85 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.2 m -103.94 -164.77 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.858 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -103.62 -174.3 2.51 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -0.935 . . . . 0.0 109.23 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.84 -37.37 64.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -68.91 -23.94 64.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.87 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -79.16 -39.36 33.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.593 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.6 mt -82.05 -11.68 58.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.52 -21.26 49.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.687 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -62.13 -18.68 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.962 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.426 ' CD2' HD12 ' A' ' 2' ' ' ILE . 2.8 m-85 -118.33 48.02 1.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.86 110.95 13.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.208 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.267 0.556 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.93 106.02 4.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.34 -0.85 . . . . 0.0 109.319 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.414 ' HB3' ' CB ' ' B' ' 7' ' ' CYS . 22.7 m-80 -103.15 -8.2 20.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 0.0 109.246 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -48.88 -36.91 18.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.215 -0.928 . . . . 0.0 109.031 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.503 ' HB3' HG12 ' I' ' 10' ' ' ILE . 18.5 t60 -95.64 -30.38 13.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.147 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.05 -70.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.492 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.5 t -53.74 -32.16 51.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 0.0 109.767 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.94 -32.21 53.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -79.2 -3.34 45.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -1.23 . . . . 0.0 109.579 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.22 -14.65 20.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.336 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 14.3 mt -91.91 -43.55 9.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.429 ' H ' HG22 ' B' ' 12' ' ' VAL . 2.7 m -56.8 -37.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.12 -36.18 81.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.332 -0.855 . . . . 0.0 109.871 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.89 11.19 39.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.081 -1.012 . . . . 0.0 109.807 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' B' ' 11' ' ' LEU . 0.7 OUTLIER -96.67 -54.91 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 7.8 p90 -63.94 -18.05 63.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.954 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -78.28 -48.18 16.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -0.888 . . . . 0.0 109.45 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.05 -47.97 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.21 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.64 -57.07 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.89 -140.34 15.13 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 20' ' ' GLY . 19.4 mt-10 -45.54 -30.79 1.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.245 . . . . 0.0 109.36 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -69.35 159.81 32.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' B' ' 24' ' ' PHE . . . -100.51 -158.24 27.86 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 11.3 p90 -178.76 177.28 0.88 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -1.142 . . . . 0.0 109.228 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.55 146.39 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.683 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.506 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 28.6 t80 -122.93 87.29 2.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -117.61 105.74 47.49 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.526 ' HB3' HG21 ' A' ' 3' ' ' VAL . 36.3 Cg_endo -78.1 -36.26 1.09 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.499 2.133 . . . . 0.0 110.538 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mttm 64.22 -87.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 109.41 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.528 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.531 HD12 ' CD2' ' C' ' 19' ' ' TYR . 15.4 tt -112.24 0.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.651 HG12 ' O ' ' C' ' 3' ' ' VAL . 55.6 t -101.15 46.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -171.58 -45.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.72 -7.43 37.34 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.696 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' CYS . . . . . 0.442 ' HB2' HG13 ' C' ' 2' ' ' ILE . 0.5 OUTLIER -127.56 -17.71 4.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.163 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -86.34 -16.18 38.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 109.862 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.4 p -86.12 -10.51 54.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 109.517 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.79 148.49 2.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 108.995 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' L' ' 5' ' ' HIS . 1.3 mp -58.25 151.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 109.382 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.7 -174.43 2.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.372 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -177.16 4.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.58 -38.86 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -66.29 -24.62 66.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -79.7 -36.87 36.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.98 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 62.4 mt -85.15 -6.83 59.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.89 -18.21 38.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -65.69 -19.77 66.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.279 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.531 ' CD2' HD12 ' C' ' 2' ' ' ILE . 2.5 m-85 -116.98 48.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.484 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.89 108.24 10.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.494 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.572 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.479 ' HB ' HD13 ' G' ' 10' ' ' ILE . 4.4 t -131.06 106.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 109.529 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -103.16 -8.78 20.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -48.82 -36.55 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -94.62 -31.31 13.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.1 mt -81.39 -71.24 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.484 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 19.5 t -49.75 -37.92 31.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.51 -35.9 68.34 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -75.25 -5.1 42.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.098 -1.236 . . . . 0.0 109.714 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -97.1 -16.27 20.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 16.9 mt -91.97 -41.87 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.818 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.03 -34.98 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 109.735 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -69.54 -34.51 74.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.36 6.83 45.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.195 -0.941 . . . . 0.0 109.84 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.9 OUTLIER -92.24 -57.27 2.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.049 -1.032 . . . . 0.0 109.494 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.524 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 7.6 p90 -61.2 -19.06 61.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.79 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.434 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 1.5 mt -78.03 -48.59 15.79 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -0.963 . . . . 0.0 109.574 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -54.49 -45.16 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.17 -54.42 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.09 -137.33 14.12 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.78 -29.0 4.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -1.138 . . . . 0.0 109.35 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.58 158.36 33.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.271 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.04 -161.8 27.57 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 6.5 p90 -167.33 178.26 5.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -1.224 . . . . 0.0 110.208 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -129.86 133.31 46.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -117.21 88.81 2.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.4 m -124.23 106.25 30.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.323 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.0 Cg_endo -78.52 -32.73 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.344 2.029 . . . . 0.0 110.629 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.53 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.425 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.456 HD12 ' CD2' ' E' ' 19' ' ' TYR . 14.4 tt -114.46 0.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.226 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 3' ' ' VAL . . . . . 0.646 ' O ' HG12 ' E' ' 3' ' ' VAL . 58.3 t -101.81 45.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.285 -0.884 . . . . 0.0 109.988 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -169.96 -42.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.96 -9.15 28.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.311 -0.868 . . . . 0.0 109.722 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.34 -14.24 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 110.352 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.67 -17.41 33.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.937 -1.102 . . . . 0.0 109.316 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -86.32 -10.01 55.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.27 151.62 3.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.498 HD13 ' HB ' ' J' ' 2' ' ' VAL . 2.0 mp -63.46 138.74 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.381 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 61.7 m -102.62 -165.62 1.2 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.081 -1.012 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -104.52 -175.46 2.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.07 -38.85 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 110.031 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -68.38 -24.16 64.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.674 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -78.03 -41.38 35.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 65.1 mt -81.28 -9.62 59.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.233 -0.917 . . . . 0.0 109.993 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.35 -17.7 48.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 109.636 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -66.15 -16.91 64.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.424 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' E' ' 2' ' ' ILE . 3.0 m-85 -119.27 50.6 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -130.48 110.21 11.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.543 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.215 0.531 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.552 ' HB ' ' CD1' ' A' ' 10' ' ' ILE . 3.9 t -138.81 107.46 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.216 -0.927 . . . . 0.0 109.468 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -103.68 -5.88 22.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.741 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -50.94 -37.54 44.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.075 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 5' ' ' HIS . . . . . 0.411 ' CB ' HG12 ' A' ' 10' ' ' ILE . 16.3 t60 -95.21 -24.68 16.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.356 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 22.0 mt -87.83 -69.85 0.67 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 10.2 t -52.96 -35.65 59.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.36 -31.69 63.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 9' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' F' ' 5' ' ' HIS . 1.1 t -77.95 -7.83 57.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -1.216 . . . . 0.0 109.576 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -93.86 -16.87 23.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 110.091 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 10.9 mt -91.41 -41.42 10.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.24 -32.27 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.5 -33.3 66.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 109.652 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' F' ' 18' ' ' VAL . . . -100.72 6.58 43.99 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.8 OUTLIER -92.46 -54.71 3.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.682 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 7.2 p90 -63.9 -20.8 66.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.81 -49.86 16.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' F' ' 14' ' ' ALA . 75.5 t -52.06 -43.53 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 79.5 m -69.49 -51.8 32.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.661 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 20' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 87.78 -139.98 16.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 21' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' F' ' 20' ' ' GLY . 17.7 mt-10 -44.95 -34.34 2.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 109.365 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -67.37 159.04 30.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.811 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.25 -165.3 24.72 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -166.69 -171.13 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -1.112 . . . . 0.0 109.621 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.04 142.62 30.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -120.76 94.68 4.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -126.98 103.36 23.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 109.216 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 28' ' ' PRO . . . . . 0.581 ' HB3' HG21 ' E' ' 3' ' ' VAL . 35.0 Cg_endo -76.7 -36.41 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.393 2.062 . . . . 0.0 110.464 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 65.54 -86.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' G' ' 19' ' ' TYR . 14.8 tt -111.16 -0.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -1.136 . . . . 0.0 109.519 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 3' ' ' VAL . . . . . 0.631 ' O ' HG12 ' G' ' 3' ' ' VAL . 55.6 t -100.42 47.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.246 -0.908 . . . . 0.0 109.708 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -171.91 -42.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.98 . . . . 0.0 109.737 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.5 -9.69 24.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 6' ' ' CYS . . . . . 0.44 ' HB2' HG13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -127.62 -9.08 5.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.931 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.47 -13.96 27.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 109.477 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 41.0 p -88.23 -14.0 39.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.34 149.33 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.479 HD13 ' HB ' ' D' ' 2' ' ' VAL . 1.8 mp -57.33 146.66 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.188 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -112.3 -168.4 1.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 110.404 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -101.78 176.28 5.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -65.71 -41.96 91.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.962 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -64.76 -25.27 67.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.281 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -78.06 -39.91 40.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.048 -1.032 . . . . 0.0 109.694 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.28 -6.09 59.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.612 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -83.75 -19.67 34.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.12 -18.87 65.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.478 -0.764 . . . . 0.0 109.408 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 19' ' ' TYR . . . . . 0.506 ' CD2' HD12 ' G' ' 2' ' ' ILE . 2.0 m-85 -118.28 51.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.381 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.94 107.62 8.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.853 . . . . 0.0 109.451 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.43 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.395 0.616 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.649 ' HB ' HD13 ' K' ' 10' ' ' ILE . 4.9 t -140.73 102.57 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.43 -0.794 . . . . 0.0 109.279 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' H' ' 4' ' ' GLN . 23.6 m-80 -100.33 -11.65 20.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 4' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' H' ' 3' ' ' ASN . 2.3 tt0 -44.76 -37.11 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.836 . . . . 0.0 109.168 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 5' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' H' ' 9' ' ' SER . 13.7 t60 -95.09 -29.48 14.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.813 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.9 mt -84.22 -69.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.5 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.477 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 1.4 t -52.88 -34.86 56.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 109.151 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.88 -32.8 60.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 9' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' H' ' 5' ' ' HIS . 1.4 t -77.66 -5.87 51.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -1.178 . . . . 0.0 109.867 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.13 -14.87 21.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.965 . . . . 0.0 109.882 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.1 mt -91.85 -42.59 9.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.642 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.453 ' H ' HG22 ' H' ' 12' ' ' VAL . 2.7 m -58.03 -35.32 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.872 . . . . 0.0 109.805 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.26 -35.84 76.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.52 8.99 44.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.287 -0.883 . . . . 0.0 109.828 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 15' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.7 OUTLIER -95.56 -55.71 2.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 8.5 p90 -62.31 -22.08 65.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.414 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 1.6 mt -74.0 -49.8 22.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.26 -44.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -52.7 49.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.963 -1.086 . . . . 0.0 109.023 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.86 -137.51 14.27 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.98 -28.41 3.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -72.64 156.55 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.92 . . . . 0.0 109.19 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.51 -163.06 29.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -171.48 -171.54 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.338 -1.095 . . . . 0.0 109.196 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 25' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 3.2 p90 -146.64 146.94 30.57 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -122.23 92.4 3.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -122.5 104.99 36.51 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.367 -0.833 . . . . 0.0 109.262 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 28' ' ' PRO . . . . . 0.596 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.9 Cg_endo -78.18 -39.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 0.0 109.977 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.6 OUTLIER 69.91 -85.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.423 -179.673 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' I' ' 19' ' ' TYR . 12.6 tt -110.51 0.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -1.151 . . . . 0.0 109.553 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 3' ' ' VAL . . . . . 0.592 ' O ' HG12 ' I' ' 3' ' ' VAL . 46.8 t -101.64 48.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.248 -0.907 . . . . 0.0 109.762 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -172.62 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.842 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.03 -11.94 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 110.009 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -126.78 -13.87 5.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.06 -15.36 41.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -87.81 -17.44 31.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.27 153.44 13.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' B' ' 5' ' ' HIS . 1.9 mp -64.59 140.78 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.987 . . . . 0.0 109.374 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 62.8 m -103.26 -163.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.44 -173.91 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp -73.28 -39.58 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.258 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -67.68 -22.67 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.41 -0.806 . . . . 0.0 109.735 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -81.0 -36.62 30.42 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.57 -9.52 57.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.55 -19.64 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 0.0 109.904 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -64.17 -20.1 65.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 19' ' ' TYR . . . . . 0.495 ' CE2' HD12 ' I' ' 2' ' ' ILE . 2.3 m-85 -115.87 48.77 1.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.523 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -128.47 109.33 11.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.377 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' E' ' 10' ' ' ILE . 4.6 t -136.01 103.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.816 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -101.31 -10.68 20.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.555 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -47.18 -35.08 6.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -96.77 -29.09 13.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.28 -69.05 0.67 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.08 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 1.4 t -53.56 -33.05 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.367 -0.833 . . . . 0.0 109.367 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.61 54.97 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -77.6 -2.49 36.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.007 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -97.95 -15.45 20.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 14.2 mt -92.49 -42.38 9.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.578 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -58.32 -34.28 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.65 -33.02 70.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.91 6.59 43.71 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.195 -0.941 . . . . 0.0 109.704 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 15' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' J' ' 11' ' ' LEU . 0.8 OUTLIER -92.62 -55.91 3.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 10.0 p90 -63.08 -18.6 63.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.15 -50.62 11.62 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.101 -1.0 . . . . 0.0 109.103 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.65 -46.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.32 -53.28 38.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 -137.93 14.78 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -47.33 -29.87 2.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.78 153.58 41.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.59 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.68 30.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -163.5 -170.72 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -1.103 . . . . 0.0 109.573 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 25' ' ' PHE . . . . . 0.445 ' CD1' ' O ' ' J' ' 25' ' ' PHE . 36.0 p90 -144.01 143.93 31.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.597 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -121.55 90.64 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.39 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -122.16 103.65 38.95 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 28' ' ' PRO . . . . . 0.538 ' HB3' HG21 ' I' ' 3' ' ' VAL . 35.3 Cg_endo -76.97 -36.76 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.425 2.083 . . . . 0.0 110.496 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 65.52 -86.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.333 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.487 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.484 HD12 ' CD2' ' K' ' 19' ' ' TYR . 15.8 tt -111.53 1.62 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -1.14 . . . . 0.0 109.649 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.621 HG12 ' O ' ' K' ' 3' ' ' VAL . 48.5 t -102.38 46.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -171.41 -42.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 109.623 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.15 33.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 109.918 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -129.71 -23.17 2.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.07 -1.019 . . . . 0.0 110.183 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 7' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' L' ' 7' ' ' CYS . 0.5 OUTLIER -79.87 -12.35 59.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.048 -1.032 . . . . 0.0 109.593 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -90.22 -9.62 47.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.09 152.77 2.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.649 HD13 ' HB ' ' H' ' 2' ' ' VAL . 1.8 mp -65.65 135.27 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.994 . . . . 0.0 109.265 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -97.29 -164.02 1.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 109.594 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.21 -173.16 2.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -74.34 -40.5 62.12 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.165 -0.959 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -66.58 -26.52 67.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.06 -37.78 57.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.876 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 55.2 mt -85.6 -6.26 59.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.899 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.1 -19.47 36.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.991 . . . . 0.0 109.274 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -64.57 -16.98 63.51 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.359 -0.838 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 19' ' ' TYR . . . . . 0.484 ' CD2' HD12 ' K' ' 2' ' ' ILE . 2.4 m-85 -119.58 47.73 1.66 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 20' ' ' CYS . . . . . 0.418 ' O ' ' OXT' ' K' ' 21' ' ' ASN . 0.1 OUTLIER -128.08 108.5 10.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.534 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 21' ' ' ASN . . . . . 0.418 ' OXT' ' O ' ' K' ' 20' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.502 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 t -136.76 107.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 109.662 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -102.95 -8.21 20.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.732 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -47.84 -34.55 8.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 5' ' ' HIS . . . . . 0.543 ' CB ' HG12 ' C' ' 10' ' ' ILE . 19.2 t60 -98.75 -29.33 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 mt -82.44 -69.75 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.107 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.478 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 11.8 t -53.88 -33.92 57.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.24 -33.41 56.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 9' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' L' ' 5' ' ' HIS . 2.0 t -77.34 -4.57 45.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -1.104 . . . . 0.0 109.637 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -98.16 -14.42 20.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.194 -0.941 . . . . 0.0 109.541 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 15.6 mt -91.98 -44.12 9.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.37 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.419 ' H ' HG22 ' L' ' 12' ' ' VAL . 2.6 m -56.57 -35.1 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.932 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -69.57 -35.57 75.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 109.699 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.69 8.7 44.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' L' ' 11' ' ' LEU . 0.7 OUTLIER -94.63 -52.73 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.773 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 12.7 p90 -66.3 -18.87 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.003 -1.061 . . . . 0.0 109.366 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.63 -48.18 17.49 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.94 -46.76 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.16 -55.22 27.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.223 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.4 -138.53 14.34 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -48.49 -29.4 4.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 0.0 109.31 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -72.04 156.04 39.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 109.438 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.55 -165.25 29.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -167.23 -176.88 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -1.13 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -137.55 146.54 44.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -124.07 85.56 2.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 105.1 50.15 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 109.534 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 28' ' ' PRO . . . . . 0.6 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.4 Cg_endo -78.86 -32.13 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 110.319 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mttm 61.77 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.349 -179.634 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.403 HD13 HD11 ' B' ' 15' ' ' LEU . 80.9 mt -122.47 -24.88 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -1.158 . . . . 0.0 109.492 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.25 -14.98 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.226 -0.921 . . . . 0.0 109.54 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.84 45.52 2.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -166.28 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.845 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.54 -24.7 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -14.6 59.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 9' ' ' SER . 33.0 p -97.56 3.1 50.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 109.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' THR . 80.9 p -179.46 137.58 0.13 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.161 -0.962 . . . . 0.0 109.688 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -54.73 147.14 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.845 . . . . 0.0 109.472 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -121.14 174.09 6.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -101.23 -177.16 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 4.4 mp -75.16 -24.87 57.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.502 -0.749 . . . . 0.0 109.654 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.98 -43.03 65.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.673 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -70.77 -42.45 70.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.647 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.74 -23.27 61.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 9.3 mt-10 -76.75 -22.46 53.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -57.74 -23.67 53.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 20' ' ' CYS . 75.2 m-85 -84.21 -104.74 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.285 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 53.41 168.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.902 -1.123 . . . . 0.0 109.791 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.03 -0.985 . . . . 0.0 109.517 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.542 HG23 ' O ' ' B' ' 2' ' ' VAL . 17.0 m -79.07 83.49 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -124.78 -26.07 3.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.981 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -38.76 69.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 109.5 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.537 ' CB ' HG12 ' I' ' 10' ' ' ILE . 12.8 t60 -88.56 -29.44 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.907 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 mt -87.93 -72.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 38.5 t -45.78 -34.91 3.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.61 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.78 -40.58 52.4 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.6 p -74.75 0.97 13.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -1.181 . . . . 0.0 109.97 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.47 -23.21 16.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 109.3 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.536 HD23 ' N ' ' B' ' 11' ' ' LEU . 4.6 mt -87.86 -36.14 17.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.407 -0.808 . . . . 0.0 109.526 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.546 HG23 ' N ' ' B' ' 13' ' ' GLU . 20.7 m -48.99 -46.65 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.407 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.546 ' N ' HG23 ' B' ' 12' ' ' VAL . 0.8 OUTLIER -67.07 -31.97 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.3 21.99 6.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.113 -0.992 . . . . 0.0 109.424 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -115.92 -60.84 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.533 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.492 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.4 p90 -64.12 -33.15 75.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.449 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.791 HD23 HD23 ' H' ' 17' ' ' LEU . 43.0 tp -63.84 -42.52 97.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.24 -61.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.605 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.42 -70.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.0 132.77 0.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 53.81 41.23 32.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -1.162 . . . . 0.0 109.795 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.429 ' HD3' ' SG ' ' A' ' 20' ' ' CYS . 1.8 ttt180 -143.19 -62.25 0.41 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.63 157.64 11.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 8.0 p90 -160.23 172.95 16.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -1.14 . . . . 0.0 109.289 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 8.0 p90 -130.31 146.95 51.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -132.47 99.82 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.715 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.69 91.39 18.14 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 109.416 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 84.22 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.501 2.134 . . . . 0.0 110.306 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -127.84 34.92 4.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.381 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.479 HG23 ' HB2' ' C' ' 6' ' ' CYS . 78.8 mt -122.3 -23.53 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.766 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.2 -12.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -137.98 35.98 2.36 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 109.232 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -155.64 -35.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' CYS . . . . . 0.479 ' HB2' HG23 ' C' ' 2' ' ' ILE . 0.9 OUTLIER -111.08 -23.84 10.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.559 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -12.16 59.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.532 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -99.72 2.47 44.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 109.78 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -178.91 138.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.28 147.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.54 178.06 4.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -104.98 -176.02 2.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 5.3 mp -76.19 -26.36 56.08 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -69.86 -43.58 71.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.862 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -70.97 -42.66 69.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 109.675 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.4 -25.68 63.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.964 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 9.2 mt-10 -74.3 -23.9 59.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.993 -1.067 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -55.66 -26.33 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' C' ' 20' ' ' CYS . 70.9 m-85 -83.25 -109.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.399 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' C' ' 19' ' ' TYR . 4.4 m 54.38 168.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 109.244 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 C--N 1.303 -1.437 0 O-C-N 121.057 -1.027 . . . . 0.0 109.515 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.0 t80 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.54 ' CG1' ' HA ' ' G' ' 9' ' ' SER . 16.0 m -81.76 84.08 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -123.82 -23.77 4.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -40.59 82.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.429 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' HIS . . . . . 0.46 ' CB ' HG12 ' G' ' 10' ' ' ILE . 11.8 t60 -87.68 -25.84 23.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.453 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 29.1 mt -92.05 -72.37 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 39.4 t -45.43 -35.56 3.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -0.855 . . . . 0.0 109.71 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.85 -39.45 54.85 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' SER . . . . . 0.412 ' HB2' ' CZ ' ' B' ' 16' ' ' TYR . 59.7 p -73.88 -2.19 22.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.787 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.52 HD23 ' N ' ' D' ' 11' ' ' LEU . 5.2 mt -89.07 -35.46 16.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.52 HG23 ' N ' ' D' ' 13' ' ' GLU . 18.4 m -50.21 -46.19 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.52 ' N ' HG23 ' D' ' 12' ' ' VAL . 1.3 pt-20 -67.04 -30.95 71.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.414 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.56 17.48 13.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.165 -0.96 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.84 -61.04 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.833 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.506 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 6.3 p90 -63.24 -32.55 73.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.682 HD23 HD23 ' J' ' 17' ' ' LEU . 46.0 tp -65.57 -37.47 86.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -57.55 -62.83 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 109.586 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -66.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.51 135.2 0.11 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 51.84 44.23 29.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -1.064 . . . . 0.0 109.555 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -146.18 -60.82 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.792 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.32 157.03 11.82 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 10.6 p90 -161.38 171.15 18.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.108 -1.231 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' PHE . . . . . 0.567 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 39.2 m-85 -125.83 154.19 42.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -140.75 95.83 2.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.565 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 85.0 m -133.58 91.4 26.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.47 83.86 2.08 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.634 2.223 . . . . 0.0 110.702 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -128.26 36.98 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 109.63 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.557 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.441 HD13 HD11 ' F' ' 15' ' ' LEU . 76.4 mt -120.89 -22.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -1.13 . . . . 0.0 109.643 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.89 -14.05 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.69 41.73 2.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -161.33 -35.99 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.27 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.0 -24.74 10.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.769 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -13.24 60.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.316 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 66.6 p -96.87 -1.67 45.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.758 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -175.36 142.7 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.54 145.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -116.87 179.44 4.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 -174.33 2.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.406 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -77.03 -27.22 54.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.176 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -69.13 -44.06 73.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.75 -39.99 76.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 110.33 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.9 mt -73.88 -24.43 59.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.943 . . . . 0.0 110.042 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.57 -26.16 59.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.063 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -53.42 -25.53 16.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' E' ' 20' ' ' CYS . 70.6 m-85 -83.29 -104.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.107 -0.996 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 20' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' E' ' 19' ' ' TYR . 0.9 OUTLIER 52.55 171.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.949 -1.094 . . . . 0.0 109.495 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 120.97 -1.081 . . . . 0.0 109.554 -179.879 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.543 ' O ' HG23 ' F' ' 2' ' ' VAL . 17.9 m -79.48 83.42 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -123.44 -26.14 4.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.058 -1.026 . . . . 0.0 109.775 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.97 70.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.487 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -85.59 -28.92 24.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 27.0 mt -88.71 -72.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.956 . . . . 0.0 109.743 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -45.25 -36.52 4.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.811 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.94 -39.05 59.78 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 97.3 p -75.49 0.59 16.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 0.0 109.736 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -97.82 -21.96 16.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.508 ' N ' HD23 ' F' ' 11' ' ' LEU . 5.3 mt -89.32 -34.7 16.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.211 -0.931 . . . . 0.0 109.417 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.567 HG23 ' N ' ' F' ' 13' ' ' GLU . 22.5 m -49.37 -46.88 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 109.312 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.567 ' N ' HG23 ' F' ' 12' ' ' VAL . 1.9 pt-20 -66.66 -33.03 74.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.547 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' L' ' 17' ' ' LEU . . . -91.74 17.48 8.91 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.266 -0.896 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.441 HD11 HD13 ' E' ' 2' ' ' ILE . 0.8 OUTLIER -112.68 -61.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 110.117 -179.579 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 6.5 p90 -63.37 -33.02 74.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.035 . . . . 0.0 109.633 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.933 HD23 HD23 ' L' ' 17' ' ' LEU . 41.9 tp -64.9 -42.1 95.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -52.48 -62.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.418 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.6 -71.13 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.536 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.37 135.71 0.37 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 50.93 43.18 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -1.132 . . . . 0.0 109.603 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.03 -66.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.365 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.77 160.22 10.82 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 24' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 13.8 p90 -168.85 163.61 11.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -1.067 . . . . 0.0 109.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -126.34 147.94 49.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 109.532 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -127.87 104.63 7.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.448 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 86.9 m -138.78 89.16 13.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.681 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.97 85.82 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.57 2.18 . . . . 0.0 110.564 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -130.51 37.52 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.286 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.88 -24.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -78.36 -12.38 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.69 34.09 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.228 -0.92 . . . . 0.0 109.696 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -152.64 -37.15 0.11 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.0 -24.62 10.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -15.02 61.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.319 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 45.9 p -98.46 -2.24 39.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.62 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 9' ' ' SER . . . . . 0.54 ' HA ' ' CG1' ' D' ' 2' ' ' VAL . 93.6 p -171.79 135.97 0.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.088 -1.008 . . . . 0.0 109.752 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.46 HG12 ' CB ' ' D' ' 5' ' ' HIS . 2.5 mp -55.01 143.99 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.229 -0.919 . . . . 0.0 108.806 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 m -115.84 177.58 4.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.954 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -104.45 178.19 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.43 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.6 -26.36 62.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.267 -0.896 . . . . 0.0 109.745 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -70.6 -40.9 72.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -72.57 -39.44 67.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.249 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.96 -22.14 58.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.852 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -76.44 -24.46 53.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 109.323 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.46 -25.44 36.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.837 . . . . 0.0 109.813 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 19' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' G' ' 20' ' ' CYS . 73.9 m-85 -83.65 -103.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 20' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' G' ' 19' ' ' TYR . 0.9 OUTLIER 51.19 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.105 . . . . 0.0 109.658 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.554 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 12.1 t80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.471 ' O ' HG23 ' H' ' 2' ' ' VAL . 16.2 m -79.61 81.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -121.87 -28.5 4.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.647 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -39.72 66.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.928 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -89.52 -21.73 22.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 109.736 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 6' ' ' LEU . . . . . 0.654 HD21 ' H5 ' ' L' ' 32' ' ' IPH . 31.0 mt -95.8 -70.7 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.5 t -46.52 -35.64 5.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.46 -39.16 57.31 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -77.0 2.92 13.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -1.182 . . . . 0.0 109.663 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -98.94 -23.39 15.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.523 ' N ' HD23 ' H' ' 11' ' ' LEU . 5.1 mt -87.98 -35.09 17.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.534 HG23 ' N ' ' H' ' 13' ' ' GLU . 18.6 m -49.5 -46.37 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.489 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 13' ' ' GLU . . . . . 0.534 ' N ' HG23 ' H' ' 12' ' ' VAL . 3.0 pt-20 -67.85 -30.92 70.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.317 -0.864 . . . . 0.0 109.418 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.689 ' HA ' HD21 ' B' ' 17' ' ' LEU . . . -95.02 21.63 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.341 -0.85 . . . . 0.0 109.635 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 -60.06 1.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.639 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.467 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 7.4 p90 -64.58 -32.6 74.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.385 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.791 HD23 HD23 ' B' ' 17' ' ' LEU . 43.8 tp -65.05 -42.52 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.383 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -51.98 -65.83 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.224 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 58.6 m -64.33 -73.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.3 136.65 0.84 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 49.87 46.06 24.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.169 -1.195 . . . . 0.0 109.333 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -147.6 -58.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.403 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.06 158.39 14.29 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 24' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 9.8 p90 -163.34 174.7 11.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -1.154 . . . . 0.0 109.428 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 25' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 15.0 p90 -129.93 157.86 41.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -144.04 91.91 2.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 84.9 m -129.19 90.52 44.82 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.75 86.32 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.433 2.089 . . . . 0.0 110.154 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -130.06 35.24 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.912 . . . . 0.0 109.595 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.546 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.418 HD13 HD11 ' J' ' 15' ' ' LEU . 85.3 mt -122.15 -26.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -1.166 . . . . 0.0 109.358 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 p -75.85 -12.86 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -138.25 43.82 2.16 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -163.04 -37.45 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.213 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 6' ' ' CYS . . . . . 0.445 ' SG ' ' O1 ' ' J' ' 32' ' ' IPH . 2.1 t -109.6 -27.05 9.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 109.151 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -72.01 -17.16 62.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 37.1 p -96.38 1.63 51.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 9' ' ' SER . . . . . 0.538 ' HA ' ' CG1' ' B' ' 2' ' ' VAL . 85.8 p -177.24 141.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.543 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' B' ' 5' ' ' HIS . 2.7 mp -60.77 139.93 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.355 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 m -110.04 -174.72 2.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.182 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -110.63 -175.98 2.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.175 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 3.3 mp -75.42 -24.27 57.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.562 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.57 -43.48 63.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.89 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -70.04 -44.58 68.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -68.63 -26.06 65.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.979 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 9.0 mt-10 -74.46 -22.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.032 . . . . 0.0 109.731 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.93 -23.2 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.704 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 19' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' I' ' 20' ' ' CYS . 71.3 m-85 -83.87 -109.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 0.0 109.114 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 20' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' I' ' 19' ' ' TYR . 0.9 OUTLIER 55.61 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.66 -1.275 . . . . 0.0 109.651 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.528 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.54 HG23 ' O ' ' J' ' 2' ' ' VAL . 16.9 m -81.48 83.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 109.568 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.6 -32.2 3.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.75 -39.29 37.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.102 -0.999 . . . . 0.0 109.882 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -88.44 -27.82 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 6' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' J' ' 7' ' ' CYS . 33.7 mt -90.96 -71.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' J' ' 6' ' ' LEU . 6.4 t -45.01 -38.89 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.05 -39.83 84.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 9' ' ' SER . . . . . 0.439 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 79.2 p -75.86 1.46 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.157 -1.202 . . . . 0.0 109.78 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -97.25 -23.41 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.642 HD22 ' C1 ' ' J' ' 32' ' ' IPH . 3.4 mt -88.43 -36.24 16.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.54 HG23 ' N ' ' J' ' 13' ' ' GLU . 23.5 m -48.09 -45.64 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.444 -0.785 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.54 ' N ' HG23 ' J' ' 12' ' ' VAL . 0.8 OUTLIER -68.45 -32.17 72.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.63 21.56 6.25 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -0.876 . . . . 0.0 109.438 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 15' ' ' LEU . . . . . 0.418 HD11 HD13 ' I' ' 2' ' ' ILE . 0.8 OUTLIER -116.05 -60.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.656 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' L' ' 9' ' ' SER . 7.8 p90 -64.66 -32.54 74.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.102 -0.999 . . . . 0.0 109.371 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.682 HD23 HD23 ' D' ' 17' ' ' LEU . 52.8 tp -65.1 -40.8 95.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.31 -61.19 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -69.6 -69.51 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.3 133.88 0.17 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 53.62 43.5 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -1.109 . . . . 0.0 109.578 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -145.38 -59.0 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.29 155.37 12.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 6.9 p90 -158.88 -179.64 8.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -1.18 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.31 158.86 43.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -144.44 94.89 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.485 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -132.35 91.51 31.03 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.46 -0.775 . . . . 0.0 109.287 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.09 86.62 1.66 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.679 2.253 . . . . 0.0 110.149 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -130.82 36.67 3.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.405 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.07 -24.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.46 HG22 ' O ' ' K' ' 3' ' ' VAL . 14.9 p -78.53 -7.71 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -142.14 34.17 1.53 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.604 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -153.35 -36.49 0.1 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.41 -26.12 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.208 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -73.28 -13.25 61.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.415 -0.803 . . . . 0.0 109.633 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 43.5 p -99.75 0.26 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.598 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p -176.31 145.64 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.902 . . . . 0.0 109.306 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.14 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.97 . . . . 0.0 109.393 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 33.7 m -108.8 -176.05 2.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.516 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -109.89 -177.5 3.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 109.16 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 13' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 3.3 mp -74.49 -25.64 59.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 0.0 109.74 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -71.24 -42.97 68.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.301 -0.875 . . . . 0.0 109.943 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -70.49 -43.53 69.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.878 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.27 -24.08 62.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 17' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 8.3 mt-10 -75.41 -24.09 57.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -56.94 -23.81 48.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 19' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' K' ' 20' ' ' CYS . 73.0 m-85 -85.07 -112.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 20' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' K' ' 19' ' ' TYR . 6.1 m 55.46 168.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.733 -1.229 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.381 179.974 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.595 HG23 ' O ' ' L' ' 2' ' ' VAL . 22.3 m -77.1 84.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 109.813 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -125.4 -27.1 3.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -37.3 66.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.562 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -91.13 -25.26 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -92.72 -69.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.351 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 4.9 t -48.23 -34.94 11.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.19 -39.1 58.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 9' ' ' SER . . . . . 0.494 ' HB2' ' OH ' ' J' ' 16' ' ' TYR . 89.1 p -76.42 1.17 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -1.136 . . . . 0.0 109.717 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 10' ' ' HIS . . . . . 0.416 ' ND1' HD22 ' H' ' 6' ' ' LEU . 3.1 m-70 -98.28 -24.08 15.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.364 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.492 HD23 ' N ' ' L' ' 11' ' ' LEU . 6.4 mt -86.72 -33.68 19.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.52 HG23 ' N ' ' L' ' 13' ' ' GLU . 19.0 m -51.83 -45.76 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.52 ' N ' HG23 ' L' ' 12' ' ' VAL . 1.7 pt-20 -67.07 -33.24 75.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -92.11 19.63 6.68 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.7 -61.69 1.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 7.5 p90 -62.57 -32.96 74.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.6 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.933 HD23 HD23 ' F' ' 17' ' ' LEU . 49.7 tp -65.05 -37.31 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.846 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.6 -59.06 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -67.38 0.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.085 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.46 134.3 0.1 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 53.27 42.41 32.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -1.175 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -145.32 -60.16 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.018 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.45 162.24 14.83 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 24' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 12.2 p90 -165.51 172.09 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -1.2 . . . . 0.0 109.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -127.49 154.18 45.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.447 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -140.43 99.31 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -136.46 91.76 15.95 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 109.578 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.18 84.41 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.74 2.293 . . . . 0.0 110.663 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -128.8 38.49 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.429 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 22' ' ' IPH . . . . . 0.4 ' H5 ' HD21 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' J' J ' 32' ' ' IPH . . . . . 0.642 ' C1 ' HD22 ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 32' ' ' IPH . . . . . 0.654 ' H5 ' HD21 ' H' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.75 3.53 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -1.15 . . . . 0.0 109.721 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 35.9 m -89.52 -11.21 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.86 43.63 2.07 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.301 -0.874 . . . . 0.0 109.356 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.25 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.043 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.4 m -115.15 26.48 10.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 45.6 t -117.64 -24.2 7.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.066 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -109.0 8.52 26.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.93 120.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mp -49.11 134.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -94.42 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.121 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -110.03 172.18 7.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -27.25 67.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 109.665 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.71 -46.29 69.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -33.13 68.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.99 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.79 -8.09 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -89.69 -23.1 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.57 -8.0 54.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -93.44 4.93 53.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.499 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 156.68 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.349 0.595 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.667 ' O ' HG13 ' B' ' 2' ' ' VAL . 7.5 p -70.88 91.04 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.885 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.98 -45.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 0.0 109.143 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.36 -32.05 58.4 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.317 -0.864 . . . . 0.0 109.14 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -70.53 -43.2 70.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 mt -74.24 -32.69 63.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.288 -0.883 . . . . 0.0 108.886 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.09 -31.43 68.99 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.466 -0.771 . . . . 0.0 109.274 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.09 -26.94 61.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.14 -10.35 59.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.25 -1.147 . . . . 0.0 109.456 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -89.59 -24.6 21.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.086 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -87.59 -43.81 11.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.48 HG23 ' N ' ' B' ' 13' ' ' GLU . 29.0 m -47.31 -42.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.48 ' N ' HG23 ' B' ' 12' ' ' VAL . 5.0 mt-10 -67.35 -39.09 85.72 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 109.752 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.505 ' CB ' ' H5 ' ' B' ' 32' ' ' IPH . . . -92.38 25.59 2.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.183 -0.948 . . . . 0.0 109.555 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.06 -49.21 2.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.399 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 18.3 p90 -79.39 -25.82 42.08 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.925 HD23 HD23 ' H' ' 17' ' ' LEU . 28.0 tp -74.76 -35.9 62.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.5 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -58.12 -60.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.64 -64.48 0.85 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.579 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.46 -129.29 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.46 82.74 3.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -1.183 . . . . 0.0 109.662 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -148.44 -68.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.48 149.71 7.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 17.3 p90 -158.69 173.27 16.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -1.141 . . . . 0.0 109.312 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.593 ' HB3' ' CD2' ' D' ' 25' ' ' PHE . 23.9 p90 -129.01 146.06 51.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -124.8 102.7 7.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.458 -0.776 . . . . 0.0 109.025 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -140.72 106.01 6.37 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.922 . . . . 0.0 109.866 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.61 78.41 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.524 2.149 . . . . 0.0 110.278 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -174.29 2.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.634 -179.877 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.39 0.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -1.122 . . . . 0.0 109.258 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.418 ' H ' HG22 ' C' ' 3' ' ' VAL . 28.6 m -85.38 -14.14 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.229 -0.919 . . . . 0.0 109.805 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.9 42.49 2.01 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.187 -0.946 . . . . 0.0 109.673 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -168.52 -34.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.229 -0.919 . . . . 0.0 109.534 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -120.89 19.7 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 109.151 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -20.31 11.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.504 -0.748 . . . . 0.0 109.205 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -111.53 7.04 20.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' SER . . . . . 0.484 ' HA ' ' HB3' ' L' ' 1' ' ' PHE . 85.6 p -175.87 120.12 0.17 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.901 . . . . 0.0 109.188 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.414 ' H ' HD12 ' C' ' 10' ' ' ILE . 2.9 mp -48.63 133.98 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.294 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.58 -169.75 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.343 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -107.43 172.84 6.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.29 -27.07 66.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.52 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -69.37 -42.92 74.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -29.23 55.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.31 -7.15 59.52 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.8 -23.66 21.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.493 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -74.53 -4.35 36.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.938 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -97.38 4.11 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.988 . . . . 0.0 109.36 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.17 155.49 18.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.469 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.597 ' O ' HG13 ' D' ' 2' ' ' VAL . 4.7 p -69.61 94.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.93 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -79.36 -33.79 42.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 109.036 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -68.26 -41.07 81.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 108.919 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.63 -34.56 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.3 -28.25 67.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.456 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.23 -27.91 50.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -78.45 -8.1 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 109.211 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -93.65 -20.23 20.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.967 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mt -93.18 -44.29 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.486 HG23 ' N ' ' D' ' 13' ' ' GLU . 20.2 m -45.89 -42.32 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.425 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.486 ' N ' HG23 ' D' ' 12' ' ' VAL . 4.3 mt-10 -68.12 -43.98 77.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.316 -0.865 . . . . 0.0 109.665 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.435 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -87.8 24.83 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.915 . . . . 0.0 109.862 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -50.53 2.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.017 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 12.0 p90 -77.92 -24.42 48.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.854 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.532 HD21 ' CB ' ' J' ' 14' ' ' ALA . 35.3 tp -76.86 -36.07 57.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.58 -61.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -66.16 -66.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.743 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.9 -129.41 8.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.57 82.35 3.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -1.159 . . . . 0.0 109.552 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -148.48 -69.9 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.587 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.61 143.08 5.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 10.9 p90 -150.13 166.58 29.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.292 -1.122 . . . . 0.0 109.289 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' B' ' 25' ' ' PHE . 11.7 m-85 -117.43 143.87 45.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.042 -1.036 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -127.04 104.84 8.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.084 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -148.83 105.37 3.42 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.28 83.68 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.397 2.065 . . . . 0.0 110.46 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.86 -179.88 2.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.441 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.393 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 tt -120.41 0.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -1.144 . . . . 0.0 109.762 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.38 -8.97 11.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.76 37.63 3.73 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.142 -0.974 . . . . 0.0 109.339 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -163.06 -42.2 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 90.3 m -113.85 26.27 10.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.228 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 51.1 t -117.24 -23.99 7.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -0.839 . . . . 0.0 109.188 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -109.93 10.97 24.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.19 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 9' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' J' ' 1' ' ' PHE . 2.2 p -178.81 119.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.41 132.51 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.744 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m -93.27 -169.91 2.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.6 175.45 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -24.59 63.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -71.88 -44.34 63.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -29.74 61.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.438 -0.789 . . . . 0.0 109.889 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -80.87 -10.35 59.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.922 . . . . 0.0 109.819 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -86.27 -25.44 25.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -70.66 -10.01 58.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.9 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -92.38 5.93 48.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 109.98 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.41 156.71 17.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.746 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.602 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.643 ' O ' HG13 ' F' ' 2' ' ' VAL . 5.9 p -74.21 88.73 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.911 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.74 -44.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.91 . . . . 0.0 109.055 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.51 -30.77 53.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -70.46 -45.14 66.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.326 -0.859 . . . . 0.0 109.043 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.48 -30.71 63.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.327 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.414 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.1 t -72.36 -29.55 63.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.753 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.73 -25.94 59.59 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -84.23 -2.61 57.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 109.653 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 10' ' ' HIS . . . . . 0.603 ' ND1' HD22 ' J' ' 6' ' ' LEU . 2.6 m-70 -97.89 -19.16 18.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 15.2 mt -92.22 -43.67 9.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.527 -0.733 . . . . 0.0 109.271 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.477 HG23 ' N ' ' F' ' 13' ' ' GLU . 22.8 m -48.26 -42.1 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.477 ' N ' HG23 ' F' ' 12' ' ' VAL . 4.7 mt-10 -67.19 -43.07 83.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.749 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.498 ' CB ' ' H5 ' ' E' ' 31' ' ' IPH . . . -87.92 21.79 2.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.283 -0.886 . . . . 0.0 109.875 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.25 -51.91 2.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 13.4 p90 -76.37 -25.48 54.68 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.189 -0.944 . . . . 0.0 109.654 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.519 HD23 HD23 ' L' ' 17' ' ' LEU . 31.9 tp -76.21 -35.54 59.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.96 . . . . 0.0 109.769 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.49 -59.23 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.686 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 17.9 m -68.44 -66.72 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.078 -1.014 . . . . 0.0 109.301 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.03 -126.07 7.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.44 78.38 5.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -1.092 . . . . 0.0 109.688 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -145.14 -71.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 109.851 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.99 138.84 4.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 24' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 14.4 p90 -145.94 173.18 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.349 -1.089 . . . . 0.0 109.019 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -125.27 145.52 49.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.032 . . . . 0.0 109.789 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -127.98 104.08 7.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.245 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -147.33 107.1 3.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.9 78.39 3.42 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.539 2.159 . . . . 0.0 110.693 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.52 179.49 5.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.551 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt -119.29 -1.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -1.091 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.42 -14.4 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.257 -0.902 . . . . 0.0 110.109 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.34 37.47 3.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.069 -1.019 . . . . 0.0 110.018 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -162.05 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.338 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -115.51 21.71 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -23.05 10.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.014 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 11.0 t -108.66 8.77 27.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -177.79 119.2 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.13 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.498 ' H ' HD12 ' G' ' 10' ' ' ILE . 3.3 mp -47.96 137.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.372 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 77.9 m -98.22 -168.34 1.64 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.61 169.26 8.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.949 . . . . 0.0 109.285 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 13' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' G' ' 13' ' ' LEU . 0.3 OUTLIER -64.38 -25.63 68.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -70.65 -42.75 70.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -28.16 57.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.42 -4.66 58.7 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.073 -1.017 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -93.29 -21.57 19.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.14 -0.975 . . . . 0.0 109.377 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.07 -9.63 58.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -92.31 1.4 57.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.15 157.82 16.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.002 . . . . 0.0 109.733 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.701 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.621 ' O ' HG13 ' H' ' 2' ' ' VAL . 5.6 p -68.77 91.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.79 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.169 -0.957 . . . . 0.0 109.432 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -77.33 -33.12 55.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -68.2 -40.7 82.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.248 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 6' ' ' LEU . . . . . 0.474 HD22 ' ND1' ' L' ' 10' ' ' HIS . 13.8 mt -77.37 -31.83 54.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 108.959 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.11 -28.02 65.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.488 -0.757 . . . . 0.0 109.338 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.98 -29.84 45.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 70.4 m -77.24 -8.35 57.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -1.179 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -93.39 -23.46 18.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' H' ' 12' ' ' VAL . 12.1 mt -88.93 -44.51 10.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.525 HG23 ' N ' ' H' ' 13' ' ' GLU . 26.3 m -45.79 -44.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 13' ' ' GLU . . . . . 0.525 ' N ' HG23 ' H' ' 12' ' ' VAL . 5.3 mt-10 -65.95 -43.86 86.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.784 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.574 ' HA ' HD21 ' B' ' 17' ' ' LEU . . . -86.92 21.11 2.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 110.03 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.45 -51.93 2.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 109.684 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 12.4 p90 -76.21 -26.03 55.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.925 HD23 HD23 ' B' ' 17' ' ' LEU . 32.2 tp -75.56 -34.93 60.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.44 -60.45 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.954 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 m -67.55 -63.62 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.69 -130.23 9.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -76.92 81.94 3.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -1.105 . . . . 0.0 109.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -146.94 -68.27 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.03 142.33 5.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 24' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 18.7 p90 -152.13 174.76 13.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.132 . . . . 0.0 109.511 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.3 162.42 26.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -143.83 92.44 2.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.84 . . . . 0.0 109.588 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -133.76 107.27 11.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.13 78.25 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.362 2.041 . . . . 0.0 109.959 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.8 -179.22 4.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.697 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.32 179.728 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -119.13 0.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 109.901 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.98 -16.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.055 -1.028 . . . . 0.0 110.075 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.75 42.88 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -169.96 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -116.91 19.51 14.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.297 -0.877 . . . . 0.0 109.211 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -24.76 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.315 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -105.28 9.38 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.633 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 9' ' ' SER . . . . . 0.438 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.9 p 179.67 118.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.453 ' H ' HD12 ' I' ' 10' ' ' ILE . 3.0 mp -43.5 149.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.859 . . . . 0.0 109.21 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -171.76 1.91 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.79 167.55 9.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.158 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 13' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' I' ' 13' ' ' LEU . 0.3 OUTLIER -63.39 -27.81 69.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.33 -43.26 77.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.85 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -27.17 56.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.811 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -84.15 -7.12 59.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 109.864 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.78 -24.85 21.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -71.15 -10.83 60.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -91.45 3.16 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 0.0 109.909 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 159.25 15.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 109.378 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 1' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' E' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.261 0.553 . . . . 0.0 109.713 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.624 ' O ' HG13 ' J' ' 2' ' ' VAL . 6.0 p -70.65 91.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.55 -42.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.146 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.17 -33.41 44.02 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.004 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -69.06 -40.06 78.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 6' ' ' LEU . . . . . 0.603 HD22 ' ND1' ' F' ' 10' ' ' HIS . 9.5 mt -78.49 -29.79 46.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.324 -0.86 . . . . 0.0 109.105 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -72.72 -27.71 62.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.333 -0.854 . . . . 0.0 109.465 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.84 -27.0 52.17 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -79.68 -7.57 58.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.568 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -94.5 -20.87 19.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.15 -43.69 9.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 109.677 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.504 HG23 ' N ' ' J' ' 13' ' ' GLU . 26.1 m -46.95 -44.21 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.504 ' N ' HG23 ' J' ' 12' ' ' VAL . 3.9 mt-10 -65.08 -44.25 89.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.601 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.532 ' CB ' HD21 ' D' ' 17' ' ' LEU . . . -87.6 24.85 1.59 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.47 -46.34 3.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 109.507 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 14.3 p90 -82.64 -23.25 34.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.98 -37.85 54.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.283 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.0 t -55.7 -61.62 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 m -66.89 -64.77 0.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.55 -129.33 8.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -77.91 85.31 4.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -1.179 . . . . 0.0 109.368 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -150.88 -75.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.07 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.32 141.21 4.42 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 15.5 p90 -149.05 165.69 30.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.79 136.44 54.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -117.37 104.91 11.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.536 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -146.18 108.19 4.23 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 109.438 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.85 79.57 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 110.994 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.89 179.6 5.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 109.337 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.324 179.923 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.6 tt -121.17 1.05 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 30.9 m -86.51 -12.9 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.89 40.38 2.47 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.688 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -164.93 -42.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.244 -0.91 . . . . 0.0 109.299 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 93.9 m -114.14 23.47 12.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 7' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 40.9 t -112.77 -26.94 8.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 109.238 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -105.48 9.4 33.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.01 118.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.804 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.475 HD12 ' H ' ' K' ' 10' ' ' ILE . 3.1 mp -45.32 135.66 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.298 -0.877 . . . . 0.0 109.597 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -98.1 -167.73 1.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.46 171.71 7.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.482 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 13' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' K' ' 13' ' ' LEU . 0.3 OUTLIER -65.24 -28.06 69.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 109.678 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -69.1 -42.34 76.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.825 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -28.82 56.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.62 -7.28 59.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 109.809 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.59 -25.12 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.678 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -72.38 -7.62 50.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -93.55 0.33 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.87 158.99 15.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.419 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 1' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' C' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.624 ' O ' HG13 ' L' ' 2' ' ' VAL . 5.1 p -70.83 89.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -175.95 -44.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -78.29 -31.88 49.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -70.63 -39.17 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.127 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 13.4 mt -78.21 -31.93 49.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 108.863 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.01 -29.99 67.19 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.12 -27.26 58.43 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -80.37 -6.24 57.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -1.127 . . . . 0.0 109.616 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 10' ' ' HIS . . . . . 0.474 ' ND1' HD22 ' H' ' 6' ' ' LEU . 4.3 m-70 -95.14 -20.63 19.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.031 -1.043 . . . . 0.0 109.633 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' L' ' 12' ' ' VAL . 11.2 mt -92.68 -44.67 8.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.943 . . . . 0.0 109.515 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.51 HG23 ' N ' ' L' ' 13' ' ' GLU . 23.4 m -45.04 -43.71 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.18 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.51 ' N ' HG23 ' L' ' 12' ' ' VAL . 4.7 mt-10 -66.76 -44.83 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.554 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.465 ' CB ' ' H5 ' ' L' ' 32' ' ' IPH . . . -86.69 23.53 1.66 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.3 -0.875 . . . . 0.0 109.936 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.62 -49.66 2.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.668 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.526 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 14.4 p90 -79.06 -24.36 43.6 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.162 -0.962 . . . . 0.0 109.663 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.519 HD23 HD23 ' F' ' 17' ' ' LEU . 38.7 tp -76.99 -33.58 57.58 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.75 -59.3 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 12.3 m -69.05 -66.08 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.568 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.98 -129.95 9.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.17 80.88 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -147.62 -68.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.092 -1.005 . . . . 0.0 109.43 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.59 131.26 3.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 24' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 9.8 p90 -135.08 -173.21 3.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 109.317 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -138.2 142.74 39.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.82 108.61 11.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.625 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -150.5 106.64 3.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.848 . . . . 0.0 109.451 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.09 79.37 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.508 2.139 . . . . 0.0 110.449 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 -179.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.537 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.505 ' H5 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.435 ' H5 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 31' ' ' IPH . . . . . 0.498 ' H5 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 22' ' ' IPH . . . . . 0.486 ' H5 ' ' CB ' ' H' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' J' J ' 32' ' ' IPH . . . . . 0.508 ' H5 ' ' CB ' ' J' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 32' ' ' IPH . . . . . 0.465 ' H5 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -97.74 -27.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' B' ' 28' ' ' PRO . 94.4 t -73.84 -44.11 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.64 52.12 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.843 . . . . 0.0 110.151 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -175.38 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.085 -1.01 . . . . 0.0 109.694 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.0 11.05 17.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.8 t -105.57 -23.05 12.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.9 p -67.17 -13.94 62.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.472 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.5 p -175.25 156.52 2.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' F' ' 2' ' ' VAL . 2.1 mp -62.84 130.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.255 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.32 -167.02 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.504 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.72 176.78 4.94 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -42.31 89.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.2 -0.938 . . . . 0.0 109.771 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -66.7 -35.85 81.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.962 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -36.67 77.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 109.437 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.65 -18.45 51.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 109.827 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.09 -14.48 47.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.481 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.6 -16.31 15.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.892 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.74 87.27 1.84 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.31 133.07 7.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.461 -0.774 . . . . 0.0 109.485 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.418 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.548 ' HB ' HD12 ' I' ' 10' ' ' ILE . 70.4 t -91.02 -7.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.248 -0.908 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 4' ' ' GLN . 11.3 p30 45.08 -172.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.443 -0.785 . . . . 0.0 109.604 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' B' ' 3' ' ' ASN . 9.4 tt0 83.53 -59.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -89.08 -24.13 22.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.191 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -96.78 -50.26 4.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.135 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -57.2 -38.04 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.98 -29.46 60.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.489 ' OG ' ' CE1' ' D' ' 16' ' ' TYR . 1.2 m -67.38 -9.08 38.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.151 . . . . 0.0 109.424 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -96.25 -36.1 11.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.023 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.49 -41.44 69.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 m -48.11 -37.7 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -72.25 -46.12 57.32 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.954 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.12 13.25 4.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 0.0 109.863 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.32 -53.29 3.39 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.003 -1.061 . . . . 0.0 109.537 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 11.3 p90 -73.12 -30.2 63.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.315 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 0.1 OUTLIER -61.93 -52.92 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.384 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.41 -30.75 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.199 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 20' ' ' GLY . 1.3 m -115.45 54.74 0.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.016 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' B' ' 22' ' ' ARG . . . -58.72 -119.73 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' B' ' 22' ' ' ARG . 25.8 mt-10 -39.52 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.975 . . . . 0.0 109.933 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' B' ' 20' ' ' GLY . 2.9 mtt180 165.37 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.657 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 172.48 27.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' D' ' 26' ' ' TYR . 50.9 p90 -170.81 162.74 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.441 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -117.72 141.5 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 0.0 109.493 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.86 111.44 17.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.709 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -140.86 98.58 6.92 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.635 ' HB3' HG21 ' A' ' 3' ' ' VAL . 35.7 Cg_endo -77.92 87.73 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.5 2.133 . . . . 0.0 110.662 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -136.1 -123.38 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.98 . . . . 0.0 109.294 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 120.741 -1.225 . . . . 0.0 109.351 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -100.3 -29.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -1.165 . . . . 0.0 109.457 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.603 HG21 ' HB3' ' D' ' 28' ' ' PRO . 79.2 t -72.81 -40.95 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 52.54 1.97 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.332 -0.855 . . . . 0.0 110.077 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -175.64 -34.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.82 11.58 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 t -105.66 -24.4 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 60.1 p -67.74 -11.94 59.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.575 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -174.81 155.5 2.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.624 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.673 HD12 ' HB ' ' L' ' 2' ' ' VAL . 1.6 mp -63.7 130.95 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 108.984 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -97.15 -167.61 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -107.12 178.8 4.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -42.29 78.65 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.288 -0.882 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -67.04 -34.82 78.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.918 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -32.5 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 11.6 mt -83.31 -21.55 33.19 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -13.59 57.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.524 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.96 -15.57 13.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.02 87.94 1.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.57 133.97 7.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.429 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' G' ' 10' ' ' ILE . 55.8 t -89.58 -9.23 10.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.422 -0.798 . . . . 0.0 109.574 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' D' ' 4' ' ' GLN . 8.6 p30 45.9 -174.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' D' ' 3' ' ' ASN . 10.2 tt0 84.07 -60.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 5' ' ' HIS . . . . . 0.454 ' HB3' HG12 ' G' ' 10' ' ' ILE . 32.4 t60 -88.02 -21.99 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.123 -0.986 . . . . 0.0 109.006 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.41 -51.28 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.839 . . . . 0.0 109.188 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 t -57.31 -37.79 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.35 59.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.68 -11.13 32.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -1.105 . . . . 0.0 109.559 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -93.09 -35.28 13.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 15.1 mt -73.52 -39.52 64.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 m -48.15 -35.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -75.63 -44.45 42.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 9.71 11.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.02 -56.77 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.711 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 9.1 p90 -71.6 -28.75 64.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.027 . . . . 0.0 109.541 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 0.1 OUTLIER -63.15 -52.99 60.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.186 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.1 t -66.27 -33.47 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 108.866 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' D' ' 20' ' ' GLY . 1.3 m -111.66 55.96 0.66 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 109.085 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' D' ' 22' ' ' ARG . . . -59.32 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' D' ' 22' ' ' ARG . 23.3 mt-10 -40.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.463 -1.022 . . . . 0.0 110.055 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' ARG . . . . . 0.483 ' CB ' ' O ' ' D' ' 21' ' ' GLU . 4.2 mtt180 165.07 -53.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 171.61 24.55 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -169.45 172.31 7.17 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -122.16 157.89 30.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.516 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.44 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 79.6 t80 -136.64 100.45 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.47 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -133.83 97.41 15.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' PRO . . . . . 0.603 ' HB3' HG21 ' C' ' 3' ' ' VAL . 34.7 Cg_endo -76.81 86.19 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.447 2.098 . . . . 0.0 110.62 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -134.16 -124.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.886 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.405 HD13 HD11 ' F' ' 15' ' ' LEU . 20.7 tt -101.69 -25.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -1.138 . . . . 0.0 109.135 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 3' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' F' ' 28' ' ' PRO . 90.6 t -77.71 -41.47 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.493 -0.754 . . . . 0.0 109.503 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.04 50.75 1.83 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.806 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.58 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.796 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 10.95 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.024 . . . . 0.0 109.504 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 7' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 33.2 t -105.07 -23.27 12.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 77.1 p -67.01 -14.73 63.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 9' ' ' SER . . . . . 0.502 ' HA ' HG21 ' J' ' 2' ' ' VAL . 5.8 p -174.15 155.85 2.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.139 -0.975 . . . . 0.0 109.819 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.567 HD12 ' HB ' ' J' ' 2' ' ' VAL . 2.1 mp -62.0 126.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.481 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -94.54 -170.09 2.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -106.91 176.7 5.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -41.04 95.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -68.74 -35.75 77.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 109.9 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -36.63 77.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 18.9 mt -79.01 -21.28 47.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.905 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -13.44 56.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.953 . . . . 0.0 109.321 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.72 -16.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.525 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.1 88.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.65 135.45 8.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.395 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.642 ' HB ' HD12 ' A' ' 10' ' ' ILE . 54.8 t -90.91 -7.45 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 3' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' F' ' 4' ' ' GLN . 9.4 p30 45.81 -174.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.77 . . . . 0.0 109.657 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 4' ' ' GLN . . . . . 0.567 ' CB ' ' O ' ' F' ' 3' ' ' ASN . 9.5 tt0 84.19 -60.54 0.11 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.641 -0.662 . . . . 0.0 109.589 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -87.89 -23.84 23.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mt -97.37 -49.47 4.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 40.1 t -59.01 -37.37 76.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -30.09 58.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.21 -15.21 62.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.325 -1.103 . . . . 0.0 109.428 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -89.18 -36.45 15.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 mt -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.036 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 m -49.86 -34.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.105 -0.997 . . . . 0.0 109.633 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -76.22 -44.84 35.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.978 . . . . 0.0 109.408 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.09 10.32 6.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.405 HD11 HD13 ' E' ' 2' ' ' ILE . 1.4 mt -96.06 -57.2 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.085 -1.009 . . . . 0.0 109.831 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 10.9 p90 -69.53 -30.54 68.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.378 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 0.1 OUTLIER -62.57 -53.43 54.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.64 -32.56 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' F' ' 20' ' ' GLY . 1.3 m -114.21 53.72 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 20' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' F' ' 22' ' ' ARG . . . -57.85 -118.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 21' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' F' ' 22' ' ' ARG . 25.4 mt-10 -40.53 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -1.012 . . . . 0.0 109.952 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 22' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' F' ' 20' ' ' GLY . 4.3 mtt180 164.56 -49.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.73 27.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -166.92 174.93 8.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -1.125 . . . . 0.0 109.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -128.41 152.58 48.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -130.89 106.98 8.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -139.25 98.36 8.3 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 28' ' ' PRO . . . . . 0.485 ' HB3' HG21 ' E' ' 3' ' ' VAL . 33.0 Cg_endo -74.97 86.03 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.416 2.077 . . . . 0.0 110.554 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 29' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -154.48 135.6 13.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 30' ' ' THR . . . . . 0.495 ' C ' ' O ' ' F' ' 29' ' ' LYS . 71.5 p . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt -98.23 -25.58 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -1.156 . . . . 0.0 109.125 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 3' ' ' VAL . . . . . 0.588 HG21 ' HB3' ' H' ' 28' ' ' PRO . 61.4 t -76.15 -42.94 37.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.461 -0.775 . . . . 0.0 109.417 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 51.64 2.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.336 -0.853 . . . . 0.0 109.684 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.98 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 109.723 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 9.65 19.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.692 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -103.64 -23.15 13.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.95 . . . . 0.0 109.818 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 74.5 p -66.92 -14.97 63.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -173.18 160.26 4.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.556 HD12 ' HB ' ' D' ' 2' ' ' VAL . 1.6 mp -66.34 128.46 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.095 -1.003 . . . . 0.0 109.368 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -94.21 -167.97 1.77 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.37 179.37 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.465 -0.772 . . . . 0.0 109.305 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.44 -41.32 80.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -68.68 -34.65 76.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -36.4 80.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.84 -21.28 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.243 -0.911 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -83.63 -9.02 59.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.634 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.97 -16.49 59.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.135 -0.978 . . . . 0.0 109.237 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.77 90.91 2.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -165.16 131.6 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.9 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.314 0.578 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.632 ' HB ' HD12 ' K' ' 10' ' ' ILE . 54.3 t -92.95 -6.71 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' H' ' 4' ' ' GLN . 9.9 p30 44.92 -173.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.52 -0.738 . . . . 0.0 110.031 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 4' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' H' ' 3' ' ' ASN . 9.0 tt0 83.78 -60.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.754 -0.591 . . . . 0.0 109.677 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -87.95 -23.78 23.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.25 -0.906 . . . . 0.0 109.06 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.3 -50.14 4.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.209 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.0 -40.23 80.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.07 -29.97 66.05 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -12.66 55.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.131 . . . . 0.0 109.492 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -93.58 -34.03 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -0.846 . . . . 0.0 109.665 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 14.0 mt -74.44 -39.25 62.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 0.0 109.707 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 m -48.21 -37.57 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.129 -0.982 . . . . 0.0 109.387 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.24 -46.26 51.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.09 7.81 10.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.384 -0.823 . . . . 0.0 109.634 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -93.36 -55.99 3.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.0 110.096 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' H' ' 17' ' ' LEU . 14.0 p90 -70.45 -31.23 68.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.624 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' H' ' 16' ' ' TYR . 0.1 OUTLIER -60.82 -53.76 53.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.509 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.19 -30.65 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 109.748 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.21 46.66 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 20' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . -66.69 170.27 32.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 21' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' H' ' 20' ' ' GLY . 33.8 mt-10 35.5 71.4 0.12 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.661 -0.905 . . . . 0.0 110.078 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 175.32 -48.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.18 -0.95 . . . . 0.0 109.34 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.47 169.74 27.9 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -168.0 169.29 11.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -122.78 145.39 48.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 109.547 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.91 105.57 9.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -137.48 98.97 9.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.415 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 28' ' ' PRO . . . . . 0.588 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.5 Cg_endo -77.84 86.68 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.538 2.159 . . . . 0.0 110.778 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -135.91 -129.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 109.055 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.578 -1.327 . . . . 0.0 109.519 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 tt -99.02 -26.68 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 3' ' ' VAL . . . . . 0.558 HG21 ' HB3' ' J' ' 28' ' ' PRO . 87.8 t -75.96 -40.59 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.64 53.61 2.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -176.28 -32.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.36 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 12.3 15.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.011 . . . . 0.0 109.86 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.73 -19.56 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -70.09 -13.48 62.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.031 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 9' ' ' SER . . . . . 0.519 ' HA ' ' CG2' ' B' ' 2' ' ' VAL . 52.5 p -174.39 156.89 2.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.478 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.548 HD12 ' HB ' ' B' ' 2' ' ' VAL . 1.8 mp -63.32 128.23 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.248 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -93.23 -165.59 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 3.7 m -110.37 -177.22 3.18 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.248 -0.908 . . . . 0.0 109.042 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -41.21 68.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -68.16 -35.14 77.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -35.79 76.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.9 mt -81.19 -19.7 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.99 -10.78 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.92 -17.61 52.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.288 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.57 89.29 2.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 0.0 109.53 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.54 134.21 6.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.234 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.377 0.608 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.567 ' HB ' HD12 ' E' ' 10' ' ' ILE . 53.1 t -91.65 -7.34 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' J' ' 4' ' ' GLN . 9.1 p30 45.51 -174.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 0.0 110.011 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' J' ' 3' ' ' ASN . 8.9 tt0 83.61 -61.48 0.11 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.705 -0.622 . . . . 0.0 109.823 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 5' ' ' HIS . . . . . 0.478 ' CB ' HG12 ' E' ' 10' ' ' ILE . 36.5 t60 -86.83 -21.23 26.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.162 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.02 -52.33 3.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.103 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.4 t -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.11 -32.33 63.18 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -67.34 -10.55 52.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -1.187 . . . . 0.0 109.543 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -93.7 -34.24 13.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.176 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.91 -41.74 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.455 -0.778 . . . . 0.0 109.711 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 15.3 m -45.88 -38.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.803 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.94 -44.17 61.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.017 -1.052 . . . . 0.0 109.829 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' D' ' 17' ' ' LEU . . . -84.68 13.92 5.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.37 -54.86 2.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.8 p90 -72.62 -29.54 63.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 0.1 OUTLIER -63.79 -52.14 61.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 109.171 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.97 -32.2 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.406 -0.809 . . . . 0.0 109.221 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' J' ' 20' ' ' GLY . 1.1 m -113.72 54.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.078 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . -57.85 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 21' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' J' ' 22' ' ' ARG . 26.0 mt-10 -40.76 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -1.15 . . . . 0.0 110.024 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' J' ' 20' ' ' GLY . 3.6 mtt180 165.58 -47.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.848 . . . . 0.0 109.338 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.8 169.42 33.85 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -164.44 172.95 12.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -1.163 . . . . 0.0 109.784 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -122.53 151.75 41.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.166 -0.959 . . . . 0.0 109.251 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -133.59 108.17 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -142.41 96.46 6.34 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 28' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' I' ' 3' ' ' VAL . 34.4 Cg_endo -76.69 93.96 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.353 2.035 . . . . 0.0 110.593 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -141.03 -119.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.353 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 120.659 -1.275 . . . . 0.0 109.652 -179.768 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 tt -98.17 -27.6 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.163 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' L' ' 28' ' ' PRO . 94.9 t -74.72 -41.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.443 -0.786 . . . . 0.0 109.682 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 4' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.0 OUTLIER -91.98 56.96 3.02 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.937 -1.102 . . . . 0.0 109.489 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 5' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 1.3 tt0 179.94 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 10.85 15.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 7' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -107.23 -19.81 13.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 0.0 108.948 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -68.97 -14.23 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 109.009 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 78.1 p -175.25 156.06 2.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.815 . . . . 0.0 109.31 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.632 HD12 ' HB ' ' H' ' 2' ' ' VAL . 1.4 mp -63.18 129.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -95.02 -170.71 2.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.855 . . . . 0.0 109.455 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.85 177.33 4.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.401 -0.812 . . . . 0.0 109.144 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -42.89 88.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.543 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -65.97 -37.57 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.102 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -35.36 73.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.75 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.769 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.28 -12.11 55.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -18.39 44.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.327 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.55 91.06 2.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.4 137.13 5.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.506 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.42 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.42 0.629 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.673 ' HB ' HD12 ' C' ' 10' ' ' ILE . 55.6 t -89.35 -7.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.443 -0.786 . . . . 0.0 109.929 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 3' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' L' ' 4' ' ' GLN . 10.8 p30 45.22 -173.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 4' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' L' ' 3' ' ' ASN . 9.1 tt0 83.84 -59.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.674 -0.641 . . . . 0.0 109.502 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 5' ' ' HIS . . . . . 0.452 ' HB3' HG12 ' C' ' 10' ' ' ILE . 33.8 t60 -89.14 -20.34 24.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 mt -101.63 -49.33 4.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -0.793 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -59.03 -32.92 70.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 108.826 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.03 -34.05 34.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -11.14 31.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -1.119 . . . . 0.0 109.272 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -93.76 -32.18 14.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.01 -39.33 50.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.476 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -47.82 -36.03 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.561 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.94 -44.51 48.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 109.293 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.93 15.03 4.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.334 -0.854 . . . . 0.0 109.687 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.42 -53.74 3.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.041 -1.037 . . . . 0.0 109.533 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.555 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 9.4 p90 -73.98 -27.1 60.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 0.1 OUTLIER -66.14 -50.1 65.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.267 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -70.04 -29.04 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.1 49.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.575 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 20' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . -70.45 167.91 49.34 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 21' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' L' ' 20' ' ' GLY . 31.1 mt-10 39.09 71.39 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.505 -0.997 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 173.21 -43.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.826 . . . . 0.0 108.93 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.48 174.23 35.48 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.12 172.33 7.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -1.138 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 17.8 p90 -125.0 145.31 49.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -127.84 109.15 11.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -0.928 . . . . 0.0 109.358 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 9.8 m -142.55 98.22 5.93 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 0.0 109.201 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 28' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.4 Cg_endo -78.66 93.9 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.369 2.046 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -139.77 -115.18 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 109.523 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 109.544 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 2' ' ' ILE . 49.7 mt -99.42 25.29 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -1.16 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 60.0 t -114.56 -47.43 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -95.47 47.45 1.12 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -168.23 -35.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.336 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 9' ' ' SER . 99.1 m -108.11 -32.31 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.655 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -69.4 -19.18 63.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 0.0 109.697 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -105.75 -7.31 18.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 5.1 p -168.08 132.35 1.7 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.426 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.445 ' HA ' ' O1 ' ' B' ' 32' ' ' IPH . 2.5 mp -52.49 138.4 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.7 m -104.39 149.6 25.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.24 158.17 29.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -29.51 58.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.782 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -64.97 -43.47 92.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.477 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -73.87 -23.55 59.62 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.42 0.4 53.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.238 -0.914 . . . . 0.0 109.967 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -90.86 -26.08 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.735 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -83.01 -7.67 59.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.932 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -90.85 15.61 10.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.65 160.16 15.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.484 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 11.2 p90 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.414 ' H ' HG12 ' B' ' 2' ' ' VAL . 2.5 p -60.96 123.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.27 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.55 -36.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.163 -0.96 . . . . 0.0 108.935 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -80.34 -42.32 23.16 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.369 -0.832 . . . . 0.0 109.276 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -58.89 -23.55 61.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -101.5 -24.45 14.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 51.1 t -75.26 -17.24 60.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.75 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -91.41 -21.87 33.53 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -81.01 -18.76 45.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -1.14 . . . . 0.0 109.302 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.445 ' ND1' HD22 ' F' ' 6' ' ' LEU . 20.1 m-70 -85.56 -18.86 32.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.624 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.487 ' CD2' ' C6 ' ' B' ' 32' ' ' IPH . 9.9 mt -93.69 -34.71 13.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.75 HG13 ' O ' ' B' ' 8' ' ' GLY . 34.0 m -60.58 -36.02 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 110.037 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.401 ' N ' HG23 ' B' ' 12' ' ' VAL . 0.8 OUTLIER -73.63 -27.91 61.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.931 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.33 17.56 17.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.163 -0.96 . . . . 0.0 109.864 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 2' ' ' ILE . 1.7 mt -114.98 -56.52 2.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.836 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -64.26 -23.65 67.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.478 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 19.7 tp -74.5 -40.25 61.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.2 -0.937 . . . . 0.0 109.306 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 71.4 t -54.69 -72.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.907 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.61 -42.6 88.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.08 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.34 -97.68 0.78 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.72 -56.54 20.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -1.143 . . . . 0.0 109.514 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -53.28 154.83 3.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.72 -167.69 27.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -170.01 169.18 8.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -1.13 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.648 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 42.1 p90 -127.78 148.66 50.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.474 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' B' ' 28' ' ' PRO . 30.5 t80 -128.29 113.57 15.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.81 92.11 13.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.482 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' B' ' 26' ' ' TYR . 36.1 Cg_endo -78.96 81.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.909 2.406 . . . . 0.0 110.515 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -133.14 112.25 11.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.089 -1.007 . . . . 0.0 109.946 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.242 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' C' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' C' ' 1' ' ' GLY . 20.4 mt 71.21 -1.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -1.231 . . . . 0.0 110.196 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 61.7 t -106.24 -49.03 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.971 -1.08 . . . . 0.0 108.917 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 44.84 1.03 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.431 -0.793 . . . . 0.0 109.239 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -165.57 -35.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' C' ' 9' ' ' SER . 93.1 m -108.27 -30.31 8.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.3 OUTLIER -71.47 -19.09 62.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 109.388 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 -6.55 19.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.726 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 6' ' ' CYS . 2.6 p -169.16 130.36 1.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.087 -1.008 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.468 ' HA ' ' O1 ' ' D' ' 32' ' ' IPH . 2.5 mp -50.44 138.08 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.647 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -104.37 149.02 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.054 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.67 159.04 29.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.14 -30.75 60.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.2 -42.2 96.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.979 . . . . 0.0 109.702 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -74.69 -23.4 58.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 72.1 mt -96.37 4.67 52.07 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -95.24 -25.85 16.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.269 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -82.78 -9.03 59.53 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -91.58 19.23 6.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.641 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.27 158.46 17.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 109.342 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.1 p90 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.413 ' H ' HG12 ' D' ' 2' ' ' VAL . 2.5 p -59.68 122.7 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.782 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' D' ' 7' ' ' CYS . 0.5 OUTLIER 175.22 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.21 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -82.1 -39.44 23.35 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.244 -0.91 . . . . 0.0 109.131 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -62.17 -22.02 65.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.0 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -102.41 -24.39 13.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.808 . . . . 0.0 109.06 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 42.2 t -74.21 -23.22 59.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.683 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -87.29 -20.26 52.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 57.6 p -81.45 -15.24 55.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.254 . . . . 0.0 109.434 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.68 -21.16 22.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.807 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 9.2 mt -90.83 -33.25 15.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.151 -0.968 . . . . 0.0 109.754 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.683 HG13 ' O ' ' D' ' 8' ' ' GLY . 35.5 m -61.85 -35.6 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.38 -26.94 60.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.021 . . . . 0.0 109.812 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.65 19.57 14.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.133 -0.979 . . . . 0.0 109.699 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' C' ' 2' ' ' ILE . 1.6 mt -117.43 -54.75 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.55 -22.8 66.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.97 . . . . 0.0 109.595 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.678 HD21 ' CB ' ' J' ' 14' ' ' ALA . 22.9 tp -77.62 -33.83 53.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.845 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 66.9 t -60.6 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 109.885 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -63.35 -42.75 98.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.59 -96.93 0.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.75 -54.73 41.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -1.121 . . . . 0.0 109.61 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -56.2 156.5 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.894 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.34 -167.54 26.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -168.13 158.14 10.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -1.113 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' PHE . . . . . 0.648 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 19.2 m-85 -113.22 142.99 45.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 109.528 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -125.31 117.0 22.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -0.995 . . . . 0.0 109.465 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.2 92.56 6.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.748 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -79.16 81.61 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.717 2.278 . . . . 0.0 110.39 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -133.68 112.25 11.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.713 HG22 ' O ' ' E' ' 2' ' ' ILE . 53.2 mt -99.83 22.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -1.115 . . . . 0.0 109.389 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 3' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 49.0 t -113.12 -47.42 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.22 -0.925 . . . . 0.0 109.735 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.71 47.88 1.12 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.136 -0.977 . . . . 0.0 109.478 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -169.99 -32.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 6' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' E' ' 9' ' ' SER . 99.9 m -111.59 -30.48 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.39 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 7' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -72.46 -17.08 61.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.955 . . . . 0.0 109.321 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -107.3 -7.56 16.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 9' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' E' ' 6' ' ' CYS . 3.5 p -168.18 134.07 1.91 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.339 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.467 ' HA ' ' O1 ' ' E' ' 31' ' ' IPH . 2.5 mp -53.73 137.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.131 -0.98 . . . . 0.0 109.736 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 88.0 m -103.3 151.23 22.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.198 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.58 158.25 28.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.01 -29.91 61.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.221 -0.925 . . . . 0.0 109.106 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.62 -45.88 85.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.42 -23.05 61.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -0.872 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.35 -0.62 49.19 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -0.939 . . . . 0.0 110.05 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -89.31 -24.8 21.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.705 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.67 -7.04 59.38 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.109 -0.995 . . . . 0.0 109.889 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.11 20.14 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.138 -0.976 . . . . 0.0 109.17 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.8 158.28 18.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.372 -0.83 . . . . 0.0 109.335 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.595 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.6 p90 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.04 124.45 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 174.32 -35.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -80.15 -43.35 21.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.363 -0.836 . . . . 0.0 108.915 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -58.09 -23.03 53.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.664 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.445 HD22 ' ND1' ' B' ' 10' ' ' HIS . 10.4 mt -101.46 -27.27 13.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 108.997 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.485 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 46.8 t -72.65 -20.22 61.29 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.597 -0.689 . . . . 0.0 109.511 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.678 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -88.83 -22.55 38.76 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 27.6 p -80.66 -17.04 52.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -1.123 . . . . 0.0 109.42 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 10' ' ' HIS . . . . . 0.716 ' ND1' HD22 ' J' ' 6' ' ' LEU . 14.5 m-70 -87.54 -18.18 30.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 9.8 mt -94.58 -32.67 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.678 HG13 ' O ' ' F' ' 8' ' ' GLY . 36.0 m -62.83 -35.04 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.856 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -26.59 59.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.53 18.38 16.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.549 HD11 HD13 ' E' ' 2' ' ' ILE . 1.7 mt -116.15 -55.89 2.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.065 -1.022 . . . . 0.0 109.617 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -64.27 -23.12 67.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.694 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 26.9 tp -77.86 -33.85 52.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.49 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 109.78 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.21 -44.09 97.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.15 -0.969 . . . . 0.0 109.7 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.93 -96.82 0.88 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.56 -55.71 30.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -1.114 . . . . 0.0 109.575 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -55.12 156.55 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 0.0 109.592 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -166.85 28.57 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.62 161.84 6.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -1.093 . . . . 0.0 108.981 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -122.29 151.18 41.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.026 -1.046 . . . . 0.0 109.589 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 26' ' ' TYR . . . . . 0.422 ' CE2' ' HG3' ' F' ' 28' ' ' PRO . 33.8 t80 -129.66 118.17 21.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.512 HG23 ' HA3' ' H' ' 23' ' ' GLY . 0.3 OUTLIER -142.33 91.27 7.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 109.352 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 28' ' ' PRO . . . . . 0.422 ' HG3' ' CE2' ' F' ' 26' ' ' TYR . 35.6 Cg_endo -78.52 82.19 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.646 2.231 . . . . 0.0 110.359 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.67 110.81 10.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 109.534 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.698 HG22 ' O ' ' G' ' 2' ' ' ILE . 46.3 mt -99.13 23.34 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 3' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' G' ' 7' ' ' CYS . 58.0 t -112.45 -48.76 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.87 46.12 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -167.37 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 6' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' G' ' 9' ' ' SER . 85.6 m -110.07 -27.79 9.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 7' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' G' ' 3' ' ' VAL . 22.7 t -72.04 -22.48 61.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 15.0 t -103.27 -6.16 22.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.455 -0.778 . . . . 0.0 109.695 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 9' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' G' ' 6' ' ' CYS . 2.2 p -169.32 132.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -52.22 137.4 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.365 -0.834 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 83.5 m -104.01 150.35 24.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.257 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.39 159.9 30.06 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -31.82 66.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.075 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -61.6 -46.57 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.418 -0.801 . . . . 0.0 109.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -72.33 -20.98 61.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 76.0 mt -96.85 -2.62 43.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.103 -0.998 . . . . 0.0 109.792 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -89.02 -24.74 22.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -82.91 -8.26 59.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 0.0 109.837 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -90.91 12.97 17.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.456 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.01 163.0 12.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.611 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.568 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.423 ' O ' HG13 ' H' ' 2' ' ' VAL . 2.6 p -59.08 121.18 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.22 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.93 -43.67 29.21 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.181 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -57.14 -23.72 49.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.553 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 6' ' ' LEU . . . . . 0.553 HD22 ' ND1' ' L' ' 10' ' ' HIS . 10.8 mt -100.86 -26.08 13.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 109.223 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.457 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 15.4 t -73.74 -20.22 60.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.469 -0.769 . . . . 0.0 109.706 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 8' ' ' GLY . . . . . 0.709 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -88.77 -20.2 48.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 87.9 p -82.04 -16.3 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -1.059 . . . . 0.0 109.508 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -89.6 -16.21 31.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.548 ' CD2' ' C6 ' ' G' ' 31' ' ' IPH . 8.0 mt -96.61 -33.42 11.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.473 -0.767 . . . . 0.0 109.547 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.709 HG13 ' O ' ' H' ' 8' ' ' GLY . 35.2 m -62.96 -29.98 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -25.87 43.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.454 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.429 ' CB ' ' H3 ' ' G' ' 31' ' ' IPH . . . -100.7 22.46 11.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 15' ' ' LEU . . . . . 0.61 HD11 HD13 ' G' ' 2' ' ' ILE . 1.9 mt -120.15 -54.19 2.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.523 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.58 -24.2 66.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.612 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 20.7 tp -77.22 -36.5 54.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.195 -0.94 . . . . 0.0 109.583 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.32 -67.41 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.932 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 19' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' H' ' 22' ' ' ARG . 43.7 m -66.97 -39.99 87.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.985 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.26 -103.37 1.07 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -50.9 -63.55 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -1.221 . . . . 0.0 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 22' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' H' ' 19' ' ' CYS . 6.9 mtt-85 -49.08 154.35 0.79 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.361 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.512 ' HA3' HG23 ' F' ' 27' ' ' THR . . . -101.42 -170.57 28.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.57 170.45 15.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 109.525 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -128.34 150.4 50.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 26' ' ' TYR . . . . . 0.418 ' CE2' ' HG3' ' H' ' 28' ' ' PRO . 31.8 t80 -131.99 118.55 19.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.55 89.86 7.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.583 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 28' ' ' PRO . . . . . 0.418 ' HG3' ' CE2' ' H' ' 26' ' ' TYR . 34.4 Cg_endo -76.47 82.64 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.72 2.28 . . . . 0.0 110.487 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.18 111.78 9.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.368 -0.833 . . . . 0.0 109.194 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.553 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.694 HG22 ' O ' ' I' ' 2' ' ' ILE . 49.6 mt -98.02 24.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -1.194 . . . . 0.0 109.314 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 3' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 57.3 t -113.46 -47.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.972 . . . . 0.0 109.57 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.01 50.49 1.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.229 -0.919 . . . . 0.0 109.33 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -172.32 -34.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.475 -0.765 . . . . 0.0 109.252 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 51.3 m -109.06 -32.61 7.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.867 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 7' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' I' ' 3' ' ' VAL . 0.5 OUTLIER -71.17 -19.49 62.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.047 . . . . 0.0 109.482 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -103.77 -6.82 21.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 p -169.51 135.66 1.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.194 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.84 145.29 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.346 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 11' ' ' CYS . . . . . 0.45 ' SG ' HD11 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -112.46 150.06 31.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.012 -1.055 . . . . 0.0 109.545 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.57 155.58 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.77 -30.15 31.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.739 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -63.88 -45.6 88.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -72.03 -23.97 61.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 16' ' ' LEU . . . . . 0.45 HD11 ' SG ' ' I' ' 11' ' ' CYS . 75.8 mt -94.88 -0.81 53.69 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -91.13 -23.66 20.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.998 . . . . 0.0 109.81 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -83.84 -9.03 59.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 109.676 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.54 15.6 10.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.12 156.59 17.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 109.67 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.215 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 9.6 p90 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.41 121.05 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.72 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.382 -0.824 . . . . 0.0 108.868 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -79.26 -40.72 29.84 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.432 -0.793 . . . . 0.0 109.5 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -61.8 -21.65 64.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 109.381 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 6' ' ' LEU . . . . . 0.716 HD22 ' ND1' ' F' ' 10' ' ' HIS . 8.8 mt -103.14 -22.25 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.319 -0.863 . . . . 0.0 108.928 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 46.1 t -77.64 -14.91 59.51 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.405 -0.809 . . . . 0.0 109.099 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.699 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -94.26 -19.2 33.78 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 38.4 p -83.41 -18.04 40.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.203 . . . . 0.0 109.179 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -86.02 -20.93 28.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.377 -0.827 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.453 ' CD2' ' C6 ' ' J' ' 32' ' ' IPH . 9.8 mt -92.07 -33.55 14.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.954 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.699 HG13 ' O ' ' J' ' 8' ' ' GLY . 32.5 m -62.2 -36.23 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.739 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.419 ' N ' HG23 ' J' ' 12' ' ' VAL . 1.0 OUTLIER -72.76 -27.11 61.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.957 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.678 ' CB ' HD21 ' D' ' 17' ' ' LEU . . . -99.09 18.35 17.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 109.74 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 15' ' ' LEU . . . . . 0.595 HD11 HD13 ' I' ' 2' ' ' ILE . 1.4 mt -116.04 -54.15 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.984 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.19 -23.96 66.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.7 -35.19 58.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.664 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.53 -68.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.688 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.08 -44.15 97.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.647 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.92 -94.94 0.8 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.02 -57.83 10.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 109.519 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -53.23 158.68 1.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.255 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.81 -172.42 25.54 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -163.33 158.24 21.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.246 . . . . 0.0 109.714 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 25' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' L' ' 25' ' ' PHE . 42.5 p90 -116.15 147.04 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.535 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -131.08 113.07 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.618 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 27' ' ' THR . . . . . 0.718 HG23 ' HA3' ' L' ' 23' ' ' GLY . 0.3 OUTLIER -138.0 92.35 12.61 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.585 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.74 81.88 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.6 2.2 . . . . 0.0 110.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.3 110.12 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.451 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.715 ' O ' HG22 ' K' ' 2' ' ' ILE . 43.7 mt -97.84 26.67 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -1.195 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 54.5 t -115.18 -49.61 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 109.429 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.02 48.1 1.24 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -169.1 -35.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.684 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 6' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' K' ' 9' ' ' SER . 77.5 m -110.0 -27.34 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.99 . . . . 0.0 109.327 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 7' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 33.6 t -73.82 -19.04 60.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -106.83 -6.04 17.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 9' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 2.1 p -167.67 135.43 2.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 109.181 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.414 ' HA ' ' O1 ' ' L' ' 32' ' ' IPH . 2.3 mp -55.89 139.81 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 109.362 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 99.7 m -105.17 147.23 28.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.723 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.17 156.9 36.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.875 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -32.69 60.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 109.501 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -61.36 -44.96 96.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -72.65 -22.22 60.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.816 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.98 2.02 51.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.241 -0.912 . . . . 0.0 109.739 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -93.31 -24.73 18.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.396 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -83.14 -9.49 59.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -90.15 15.81 9.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.5 161.99 13.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.446 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.632 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 10.0 p90 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.13 124.4 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.366 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.93 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -80.75 -40.87 24.44 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -61.31 -20.65 63.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.356 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.06 -25.03 13.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.483 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 35.2 t -74.96 -19.72 59.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.566 -0.709 . . . . 0.0 109.381 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.683 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -89.59 -20.97 42.11 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p -80.6 -18.48 48.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 10' ' ' HIS . . . . . 0.553 ' ND1' HD22 ' H' ' 6' ' ' LEU . 21.5 m-70 -87.32 -18.65 29.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.582 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.7 mt -94.0 -30.11 14.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.821 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.683 HG13 ' O ' ' L' ' 8' ' ' GLY . 35.3 m -66.61 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -74.34 -25.67 59.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.02 19.69 16.95 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.122 -0.986 . . . . 0.0 109.698 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.584 HD11 HD13 ' K' ' 2' ' ' ILE . 1.4 mt -117.21 -54.16 2.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -65.93 -23.68 66.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -78.82 -30.37 45.28 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.262 -0.898 . . . . 0.0 109.885 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.52 -68.67 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.23 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.2 -44.47 96.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -96.79 0.94 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.73 -59.38 5.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.272 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -51.36 157.89 0.93 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.327 -0.858 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' J' ' 27' ' ' THR . . . -103.14 -166.99 25.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -171.79 155.78 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -1.107 . . . . 0.0 109.3 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 25' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' L' ' 25' ' ' PHE . 18.1 p90 -113.88 152.47 30.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.0 109.302 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -132.51 116.64 17.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 109.247 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.57 91.54 7.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.261 -0.9 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.67 80.23 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.542 2.161 . . . . 0.0 110.202 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.26 111.7 11.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.487 ' C6 ' ' CD2' ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.468 ' O1 ' ' HA ' ' C' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 31' ' ' IPH . . . . . 0.527 ' H5 ' HD21 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 31' ' ' IPH . . . . . 0.548 ' C6 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' J' J ' 32' ' ' IPH . . . . . 0.453 ' C6 ' ' CD2' ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 32' ' ' IPH . . . . . 0.441 ' H5 ' HD21 ' H' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' J' J ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' A' ' 2' ' ' ILE . 4.5 tt -118.61 18.52 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -1.166 . . . . 0.0 109.263 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 t -121.45 -7.0 9.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.35 -0.844 . . . . 0.0 109.189 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.88 -9.78 19.6 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.356 -0.84 . . . . 0.0 109.612 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -130.96 12.82 5.23 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.307 -0.87 . . . . 0.0 109.644 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -47.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.364 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.93 -15.64 59.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.3 p -97.74 -34.23 10.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 109.494 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 0.0 109.384 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.3 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.935 . . . . 0.0 109.266 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.3 m -95.81 172.51 7.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.85 167.31 10.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.22 91.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.334 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -64.67 -33.67 76.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.84 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -50.62 70.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.24 -20.13 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.12 -21.62 61.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -64.73 -25.04 67.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.457 ' CD2' HD12 ' A' ' 2' ' ' ILE . 40.4 m-85 -100.53 -25.63 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.53 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.85 119.18 8.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.599 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.535 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' I' ' 8' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.489 ' O ' ' ND2' ' B' ' 3' ' ' ASN . 4.7 p -59.36 142.08 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.635 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' B' ' 2' ' ' VAL . 0.6 OUTLIER 168.94 -39.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -76.19 -36.75 58.52 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.409 ' HB2' HD11 ' I' ' 10' ' ' ILE . 85.3 t60 -62.1 -37.79 86.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.185 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.608 HD21 ' H5 ' ' J' ' 32' ' ' IPH . 9.5 mt -84.55 -23.53 29.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 108.973 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.423 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 38.7 t -69.31 -36.23 76.79 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.93 -21.48 65.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 61.3 p -77.03 -17.13 59.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.486 -1.008 . . . . 0.0 109.494 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -88.07 -24.51 23.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.451 HD22 ' C2 ' ' B' ' 32' ' ' IPH . 10.9 mt -81.14 -39.24 25.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 m -49.99 -40.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -70.07 -40.97 74.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.005 . . . . 0.0 109.24 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.64 27.36 1.77 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.75 -48.29 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.312 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.599 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 11.6 p90 -74.38 -17.59 60.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.925 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.599 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 8.3 mt -78.81 -19.47 52.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.408 -0.808 . . . . 0.0 109.483 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.3 -50.64 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.87 -69.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.372 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.29 -106.29 3.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -62.42 -36.36 82.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -1.134 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -68.5 171.56 7.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.012 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -115.05 178.51 17.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.89 159.55 44.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -1.183 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.581 ' CD1' ' O ' ' B' ' 25' ' ' PHE . 21.5 p90 -113.45 139.42 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -123.13 114.35 20.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.36 87.67 54.6 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.28 79.01 3.42 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.588 2.192 . . . . 0.0 110.509 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -132.04 161.42 33.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.202 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.645 -179.811 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.479 HD12 ' CD2' ' C' ' 19' ' ' TYR . 5.1 tt -116.61 13.84 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -116.61 -5.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.9 -4.49 22.1 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.276 -0.89 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.98 5.04 3.85 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.061 -1.025 . . . . 0.0 110.222 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.06 -42.29 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.043 . . . . 0.0 109.192 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.03 -16.01 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.535 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 71.4 p -96.59 -37.64 10.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.333 -0.854 . . . . 0.0 109.291 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 7.9 m -138.86 144.2 39.1 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' L' ' 5' ' ' HIS . 2.6 mp -53.48 138.25 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 m -102.36 159.76 15.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 109.622 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 170.98 11.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.845 . . . . 0.0 110.329 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -48.93 71.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 109.253 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -61.49 -33.43 73.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 109.241 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -47.75 81.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.725 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mt -71.97 -19.88 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.224 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.47 -22.75 61.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -63.68 -24.66 67.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.534 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.479 ' CD2' HD12 ' C' ' 2' ' ' ILE . 27.5 m-85 -100.92 -27.24 13.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.519 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -58.5 119.6 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.105 -0.997 . . . . 0.0 109.475 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.6 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.539 ' O ' ' ND2' ' D' ' 3' ' ' ASN . 7.6 p -61.52 144.41 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' D' ' 2' ' ' VAL . 0.7 OUTLIER 165.45 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.019 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.07 -34.77 43.34 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -64.18 -37.69 88.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.384 -0.822 . . . . 0.0 108.928 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -82.39 -30.79 30.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 108.938 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.2 t -63.51 -35.48 80.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.47 -0.769 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.37 -22.34 65.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' SER . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 16' ' ' TYR . 90.7 p -79.43 -17.79 53.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.221 -1.164 . . . . 0.0 109.149 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -83.37 -27.93 29.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 109.342 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 11.1 mt -78.76 -45.05 21.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.464 HG23 ' N ' ' D' ' 13' ' ' GLU . 12.8 m -43.02 -45.3 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.464 ' N ' HG23 ' D' ' 12' ' ' VAL . 11.8 mt-10 -66.08 -40.53 90.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.29 23.98 2.71 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 109.795 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.33 -48.34 2.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 9.5 p90 -73.72 -18.66 60.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.237 -0.914 . . . . 0.0 109.311 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 8.6 mt -77.51 -20.35 54.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.817 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.62 -50.21 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 45.1 m -74.77 -68.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.93 -109.72 3.87 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.59 -37.94 76.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.124 . . . . 0.0 109.316 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -68.42 161.09 28.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.812 . . . . 0.0 109.545 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.52 -175.06 25.01 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -158.19 157.66 33.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -1.219 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -111.78 142.62 43.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.331 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.49 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 39.3 t80 -127.76 115.92 19.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 89.99 47.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 28' ' ' PRO . . . . . 0.413 ' HD2' ' CA ' ' B' ' 23' ' ' GLY . 35.8 Cg_endo -78.63 74.42 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.733 2.289 . . . . 0.0 110.503 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -127.02 159.55 33.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.486 179.894 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.475 HD12 ' CD2' ' E' ' 19' ' ' TYR . 6.4 tt -118.0 16.32 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.272 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 t -118.47 -10.13 11.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.514 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -100.06 -10.2 21.8 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.343 -0.848 . . . . 0.0 109.851 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.03 15.28 6.28 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.35 -50.52 0.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -13.91 25.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.696 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 65.2 p -98.74 -34.26 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.042 -1.036 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.3 m -142.72 145.05 32.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.05 139.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -0.983 . . . . 0.0 109.752 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -97.67 171.42 8.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.775 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.23 167.03 10.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 109.367 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -47.72 85.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.265 -0.897 . . . . 0.0 109.141 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -63.76 -34.18 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 0.0 109.606 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -49.53 76.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.77 -18.65 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 0.0 109.682 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.71 -24.24 60.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -61.53 -25.41 67.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.873 . . . . 0.0 109.786 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.475 ' CD2' HD12 ' E' ' 2' ' ' ILE . 24.0 m-85 -100.59 -27.05 13.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.589 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.27 118.53 5.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.584 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.458 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.231 0.539 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.507 ' O ' ' ND2' ' F' ' 3' ' ' ASN . 7.6 p -63.91 145.12 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 3' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' F' ' 2' ' ' VAL . 0.8 OUTLIER 165.21 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.861 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.54 -37.54 42.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.311 -0.868 . . . . 0.0 109.102 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.47 -36.42 82.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 mt -84.51 -28.68 26.56 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 44.0 t -66.0 -33.27 75.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.676 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.34 -20.21 62.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 9' ' ' SER . . . . . 0.435 ' O ' ' CG2' ' F' ' 12' ' ' VAL . 5.6 p -80.08 -18.02 51.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.047 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -84.13 -26.71 28.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.106 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -78.6 -45.8 20.82 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.342 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.473 HG23 ' N ' ' F' ' 13' ' ' GLU . 13.0 m -42.95 -44.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.398 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.473 ' N ' HG23 ' F' ' 12' ' ' VAL . 14.5 mt-10 -65.9 -41.31 91.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 0.0 109.941 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.81 25.74 2.28 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 0.0 109.888 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.53 -48.23 2.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.4 p90 -74.0 -17.62 60.97 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 8.4 mt -79.8 -19.53 48.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.874 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.78 -51.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.055 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.1 -69.3 0.43 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.43 -109.17 3.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -58.77 -41.6 86.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.326 -1.102 . . . . 0.0 109.342 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -63.71 163.37 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 0.0 109.733 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.11 -175.86 23.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -161.66 163.51 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 25' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.5 p90 -119.85 156.02 31.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 26' ' ' TYR . . . . . 0.431 ' O ' ' HD3' ' F' ' 28' ' ' PRO . 31.4 t80 -134.48 105.23 6.45 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.63 87.65 21.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 28' ' ' PRO . . . . . 0.501 ' HD2' ' CA ' ' H' ' 23' ' ' GLY . 35.1 Cg_endo -78.47 73.77 5.71 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.771 2.314 . . . . 0.0 110.713 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -125.88 165.14 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.519 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.494 HD12 ' CD2' ' G' ' 19' ' ' TYR . 5.3 tt -113.16 13.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -1.135 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -115.53 -7.51 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 109.723 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -102.49 -11.31 18.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.59 16.76 6.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.108 -0.995 . . . . 0.0 109.479 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.54 -50.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.436 -0.79 . . . . 0.0 109.255 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.3 -15.66 37.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.428 -0.795 . . . . 0.0 109.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 71.2 p -97.39 -39.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 m -136.29 139.77 42.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -50.62 137.8 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 97.1 m -94.97 172.09 8.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.514 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 12' ' ' SER . . . . . 0.4 ' O ' HD12 ' G' ' 16' ' ' LEU . 0.3 OUTLIER -101.26 170.73 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 108.932 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -45.96 85.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.165 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.41 -33.28 75.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -49.6 74.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 16' ' ' LEU . . . . . 0.4 HD12 ' O ' ' G' ' 12' ' ' SER . 2.1 mt -70.47 -19.79 62.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.553 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.85 -22.44 61.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -63.53 -29.48 70.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.033 -1.042 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 19' ' ' TYR . . . . . 0.494 ' CD2' HD12 ' G' ' 2' ' ' ILE . 29.4 m-85 -94.53 -31.87 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.975 . . . . 0.0 109.506 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 121.9 9.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.566 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.498 ' O ' ' ND2' ' H' ' 3' ' ' ASN . 7.3 p -62.63 144.09 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' H' ' 2' ' ' VAL . 0.9 OUTLIER 166.09 -42.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.192 -0.942 . . . . 0.0 108.964 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.49 -36.61 60.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.228 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.86 -37.48 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -83.3 -28.08 29.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.092 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 16.8 t -66.55 -33.5 75.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.681 . . . . 0.0 109.233 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.65 56.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 3.5 p -75.45 -18.0 60.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -1.081 . . . . 0.0 109.571 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -84.52 -24.76 29.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.823 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 11.0 mt -82.54 -42.33 18.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.426 HG23 ' N ' ' H' ' 13' ' ' GLU . 12.0 m -45.68 -43.02 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.333 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 13' ' ' GLU . . . . . 0.426 ' N ' HG23 ' H' ' 12' ' ' VAL . 12.7 mt-10 -66.66 -42.91 85.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.4 26.39 1.46 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.887 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.42 -47.25 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.045 . . . . 0.0 109.37 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.587 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 8.9 p90 -74.92 -16.68 60.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 7.9 mt -80.33 -19.92 45.42 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.489 -0.757 . . . . 0.0 109.397 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.1 t -79.41 -52.29 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.265 -0.897 . . . . 0.0 109.428 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.36 -65.7 0.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.2 -105.66 3.26 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.71 -39.73 92.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -1.204 . . . . 0.0 109.405 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.94 165.9 12.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.501 ' CA ' ' HD2' ' F' ' 28' ' ' PRO . . . -109.97 -176.75 21.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -159.05 153.51 24.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.409 -1.054 . . . . 0.0 109.347 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' H' ' 25' ' ' PHE . 37.5 p90 -110.79 141.33 44.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.263 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.99 118.88 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.93 . . . . 0.0 109.447 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.5 87.69 49.42 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.611 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.94 77.79 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.644 2.23 . . . . 0.0 110.678 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -129.13 160.44 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.545 179.915 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.467 HD12 ' CD2' ' I' ' 19' ' ' TYR . 4.2 tt -122.14 15.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -1.207 . . . . 0.0 109.38 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 t -118.73 -3.13 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.299 -0.875 . . . . 0.0 109.311 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.71 -6.14 17.0 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.92 2.04 4.35 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 109.79 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 50.9 m -127.15 -39.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -69.46 -13.62 62.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.99 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 8' ' ' THR . . . . . 0.508 ' O ' ' HB3' ' B' ' 1' ' ' PHE . 67.3 p -102.19 -20.72 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.605 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -153.64 138.09 16.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 109.358 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 5' ' ' HIS . 2.3 mp -50.18 138.08 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 109.014 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.0 m -102.26 161.1 13.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 12' ' ' SER . . . . . 0.422 ' O ' HD12 ' I' ' 16' ' ' LEU . 0.3 OUTLIER -89.55 170.92 10.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.341 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -49.41 72.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.542 -0.724 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -60.42 -35.07 74.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.18 -48.69 78.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.577 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 16' ' ' LEU . . . . . 0.422 HD12 ' O ' ' I' ' 12' ' ' SER . 2.1 mt -72.39 -15.36 61.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.266 -0.896 . . . . 0.0 109.736 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -61.59 -29.91 70.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 19' ' ' TYR . . . . . 0.467 ' CD2' HD12 ' I' ' 2' ' ' ILE . 28.3 m-85 -96.21 -30.3 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.705 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.16 118.86 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.495 179.902 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.262 0.554 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.517 ' O ' ' ND2' ' J' ' 3' ' ' ASN . 7.3 p -64.21 145.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 3' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' J' ' 2' ' ' VAL . 0.7 OUTLIER 165.3 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -77.99 -38.1 45.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.217 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.32 -35.29 78.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -0.853 . . . . 0.0 108.916 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -85.33 -27.46 25.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 12.9 t -67.23 -33.95 76.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.793 . . . . 0.0 109.42 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.91 -22.67 60.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 93.3 p -77.28 -16.99 58.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -1.026 . . . . 0.0 109.322 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 10' ' ' HIS . . . . . 0.489 ' CG ' HD22 ' B' ' 6' ' ' LEU . 10.3 m-70 -88.02 -21.65 24.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.892 . . . . 0.0 109.665 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.8 mt -84.02 -38.97 20.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.409 HG23 ' N ' ' J' ' 13' ' ' GLU . 11.8 m -49.67 -40.61 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.409 ' N ' HG23 ' J' ' 12' ' ' VAL . 11.8 mt-10 -69.44 -40.52 77.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.2 27.81 1.8 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.381 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.56 -46.41 2.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.594 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 12.6 p90 -76.22 -16.22 59.87 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.056 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 7.9 mt -80.83 -17.37 51.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.499 -0.75 . . . . 0.0 109.792 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -82.69 -49.42 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -63.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 109.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.74 -105.95 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -61.05 -39.12 88.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -66.63 157.51 32.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.936 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -175.87 29.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -161.1 157.9 26.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.058 -1.26 . . . . 0.0 109.726 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -115.97 142.68 46.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.76 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -122.67 119.25 30.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.406 -0.809 . . . . 0.0 109.121 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 87.38 53.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.72 77.84 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.628 2.218 . . . . 0.0 110.679 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -128.93 160.54 32.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.342 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' K' ' 2' ' ' ILE . 6.2 tt -117.66 17.22 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.316 -1.108 . . . . 0.0 109.718 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 t -119.94 -8.42 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.63 -10.37 21.0 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.279 -0.888 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.94 16.44 5.18 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.56 -47.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.314 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -16.09 56.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.196 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 66.9 p -96.04 -41.33 8.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.823 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 75.3 m -134.35 144.41 48.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.142 -0.974 . . . . 0.0 109.721 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.43 137.22 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.29 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.83 169.38 10.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 109.887 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.03 167.49 10.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.38 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -46.44 90.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.387 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.61 -35.0 79.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -49.06 78.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 109.598 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.23 -18.34 62.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.931 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.45 -23.12 60.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 109.188 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.576 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 19' ' ' TYR . . . . . 0.431 ' CD2' HD12 ' K' ' 2' ' ' ILE . 24.1 m-85 -99.33 -27.82 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.08 120.94 8.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.486 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' L' L ' 1' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' C' ' 8' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.264 0.554 . . . . 0.0 109.587 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.467 ' O ' ' ND2' ' L' ' 3' ' ' ASN . 7.3 p -63.14 143.86 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.013 -1.055 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 3' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' L' ' 2' ' ' VAL . 0.7 OUTLIER 167.27 -39.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.017 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -77.07 -39.89 48.16 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.374 -0.829 . . . . 0.0 108.81 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 5' ' ' HIS . . . . . 0.666 ' HB2' HD11 ' C' ' 10' ' ' ILE . 86.3 t60 -60.67 -36.61 79.16 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 6' ' ' LEU . . . . . 0.425 HD21 ' H5 ' ' D' ' 32' ' ' IPH . 10.8 mt -84.01 -29.34 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.448 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 40.7 t -66.12 -32.68 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.578 -0.701 . . . . 0.0 109.595 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.44 -26.7 53.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 9' ' ' SER . . . . . 0.41 ' O ' HG22 ' L' ' 12' ' ' VAL . 59.9 p -74.01 -19.74 60.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.48 -1.012 . . . . 0.0 109.329 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -83.78 -23.28 31.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 0.0 109.564 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 10.5 mt -82.55 -42.65 18.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 109.566 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.41 HG22 ' O ' ' L' ' 9' ' ' SER . 13.9 m -46.49 -40.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -70.36 -40.21 74.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.89 21.46 3.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 109.666 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -49.28 2.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.561 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 11.5 p90 -73.05 -17.3 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.962 . . . . 0.0 109.695 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 8.4 mt -79.01 -19.51 51.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.684 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.49 -50.79 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 57.1 m -73.83 -68.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.35 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.82 -108.38 3.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.93 -38.22 85.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -1.169 . . . . 0.0 109.217 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -67.44 160.53 27.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.433 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.62 -175.46 24.91 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -155.33 170.5 21.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -125.57 136.71 53.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.968 -1.083 . . . . 0.0 109.315 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -120.16 117.08 26.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.74 87.16 50.35 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.483 -0.761 . . . . 0.0 109.307 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.99 79.14 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.593 2.196 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -130.07 161.39 31.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 0.0 109.312 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.414 179.872 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.451 ' C2 ' HD22 ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.425 ' H5 ' HD21 ' L' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 31' ' ' IPH . . . . . 0.41 ' C2 ' HD22 ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' J' J ' 32' ' ' IPH . . . . . 0.608 ' H5 ' HD21 ' B' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.483 HD13 HD11 ' B' ' 15' ' ' LEU . 51.4 mt -87.27 -27.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.88 -27.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.209 -0.932 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 55.01 0.65 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.22 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.37 -36.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -101.66 -32.22 10.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.339 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.454 ' O ' HG12 ' F' ' 2' ' ' VAL . 1.7 m -68.89 -32.04 71.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 108.975 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.7 p -88.45 -16.1 33.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.416 -0.803 . . . . 0.0 109.45 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 10' ' ' ILE . 1.4 p -169.49 121.15 0.71 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.444 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 9' ' ' SER . 3.1 mt -44.61 107.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.14 154.96 21.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.299 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -71.99 167.56 19.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.23 -38.33 85.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.713 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.8 -43.07 94.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.873 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -63.84 -39.6 94.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.4 mt -77.16 -15.17 59.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -78.09 -22.51 48.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -85.35 17.39 3.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.24 -13.7 12.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.116 -0.99 . . . . 0.0 109.299 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.88 156.99 25.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.193 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.509 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.239 0.542 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.3 150.64 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.055 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 173.32 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.006 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -74.61 -32.67 62.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.174 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -69.03 -39.37 79.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.08 -23.48 35.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.484 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 42.4 t -74.57 -34.91 63.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.429 -0.794 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -16.01 80.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.89 -19.95 28.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.413 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.736 ' CG ' HD22 ' F' ' 6' ' ' LEU . 10.9 m-70 -83.97 -15.07 49.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 12.9 mt -91.98 -49.71 6.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.756 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.454 HG23 ' N ' ' B' ' 13' ' ' GLU . 9.0 m -46.56 -45.18 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.454 ' N ' HG23 ' B' ' 12' ' ' VAL . 67.4 mt-10 -62.03 -42.79 99.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.54 22.67 2.49 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.173 -0.955 . . . . 0.0 109.631 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.483 HD11 HD13 ' A' ' 2' ' ' ILE . 0.7 OUTLIER -115.89 -58.41 2.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.903 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -59.46 -27.86 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.197 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.03 -42.68 80.24 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.554 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -54.56 -47.99 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -61.44 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' B' ' 21' ' ' GLU . . . 103.65 40.04 2.43 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' B' ' 20' ' ' GLY . 3.0 tt0 78.86 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.434 -1.039 . . . . 0.0 109.419 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.21 -54.81 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 109.581 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.02 152.38 5.7 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -163.52 159.87 22.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -119.81 143.24 47.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.601 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 40.2 t80 -119.71 104.7 10.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.103 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -132.07 97.92 17.89 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.76 113.15 3.59 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.504 2.136 . . . . 0.0 110.637 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -168.17 158.25 10.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.438 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . 0.488 HD13 HD11 ' D' ' 15' ' ' LEU . 46.0 mt -90.17 -28.37 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 109.316 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.49 -29.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.98 53.11 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.34 -36.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' C' ' 9' ' ' SER . 63.3 m -101.62 -33.62 9.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.357 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -68.1 -30.51 69.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.904 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 75.0 p -89.82 -17.26 28.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.317 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . 0.413 ' O ' ' C ' ' C' ' 10' ' ' ILE . 1.3 p -167.82 120.34 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' C' ' 9' ' ' SER . 3.1 mt -44.29 108.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.22 155.98 16.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 t -72.68 165.83 24.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.11 -37.63 86.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.968 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.24 -44.5 88.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.884 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . 0.464 ' HA ' ' ND2' ' C' ' 18' ' ' ASN . 27.8 mt-30 -61.6 -40.98 96.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 47.0 mt -74.62 -17.2 60.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 109.828 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.11 -18.79 52.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.011 -1.055 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' C' ' 15' ' ' GLN . 26.8 p30 -88.24 16.34 6.39 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.117 -0.99 . . . . 0.0 109.47 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -112.26 -12.95 13.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.51 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.22 152.56 25.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.552 -179.921 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.63 HG23 HD11 ' G' ' 10' ' ' ILE . 7.3 p -60.18 152.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.223 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' D' ' 7' ' ' CYS . 3.9 m-20 170.92 -38.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.377 -0.827 . . . . 0.0 109.219 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -75.36 -31.02 60.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -70.18 -40.36 74.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.143 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -81.87 -22.35 36.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.06 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 49.9 t -75.34 -34.53 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.39 -0.819 . . . . 0.0 109.674 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.08 -16.95 80.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.85 -19.6 32.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -1.041 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . 0.704 ' CG ' HD22 ' L' ' 6' ' ' LEU . 15.5 m-70 -85.57 -13.91 47.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.298 -0.876 . . . . 0.0 109.137 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 13.8 mt -92.04 -52.72 4.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.527 HG23 ' N ' ' D' ' 13' ' ' GLU . 11.5 m -43.79 -48.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.527 ' N ' HG23 ' D' ' 12' ' ' VAL . 82.3 mt-10 -58.71 -43.74 90.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.865 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.65 23.5 2.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.237 -0.914 . . . . 0.0 110.071 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.488 HD11 HD13 ' C' ' 2' ' ' ILE . 0.8 OUTLIER -115.56 -59.28 2.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' D' ' 13' ' ' GLU . 16.5 p90 -58.42 -27.4 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' D' ' 17' ' ' LEU . 4.9 mt -68.14 -43.1 79.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.385 -0.822 . . . . 0.0 109.586 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.21 -47.77 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -60.25 3.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' D' ' 21' ' ' GLU . . . 101.23 40.55 2.79 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' D' ' 20' ' ' GLY . 1.9 tt0 79.55 50.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.434 -1.039 . . . . 0.0 109.867 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -51.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.41 150.49 6.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 30.0 p90 -155.28 172.46 18.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.31 -1.112 . . . . 0.0 109.364 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' D' ' 25' ' ' PHE . 12.8 m-85 -129.12 139.03 52.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.277 -0.889 . . . . 0.0 109.37 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -120.97 99.42 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.577 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 32.4 m -126.48 100.61 28.7 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.401 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.85 110.93 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.569 2.179 . . . . 0.0 110.543 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -167.18 155.75 9.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.379 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.517 HD13 HD11 ' F' ' 15' ' ' LEU . 50.5 mt -87.11 -27.37 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.5 -28.01 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -108.04 53.22 0.69 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.275 -0.891 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.78 -34.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' E' ' 2' ' ' ILE . 64.3 m -102.63 -30.28 11.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.221 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 4.8 t -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.339 -0.851 . . . . 0.0 109.306 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -87.67 -15.74 36.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . 0.437 ' O ' ' C ' ' E' ' 10' ' ' ILE . 76.7 p -169.19 117.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.227 -0.92 . . . . 0.0 109.34 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.509 HD11 HG23 ' J' ' 2' ' ' VAL . 3.1 mt -42.25 106.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.06 155.19 14.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.726 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 27.7 t -70.57 168.86 15.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.43 -37.13 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -64.74 -47.12 79.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -0.836 . . . . 0.0 109.475 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . 0.445 ' HA ' ' ND2' ' E' ' 18' ' ' ASN . 28.1 mt-30 -60.54 -39.66 88.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.899 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.288 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -76.99 -18.96 57.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' E' ' 15' ' ' GLN . 27.5 p30 -89.07 13.81 12.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.04 -1.038 . . . . 0.0 110.002 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -109.03 -13.38 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.04 -1.037 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 153.42 27.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.865 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.289 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 7' ' ' CYS . 10.0 p -58.26 149.97 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 174.32 -41.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -72.89 -27.93 62.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -72.84 -40.01 66.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.039 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.736 HD22 ' CG ' ' B' ' 10' ' ' HIS . 6.6 mt -82.46 -19.8 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 108.989 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.422 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 42.3 t -75.68 -38.61 58.58 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.523 -0.735 . . . . 0.0 109.472 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.04 -15.17 79.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -21.4 29.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.18 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -82.57 -18.58 40.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.9 mt -89.14 -49.86 6.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.746 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.489 HG23 ' N ' ' F' ' 13' ' ' GLU . 12.4 m -46.65 -45.81 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.111 -0.993 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . 0.489 ' N ' HG23 ' F' ' 12' ' ' VAL . 79.4 mt-10 -62.44 -40.61 97.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.03 25.06 2.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.517 HD11 HD13 ' E' ' 2' ' ' ILE . 0.7 OUTLIER -117.97 -58.85 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -59.34 -27.73 66.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.297 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' F' ' 17' ' ' LEU . 5.3 mt -68.07 -43.51 78.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.857 . . . . 0.0 109.493 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.06 -51.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 109.402 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -47.8 -62.23 1.56 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' F' ' 21' ' ' GLU . . . 103.63 40.42 2.36 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' F' ' 20' ' ' GLY . 2.2 tt0 79.65 49.51 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -1.046 . . . . 0.0 109.788 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -123.53 -46.8 2.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.04 -1.038 . . . . 0.0 109.563 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.22 153.14 7.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -162.81 175.68 11.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 2.4 p90 -132.76 158.18 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.383 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -138.25 93.78 2.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.411 -0.806 . . . . 0.0 109.103 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 28.5 m -120.34 99.34 48.22 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.492 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 108.59 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.424 2.083 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -164.64 155.73 15.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 44.3 p . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.568 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . 0.503 HD13 HD11 ' H' ' 15' ' ' LEU . 36.4 mt -84.48 -30.52 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.751 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.15 -30.05 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 109.63 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.7 52.45 0.73 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.175 -0.953 . . . . 0.0 109.888 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.05 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.379 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.5 -35.06 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.83 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.075 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -89.05 -17.4 29.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.361 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . 0.43 ' O ' ' C ' ' G' ' 10' ' ' ILE . 1.9 p -168.75 119.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . 0.63 HD11 HG23 ' D' ' 2' ' ' VAL . 3.1 mt -42.82 106.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.578 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 62.6 m -60.62 153.97 22.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.373 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -68.76 170.16 10.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' G' ' 13' ' ' LEU . 1.3 mm? -70.79 -37.83 73.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 109.188 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.28 -44.82 90.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.431 -0.793 . . . . 0.0 109.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . 0.452 ' HA ' ' ND2' ' G' ' 18' ' ' ASN . 21.4 mt-30 -61.92 -39.66 92.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.91 -15.36 59.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.203 -0.936 . . . . 0.0 109.544 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -79.32 -19.86 49.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.679 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' G' ' 15' ' ' GLN . 27.6 p30 -86.54 11.99 11.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -108.86 -10.94 15.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.855 . . . . 0.0 109.796 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.41 152.63 23.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.654 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.399 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.408 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.5 p -60.06 152.56 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 3.6 m-20 170.72 -37.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -74.8 -33.81 62.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.25 -0.906 . . . . 0.0 108.855 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . 0.6 ' CB ' HD11 ' K' ' 10' ' ' ILE . 54.2 t60 -67.49 -42.2 83.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.513 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mt -79.22 -26.8 42.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.85 . . . . 0.0 109.427 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 42.4 t -72.21 -34.23 68.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.55 -21.47 79.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.73 -20.68 38.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -1.061 . . . . 0.0 109.665 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -82.34 -15.75 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.113 -0.992 . . . . 0.0 109.76 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.433 HD13 HG22 ' G' ' 2' ' ' ILE . 9.6 mt -92.41 -49.16 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.594 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.497 HG23 ' N ' ' H' ' 13' ' ' GLU . 10.8 m -46.16 -47.11 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . 0.497 ' N ' HG23 ' H' ' 12' ' ' VAL . 78.3 mt-10 -61.42 -42.45 98.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.32 19.37 3.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 110.063 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . 0.503 HD11 HD13 ' G' ' 2' ' ' ILE . 0.7 OUTLIER -112.5 -59.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.07 -28.62 64.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' H' ' 17' ' ' LEU . 5.4 mt -67.07 -43.32 82.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.518 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -53.94 -45.81 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -57.16 12.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' H' ' 21' ' ' GLU . . . 99.73 38.88 3.53 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' H' ' 20' ' ' GLY . 2.2 tt0 80.93 50.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.26 -56.81 1.61 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.962 . . . . 0.0 109.475 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.37 153.25 5.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.67 158.27 17.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -1.153 . . . . 0.0 109.186 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 28.5 p90 -121.39 141.09 51.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.697 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -117.09 106.25 13.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 32.5 m -132.29 99.06 16.35 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.55 -0.719 . . . . 0.0 109.454 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.44 112.61 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.489 2.126 . . . . 0.0 110.47 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.61 153.18 8.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.612 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.514 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.494 HD13 HD11 ' J' ' 15' ' ' LEU . 32.8 mt -86.37 -30.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -1.125 . . . . 0.0 109.4 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.46 -28.23 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -108.09 49.4 0.81 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.11 -0.994 . . . . 0.0 109.688 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.12 -34.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.22 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -102.97 -32.53 9.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.06 -26.63 64.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 46.8 p -93.76 -17.2 23.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.035 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . 0.417 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.2 p -167.52 119.29 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' I' ' 9' ' ' SER . 3.1 mt -43.73 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.5 m -59.57 156.55 13.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.482 -0.761 . . . . 0.0 109.457 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -73.7 169.01 18.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.86 -38.16 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -65.56 -43.75 88.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . 0.433 ' HA ' ' ND2' ' I' ' 18' ' ' ASN . 26.9 mt-30 -62.97 -38.0 89.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.187 -0.945 . . . . 0.0 109.441 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 42.3 mt -78.84 -13.51 59.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -81.01 -21.55 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.08 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' I' ' 15' ' ' GLN . 27.3 p30 -85.09 15.8 3.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.314 -0.866 . . . . 0.0 109.739 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.64 -11.73 13.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.382 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.12 154.65 24.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.526 -179.859 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.509 HG23 HD11 ' E' ' 10' ' ' ILE . 11.2 p -59.99 151.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 171.8 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.048 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -74.08 -33.49 63.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.249 -0.907 . . . . 0.0 109.105 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 t60 -68.38 -39.55 81.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.508 -0.745 . . . . 0.0 109.705 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 mt -82.19 -24.64 34.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.465 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 48.7 t -72.89 -37.31 67.32 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -0.817 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.88 -20.52 78.83 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . 0.461 ' HB3' ' OH ' ' L' ' 16' ' ' TYR . 1.3 m -82.38 -19.71 38.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -1.11 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.46 -16.81 44.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.574 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.1 mt -91.08 -48.16 7.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.481 HG23 ' N ' ' J' ' 13' ' ' GLU . 11.7 m -47.9 -46.15 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.276 -0.89 . . . . 0.0 109.981 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.481 ' N ' HG23 ' J' ' 12' ' ' VAL . 60.9 mt-10 -62.27 -39.61 93.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.26 23.36 3.37 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.864 . . . . 0.0 109.753 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . 0.494 HD11 HD13 ' I' ' 2' ' ' ILE . 0.8 OUTLIER -116.32 -58.01 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.018 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -60.37 -28.44 68.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' J' ' 17' ' ' LEU . 5.5 mt -66.17 -44.55 83.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.214 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -51.27 -48.58 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.282 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -50.77 69.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.08 -1.013 . . . . 0.0 108.831 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' J' ' 21' ' ' GLU . . . 108.77 -43.54 1.69 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' J' ' 20' ' ' GLY . 2.4 tt0 167.44 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -53.44 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.59 157.07 7.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 25.1 p90 -159.27 171.24 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -1.142 . . . . 0.0 109.742 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 1.7 p90 -128.0 141.26 51.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -121.75 98.76 6.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.873 . . . . 0.0 109.473 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -125.8 100.23 31.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.433 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.86 109.02 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.426 2.084 . . . . 0.0 110.621 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -164.29 156.85 17.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.553 -179.842 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . 0.508 HD13 HD11 ' L' ' 15' ' ' LEU . 38.0 mt -85.06 -29.23 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 39.4 t -69.24 -31.63 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.265 -0.897 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.95 51.96 0.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.262 -0.899 . . . . 0.0 109.975 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.28 -37.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.161 -0.962 . . . . 0.0 109.227 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 64.5 m -99.59 -34.67 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.305 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 1.7 m -68.07 -22.95 64.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 38.0 p -96.95 -20.42 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 108.978 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . 0.414 ' O ' ' C ' ' K' ' 10' ' ' ILE . 33.8 p -165.27 119.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.324 -0.86 . . . . 0.0 108.959 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . 0.6 HD11 ' CB ' ' H' ' 5' ' ' HIS . 2.9 mp -42.99 107.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.749 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 68.7 m -59.13 156.3 12.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -73.27 169.36 17.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.52 -34.84 74.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 0.0 109.744 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.97 -45.11 75.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.995 . . . . 0.0 109.377 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . 0.441 ' HA ' ' ND2' ' K' ' 18' ' ' ASN . 24.0 mt-30 -60.78 -40.43 92.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 42.5 mt -76.41 -15.57 59.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.94 -19.75 47.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.983 . . . . 0.0 109.558 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' K' ' 15' ' ' GLN . 27.5 p30 -87.17 14.18 8.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.887 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.42 -10.82 14.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.292 -0.88 . . . . 0.0 109.562 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.0 154.22 22.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.551 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.196 0.522 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.72 151.6 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.012 -1.055 . . . . 0.0 109.198 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 172.86 -40.24 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 108.907 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.4 -33.0 64.76 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.297 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -68.73 -39.65 80.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . 0.704 HD22 ' CG ' ' D' ' 10' ' ' HIS . 7.9 mt -82.23 -22.64 35.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.0 109.223 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 48.6 t -74.97 -32.65 61.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.432 -0.792 . . . . 0.0 109.821 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 -13.38 83.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -17.58 31.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.235 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -85.46 -19.19 31.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 11.9 mt -87.23 -51.55 5.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.51 HG23 ' N ' ' L' ' 13' ' ' GLU . 8.4 m -46.1 -49.08 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.641 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . 0.51 ' N ' HG23 ' L' ' 12' ' ' VAL . 62.3 mt-10 -58.98 -42.57 90.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.39 22.79 2.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . 0.508 HD11 HD13 ' K' ' 2' ' ' ILE . 0.7 OUTLIER -115.67 -57.81 2.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 0.0 109.824 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.461 ' OH ' ' HB3' ' J' ' 9' ' ' SER . 18.0 p90 -60.45 -26.97 67.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.17 -0.956 . . . . 0.0 109.393 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' L' ' 17' ' ' LEU . 5.0 mt -68.59 -41.13 80.04 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.37 -49.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -59.48 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.533 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' L' ' 21' ' ' GLU . . . 101.07 39.14 3.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' L' ' 20' ' ' GLY . 2.7 tt0 80.38 48.08 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.489 -1.006 . . . . 0.0 109.929 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.36 -53.86 2.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.38 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.31 151.26 5.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -160.68 169.59 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -1.105 . . . . 0.0 108.949 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 2.5 p90 -129.38 147.61 51.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 36.8 t80 -123.85 107.12 11.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.889 . . . . 0.0 109.166 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -133.17 98.48 15.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.305 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 110.7 3.05 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.471 2.114 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.0 158.52 17.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.418 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.658 -179.846 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.4 2.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -1.176 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 48.0 t -95.04 -36.65 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.958 -1.089 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.43 38.93 1.42 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.477 -0.764 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -156.34 -39.29 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 109.513 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.5 m -104.04 -38.96 6.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 109.636 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 49.3 t -62.09 -24.3 67.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.602 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 p -77.65 -31.67 52.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -153.1 145.78 24.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.545 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -46.81 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -0.869 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.428 ' HB3' ' HG ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.56 163.23 7.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.615 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.17 165.23 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.294 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -36.5 77.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.843 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -68.89 -32.03 71.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -46.15 46.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' A' ' 11' ' ' CYS . 64.8 mt -67.23 -17.34 64.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.053 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -26.15 62.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.069 -1.02 . . . . 0.0 109.335 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -55.08 -32.02 61.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.94 55.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.038 -1.039 . . . . 0.0 109.546 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -123.66 131.88 53.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.392 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.627 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.474 ' O ' HG13 ' B' ' 2' ' ' VAL . 11.1 p -66.98 127.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.579 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 t30 179.96 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.95 -26.34 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -78.48 -39.4 38.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.08 -22.35 36.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 39.7 t -81.81 -33.07 30.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.941 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.81 -26.71 55.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.27 63.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -96.97 -21.17 17.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 59.5 mt -81.76 -33.45 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.58 -33.02 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -73.77 -38.17 64.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.152 -0.968 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -64.59 -58.06 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.543 ' HA ' ' HB ' ' B' ' 18' ' ' VAL . 9.4 mt -53.43 -23.01 8.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.992 . . . . 0.0 109.689 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -53.04 58.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 110.02 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -88.88 -23.27 22.8 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' B' ' 15' ' ' LEU . 83.7 t -65.44 -22.69 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 109.688 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.2 -34.62 8.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.626 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.48 -147.4 18.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -78.41 -1.43 33.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.252 -1.146 . . . . 0.0 109.701 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -65.83 -26.5 67.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 174.28 48.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -157.14 176.79 12.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 0.0 109.549 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.61 ' HB2' ' CE1' ' D' ' 25' ' ' PHE . 6.3 p90 -133.13 153.99 51.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.95 . . . . 0.0 109.585 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -130.92 109.4 10.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.383 -0.823 . . . . 0.0 109.302 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 40.3 m -159.7 105.89 1.46 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 109.34 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.42 -88.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.26 1.973 . . . . 0.0 110.233 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.29 -153.97 0.38 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.425 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . 0.443 HD12 ' CD2' ' C' ' 19' ' ' TYR . 8.9 tt -103.02 0.96 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.644 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' C' ' 7' ' ' CYS . 48.2 t -92.62 -35.94 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.86 48.27 0.86 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.181 -0.949 . . . . 0.0 109.373 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -166.44 -36.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.459 -0.775 . . . . 0.0 109.097 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m -106.5 -39.69 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.394 -0.816 . . . . 0.0 109.374 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' C' ' 3' ' ' VAL . 47.0 t -64.14 -22.07 66.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.849 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -80.31 -31.73 38.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.587 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.28 146.68 26.21 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -48.76 101.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.571 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . 0.402 ' HB3' ' HG ' ' C' ' 16' ' ' LEU . 0.3 OUTLIER -58.32 160.12 5.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 169.91 13.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.6 -38.23 70.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.697 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.6 -31.14 70.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.43 -43.89 47.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 109.821 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' C' ' 11' ' ' CYS . 67.0 mt -69.73 -16.51 63.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.87 . . . . 0.0 109.812 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -23.13 61.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.634 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -58.72 -29.83 66.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.443 ' CD2' HD12 ' C' ' 2' ' ' ILE . 10.6 m-85 -101.39 57.58 0.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -126.6 130.39 50.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.466 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.485 ' O ' HG13 ' D' ' 2' ' ' VAL . 13.0 p -64.8 128.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.587 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 179.25 -42.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.118 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.03 -25.36 60.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.779 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -80.83 -35.58 32.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -85.38 -20.33 30.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.147 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.472 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 41.8 t -84.31 -31.65 24.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.442 -0.786 . . . . 0.0 109.974 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.443 ' HA3' ' OH ' ' D' ' 26' ' ' TYR . . . -81.09 -27.02 51.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -15.23 63.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.34 -1.094 . . . . 0.0 109.364 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -97.06 -21.24 17.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.187 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 57.2 mt -83.81 -28.19 28.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -63.99 -32.06 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -75.32 -37.53 60.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.317 -0.864 . . . . 0.0 109.611 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -65.73 -55.12 18.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.942 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.503 ' HA ' ' HB ' ' D' ' 18' ' ' VAL . 9.6 mt -55.13 -24.4 25.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.38 -53.77 40.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.005 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 35.3 mt -87.98 -24.85 23.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 110.463 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' D' ' 15' ' ' LEU . 78.9 t -63.68 -22.76 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.12 -37.65 7.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.383 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.74 -144.73 17.46 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.78 4.5 21.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -1.161 . . . . 0.0 109.593 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -72.67 -22.72 60.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.883 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.02 177.94 50.97 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -159.05 167.44 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -1.208 . . . . 0.0 109.925 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' B' ' 25' ' ' PHE . 2.3 m-85 -118.41 149.6 40.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.415 -0.803 . . . . 0.0 109.449 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.443 ' OH ' ' HA3' ' D' ' 8' ' ' GLY . 64.0 t80 -133.05 100.4 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.327 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.3 m -154.05 109.21 2.47 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.152 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.32 -87.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 110.313 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.18 -153.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.464 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.605 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' E' ' 19' ' ' TYR . 5.1 tt -102.35 0.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -1.087 . . . . 0.0 109.444 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 42.5 t -92.9 -38.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.301 -0.874 . . . . 0.0 109.66 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.81 45.29 0.99 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.885 . . . . 0.0 109.406 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -163.68 -36.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.456 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 74.9 m -107.01 -41.21 5.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' F' ' 11' ' ' LEU . 0.6 OUTLIER -62.36 -20.86 64.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -79.95 -34.16 39.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -150.8 146.72 26.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.265 -0.897 . . . . 0.0 109.335 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mt -47.32 102.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.678 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 162.04 6.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.366 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.47 167.65 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.516 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -39.04 77.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.163 -0.961 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -67.02 -31.33 71.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.34 -42.7 53.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 110.08 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 mt -70.67 -16.98 62.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.71 -26.66 63.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -54.62 -30.68 55.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.431 ' CD2' HD12 ' E' ' 2' ' ' ILE . 10.6 m-85 -101.42 59.27 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -127.3 132.09 50.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.317 -179.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.356 0.598 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.476 ' O ' HG13 ' F' ' 2' ' ' VAL . 11.5 p -62.29 127.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.389 -0.819 . . . . 0.0 109.911 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 t30 179.39 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.06 -27.31 57.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -79.54 -33.54 41.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.594 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -87.41 -22.67 24.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.107 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 37.3 t -82.53 -26.52 32.39 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.44 -27.08 31.12 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.55 -15.78 63.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -1.122 . . . . 0.0 109.181 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -96.27 -24.27 16.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.313 -0.867 . . . . 0.0 109.633 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.581 HD11 ' SG ' ' E' ' 7' ' ' CYS . 52.2 mt -79.86 -31.28 40.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.553 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.407 HG22 ' H ' ' F' ' 12' ' ' VAL . 4.1 m -60.45 -33.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.95 -35.38 62.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 109.823 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.548 ' CB ' HD13 ' L' ' 17' ' ' LEU . . . -67.9 -54.83 15.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.571 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.519 ' HA ' ' HB ' ' F' ' 18' ' ' VAL . 12.0 mt -55.83 -22.28 24.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 109.598 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -55.02 35.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.482 HD21 ' NE2' ' H' ' 5' ' ' HIS . 42.2 mt -85.76 -26.53 25.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.27 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . 0.541 HG23 ' O ' ' F' ' 14' ' ' ALA . 89.5 t -61.96 -23.14 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.116 -0.99 . . . . 0.0 109.753 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.97 -35.15 8.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.6 -143.19 16.5 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -82.79 2.69 32.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -1.14 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.53 -31.6 68.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.65 -177.35 31.8 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -169.88 154.03 5.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.433 -1.04 . . . . 0.0 109.136 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -112.25 157.88 20.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.68 108.51 8.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 108.918 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -158.71 109.22 1.62 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.688 . . . . 0.0 109.405 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.5 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.372 2.048 . . . . 0.0 110.213 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.91 -156.08 0.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.373 -0.829 . . . . 0.0 109.769 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . 0.418 HD12 ' CD2' ' G' ' 19' ' ' TYR . 7.4 tt -100.21 1.48 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -1.159 . . . . 0.0 109.61 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -92.97 -40.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.38 47.69 1.03 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -166.78 -34.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 77.9 m -108.58 -38.11 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.46 -23.63 67.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.381 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 3.1 p -77.35 -30.84 54.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.13 146.68 25.02 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.211 -0.93 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 mt -49.06 103.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.148 -0.97 . . . . 0.0 109.289 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.18 162.63 5.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.06 164.41 15.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 109.244 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -41.3 91.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.88 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -64.62 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -44.77 50.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.086 -1.008 . . . . 0.0 109.863 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.57 -16.43 63.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -25.4 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 0.0 109.26 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -56.11 -28.84 59.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.864 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . 0.418 ' CD2' HD12 ' G' ' 2' ' ' ILE . 10.2 m-85 -103.19 56.52 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 128.06 47.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 109.553 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 109.446 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.538 ' O ' HG13 ' H' ' 2' ' ' VAL . 14.0 p -66.3 126.3 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -179.36 -41.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.58 -25.04 60.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.588 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . 0.482 ' NE2' HD21 ' F' ' 17' ' ' LEU . 37.1 t60 -80.01 -39.48 29.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.302 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -82.75 -16.41 48.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.438 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 44.4 t -88.89 -30.8 18.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.848 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.25 -28.22 45.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -67.29 -19.02 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -1.131 . . . . 0.0 109.559 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -93.48 -23.12 18.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.153 -0.967 . . . . 0.0 109.666 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 43.4 mt -81.56 -30.81 32.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.404 ' H ' HG22 ' H' ' 12' ' ' VAL . 3.6 m -60.58 -31.71 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.061 -1.024 . . . . 0.0 109.631 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -75.94 -35.37 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . 0.567 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -66.44 -54.13 27.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -0.98 . . . . 0.0 109.436 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . 0.478 ' HA ' ' HB ' ' H' ' 18' ' ' VAL . 12.6 mt -57.17 -24.52 54.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.873 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -51.47 61.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -89.22 -25.56 21.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . 0.567 HG23 ' O ' ' H' ' 14' ' ' ALA . 91.4 t -63.62 -26.24 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.034 -1.042 . . . . 0.0 109.65 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -39.15 9.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 109.544 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.95 -143.93 16.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.76 2.89 31.64 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.072 -1.252 . . . . 0.0 109.612 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -70.2 -24.88 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.14 -171.87 35.96 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -172.1 163.4 5.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -1.234 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -120.84 154.68 35.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.024 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -134.9 101.51 4.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.461 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 22.9 m -152.83 108.14 2.69 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 109.509 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.83 -87.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.343 2.029 . . . . 0.0 110.745 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.59 -154.91 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.393 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' I' ' 19' ' ' TYR . 7.9 tt -104.48 1.64 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -1.192 . . . . 0.0 109.523 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 42.4 t -93.52 -37.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.73 37.62 1.58 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.564 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -154.59 -38.82 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -104.57 -41.52 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . 0.527 ' SG ' HD11 ' J' ' 11' ' ' LEU . 0.6 OUTLIER -60.34 -20.42 59.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.711 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -81.57 -33.4 31.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.23 147.72 28.03 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.32 -0.863 . . . . 0.0 108.949 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.92 101.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.34 164.63 1.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.62 168.71 11.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.008 . . . . 0.0 109.06 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.69 -42.84 77.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -63.55 -32.01 73.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 110.078 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -43.26 55.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.988 . . . . 0.0 109.949 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 mt -70.35 -16.01 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.826 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -19.57 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.18 -0.95 . . . . 0.0 109.65 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -62.21 -28.09 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.247 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' I' ' 2' ' ' ILE . 11.5 m-85 -102.11 58.47 0.82 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.17 129.83 47.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.362 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.514 ' O ' HG13 ' J' ' 2' ' ' VAL . 12.3 p -65.47 127.33 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -179.95 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -75.13 -27.62 59.86 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.874 . . . . 0.0 109.619 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -76.8 -36.61 56.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 13.3 mt -84.98 -21.97 29.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.418 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.422 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 43.7 t -83.1 -27.19 30.36 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.31 -0.869 . . . . 0.0 109.644 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.41 -27.48 30.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . 0.515 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 0.4 OUTLIER -69.82 -12.18 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -1.129 . . . . 0.0 109.477 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -99.43 -21.52 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.322 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.527 HD11 ' SG ' ' I' ' 7' ' ' CYS . 40.5 mt -83.37 -32.2 26.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 109.603 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.418 HG22 ' H ' ' J' ' 12' ' ' VAL . 6.2 m -58.72 -32.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.354 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -74.3 -37.81 63.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.686 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . 0.417 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -65.03 -59.65 3.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.568 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . 0.521 ' HA ' ' HB ' ' J' ' 18' ' ' VAL . 10.7 mt -51.0 -25.77 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.725 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -55.48 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.119 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 mt -85.9 -27.82 24.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 0.0 110.229 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' J' ' 15' ' ' LEU . 87.7 t -59.34 -26.33 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 109.935 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -99.47 -39.32 8.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.566 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 -145.11 17.18 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.35 1.18 33.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.21 -1.17 . . . . 0.0 109.578 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -66.98 -27.31 67.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.13 -177.55 41.36 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -170.5 165.1 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -1.089 . . . . 0.0 109.189 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -125.33 157.28 37.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.738 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -129.91 110.55 11.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.544 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 38.4 m -159.71 106.67 1.46 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.588 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.37 -88.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.397 2.065 . . . . 0.0 110.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.7 -158.03 0.31 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.248 -0.908 . . . . 0.0 109.354 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.919 -1.038 . . . . 0.0 109.347 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . 0.441 HD12 ' CD2' ' K' ' 19' ' ' TYR . 7.1 tt -104.48 1.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -1.104 . . . . 0.0 109.159 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 46.5 t -93.5 -40.3 11.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 46.86 1.0 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -165.05 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.829 . . . . 0.0 109.235 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 81.7 m -107.01 -42.54 4.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 109.27 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' L' ' 11' ' ' LEU . 0.6 OUTLIER -60.11 -22.27 62.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -79.43 -31.88 42.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.137 -0.977 . . . . 0.0 109.586 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.37 146.75 24.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.74 102.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.873 . . . . 0.0 109.542 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 161.53 7.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -85.93 165.77 16.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.275 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -41.99 83.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.05 -31.46 72.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.52 -0.738 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -42.65 46.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 109.73 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 mt -70.17 -16.47 63.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.718 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -23.49 61.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.92 . . . . 0.0 109.167 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -57.98 -28.12 64.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.299 -0.876 . . . . 0.0 109.359 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . 0.441 ' CD2' HD12 ' K' ' 2' ' ' ILE . 11.0 m-85 -103.66 58.29 0.74 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 7.2 t -127.08 131.86 50.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.573 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.33 0.586 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.461 ' O ' HG13 ' L' ' 2' ' ' VAL . 11.6 p -64.61 128.09 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.729 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 14.6 t30 177.52 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.536 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -77.92 -25.25 48.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -79.74 -38.15 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.78 -25.1 33.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.815 . . . . 0.0 109.4 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.451 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 45.4 t -79.45 -30.09 42.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.744 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.2 -32.36 28.93 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -64.88 -12.96 54.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 109.698 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -98.44 -23.5 15.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.546 HD11 ' SG ' ' K' ' 7' ' ' CYS . 55.7 mt -81.35 -28.04 34.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.856 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.48 -30.32 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.569 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -76.67 -37.66 55.86 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.205 -0.935 . . . . 0.0 109.485 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . 0.429 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -65.18 -56.73 11.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . 0.454 ' HA ' ' HB ' ' L' ' 18' ' ' VAL . 14.7 mt -54.05 -25.73 23.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.079 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' J' ' 9' ' ' SER . 0.4 OUTLIER -52.05 -53.74 38.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 109.941 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.548 HD13 ' CB ' ' F' ' 14' ' ' ALA . 35.9 mt -87.24 -27.99 22.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.657 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' L' ' 15' ' ' LEU . 88.5 t -59.77 -25.15 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.956 -1.09 . . . . 0.0 109.648 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -99.48 -41.76 7.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.391 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.95 -142.26 15.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -83.2 1.29 41.39 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.275 -1.132 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -67.5 -27.93 67.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 110.022 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 -176.33 39.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -171.38 167.02 6.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -1.124 . . . . 0.0 109.488 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 3.1 p90 -126.45 151.69 47.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.632 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -126.85 106.11 9.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.312 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 32.8 m -155.71 108.55 2.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -82.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.475 2.117 . . . . 0.0 110.843 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.65 -155.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 109.406 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 109.816 -179.61 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.5 mt -80.39 -30.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 109.518 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.58 -35.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.951 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -104.46 56.2 0.71 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.806 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.436 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 22.6 tt0 -178.58 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.582 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' SER . 63.7 m -102.16 -29.46 11.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.02 -41.48 59.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.236 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.2 p -81.34 -15.95 53.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.501 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -160.32 120.57 2.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 109.565 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.554 HD12 ' O ' ' F' ' 1' ' ' PHE . 2.1 mp -47.87 101.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.319 -0.863 . . . . 0.0 109.455 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m -53.12 158.8 1.4 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.81 163.68 16.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.264 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -45.17 84.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 109.655 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -61.88 -33.49 74.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.549 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -67.72 -36.87 81.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.436 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.2 mt -83.91 -8.74 59.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.24 -0.912 . . . . 0.0 109.739 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.15 -27.96 38.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 15' ' ' GLN . 53.0 p30 -73.37 -11.91 60.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.432 ' N ' ' OD1' ' A' ' 18' ' ' ASN . 35.0 m-85 -98.32 -3.45 37.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 109.95 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.6 168.33 19.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.513 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.622 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.55 ' O ' HG13 ' B' ' 2' ' ' VAL . 3.8 p -172.25 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 4.6 p30 170.73 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.875 . . . . 0.0 109.242 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -85.57 -24.29 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.822 . . . . 0.0 109.364 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.84 -39.42 35.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.319 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mt -81.01 -38.03 28.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 9.4 t -63.14 -36.33 83.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.33 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.436 ' O ' HG22 ' B' ' 12' ' ' VAL . . . -79.4 -22.01 65.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 71.7 m -79.66 -8.88 59.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.399 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.79 -25.69 15.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.932 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 9.7 mt -79.43 -48.23 14.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.443 ' H ' HG22 ' B' ' 12' ' ' VAL . 2.6 m -52.18 -34.01 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 109.958 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.47 -48.31 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.995 . . . . 0.0 109.423 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.48 11.92 6.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 -50.67 5.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.949 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 13.4 p90 -71.98 -21.49 61.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.07 -1.019 . . . . 0.0 109.549 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.948 HD23 HD23 ' H' ' 17' ' ' LEU . 46.9 tp -74.52 -35.98 63.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -76.02 -46.7 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -57.1 -41.74 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.928 . . . . 0.0 109.327 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.39 -141.14 15.39 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.07 4.55 33.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -1.173 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.6 -74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' B' ' 19' ' ' CYS . . . 141.17 165.6 10.41 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 13.5 p90 -161.45 167.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -1.206 . . . . 0.0 109.317 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.605 ' HB2' ' CD2' ' D' ' 25' ' ' PHE . 35.8 p90 -123.57 162.62 22.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.596 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -142.08 83.69 1.85 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 109.644 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.437 HG21 HD21 ' C' ' 21' ' ' ASN . 0.2 OUTLIER -133.77 92.68 22.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.13 -57.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.777 2.318 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tttt 54.37 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.552 179.699 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 74.1 mt -79.72 -29.48 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -1.112 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.27 -38.51 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 5.7 mm-40 -103.41 60.59 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.803 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 22.2 tt0 178.3 -32.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.592 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 70.2 m -104.03 -31.45 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.392 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 9.9 t -73.22 -40.11 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.963 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 32.1 p -82.84 -16.14 48.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.93 118.42 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.744 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -45.76 100.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 96.8 m -51.9 160.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.004 . . . . 0.0 109.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.16 162.69 15.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.232 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.24 84.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 109.687 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -63.5 -33.73 76.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . 0.436 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -67.15 -35.94 80.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 109.685 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.63 -9.5 58.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -79.19 -26.77 42.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.458 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' C' ' 15' ' ' GLN . 52.8 p30 -76.84 -8.01 56.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -101.4 -6.54 23.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.19 167.68 21.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.66 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . 0.437 HD21 HG21 ' B' ' 27' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.349 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.487 ' O ' HG13 ' D' ' 2' ' ' VAL . 2.5 p -171.76 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.184 -0.947 . . . . 0.0 109.279 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 p30 173.42 -36.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 109.261 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.56 -25.39 38.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.168 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.98 -41.79 41.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.453 ' N ' HD23 ' D' ' 6' ' ' LEU . 4.3 mt -79.39 -36.81 38.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.418 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.5 t -63.37 -36.4 83.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.507 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.55 -18.66 67.94 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -81.95 -8.64 59.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -1.125 . . . . 0.0 109.705 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -96.96 -25.88 15.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.585 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 10.6 mt -77.42 -49.87 13.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -51.55 -33.19 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -68.73 -46.78 68.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.108 -0.995 . . . . 0.0 109.717 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.16 9.73 14.19 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.813 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 -52.33 4.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.726 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 15.6 p90 -70.85 -22.69 62.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.862 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.509 HD23 HD23 ' J' ' 17' ' ' LEU . 48.9 tp -72.86 -38.15 67.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.105 -0.997 . . . . 0.0 109.63 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.2 -46.27 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -58.16 -44.87 88.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -139.03 14.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.43 5.42 35.14 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.338 -1.095 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -70.45 -75.33 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.535 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' D' ' 19' ' ' CYS . . . 142.4 166.47 10.99 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 17.7 p90 -156.94 162.35 39.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.949 -1.324 . . . . 0.0 110.068 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' B' ' 25' ' ' PHE . 55.4 m-85 -114.2 150.41 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -138.55 85.01 2.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.63 92.86 9.97 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 108.783 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.22 -61.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.674 2.249 . . . . 0.0 110.568 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttt 59.13 94.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.666 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 75.6 mt -83.94 -29.86 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -1.135 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 64.0 t -68.85 -37.31 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 4.6 mm-40 -104.12 61.43 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.976 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 22.9 tt0 176.94 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 109.514 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 66.2 m -102.06 -30.39 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.6 t -73.65 -43.03 60.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.271 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 31.6 p -80.19 -15.04 57.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.622 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' J' ' 1' ' ' PHE . 0.0 OUTLIER -161.14 116.9 2.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.141 -0.974 . . . . 0.0 109.46 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mp -45.27 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.456 -0.777 . . . . 0.0 109.59 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . 0.427 ' SG ' ' HG2' ' E' ' 5' ' ' GLN . 94.4 m -49.95 160.83 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.079 -1.013 . . . . 0.0 109.332 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.6 167.44 12.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.073 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.69 94.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.512 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -62.11 -35.31 78.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -35.19 79.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.017 . . . . 0.0 109.4 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.35 -4.52 59.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -84.59 -29.81 25.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.142 -0.974 . . . . 0.0 109.376 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' E' ' 19' ' ' TYR . 54.6 p30 -72.31 -10.32 59.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.888 . . . . 0.0 109.679 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' E' ' 18' ' ' ASN . 32.8 m-85 -100.21 -1.03 37.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.886 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 169.13 14.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 110.059 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.717 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . 0.554 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.8 m-85 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.577 ' O ' HG13 ' F' ' 2' ' ' VAL . 5.7 p -170.23 108.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.865 . . . . 0.0 109.67 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 171.56 -37.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -79.43 -26.94 41.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 0.0 109.51 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -76.18 -40.41 52.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.938 . . . . 0.0 109.84 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.61 -34.36 30.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.441 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 11.3 t -66.63 -31.44 72.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.261 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.431 ' O ' HG22 ' F' ' 12' ' ' VAL . . . -84.26 -19.27 60.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -83.21 -7.45 59.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -1.091 . . . . 0.0 109.574 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -98.81 -22.22 15.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -81.64 -45.96 15.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.649 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.431 HG22 ' O ' ' F' ' 8' ' ' GLY . 2.4 m -55.23 -33.37 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.09 -48.49 65.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.24 8.21 14.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -0.894 . . . . 0.0 110.065 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -51.52 5.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 109.858 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.531 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 13.5 p90 -71.51 -21.43 61.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 109.744 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.485 HD23 HD23 ' L' ' 17' ' ' LEU . 52.1 tp -74.8 -34.76 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.444 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.45 -42.93 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -37.73 86.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.036 . . . . 0.0 109.106 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.36 -139.76 15.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -83.54 -0.67 51.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.951 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -65.03 -73.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.284 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.16 168.65 11.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 12.3 p90 -163.61 172.69 13.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 109.422 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -130.41 162.53 28.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.275 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -138.99 93.16 2.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.034 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.08 89.45 7.81 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.483 -0.76 . . . . 0.0 109.477 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.38 -62.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.675 2.25 . . . . 0.0 110.115 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 62.22 93.18 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 109.648 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.568 179.904 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . 0.41 HD13 HD11 ' H' ' 15' ' ' LEU . 73.6 mt -81.95 -26.69 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.13 -33.33 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 5.4 mm-40 -108.69 61.47 0.6 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 22.0 tt0 176.43 -31.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -104.36 -32.97 8.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 10.1 t -72.14 -43.5 64.57 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.124 -0.985 . . . . 0.0 109.286 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -77.36 -21.37 53.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 121.25 5.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.155 -0.965 . . . . 0.0 109.486 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -47.69 103.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.97 . . . . 0.0 109.156 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 69.1 m -53.32 162.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 109.617 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.1 163.28 14.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 109.33 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.36 84.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -61.04 -36.58 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.341 -0.849 . . . . 0.0 109.404 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' G' ' 18' ' ' ASN . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.7 mt -80.91 -11.32 59.6 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.906 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.56 -29.86 56.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.08 -1.012 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' G' ' 15' ' ' GLN . 53.4 p30 -73.16 -5.94 42.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.965 . . . . 0.0 109.613 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -102.17 -16.4 16.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.988 . . . . 0.0 109.76 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 6.9 m -66.51 172.86 3.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 108.814 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.423 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.585 ' O ' HG13 ' H' ' 2' ' ' VAL . 4.4 p -171.05 107.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.55 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 172.54 -34.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.66 -22.13 32.23 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.304 -0.872 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -80.65 -39.79 26.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . 0.44 HD23 ' N ' ' H' ' 6' ' ' LEU . 4.3 mt -81.12 -37.09 29.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.216 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.4 t -63.15 -37.23 86.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.683 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . 0.448 ' O ' HG22 ' H' ' 12' ' ' VAL . . . -79.91 -18.73 71.85 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 58.5 m -83.06 -6.33 59.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -1.116 . . . . 0.0 109.559 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -100.47 -19.33 16.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.072 -1.017 . . . . 0.0 109.149 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.8 mt -84.23 -46.51 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.448 HG22 ' O ' ' H' ' 8' ' ' GLY . 2.3 m -54.64 -33.17 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.726 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.27 -48.03 66.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.824 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.98 11.47 9.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -93.04 -48.63 6.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.996 -1.065 . . . . 0.0 109.724 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 13.2 p90 -73.12 -22.57 60.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.368 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.948 HD23 HD23 ' B' ' 17' ' ' LEU . 47.1 tp -73.47 -33.52 64.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.301 -0.875 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.25 -57.44 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -49.85 -38.41 35.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 0.0 109.245 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.5 -146.19 18.8 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -75.51 -3.96 37.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 110.046 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -61.59 -74.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.282 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.99 171.74 12.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 15.8 p90 -165.82 170.41 13.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -1.212 . . . . 0.0 109.678 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 13.1 p90 -128.5 156.74 42.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 109.496 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -136.35 91.21 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.386 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.67 90.09 8.88 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.97 -59.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.733 2.289 . . . . 0.0 110.533 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 57.56 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.335 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.507 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt -81.69 -28.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -1.105 . . . . 0.0 109.433 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.1 -32.26 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 5.8 mm-40 -108.15 58.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.277 -0.889 . . . . 0.0 109.545 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 25.3 tt0 177.34 -32.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -101.23 -30.44 11.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 109.44 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.4 -43.28 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.852 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -79.02 -14.31 59.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . 0.424 ' O ' ' N ' ' I' ' 11' ' ' CYS . 0.0 OUTLIER -161.75 126.55 3.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.329 -0.857 . . . . 0.0 108.988 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' I' ' 11' ' ' CYS . 2.2 mp -56.17 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.851 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 10' ' ' ILE . 0.8 OUTLIER -43.23 161.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.272 -0.893 . . . . 0.0 109.346 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.2 169.34 11.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -46.16 91.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -59.74 -34.78 73.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.27 82.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.71 -9.45 58.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 109.581 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.16 -29.0 42.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' I' ' 19' ' ' TYR . 54.9 p30 -74.2 -9.74 58.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.683 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . 0.406 ' N ' ' OD1' ' I' ' 18' ' ' ASN . 29.5 m-85 -99.48 -3.48 33.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.579 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.26 167.66 19.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' E' ' 9' ' ' SER . 1.8 m-85 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.521 ' O ' HG13 ' J' ' 2' ' ' VAL . 3.2 p -170.14 108.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.077 -1.014 . . . . 0.0 109.382 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 p30 172.81 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -85.03 -23.68 28.51 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.32 -0.862 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -78.37 -40.69 35.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.965 . . . . 0.0 109.384 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . 0.414 ' N ' HD23 ' J' ' 6' ' ' LEU . 5.6 mt -80.12 -37.69 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.32 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.421 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 10.8 t -63.17 -36.82 84.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.435 ' O ' HG22 ' J' ' 12' ' ' VAL . . . -79.84 -17.57 74.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -84.06 -10.9 57.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -94.1 -23.82 17.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.601 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 9.3 mt -80.39 -47.73 13.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 109.661 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.442 ' H ' HG22 ' J' ' 12' ' ' VAL . 2.6 m -53.06 -32.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 109.99 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.47 -48.97 59.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 109.733 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.88 12.34 6.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.27 -50.23 5.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 12.9 p90 -72.56 -20.82 61.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.509 HD23 HD23 ' D' ' 17' ' ' LEU . 46.1 tp -76.57 -31.74 57.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.59 -46.89 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 109.052 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' J' ' 23' ' ' GLY . 0.1 OUTLIER -56.21 -42.24 76.89 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 108.977 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -140.79 15.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.2 -0.34 48.95 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.234 -1.156 . . . . 0.0 109.751 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -64.67 -67.99 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.103 -0.998 . . . . 0.0 109.524 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' J' ' 19' ' ' CYS . . . 133.06 171.8 12.82 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 13.1 p90 -164.81 177.89 7.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.125 -1.221 . . . . 0.0 109.443 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.02 156.14 48.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -137.38 94.04 2.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.03 89.31 6.53 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 109.636 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.61 -60.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.565 2.176 . . . . 0.0 110.574 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' J' ' 30' ' ' THR . 4.3 tttt 59.24 92.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.519 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' J' ' 29' ' ' LYS . 13.6 m . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.6 -31.84 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -1.099 . . . . 0.0 109.238 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.99 -35.88 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.8 . . . . 0.0 109.757 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 7.0 mm-40 -105.23 59.3 0.68 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 23.5 tt0 179.25 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.488 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' K' ' 9' ' ' SER . 72.2 m -100.85 -35.66 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.31 -40.23 77.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 55.4 p -82.6 -17.22 45.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.011 . . . . 0.0 109.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.0 OUTLIER -159.27 119.74 3.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 mp -47.54 100.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.578 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' HG2' ' K' ' 5' ' ' GLN . 88.8 m -52.12 159.83 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 109.435 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.57 167.21 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -43.2 99.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -0.934 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -62.68 -35.47 79.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.184 -0.947 . . . . 0.0 109.387 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' K' ' 18' ' ' ASN . 0.0 OUTLIER -65.79 -38.41 88.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -81.86 -9.72 59.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -79.19 -28.21 42.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 109.675 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' K' ' 15' ' ' GLN . 55.2 p30 -74.58 -7.6 53.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 109.75 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.41 -8.41 22.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.25 169.41 17.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.132 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.37 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.569 ' O ' HG13 ' L' ' 2' ' ' VAL . 5.6 p -172.64 108.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.151 -0.968 . . . . 0.0 109.401 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p30 172.14 -36.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.049 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -81.03 -27.38 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.364 -0.835 . . . . 0.0 109.375 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -75.32 -38.42 60.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . 0.437 ' N ' HD23 ' L' ' 6' ' ' LEU . 4.7 mt -82.82 -38.67 22.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 109.568 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 51.7 t -62.09 -33.7 74.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.93 -19.95 62.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 74.3 m -82.83 -5.97 59.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -1.11 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -99.5 -22.0 15.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 109.161 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.5 mt -82.98 -47.68 11.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -53.19 -33.85 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.01 -1.056 . . . . 0.0 109.552 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.08 -46.61 70.53 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.24 11.01 13.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.68 -51.13 5.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 13.5 p90 -71.3 -22.9 61.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.485 HD23 HD23 ' F' ' 17' ' ' LEU . 49.8 tp -74.5 -34.61 63.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.776 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.93 -47.74 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.65 -37.86 68.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.5 -145.97 18.29 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -81.58 0.27 39.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.58 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -62.95 -73.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.32 165.01 10.16 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 11.2 p90 -160.24 169.3 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -1.087 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -129.8 152.49 49.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.192 -0.943 . . . . 0.0 109.389 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -129.9 96.62 4.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.853 . . . . 0.0 109.714 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.82 89.51 6.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.57 -62.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.597 2.198 . . . . 0.0 110.195 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt 62.09 92.89 0.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.53 179.77 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.435 HG23 HG13 ' A' ' 3' ' ' VAL . 20.7 tt -133.22 6.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -1.108 . . . . 0.0 109.429 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 HG23 ' A' ' 2' ' ' ILE . 16.4 m -126.03 -8.37 5.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.264 -0.898 . . . . 0.0 109.75 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -111.77 1.61 16.72 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.199 -0.938 . . . . 0.0 109.792 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.86 13.19 2.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.178 -0.951 . . . . 0.0 109.304 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.73 -42.59 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.33 -16.34 63.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.423 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.9 p -70.89 -22.03 62.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.014 . . . . 0.0 109.414 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 p -163.69 144.12 8.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mt -52.62 113.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.4 m -84.29 -164.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 0.0 109.1 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.25 171.39 7.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -34.93 75.9 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 109.277 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -67.4 -38.87 85.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.955 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.92 -14.91 59.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 109.938 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.92 -28.87 63.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.023 . . . . 0.0 109.46 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -57.24 -19.03 18.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.57 59.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.1 t -123.13 119.76 31.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.641 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.2 t30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.343 179.783 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' I' ' 9' ' ' SER . 25.8 m -131.06 46.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 109.875 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.53 -3.28 28.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -48.28 -38.53 19.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.31 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -93.42 -30.6 14.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.589 HD22 ' CG ' ' J' ' 10' ' ' HIS . 39.6 mt -80.95 -70.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 108.957 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.6 t -51.2 -37.82 48.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.665 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.438 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -61.85 -44.28 98.07 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 31.0 p -67.84 -12.86 61.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 110.008 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -86.15 -24.63 26.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.119 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 5.7 mt -90.47 -33.77 15.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.516 HG21 ' CZ ' ' D' ' 16' ' ' TYR . 16.8 m -68.43 -38.54 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.472 ' N ' HG23 ' B' ' 12' ' ' VAL . 13.9 tt0 -66.04 -23.86 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.78 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -94.42 -12.89 26.93 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mt -78.67 -28.66 45.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.547 ' CZ ' HG21 ' D' ' 12' ' ' VAL . 60.3 m-85 -48.25 -46.58 35.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -82.26 -36.26 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.78 HG23 ' O ' ' B' ' 14' ' ' ALA . 69.7 t -47.04 -46.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.87 -30.72 26.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.459 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.04 -134.98 11.89 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -7.93 52.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.304 -1.115 . . . . 0.0 109.69 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -57.05 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.11 179.08 29.17 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.408 ' HZ ' ' CZ ' ' B' ' 16' ' ' TYR . 0.3 OUTLIER -166.31 168.23 15.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -1.182 . . . . 0.0 110.031 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.631 ' HB2' ' CD1' ' D' ' 25' ' ' PHE . 32.8 p90 -127.53 154.77 44.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.437 ' CD2' HG11 ' B' ' 12' ' ' VAL . 24.3 t80 -140.85 112.17 7.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 15.1 m -133.2 93.25 22.9 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 109.675 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.07 99.53 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.506 2.137 . . . . 0.0 110.389 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.33 -58.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -132.69 7.66 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.158 -1.201 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.92 -6.29 4.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.211 -0.931 . . . . 0.0 109.74 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -114.07 -0.39 14.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.128 -0.983 . . . . 0.0 109.604 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -134.65 9.46 3.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.189 -0.944 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.25 -39.85 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.705 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 t -66.93 -16.17 64.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 43.1 p -70.22 -24.53 63.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.92 . . . . 0.0 109.302 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . 0.404 ' HA ' HG11 ' L' ' 2' ' ' VAL . 94.9 p -160.47 146.09 14.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.502 HD11 ' O ' ' L' ' 2' ' ' VAL . 4.3 mt -54.55 117.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.7 m -89.45 -165.48 1.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 109.714 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -107.17 166.27 10.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -34.56 78.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.73 -37.56 79.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.859 . . . . 0.0 109.601 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.91 -38.39 86.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 109.53 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.81 -16.23 55.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 109.757 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.51 -30.3 68.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -56.42 -19.13 13.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.09 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -110.6 58.61 0.61 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.231 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 t -121.64 118.44 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . 0.559 ' ND2' ' CZ ' ' D' ' 25' ' ' PHE . 9.5 t30 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.509 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.359 0.6 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' G' ' 9' ' ' SER . 30.9 m -132.02 44.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.244 -0.91 . . . . 0.0 109.159 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -100.15 -8.56 23.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 109.552 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -44.34 -40.46 5.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.44 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -90.74 -32.38 16.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.504 HD22 ' CG ' ' H' ' 10' ' ' HIS . 29.0 mt -80.34 -71.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.477 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 8.3 t -51.37 -34.39 34.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.501 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -64.33 -43.86 96.28 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . 0.428 ' HA ' HG22 ' D' ' 12' ' ' VAL . 17.2 p -69.41 -14.94 63.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -1.162 . . . . 0.0 109.711 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.94 -24.38 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.895 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 6.7 mt -92.79 -32.79 14.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.547 HG21 ' CZ ' ' B' ' 16' ' ' TYR . 15.4 m -68.29 -38.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.475 ' N ' HG23 ' D' ' 12' ' ' VAL . 15.0 tt0 -64.91 -27.06 68.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . 0.705 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -91.62 -12.06 35.32 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.333 -0.854 . . . . 0.0 109.853 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.21 -28.82 38.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.516 ' CZ ' HG21 ' B' ' 12' ' ' VAL . 62.3 m-85 -48.38 -45.07 35.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.199 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 mt -81.89 -38.5 25.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.705 HG23 ' O ' ' D' ' 14' ' ' ALA . 67.5 t -45.85 -44.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.891 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.86 -29.77 25.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.899 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.2 -131.66 10.65 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.73 -6.99 38.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.65 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -56.69 -81.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.061 -1.024 . . . . 0.0 109.467 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.78 176.74 28.28 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 25' ' ' PHE . 0.4 OUTLIER -164.07 161.31 22.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -1.208 . . . . 0.0 109.883 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . 0.631 ' CD1' ' HB2' ' B' ' 25' ' ' PHE . 4.4 m-85 -119.11 163.16 17.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.416 -0.803 . . . . 0.0 109.284 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.43 ' CD2' HG11 ' D' ' 12' ' ' VAL . 33.0 t80 -151.16 105.69 3.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 108.896 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 24.4 m -127.19 94.43 38.89 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.594 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.98 97.28 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.555 2.17 . . . . 0.0 110.369 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -61.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.221 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.35 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.44 3.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -1.125 . . . . 0.0 109.563 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.9 -9.58 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.94 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.89 1.69 19.35 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.104 -0.997 . . . . 0.0 110.164 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -136.7 11.33 3.16 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.041 -1.037 . . . . 0.0 109.669 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' E' ' 9' ' ' SER . 0.0 OUTLIER -144.32 -40.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.55 -18.0 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 108.954 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 41.4 p -69.61 -25.1 63.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.376 -0.828 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . 0.421 ' O ' ' O ' ' E' ' 6' ' ' CYS . 12.5 p -159.56 148.82 18.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.438 HG12 ' HB3' ' J' ' 5' ' ' HIS . 4.0 mt -58.7 115.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.55 -158.69 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.785 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.1 167.82 10.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' L' ' 17' ' ' LEU . 0.1 OUTLIER -66.11 -35.78 81.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -66.05 -40.79 91.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.986 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -80.37 -15.45 56.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -0.973 . . . . 0.0 109.594 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.14 -25.79 62.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.722 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -60.42 -19.49 56.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.215 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.7 62.05 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 t -125.45 119.67 28.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.461 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.424 ' O ' HG23 ' F' ' 2' ' ' VAL . 25.4 m -129.38 44.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.264 -0.898 . . . . 0.0 109.375 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -100.52 -4.68 28.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.377 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -48.6 -38.04 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -93.32 -30.92 14.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 35.2 mt -81.36 -71.1 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.085 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.495 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.5 t -50.18 -37.21 33.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.44 -0.787 . . . . 0.0 109.356 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.483 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -61.76 -42.97 99.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . 0.469 ' HA ' HG22 ' F' ' 12' ' ' VAL . 58.4 p -70.85 -13.53 62.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.132 -1.216 . . . . 0.0 110.043 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -84.07 -24.38 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.985 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 6.5 mt -91.64 -33.45 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.813 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.557 HG21 ' CZ ' ' H' ' 16' ' ' TYR . 18.4 m -69.22 -36.26 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 109.848 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . 0.419 ' N ' HG23 ' F' ' 12' ' ' VAL . 16.0 tt0 -69.11 -22.22 63.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.769 ' O ' HG23 ' F' ' 18' ' ' VAL . . . -95.52 -11.03 28.1 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.71 -28.19 36.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.499 ' CZ ' HG21 ' H' ' 12' ' ' VAL . 54.0 m-85 -48.61 -47.61 39.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 109.655 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' F' ' 18' ' ' VAL . 12.4 mt -80.93 -38.59 27.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . 0.769 HG23 ' O ' ' F' ' 14' ' ' ALA . 70.8 t -44.62 -45.68 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.96 -30.04 26.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.36 -133.21 11.22 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.0 -12.89 29.54 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.256 -1.144 . . . . 0.0 109.538 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 23.0 mtt180 -50.72 -83.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.2 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.04 -177.46 33.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . 0.408 ' HZ ' ' CZ ' ' F' ' 16' ' ' TYR . 0.2 OUTLIER -171.45 168.86 6.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -1.134 . . . . 0.0 109.469 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -132.07 166.12 22.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -147.42 115.44 6.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.52 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -132.66 91.53 29.72 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.32 98.51 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.191 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.0 -58.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.59 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.578 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.08 8.26 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -1.2 . . . . 0.0 109.735 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -127.2 -5.76 4.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -113.23 -1.14 14.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.021 -1.049 . . . . 0.0 109.812 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -134.4 11.58 3.8 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.083 -1.011 . . . . 0.0 109.704 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' G' ' 9' ' ' SER . 0.1 OUTLIER -143.98 -40.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 t -66.4 -18.11 65.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 60.5 p -69.17 -22.28 63.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.48 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . 0.659 ' HA ' HG11 ' D' ' 2' ' ' VAL . 4.3 p -162.67 148.58 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.299 -0.875 . . . . 0.0 109.433 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mt -58.08 115.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.77 -165.02 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.1 167.4 10.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -35.55 81.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.732 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -67.27 -37.75 83.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.967 . . . . 0.0 109.852 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.39 -40.5 89.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -77.51 -14.14 59.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.15 -30.35 63.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.338 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -53.9 -23.45 12.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.37 64.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.97 120.89 30.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.331 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.562 -179.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.298 0.57 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 31.8 m -126.17 41.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' H' ' 4' ' ' GLN . 11.6 m120 -96.92 -9.92 27.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' H' ' 3' ' ' ASN . 50.2 tt0 -43.03 -40.14 2.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -90.98 -33.22 15.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 109.313 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 29.9 mt -78.44 -73.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 7.7 t -47.13 -41.46 17.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.815 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . 0.441 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -58.84 -44.87 95.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . 0.411 ' HA ' HG22 ' H' ' 12' ' ' VAL . 24.3 p -67.33 -14.92 63.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -1.114 . . . . 0.0 109.838 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . 0.504 ' CG ' HD22 ' D' ' 6' ' ' LEU . 5.6 m-70 -85.88 -20.36 29.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.665 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.0 mt -94.87 -35.3 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.384 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.499 HG21 ' CZ ' ' F' ' 16' ' ' TYR . 15.6 m -68.1 -34.18 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -69.82 -23.08 63.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.141 -0.974 . . . . 0.0 109.219 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . 0.756 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -95.09 -9.99 32.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.39 -0.819 . . . . 0.0 109.538 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -82.37 -26.83 32.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.557 ' CZ ' HG21 ' F' ' 12' ' ' VAL . 53.5 m-85 -50.04 -44.06 51.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.615 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.09 -36.45 21.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.27 -0.894 . . . . 0.0 109.724 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . 0.756 HG23 ' O ' ' H' ' 14' ' ' ALA . 76.5 t -46.33 -42.67 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 -29.39 21.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.79 -133.34 11.31 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -11.5 38.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -1.17 . . . . 0.0 109.738 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -53.01 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.037 . . . . 0.0 109.646 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.98 176.94 23.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.24 175.41 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 109.429 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 8.6 p90 -137.94 167.24 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.526 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -149.57 115.48 5.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.288 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -133.84 90.82 26.33 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.227 -0.92 . . . . 0.0 109.328 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.16 101.0 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.674 2.249 . . . . 0.0 110.092 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.82 -57.58 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 109.656 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.056 -0.974 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.439 HG23 HG13 ' I' ' 3' ' ' VAL . 19.6 tt -131.08 8.05 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 0.0 109.501 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . 0.439 HG13 HG23 ' I' ' 2' ' ' ILE . 15.9 m -128.71 -5.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.299 -0.876 . . . . 0.0 109.771 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -115.06 -0.06 13.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.172 -0.955 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -135.01 8.16 3.47 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.47 -41.43 0.41 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.75 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -64.63 -20.71 66.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . 0.425 ' O ' HG11 ' B' ' 2' ' ' VAL . 39.0 p -66.44 -23.39 66.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . 0.604 ' HA ' HG11 ' B' ' 2' ' ' VAL . 7.5 p -161.65 146.32 13.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.65 114.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.56 -164.25 0.98 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -109.56 168.12 9.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -34.77 78.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -67.3 -39.56 85.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.45 -39.99 92.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.32 -14.3 59.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.852 . . . . 0.0 109.899 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.81 -27.17 62.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -58.05 -18.62 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.359 -0.838 . . . . 0.0 109.74 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -111.97 61.31 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -122.84 121.85 37.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.198 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.504 -179.759 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 11.0 t80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.271 0.557 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.42 HG23 ' O ' ' J' ' 2' ' ' VAL . 31.0 m -133.33 47.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' J' ' 4' ' ' GLN . 13.2 m120 -102.57 -8.46 20.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.842 . . . . 0.0 109.33 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' J' ' 3' ' ' ASN . 50.4 tt0 -44.03 -38.38 3.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.352 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . 0.438 ' HB3' HG12 ' E' ' 10' ' ' ILE . 86.4 t60 -93.34 -33.95 13.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.94 . . . . 0.0 109.211 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 38.9 mt -78.03 -70.28 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.437 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.499 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 7.3 t -51.97 -37.51 53.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.354 -0.842 . . . . 0.0 109.477 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.439 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -60.76 -45.17 96.98 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . 0.493 ' HA ' HG22 ' J' ' 12' ' ' VAL . 86.6 p -68.51 -16.08 63.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -1.211 . . . . 0.0 110.078 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . 0.589 ' CG ' HD22 ' B' ' 6' ' ' LEU . 4.7 m-70 -82.92 -20.49 35.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.043 . . . . 0.0 109.716 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 7.8 mt -95.16 -34.18 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.508 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.504 HG21 ' CZ ' ' L' ' 16' ' ' TYR . 19.1 m -68.19 -33.9 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.107 -0.995 . . . . 0.0 109.239 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -70.97 -23.77 62.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.605 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . 0.81 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -95.55 -8.1 36.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.31 -0.869 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.8 -25.39 30.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.505 ' CZ ' HG21 ' L' ' 12' ' ' VAL . 46.3 m-85 -51.93 -44.54 63.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.456 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.34 -39.17 21.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.618 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . 0.81 HG23 ' O ' ' J' ' 14' ' ' ALA . 69.5 t -44.75 -44.15 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.54 -30.62 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.61 -135.42 12.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -9.78 44.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.214 -1.168 . . . . 0.0 109.949 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -53.84 -76.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 0.0 109.664 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.46 176.8 22.99 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.21 171.16 11.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 109.688 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 6.1 p90 -134.39 165.07 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.47 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . 0.411 ' CD2' HG11 ' J' ' 12' ' ' VAL . 23.3 t80 -146.07 118.76 8.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.254 -0.904 . . . . 0.0 109.26 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 23.7 m -136.89 91.0 15.59 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.717 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.34 100.05 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.243 . . . . 0.0 110.413 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -59.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.256 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.495 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . 0.428 HG23 HG13 ' K' ' 3' ' ' VAL . 20.6 tt -133.03 9.5 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -1.1 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.428 HG13 HG23 ' K' ' 2' ' ' ILE . 15.6 m -129.71 -3.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.936 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -116.25 -2.1 12.22 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.08 -1.013 . . . . 0.0 109.446 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -133.23 11.18 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.341 -0.849 . . . . 0.0 109.408 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 -40.78 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 109.739 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -66.16 -16.76 64.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.964 . . . . 0.0 109.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -69.42 -26.29 64.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.236 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 6.4 p -158.08 149.9 21.69 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -0.913 . . . . 0.0 109.544 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.58 115.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -87.78 -164.27 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.984 . . . . 0.0 109.49 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.28 171.08 7.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.301 -0.874 . . . . 0.0 109.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -36.78 77.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.348 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -65.57 -38.66 90.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.669 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -66.05 -40.38 90.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.1 mt -78.43 -13.54 59.79 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.851 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.88 -28.29 63.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -57.97 -17.23 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -0.79 . . . . 0.0 109.659 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.82 60.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 t -123.17 120.36 32.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.393 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.502 ' O ' HD11 ' C' ' 10' ' ' ILE . 29.0 m -127.8 45.75 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.54 -6.57 23.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -46.06 -39.69 9.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -92.26 -30.75 15.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 31.7 mt -80.73 -72.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.193 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.496 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 8.3 t -49.49 -39.95 35.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.416 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -59.68 -43.53 97.69 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 87.4 p -68.33 -18.15 64.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.16 -1.2 . . . . 0.0 109.784 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -81.56 -21.73 38.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.992 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 6.7 mt -93.75 -34.35 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.505 HG21 ' CZ ' ' J' ' 16' ' ' TYR . 18.6 m -67.28 -38.57 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.01 . . . . 0.0 109.51 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . 0.449 ' N ' HG23 ' L' ' 12' ' ' VAL . 17.1 tt0 -65.72 -25.07 67.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.898 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . 0.752 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -92.57 -14.14 28.71 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 6.7 mt -78.63 -31.31 46.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 0.0 109.401 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.504 ' CZ ' HG21 ' J' ' 12' ' ' VAL . 44.7 m-85 -45.51 -45.38 13.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.9 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' E' ' 13' ' ' LEU . 13.1 mt -84.0 -35.75 23.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 109.933 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . 0.752 HG23 ' O ' ' L' ' 14' ' ' ALA . 70.3 t -47.42 -45.36 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.61 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.81 -33.52 27.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.234 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.75 -134.96 12.02 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -11.49 39.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.19 -1.182 . . . . 0.0 109.471 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -52.71 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.921 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.34 178.47 27.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.29 172.29 9.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.158 -1.201 . . . . 0.0 109.69 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -134.21 163.62 29.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -147.38 113.34 5.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.226 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -132.56 89.91 34.67 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.767 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.16 100.6 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 110.47 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -159.63 -62.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.337 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.426 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.3 tt -109.19 0.15 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.215 -1.167 . . . . 0.0 109.618 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 3' ' ' VAL . 59.2 t -100.82 46.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.002 . . . . 0.0 109.681 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -171.58 -40.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.31 -7.17 26.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.126 -0.984 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.85 -18.94 3.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.482 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 0.5 OUTLIER -82.73 -18.26 41.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 109.117 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.3 p -83.72 -12.51 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.533 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.84 2.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.552 ' CD1' ' HB ' ' F' ' 2' ' ' VAL . 2.0 mp -61.57 140.85 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.2 m -103.94 -164.77 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.858 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -103.62 -174.3 2.51 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -0.935 . . . . 0.0 109.23 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.84 -37.37 64.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -68.91 -23.94 64.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.87 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -79.16 -39.36 33.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.593 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.6 mt -82.05 -11.68 58.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.52 -21.26 49.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.687 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -62.13 -18.68 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.962 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.426 ' CD2' HD12 ' A' ' 2' ' ' ILE . 2.8 m-85 -118.33 48.02 1.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.86 110.95 13.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.208 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.644 -179.709 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.267 0.556 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.93 106.02 4.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.34 -0.85 . . . . 0.0 109.319 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.414 ' HB3' ' CB ' ' B' ' 7' ' ' CYS . 22.7 m-80 -103.15 -8.2 20.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 0.0 109.246 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -48.88 -36.91 18.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.215 -0.928 . . . . 0.0 109.031 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.503 ' HB3' HG12 ' I' ' 10' ' ' ILE . 18.5 t60 -95.64 -30.38 13.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.147 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.05 -70.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.492 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.5 t -53.74 -32.16 51.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 0.0 109.767 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.94 -32.21 53.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -79.2 -3.34 45.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -1.23 . . . . 0.0 109.579 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.22 -14.65 20.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.336 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 14.3 mt -91.91 -43.55 9.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.429 ' H ' HG22 ' B' ' 12' ' ' VAL . 2.7 m -56.8 -37.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.12 -36.18 81.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.332 -0.855 . . . . 0.0 109.871 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.89 11.19 39.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.081 -1.012 . . . . 0.0 109.807 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' B' ' 11' ' ' LEU . 0.7 OUTLIER -96.67 -54.91 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 7.8 p90 -63.94 -18.05 63.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.954 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -78.28 -48.18 16.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -0.888 . . . . 0.0 109.45 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.05 -47.97 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.21 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.64 -57.07 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.89 -140.34 15.13 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 20' ' ' GLY . 19.4 mt-10 -45.54 -30.79 1.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.245 . . . . 0.0 109.36 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -69.35 159.81 32.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' B' ' 24' ' ' PHE . . . -100.51 -158.24 27.86 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 11.3 p90 -178.76 177.28 0.88 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -1.142 . . . . 0.0 109.228 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.55 146.39 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.683 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.506 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 28.6 t80 -122.93 87.29 2.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -117.61 105.74 47.49 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.526 ' HB3' HG21 ' A' ' 3' ' ' VAL . 36.3 Cg_endo -78.1 -36.26 1.09 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.499 2.133 . . . . 0.0 110.538 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mttm 64.22 -87.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 109.41 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.528 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . 0.531 HD12 ' CD2' ' C' ' 19' ' ' TYR . 15.4 tt -112.24 0.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . 0.651 HG12 ' O ' ' C' ' 3' ' ' VAL . 55.6 t -101.15 46.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -171.58 -45.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.72 -7.43 37.34 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.696 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . 0.442 ' HB2' HG13 ' C' ' 2' ' ' ILE . 0.5 OUTLIER -127.56 -17.71 4.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.163 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -86.34 -16.18 38.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 109.862 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.4 p -86.12 -10.51 54.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 109.517 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.79 148.49 2.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 108.995 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' L' ' 5' ' ' HIS . 1.3 mp -58.25 151.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 109.382 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.7 -174.43 2.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.372 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -177.16 4.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.58 -38.86 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -66.29 -24.62 66.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -79.7 -36.87 36.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.98 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 62.4 mt -85.15 -6.83 59.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.89 -18.21 38.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -65.69 -19.77 66.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.279 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.531 ' CD2' HD12 ' C' ' 2' ' ' ILE . 2.5 m-85 -116.98 48.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.484 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.89 108.24 10.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.494 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.572 -179.877 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.479 ' HB ' HD13 ' G' ' 10' ' ' ILE . 4.4 t -131.06 106.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 109.529 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -103.16 -8.78 20.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -48.82 -36.55 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -94.62 -31.31 13.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.1 mt -81.39 -71.24 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.484 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 19.5 t -49.75 -37.92 31.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.51 -35.9 68.34 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -75.25 -5.1 42.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.098 -1.236 . . . . 0.0 109.714 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -97.1 -16.27 20.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 16.9 mt -91.97 -41.87 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.818 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.03 -34.98 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 109.735 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -69.54 -34.51 74.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.36 6.83 45.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.195 -0.941 . . . . 0.0 109.84 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.9 OUTLIER -92.24 -57.27 2.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.049 -1.032 . . . . 0.0 109.494 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.524 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 7.6 p90 -61.2 -19.06 61.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.79 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.434 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 1.5 mt -78.03 -48.59 15.79 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -0.963 . . . . 0.0 109.574 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -54.49 -45.16 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.17 -54.42 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.09 -137.33 14.12 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.78 -29.0 4.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -1.138 . . . . 0.0 109.35 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.58 158.36 33.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.271 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.04 -161.8 27.57 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 6.5 p90 -167.33 178.26 5.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -1.224 . . . . 0.0 110.208 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -129.86 133.31 46.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -117.21 88.81 2.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.4 m -124.23 106.25 30.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.323 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.0 Cg_endo -78.52 -32.73 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.344 2.029 . . . . 0.0 110.629 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.53 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.425 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.456 HD12 ' CD2' ' E' ' 19' ' ' TYR . 14.4 tt -114.46 0.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.226 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . 0.646 ' O ' HG12 ' E' ' 3' ' ' VAL . 58.3 t -101.81 45.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.285 -0.884 . . . . 0.0 109.988 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -169.96 -42.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.96 -9.15 28.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.311 -0.868 . . . . 0.0 109.722 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.34 -14.24 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 110.352 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.67 -17.41 33.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.937 -1.102 . . . . 0.0 109.316 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -86.32 -10.01 55.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.27 151.62 3.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.498 HD13 ' HB ' ' J' ' 2' ' ' VAL . 2.0 mp -63.46 138.74 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.381 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 61.7 m -102.62 -165.62 1.2 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.081 -1.012 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -104.52 -175.46 2.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.07 -38.85 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 110.031 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -68.38 -24.16 64.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.674 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -78.03 -41.38 35.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 65.1 mt -81.28 -9.62 59.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.233 -0.917 . . . . 0.0 109.993 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.35 -17.7 48.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 109.636 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -66.15 -16.91 64.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.424 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' E' ' 2' ' ' ILE . 3.0 m-85 -119.27 50.6 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -130.48 110.21 11.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.543 -179.934 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.215 0.531 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.552 ' HB ' ' CD1' ' A' ' 10' ' ' ILE . 3.9 t -138.81 107.46 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.216 -0.927 . . . . 0.0 109.468 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -103.68 -5.88 22.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.741 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -50.94 -37.54 44.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.075 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . 0.411 ' CB ' HG12 ' A' ' 10' ' ' ILE . 16.3 t60 -95.21 -24.68 16.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.356 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 22.0 mt -87.83 -69.85 0.67 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 10.2 t -52.96 -35.65 59.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.36 -31.69 63.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' F' ' 5' ' ' HIS . 1.1 t -77.95 -7.83 57.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -1.216 . . . . 0.0 109.576 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -93.86 -16.87 23.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 110.091 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 10.9 mt -91.41 -41.42 10.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.24 -32.27 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.5 -33.3 66.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 109.652 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' F' ' 18' ' ' VAL . . . -100.72 6.58 43.99 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.8 OUTLIER -92.46 -54.71 3.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.682 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 7.2 p90 -63.9 -20.8 66.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.81 -49.86 16.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' F' ' 14' ' ' ALA . 75.5 t -52.06 -43.53 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 79.5 m -69.49 -51.8 32.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.661 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 87.78 -139.98 16.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' F' ' 20' ' ' GLY . 17.7 mt-10 -44.95 -34.34 2.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 109.365 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -67.37 159.04 30.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.811 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.25 -165.3 24.72 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -166.69 -171.13 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -1.112 . . . . 0.0 109.621 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.04 142.62 30.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -120.76 94.68 4.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -126.98 103.36 23.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 109.216 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . 0.581 ' HB3' HG21 ' E' ' 3' ' ' VAL . 35.0 Cg_endo -76.7 -36.41 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.393 2.062 . . . . 0.0 110.464 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 65.54 -86.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' G' ' 19' ' ' TYR . 14.8 tt -111.16 -0.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -1.136 . . . . 0.0 109.519 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . 0.631 ' O ' HG12 ' G' ' 3' ' ' VAL . 55.6 t -100.42 47.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.246 -0.908 . . . . 0.0 109.708 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -171.91 -42.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.98 . . . . 0.0 109.737 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.5 -9.69 24.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . 0.44 ' HB2' HG13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -127.62 -9.08 5.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.931 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.47 -13.96 27.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 109.477 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 41.0 p -88.23 -14.0 39.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.34 149.33 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . 0.479 HD13 ' HB ' ' D' ' 2' ' ' VAL . 1.8 mp -57.33 146.66 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.188 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -112.3 -168.4 1.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 110.404 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -101.78 176.28 5.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -65.71 -41.96 91.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.962 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -64.76 -25.27 67.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.281 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -78.06 -39.91 40.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.048 -1.032 . . . . 0.0 109.694 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.28 -6.09 59.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.612 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -83.75 -19.67 34.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.12 -18.87 65.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.478 -0.764 . . . . 0.0 109.408 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . 0.506 ' CD2' HD12 ' G' ' 2' ' ' ILE . 2.0 m-85 -118.28 51.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.381 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.94 107.62 8.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.853 . . . . 0.0 109.451 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.43 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.395 0.616 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.649 ' HB ' HD13 ' K' ' 10' ' ' ILE . 4.9 t -140.73 102.57 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.43 -0.794 . . . . 0.0 109.279 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' H' ' 4' ' ' GLN . 23.6 m-80 -100.33 -11.65 20.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' H' ' 3' ' ' ASN . 2.3 tt0 -44.76 -37.11 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.836 . . . . 0.0 109.168 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' H' ' 9' ' ' SER . 13.7 t60 -95.09 -29.48 14.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.813 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.9 mt -84.22 -69.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.5 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.477 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 1.4 t -52.88 -34.86 56.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 109.151 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.88 -32.8 60.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' H' ' 5' ' ' HIS . 1.4 t -77.66 -5.87 51.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -1.178 . . . . 0.0 109.867 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.13 -14.87 21.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.965 . . . . 0.0 109.882 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.1 mt -91.85 -42.59 9.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.642 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.453 ' H ' HG22 ' H' ' 12' ' ' VAL . 2.7 m -58.03 -35.32 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.872 . . . . 0.0 109.805 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.26 -35.84 76.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.52 8.99 44.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.287 -0.883 . . . . 0.0 109.828 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.7 OUTLIER -95.56 -55.71 2.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 8.5 p90 -62.31 -22.08 65.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.414 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 1.6 mt -74.0 -49.8 22.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.26 -44.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -52.7 49.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.963 -1.086 . . . . 0.0 109.023 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.86 -137.51 14.27 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.98 -28.41 3.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -72.64 156.55 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.92 . . . . 0.0 109.19 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.51 -163.06 29.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -171.48 -171.54 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.338 -1.095 . . . . 0.0 109.196 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 3.2 p90 -146.64 146.94 30.57 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -122.23 92.4 3.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -122.5 104.99 36.51 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.367 -0.833 . . . . 0.0 109.262 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . 0.596 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.9 Cg_endo -78.18 -39.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 0.0 109.977 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.6 OUTLIER 69.91 -85.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.423 -179.673 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' I' ' 19' ' ' TYR . 12.6 tt -110.51 0.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -1.151 . . . . 0.0 109.553 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . 0.592 ' O ' HG12 ' I' ' 3' ' ' VAL . 46.8 t -101.64 48.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.248 -0.907 . . . . 0.0 109.762 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -172.62 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.842 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.03 -11.94 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 110.009 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -126.78 -13.87 5.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.06 -15.36 41.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -87.81 -17.44 31.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.27 153.44 13.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' B' ' 5' ' ' HIS . 1.9 mp -64.59 140.78 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.987 . . . . 0.0 109.374 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 62.8 m -103.26 -163.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.44 -173.91 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp -73.28 -39.58 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.258 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -67.68 -22.67 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.41 -0.806 . . . . 0.0 109.735 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -81.0 -36.62 30.42 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.57 -9.52 57.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.55 -19.64 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 0.0 109.904 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -64.17 -20.1 65.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . 0.495 ' CE2' HD12 ' I' ' 2' ' ' ILE . 2.3 m-85 -115.87 48.77 1.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.523 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -128.47 109.33 11.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.377 179.82 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' E' ' 10' ' ' ILE . 4.6 t -136.01 103.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.816 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -101.31 -10.68 20.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.555 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -47.18 -35.08 6.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -96.77 -29.09 13.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.28 -69.05 0.67 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.08 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 1.4 t -53.56 -33.05 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.367 -0.833 . . . . 0.0 109.367 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.61 54.97 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -77.6 -2.49 36.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.007 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -97.95 -15.45 20.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 14.2 mt -92.49 -42.38 9.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.578 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -58.32 -34.28 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.65 -33.02 70.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.91 6.59 43.71 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.195 -0.941 . . . . 0.0 109.704 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' J' ' 11' ' ' LEU . 0.8 OUTLIER -92.62 -55.91 3.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 10.0 p90 -63.08 -18.6 63.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.15 -50.62 11.62 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.101 -1.0 . . . . 0.0 109.103 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.65 -46.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.32 -53.28 38.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 -137.93 14.78 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -47.33 -29.87 2.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.78 153.58 41.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.59 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.68 30.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -163.5 -170.72 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -1.103 . . . . 0.0 109.573 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . 0.445 ' CD1' ' O ' ' J' ' 25' ' ' PHE . 36.0 p90 -144.01 143.93 31.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.597 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -121.55 90.64 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.39 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -122.16 103.65 38.95 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . 0.538 ' HB3' HG21 ' I' ' 3' ' ' VAL . 35.3 Cg_endo -76.97 -36.76 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.425 2.083 . . . . 0.0 110.496 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 65.52 -86.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.333 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.487 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . 0.484 HD12 ' CD2' ' K' ' 19' ' ' TYR . 15.8 tt -111.53 1.62 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -1.14 . . . . 0.0 109.649 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.621 HG12 ' O ' ' K' ' 3' ' ' VAL . 48.5 t -102.38 46.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -171.41 -42.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 109.623 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.15 33.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 109.918 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -129.71 -23.17 2.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.07 -1.019 . . . . 0.0 110.183 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' L' ' 7' ' ' CYS . 0.5 OUTLIER -79.87 -12.35 59.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.048 -1.032 . . . . 0.0 109.593 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -90.22 -9.62 47.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.09 152.77 2.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . 0.649 HD13 ' HB ' ' H' ' 2' ' ' VAL . 1.8 mp -65.65 135.27 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.994 . . . . 0.0 109.265 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -97.29 -164.02 1.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 109.594 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.21 -173.16 2.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -74.34 -40.5 62.12 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.165 -0.959 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -66.58 -26.52 67.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.06 -37.78 57.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.876 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 55.2 mt -85.6 -6.26 59.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.899 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.1 -19.47 36.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.991 . . . . 0.0 109.274 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -64.57 -16.98 63.51 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.359 -0.838 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . 0.484 ' CD2' HD12 ' K' ' 2' ' ' ILE . 2.4 m-85 -119.58 47.73 1.66 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . 0.418 ' O ' ' OXT' ' K' ' 21' ' ' ASN . 0.1 OUTLIER -128.08 108.5 10.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.534 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . 0.418 ' OXT' ' O ' ' K' ' 20' ' ' CYS . 6.4 t-20 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.502 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 t -136.76 107.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 109.662 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -102.95 -8.21 20.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.732 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -47.84 -34.55 8.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . 0.543 ' CB ' HG12 ' C' ' 10' ' ' ILE . 19.2 t60 -98.75 -29.33 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 mt -82.44 -69.75 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.107 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.478 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 11.8 t -53.88 -33.92 57.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.24 -33.41 56.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' L' ' 5' ' ' HIS . 2.0 t -77.34 -4.57 45.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -1.104 . . . . 0.0 109.637 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -98.16 -14.42 20.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.194 -0.941 . . . . 0.0 109.541 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 15.6 mt -91.98 -44.12 9.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.37 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.419 ' H ' HG22 ' L' ' 12' ' ' VAL . 2.6 m -56.57 -35.1 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.932 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -69.57 -35.57 75.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 109.699 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.69 8.7 44.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' L' ' 11' ' ' LEU . 0.7 OUTLIER -94.63 -52.73 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.773 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 12.7 p90 -66.3 -18.87 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.003 -1.061 . . . . 0.0 109.366 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.63 -48.18 17.49 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.94 -46.76 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.16 -55.22 27.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.223 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.4 -138.53 14.34 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -48.49 -29.4 4.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 0.0 109.31 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -72.04 156.04 39.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 109.438 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.55 -165.25 29.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -167.23 -176.88 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -1.13 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -137.55 146.54 44.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -124.07 85.56 2.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 105.1 50.15 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 109.534 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . 0.6 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.4 Cg_endo -78.86 -32.13 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 110.319 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mttm 61.77 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.349 -179.634 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.403 HD13 HD11 ' B' ' 15' ' ' LEU . 80.9 mt -122.47 -24.88 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -1.158 . . . . 0.0 109.492 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.25 -14.98 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.226 -0.921 . . . . 0.0 109.54 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.84 45.52 2.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -166.28 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.845 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.54 -24.7 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -14.6 59.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 9' ' ' SER . 33.0 p -97.56 3.1 50.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 109.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' THR . 80.9 p -179.46 137.58 0.13 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.161 -0.962 . . . . 0.0 109.688 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -54.73 147.14 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.845 . . . . 0.0 109.472 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -121.14 174.09 6.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -101.23 -177.16 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 4.4 mp -75.16 -24.87 57.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.502 -0.749 . . . . 0.0 109.654 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.98 -43.03 65.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.673 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -70.77 -42.45 70.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.647 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.74 -23.27 61.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 9.3 mt-10 -76.75 -22.46 53.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -57.74 -23.67 53.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 20' ' ' CYS . 75.2 m-85 -84.21 -104.74 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.285 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 53.41 168.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.902 -1.123 . . . . 0.0 109.791 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.03 -0.985 . . . . 0.0 109.517 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.542 HG23 ' O ' ' B' ' 2' ' ' VAL . 17.0 m -79.07 83.49 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -124.78 -26.07 3.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.981 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -38.76 69.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 109.5 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.537 ' CB ' HG12 ' I' ' 10' ' ' ILE . 12.8 t60 -88.56 -29.44 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.907 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 mt -87.93 -72.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 38.5 t -45.78 -34.91 3.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.61 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.78 -40.58 52.4 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.6 p -74.75 0.97 13.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -1.181 . . . . 0.0 109.97 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.47 -23.21 16.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 109.3 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.536 HD23 ' N ' ' B' ' 11' ' ' LEU . 4.6 mt -87.86 -36.14 17.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.407 -0.808 . . . . 0.0 109.526 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.546 HG23 ' N ' ' B' ' 13' ' ' GLU . 20.7 m -48.99 -46.65 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.407 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.546 ' N ' HG23 ' B' ' 12' ' ' VAL . 0.8 OUTLIER -67.07 -31.97 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.3 21.99 6.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.113 -0.992 . . . . 0.0 109.424 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -115.92 -60.84 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.533 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.492 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.4 p90 -64.12 -33.15 75.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.449 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.791 HD23 HD23 ' H' ' 17' ' ' LEU . 43.0 tp -63.84 -42.52 97.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.24 -61.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.605 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.42 -70.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.0 132.77 0.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 53.81 41.23 32.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -1.162 . . . . 0.0 109.795 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.429 ' HD3' ' SG ' ' A' ' 20' ' ' CYS . 1.8 ttt180 -143.19 -62.25 0.41 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.63 157.64 11.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 8.0 p90 -160.23 172.95 16.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -1.14 . . . . 0.0 109.289 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 8.0 p90 -130.31 146.95 51.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -132.47 99.82 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.715 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.69 91.39 18.14 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 109.416 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 84.22 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.501 2.134 . . . . 0.0 110.306 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -127.84 34.92 4.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.381 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . 0.479 HG23 ' HB2' ' C' ' 6' ' ' CYS . 78.8 mt -122.3 -23.53 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.766 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.2 -12.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -137.98 35.98 2.36 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 109.232 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -155.64 -35.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . 0.479 ' HB2' HG23 ' C' ' 2' ' ' ILE . 0.9 OUTLIER -111.08 -23.84 10.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.559 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -12.16 59.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.532 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -99.72 2.47 44.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 109.78 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -178.91 138.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.28 147.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.54 178.06 4.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -104.98 -176.02 2.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 5.3 mp -76.19 -26.36 56.08 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -69.86 -43.58 71.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.862 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -70.97 -42.66 69.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 109.675 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.4 -25.68 63.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.964 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 9.2 mt-10 -74.3 -23.9 59.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.993 -1.067 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -55.66 -26.33 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' C' ' 20' ' ' CYS . 70.9 m-85 -83.25 -109.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.399 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' C' ' 19' ' ' TYR . 4.4 m 54.38 168.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 109.244 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 C--N 1.303 -1.437 0 O-C-N 121.057 -1.027 . . . . 0.0 109.515 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.0 t80 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.54 ' CG1' ' HA ' ' G' ' 9' ' ' SER . 16.0 m -81.76 84.08 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -123.82 -23.77 4.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -40.59 82.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.429 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . 0.46 ' CB ' HG12 ' G' ' 10' ' ' ILE . 11.8 t60 -87.68 -25.84 23.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.453 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 29.1 mt -92.05 -72.37 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 39.4 t -45.43 -35.56 3.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -0.855 . . . . 0.0 109.71 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.85 -39.45 54.85 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . 0.412 ' HB2' ' CZ ' ' B' ' 16' ' ' TYR . 59.7 p -73.88 -2.19 22.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.787 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.52 HD23 ' N ' ' D' ' 11' ' ' LEU . 5.2 mt -89.07 -35.46 16.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.52 HG23 ' N ' ' D' ' 13' ' ' GLU . 18.4 m -50.21 -46.19 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.52 ' N ' HG23 ' D' ' 12' ' ' VAL . 1.3 pt-20 -67.04 -30.95 71.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . 0.414 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.56 17.48 13.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.165 -0.96 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.84 -61.04 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.833 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.506 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 6.3 p90 -63.24 -32.55 73.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.682 HD23 HD23 ' J' ' 17' ' ' LEU . 46.0 tp -65.57 -37.47 86.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -57.55 -62.83 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 109.586 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -66.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.51 135.2 0.11 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 51.84 44.23 29.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -1.064 . . . . 0.0 109.555 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -146.18 -60.82 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.792 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.32 157.03 11.82 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 10.6 p90 -161.38 171.15 18.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.108 -1.231 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . 0.567 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 39.2 m-85 -125.83 154.19 42.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -140.75 95.83 2.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.565 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 85.0 m -133.58 91.4 26.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.47 83.86 2.08 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.634 2.223 . . . . 0.0 110.702 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -128.26 36.98 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 109.63 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.557 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.441 HD13 HD11 ' F' ' 15' ' ' LEU . 76.4 mt -120.89 -22.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -1.13 . . . . 0.0 109.643 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.89 -14.05 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.69 41.73 2.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -161.33 -35.99 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.27 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.0 -24.74 10.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.769 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -13.24 60.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.316 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 66.6 p -96.87 -1.67 45.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.758 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -175.36 142.7 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.54 145.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -116.87 179.44 4.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 -174.33 2.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.406 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -77.03 -27.22 54.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.176 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -69.13 -44.06 73.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.75 -39.99 76.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 110.33 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.9 mt -73.88 -24.43 59.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.943 . . . . 0.0 110.042 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.57 -26.16 59.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.063 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -53.42 -25.53 16.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' E' ' 20' ' ' CYS . 70.6 m-85 -83.29 -104.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.107 -0.996 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' E' ' 19' ' ' TYR . 0.9 OUTLIER 52.55 171.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.949 -1.094 . . . . 0.0 109.495 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 120.97 -1.081 . . . . 0.0 109.554 -179.879 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.543 ' O ' HG23 ' F' ' 2' ' ' VAL . 17.9 m -79.48 83.42 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -123.44 -26.14 4.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.058 -1.026 . . . . 0.0 109.775 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.97 70.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.487 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -85.59 -28.92 24.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 27.0 mt -88.71 -72.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.956 . . . . 0.0 109.743 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -45.25 -36.52 4.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.811 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.94 -39.05 59.78 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 97.3 p -75.49 0.59 16.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 0.0 109.736 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -97.82 -21.96 16.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.508 ' N ' HD23 ' F' ' 11' ' ' LEU . 5.3 mt -89.32 -34.7 16.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.211 -0.931 . . . . 0.0 109.417 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.567 HG23 ' N ' ' F' ' 13' ' ' GLU . 22.5 m -49.37 -46.88 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 109.312 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . 0.567 ' N ' HG23 ' F' ' 12' ' ' VAL . 1.9 pt-20 -66.66 -33.03 74.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.547 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' L' ' 17' ' ' LEU . . . -91.74 17.48 8.91 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.266 -0.896 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.441 HD11 HD13 ' E' ' 2' ' ' ILE . 0.8 OUTLIER -112.68 -61.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 110.117 -179.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 6.5 p90 -63.37 -33.02 74.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.035 . . . . 0.0 109.633 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.933 HD23 HD23 ' L' ' 17' ' ' LEU . 41.9 tp -64.9 -42.1 95.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -52.48 -62.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.418 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.6 -71.13 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.536 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.37 135.71 0.37 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 50.93 43.18 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -1.132 . . . . 0.0 109.603 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.03 -66.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.365 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.77 160.22 10.82 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 13.8 p90 -168.85 163.61 11.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -1.067 . . . . 0.0 109.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -126.34 147.94 49.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 109.532 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -127.87 104.63 7.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.448 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 86.9 m -138.78 89.16 13.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.681 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.97 85.82 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.57 2.18 . . . . 0.0 110.564 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -130.51 37.52 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.286 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.88 -24.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -78.36 -12.38 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.69 34.09 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.228 -0.92 . . . . 0.0 109.696 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -152.64 -37.15 0.11 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.0 -24.62 10.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -15.02 61.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.319 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 45.9 p -98.46 -2.24 39.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.62 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . 0.54 ' HA ' ' CG1' ' D' ' 2' ' ' VAL . 93.6 p -171.79 135.97 0.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.088 -1.008 . . . . 0.0 109.752 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . 0.46 HG12 ' CB ' ' D' ' 5' ' ' HIS . 2.5 mp -55.01 143.99 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.229 -0.919 . . . . 0.0 108.806 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 m -115.84 177.58 4.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.954 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -104.45 178.19 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.43 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.6 -26.36 62.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.267 -0.896 . . . . 0.0 109.745 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -70.6 -40.9 72.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -72.57 -39.44 67.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.249 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.96 -22.14 58.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.852 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -76.44 -24.46 53.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 109.323 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.46 -25.44 36.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.837 . . . . 0.0 109.813 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' G' ' 20' ' ' CYS . 73.9 m-85 -83.65 -103.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' G' ' 19' ' ' TYR . 0.9 OUTLIER 51.19 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.105 . . . . 0.0 109.658 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.554 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 12.1 t80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.471 ' O ' HG23 ' H' ' 2' ' ' VAL . 16.2 m -79.61 81.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -121.87 -28.5 4.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.647 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -39.72 66.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.928 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -89.52 -21.73 22.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 109.736 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . 0.416 HD22 ' ND1' ' L' ' 10' ' ' HIS . 31.0 mt -95.8 -70.7 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.5 t -46.52 -35.64 5.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.46 -39.16 57.31 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -77.0 2.92 13.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -1.182 . . . . 0.0 109.663 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -98.94 -23.39 15.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.523 ' N ' HD23 ' H' ' 11' ' ' LEU . 5.1 mt -87.98 -35.09 17.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.534 HG23 ' N ' ' H' ' 13' ' ' GLU . 18.6 m -49.5 -46.37 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.489 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . 0.534 ' N ' HG23 ' H' ' 12' ' ' VAL . 3.0 pt-20 -67.85 -30.92 70.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.317 -0.864 . . . . 0.0 109.418 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . 0.689 ' HA ' HD21 ' B' ' 17' ' ' LEU . . . -95.02 21.63 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.341 -0.85 . . . . 0.0 109.635 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 -60.06 1.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.639 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.467 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 7.4 p90 -64.58 -32.6 74.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.385 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.791 HD23 HD23 ' B' ' 17' ' ' LEU . 43.8 tp -65.05 -42.52 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.383 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -51.98 -65.83 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.224 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 58.6 m -64.33 -73.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.3 136.65 0.84 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 49.87 46.06 24.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.169 -1.195 . . . . 0.0 109.333 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -147.6 -58.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.403 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.06 158.39 14.29 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 9.8 p90 -163.34 174.7 11.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -1.154 . . . . 0.0 109.428 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 15.0 p90 -129.93 157.86 41.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -144.04 91.91 2.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 84.9 m -129.19 90.52 44.82 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.75 86.32 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.433 2.089 . . . . 0.0 110.154 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -130.06 35.24 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.912 . . . . 0.0 109.595 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.546 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.418 HD13 HD11 ' J' ' 15' ' ' LEU . 85.3 mt -122.15 -26.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -1.166 . . . . 0.0 109.358 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 p -75.85 -12.86 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -138.25 43.82 2.16 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -163.04 -37.45 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.213 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 2.1 t -109.6 -27.05 9.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 109.151 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -72.01 -17.16 62.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 37.1 p -96.38 1.63 51.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . 0.538 ' HA ' ' CG1' ' B' ' 2' ' ' VAL . 85.8 p -177.24 141.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.543 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' B' ' 5' ' ' HIS . 2.7 mp -60.77 139.93 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.355 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 m -110.04 -174.72 2.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.182 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -110.63 -175.98 2.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.175 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 3.3 mp -75.42 -24.27 57.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.562 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.57 -43.48 63.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.89 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -70.04 -44.58 68.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -68.63 -26.06 65.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.979 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 9.0 mt-10 -74.46 -22.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.032 . . . . 0.0 109.731 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.93 -23.2 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.704 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' I' ' 20' ' ' CYS . 71.3 m-85 -83.87 -109.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 0.0 109.114 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' I' ' 19' ' ' TYR . 0.9 OUTLIER 55.61 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.66 -1.275 . . . . 0.0 109.651 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.528 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.54 HG23 ' O ' ' J' ' 2' ' ' VAL . 16.9 m -81.48 83.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 109.568 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.6 -32.2 3.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.75 -39.29 37.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.102 -0.999 . . . . 0.0 109.882 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -88.44 -27.82 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' J' ' 7' ' ' CYS . 33.7 mt -90.96 -71.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' J' ' 6' ' ' LEU . 6.4 t -45.01 -38.89 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.05 -39.83 84.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . 0.439 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 79.2 p -75.86 1.46 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.157 -1.202 . . . . 0.0 109.78 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -97.25 -23.41 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.553 HD23 ' N ' ' J' ' 11' ' ' LEU . 3.4 mt -88.43 -36.24 16.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.54 HG23 ' N ' ' J' ' 13' ' ' GLU . 23.5 m -48.09 -45.64 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.444 -0.785 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.54 ' N ' HG23 ' J' ' 12' ' ' VAL . 0.8 OUTLIER -68.45 -32.17 72.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.63 21.56 6.25 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -0.876 . . . . 0.0 109.438 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . 0.418 HD11 HD13 ' I' ' 2' ' ' ILE . 0.8 OUTLIER -116.05 -60.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.656 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' L' ' 9' ' ' SER . 7.8 p90 -64.66 -32.54 74.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.102 -0.999 . . . . 0.0 109.371 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.682 HD23 HD23 ' D' ' 17' ' ' LEU . 52.8 tp -65.1 -40.8 95.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.31 -61.19 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -69.6 -69.51 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.3 133.88 0.17 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 53.62 43.5 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -1.109 . . . . 0.0 109.578 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -145.38 -59.0 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.29 155.37 12.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 6.9 p90 -158.88 -179.64 8.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -1.18 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.31 158.86 43.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -144.44 94.89 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.485 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -132.35 91.51 31.03 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.46 -0.775 . . . . 0.0 109.287 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.09 86.62 1.66 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.679 2.253 . . . . 0.0 110.149 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -130.82 36.67 3.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.405 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.07 -24.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.46 HG22 ' O ' ' K' ' 3' ' ' VAL . 14.9 p -78.53 -7.71 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -142.14 34.17 1.53 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.604 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -153.35 -36.49 0.1 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.41 -26.12 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.208 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -73.28 -13.25 61.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.415 -0.803 . . . . 0.0 109.633 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 43.5 p -99.75 0.26 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.598 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p -176.31 145.64 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.902 . . . . 0.0 109.306 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.14 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.97 . . . . 0.0 109.393 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 33.7 m -108.8 -176.05 2.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.516 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -109.89 -177.5 3.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 109.16 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 3.3 mp -74.49 -25.64 59.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 0.0 109.74 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -71.24 -42.97 68.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.301 -0.875 . . . . 0.0 109.943 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -70.49 -43.53 69.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.878 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.27 -24.08 62.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 8.3 mt-10 -75.41 -24.09 57.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -56.94 -23.81 48.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' K' ' 20' ' ' CYS . 73.0 m-85 -85.07 -112.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' K' ' 19' ' ' TYR . 6.1 m 55.46 168.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.733 -1.229 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.381 179.974 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.595 HG23 ' O ' ' L' ' 2' ' ' VAL . 22.3 m -77.1 84.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 109.813 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -125.4 -27.1 3.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -37.3 66.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.562 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -91.13 -25.26 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -92.72 -69.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.351 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 4.9 t -48.23 -34.94 11.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.19 -39.1 58.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . 0.494 ' HB2' ' OH ' ' J' ' 16' ' ' TYR . 89.1 p -76.42 1.17 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -1.136 . . . . 0.0 109.717 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . 0.416 ' ND1' HD22 ' H' ' 6' ' ' LEU . 3.1 m-70 -98.28 -24.08 15.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.364 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.492 HD23 ' N ' ' L' ' 11' ' ' LEU . 6.4 mt -86.72 -33.68 19.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.52 HG23 ' N ' ' L' ' 13' ' ' GLU . 19.0 m -51.83 -45.76 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . 0.52 ' N ' HG23 ' L' ' 12' ' ' VAL . 1.7 pt-20 -67.07 -33.24 75.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -92.11 19.63 6.68 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.7 -61.69 1.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 7.5 p90 -62.57 -32.96 74.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.6 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.933 HD23 HD23 ' F' ' 17' ' ' LEU . 49.7 tp -65.05 -37.31 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.846 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.6 -59.06 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -67.38 0.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.085 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.46 134.3 0.1 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 53.27 42.41 32.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -1.175 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -145.32 -60.16 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.018 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.45 162.24 14.83 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 12.2 p90 -165.51 172.09 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -1.2 . . . . 0.0 109.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -127.49 154.18 45.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.447 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -140.43 99.31 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -136.46 91.76 15.95 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 109.578 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.18 84.41 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.74 2.293 . . . . 0.0 110.663 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -128.8 38.49 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.429 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.75 3.53 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -1.15 . . . . 0.0 109.721 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 35.9 m -89.52 -11.21 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.86 43.63 2.07 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.301 -0.874 . . . . 0.0 109.356 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.25 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.043 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.4 m -115.15 26.48 10.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 45.6 t -117.64 -24.2 7.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.066 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -109.0 8.52 26.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.93 120.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mp -49.11 134.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -94.42 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.121 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -110.03 172.18 7.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -27.25 67.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 109.665 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.71 -46.29 69.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -33.13 68.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.99 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.79 -8.09 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -89.69 -23.1 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.57 -8.0 54.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -93.44 4.93 53.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.499 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 156.68 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.349 0.595 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.667 ' O ' HG13 ' B' ' 2' ' ' VAL . 7.5 p -70.88 91.04 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.885 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.98 -45.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 0.0 109.143 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.36 -32.05 58.4 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.317 -0.864 . . . . 0.0 109.14 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -70.53 -43.2 70.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 mt -74.24 -32.69 63.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.288 -0.883 . . . . 0.0 108.886 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.09 -31.43 68.99 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.466 -0.771 . . . . 0.0 109.274 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.09 -26.94 61.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.14 -10.35 59.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.25 -1.147 . . . . 0.0 109.456 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -89.59 -24.6 21.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.086 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -87.59 -43.81 11.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.48 HG23 ' N ' ' B' ' 13' ' ' GLU . 29.0 m -47.31 -42.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.48 ' N ' HG23 ' B' ' 12' ' ' VAL . 5.0 mt-10 -67.35 -39.09 85.72 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 109.752 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.38 25.59 2.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.183 -0.948 . . . . 0.0 109.555 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.06 -49.21 2.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.399 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 18.3 p90 -79.39 -25.82 42.08 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.925 HD23 HD23 ' H' ' 17' ' ' LEU . 28.0 tp -74.76 -35.9 62.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.5 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -58.12 -60.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.64 -64.48 0.85 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.579 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.46 -129.29 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.46 82.74 3.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -1.183 . . . . 0.0 109.662 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -148.44 -68.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.48 149.71 7.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 17.3 p90 -158.69 173.27 16.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -1.141 . . . . 0.0 109.312 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.593 ' HB3' ' CD2' ' D' ' 25' ' ' PHE . 23.9 p90 -129.01 146.06 51.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -124.8 102.7 7.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.458 -0.776 . . . . 0.0 109.025 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -140.72 106.01 6.37 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.922 . . . . 0.0 109.866 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.61 78.41 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.524 2.149 . . . . 0.0 110.278 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -174.29 2.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.634 -179.877 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.39 0.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -1.122 . . . . 0.0 109.258 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . 0.418 ' H ' HG22 ' C' ' 3' ' ' VAL . 28.6 m -85.38 -14.14 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.229 -0.919 . . . . 0.0 109.805 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.9 42.49 2.01 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.187 -0.946 . . . . 0.0 109.673 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -168.52 -34.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.229 -0.919 . . . . 0.0 109.534 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -120.89 19.7 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 109.151 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -20.31 11.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.504 -0.748 . . . . 0.0 109.205 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -111.53 7.04 20.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . 0.484 ' HA ' ' HB3' ' L' ' 1' ' ' PHE . 85.6 p -175.87 120.12 0.17 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.901 . . . . 0.0 109.188 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.414 ' H ' HD12 ' C' ' 10' ' ' ILE . 2.9 mp -48.63 133.98 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.294 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.58 -169.75 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.343 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -107.43 172.84 6.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.29 -27.07 66.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.52 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -69.37 -42.92 74.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -29.23 55.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.31 -7.15 59.52 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.8 -23.66 21.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.493 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -74.53 -4.35 36.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.938 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -97.38 4.11 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.988 . . . . 0.0 109.36 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.17 155.49 18.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.469 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.597 ' O ' HG13 ' D' ' 2' ' ' VAL . 4.7 p -69.61 94.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.93 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -79.36 -33.79 42.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 109.036 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -68.26 -41.07 81.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 108.919 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.63 -34.56 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.3 -28.25 67.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.456 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.23 -27.91 50.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -78.45 -8.1 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 109.211 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -93.65 -20.23 20.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.967 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mt -93.18 -44.29 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.486 HG23 ' N ' ' D' ' 13' ' ' GLU . 20.2 m -45.89 -42.32 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.425 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.486 ' N ' HG23 ' D' ' 12' ' ' VAL . 4.3 mt-10 -68.12 -43.98 77.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.316 -0.865 . . . . 0.0 109.665 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.8 24.83 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.915 . . . . 0.0 109.862 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -50.53 2.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.017 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 12.0 p90 -77.92 -24.42 48.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.854 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.532 HD21 ' CB ' ' J' ' 14' ' ' ALA . 35.3 tp -76.86 -36.07 57.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.58 -61.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -66.16 -66.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.743 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.9 -129.41 8.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.57 82.35 3.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -1.159 . . . . 0.0 109.552 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -148.48 -69.9 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.587 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.61 143.08 5.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 10.9 p90 -150.13 166.58 29.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.292 -1.122 . . . . 0.0 109.289 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' B' ' 25' ' ' PHE . 11.7 m-85 -117.43 143.87 45.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.042 -1.036 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -127.04 104.84 8.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.084 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -148.83 105.37 3.42 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.28 83.68 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.397 2.065 . . . . 0.0 110.46 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.86 -179.88 2.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.441 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.393 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 tt -120.41 0.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -1.144 . . . . 0.0 109.762 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.38 -8.97 11.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.76 37.63 3.73 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.142 -0.974 . . . . 0.0 109.339 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -163.06 -42.2 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 90.3 m -113.85 26.27 10.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.228 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 51.1 t -117.24 -23.99 7.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -0.839 . . . . 0.0 109.188 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -109.93 10.97 24.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.19 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' J' ' 1' ' ' PHE . 2.2 p -178.81 119.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.41 132.51 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.744 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m -93.27 -169.91 2.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.6 175.45 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -24.59 63.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -71.88 -44.34 63.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -29.74 61.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.438 -0.789 . . . . 0.0 109.889 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -80.87 -10.35 59.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.922 . . . . 0.0 109.819 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -86.27 -25.44 25.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -70.66 -10.01 58.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.9 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -92.38 5.93 48.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 109.98 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.41 156.71 17.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.746 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.602 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.643 ' O ' HG13 ' F' ' 2' ' ' VAL . 5.9 p -74.21 88.73 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.911 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.74 -44.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.91 . . . . 0.0 109.055 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.51 -30.77 53.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -70.46 -45.14 66.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.326 -0.859 . . . . 0.0 109.043 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.48 -30.71 63.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.327 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.414 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.1 t -72.36 -29.55 63.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.753 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.73 -25.94 59.59 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -84.23 -2.61 57.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 109.653 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . 0.603 ' ND1' HD22 ' J' ' 6' ' ' LEU . 2.6 m-70 -97.89 -19.16 18.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 15.2 mt -92.22 -43.67 9.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.527 -0.733 . . . . 0.0 109.271 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.477 HG23 ' N ' ' F' ' 13' ' ' GLU . 22.8 m -48.26 -42.1 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . 0.477 ' N ' HG23 ' F' ' 12' ' ' VAL . 4.7 mt-10 -67.19 -43.07 83.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.749 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.92 21.79 2.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.283 -0.886 . . . . 0.0 109.875 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.25 -51.91 2.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 13.4 p90 -76.37 -25.48 54.68 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.189 -0.944 . . . . 0.0 109.654 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.519 HD23 HD23 ' L' ' 17' ' ' LEU . 31.9 tp -76.21 -35.54 59.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.96 . . . . 0.0 109.769 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.49 -59.23 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.686 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 17.9 m -68.44 -66.72 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.078 -1.014 . . . . 0.0 109.301 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.03 -126.07 7.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.44 78.38 5.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -1.092 . . . . 0.0 109.688 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -145.14 -71.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 109.851 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.99 138.84 4.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 14.4 p90 -145.94 173.18 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.349 -1.089 . . . . 0.0 109.019 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -125.27 145.52 49.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.032 . . . . 0.0 109.789 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -127.98 104.08 7.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.245 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -147.33 107.1 3.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.9 78.39 3.42 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.539 2.159 . . . . 0.0 110.693 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.52 179.49 5.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.551 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt -119.29 -1.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -1.091 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.42 -14.4 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.257 -0.902 . . . . 0.0 110.109 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.34 37.47 3.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.069 -1.019 . . . . 0.0 110.018 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -162.05 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.338 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -115.51 21.71 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -23.05 10.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.014 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 11.0 t -108.66 8.77 27.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -177.79 119.2 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.13 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . 0.498 ' H ' HD12 ' G' ' 10' ' ' ILE . 3.3 mp -47.96 137.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.372 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 77.9 m -98.22 -168.34 1.64 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.61 169.26 8.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.949 . . . . 0.0 109.285 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' G' ' 13' ' ' LEU . 0.3 OUTLIER -64.38 -25.63 68.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -70.65 -42.75 70.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -28.16 57.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.42 -4.66 58.7 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.073 -1.017 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -93.29 -21.57 19.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.14 -0.975 . . . . 0.0 109.377 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.07 -9.63 58.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -92.31 1.4 57.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.15 157.82 16.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.002 . . . . 0.0 109.733 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.701 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.621 ' O ' HG13 ' H' ' 2' ' ' VAL . 5.6 p -68.77 91.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.79 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.169 -0.957 . . . . 0.0 109.432 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -77.33 -33.12 55.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -68.2 -40.7 82.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.248 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . 0.474 HD22 ' ND1' ' L' ' 10' ' ' HIS . 13.8 mt -77.37 -31.83 54.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 108.959 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.11 -28.02 65.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.488 -0.757 . . . . 0.0 109.338 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.98 -29.84 45.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 70.4 m -77.24 -8.35 57.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -1.179 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -93.39 -23.46 18.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' H' ' 12' ' ' VAL . 12.1 mt -88.93 -44.51 10.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.525 HG23 ' N ' ' H' ' 13' ' ' GLU . 26.3 m -45.79 -44.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . 0.525 ' N ' HG23 ' H' ' 12' ' ' VAL . 5.3 mt-10 -65.95 -43.86 86.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.784 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . 0.574 ' HA ' HD21 ' B' ' 17' ' ' LEU . . . -86.92 21.11 2.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 110.03 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.45 -51.93 2.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 109.684 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 12.4 p90 -76.21 -26.03 55.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.925 HD23 HD23 ' B' ' 17' ' ' LEU . 32.2 tp -75.56 -34.93 60.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.44 -60.45 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.954 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 m -67.55 -63.62 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.69 -130.23 9.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -76.92 81.94 3.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -1.105 . . . . 0.0 109.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -146.94 -68.27 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.03 142.33 5.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 18.7 p90 -152.13 174.76 13.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.132 . . . . 0.0 109.511 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.3 162.42 26.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -143.83 92.44 2.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.84 . . . . 0.0 109.588 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -133.76 107.27 11.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.13 78.25 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.362 2.041 . . . . 0.0 109.959 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.8 -179.22 4.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.697 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.32 179.728 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -119.13 0.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 109.901 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.98 -16.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.055 -1.028 . . . . 0.0 110.075 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.75 42.88 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -169.96 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -116.91 19.51 14.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.297 -0.877 . . . . 0.0 109.211 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -24.76 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.315 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -105.28 9.38 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.633 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . 0.438 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.9 p 179.67 118.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.453 ' H ' HD12 ' I' ' 10' ' ' ILE . 3.0 mp -43.5 149.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.859 . . . . 0.0 109.21 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -171.76 1.91 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.79 167.55 9.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.158 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' I' ' 13' ' ' LEU . 0.3 OUTLIER -63.39 -27.81 69.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.33 -43.26 77.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.85 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -27.17 56.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.811 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -84.15 -7.12 59.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 109.864 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.78 -24.85 21.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -71.15 -10.83 60.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -91.45 3.16 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 0.0 109.909 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 159.25 15.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 109.378 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' E' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.261 0.553 . . . . 0.0 109.713 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.624 ' O ' HG13 ' J' ' 2' ' ' VAL . 6.0 p -70.65 91.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.55 -42.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.146 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.17 -33.41 44.02 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.004 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -69.06 -40.06 78.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . 0.603 HD22 ' ND1' ' F' ' 10' ' ' HIS . 9.5 mt -78.49 -29.79 46.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.324 -0.86 . . . . 0.0 109.105 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -72.72 -27.71 62.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.333 -0.854 . . . . 0.0 109.465 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.84 -27.0 52.17 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -79.68 -7.57 58.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.568 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -94.5 -20.87 19.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.15 -43.69 9.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 109.677 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.504 HG23 ' N ' ' J' ' 13' ' ' GLU . 26.1 m -46.95 -44.21 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.504 ' N ' HG23 ' J' ' 12' ' ' VAL . 3.9 mt-10 -65.08 -44.25 89.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.601 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . 0.532 ' CB ' HD21 ' D' ' 17' ' ' LEU . . . -87.6 24.85 1.59 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.47 -46.34 3.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 109.507 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 14.3 p90 -82.64 -23.25 34.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.98 -37.85 54.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.283 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.0 t -55.7 -61.62 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 m -66.89 -64.77 0.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.55 -129.33 8.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -77.91 85.31 4.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -1.179 . . . . 0.0 109.368 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -150.88 -75.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.07 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.32 141.21 4.42 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 15.5 p90 -149.05 165.69 30.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.79 136.44 54.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -117.37 104.91 11.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.536 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -146.18 108.19 4.23 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 109.438 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.85 79.57 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 110.994 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.89 179.6 5.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 109.337 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.324 179.923 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.6 tt -121.17 1.05 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 30.9 m -86.51 -12.9 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.89 40.38 2.47 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.688 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -164.93 -42.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.244 -0.91 . . . . 0.0 109.299 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 93.9 m -114.14 23.47 12.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 40.9 t -112.77 -26.94 8.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 109.238 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -105.48 9.4 33.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.01 118.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.804 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . 0.475 HD12 ' H ' ' K' ' 10' ' ' ILE . 3.1 mp -45.32 135.66 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.298 -0.877 . . . . 0.0 109.597 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -98.1 -167.73 1.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.46 171.71 7.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.482 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' K' ' 13' ' ' LEU . 0.3 OUTLIER -65.24 -28.06 69.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 109.678 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -69.1 -42.34 76.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.825 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -28.82 56.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.62 -7.28 59.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 109.809 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.59 -25.12 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.678 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -72.38 -7.62 50.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -93.55 0.33 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.87 158.99 15.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.419 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' C' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.624 ' O ' HG13 ' L' ' 2' ' ' VAL . 5.1 p -70.83 89.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -175.95 -44.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -78.29 -31.88 49.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -70.63 -39.17 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.127 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 13.4 mt -78.21 -31.93 49.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 108.863 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.01 -29.99 67.19 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.12 -27.26 58.43 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -80.37 -6.24 57.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -1.127 . . . . 0.0 109.616 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . 0.474 ' ND1' HD22 ' H' ' 6' ' ' LEU . 4.3 m-70 -95.14 -20.63 19.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.031 -1.043 . . . . 0.0 109.633 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' L' ' 12' ' ' VAL . 11.2 mt -92.68 -44.67 8.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.943 . . . . 0.0 109.515 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.51 HG23 ' N ' ' L' ' 13' ' ' GLU . 23.4 m -45.04 -43.71 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.18 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . 0.51 ' N ' HG23 ' L' ' 12' ' ' VAL . 4.7 mt-10 -66.76 -44.83 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.554 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.69 23.53 1.66 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.3 -0.875 . . . . 0.0 109.936 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.62 -49.66 2.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.668 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.526 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 14.4 p90 -79.06 -24.36 43.6 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.162 -0.962 . . . . 0.0 109.663 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.519 HD23 HD23 ' F' ' 17' ' ' LEU . 38.7 tp -76.99 -33.58 57.58 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.75 -59.3 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 12.3 m -69.05 -66.08 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.568 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.98 -129.95 9.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.17 80.88 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -147.62 -68.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.092 -1.005 . . . . 0.0 109.43 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.59 131.26 3.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 9.8 p90 -135.08 -173.21 3.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 109.317 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -138.2 142.74 39.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.82 108.61 11.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.625 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -150.5 106.64 3.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.848 . . . . 0.0 109.451 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.09 79.37 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.508 2.139 . . . . 0.0 110.449 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 -179.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.537 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -97.74 -27.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' B' ' 28' ' ' PRO . 94.4 t -73.84 -44.11 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.64 52.12 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.843 . . . . 0.0 110.151 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -175.38 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.085 -1.01 . . . . 0.0 109.694 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.0 11.05 17.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.8 t -105.57 -23.05 12.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.9 p -67.17 -13.94 62.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.472 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.5 p -175.25 156.52 2.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' F' ' 2' ' ' VAL . 2.1 mp -62.84 130.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.255 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.32 -167.02 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.504 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.72 176.78 4.94 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -42.31 89.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.2 -0.938 . . . . 0.0 109.771 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -66.7 -35.85 81.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.962 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -36.67 77.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 109.437 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.65 -18.45 51.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 109.827 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.09 -14.48 47.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.481 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.6 -16.31 15.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.892 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.74 87.27 1.84 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.31 133.07 7.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.461 -0.774 . . . . 0.0 109.485 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.418 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.548 ' HB ' HD12 ' I' ' 10' ' ' ILE . 70.4 t -91.02 -7.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.248 -0.908 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 4' ' ' GLN . 11.3 p30 45.08 -172.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.443 -0.785 . . . . 0.0 109.604 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' B' ' 3' ' ' ASN . 9.4 tt0 83.53 -59.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -89.08 -24.13 22.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.191 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -96.78 -50.26 4.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.135 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -57.2 -38.04 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.98 -29.46 60.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.489 ' OG ' ' CE1' ' D' ' 16' ' ' TYR . 1.2 m -67.38 -9.08 38.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.151 . . . . 0.0 109.424 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -96.25 -36.1 11.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.023 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.49 -41.44 69.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 m -48.11 -37.7 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -72.25 -46.12 57.32 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.954 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.12 13.25 4.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 0.0 109.863 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.32 -53.29 3.39 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.003 -1.061 . . . . 0.0 109.537 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 11.3 p90 -73.12 -30.2 63.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.315 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 0.1 OUTLIER -61.93 -52.92 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.384 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.41 -30.75 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.199 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 20' ' ' GLY . 1.3 m -115.45 54.74 0.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.016 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' B' ' 22' ' ' ARG . . . -58.72 -119.73 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' B' ' 22' ' ' ARG . 25.8 mt-10 -39.52 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.975 . . . . 0.0 109.933 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' B' ' 20' ' ' GLY . 2.9 mtt180 165.37 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.657 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 172.48 27.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' D' ' 26' ' ' TYR . 50.9 p90 -170.81 162.74 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.441 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -117.72 141.5 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 0.0 109.493 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.86 111.44 17.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.709 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -140.86 98.58 6.92 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.635 ' HB3' HG21 ' A' ' 3' ' ' VAL . 35.7 Cg_endo -77.92 87.73 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.5 2.133 . . . . 0.0 110.662 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -136.1 -123.38 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.98 . . . . 0.0 109.294 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 120.741 -1.225 . . . . 0.0 109.351 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -100.3 -29.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -1.165 . . . . 0.0 109.457 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . 0.603 HG21 ' HB3' ' D' ' 28' ' ' PRO . 79.2 t -72.81 -40.95 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 52.54 1.97 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.332 -0.855 . . . . 0.0 110.077 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -175.64 -34.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.82 11.58 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 t -105.66 -24.4 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 60.1 p -67.74 -11.94 59.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.575 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -174.81 155.5 2.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.624 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.673 HD12 ' HB ' ' L' ' 2' ' ' VAL . 1.6 mp -63.7 130.95 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 108.984 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -97.15 -167.61 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -107.12 178.8 4.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -42.29 78.65 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.288 -0.882 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -67.04 -34.82 78.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.918 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -32.5 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 11.6 mt -83.31 -21.55 33.19 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -13.59 57.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.524 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.96 -15.57 13.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.02 87.94 1.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.57 133.97 7.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.429 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' G' ' 10' ' ' ILE . 55.8 t -89.58 -9.23 10.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.422 -0.798 . . . . 0.0 109.574 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' D' ' 4' ' ' GLN . 8.6 p30 45.9 -174.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' D' ' 3' ' ' ASN . 10.2 tt0 84.07 -60.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . 0.454 ' HB3' HG12 ' G' ' 10' ' ' ILE . 32.4 t60 -88.02 -21.99 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.123 -0.986 . . . . 0.0 109.006 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.41 -51.28 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.839 . . . . 0.0 109.188 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 t -57.31 -37.79 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.35 59.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.68 -11.13 32.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -1.105 . . . . 0.0 109.559 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -93.09 -35.28 13.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 15.1 mt -73.52 -39.52 64.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 m -48.15 -35.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -75.63 -44.45 42.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 9.71 11.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.02 -56.77 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.711 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 9.1 p90 -71.6 -28.75 64.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.027 . . . . 0.0 109.541 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 0.1 OUTLIER -63.15 -52.99 60.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.186 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.1 t -66.27 -33.47 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 108.866 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' D' ' 20' ' ' GLY . 1.3 m -111.66 55.96 0.66 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 109.085 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' D' ' 22' ' ' ARG . . . -59.32 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' D' ' 22' ' ' ARG . 23.3 mt-10 -40.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.463 -1.022 . . . . 0.0 110.055 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . 0.483 ' CB ' ' O ' ' D' ' 21' ' ' GLU . 4.2 mtt180 165.07 -53.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 171.61 24.55 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -169.45 172.31 7.17 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -122.16 157.89 30.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.516 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.44 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 79.6 t80 -136.64 100.45 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.47 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -133.83 97.41 15.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . 0.603 ' HB3' HG21 ' C' ' 3' ' ' VAL . 34.7 Cg_endo -76.81 86.19 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.447 2.098 . . . . 0.0 110.62 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -134.16 -124.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.886 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.405 HD13 HD11 ' F' ' 15' ' ' LEU . 20.7 tt -101.69 -25.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -1.138 . . . . 0.0 109.135 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' F' ' 28' ' ' PRO . 90.6 t -77.71 -41.47 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.493 -0.754 . . . . 0.0 109.503 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.04 50.75 1.83 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.806 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.58 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.796 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 10.95 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.024 . . . . 0.0 109.504 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 33.2 t -105.07 -23.27 12.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 77.1 p -67.01 -14.73 63.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . 0.502 ' HA ' HG21 ' J' ' 2' ' ' VAL . 5.8 p -174.15 155.85 2.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.139 -0.975 . . . . 0.0 109.819 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.567 HD12 ' HB ' ' J' ' 2' ' ' VAL . 2.1 mp -62.0 126.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.481 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -94.54 -170.09 2.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -106.91 176.7 5.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -41.04 95.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -68.74 -35.75 77.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 109.9 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -36.63 77.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 18.9 mt -79.01 -21.28 47.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.905 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -13.44 56.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.953 . . . . 0.0 109.321 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.72 -16.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.525 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.1 88.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.65 135.45 8.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.395 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.642 ' HB ' HD12 ' A' ' 10' ' ' ILE . 54.8 t -90.91 -7.45 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' F' ' 4' ' ' GLN . 9.4 p30 45.81 -174.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.77 . . . . 0.0 109.657 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . 0.567 ' CB ' ' O ' ' F' ' 3' ' ' ASN . 9.5 tt0 84.19 -60.54 0.11 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.641 -0.662 . . . . 0.0 109.589 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -87.89 -23.84 23.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mt -97.37 -49.47 4.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 40.1 t -59.01 -37.37 76.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -30.09 58.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.21 -15.21 62.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.325 -1.103 . . . . 0.0 109.428 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -89.18 -36.45 15.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 mt -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.036 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 m -49.86 -34.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.105 -0.997 . . . . 0.0 109.633 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -76.22 -44.84 35.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.978 . . . . 0.0 109.408 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.09 10.32 6.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.405 HD11 HD13 ' E' ' 2' ' ' ILE . 1.4 mt -96.06 -57.2 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.085 -1.009 . . . . 0.0 109.831 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 10.9 p90 -69.53 -30.54 68.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.378 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 0.1 OUTLIER -62.57 -53.43 54.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.64 -32.56 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' F' ' 20' ' ' GLY . 1.3 m -114.21 53.72 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' F' ' 22' ' ' ARG . . . -57.85 -118.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' F' ' 22' ' ' ARG . 25.4 mt-10 -40.53 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -1.012 . . . . 0.0 109.952 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' F' ' 20' ' ' GLY . 4.3 mtt180 164.56 -49.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.73 27.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -166.92 174.93 8.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -1.125 . . . . 0.0 109.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -128.41 152.58 48.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -130.89 106.98 8.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -139.25 98.36 8.3 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . 0.485 ' HB3' HG21 ' E' ' 3' ' ' VAL . 33.0 Cg_endo -74.97 86.03 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.416 2.077 . . . . 0.0 110.554 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -154.48 135.6 13.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . 0.495 ' C ' ' O ' ' F' ' 29' ' ' LYS . 71.5 p . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt -98.23 -25.58 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -1.156 . . . . 0.0 109.125 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . 0.588 HG21 ' HB3' ' H' ' 28' ' ' PRO . 61.4 t -76.15 -42.94 37.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.461 -0.775 . . . . 0.0 109.417 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 51.64 2.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.336 -0.853 . . . . 0.0 109.684 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.98 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 109.723 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 9.65 19.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.692 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -103.64 -23.15 13.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.95 . . . . 0.0 109.818 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 74.5 p -66.92 -14.97 63.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -173.18 160.26 4.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . 0.556 HD12 ' HB ' ' D' ' 2' ' ' VAL . 1.6 mp -66.34 128.46 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.095 -1.003 . . . . 0.0 109.368 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -94.21 -167.97 1.77 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.37 179.37 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.465 -0.772 . . . . 0.0 109.305 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.44 -41.32 80.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -68.68 -34.65 76.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -36.4 80.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.84 -21.28 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.243 -0.911 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -83.63 -9.02 59.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.634 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.97 -16.49 59.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.135 -0.978 . . . . 0.0 109.237 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.77 90.91 2.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -165.16 131.6 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.9 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.314 0.578 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.632 ' HB ' HD12 ' K' ' 10' ' ' ILE . 54.3 t -92.95 -6.71 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' H' ' 4' ' ' GLN . 9.9 p30 44.92 -173.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.52 -0.738 . . . . 0.0 110.031 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' H' ' 3' ' ' ASN . 9.0 tt0 83.78 -60.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.754 -0.591 . . . . 0.0 109.677 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -87.95 -23.78 23.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.25 -0.906 . . . . 0.0 109.06 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.3 -50.14 4.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.209 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.0 -40.23 80.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.07 -29.97 66.05 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -12.66 55.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.131 . . . . 0.0 109.492 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -93.58 -34.03 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -0.846 . . . . 0.0 109.665 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 14.0 mt -74.44 -39.25 62.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 0.0 109.707 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 m -48.21 -37.57 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.129 -0.982 . . . . 0.0 109.387 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.24 -46.26 51.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.09 7.81 10.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.384 -0.823 . . . . 0.0 109.634 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -93.36 -55.99 3.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.0 110.096 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' H' ' 17' ' ' LEU . 14.0 p90 -70.45 -31.23 68.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.624 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' H' ' 16' ' ' TYR . 0.1 OUTLIER -60.82 -53.76 53.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.509 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.19 -30.65 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 109.748 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.21 46.66 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . -66.69 170.27 32.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' H' ' 20' ' ' GLY . 33.8 mt-10 35.5 71.4 0.12 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.661 -0.905 . . . . 0.0 110.078 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 175.32 -48.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.18 -0.95 . . . . 0.0 109.34 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.47 169.74 27.9 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -168.0 169.29 11.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -122.78 145.39 48.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 109.547 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.91 105.57 9.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -137.48 98.97 9.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.415 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . 0.588 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.5 Cg_endo -77.84 86.68 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.538 2.159 . . . . 0.0 110.778 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -135.91 -129.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 109.055 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.578 -1.327 . . . . 0.0 109.519 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 tt -99.02 -26.68 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . 0.558 HG21 ' HB3' ' J' ' 28' ' ' PRO . 87.8 t -75.96 -40.59 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.64 53.61 2.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -176.28 -32.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.36 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 12.3 15.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.011 . . . . 0.0 109.86 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.73 -19.56 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -70.09 -13.48 62.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.031 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . 0.519 ' HA ' ' CG2' ' B' ' 2' ' ' VAL . 52.5 p -174.39 156.89 2.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.478 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.548 HD12 ' HB ' ' B' ' 2' ' ' VAL . 1.8 mp -63.32 128.23 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.248 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -93.23 -165.59 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 3.7 m -110.37 -177.22 3.18 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.248 -0.908 . . . . 0.0 109.042 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -41.21 68.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -68.16 -35.14 77.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -35.79 76.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.9 mt -81.19 -19.7 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.99 -10.78 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.92 -17.61 52.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.288 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.57 89.29 2.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 0.0 109.53 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.54 134.21 6.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.234 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.377 0.608 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.567 ' HB ' HD12 ' E' ' 10' ' ' ILE . 53.1 t -91.65 -7.34 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' J' ' 4' ' ' GLN . 9.1 p30 45.51 -174.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 0.0 110.011 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' J' ' 3' ' ' ASN . 8.9 tt0 83.61 -61.48 0.11 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.705 -0.622 . . . . 0.0 109.823 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . 0.478 ' CB ' HG12 ' E' ' 10' ' ' ILE . 36.5 t60 -86.83 -21.23 26.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.162 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.02 -52.33 3.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.103 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.4 t -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.11 -32.33 63.18 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -67.34 -10.55 52.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -1.187 . . . . 0.0 109.543 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -93.7 -34.24 13.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.176 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.91 -41.74 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.455 -0.778 . . . . 0.0 109.711 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 15.3 m -45.88 -38.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.803 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.94 -44.17 61.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.017 -1.052 . . . . 0.0 109.829 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' D' ' 17' ' ' LEU . . . -84.68 13.92 5.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.37 -54.86 2.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.8 p90 -72.62 -29.54 63.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 0.1 OUTLIER -63.79 -52.14 61.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 109.171 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.97 -32.2 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.406 -0.809 . . . . 0.0 109.221 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' J' ' 20' ' ' GLY . 1.1 m -113.72 54.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.078 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . -57.85 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' J' ' 22' ' ' ARG . 26.0 mt-10 -40.76 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -1.15 . . . . 0.0 110.024 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' J' ' 20' ' ' GLY . 3.6 mtt180 165.58 -47.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.848 . . . . 0.0 109.338 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.8 169.42 33.85 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -164.44 172.95 12.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -1.163 . . . . 0.0 109.784 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -122.53 151.75 41.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.166 -0.959 . . . . 0.0 109.251 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -133.59 108.17 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -142.41 96.46 6.34 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' I' ' 3' ' ' VAL . 34.4 Cg_endo -76.69 93.96 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.353 2.035 . . . . 0.0 110.593 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -141.03 -119.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.353 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 120.659 -1.275 . . . . 0.0 109.652 -179.768 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 tt -98.17 -27.6 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.163 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' L' ' 28' ' ' PRO . 94.9 t -74.72 -41.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.443 -0.786 . . . . 0.0 109.682 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.0 OUTLIER -91.98 56.96 3.02 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.937 -1.102 . . . . 0.0 109.489 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 1.3 tt0 179.94 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 10.85 15.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -107.23 -19.81 13.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 0.0 108.948 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -68.97 -14.23 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 109.009 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 78.1 p -175.25 156.06 2.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.815 . . . . 0.0 109.31 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . 0.632 HD12 ' HB ' ' H' ' 2' ' ' VAL . 1.4 mp -63.18 129.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -95.02 -170.71 2.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.855 . . . . 0.0 109.455 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.85 177.33 4.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.401 -0.812 . . . . 0.0 109.144 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -42.89 88.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.543 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -65.97 -37.57 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.102 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -35.36 73.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.75 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.769 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.28 -12.11 55.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -18.39 44.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.327 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.55 91.06 2.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.4 137.13 5.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.506 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.42 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.42 0.629 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.673 ' HB ' HD12 ' C' ' 10' ' ' ILE . 55.6 t -89.35 -7.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.443 -0.786 . . . . 0.0 109.929 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' L' ' 4' ' ' GLN . 10.8 p30 45.22 -173.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' L' ' 3' ' ' ASN . 9.1 tt0 83.84 -59.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.674 -0.641 . . . . 0.0 109.502 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . 0.452 ' HB3' HG12 ' C' ' 10' ' ' ILE . 33.8 t60 -89.14 -20.34 24.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 mt -101.63 -49.33 4.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -0.793 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -59.03 -32.92 70.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 108.826 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.03 -34.05 34.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -11.14 31.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -1.119 . . . . 0.0 109.272 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -93.76 -32.18 14.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.01 -39.33 50.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.476 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -47.82 -36.03 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.561 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.94 -44.51 48.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 109.293 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.93 15.03 4.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.334 -0.854 . . . . 0.0 109.687 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.42 -53.74 3.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.041 -1.037 . . . . 0.0 109.533 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.555 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 9.4 p90 -73.98 -27.1 60.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 0.1 OUTLIER -66.14 -50.1 65.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.267 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -70.04 -29.04 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.1 49.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.575 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . -70.45 167.91 49.34 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' L' ' 20' ' ' GLY . 31.1 mt-10 39.09 71.39 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.505 -0.997 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 173.21 -43.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.826 . . . . 0.0 108.93 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.48 174.23 35.48 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.12 172.33 7.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -1.138 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 17.8 p90 -125.0 145.31 49.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -127.84 109.15 11.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -0.928 . . . . 0.0 109.358 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 9.8 m -142.55 98.22 5.93 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 0.0 109.201 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.4 Cg_endo -78.66 93.9 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.369 2.046 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -139.77 -115.18 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 109.523 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 109.544 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 2' ' ' ILE . 49.7 mt -99.42 25.29 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -1.16 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 60.0 t -114.56 -47.43 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -95.47 47.45 1.12 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -168.23 -35.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.336 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 9' ' ' SER . 99.1 m -108.11 -32.31 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.655 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -69.4 -19.18 63.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 0.0 109.697 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -105.75 -7.31 18.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 5.1 p -168.08 132.35 1.7 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.426 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -52.49 138.4 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.7 m -104.39 149.6 25.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.24 158.17 29.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -29.51 58.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.782 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -64.97 -43.47 92.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.477 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -73.87 -23.55 59.62 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.42 0.4 53.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.238 -0.914 . . . . 0.0 109.967 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -90.86 -26.08 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.735 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -83.01 -7.67 59.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.932 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -90.85 15.61 10.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.65 160.16 15.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.484 -179.891 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 11.2 p90 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.414 ' H ' HG12 ' B' ' 2' ' ' VAL . 2.5 p -60.96 123.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.27 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 175.55 -36.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.163 -0.96 . . . . 0.0 108.935 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -80.34 -42.32 23.16 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.369 -0.832 . . . . 0.0 109.276 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -58.89 -23.55 61.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -101.5 -24.45 14.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 51.1 t -75.26 -17.24 60.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.75 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -91.41 -21.87 33.53 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -81.01 -18.76 45.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -1.14 . . . . 0.0 109.302 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.445 ' ND1' HD22 ' F' ' 6' ' ' LEU . 20.1 m-70 -85.56 -18.86 32.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.624 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 9.9 mt -93.69 -34.71 13.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.75 HG13 ' O ' ' B' ' 8' ' ' GLY . 34.0 m -60.58 -36.02 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 110.037 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.401 ' N ' HG23 ' B' ' 12' ' ' VAL . 0.8 OUTLIER -73.63 -27.91 61.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.931 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.33 17.56 17.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.163 -0.96 . . . . 0.0 109.864 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 2' ' ' ILE . 1.7 mt -114.98 -56.52 2.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.836 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -64.26 -23.65 67.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.478 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 19.7 tp -74.5 -40.25 61.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.2 -0.937 . . . . 0.0 109.306 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 71.4 t -54.69 -72.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.907 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.61 -42.6 88.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.08 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.34 -97.68 0.78 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.72 -56.54 20.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -1.143 . . . . 0.0 109.514 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -53.28 154.83 3.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.72 -167.69 27.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -170.01 169.18 8.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -1.13 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.648 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 42.1 p90 -127.78 148.66 50.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.474 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' B' ' 28' ' ' PRO . 30.5 t80 -128.29 113.57 15.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.81 92.11 13.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.482 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' B' ' 26' ' ' TYR . 36.1 Cg_endo -78.96 81.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.909 2.406 . . . . 0.0 110.515 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -133.14 112.25 11.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.089 -1.007 . . . . 0.0 109.946 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.242 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' C' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' C' ' 1' ' ' GLY . 20.4 mt 71.21 -1.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -1.231 . . . . 0.0 110.196 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 61.7 t -106.24 -49.03 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.971 -1.08 . . . . 0.0 108.917 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 44.84 1.03 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.431 -0.793 . . . . 0.0 109.239 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -165.57 -35.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' C' ' 9' ' ' SER . 93.1 m -108.27 -30.31 8.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.3 OUTLIER -71.47 -19.09 62.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 109.388 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 -6.55 19.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.726 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 6' ' ' CYS . 2.6 p -169.16 130.36 1.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.087 -1.008 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -50.44 138.08 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.647 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -104.37 149.02 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.054 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.67 159.04 29.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.14 -30.75 60.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.2 -42.2 96.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.979 . . . . 0.0 109.702 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -74.69 -23.4 58.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 72.1 mt -96.37 4.67 52.07 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -95.24 -25.85 16.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.269 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -82.78 -9.03 59.53 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -91.58 19.23 6.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.641 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.27 158.46 17.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 109.342 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.1 p90 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.413 ' H ' HG12 ' D' ' 2' ' ' VAL . 2.5 p -59.68 122.7 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.782 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' D' ' 7' ' ' CYS . 0.5 OUTLIER 175.22 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.21 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -82.1 -39.44 23.35 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.244 -0.91 . . . . 0.0 109.131 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -62.17 -22.02 65.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.0 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -102.41 -24.39 13.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.808 . . . . 0.0 109.06 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 42.2 t -74.21 -23.22 59.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.683 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -87.29 -20.26 52.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 57.6 p -81.45 -15.24 55.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.254 . . . . 0.0 109.434 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.68 -21.16 22.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.807 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 9.2 mt -90.83 -33.25 15.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.151 -0.968 . . . . 0.0 109.754 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.683 HG13 ' O ' ' D' ' 8' ' ' GLY . 35.5 m -61.85 -35.6 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.38 -26.94 60.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.021 . . . . 0.0 109.812 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.65 19.57 14.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.133 -0.979 . . . . 0.0 109.699 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' C' ' 2' ' ' ILE . 1.6 mt -117.43 -54.75 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.55 -22.8 66.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.97 . . . . 0.0 109.595 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.678 HD21 ' CB ' ' J' ' 14' ' ' ALA . 22.9 tp -77.62 -33.83 53.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.845 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 66.9 t -60.6 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 109.885 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -63.35 -42.75 98.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.59 -96.93 0.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.75 -54.73 41.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -1.121 . . . . 0.0 109.61 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -56.2 156.5 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.894 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.34 -167.54 26.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -168.13 158.14 10.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -1.113 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . 0.648 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 19.2 m-85 -113.22 142.99 45.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 109.528 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -125.31 117.0 22.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -0.995 . . . . 0.0 109.465 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.2 92.56 6.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.748 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -79.16 81.61 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.717 2.278 . . . . 0.0 110.39 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -133.68 112.25 11.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.713 HG22 ' O ' ' E' ' 2' ' ' ILE . 53.2 mt -99.83 22.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -1.115 . . . . 0.0 109.389 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 49.0 t -113.12 -47.42 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.22 -0.925 . . . . 0.0 109.735 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.71 47.88 1.12 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.136 -0.977 . . . . 0.0 109.478 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -169.99 -32.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' E' ' 9' ' ' SER . 99.9 m -111.59 -30.48 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.39 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -72.46 -17.08 61.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.955 . . . . 0.0 109.321 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -107.3 -7.56 16.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' E' ' 6' ' ' CYS . 3.5 p -168.18 134.07 1.91 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.339 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -53.73 137.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.131 -0.98 . . . . 0.0 109.736 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 88.0 m -103.3 151.23 22.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.198 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.58 158.25 28.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.01 -29.91 61.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.221 -0.925 . . . . 0.0 109.106 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.62 -45.88 85.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.42 -23.05 61.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -0.872 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.35 -0.62 49.19 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -0.939 . . . . 0.0 110.05 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -89.31 -24.8 21.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.705 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.67 -7.04 59.38 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.109 -0.995 . . . . 0.0 109.889 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.11 20.14 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.138 -0.976 . . . . 0.0 109.17 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.8 158.28 18.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.372 -0.83 . . . . 0.0 109.335 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.595 -179.829 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.6 p90 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.04 124.45 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.32 -35.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -80.15 -43.35 21.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.363 -0.836 . . . . 0.0 108.915 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -58.09 -23.03 53.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.664 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.445 HD22 ' ND1' ' B' ' 10' ' ' HIS . 10.4 mt -101.46 -27.27 13.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 108.997 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.485 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 46.8 t -72.65 -20.22 61.29 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.597 -0.689 . . . . 0.0 109.511 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.678 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -88.83 -22.55 38.76 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 27.6 p -80.66 -17.04 52.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -1.123 . . . . 0.0 109.42 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . 0.716 ' ND1' HD22 ' J' ' 6' ' ' LEU . 14.5 m-70 -87.54 -18.18 30.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 9.8 mt -94.58 -32.67 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.678 HG13 ' O ' ' F' ' 8' ' ' GLY . 36.0 m -62.83 -35.04 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.856 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -26.59 59.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.53 18.38 16.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.549 HD11 HD13 ' E' ' 2' ' ' ILE . 1.7 mt -116.15 -55.89 2.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.065 -1.022 . . . . 0.0 109.617 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -64.27 -23.12 67.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.694 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 26.9 tp -77.86 -33.85 52.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.49 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 109.78 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.21 -44.09 97.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.15 -0.969 . . . . 0.0 109.7 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.93 -96.82 0.88 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.56 -55.71 30.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -1.114 . . . . 0.0 109.575 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -55.12 156.55 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 0.0 109.592 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -166.85 28.57 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.62 161.84 6.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -1.093 . . . . 0.0 108.981 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -122.29 151.18 41.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.026 -1.046 . . . . 0.0 109.589 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . 0.422 ' CE2' ' HG3' ' F' ' 28' ' ' PRO . 33.8 t80 -129.66 118.17 21.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.512 HG23 ' HA3' ' H' ' 23' ' ' GLY . 0.3 OUTLIER -142.33 91.27 7.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 109.352 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . 0.422 ' HG3' ' CE2' ' F' ' 26' ' ' TYR . 35.6 Cg_endo -78.52 82.19 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.646 2.231 . . . . 0.0 110.359 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.67 110.81 10.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 109.534 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . 0.698 HG22 ' O ' ' G' ' 2' ' ' ILE . 46.3 mt -99.13 23.34 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' G' ' 7' ' ' CYS . 58.0 t -112.45 -48.76 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.87 46.12 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -167.37 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' G' ' 9' ' ' SER . 85.6 m -110.07 -27.79 9.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' G' ' 3' ' ' VAL . 22.7 t -72.04 -22.48 61.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 15.0 t -103.27 -6.16 22.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.455 -0.778 . . . . 0.0 109.695 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' G' ' 6' ' ' CYS . 2.2 p -169.32 132.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -52.22 137.4 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.365 -0.834 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 83.5 m -104.01 150.35 24.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.257 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.39 159.9 30.06 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -31.82 66.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.075 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -61.6 -46.57 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.418 -0.801 . . . . 0.0 109.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -72.33 -20.98 61.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 76.0 mt -96.85 -2.62 43.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.103 -0.998 . . . . 0.0 109.792 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -89.02 -24.74 22.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -82.91 -8.26 59.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 0.0 109.837 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -90.91 12.97 17.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.456 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.01 163.0 12.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.611 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.568 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.423 ' O ' HG13 ' H' ' 2' ' ' VAL . 2.6 p -59.08 121.18 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.22 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.93 -43.67 29.21 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.181 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -57.14 -23.72 49.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.553 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . 0.553 HD22 ' ND1' ' L' ' 10' ' ' HIS . 10.8 mt -100.86 -26.08 13.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 109.223 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.457 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 15.4 t -73.74 -20.22 60.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.469 -0.769 . . . . 0.0 109.706 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . 0.709 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -88.77 -20.2 48.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 87.9 p -82.04 -16.3 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -1.059 . . . . 0.0 109.508 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -89.6 -16.21 31.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 8.0 mt -96.61 -33.42 11.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.473 -0.767 . . . . 0.0 109.547 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.709 HG13 ' O ' ' H' ' 8' ' ' GLY . 35.2 m -62.96 -29.98 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -25.87 43.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.454 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.7 22.46 11.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . 0.61 HD11 HD13 ' G' ' 2' ' ' ILE . 1.9 mt -120.15 -54.19 2.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.523 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.58 -24.2 66.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.612 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 20.7 tp -77.22 -36.5 54.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.195 -0.94 . . . . 0.0 109.583 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.32 -67.41 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.932 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' H' ' 22' ' ' ARG . 43.7 m -66.97 -39.99 87.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.985 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.26 -103.37 1.07 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -50.9 -63.55 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -1.221 . . . . 0.0 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' H' ' 19' ' ' CYS . 6.9 mtt-85 -49.08 154.35 0.79 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.361 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.512 ' HA3' HG23 ' F' ' 27' ' ' THR . . . -101.42 -170.57 28.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.57 170.45 15.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 109.525 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -128.34 150.4 50.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . 0.418 ' CE2' ' HG3' ' H' ' 28' ' ' PRO . 31.8 t80 -131.99 118.55 19.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.55 89.86 7.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.583 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . 0.418 ' HG3' ' CE2' ' H' ' 26' ' ' TYR . 34.4 Cg_endo -76.47 82.64 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.72 2.28 . . . . 0.0 110.487 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.18 111.78 9.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.368 -0.833 . . . . 0.0 109.194 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.553 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.694 HG22 ' O ' ' I' ' 2' ' ' ILE . 49.6 mt -98.02 24.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -1.194 . . . . 0.0 109.314 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 57.3 t -113.46 -47.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.972 . . . . 0.0 109.57 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.01 50.49 1.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.229 -0.919 . . . . 0.0 109.33 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -172.32 -34.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.475 -0.765 . . . . 0.0 109.252 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 51.3 m -109.06 -32.61 7.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.867 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' I' ' 3' ' ' VAL . 0.5 OUTLIER -71.17 -19.49 62.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.047 . . . . 0.0 109.482 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -103.77 -6.82 21.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 p -169.51 135.66 1.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.194 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.84 145.29 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.346 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . 0.45 ' SG ' HD11 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -112.46 150.06 31.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.012 -1.055 . . . . 0.0 109.545 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.57 155.58 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.77 -30.15 31.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.739 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -63.88 -45.6 88.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -72.03 -23.97 61.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . 0.45 HD11 ' SG ' ' I' ' 11' ' ' CYS . 75.8 mt -94.88 -0.81 53.69 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -91.13 -23.66 20.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.998 . . . . 0.0 109.81 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -83.84 -9.03 59.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 109.676 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.54 15.6 10.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.12 156.59 17.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 109.67 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.215 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 9.6 p90 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.41 121.05 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.72 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.382 -0.824 . . . . 0.0 108.868 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -79.26 -40.72 29.84 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.432 -0.793 . . . . 0.0 109.5 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -61.8 -21.65 64.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 109.381 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . 0.716 HD22 ' ND1' ' F' ' 10' ' ' HIS . 8.8 mt -103.14 -22.25 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.319 -0.863 . . . . 0.0 108.928 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 46.1 t -77.64 -14.91 59.51 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.405 -0.809 . . . . 0.0 109.099 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.699 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -94.26 -19.2 33.78 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 38.4 p -83.41 -18.04 40.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.203 . . . . 0.0 109.179 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -86.02 -20.93 28.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.377 -0.827 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 9.8 mt -92.07 -33.55 14.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.954 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.699 HG13 ' O ' ' J' ' 8' ' ' GLY . 32.5 m -62.2 -36.23 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.739 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.419 ' N ' HG23 ' J' ' 12' ' ' VAL . 1.0 OUTLIER -72.76 -27.11 61.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.957 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . 0.678 ' CB ' HD21 ' D' ' 17' ' ' LEU . . . -99.09 18.35 17.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 109.74 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . 0.595 HD11 HD13 ' I' ' 2' ' ' ILE . 1.4 mt -116.04 -54.15 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.984 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.19 -23.96 66.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.7 -35.19 58.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.664 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.53 -68.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.688 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.08 -44.15 97.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.647 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.92 -94.94 0.8 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.02 -57.83 10.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 109.519 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -53.23 158.68 1.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.255 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.81 -172.42 25.54 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -163.33 158.24 21.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.246 . . . . 0.0 109.714 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' L' ' 25' ' ' PHE . 42.5 p90 -116.15 147.04 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.535 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -131.08 113.07 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.618 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . 0.718 HG23 ' HA3' ' L' ' 23' ' ' GLY . 0.3 OUTLIER -138.0 92.35 12.61 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.585 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.74 81.88 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.6 2.2 . . . . 0.0 110.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.3 110.12 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.451 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . 0.715 ' O ' HG22 ' K' ' 2' ' ' ILE . 43.7 mt -97.84 26.67 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -1.195 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 54.5 t -115.18 -49.61 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 109.429 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.02 48.1 1.24 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -169.1 -35.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.684 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' K' ' 9' ' ' SER . 77.5 m -110.0 -27.34 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.99 . . . . 0.0 109.327 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 33.6 t -73.82 -19.04 60.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -106.83 -6.04 17.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 2.1 p -167.67 135.43 2.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 109.181 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -55.89 139.81 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 109.362 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 99.7 m -105.17 147.23 28.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.723 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.17 156.9 36.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.875 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -32.69 60.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 109.501 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -61.36 -44.96 96.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -72.65 -22.22 60.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.816 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.98 2.02 51.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.241 -0.912 . . . . 0.0 109.739 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -93.31 -24.73 18.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.396 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -83.14 -9.49 59.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -90.15 15.81 9.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.5 161.99 13.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.446 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.632 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 10.0 p90 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.13 124.4 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.366 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.93 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -80.75 -40.87 24.44 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -61.31 -20.65 63.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.356 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.06 -25.03 13.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.483 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 35.2 t -74.96 -19.72 59.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.566 -0.709 . . . . 0.0 109.381 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.683 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -89.59 -20.97 42.11 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p -80.6 -18.48 48.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . 0.553 ' ND1' HD22 ' H' ' 6' ' ' LEU . 21.5 m-70 -87.32 -18.65 29.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.582 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.7 mt -94.0 -30.11 14.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.821 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.683 HG13 ' O ' ' L' ' 8' ' ' GLY . 35.3 m -66.61 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -74.34 -25.67 59.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.02 19.69 16.95 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.122 -0.986 . . . . 0.0 109.698 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . 0.584 HD11 HD13 ' K' ' 2' ' ' ILE . 1.4 mt -117.21 -54.16 2.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -65.93 -23.68 66.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -78.82 -30.37 45.28 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.262 -0.898 . . . . 0.0 109.885 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.52 -68.67 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.23 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.2 -44.47 96.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -96.79 0.94 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.73 -59.38 5.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.272 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -51.36 157.89 0.93 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.327 -0.858 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' J' ' 27' ' ' THR . . . -103.14 -166.99 25.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -171.79 155.78 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -1.107 . . . . 0.0 109.3 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' L' ' 25' ' ' PHE . 18.1 p90 -113.88 152.47 30.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.0 109.302 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -132.51 116.64 17.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 109.247 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.57 91.54 7.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.261 -0.9 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.67 80.23 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.542 2.161 . . . . 0.0 110.202 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.26 111.7 11.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' A' ' 2' ' ' ILE . 4.5 tt -118.61 18.52 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -1.166 . . . . 0.0 109.263 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 t -121.45 -7.0 9.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.35 -0.844 . . . . 0.0 109.189 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.88 -9.78 19.6 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.356 -0.84 . . . . 0.0 109.612 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -130.96 12.82 5.23 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.307 -0.87 . . . . 0.0 109.644 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -47.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.364 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.93 -15.64 59.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.3 p -97.74 -34.23 10.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 109.494 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 0.0 109.384 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.3 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.935 . . . . 0.0 109.266 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.3 m -95.81 172.51 7.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.85 167.31 10.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.22 91.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.334 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -64.67 -33.67 76.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.84 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -50.62 70.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.24 -20.13 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.12 -21.62 61.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -64.73 -25.04 67.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.457 ' CD2' HD12 ' A' ' 2' ' ' ILE . 40.4 m-85 -100.53 -25.63 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.53 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.85 119.18 8.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.599 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.535 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' I' ' 8' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.36 142.08 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.635 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 168.94 -39.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -76.19 -36.75 58.52 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.409 ' HB2' HD11 ' I' ' 10' ' ' ILE . 85.3 t60 -62.1 -37.79 86.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.185 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' J' ' 10' ' ' HIS . 9.5 mt -84.55 -23.53 29.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 108.973 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.423 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 38.7 t -69.31 -36.23 76.79 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.93 -21.48 65.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 61.3 p -77.03 -17.13 59.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.486 -1.008 . . . . 0.0 109.494 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -88.07 -24.51 23.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 10.9 mt -81.14 -39.24 25.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 m -49.99 -40.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -70.07 -40.97 74.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.005 . . . . 0.0 109.24 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.64 27.36 1.77 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.75 -48.29 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.312 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.599 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 11.6 p90 -74.38 -17.59 60.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.925 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.599 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 8.3 mt -78.81 -19.47 52.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.408 -0.808 . . . . 0.0 109.483 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.3 -50.64 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.87 -69.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.372 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.29 -106.29 3.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -62.42 -36.36 82.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -1.134 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -68.5 171.56 7.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.012 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -115.05 178.51 17.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.89 159.55 44.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -1.183 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.581 ' CD1' ' O ' ' B' ' 25' ' ' PHE . 21.5 p90 -113.45 139.42 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -123.13 114.35 20.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.36 87.67 54.6 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.28 79.01 3.42 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.588 2.192 . . . . 0.0 110.509 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -132.04 161.42 33.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.202 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.645 -179.811 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . 0.479 HD12 ' CD2' ' C' ' 19' ' ' TYR . 5.1 tt -116.61 13.84 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -116.61 -5.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.9 -4.49 22.1 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.276 -0.89 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.98 5.04 3.85 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.061 -1.025 . . . . 0.0 110.222 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.06 -42.29 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.043 . . . . 0.0 109.192 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.03 -16.01 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.535 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 71.4 p -96.59 -37.64 10.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.333 -0.854 . . . . 0.0 109.291 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 7.9 m -138.86 144.2 39.1 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' L' ' 5' ' ' HIS . 2.6 mp -53.48 138.25 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 m -102.36 159.76 15.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 109.622 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 170.98 11.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.845 . . . . 0.0 110.329 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -48.93 71.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 109.253 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -61.49 -33.43 73.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 109.241 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -47.75 81.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.725 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mt -71.97 -19.88 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.224 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.47 -22.75 61.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -63.68 -24.66 67.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.534 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.479 ' CD2' HD12 ' C' ' 2' ' ' ILE . 27.5 m-85 -100.92 -27.24 13.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.519 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -58.5 119.6 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.105 -0.997 . . . . 0.0 109.475 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.6 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.463 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 7.6 p -61.52 144.41 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 0.6 OUTLIER 165.45 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.019 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.07 -34.77 43.34 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -64.18 -37.69 88.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.384 -0.822 . . . . 0.0 108.928 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -82.39 -30.79 30.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 108.938 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.2 t -63.51 -35.48 80.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.47 -0.769 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.37 -22.34 65.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 16' ' ' TYR . 90.7 p -79.43 -17.79 53.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.221 -1.164 . . . . 0.0 109.149 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -83.37 -27.93 29.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 109.342 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 11.1 mt -78.76 -45.05 21.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.464 HG23 ' N ' ' D' ' 13' ' ' GLU . 12.8 m -43.02 -45.3 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.464 ' N ' HG23 ' D' ' 12' ' ' VAL . 11.8 mt-10 -66.08 -40.53 90.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.29 23.98 2.71 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 109.795 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.33 -48.34 2.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 9.5 p90 -73.72 -18.66 60.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.237 -0.914 . . . . 0.0 109.311 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 8.6 mt -77.51 -20.35 54.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.817 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.62 -50.21 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 45.1 m -74.77 -68.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.93 -109.72 3.87 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.59 -37.94 76.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.124 . . . . 0.0 109.316 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -68.42 161.09 28.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.812 . . . . 0.0 109.545 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.52 -175.06 25.01 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -158.19 157.66 33.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -1.219 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -111.78 142.62 43.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.331 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.49 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 39.3 t80 -127.76 115.92 19.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 89.99 47.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . 0.413 ' HD2' ' CA ' ' B' ' 23' ' ' GLY . 35.8 Cg_endo -78.63 74.42 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.733 2.289 . . . . 0.0 110.503 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -127.02 159.55 33.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.486 179.894 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.475 HD12 ' CD2' ' E' ' 19' ' ' TYR . 6.4 tt -118.0 16.32 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.272 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 t -118.47 -10.13 11.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.514 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -100.06 -10.2 21.8 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.343 -0.848 . . . . 0.0 109.851 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -129.03 15.28 6.28 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.35 -50.52 0.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -13.91 25.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.696 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 65.2 p -98.74 -34.26 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.042 -1.036 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.3 m -142.72 145.05 32.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.05 139.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -0.983 . . . . 0.0 109.752 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -97.67 171.42 8.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.775 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.23 167.03 10.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 109.367 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -47.72 85.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.265 -0.897 . . . . 0.0 109.141 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -63.76 -34.18 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 0.0 109.606 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -49.53 76.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.77 -18.65 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 0.0 109.682 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.71 -24.24 60.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -61.53 -25.41 67.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.873 . . . . 0.0 109.786 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.475 ' CD2' HD12 ' E' ' 2' ' ' ILE . 24.0 m-85 -100.59 -27.05 13.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.589 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.27 118.53 5.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.584 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.458 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.231 0.539 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 7.6 p -63.91 145.12 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 0.6 OUTLIER 165.21 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.861 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.54 -37.54 42.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.311 -0.868 . . . . 0.0 109.102 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.47 -36.42 82.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 mt -84.51 -28.68 26.56 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 44.0 t -66.0 -33.27 75.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.676 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.34 -20.21 62.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . 0.435 ' O ' ' CG2' ' F' ' 12' ' ' VAL . 5.6 p -80.08 -18.02 51.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.047 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -84.13 -26.71 28.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.106 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -78.6 -45.8 20.82 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.342 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.473 HG23 ' N ' ' F' ' 13' ' ' GLU . 13.0 m -42.95 -44.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.398 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . 0.473 ' N ' HG23 ' F' ' 12' ' ' VAL . 14.5 mt-10 -65.9 -41.31 91.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 0.0 109.941 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.81 25.74 2.28 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 0.0 109.888 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.53 -48.23 2.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.4 p90 -74.0 -17.62 60.97 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 8.4 mt -79.8 -19.53 48.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.874 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.78 -51.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.055 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.1 -69.3 0.43 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.43 -109.17 3.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -58.77 -41.6 86.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.326 -1.102 . . . . 0.0 109.342 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -63.71 163.37 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 0.0 109.733 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.11 -175.86 23.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -161.66 163.51 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.5 p90 -119.85 156.02 31.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . 0.431 ' O ' ' HD3' ' F' ' 28' ' ' PRO . 31.4 t80 -134.48 105.23 6.45 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.63 87.65 21.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . 0.501 ' HD2' ' CA ' ' H' ' 23' ' ' GLY . 35.1 Cg_endo -78.47 73.77 5.71 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.771 2.314 . . . . 0.0 110.713 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -125.88 165.14 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.519 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . 0.494 HD12 ' CD2' ' G' ' 19' ' ' TYR . 5.3 tt -113.16 13.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -1.135 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -115.53 -7.51 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 109.723 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -102.49 -11.31 18.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -128.59 16.76 6.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.108 -0.995 . . . . 0.0 109.479 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.54 -50.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.436 -0.79 . . . . 0.0 109.255 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.3 -15.66 37.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.428 -0.795 . . . . 0.0 109.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 71.2 p -97.39 -39.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 m -136.29 139.77 42.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -50.62 137.8 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 97.1 m -94.97 172.09 8.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.514 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . 0.4 ' O ' HD12 ' G' ' 16' ' ' LEU . 0.3 OUTLIER -101.26 170.73 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 108.932 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -45.96 85.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.165 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.41 -33.28 75.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -49.6 74.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . 0.4 HD12 ' O ' ' G' ' 12' ' ' SER . 2.1 mt -70.47 -19.79 62.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.553 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.85 -22.44 61.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -63.53 -29.48 70.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.033 -1.042 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . 0.494 ' CD2' HD12 ' G' ' 2' ' ' ILE . 29.4 m-85 -94.53 -31.87 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.975 . . . . 0.0 109.506 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 121.9 9.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.566 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.3 p -62.63 144.09 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 0.5 OUTLIER 166.09 -42.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.192 -0.942 . . . . 0.0 108.964 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.49 -36.61 60.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.228 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.86 -37.48 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -83.3 -28.08 29.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.092 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 16.8 t -66.55 -33.5 75.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.681 . . . . 0.0 109.233 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.65 56.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 3.5 p -75.45 -18.0 60.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -1.081 . . . . 0.0 109.571 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -84.52 -24.76 29.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.823 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 11.0 mt -82.54 -42.33 18.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.426 HG23 ' N ' ' H' ' 13' ' ' GLU . 12.0 m -45.68 -43.02 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.333 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . 0.426 ' N ' HG23 ' H' ' 12' ' ' VAL . 12.7 mt-10 -66.66 -42.91 85.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.4 26.39 1.46 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.887 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.42 -47.25 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.045 . . . . 0.0 109.37 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.587 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 8.9 p90 -74.92 -16.68 60.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 7.9 mt -80.33 -19.92 45.42 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.489 -0.757 . . . . 0.0 109.397 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.1 t -79.41 -52.29 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.265 -0.897 . . . . 0.0 109.428 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.36 -65.7 0.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.2 -105.66 3.26 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.71 -39.73 92.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -1.204 . . . . 0.0 109.405 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.94 165.9 12.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.501 ' CA ' ' HD2' ' F' ' 28' ' ' PRO . . . -109.97 -176.75 21.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -159.05 153.51 24.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.409 -1.054 . . . . 0.0 109.347 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' H' ' 25' ' ' PHE . 37.5 p90 -110.79 141.33 44.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.263 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.99 118.88 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.93 . . . . 0.0 109.447 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.5 87.69 49.42 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.611 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.94 77.79 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.644 2.23 . . . . 0.0 110.678 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -129.13 160.44 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.545 179.915 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.467 HD12 ' CD2' ' I' ' 19' ' ' TYR . 4.2 tt -122.14 15.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -1.207 . . . . 0.0 109.38 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 t -118.73 -3.13 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.299 -0.875 . . . . 0.0 109.311 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.71 -6.14 17.0 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -130.92 2.04 4.35 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 109.79 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 50.9 m -127.15 -39.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -69.46 -13.62 62.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.99 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . 0.508 ' O ' ' HB3' ' B' ' 1' ' ' PHE . 67.3 p -102.19 -20.72 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.605 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -153.64 138.09 16.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 109.358 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 5' ' ' HIS . 2.3 mp -50.18 138.08 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 109.014 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.0 m -102.26 161.1 13.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . 0.422 ' O ' HD12 ' I' ' 16' ' ' LEU . 0.3 OUTLIER -89.55 170.92 10.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.341 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -49.41 72.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.542 -0.724 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -60.42 -35.07 74.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.18 -48.69 78.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.577 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . 0.422 HD12 ' O ' ' I' ' 12' ' ' SER . 2.1 mt -72.39 -15.36 61.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.266 -0.896 . . . . 0.0 109.736 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -61.59 -29.91 70.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . 0.467 ' CD2' HD12 ' I' ' 2' ' ' ILE . 28.3 m-85 -96.21 -30.3 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.705 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.16 118.86 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.495 179.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.262 0.554 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 7.3 p -64.21 145.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 0.6 OUTLIER 165.3 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -77.99 -38.1 45.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.217 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.32 -35.29 78.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -0.853 . . . . 0.0 108.916 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -85.33 -27.46 25.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 12.9 t -67.23 -33.95 76.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.793 . . . . 0.0 109.42 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.91 -22.67 60.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 93.3 p -77.28 -16.99 58.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -1.026 . . . . 0.0 109.322 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . 0.489 ' CG ' HD22 ' B' ' 6' ' ' LEU . 10.3 m-70 -88.02 -21.65 24.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.892 . . . . 0.0 109.665 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.8 mt -84.02 -38.97 20.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.409 HG23 ' N ' ' J' ' 13' ' ' GLU . 11.8 m -49.67 -40.61 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.409 ' N ' HG23 ' J' ' 12' ' ' VAL . 11.8 mt-10 -69.44 -40.52 77.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.2 27.81 1.8 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.381 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.56 -46.41 2.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.594 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 12.6 p90 -76.22 -16.22 59.87 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.056 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 7.9 mt -80.83 -17.37 51.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.499 -0.75 . . . . 0.0 109.792 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -82.69 -49.42 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -63.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 109.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.74 -105.95 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -61.05 -39.12 88.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -66.63 157.51 32.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.936 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -175.87 29.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -161.1 157.9 26.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.058 -1.26 . . . . 0.0 109.726 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -115.97 142.68 46.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.76 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -122.67 119.25 30.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.406 -0.809 . . . . 0.0 109.121 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 87.38 53.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.72 77.84 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.628 2.218 . . . . 0.0 110.679 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -128.93 160.54 32.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.342 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' K' ' 2' ' ' ILE . 6.2 tt -117.66 17.22 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.316 -1.108 . . . . 0.0 109.718 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 t -119.94 -8.42 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.63 -10.37 21.0 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.279 -0.888 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -130.94 16.44 5.18 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.56 -47.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.314 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -16.09 56.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.196 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 66.9 p -96.04 -41.33 8.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.823 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 75.3 m -134.35 144.41 48.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.142 -0.974 . . . . 0.0 109.721 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.43 137.22 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.29 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.83 169.38 10.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 109.887 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.03 167.49 10.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.38 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -46.44 90.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.387 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.61 -35.0 79.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -49.06 78.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 109.598 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.23 -18.34 62.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.931 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.45 -23.12 60.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 109.188 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.576 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . 0.431 ' CD2' HD12 ' K' ' 2' ' ' ILE . 24.1 m-85 -99.33 -27.82 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.08 120.94 8.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.486 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' C' ' 8' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.264 0.554 . . . . 0.0 109.587 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 7.3 p -63.14 143.86 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.013 -1.055 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 0.6 OUTLIER 167.27 -39.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.017 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -77.07 -39.89 48.16 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.374 -0.829 . . . . 0.0 108.81 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . 0.666 ' HB2' HD11 ' C' ' 10' ' ' ILE . 86.3 t60 -60.67 -36.61 79.16 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.8 mt -84.01 -29.34 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.448 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 40.7 t -66.12 -32.68 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.578 -0.701 . . . . 0.0 109.595 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.44 -26.7 53.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . 0.41 ' O ' HG22 ' L' ' 12' ' ' VAL . 59.9 p -74.01 -19.74 60.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.48 -1.012 . . . . 0.0 109.329 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -83.78 -23.28 31.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 0.0 109.564 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 10.5 mt -82.55 -42.65 18.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 109.566 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.41 HG22 ' O ' ' L' ' 9' ' ' SER . 13.9 m -46.49 -40.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -70.36 -40.21 74.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.89 21.46 3.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 109.666 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -49.28 2.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.561 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 11.5 p90 -73.05 -17.3 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.962 . . . . 0.0 109.695 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 8.4 mt -79.01 -19.51 51.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.684 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.49 -50.79 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 57.1 m -73.83 -68.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.35 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.82 -108.38 3.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.93 -38.22 85.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -1.169 . . . . 0.0 109.217 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -67.44 160.53 27.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.433 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.62 -175.46 24.91 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -155.33 170.5 21.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -125.57 136.71 53.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.968 -1.083 . . . . 0.0 109.315 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -120.16 117.08 26.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.74 87.16 50.35 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.483 -0.761 . . . . 0.0 109.307 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.99 79.14 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.593 2.196 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -130.07 161.39 31.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 0.0 109.312 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.414 179.872 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.483 HD13 HD11 ' B' ' 15' ' ' LEU . 51.4 mt -87.27 -27.65 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.88 -27.95 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.209 -0.932 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 55.01 0.65 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.22 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.37 -36.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.2 m -101.66 -32.22 10.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.339 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.454 ' O ' HG12 ' F' ' 2' ' ' VAL . 1.7 m -68.89 -32.04 71.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 108.975 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.7 p -88.45 -16.1 33.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.416 -0.803 . . . . 0.0 109.45 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 10' ' ' ILE . 1.4 p -169.49 121.15 0.71 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.444 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 9' ' ' SER . 3.1 mt -44.61 107.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.14 154.96 21.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.299 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -71.99 167.56 19.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.708 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.23 -38.33 85.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.713 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.8 -43.07 94.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.873 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -63.84 -39.6 94.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.4 mt -77.16 -15.17 59.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -78.09 -22.51 48.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -85.35 17.39 3.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.24 -13.7 12.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.116 -0.99 . . . . 0.0 109.299 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.88 156.99 25.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.84 . . . . 0.0 109.193 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.509 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.239 0.542 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.3 150.64 6.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.137 -0.977 . . . . 0.0 109.055 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 173.32 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.006 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -74.61 -32.67 62.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.174 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -69.03 -39.37 79.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.08 -23.48 35.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.484 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 42.4 t -74.57 -34.91 63.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.429 -0.794 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.99 -16.01 80.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.89 -19.95 28.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 109.413 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.736 ' CG ' HD22 ' F' ' 6' ' ' LEU . 10.9 m-70 -83.97 -15.07 49.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 12.9 mt -91.98 -49.71 6.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.756 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.454 HG23 ' N ' ' B' ' 13' ' ' GLU . 9.0 m -46.56 -45.18 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 109.415 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.454 ' N ' HG23 ' B' ' 12' ' ' VAL . 67.4 mt-10 -62.03 -42.79 99.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.378 -0.826 . . . . 0.0 109.797 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.49 ' CB ' ' H5 ' ' B' ' 32' ' ' IPH . . . -88.54 22.67 2.49 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.173 -0.955 . . . . 0.0 109.631 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.483 HD11 HD13 ' A' ' 2' ' ' ILE . 0.7 OUTLIER -115.89 -58.41 2.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.903 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -59.46 -27.86 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.197 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.03 -42.68 80.24 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.444 -0.785 . . . . 0.0 109.554 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 86.8 t -54.56 -47.99 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -61.44 2.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' B' ' 21' ' ' GLU . . . 103.65 40.04 2.43 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' B' ' 20' ' ' GLY . 3.0 tt0 78.86 49.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.434 -1.039 . . . . 0.0 109.419 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.21 -54.81 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.947 . . . . 0.0 109.581 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.02 152.38 5.7 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -163.52 159.87 22.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -119.81 143.24 47.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.601 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 40.2 t80 -119.71 104.7 10.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.103 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -132.07 97.92 17.89 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.76 113.15 3.59 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.504 2.136 . . . . 0.0 110.637 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -168.17 158.25 10.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.438 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.488 HD13 HD11 ' D' ' 15' ' ' LEU . 46.0 mt -90.17 -28.37 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 109.316 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.49 -29.45 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.98 53.11 0.71 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.287 -0.883 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.34 -36.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' C' ' 9' ' ' SER . 63.3 m -101.62 -33.62 9.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.357 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -68.1 -30.51 69.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.904 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 75.0 p -89.82 -17.26 28.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.317 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . 0.413 ' O ' ' C ' ' C' ' 10' ' ' ILE . 1.3 p -167.82 120.34 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' C' ' 9' ' ' SER . 3.1 mt -44.29 108.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 80.1 m -60.22 155.98 16.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.7 t -72.68 165.83 24.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.11 -37.63 86.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.968 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.24 -44.5 88.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.884 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . 0.464 ' HA ' ' ND2' ' C' ' 18' ' ' ASN . 27.8 mt-30 -61.6 -40.98 96.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 0.0 109.36 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 47.0 mt -74.62 -17.2 60.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 109.828 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.11 -18.79 52.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.011 -1.055 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' C' ' 15' ' ' GLN . 26.8 p30 -88.24 16.34 6.39 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.117 -0.99 . . . . 0.0 109.47 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -112.26 -12.95 13.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.51 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.22 152.56 25.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.552 -179.921 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.63 HG23 HD11 ' G' ' 10' ' ' ILE . 7.3 p -60.18 152.31 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.223 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' D' ' 7' ' ' CYS . 3.9 m-20 170.92 -38.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.377 -0.827 . . . . 0.0 109.219 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -75.36 -31.02 60.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -70.18 -40.36 74.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 0.0 109.143 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -81.87 -22.35 36.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.415 -0.803 . . . . 0.0 109.06 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 49.9 t -75.34 -34.53 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.39 -0.819 . . . . 0.0 109.674 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.08 -16.95 80.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.85 -19.6 32.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -1.041 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . 0.704 ' CG ' HD22 ' L' ' 6' ' ' LEU . 15.5 m-70 -85.57 -13.91 47.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.298 -0.876 . . . . 0.0 109.137 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 13.8 mt -92.04 -52.72 4.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.836 . . . . 0.0 109.449 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.527 HG23 ' N ' ' D' ' 13' ' ' GLU . 11.5 m -43.79 -48.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.244 -0.91 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.527 ' N ' HG23 ' D' ' 12' ' ' VAL . 82.3 mt-10 -58.71 -43.74 90.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.865 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.467 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -88.65 23.5 2.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.237 -0.914 . . . . 0.0 110.071 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.488 HD11 HD13 ' C' ' 2' ' ' ILE . 0.8 OUTLIER -115.56 -59.28 2.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' D' ' 13' ' ' GLU . 16.5 p90 -58.42 -27.4 64.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.36 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' D' ' 17' ' ' LEU . 4.9 mt -68.14 -43.1 79.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.385 -0.822 . . . . 0.0 109.586 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -55.21 -47.77 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -60.25 3.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' D' ' 21' ' ' GLU . . . 101.23 40.55 2.79 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' D' ' 20' ' ' GLY . 1.9 tt0 79.55 50.81 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.434 -1.039 . . . . 0.0 109.867 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.15 -51.9 1.53 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.41 150.49 6.02 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 30.0 p90 -155.28 172.46 18.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.31 -1.112 . . . . 0.0 109.364 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' D' ' 25' ' ' PHE . 12.8 m-85 -129.12 139.03 52.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.277 -0.889 . . . . 0.0 109.37 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -120.97 99.42 6.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.577 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 32.4 m -126.48 100.61 28.7 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.401 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.85 110.93 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.569 2.179 . . . . 0.0 110.543 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -167.18 155.75 9.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.379 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.517 HD13 HD11 ' F' ' 15' ' ' LEU . 50.5 mt -87.11 -27.37 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.5 -28.01 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.319 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -108.04 53.22 0.69 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.275 -0.891 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.78 -34.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.344 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' E' ' 2' ' ' ILE . 64.3 m -102.63 -30.28 11.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.221 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 4.8 t -70.31 -33.61 71.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.339 -0.851 . . . . 0.0 109.306 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 62.9 p -87.67 -15.74 36.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . 0.437 ' O ' ' C ' ' E' ' 10' ' ' ILE . 76.7 p -169.19 117.97 0.66 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.227 -0.92 . . . . 0.0 109.34 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.509 HD11 HG23 ' J' ' 2' ' ' VAL . 3.1 mt -42.25 106.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.06 155.19 14.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.726 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 27.7 t -70.57 168.86 15.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.483 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -69.43 -37.13 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -64.74 -47.12 79.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.362 -0.836 . . . . 0.0 109.475 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . 0.445 ' HA ' ' ND2' ' E' ' 18' ' ' ASN . 28.1 mt-30 -60.54 -39.66 88.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.899 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 43.1 mt -76.47 -17.97 59.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.288 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -76.99 -18.96 57.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 109.908 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' E' ' 15' ' ' GLN . 27.5 p30 -89.07 13.81 12.17 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.04 -1.038 . . . . 0.0 110.002 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -109.03 -13.38 14.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.04 -1.037 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 153.42 27.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.865 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.289 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 7' ' ' CYS . 10.0 p -58.26 149.97 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 174.32 -41.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -72.89 -27.93 62.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -72.84 -40.01 66.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.039 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.736 HD22 ' CG ' ' B' ' 10' ' ' HIS . 6.6 mt -82.46 -19.8 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.401 -0.812 . . . . 0.0 108.989 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.422 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 42.3 t -75.68 -38.61 58.58 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.523 -0.735 . . . . 0.0 109.472 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.04 -15.17 79.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -21.4 29.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.18 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -82.57 -18.58 40.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.43 -0.794 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.9 mt -89.14 -49.86 6.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.746 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.489 HG23 ' N ' ' F' ' 13' ' ' GLU . 12.4 m -46.65 -45.81 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.111 -0.993 . . . . 0.0 109.553 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.489 ' N ' HG23 ' F' ' 12' ' ' VAL . 79.4 mt-10 -62.44 -40.61 97.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.523 ' CB ' ' H5 ' ' E' ' 22' ' ' IPH . . . -91.03 25.06 2.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.87 . . . . 0.0 109.566 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.517 HD11 HD13 ' E' ' 2' ' ' ILE . 0.7 OUTLIER -117.97 -58.85 1.97 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.532 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -59.34 -27.73 66.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.297 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' F' ' 17' ' ' LEU . 5.3 mt -68.07 -43.51 78.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.33 -0.857 . . . . 0.0 109.493 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.06 -51.51 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 109.402 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -47.8 -62.23 1.56 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.271 -0.893 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' F' ' 21' ' ' GLU . . . 103.63 40.42 2.36 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' F' ' 20' ' ' GLY . 2.2 tt0 79.65 49.51 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -1.046 . . . . 0.0 109.788 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -123.53 -46.8 2.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.04 -1.038 . . . . 0.0 109.563 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.22 153.14 7.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -162.81 175.68 11.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.244 . . . . 0.0 109.52 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 2.4 p90 -132.76 158.18 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.383 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -138.25 93.78 2.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.411 -0.806 . . . . 0.0 109.103 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 28.5 m -120.34 99.34 48.22 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.492 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.97 108.59 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.424 2.083 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -164.64 155.73 15.06 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 44.3 p . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.568 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.503 HD13 HD11 ' H' ' 15' ' ' LEU . 36.4 mt -84.48 -30.52 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.751 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.15 -30.05 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 109.63 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -105.7 52.45 0.73 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.175 -0.953 . . . . 0.0 109.888 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.05 -34.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.379 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 67.2 m -102.5 -35.06 8.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.83 -31.26 71.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -0.935 . . . . 0.0 109.075 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 40.7 p -89.05 -17.4 29.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.361 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . 0.43 ' O ' ' C ' ' G' ' 10' ' ' ILE . 1.9 p -168.75 119.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.63 HD11 HG23 ' D' ' 2' ' ' VAL . 3.1 mt -42.82 106.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.578 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 62.6 m -60.62 153.97 22.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.373 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -68.76 170.16 10.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' G' ' 13' ' ' LEU . 1.3 mm? -70.79 -37.83 73.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.255 -0.903 . . . . 0.0 109.188 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.28 -44.82 90.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.431 -0.793 . . . . 0.0 109.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . 0.452 ' HA ' ' ND2' ' G' ' 18' ' ' ASN . 21.4 mt-30 -61.92 -39.66 92.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.334 -0.854 . . . . 0.0 109.514 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.91 -15.36 59.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.203 -0.936 . . . . 0.0 109.544 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -79.32 -19.86 49.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.679 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' G' ' 15' ' ' GLN . 27.6 p30 -86.54 11.99 11.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -108.86 -10.94 15.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.855 . . . . 0.0 109.796 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.41 152.63 23.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.654 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.399 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.408 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.5 p -60.06 152.56 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 3.6 m-20 170.72 -37.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.2 -0.937 . . . . 0.0 109.099 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -74.8 -33.81 62.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.25 -0.906 . . . . 0.0 108.855 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . 0.6 ' CB ' HD11 ' K' ' 10' ' ' ILE . 54.2 t60 -67.49 -42.2 83.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.513 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mt -79.22 -26.8 42.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.85 . . . . 0.0 109.427 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 42.4 t -72.21 -34.23 68.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.55 -21.47 79.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.73 -20.68 38.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -1.061 . . . . 0.0 109.665 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -82.34 -15.75 51.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.113 -0.992 . . . . 0.0 109.76 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.433 HD13 HG22 ' G' ' 2' ' ' ILE . 9.6 mt -92.41 -49.16 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.594 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.497 HG23 ' N ' ' H' ' 13' ' ' GLU . 10.8 m -46.16 -47.11 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . 0.497 ' N ' HG23 ' H' ' 12' ' ' VAL . 78.3 mt-10 -61.42 -42.45 98.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.482 ' CB ' ' H5 ' ' G' ' 22' ' ' IPH . . . -88.32 19.37 3.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.211 -0.931 . . . . 0.0 110.063 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . 0.503 HD11 HD13 ' G' ' 2' ' ' ILE . 0.7 OUTLIER -112.5 -59.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -58.07 -28.62 64.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.593 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' H' ' 17' ' ' LEU . 5.4 mt -67.07 -43.32 82.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.518 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -53.94 -45.81 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.845 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -57.16 12.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' H' ' 21' ' ' GLU . . . 99.73 38.88 3.53 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' H' ' 20' ' ' GLY . 2.2 tt0 80.93 50.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 109.711 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.26 -56.81 1.61 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.16 -0.962 . . . . 0.0 109.475 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.37 153.25 5.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.67 158.27 17.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.239 -1.153 . . . . 0.0 109.186 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 28.5 p90 -121.39 141.09 51.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.697 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -117.09 106.25 13.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.342 -0.849 . . . . 0.0 109.618 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 32.5 m -132.29 99.06 16.35 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.55 -0.719 . . . . 0.0 109.454 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.44 112.61 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.489 2.126 . . . . 0.0 110.47 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.61 153.18 8.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.612 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.514 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.494 HD13 HD11 ' J' ' 15' ' ' LEU . 32.8 mt -86.37 -30.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -1.125 . . . . 0.0 109.4 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.46 -28.23 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -108.09 49.4 0.81 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.11 -0.994 . . . . 0.0 109.688 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.12 -34.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.385 -0.822 . . . . 0.0 109.22 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -102.97 -32.53 9.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.06 -26.63 64.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 46.8 p -93.76 -17.2 23.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.035 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . 0.417 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.2 p -167.52 119.29 0.89 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.307 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' I' ' 9' ' ' SER . 3.1 mt -43.73 107.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.5 m -59.57 156.55 13.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.482 -0.761 . . . . 0.0 109.457 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 6.4 t -73.7 169.01 18.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.86 -38.16 79.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.276 -0.89 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -65.56 -43.75 88.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.68 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . 0.433 ' HA ' ' ND2' ' I' ' 18' ' ' ASN . 26.9 mt-30 -62.97 -38.0 89.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.187 -0.945 . . . . 0.0 109.441 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 42.3 mt -78.84 -13.51 59.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -81.01 -21.55 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.08 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' I' ' 15' ' ' GLN . 27.3 p30 -85.09 15.8 3.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.314 -0.866 . . . . 0.0 109.739 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.64 -11.73 13.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.382 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.12 154.65 24.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.312 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.526 -179.859 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.509 HG23 HD11 ' E' ' 10' ' ' ILE . 11.2 p -59.99 151.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 171.8 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.048 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -74.08 -33.49 63.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.249 -0.907 . . . . 0.0 109.105 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 t60 -68.38 -39.55 81.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.508 -0.745 . . . . 0.0 109.705 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 mt -82.19 -24.64 34.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.465 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 48.7 t -72.89 -37.31 67.32 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -0.817 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.88 -20.52 78.83 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . 0.461 ' HB3' ' OH ' ' L' ' 16' ' ' TYR . 1.3 m -82.38 -19.71 38.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -1.11 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.46 -16.81 44.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.574 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.1 mt -91.08 -48.16 7.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.481 HG23 ' N ' ' J' ' 13' ' ' GLU . 11.7 m -47.9 -46.15 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.276 -0.89 . . . . 0.0 109.981 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.481 ' N ' HG23 ' J' ' 12' ' ' VAL . 60.9 mt-10 -62.27 -39.61 93.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.489 ' CB ' ' H5 ' ' J' ' 32' ' ' IPH . . . -91.26 23.36 3.37 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.317 -0.864 . . . . 0.0 109.753 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . 0.494 HD11 HD13 ' I' ' 2' ' ' ILE . 0.8 OUTLIER -116.32 -58.01 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.018 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -60.37 -28.44 68.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' J' ' 17' ' ' LEU . 5.5 mt -66.17 -44.55 83.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.214 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 67.6 t -51.27 -48.58 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.282 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -50.77 69.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.08 -1.013 . . . . 0.0 108.831 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' J' ' 21' ' ' GLU . . . 108.77 -43.54 1.69 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' J' ' 20' ' ' GLY . 2.4 tt0 167.44 45.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -53.44 2.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.59 157.07 7.26 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 25.1 p90 -159.27 171.24 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -1.142 . . . . 0.0 109.742 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 1.7 p90 -128.0 141.26 51.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -121.75 98.76 6.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.873 . . . . 0.0 109.473 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -125.8 100.23 31.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.433 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.86 109.02 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.426 2.084 . . . . 0.0 110.621 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -164.29 156.85 17.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.464 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 61.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.553 -179.842 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.508 HD13 HD11 ' L' ' 15' ' ' LEU . 38.0 mt -85.06 -29.23 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -1.1 . . . . 0.0 109.417 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 39.4 t -69.24 -31.63 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.265 -0.897 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.95 51.96 0.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.262 -0.899 . . . . 0.0 109.975 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.28 -37.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.161 -0.962 . . . . 0.0 109.227 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 64.5 m -99.59 -34.67 10.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.305 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 1.7 m -68.07 -22.95 64.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 38.0 p -96.95 -20.42 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 108.978 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . 0.414 ' O ' ' C ' ' K' ' 10' ' ' ILE . 33.8 p -165.27 119.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.324 -0.86 . . . . 0.0 108.959 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.6 HD11 ' CB ' ' H' ' 5' ' ' HIS . 2.9 mp -42.99 107.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 109.749 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 68.7 m -59.13 156.3 12.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -73.27 169.36 17.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.586 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.52 -34.84 74.84 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.866 . . . . 0.0 109.744 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -67.97 -45.11 75.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.995 . . . . 0.0 109.377 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . 0.441 ' HA ' ' ND2' ' K' ' 18' ' ' ASN . 24.0 mt-30 -60.78 -40.43 92.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 42.5 mt -76.41 -15.57 59.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.265 -0.897 . . . . 0.0 109.93 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.94 -19.75 47.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.983 . . . . 0.0 109.558 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' K' ' 15' ' ' GLN . 27.5 p30 -87.17 14.18 8.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.887 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.42 -10.82 14.55 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.292 -0.88 . . . . 0.0 109.562 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.0 154.22 22.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.111 -0.993 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.551 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.196 0.522 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.72 151.6 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.012 -1.055 . . . . 0.0 109.198 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 172.86 -40.24 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 108.907 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.4 -33.0 64.76 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.297 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -68.73 -39.65 80.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . 0.704 HD22 ' CG ' ' D' ' 10' ' ' HIS . 7.9 mt -82.23 -22.64 35.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.0 109.223 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 48.6 t -74.97 -32.65 61.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.432 -0.792 . . . . 0.0 109.821 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 -13.38 83.2 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -17.58 31.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.235 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -85.46 -19.19 31.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 108.969 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 11.9 mt -87.23 -51.55 5.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 109.486 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.51 HG23 ' N ' ' L' ' 13' ' ' GLU . 8.4 m -46.1 -49.08 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.641 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.51 ' N ' HG23 ' L' ' 12' ' ' VAL . 62.3 mt-10 -58.98 -42.57 90.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.85 . . . . 0.0 109.717 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.469 ' CB ' ' H5 ' ' L' ' 32' ' ' IPH . . . -89.39 22.79 2.77 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.243 -0.911 . . . . 0.0 110.21 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.508 HD11 HD13 ' K' ' 2' ' ' ILE . 0.7 OUTLIER -115.67 -57.81 2.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 0.0 109.824 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.461 ' OH ' ' HB3' ' J' ' 9' ' ' SER . 18.0 p90 -60.45 -26.97 67.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.17 -0.956 . . . . 0.0 109.393 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' L' ' 17' ' ' LEU . 5.0 mt -68.59 -41.13 80.04 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 84.5 t -55.37 -49.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -59.48 3.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.385 -0.822 . . . . 0.0 109.533 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' L' ' 21' ' ' GLU . . . 101.07 39.14 3.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' L' ' 20' ' ' GLY . 2.7 tt0 80.38 48.08 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.489 -1.006 . . . . 0.0 109.929 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -121.36 -53.86 2.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.38 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.31 151.26 5.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -160.68 169.59 22.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -1.105 . . . . 0.0 108.949 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 2.5 p90 -129.38 147.61 51.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 36.8 t80 -123.85 107.12 11.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.277 -0.889 . . . . 0.0 109.166 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 35.6 m -133.17 98.48 15.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.305 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 110.7 3.05 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.471 2.114 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.0 158.52 17.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.418 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.658 -179.846 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.49 ' H5 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.467 ' H5 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' IPH . . . . . 0.523 ' H5 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 22' ' ' IPH . . . . . 0.482 ' H5 ' ' CB ' ' H' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . 0.489 ' H5 ' ' CB ' ' J' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . 0.469 ' H5 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.4 2.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -1.176 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 48.0 t -95.04 -36.65 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.958 -1.089 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.43 38.93 1.42 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.477 -0.764 . . . . 0.0 109.602 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -156.34 -39.29 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.956 . . . . 0.0 109.513 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.5 m -104.04 -38.96 6.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 109.636 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 49.3 t -62.09 -24.3 67.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.602 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.1 p -77.65 -31.67 52.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -153.1 145.78 24.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.545 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -46.81 104.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.309 -0.869 . . . . 0.0 109.488 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.428 ' HB3' ' HG ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.56 163.23 7.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.875 . . . . 0.0 109.615 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.17 165.23 15.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.294 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -36.5 77.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.843 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -68.89 -32.03 71.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -46.15 46.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.298 -0.876 . . . . 0.0 109.623 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' A' ' 11' ' ' CYS . 64.8 mt -67.23 -17.34 64.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.053 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -26.15 62.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.069 -1.02 . . . . 0.0 109.335 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -55.08 -32.02 61.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.396 -0.815 . . . . 0.0 109.957 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.94 55.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.038 -1.039 . . . . 0.0 109.546 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -123.66 131.88 53.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.392 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.627 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.474 ' O ' HG13 ' B' ' 2' ' ' VAL . 11.1 p -66.98 127.04 27.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.222 -0.924 . . . . 0.0 109.579 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.9 t30 179.96 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.95 -26.34 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 109.446 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -78.48 -39.4 38.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.488 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.08 -22.35 36.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 39.7 t -81.81 -33.07 30.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.34 -0.85 . . . . 0.0 109.941 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.81 -26.71 55.59 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -16.27 63.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -96.97 -21.17 17.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 59.5 mt -81.76 -33.45 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.58 -33.02 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.657 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -73.77 -38.17 64.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.152 -0.968 . . . . 0.0 109.601 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -64.59 -58.06 7.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.336 -0.852 . . . . 0.0 109.881 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.543 ' HA ' ' HB ' ' B' ' 18' ' ' VAL . 9.4 mt -53.43 -23.01 8.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.992 . . . . 0.0 109.689 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -53.04 58.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 110.02 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -88.88 -23.27 22.8 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' B' ' 15' ' ' LEU . 83.7 t -65.44 -22.69 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.081 . . . . 0.0 109.688 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.2 -34.62 8.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.626 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.48 -147.4 18.58 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -78.41 -1.43 33.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.252 -1.146 . . . . 0.0 109.701 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -65.83 -26.5 67.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.32 174.28 48.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -157.14 176.79 12.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 0.0 109.549 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.61 ' HB2' ' CE1' ' D' ' 25' ' ' PHE . 6.3 p90 -133.13 153.99 51.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.95 . . . . 0.0 109.585 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -130.92 109.4 10.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.383 -0.823 . . . . 0.0 109.302 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 40.3 m -159.7 105.89 1.46 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 109.34 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.42 -88.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.26 1.973 . . . . 0.0 110.233 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.29 -153.97 0.38 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.425 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.443 HD12 ' CD2' ' C' ' 19' ' ' TYR . 8.9 tt -103.02 0.96 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.644 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' C' ' 7' ' ' CYS . 48.2 t -92.62 -35.94 7.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.86 48.27 0.86 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.181 -0.949 . . . . 0.0 109.373 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -166.44 -36.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.459 -0.775 . . . . 0.0 109.097 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m -106.5 -39.69 5.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.394 -0.816 . . . . 0.0 109.374 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' C' ' 3' ' ' VAL . 47.0 t -64.14 -22.07 66.8 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.849 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -80.31 -31.73 38.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.587 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.28 146.68 26.21 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mt -48.76 101.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.571 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . 0.402 ' HB3' ' HG ' ' C' ' 16' ' ' LEU . 0.3 OUTLIER -58.32 160.12 5.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.68 169.91 13.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.6 -38.23 70.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.697 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -67.6 -31.14 70.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.739 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.43 -43.89 47.41 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 109.821 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' C' ' 11' ' ' CYS . 67.0 mt -69.73 -16.51 63.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.87 . . . . 0.0 109.812 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -23.13 61.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 109.634 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -58.72 -29.83 66.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.443 ' CD2' HD12 ' C' ' 2' ' ' ILE . 10.6 m-85 -101.39 57.58 0.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -126.6 130.39 50.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.466 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.485 ' O ' HG13 ' D' ' 2' ' ' VAL . 13.0 p -64.8 128.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 0.0 109.587 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 179.25 -42.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.118 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.03 -25.36 60.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.779 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -80.83 -35.58 32.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -85.38 -20.33 30.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 109.147 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.472 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 41.8 t -84.31 -31.65 24.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.442 -0.786 . . . . 0.0 109.974 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.443 ' HA3' ' OH ' ' D' ' 26' ' ' TYR . . . -81.09 -27.02 51.24 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -15.23 63.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.34 -1.094 . . . . 0.0 109.364 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -97.06 -21.24 17.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.187 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 57.2 mt -83.81 -28.19 28.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 109.394 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 m -63.99 -32.06 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -0.881 . . . . 0.0 109.456 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -75.32 -37.53 60.73 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.317 -0.864 . . . . 0.0 109.611 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -65.73 -55.12 18.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.245 -0.909 . . . . 0.0 109.942 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.503 ' HA ' ' HB ' ' D' ' 18' ' ' VAL . 9.6 mt -55.13 -24.4 25.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.584 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.38 -53.77 40.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.005 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 35.3 mt -87.98 -24.85 23.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 110.463 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' D' ' 15' ' ' LEU . 78.9 t -63.68 -22.76 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 109.643 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.12 -37.65 7.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.383 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.74 -144.73 17.46 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.78 4.5 21.85 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.227 -1.161 . . . . 0.0 109.593 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -72.67 -22.72 60.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.883 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.02 177.94 50.97 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -159.05 167.44 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -1.208 . . . . 0.0 109.925 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . 0.61 ' CE1' ' HB2' ' B' ' 25' ' ' PHE . 2.3 m-85 -118.41 149.6 40.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.415 -0.803 . . . . 0.0 109.449 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.443 ' OH ' ' HA3' ' D' ' 8' ' ' GLY . 64.0 t80 -133.05 100.4 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.327 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.3 m -154.05 109.21 2.47 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.152 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.32 -87.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 110.313 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 57.18 -153.15 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.464 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.605 -179.789 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' E' ' 19' ' ' TYR . 5.1 tt -102.35 0.37 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -1.087 . . . . 0.0 109.444 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 42.5 t -92.9 -38.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.301 -0.874 . . . . 0.0 109.66 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.81 45.29 0.99 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.885 . . . . 0.0 109.406 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -163.68 -36.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.216 -0.927 . . . . 0.0 109.456 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 74.9 m -107.01 -41.21 5.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' F' ' 11' ' ' LEU . 0.6 OUTLIER -62.36 -20.86 64.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.349 -0.844 . . . . 0.0 109.447 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -79.95 -34.16 39.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.466 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -150.8 146.72 26.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.265 -0.897 . . . . 0.0 109.335 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.423 ' HA ' ' H2 ' ' E' ' 22' ' ' IPH . 2.7 mt -47.32 102.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.678 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 162.04 6.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.366 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.47 167.65 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.516 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -39.04 77.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.163 -0.961 . . . . 0.0 109.773 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -67.02 -31.33 71.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.34 -42.7 53.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 110.08 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 mt -70.67 -16.98 62.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.71 -26.66 63.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -54.62 -30.68 55.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.431 ' CD2' HD12 ' E' ' 2' ' ' ILE . 10.6 m-85 -101.42 59.27 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.219 -0.925 . . . . 0.0 109.482 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -127.3 132.09 50.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.317 -179.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.356 0.598 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.476 ' O ' HG13 ' F' ' 2' ' ' VAL . 11.5 p -62.29 127.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.389 -0.819 . . . . 0.0 109.911 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 17.5 t30 179.39 -38.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.06 -27.31 57.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.564 -0.71 . . . . 0.0 109.586 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -79.54 -33.54 41.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.594 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -87.41 -22.67 24.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.107 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 37.3 t -82.53 -26.52 32.39 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.44 -27.08 31.12 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.55 -15.78 63.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -1.122 . . . . 0.0 109.181 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -96.27 -24.27 16.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.313 -0.867 . . . . 0.0 109.633 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.581 HD11 ' SG ' ' E' ' 7' ' ' CYS . 52.2 mt -79.86 -31.28 40.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.553 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.407 HG22 ' H ' ' F' ' 12' ' ' VAL . 4.1 m -60.45 -33.34 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.95 -35.38 62.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 109.823 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.548 ' CB ' HD13 ' L' ' 17' ' ' LEU . . . -67.9 -54.83 15.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.571 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.519 ' HA ' ' HB ' ' F' ' 18' ' ' VAL . 12.0 mt -55.83 -22.28 24.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 109.598 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -55.02 35.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.482 HD21 ' NE2' ' H' ' 5' ' ' HIS . 42.2 mt -85.76 -26.53 25.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.27 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.541 HG23 ' O ' ' F' ' 14' ' ' ALA . 89.5 t -61.96 -23.14 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.116 -0.99 . . . . 0.0 109.753 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.97 -35.15 8.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.097 -1.002 . . . . 0.0 109.397 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.6 -143.19 16.5 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -82.79 2.69 32.78 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.262 -1.14 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.53 -31.6 68.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.65 -177.35 31.8 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -169.88 154.03 5.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.433 -1.04 . . . . 0.0 109.136 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -112.25 157.88 20.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.68 108.51 8.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 108.918 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 96.7 m -158.71 109.22 1.62 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.688 . . . . 0.0 109.405 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.5 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.372 2.048 . . . . 0.0 110.213 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.91 -156.08 0.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.373 -0.829 . . . . 0.0 109.769 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.418 HD12 ' CD2' ' G' ' 19' ' ' TYR . 7.4 tt -100.21 1.48 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -1.159 . . . . 0.0 109.61 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -92.97 -40.86 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.38 47.69 1.03 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.302 -0.874 . . . . 0.0 109.673 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -166.78 -34.97 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.518 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 77.9 m -108.58 -38.11 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.46 -23.63 67.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.381 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 3.1 p -77.35 -30.84 54.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.13 146.68 25.02 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.211 -0.93 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 mt -49.06 103.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.148 -0.97 . . . . 0.0 109.289 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.18 162.63 5.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.06 164.41 15.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 109.244 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -41.3 91.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.88 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -64.62 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -44.77 50.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.086 -1.008 . . . . 0.0 109.863 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.57 -16.43 63.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -25.4 62.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 0.0 109.26 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -56.11 -28.84 59.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.864 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . 0.418 ' CD2' HD12 ' G' ' 2' ' ' ILE . 10.2 m-85 -103.19 56.52 0.75 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 128.06 47.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 109.553 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.001 . . . . 0.0 109.446 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.538 ' O ' HG13 ' H' ' 2' ' ' VAL . 14.0 p -66.3 126.3 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -179.36 -41.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.58 -25.04 60.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.588 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . 0.482 ' NE2' HD21 ' F' ' 17' ' ' LEU . 37.1 t60 -80.01 -39.48 29.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.302 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -82.75 -16.41 48.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.438 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 44.4 t -88.89 -30.8 18.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.344 -0.848 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.25 -28.22 45.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -67.29 -19.02 65.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -1.131 . . . . 0.0 109.559 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -93.48 -23.12 18.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.153 -0.967 . . . . 0.0 109.666 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 43.4 mt -81.56 -30.81 32.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.404 ' H ' HG22 ' H' ' 12' ' ' VAL . 3.6 m -60.58 -31.71 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.061 -1.024 . . . . 0.0 109.631 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -75.94 -35.37 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.728 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.567 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -66.44 -54.13 27.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -0.98 . . . . 0.0 109.436 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . 0.478 ' HA ' ' HB ' ' H' ' 18' ' ' VAL . 12.6 mt -57.17 -24.52 54.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.873 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -51.47 61.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 51.3 mt -89.22 -25.56 21.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -0.872 . . . . 0.0 110.42 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.567 HG23 ' O ' ' H' ' 14' ' ' ALA . 91.4 t -63.62 -26.24 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.034 -1.042 . . . . 0.0 109.65 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -39.15 9.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 109.544 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.95 -143.93 16.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.76 2.89 31.64 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.072 -1.252 . . . . 0.0 109.612 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -70.2 -24.88 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.14 -171.87 35.96 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -172.1 163.4 5.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.101 -1.234 . . . . 0.0 109.445 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -120.84 154.68 35.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.128 -0.983 . . . . 0.0 110.024 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -134.9 101.51 4.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 109.461 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 22.9 m -152.83 108.14 2.69 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 109.509 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.83 -87.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.343 2.029 . . . . 0.0 110.745 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.59 -154.91 0.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.393 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' I' ' 19' ' ' TYR . 7.9 tt -104.48 1.64 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.174 -1.192 . . . . 0.0 109.523 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 42.4 t -93.52 -37.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.202 -0.936 . . . . 0.0 109.931 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.73 37.62 1.58 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.291 -0.881 . . . . 0.0 109.564 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -154.59 -38.82 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.305 -0.872 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 77.7 m -104.57 -41.52 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 109.766 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . 0.527 ' SG ' HD11 ' J' ' 11' ' ' LEU . 0.6 OUTLIER -60.34 -20.42 59.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.711 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -81.57 -33.4 31.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.23 147.72 28.03 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.32 -0.863 . . . . 0.0 108.949 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -49.92 101.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.34 164.63 1.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.146 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.62 168.71 11.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.088 -1.008 . . . . 0.0 109.06 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.69 -42.84 77.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.145 -0.972 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -63.55 -32.01 73.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 110.078 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.84 -43.26 55.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.988 . . . . 0.0 109.949 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 mt -70.35 -16.01 62.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.826 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -19.57 61.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.18 -0.95 . . . . 0.0 109.65 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -62.21 -28.09 69.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.247 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' I' ' 2' ' ' ILE . 11.5 m-85 -102.11 58.47 0.82 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 t -128.17 129.83 47.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.362 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.514 ' O ' HG13 ' J' ' 2' ' ' VAL . 12.3 p -65.47 127.33 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -179.95 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -75.13 -27.62 59.86 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.301 -0.874 . . . . 0.0 109.619 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -76.8 -36.61 56.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.971 . . . . 0.0 109.395 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . 0.401 HD21 ' C6 ' ' E' ' 22' ' ' IPH . 13.3 mt -84.98 -21.97 29.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.418 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.422 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 43.7 t -83.1 -27.19 30.36 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.31 -0.869 . . . . 0.0 109.644 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.41 -27.48 30.1 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . 0.515 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 0.4 OUTLIER -69.82 -12.18 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -1.129 . . . . 0.0 109.477 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -99.43 -21.52 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 109.322 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.527 HD11 ' SG ' ' I' ' 7' ' ' CYS . 40.5 mt -83.37 -32.2 26.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 109.603 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.418 HG22 ' H ' ' J' ' 12' ' ' VAL . 6.2 m -58.72 -32.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.354 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -74.3 -37.81 63.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.686 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.417 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -65.03 -59.65 3.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.568 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . 0.521 ' HA ' ' HB ' ' J' ' 18' ' ' VAL . 10.7 mt -51.0 -25.77 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.725 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -55.48 18.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.119 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 mt -85.9 -27.82 24.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 0.0 110.229 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' J' ' 15' ' ' LEU . 87.7 t -59.34 -26.33 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.137 -0.977 . . . . 0.0 109.935 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -99.47 -39.32 8.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.566 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 -145.11 17.18 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.35 1.18 33.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.21 -1.17 . . . . 0.0 109.578 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -66.98 -27.31 67.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.13 -177.55 41.36 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -170.5 165.1 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -1.089 . . . . 0.0 109.189 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -125.33 157.28 37.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.738 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -129.91 110.55 11.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.544 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 38.4 m -159.71 106.67 1.46 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.588 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.37 -88.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.397 2.065 . . . . 0.0 110.354 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.7 -158.03 0.31 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.248 -0.908 . . . . 0.0 109.354 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.919 -1.038 . . . . 0.0 109.347 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.441 HD12 ' CD2' ' K' ' 19' ' ' TYR . 7.1 tt -104.48 1.66 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -1.104 . . . . 0.0 109.159 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 46.5 t -93.5 -40.3 11.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 46.86 1.0 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -165.05 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.829 . . . . 0.0 109.235 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 81.7 m -107.01 -42.54 4.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.371 -0.831 . . . . 0.0 109.27 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' L' ' 11' ' ' LEU . 0.6 OUTLIER -60.11 -22.27 62.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -79.43 -31.88 42.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.137 -0.977 . . . . 0.0 109.586 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.37 146.75 24.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.74 102.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.873 . . . . 0.0 109.542 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 161.53 7.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -85.93 165.77 16.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.186 -0.946 . . . . 0.0 109.275 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -41.99 83.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.05 -31.46 72.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.52 -0.738 . . . . 0.0 109.925 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.06 -42.65 46.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 0.0 109.73 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 60.7 mt -70.17 -16.47 63.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.09 -1.006 . . . . 0.0 109.718 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.22 -23.49 61.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.92 . . . . 0.0 109.167 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -57.98 -28.12 64.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.299 -0.876 . . . . 0.0 109.359 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . 0.441 ' CD2' HD12 ' K' ' 2' ' ' ILE . 11.0 m-85 -103.66 58.29 0.74 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.52 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 7.2 t -127.08 131.86 50.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.573 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.33 0.586 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.461 ' O ' HG13 ' L' ' 2' ' ' VAL . 11.6 p -64.61 128.09 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.729 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 14.6 t30 177.52 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -0.849 . . . . 0.0 109.536 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -77.92 -25.25 48.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -79.74 -38.15 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.78 -25.1 33.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.815 . . . . 0.0 109.4 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.451 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 45.4 t -79.45 -30.09 42.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.744 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.2 -32.36 28.93 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -64.88 -12.96 54.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 109.698 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -98.44 -23.5 15.54 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.252 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.546 HD11 ' SG ' ' K' ' 7' ' ' CYS . 55.7 mt -81.35 -28.04 34.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.856 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.48 -30.32 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.097 -1.002 . . . . 0.0 109.569 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -76.67 -37.66 55.86 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.205 -0.935 . . . . 0.0 109.485 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.429 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -65.18 -56.73 11.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.549 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.454 ' HA ' ' HB ' ' L' ' 18' ' ' VAL . 14.7 mt -54.05 -25.73 23.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.079 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' J' ' 9' ' ' SER . 0.4 OUTLIER -52.05 -53.74 38.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.146 -0.971 . . . . 0.0 109.941 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.548 HD13 ' CB ' ' F' ' 14' ' ' ALA . 35.9 mt -87.24 -27.99 22.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 110.657 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' L' ' 15' ' ' LEU . 88.5 t -59.77 -25.15 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.956 -1.09 . . . . 0.0 109.648 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -99.48 -41.76 7.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.391 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.95 -142.26 15.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -83.2 1.29 41.39 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.275 -1.132 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -67.5 -27.93 67.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 110.022 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 -176.33 39.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -171.38 167.02 6.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -1.124 . . . . 0.0 109.488 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 3.1 p90 -126.45 151.69 47.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.632 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -126.85 106.11 9.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.835 . . . . 0.0 109.312 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 32.8 m -155.71 108.55 2.17 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -82.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.475 2.117 . . . . 0.0 110.843 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.65 -155.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 109.406 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.062 -1.024 . . . . 0.0 109.816 -179.61 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' IPH . . . . . 0.423 ' H2 ' ' HA ' ' E' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.5 mt -80.39 -30.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 109.518 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.58 -35.81 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.951 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -104.46 56.2 0.71 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.806 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.436 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 22.6 tt0 -178.58 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.582 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' SER . 63.7 m -102.16 -29.46 11.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 109.656 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 t -75.02 -41.48 59.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.236 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.2 p -81.34 -15.95 53.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.501 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -160.32 120.57 2.89 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 109.565 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.554 HD12 ' O ' ' F' ' 1' ' ' PHE . 2.1 mp -47.87 101.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.319 -0.863 . . . . 0.0 109.455 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m -53.12 158.8 1.4 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.222 -0.924 . . . . 0.0 109.304 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.81 163.68 16.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.264 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -45.17 84.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 109.655 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -61.88 -33.49 74.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.549 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -67.72 -36.87 81.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.072 -1.017 . . . . 0.0 109.436 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.2 mt -83.91 -8.74 59.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.24 -0.912 . . . . 0.0 109.739 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.15 -27.96 38.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 15' ' ' GLN . 53.0 p30 -73.37 -11.91 60.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 109.759 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.432 ' N ' ' OD1' ' A' ' 18' ' ' ASN . 35.0 m-85 -98.32 -3.45 37.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 109.95 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.6 168.33 19.02 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.137 -0.977 . . . . 0.0 109.513 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.622 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.55 ' O ' HG13 ' B' ' 2' ' ' VAL . 3.8 p -172.25 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 4.6 p30 170.73 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.301 -0.875 . . . . 0.0 109.242 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -85.57 -24.29 27.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.822 . . . . 0.0 109.364 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.84 -39.42 35.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.319 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mt -81.01 -38.03 28.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.406 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 9.4 t -63.14 -36.33 83.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.33 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.436 ' O ' HG22 ' B' ' 12' ' ' VAL . . . -79.4 -22.01 65.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 71.7 m -79.66 -8.88 59.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.399 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -96.79 -25.69 15.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.932 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 9.7 mt -79.43 -48.23 14.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.213 -0.929 . . . . 0.0 110.192 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.443 ' H ' HG22 ' B' ' 12' ' ' VAL . 2.6 m -52.18 -34.01 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 109.958 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.47 -48.31 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.109 -0.995 . . . . 0.0 109.423 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.452 ' CB ' ' H3 ' ' B' ' 32' ' ' IPH . . . -83.48 11.92 6.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -0.857 . . . . 0.0 110.137 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 -50.67 5.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.949 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 13.4 p90 -71.98 -21.49 61.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.07 -1.019 . . . . 0.0 109.549 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.948 HD23 HD23 ' H' ' 17' ' ' LEU . 46.9 tp -74.52 -35.98 63.16 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -76.02 -46.7 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.72 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -57.1 -41.74 79.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.928 . . . . 0.0 109.327 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.39 -141.14 15.39 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -85.07 4.55 33.55 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.207 -1.173 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.6 -74.92 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' B' ' 19' ' ' CYS . . . 141.17 165.6 10.41 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 13.5 p90 -161.45 167.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -1.206 . . . . 0.0 109.317 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.605 ' HB2' ' CD2' ' D' ' 25' ' ' PHE . 35.8 p90 -123.57 162.62 22.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.596 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -142.08 83.69 1.85 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.192 -0.942 . . . . 0.0 109.644 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.437 HG21 HD21 ' C' ' 21' ' ' ASN . 0.2 OUTLIER -133.77 92.68 22.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.345 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.13 -57.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.777 2.318 . . . . 0.0 110.423 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tttt 54.37 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.552 179.699 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 74.1 mt -79.72 -29.48 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -1.112 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.27 -38.51 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 5.7 mm-40 -103.41 60.59 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.803 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 22.2 tt0 178.3 -32.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 109.592 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 70.2 m -104.03 -31.45 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -0.958 . . . . 0.0 109.392 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 9.9 t -73.22 -40.11 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.963 . . . . 0.0 109.437 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 32.1 p -82.84 -16.14 48.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.93 118.42 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.744 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -45.76 100.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 96.8 m -51.9 160.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.004 . . . . 0.0 109.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.16 162.69 15.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.232 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -43.24 84.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -0.954 . . . . 0.0 109.687 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -63.5 -33.73 76.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . 0.436 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -67.15 -35.94 80.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 109.685 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.63 -9.5 58.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.946 . . . . 0.0 109.636 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -79.19 -26.77 42.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.861 . . . . 0.0 109.458 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' C' ' 15' ' ' GLN . 52.8 p30 -76.84 -8.01 56.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -101.4 -6.54 23.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.47 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -78.19 167.68 21.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.66 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . 0.437 HD21 HG21 ' B' ' 27' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.349 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.487 ' O ' HG13 ' D' ' 2' ' ' VAL . 2.5 p -171.76 107.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.184 -0.947 . . . . 0.0 109.279 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 5.3 p30 173.42 -36.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 109.261 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.56 -25.39 38.61 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.419 -0.801 . . . . 0.0 109.168 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.98 -41.79 41.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.453 ' N ' HD23 ' D' ' 6' ' ' LEU . 4.3 mt -79.39 -36.81 38.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.214 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.418 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.5 t -63.37 -36.4 83.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.0 109.507 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.55 -18.66 67.94 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 57.9 m -81.95 -8.64 59.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -1.125 . . . . 0.0 109.705 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -96.96 -25.88 15.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.585 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 10.6 mt -77.42 -49.87 13.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -51.55 -33.19 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 109.904 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -68.73 -46.78 68.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.108 -0.995 . . . . 0.0 109.717 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.424 ' CB ' ' H3 ' ' D' ' 32' ' ' IPH . . . -85.16 9.73 14.19 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.813 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 -52.33 4.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.726 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 15.6 p90 -70.85 -22.69 62.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.862 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.509 HD23 HD23 ' J' ' 17' ' ' LEU . 48.9 tp -72.86 -38.15 67.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.105 -0.997 . . . . 0.0 109.63 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -73.2 -46.27 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.832 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -58.16 -44.87 88.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.63 -139.03 14.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -86.43 5.42 35.14 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.338 -1.095 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -70.45 -75.33 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.351 -0.843 . . . . 0.0 109.535 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' D' ' 19' ' ' CYS . . . 142.4 166.47 10.99 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 17.7 p90 -156.94 162.35 39.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.949 -1.324 . . . . 0.0 110.068 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' B' ' 25' ' ' PHE . 55.4 m-85 -114.2 150.41 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -138.55 85.01 2.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.594 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.63 92.86 9.97 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.278 -0.889 . . . . 0.0 108.783 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.22 -61.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.674 2.249 . . . . 0.0 110.568 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttt 59.13 94.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.459 -0.776 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.666 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 75.6 mt -83.94 -29.86 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -1.135 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 64.0 t -68.85 -37.31 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 4.6 mm-40 -104.12 61.43 0.73 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.329 -0.857 . . . . 0.0 109.976 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 22.9 tt0 176.94 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 109.514 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 66.2 m -102.06 -30.39 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.6 t -73.65 -43.03 60.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.271 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 31.6 p -80.19 -15.04 57.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.622 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' J' ' 1' ' ' PHE . 0.0 OUTLIER -161.14 116.9 2.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.141 -0.974 . . . . 0.0 109.46 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mp -45.27 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.456 -0.777 . . . . 0.0 109.59 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . 0.427 ' SG ' ' HG2' ' E' ' 5' ' ' GLN . 94.4 m -49.95 160.83 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.079 -1.013 . . . . 0.0 109.332 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.6 167.44 12.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.073 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -44.69 94.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.512 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -62.11 -35.31 78.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -35.19 79.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.072 -1.017 . . . . 0.0 109.4 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -85.35 -4.52 59.18 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.207 -0.933 . . . . 0.0 109.776 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -84.59 -29.81 25.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.142 -0.974 . . . . 0.0 109.376 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' E' ' 19' ' ' TYR . 54.6 p30 -72.31 -10.32 59.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.888 . . . . 0.0 109.679 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' E' ' 18' ' ' ASN . 32.8 m-85 -100.21 -1.03 37.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.121 -0.987 . . . . 0.0 109.886 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.9 169.13 14.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 110.059 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.717 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . 0.554 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.8 m-85 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.577 ' O ' HG13 ' F' ' 2' ' ' VAL . 5.7 p -170.23 108.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.865 . . . . 0.0 109.67 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 p30 171.56 -37.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -79.43 -26.94 41.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -0.857 . . . . 0.0 109.51 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -76.18 -40.41 52.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.938 . . . . 0.0 109.84 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.61 -34.36 30.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.441 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 11.3 t -66.63 -31.44 72.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.261 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.431 ' O ' HG22 ' F' ' 12' ' ' VAL . . . -84.26 -19.27 60.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -83.21 -7.45 59.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -1.091 . . . . 0.0 109.574 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -98.81 -22.22 15.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -81.64 -45.96 15.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.649 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.431 HG22 ' O ' ' F' ' 8' ' ' GLY . 2.4 m -55.23 -33.37 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.09 -48.49 65.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.219 -0.926 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.49 ' CB ' ' H3 ' ' E' ' 22' ' ' IPH . . . -83.24 8.21 14.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -0.894 . . . . 0.0 110.065 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -51.52 5.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 109.858 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.531 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 13.5 p90 -71.51 -21.43 61.92 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.219 -0.925 . . . . 0.0 109.744 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.485 HD23 HD23 ' L' ' 17' ' ' LEU . 52.1 tp -74.8 -34.76 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.444 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.45 -42.93 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -37.73 86.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.043 -1.036 . . . . 0.0 109.106 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.36 -139.76 15.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -83.54 -0.67 51.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.951 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -65.03 -73.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.284 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 139.16 168.65 11.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . 0.531 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 12.3 p90 -163.61 172.69 13.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 109.422 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -130.41 162.53 28.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.275 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -138.99 93.16 2.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.329 -0.857 . . . . 0.0 109.034 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.08 89.45 7.81 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.483 -0.76 . . . . 0.0 109.477 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.38 -62.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.675 2.25 . . . . 0.0 110.115 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 62.22 93.18 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.799 . . . . 0.0 109.648 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.568 179.904 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.41 HD13 HD11 ' H' ' 15' ' ' LEU . 73.6 mt -81.95 -26.69 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.13 -33.33 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 5.4 mm-40 -108.69 61.47 0.6 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.284 -0.885 . . . . 0.0 109.857 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 22.0 tt0 176.43 -31.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.353 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -104.36 -32.97 8.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 10.1 t -72.14 -43.5 64.57 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.124 -0.985 . . . . 0.0 109.286 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -77.36 -21.37 53.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.511 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 121.25 5.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.155 -0.965 . . . . 0.0 109.486 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -47.69 103.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.97 . . . . 0.0 109.156 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 69.1 m -53.32 162.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.971 . . . . 0.0 109.617 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.1 163.28 14.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 109.33 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.36 84.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -61.04 -36.58 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.341 -0.849 . . . . 0.0 109.404 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . 0.438 ' O ' ' OD1' ' G' ' 18' ' ' ASN . 0.0 OUTLIER -63.87 -39.22 93.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.7 mt -80.91 -11.32 59.6 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.254 -0.904 . . . . 0.0 109.906 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.56 -29.86 56.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.08 -1.012 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' G' ' 15' ' ' GLN . 53.4 p30 -73.16 -5.94 42.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.965 . . . . 0.0 109.613 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -102.17 -16.4 16.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.988 . . . . 0.0 109.76 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 6.9 m -66.51 172.86 3.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.06 -1.025 . . . . 0.0 108.814 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.423 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.585 ' O ' HG13 ' H' ' 2' ' ' VAL . 4.4 p -171.05 107.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.384 -0.823 . . . . 0.0 109.55 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 172.54 -34.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.66 -22.13 32.23 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.304 -0.872 . . . . 0.0 109.361 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -80.65 -39.79 26.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . 0.44 HD23 ' N ' ' H' ' 6' ' ' LEU . 4.3 mt -81.12 -37.09 29.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.216 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.42 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.4 t -63.15 -37.23 86.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.683 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . 0.448 ' O ' HG22 ' H' ' 12' ' ' VAL . . . -79.91 -18.73 71.85 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 58.5 m -83.06 -6.33 59.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -1.116 . . . . 0.0 109.559 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -100.47 -19.33 16.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.072 -1.017 . . . . 0.0 109.149 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 9.8 mt -84.23 -46.51 11.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.598 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.448 HG22 ' O ' ' H' ' 8' ' ' GLY . 2.3 m -54.64 -33.17 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.726 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.27 -48.03 66.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.968 . . . . 0.0 109.824 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.98 11.47 9.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.286 -0.884 . . . . 0.0 110.052 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -93.04 -48.63 6.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.996 -1.065 . . . . 0.0 109.724 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 13.2 p90 -73.12 -22.57 60.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.368 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.948 HD23 HD23 ' B' ' 17' ' ' LEU . 47.1 tp -73.47 -33.52 64.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.301 -0.875 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.25 -57.44 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 109.845 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.5 m -49.85 -38.41 35.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.05 -1.031 . . . . 0.0 109.245 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.5 -146.19 18.8 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -75.51 -3.96 37.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -1.087 . . . . 0.0 110.046 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -61.59 -74.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.282 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.99 171.74 12.7 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 15.8 p90 -165.82 170.41 13.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -1.212 . . . . 0.0 109.678 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 13.1 p90 -128.5 156.74 42.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 109.496 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -136.35 91.21 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.918 . . . . 0.0 109.386 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.67 90.09 8.88 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.97 -59.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.733 2.289 . . . . 0.0 110.533 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 57.56 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.335 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.507 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 74.2 mt -81.69 -28.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -1.105 . . . . 0.0 109.433 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.1 -32.26 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.221 -0.924 . . . . 0.0 109.6 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 5.8 mm-40 -108.15 58.89 0.61 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.277 -0.889 . . . . 0.0 109.545 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 25.3 tt0 177.34 -32.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -101.23 -30.44 11.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 109.44 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.4 -43.28 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.852 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -79.02 -14.31 59.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . 0.424 ' O ' ' N ' ' I' ' 11' ' ' CYS . 0.0 OUTLIER -161.75 126.55 3.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.329 -0.857 . . . . 0.0 108.988 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' I' ' 11' ' ' CYS . 2.2 mp -56.17 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.851 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 10' ' ' ILE . 0.8 OUTLIER -43.23 161.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.272 -0.893 . . . . 0.0 109.346 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.2 169.34 11.97 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -46.16 91.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -59.74 -34.78 73.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.592 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.27 82.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.6 mt -83.71 -9.45 58.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 109.581 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.16 -29.0 42.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' I' ' 19' ' ' TYR . 54.9 p30 -74.2 -9.74 58.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.22 -0.925 . . . . 0.0 109.683 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . 0.406 ' N ' ' OD1' ' I' ' 18' ' ' ASN . 29.5 m-85 -99.48 -3.48 33.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.579 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.26 167.66 19.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.159 -0.963 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' E' ' 9' ' ' SER . 1.8 m-85 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.521 ' O ' HG13 ' J' ' 2' ' ' VAL . 3.2 p -170.14 108.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.077 -1.014 . . . . 0.0 109.382 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 p30 172.81 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.346 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -85.03 -23.68 28.51 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.32 -0.862 . . . . 0.0 109.441 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -78.37 -40.69 35.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.157 -0.965 . . . . 0.0 109.384 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . 0.414 ' N ' HD23 ' J' ' 6' ' ' LEU . 5.6 mt -80.12 -37.69 33.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.32 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.421 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 10.8 t -63.17 -36.82 84.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 109.602 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.435 ' O ' HG22 ' J' ' 12' ' ' VAL . . . -79.84 -17.57 74.7 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -84.06 -10.9 57.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -1.18 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -94.1 -23.82 17.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.601 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 9.3 mt -80.39 -47.73 13.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.993 . . . . 0.0 109.661 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.442 ' H ' HG22 ' J' ' 12' ' ' VAL . 2.6 m -53.06 -32.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 109.99 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.47 -48.97 59.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.029 -1.045 . . . . 0.0 109.733 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.88 12.34 6.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.27 -50.23 5.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.042 -1.036 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 12.9 p90 -72.56 -20.82 61.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.3 -0.875 . . . . 0.0 109.61 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.509 HD23 HD23 ' D' ' 17' ' ' LEU . 46.1 tp -76.57 -31.74 57.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.59 -46.89 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 109.052 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' J' ' 23' ' ' GLY . 0.1 OUTLIER -56.21 -42.24 76.89 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.274 -0.891 . . . . 0.0 108.977 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -140.79 15.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.2 -0.34 48.95 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.234 -1.156 . . . . 0.0 109.751 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -64.67 -67.99 0.39 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.103 -0.998 . . . . 0.0 109.524 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' J' ' 19' ' ' CYS . . . 133.06 171.8 12.82 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 13.1 p90 -164.81 177.89 7.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.125 -1.221 . . . . 0.0 109.443 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -134.02 156.14 48.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -137.38 94.04 2.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.03 89.31 6.53 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 109.636 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.61 -60.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.565 2.176 . . . . 0.0 110.574 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' J' ' 30' ' ' THR . 4.3 tttt 59.24 92.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.519 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' J' ' 29' ' ' LYS . 13.6 m . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.6 -31.84 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -1.099 . . . . 0.0 109.238 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.99 -35.88 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.8 . . . . 0.0 109.757 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 7.0 mm-40 -105.23 59.3 0.68 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 23.5 tt0 179.25 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.488 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' K' ' 9' ' ' SER . 72.2 m -100.85 -35.66 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -69.31 -40.23 77.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 55.4 p -82.6 -17.22 45.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.011 . . . . 0.0 109.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.0 OUTLIER -159.27 119.74 3.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.0 mp -47.54 100.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 109.578 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' HG2' ' K' ' 5' ' ' GLN . 88.8 m -52.12 159.83 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 109.435 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.57 167.21 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -43.2 99.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -0.934 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -62.68 -35.47 79.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.184 -0.947 . . . . 0.0 109.387 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' K' ' 18' ' ' ASN . 0.0 OUTLIER -65.79 -38.41 88.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -81.86 -9.72 59.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -79.19 -28.21 42.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 109.675 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' K' ' 15' ' ' GLN . 55.2 p30 -74.58 -7.6 53.64 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 109.75 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -101.41 -8.41 22.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.25 169.41 17.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.132 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.37 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.569 ' O ' HG13 ' L' ' 2' ' ' VAL . 5.6 p -172.64 108.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.151 -0.968 . . . . 0.0 109.401 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p30 172.14 -36.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.049 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -81.03 -27.38 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.364 -0.835 . . . . 0.0 109.375 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -75.32 -38.42 60.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.528 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . 0.437 ' N ' HD23 ' L' ' 6' ' ' LEU . 4.7 mt -82.82 -38.67 22.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 109.568 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 51.7 t -62.09 -33.7 74.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.93 -19.95 62.12 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 74.3 m -82.83 -5.97 59.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -1.11 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -99.5 -22.0 15.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 109.161 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.5 mt -82.98 -47.68 11.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -53.19 -33.85 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.01 -1.056 . . . . 0.0 109.552 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.08 -46.61 70.53 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.472 ' CB ' ' H3 ' ' L' ' 32' ' ' IPH . . . -86.24 11.01 13.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.273 -0.892 . . . . 0.0 109.851 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.68 -51.13 5.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 13.5 p90 -71.3 -22.9 61.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 109.901 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.485 HD23 HD23 ' F' ' 17' ' ' LEU . 49.8 tp -74.5 -34.61 63.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.776 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.93 -47.74 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 0.0 109.574 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.65 -37.86 68.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 109.797 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.5 -145.97 18.29 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -81.58 0.27 39.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -1.169 . . . . 0.0 109.58 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -62.95 -73.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.419 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.32 165.01 10.16 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 11.2 p90 -160.24 169.3 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.352 -1.087 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -129.8 152.49 49.23 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.192 -0.943 . . . . 0.0 109.389 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -129.9 96.62 4.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.334 -0.853 . . . . 0.0 109.714 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.82 89.51 6.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.57 -62.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.597 2.198 . . . . 0.0 110.195 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt 62.09 92.89 0.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.53 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.452 ' H3 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.424 ' H3 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' IPH . . . . . 0.49 ' H3 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . 0.472 ' H3 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.435 HG23 HG13 ' A' ' 3' ' ' VAL . 20.7 tt -133.22 6.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -1.108 . . . . 0.0 109.429 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 HG23 ' A' ' 2' ' ' ILE . 16.4 m -126.03 -8.37 5.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.264 -0.898 . . . . 0.0 109.75 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -111.77 1.61 16.72 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.199 -0.938 . . . . 0.0 109.792 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.86 13.19 2.91 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.178 -0.951 . . . . 0.0 109.304 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.73 -42.59 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 t -65.33 -16.34 63.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.423 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.9 p -70.89 -22.03 62.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.078 -1.014 . . . . 0.0 109.414 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 p -163.69 144.12 8.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mt -52.62 113.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.4 m -84.29 -164.64 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 0.0 109.1 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.25 171.39 7.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -34.93 75.9 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -0.916 . . . . 0.0 109.277 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -67.4 -38.87 85.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.343 -0.848 . . . . 0.0 109.679 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.955 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.1 mt -77.92 -14.91 59.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 109.938 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.92 -28.87 63.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.023 . . . . 0.0 109.46 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -57.24 -19.03 18.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.57 59.88 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.1 t -123.13 119.76 31.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.641 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.2 t30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.343 179.783 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.604 HG11 ' HA ' ' I' ' 9' ' ' SER . 25.8 m -131.06 46.35 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 109.875 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -101.53 -3.28 28.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -48.28 -38.53 19.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.154 -0.966 . . . . 0.0 109.31 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -93.42 -30.6 14.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.589 HD22 ' CG ' ' J' ' 10' ' ' HIS . 39.6 mt -80.95 -70.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 108.957 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.6 t -51.2 -37.82 48.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.665 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.438 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -61.85 -44.28 98.07 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 31.0 p -67.84 -12.86 61.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 110.008 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -86.15 -24.63 26.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.119 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.531 HD22 ' C1 ' ' B' ' 32' ' ' IPH . 5.7 mt -90.47 -33.77 15.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -0.999 . . . . 0.0 109.519 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.516 HG21 ' CZ ' ' D' ' 16' ' ' TYR . 16.8 m -68.43 -38.54 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.06 -1.025 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.472 ' N ' HG23 ' B' ' 12' ' ' VAL . 13.9 tt0 -66.04 -23.86 66.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.78 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -94.42 -12.89 26.93 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mt -78.67 -28.66 45.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.547 ' CZ ' HG21 ' D' ' 12' ' ' VAL . 60.3 m-85 -48.25 -46.58 35.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 14.7 mt -82.26 -36.26 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.78 HG23 ' O ' ' B' ' 14' ' ' ALA . 69.7 t -47.04 -46.2 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.87 -30.72 26.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.459 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.04 -134.98 11.89 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -7.93 52.15 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.304 -1.115 . . . . 0.0 109.69 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -57.05 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.11 179.08 29.17 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.408 ' HZ ' ' CZ ' ' B' ' 16' ' ' TYR . 0.3 OUTLIER -166.31 168.23 15.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -1.182 . . . . 0.0 110.031 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.631 ' HB2' ' CD1' ' D' ' 25' ' ' PHE . 32.8 p90 -127.53 154.77 44.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.437 ' CD2' HG11 ' B' ' 12' ' ' VAL . 24.3 t80 -140.85 112.17 7.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 15.1 m -133.2 93.25 22.9 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.231 -0.918 . . . . 0.0 109.675 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.07 99.53 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.506 2.137 . . . . 0.0 110.389 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.33 -58.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.531 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.529 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -132.69 7.66 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.158 -1.201 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.92 -6.29 4.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.211 -0.931 . . . . 0.0 109.74 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -114.07 -0.39 14.04 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.128 -0.983 . . . . 0.0 109.604 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -134.65 9.46 3.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.189 -0.944 . . . . 0.0 109.771 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.25 -39.85 0.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.705 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.3 t -66.93 -16.17 64.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 43.1 p -70.22 -24.53 63.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.92 . . . . 0.0 109.302 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . 0.404 ' HA ' HG11 ' L' ' 2' ' ' VAL . 94.9 p -160.47 146.09 14.94 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.409 -0.807 . . . . 0.0 109.355 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.502 HD11 ' O ' ' L' ' 2' ' ' VAL . 4.3 mt -54.55 117.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.7 m -89.45 -165.48 1.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 109.714 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -107.17 166.27 10.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -34.56 78.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.538 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.73 -37.56 79.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.859 . . . . 0.0 109.601 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -66.91 -38.39 86.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 109.53 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.81 -16.23 55.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.884 . . . . 0.0 109.757 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.51 -30.3 68.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -56.42 -19.13 13.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 110.09 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -110.6 58.61 0.61 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.231 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 t -121.64 118.44 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.379 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . 0.559 ' ND2' ' CZ ' ' D' ' 25' ' ' PHE . 9.5 t30 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.509 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.359 0.6 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' G' ' 9' ' ' SER . 30.9 m -132.02 44.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.244 -0.91 . . . . 0.0 109.159 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -100.15 -8.56 23.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 109.552 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -44.34 -40.46 5.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.44 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -90.74 -32.38 16.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.504 HD22 ' CG ' ' H' ' 10' ' ' HIS . 29.0 mt -80.34 -71.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.477 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 8.3 t -51.37 -34.39 34.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.501 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -64.33 -43.86 96.28 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . 0.428 ' HA ' HG22 ' D' ' 12' ' ' VAL . 17.2 p -69.41 -14.94 63.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -1.162 . . . . 0.0 109.711 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.94 -24.38 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.895 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.573 HD22 ' C1 ' ' D' ' 32' ' ' IPH . 6.7 mt -92.79 -32.79 14.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.547 HG21 ' CZ ' ' B' ' 16' ' ' TYR . 15.4 m -68.29 -38.93 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.475 ' N ' HG23 ' D' ' 12' ' ' VAL . 15.0 tt0 -64.91 -27.06 68.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.705 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -91.62 -12.06 35.32 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.333 -0.854 . . . . 0.0 109.853 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.21 -28.82 38.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.516 ' CZ ' HG21 ' B' ' 12' ' ' VAL . 62.3 m-85 -48.38 -45.07 35.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.199 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 mt -81.89 -38.5 25.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.705 HG23 ' O ' ' D' ' 14' ' ' ALA . 67.5 t -45.85 -44.38 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.891 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -84.86 -29.77 25.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.899 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.2 -131.66 10.65 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.73 -6.99 38.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.65 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -56.69 -81.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.061 -1.024 . . . . 0.0 109.467 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.78 176.74 28.28 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 25' ' ' PHE . 0.4 OUTLIER -164.07 161.31 22.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.146 -1.208 . . . . 0.0 109.883 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . 0.631 ' CD1' ' HB2' ' B' ' 25' ' ' PHE . 4.4 m-85 -119.11 163.16 17.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.416 -0.803 . . . . 0.0 109.284 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.43 ' CD2' HG11 ' D' ' 12' ' ' VAL . 33.0 t80 -151.16 105.69 3.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 108.896 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 24.4 m -127.19 94.43 38.89 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 109.594 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.98 97.28 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.555 2.17 . . . . 0.0 110.369 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.13 -61.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.221 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.35 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 tt -132.44 3.16 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -1.125 . . . . 0.0 109.563 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 m -122.9 -9.58 8.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.19 -0.944 . . . . 0.0 109.94 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.89 1.69 19.35 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.104 -0.997 . . . . 0.0 110.164 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -136.7 11.33 3.16 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.041 -1.037 . . . . 0.0 109.669 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' E' ' 9' ' ' SER . 0.0 OUTLIER -144.32 -40.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 8.1 t -64.55 -18.0 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 108.954 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 41.4 p -69.61 -25.1 63.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.376 -0.828 . . . . 0.0 109.413 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . 0.421 ' O ' ' O ' ' E' ' 6' ' ' CYS . 12.5 p -159.56 148.82 18.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.372 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.438 HG12 ' HB3' ' J' ' 5' ' ' HIS . 4.0 mt -58.7 115.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -86.55 -158.69 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.785 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.1 167.82 10.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' L' ' 17' ' ' LEU . 0.1 OUTLIER -66.11 -35.78 81.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -66.05 -40.79 91.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.986 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -80.37 -15.45 56.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -0.973 . . . . 0.0 109.594 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.14 -25.79 62.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.722 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -60.42 -19.49 56.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.215 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.7 62.05 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 34.5 t -125.45 119.67 28.88 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.461 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.424 ' O ' HG23 ' F' ' 2' ' ' VAL . 25.4 m -129.38 44.6 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.264 -0.898 . . . . 0.0 109.375 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -100.52 -4.68 28.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.377 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -48.6 -38.04 19.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -93.32 -30.92 14.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.584 HD21 ' H3 ' ' B' ' 32' ' ' IPH . 35.2 mt -81.36 -71.1 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.085 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.495 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.5 t -50.18 -37.21 33.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.44 -0.787 . . . . 0.0 109.356 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.483 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -61.76 -42.97 99.82 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . 0.469 ' HA ' HG22 ' F' ' 12' ' ' VAL . 58.4 p -70.85 -13.53 62.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.132 -1.216 . . . . 0.0 110.043 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -84.07 -24.38 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.985 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.499 HD22 ' C1 ' ' E' ' 31' ' ' IPH . 6.5 mt -91.64 -33.45 15.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.813 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.557 HG21 ' CZ ' ' H' ' 16' ' ' TYR . 18.4 m -69.22 -36.26 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 109.848 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.419 ' N ' HG23 ' F' ' 12' ' ' VAL . 16.0 tt0 -69.11 -22.22 63.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.769 ' O ' HG23 ' F' ' 18' ' ' VAL . . . -95.52 -11.03 28.1 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.251 -0.906 . . . . 0.0 109.432 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.71 -28.19 36.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.272 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.499 ' CZ ' HG21 ' H' ' 12' ' ' VAL . 54.0 m-85 -48.61 -47.61 39.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 109.655 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' F' ' 18' ' ' VAL . 12.4 mt -80.93 -38.59 27.59 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.769 HG23 ' O ' ' F' ' 14' ' ' ALA . 70.8 t -44.62 -45.68 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 m -83.96 -30.04 26.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.36 -133.21 11.22 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.0 -12.89 29.54 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.256 -1.144 . . . . 0.0 109.538 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 23.0 mtt180 -50.72 -83.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.2 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.04 -177.46 33.09 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . 0.408 ' HZ ' ' CZ ' ' F' ' 16' ' ' TYR . 0.2 OUTLIER -171.45 168.86 6.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -1.134 . . . . 0.0 109.469 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -132.07 166.12 22.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.602 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -147.42 115.44 6.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.52 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -132.66 91.53 29.72 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.32 98.51 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.612 2.208 . . . . 0.0 110.191 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.0 -58.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.59 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.578 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.08 8.26 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -1.2 . . . . 0.0 109.735 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -127.2 -5.76 4.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -113.23 -1.14 14.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.021 -1.049 . . . . 0.0 109.812 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -134.4 11.58 3.8 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.083 -1.011 . . . . 0.0 109.704 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' G' ' 9' ' ' SER . 0.1 OUTLIER -143.98 -40.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 t -66.4 -18.11 65.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 60.5 p -69.17 -22.28 63.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.48 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . 0.659 ' HA ' HG11 ' D' ' 2' ' ' VAL . 4.3 p -162.67 148.58 12.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.299 -0.875 . . . . 0.0 109.433 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mt -58.08 115.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.672 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.77 -165.02 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 109.667 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.1 167.4 10.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -35.55 81.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.732 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -67.27 -37.75 83.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.154 -0.967 . . . . 0.0 109.852 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.39 -40.5 89.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -77.51 -14.14 59.74 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -73.15 -30.35 63.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.338 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -53.9 -23.45 12.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -108.37 64.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.97 120.89 30.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.331 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.562 -179.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.9 t80 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.298 0.57 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 31.8 m -126.17 41.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' H' ' 4' ' ' GLN . 11.6 m120 -96.92 -9.92 27.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' H' ' 3' ' ' ASN . 50.2 tt0 -43.03 -40.14 2.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -90.98 -33.22 15.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.347 -0.846 . . . . 0.0 109.313 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 29.9 mt -78.44 -73.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 7.7 t -47.13 -41.46 17.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.815 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . 0.441 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -58.84 -44.87 95.7 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . 0.411 ' HA ' HG22 ' H' ' 12' ' ' VAL . 24.3 p -67.33 -14.92 63.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -1.114 . . . . 0.0 109.838 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . 0.504 ' CG ' HD22 ' D' ' 6' ' ' LEU . 5.6 m-70 -85.88 -20.36 29.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.665 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.572 HD22 ' C1 ' ' G' ' 31' ' ' IPH . 9.0 mt -94.87 -35.3 12.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.384 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.499 HG21 ' CZ ' ' F' ' 16' ' ' TYR . 15.6 m -68.1 -34.18 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.899 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -69.82 -23.08 63.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.141 -0.974 . . . . 0.0 109.219 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.756 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -95.09 -9.99 32.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.39 -0.819 . . . . 0.0 109.538 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -82.37 -26.83 32.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.557 ' CZ ' HG21 ' F' ' 12' ' ' VAL . 53.5 m-85 -50.04 -44.06 51.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 109.615 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.09 -36.45 21.16 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.27 -0.894 . . . . 0.0 109.724 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.756 HG23 ' O ' ' H' ' 14' ' ' ALA . 76.5 t -46.33 -42.67 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 -29.39 21.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.79 -133.34 11.31 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.25 -11.5 38.01 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -1.17 . . . . 0.0 109.738 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -53.01 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.037 . . . . 0.0 109.646 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.98 176.94 23.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.24 175.41 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 109.429 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 8.6 p90 -137.94 167.24 22.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.991 . . . . 0.0 109.526 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -149.57 115.48 5.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.288 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 24.7 m -133.84 90.82 26.33 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.227 -0.92 . . . . 0.0 109.328 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.16 101.0 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.674 2.249 . . . . 0.0 110.092 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.82 -57.58 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 109.656 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.056 -0.974 . . . . 0.0 109.552 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.439 HG23 HG13 ' I' ' 3' ' ' VAL . 19.6 tt -131.08 8.05 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -1.089 . . . . 0.0 109.501 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . 0.439 HG13 HG23 ' I' ' 2' ' ' ILE . 15.9 m -128.71 -5.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.299 -0.876 . . . . 0.0 109.771 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -115.06 -0.06 13.46 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.172 -0.955 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -135.01 8.16 3.47 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.47 -41.43 0.41 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.75 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -64.63 -20.71 66.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . 0.425 ' O ' HG11 ' B' ' 2' ' ' VAL . 39.0 p -66.44 -23.39 66.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . 0.604 ' HA ' HG11 ' B' ' 2' ' ' VAL . 7.5 p -161.65 146.32 13.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.167 -0.958 . . . . 0.0 109.697 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.65 114.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.56 -164.25 0.98 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 0.0 109.409 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -109.56 168.12 9.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -34.77 78.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -67.3 -39.56 85.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.45 -39.99 92.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.838 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mt -79.32 -14.3 59.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.336 -0.852 . . . . 0.0 109.899 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -71.81 -27.17 62.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -58.05 -18.62 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.359 -0.838 . . . . 0.0 109.74 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -111.97 61.31 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 t -122.84 121.85 37.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.364 -0.835 . . . . 0.0 109.198 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.504 -179.759 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 11.0 t80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.271 0.557 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.42 HG23 ' O ' ' J' ' 2' ' ' VAL . 31.0 m -133.33 47.29 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' J' ' 4' ' ' GLN . 13.2 m120 -102.57 -8.46 20.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.842 . . . . 0.0 109.33 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' J' ' 3' ' ' ASN . 50.4 tt0 -44.03 -38.38 3.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 109.352 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . 0.438 ' HB3' HG12 ' E' ' 10' ' ' ILE . 86.4 t60 -93.34 -33.95 13.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.94 . . . . 0.0 109.211 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . 0.509 HD21 ' H3 ' ' E' ' 31' ' ' IPH . 38.9 mt -78.03 -70.28 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.437 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.499 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 7.3 t -51.97 -37.51 53.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.354 -0.842 . . . . 0.0 109.477 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.439 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -60.76 -45.17 96.98 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . 0.493 ' HA ' HG22 ' J' ' 12' ' ' VAL . 86.6 p -68.51 -16.08 63.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.141 -1.211 . . . . 0.0 110.078 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . 0.589 ' CG ' HD22 ' B' ' 6' ' ' LEU . 4.7 m-70 -82.92 -20.49 35.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.043 . . . . 0.0 109.716 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.547 HD22 ' C1 ' ' J' ' 32' ' ' IPH . 7.8 mt -95.16 -34.18 12.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.508 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.504 HG21 ' CZ ' ' L' ' 16' ' ' TYR . 19.1 m -68.19 -33.9 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.107 -0.995 . . . . 0.0 109.239 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -70.97 -23.77 62.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.605 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.81 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -95.55 -8.1 36.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.31 -0.869 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.8 -25.39 30.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.505 ' CZ ' HG21 ' L' ' 12' ' ' VAL . 46.3 m-85 -51.93 -44.54 63.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.456 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 13.1 mt -83.34 -39.17 21.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.618 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . 0.81 HG23 ' O ' ' J' ' 14' ' ' ALA . 69.5 t -44.75 -44.15 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.578 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -85.54 -30.62 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.359 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.61 -135.42 12.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -9.78 44.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.214 -1.168 . . . . 0.0 109.949 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -53.84 -76.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 0.0 109.664 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.46 176.8 22.99 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.21 171.16 11.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 109.688 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 6.1 p90 -134.39 165.07 26.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.47 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . 0.411 ' CD2' HG11 ' J' ' 12' ' ' VAL . 23.3 t80 -146.07 118.76 8.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.254 -0.904 . . . . 0.0 109.26 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 23.7 m -136.89 91.0 15.59 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.717 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.34 100.05 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.664 2.243 . . . . 0.0 110.413 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -59.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.316 -0.865 . . . . 0.0 109.256 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.495 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.428 HG23 HG13 ' K' ' 3' ' ' VAL . 20.6 tt -133.03 9.5 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -1.1 . . . . 0.0 109.473 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.428 HG13 HG23 ' K' ' 2' ' ' ILE . 15.6 m -129.71 -3.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.936 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -116.25 -2.1 12.22 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.08 -1.013 . . . . 0.0 109.446 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -133.23 11.18 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.341 -0.849 . . . . 0.0 109.408 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.5 -40.78 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 109.739 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -66.16 -16.76 64.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.964 . . . . 0.0 109.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -69.42 -26.29 64.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.236 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 6.4 p -158.08 149.9 21.69 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -0.913 . . . . 0.0 109.544 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.58 115.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.2 -0.937 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -87.78 -164.27 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.125 -0.984 . . . . 0.0 109.49 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.28 171.08 7.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.301 -0.874 . . . . 0.0 109.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.38 -36.78 77.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.361 -0.837 . . . . 0.0 109.348 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -65.57 -38.66 90.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.448 -0.783 . . . . 0.0 109.669 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -66.05 -40.38 90.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.853 . . . . 0.0 109.742 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.1 mt -78.43 -13.54 59.79 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.851 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.88 -28.29 63.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -57.97 -17.23 15.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -0.79 . . . . 0.0 109.659 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -112.82 60.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.314 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 t -123.17 120.36 32.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.393 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.502 ' O ' HD11 ' C' ' 10' ' ' ILE . 29.0 m -127.8 45.75 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.54 -6.57 23.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.541 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -46.06 -39.69 9.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -92.26 -30.75 15.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . 0.622 HD21 ' H3 ' ' D' ' 32' ' ' IPH . 31.7 mt -80.73 -72.08 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.237 -0.914 . . . . 0.0 109.193 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.496 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 8.3 t -49.49 -39.95 35.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.416 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -59.68 -43.53 97.69 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 87.4 p -68.33 -18.15 64.43 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.16 -1.2 . . . . 0.0 109.784 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -81.56 -21.73 38.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.992 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.511 HD22 ' C1 ' ' L' ' 32' ' ' IPH . 6.7 mt -93.75 -34.35 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.505 HG21 ' CZ ' ' J' ' 16' ' ' TYR . 18.6 m -67.28 -38.57 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.01 . . . . 0.0 109.51 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.449 ' N ' HG23 ' L' ' 12' ' ' VAL . 17.1 tt0 -65.72 -25.07 67.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.898 . . . . 0.0 109.345 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.752 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -92.57 -14.14 28.71 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 6.7 mt -78.63 -31.31 46.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 0.0 109.401 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.504 ' CZ ' HG21 ' J' ' 12' ' ' VAL . 44.7 m-85 -45.51 -45.38 13.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.9 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' E' ' 13' ' ' LEU . 13.1 mt -84.0 -35.75 23.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 109.933 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . 0.752 HG23 ' O ' ' L' ' 14' ' ' ALA . 70.3 t -47.42 -45.36 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.61 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.81 -33.52 27.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.234 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.75 -134.96 12.02 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.82 -11.49 39.22 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.19 -1.182 . . . . 0.0 109.471 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -52.71 -79.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.921 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.34 178.47 27.93 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -167.29 172.29 9.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.158 -1.201 . . . . 0.0 109.69 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -134.21 163.62 29.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -147.38 113.34 5.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.349 -0.845 . . . . 0.0 109.226 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -132.56 89.91 34.67 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.767 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.16 100.6 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.525 2.15 . . . . 0.0 110.47 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -159.63 -62.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.337 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.584 ' H3 ' HD21 ' F' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.622 ' H3 ' HD21 ' L' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 31' ' ' IPH . . . . . 0.509 ' H3 ' HD21 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 31' ' ' IPH . . . . . 0.572 ' C1 ' HD22 ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . 0.547 ' C1 ' HD22 ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . 0.511 ' C1 ' HD22 ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.426 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.3 tt -109.19 0.15 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.215 -1.167 . . . . 0.0 109.618 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 3' ' ' VAL . 59.2 t -100.82 46.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.097 -1.002 . . . . 0.0 109.681 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -171.58 -40.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.31 -7.17 26.7 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.126 -0.984 . . . . 0.0 109.814 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.85 -18.94 3.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.482 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 0.5 OUTLIER -82.73 -18.26 41.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 109.117 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.3 p -83.72 -12.51 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.533 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.84 2.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.552 ' CD1' ' HB ' ' F' ' 2' ' ' VAL . 2.0 mp -61.57 140.85 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.2 m -103.94 -164.77 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.858 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -103.62 -174.3 2.51 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -0.935 . . . . 0.0 109.23 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.84 -37.37 64.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -68.91 -23.94 64.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.87 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -79.16 -39.36 33.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -0.938 . . . . 0.0 109.593 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.6 mt -82.05 -11.68 58.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.52 -21.26 49.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.687 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -62.13 -18.68 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.932 . . . . 0.0 109.962 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.426 ' CD2' HD12 ' A' ' 2' ' ' ILE . 2.8 m-85 -118.33 48.02 1.5 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.86 110.95 13.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.208 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.644 -179.709 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.267 0.556 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.93 106.02 4.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.34 -0.85 . . . . 0.0 109.319 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.414 ' HB3' ' CB ' ' B' ' 7' ' ' CYS . 22.7 m-80 -103.15 -8.2 20.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 0.0 109.246 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -48.88 -36.91 18.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.215 -0.928 . . . . 0.0 109.031 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.503 ' HB3' HG12 ' I' ' 10' ' ' ILE . 18.5 t60 -95.64 -30.38 13.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.147 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.05 -70.72 0.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.492 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 11.5 t -53.74 -32.16 51.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 0.0 109.767 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.94 -32.21 53.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -79.2 -3.34 45.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -1.23 . . . . 0.0 109.579 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.22 -14.65 20.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.336 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 14.3 mt -91.91 -43.55 9.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.429 ' H ' HG22 ' B' ' 12' ' ' VAL . 2.7 m -56.8 -37.03 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.12 -36.18 81.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.332 -0.855 . . . . 0.0 109.871 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.89 11.19 39.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.081 -1.012 . . . . 0.0 109.807 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' B' ' 11' ' ' LEU . 0.7 OUTLIER -96.67 -54.91 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 7.8 p90 -63.94 -18.05 63.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.954 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -78.28 -48.18 16.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.279 -0.888 . . . . 0.0 109.45 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.05 -47.97 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.21 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.64 -57.07 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 91.89 -140.34 15.13 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 20' ' ' GLY . 19.4 mt-10 -45.54 -30.79 1.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.084 -1.245 . . . . 0.0 109.36 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -69.35 159.81 32.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' B' ' 24' ' ' PHE . . . -100.51 -158.24 27.86 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 11.3 p90 -178.76 177.28 0.88 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -1.142 . . . . 0.0 109.228 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.55 146.39 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 109.683 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.506 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 28.6 t80 -122.93 87.29 2.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.318 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -117.61 105.74 47.49 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 109.684 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.526 ' HB3' HG21 ' A' ' 3' ' ' VAL . 36.3 Cg_endo -78.1 -36.26 1.09 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.499 2.133 . . . . 0.0 110.538 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mttm 64.22 -87.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 109.41 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.528 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.531 HD12 ' CD2' ' C' ' 19' ' ' TYR . 15.4 tt -112.24 0.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.155 -1.203 . . . . 0.0 109.558 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.651 HG12 ' O ' ' C' ' 3' ' ' VAL . 55.6 t -101.15 46.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -171.58 -45.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.72 -7.43 37.34 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.696 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . 0.442 ' HB2' HG13 ' C' ' 2' ' ' ILE . 0.5 OUTLIER -127.56 -17.71 4.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.163 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -86.34 -16.18 38.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.897 -1.127 . . . . 0.0 109.862 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.4 p -86.12 -10.51 54.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 109.517 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.79 148.49 2.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 108.995 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' L' ' 5' ' ' HIS . 1.3 mp -58.25 151.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.991 -1.068 . . . . 0.0 109.382 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.7 -174.43 2.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.372 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -177.16 4.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.717 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.58 -38.86 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -66.29 -24.62 66.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -79.7 -36.87 36.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.26 -0.9 . . . . 0.0 109.98 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 62.4 mt -85.15 -6.83 59.28 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.89 -18.21 38.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -65.69 -19.77 66.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.279 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.531 ' CD2' HD12 ' C' ' 2' ' ' ILE . 2.5 m-85 -116.98 48.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.484 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.89 108.24 10.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.169 -0.957 . . . . 0.0 109.494 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.572 -179.877 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.479 ' HB ' HD13 ' G' ' 10' ' ' ILE . 4.4 t -131.06 106.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 109.529 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -103.16 -8.78 20.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.495 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -48.82 -36.55 17.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.97 . . . . 0.0 109.375 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -94.62 -31.31 13.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.1 mt -81.39 -71.24 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.484 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 19.5 t -49.75 -37.92 31.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 0.0 109.52 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.51 -35.9 68.34 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -75.25 -5.1 42.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.098 -1.236 . . . . 0.0 109.714 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -97.1 -16.27 20.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 16.9 mt -91.97 -41.87 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.818 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.03 -34.98 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.125 -0.984 . . . . 0.0 109.735 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -69.54 -34.51 74.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -0.932 . . . . 0.0 109.643 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.36 6.83 45.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.195 -0.941 . . . . 0.0 109.84 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.9 OUTLIER -92.24 -57.27 2.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.049 -1.032 . . . . 0.0 109.494 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.524 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 7.6 p90 -61.2 -19.06 61.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 109.79 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.434 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 1.5 mt -78.03 -48.59 15.79 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -0.963 . . . . 0.0 109.574 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -54.49 -45.16 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.17 -54.42 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.09 -137.33 14.12 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.78 -29.0 4.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -1.138 . . . . 0.0 109.35 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.58 158.36 33.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.271 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.04 -161.8 27.57 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 6.5 p90 -167.33 178.26 5.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -1.224 . . . . 0.0 110.208 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -129.86 133.31 46.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.789 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -117.21 88.81 2.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.303 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.4 m -124.23 106.25 30.84 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.351 -0.843 . . . . 0.0 109.323 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.0 Cg_endo -78.52 -32.73 2.06 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.344 2.029 . . . . 0.0 110.629 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.53 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.425 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.456 HD12 ' CD2' ' E' ' 19' ' ' TYR . 14.4 tt -114.46 0.55 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -1.075 . . . . 0.0 109.226 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . 0.646 ' O ' HG12 ' E' ' 3' ' ' VAL . 58.3 t -101.81 45.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.285 -0.884 . . . . 0.0 109.988 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -169.96 -42.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.96 -9.15 28.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.311 -0.868 . . . . 0.0 109.722 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -127.34 -14.24 5.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.958 . . . . 0.0 110.352 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.67 -17.41 33.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.937 -1.102 . . . . 0.0 109.316 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 43.9 p -86.32 -10.01 55.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.27 151.62 3.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.492 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.498 HD13 ' HB ' ' J' ' 2' ' ' VAL . 2.0 mp -63.46 138.74 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.381 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 61.7 m -102.62 -165.62 1.2 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.081 -1.012 . . . . 0.0 109.601 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -104.52 -175.46 2.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -72.07 -38.85 69.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 110.031 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -68.38 -24.16 64.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.076 -1.015 . . . . 0.0 109.674 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -78.03 -41.38 35.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 65.1 mt -81.28 -9.62 59.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.233 -0.917 . . . . 0.0 109.993 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.35 -17.7 48.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 109.636 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -66.15 -16.91 64.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.15 -0.969 . . . . 0.0 109.424 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' E' ' 2' ' ' ILE . 3.0 m-85 -119.27 50.6 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -130.48 110.21 11.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.543 -179.934 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.215 0.531 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.552 ' HB ' ' CD1' ' A' ' 10' ' ' ILE . 3.9 t -138.81 107.46 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.216 -0.927 . . . . 0.0 109.468 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -103.68 -5.88 22.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.741 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -50.94 -37.54 44.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.075 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . 0.411 ' CB ' HG12 ' A' ' 10' ' ' ILE . 16.3 t60 -95.21 -24.68 16.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.356 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 22.0 mt -87.83 -69.85 0.67 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 10.2 t -52.96 -35.65 59.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.36 -31.69 63.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' F' ' 5' ' ' HIS . 1.1 t -77.95 -7.83 57.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -1.216 . . . . 0.0 109.576 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -93.86 -16.87 23.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 110.091 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 10.9 mt -91.41 -41.42 10.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.24 -32.27 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.12 -0.988 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -72.5 -33.3 66.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 109.652 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' F' ' 18' ' ' VAL . . . -100.72 6.58 43.99 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.8 OUTLIER -92.46 -54.71 3.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.682 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 7.2 p90 -63.9 -20.8 66.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.458 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.81 -49.86 16.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.066 -1.021 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' F' ' 14' ' ' ALA . 75.5 t -52.06 -43.53 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.917 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 79.5 m -69.49 -51.8 32.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 109.661 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 87.78 -139.98 16.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' F' ' 20' ' ' GLY . 17.7 mt-10 -44.95 -34.34 2.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -1.149 . . . . 0.0 109.365 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -67.37 159.04 30.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.811 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.25 -165.3 24.72 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -166.69 -171.13 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -1.112 . . . . 0.0 109.621 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.04 142.62 30.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -120.76 94.68 4.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.9 m -126.98 103.36 23.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.425 -0.797 . . . . 0.0 109.216 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . 0.581 ' HB3' HG21 ' E' ' 3' ' ' VAL . 35.0 Cg_endo -76.7 -36.41 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.393 2.062 . . . . 0.0 110.464 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mttm 65.54 -86.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.164 -0.96 . . . . 0.0 109.482 -179.75 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.506 HD12 ' CD2' ' G' ' 19' ' ' TYR . 14.8 tt -111.16 -0.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -1.136 . . . . 0.0 109.519 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . 0.631 ' O ' HG12 ' G' ' 3' ' ' VAL . 55.6 t -100.42 47.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.246 -0.908 . . . . 0.0 109.708 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -171.91 -42.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.98 . . . . 0.0 109.737 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.5 -9.69 24.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . 0.44 ' HB2' HG13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -127.62 -9.08 5.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.931 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.47 -13.96 27.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 109.477 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 41.0 p -88.23 -14.0 39.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.6 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.34 149.33 5.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.479 HD13 ' HB ' ' D' ' 2' ' ' VAL . 1.8 mp -57.33 146.66 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 109.188 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -112.3 -168.4 1.31 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 110.404 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -101.78 176.28 5.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.632 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 tp -65.71 -41.96 91.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.962 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -64.76 -25.27 67.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.281 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -78.06 -39.91 40.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.048 -1.032 . . . . 0.0 109.694 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.28 -6.09 59.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.612 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -83.75 -19.67 34.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.12 -18.87 65.66 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.478 -0.764 . . . . 0.0 109.408 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . 0.506 ' CD2' HD12 ' G' ' 2' ' ' ILE . 2.0 m-85 -118.28 51.83 1.06 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.381 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.94 107.62 8.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.853 . . . . 0.0 109.451 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.43 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.395 0.616 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.649 ' HB ' HD13 ' K' ' 10' ' ' ILE . 4.9 t -140.73 102.57 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.43 -0.794 . . . . 0.0 109.279 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' H' ' 4' ' ' GLN . 23.6 m-80 -100.33 -11.65 20.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.547 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' H' ' 3' ' ' ASN . 2.3 tt0 -44.76 -37.11 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.836 . . . . 0.0 109.168 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' H' ' 9' ' ' SER . 13.7 t60 -95.09 -29.48 14.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.813 . . . . 0.0 109.464 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.9 mt -84.22 -69.97 0.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.5 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.477 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 1.4 t -52.88 -34.86 56.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 109.151 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.88 -32.8 60.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' H' ' 5' ' ' HIS . 1.4 t -77.66 -5.87 51.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -1.178 . . . . 0.0 109.867 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.13 -14.87 21.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.965 . . . . 0.0 109.882 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.1 mt -91.85 -42.59 9.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.642 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.453 ' H ' HG22 ' H' ' 12' ' ' VAL . 2.7 m -58.03 -35.32 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.872 . . . . 0.0 109.805 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.26 -35.84 76.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.52 8.99 44.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.287 -0.883 . . . . 0.0 109.828 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.7 OUTLIER -95.56 -55.71 2.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 8.5 p90 -62.31 -22.08 65.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.151 -0.968 . . . . 0.0 109.404 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.414 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 1.6 mt -74.0 -49.8 22.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.702 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.26 -44.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.933 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.72 -52.7 49.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.963 -1.086 . . . . 0.0 109.023 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.86 -137.51 14.27 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -48.98 -28.41 3.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 0.0 109.425 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -72.64 156.55 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.92 . . . . 0.0 109.19 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.51 -163.06 29.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -171.48 -171.54 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.338 -1.095 . . . . 0.0 109.196 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 3.2 p90 -146.64 146.94 30.57 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -122.23 92.4 3.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.313 -0.867 . . . . 0.0 109.344 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 1.5 m -122.5 104.99 36.51 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.367 -0.833 . . . . 0.0 109.262 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . 0.596 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.9 Cg_endo -78.18 -39.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 0.0 109.977 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.6 OUTLIER 69.91 -85.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.423 -179.673 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' I' ' 19' ' ' TYR . 12.6 tt -110.51 0.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -1.151 . . . . 0.0 109.553 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . 0.592 ' O ' HG12 ' I' ' 3' ' ' VAL . 46.8 t -101.64 48.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.248 -0.907 . . . . 0.0 109.762 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -172.62 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.354 -0.842 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.03 -11.94 29.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.252 -0.905 . . . . 0.0 110.009 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -126.78 -13.87 5.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.06 -15.36 41.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.314 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -87.81 -17.44 31.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.27 153.44 13.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.0 109.276 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' B' ' 5' ' ' HIS . 1.9 mp -64.59 140.78 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.987 . . . . 0.0 109.374 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 62.8 m -103.26 -163.46 0.99 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.44 -173.91 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp -73.28 -39.58 65.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.307 -0.871 . . . . 0.0 109.258 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -67.68 -22.67 65.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.41 -0.806 . . . . 0.0 109.735 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -81.0 -36.62 30.42 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.57 -9.52 57.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.55 -19.64 48.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 0.0 109.904 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -64.17 -20.1 65.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . 0.495 ' CE2' HD12 ' I' ' 2' ' ' ILE . 2.3 m-85 -115.87 48.77 1.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.523 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -128.47 109.33 11.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.377 179.82 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' E' ' 10' ' ' ILE . 4.6 t -136.01 103.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.362 -0.836 . . . . 0.0 109.816 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -101.31 -10.68 20.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.555 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -47.18 -35.08 6.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -96.77 -29.09 13.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 0.0 109.181 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -84.28 -69.05 0.67 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.08 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 1.4 t -53.56 -33.05 53.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.367 -0.833 . . . . 0.0 109.367 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.61 54.97 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -77.6 -2.49 36.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.007 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -97.95 -15.45 20.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 14.2 mt -92.49 -42.38 9.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.578 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -58.32 -34.28 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -0.97 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.65 -33.02 70.52 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.91 6.59 43.71 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.195 -0.941 . . . . 0.0 109.704 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' J' ' 11' ' ' LEU . 0.8 OUTLIER -92.62 -55.91 3.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 10.0 p90 -63.08 -18.6 63.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -78.15 -50.62 11.62 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.101 -1.0 . . . . 0.0 109.103 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.65 -46.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 67.8 m -66.32 -53.28 38.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.98 -137.93 14.78 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -47.33 -29.87 2.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.78 153.58 41.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.59 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.68 30.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -163.5 -170.72 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -1.103 . . . . 0.0 109.573 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . 0.445 ' CD1' ' O ' ' J' ' 25' ' ' PHE . 36.0 p90 -144.01 143.93 31.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.597 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -121.55 90.64 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -0.856 . . . . 0.0 109.39 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -122.16 103.65 38.95 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . 0.538 ' HB3' HG21 ' I' ' 3' ' ' VAL . 35.3 Cg_endo -76.97 -36.76 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.425 2.083 . . . . 0.0 110.496 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm 65.52 -86.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.333 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.487 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.484 HD12 ' CD2' ' K' ' 19' ' ' TYR . 15.8 tt -111.53 1.62 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -1.14 . . . . 0.0 109.649 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.621 HG12 ' O ' ' K' ' 3' ' ' VAL . 48.5 t -102.38 46.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -171.41 -42.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.15 -0.969 . . . . 0.0 109.623 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.15 33.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 109.918 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 t -129.71 -23.17 2.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.07 -1.019 . . . . 0.0 110.183 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' L' ' 7' ' ' CYS . 0.5 OUTLIER -79.87 -12.35 59.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.048 -1.032 . . . . 0.0 109.593 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -90.22 -9.62 47.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.09 152.77 2.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.649 HD13 ' HB ' ' H' ' 2' ' ' VAL . 1.8 mp -65.65 135.27 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.994 . . . . 0.0 109.265 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -97.29 -164.02 1.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 109.594 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -104.21 -173.16 2.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -74.34 -40.5 62.12 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.165 -0.959 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -66.58 -26.52 67.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.735 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.06 -37.78 57.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.876 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 55.2 mt -85.6 -6.26 59.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.899 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.1 -19.47 36.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.991 . . . . 0.0 109.274 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -64.57 -16.98 63.51 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.359 -0.838 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . 0.484 ' CD2' HD12 ' K' ' 2' ' ' ILE . 2.4 m-85 -119.58 47.73 1.66 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.93 . . . . 0.0 109.627 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . 0.418 ' O ' ' OXT' ' K' ' 21' ' ' ASN . 0.1 OUTLIER -128.08 108.5 10.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.534 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . 0.418 ' OXT' ' O ' ' K' ' 20' ' ' CYS . 6.4 t-20 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.502 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 t -136.76 107.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 109.662 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -102.95 -8.21 20.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.732 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -47.84 -34.55 8.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . 0.543 ' CB ' HG12 ' C' ' 10' ' ' ILE . 19.2 t60 -98.75 -29.33 13.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.213 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 mt -82.44 -69.75 0.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.107 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.478 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 11.8 t -53.88 -33.92 57.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.24 -33.41 56.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' L' ' 5' ' ' HIS . 2.0 t -77.34 -4.57 45.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.324 -1.104 . . . . 0.0 109.637 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -98.16 -14.42 20.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.194 -0.941 . . . . 0.0 109.541 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 15.6 mt -91.98 -44.12 9.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.37 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.419 ' H ' HG22 ' L' ' 12' ' ' VAL . 2.6 m -56.57 -35.1 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.932 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -69.57 -35.57 75.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 109.699 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.69 8.7 44.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' L' ' 11' ' ' LEU . 0.7 OUTLIER -94.63 -52.73 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.773 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 12.7 p90 -66.3 -18.87 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.003 -1.061 . . . . 0.0 109.366 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.63 -48.18 17.49 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.94 -46.76 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.16 -55.22 27.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.223 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.4 -138.53 14.34 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -48.49 -29.4 4.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -1.178 . . . . 0.0 109.31 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -72.04 156.04 39.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 0.0 109.438 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.55 -165.25 29.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -167.23 -176.88 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -1.13 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -137.55 146.54 44.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.48 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -124.07 85.56 2.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.86 105.1 50.15 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 109.534 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . 0.6 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.4 Cg_endo -78.86 -32.13 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 110.319 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 mttm 61.77 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 0.0 109.837 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.349 -179.634 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.403 HD13 HD11 ' B' ' 15' ' ' LEU . 80.9 mt -122.47 -24.88 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -1.158 . . . . 0.0 109.492 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.25 -14.98 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.226 -0.921 . . . . 0.0 109.54 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.84 45.52 2.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.233 -0.917 . . . . 0.0 109.347 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -166.28 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.347 -0.845 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.54 -24.7 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -14.6 59.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.462 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 9' ' ' SER . 33.0 p -97.56 3.1 50.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 109.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' THR . 80.9 p -179.46 137.58 0.13 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.161 -0.962 . . . . 0.0 109.688 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -54.73 147.14 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.845 . . . . 0.0 109.472 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -121.14 174.09 6.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -101.23 -177.16 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 4.4 mp -75.16 -24.87 57.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.502 -0.749 . . . . 0.0 109.654 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.98 -43.03 65.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.673 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -70.77 -42.45 70.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.647 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.74 -23.27 61.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.854 . . . . 0.0 110.157 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 9.3 mt-10 -76.75 -22.46 53.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -57.74 -23.67 53.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.846 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 20' ' ' CYS . 75.2 m-85 -84.21 -104.74 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.285 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER 53.41 168.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.902 -1.123 . . . . 0.0 109.791 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.03 -0.985 . . . . 0.0 109.517 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.542 HG23 ' O ' ' B' ' 2' ' ' VAL . 17.0 m -79.07 83.49 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -124.78 -26.07 3.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.981 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -38.76 69.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 109.5 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.537 ' CB ' HG12 ' I' ' 10' ' ' ILE . 12.8 t60 -88.56 -29.44 20.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.907 . . . . 0.0 109.42 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 mt -87.93 -72.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 38.5 t -45.78 -34.91 3.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.61 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.78 -40.58 52.4 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 93.6 p -74.75 0.97 13.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -1.181 . . . . 0.0 109.97 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -97.47 -23.21 16.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 109.3 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.536 HD23 ' N ' ' B' ' 11' ' ' LEU . 4.6 mt -87.86 -36.14 17.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.407 -0.808 . . . . 0.0 109.526 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.546 HG23 ' N ' ' B' ' 13' ' ' GLU . 20.7 m -48.99 -46.65 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.407 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.546 ' N ' HG23 ' B' ' 12' ' ' VAL . 0.8 OUTLIER -67.07 -31.97 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.3 21.99 6.45 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.113 -0.992 . . . . 0.0 109.424 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.403 HD11 HD13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -115.92 -60.84 1.82 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.533 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.492 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 7.4 p90 -64.12 -33.15 75.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.449 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.791 HD23 HD23 ' H' ' 17' ' ' LEU . 43.0 tp -63.84 -42.52 97.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.24 -61.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.318 -0.864 . . . . 0.0 109.605 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 66.0 m -67.42 -70.31 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.0 132.77 0.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 53.81 41.23 32.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -1.162 . . . . 0.0 109.795 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.429 ' HD3' ' SG ' ' A' ' 20' ' ' CYS . 1.8 ttt180 -143.19 -62.25 0.41 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.63 157.64 11.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 8.0 p90 -160.23 172.95 16.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -1.14 . . . . 0.0 109.289 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.567 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 8.0 p90 -130.31 146.95 51.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -132.47 99.82 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.715 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -135.69 91.39 18.14 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 109.416 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 84.22 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.501 2.134 . . . . 0.0 110.306 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -127.84 34.92 4.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.381 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.479 HG23 ' HB2' ' C' ' 6' ' ' CYS . 78.8 mt -122.3 -23.53 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.766 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.2 -12.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.17 -0.956 . . . . 0.0 109.733 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -137.98 35.98 2.36 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 109.232 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -155.64 -35.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . 0.479 ' HB2' HG23 ' C' ' 2' ' ' ILE . 0.9 OUTLIER -111.08 -23.84 10.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.559 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -12.16 59.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.532 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -99.72 2.47 44.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.965 . . . . 0.0 109.78 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -178.91 138.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -55.28 147.61 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.4 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.54 178.06 4.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.565 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -104.98 -176.02 2.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 5.3 mp -76.19 -26.36 56.08 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -69.86 -43.58 71.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.862 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -70.97 -42.66 69.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 109.675 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.4 -25.68 63.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.964 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 9.2 mt-10 -74.3 -23.9 59.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.993 -1.067 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -55.66 -26.33 44.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.714 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' C' ' 20' ' ' CYS . 70.9 m-85 -83.25 -109.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.951 . . . . 0.0 109.399 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' C' ' 19' ' ' TYR . 4.4 m 54.38 168.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.027 -1.046 . . . . 0.0 109.244 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 C--N 1.303 -1.437 0 O-C-N 121.057 -1.027 . . . . 0.0 109.515 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.0 t80 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.54 ' CG1' ' HA ' ' G' ' 9' ' ' SER . 16.0 m -81.76 84.08 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 109.67 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -123.82 -23.77 4.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -40.59 82.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.429 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . 0.46 ' CB ' HG12 ' G' ' 10' ' ' ILE . 11.8 t60 -87.68 -25.84 23.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.171 -0.956 . . . . 0.0 109.453 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 29.1 mt -92.05 -72.37 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.559 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 39.4 t -45.43 -35.56 3.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -0.855 . . . . 0.0 109.71 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.85 -39.45 54.85 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . 0.412 ' HB2' ' CZ ' ' B' ' 16' ' ' TYR . 59.7 p -73.88 -2.19 22.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.787 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.52 HD23 ' N ' ' D' ' 11' ' ' LEU . 5.2 mt -89.07 -35.46 16.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.52 HG23 ' N ' ' D' ' 13' ' ' GLU . 18.4 m -50.21 -46.19 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.52 ' N ' HG23 ' D' ' 12' ' ' VAL . 1.3 pt-20 -67.04 -30.95 71.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.414 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.56 17.48 13.16 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.165 -0.96 . . . . 0.0 109.607 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.84 -61.04 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.833 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.506 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 6.3 p90 -63.24 -32.55 73.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.682 HD23 HD23 ' J' ' 17' ' ' LEU . 46.0 tp -65.57 -37.47 86.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -57.55 -62.83 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 109.586 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -66.55 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.51 135.2 0.11 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 51.84 44.23 29.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.392 -1.064 . . . . 0.0 109.555 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -146.18 -60.82 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.792 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.32 157.03 11.82 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 10.6 p90 -161.38 171.15 18.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.108 -1.231 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . 0.567 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 39.2 m-85 -125.83 154.19 42.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -140.75 95.83 2.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.565 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 85.0 m -133.58 91.4 26.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.47 83.86 2.08 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.634 2.223 . . . . 0.0 110.702 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 tptt -128.26 36.98 4.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.079 -1.013 . . . . 0.0 109.63 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.557 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.441 HD13 HD11 ' F' ' 15' ' ' LEU . 76.4 mt -120.89 -22.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -1.13 . . . . 0.0 109.643 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.89 -14.05 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -136.69 41.73 2.52 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -161.33 -35.99 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.27 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -111.0 -24.74 10.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.769 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -13.24 60.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.316 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 66.6 p -96.87 -1.67 45.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.758 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 82.6 p -175.36 142.7 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -59.54 145.19 11.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.097 -1.002 . . . . 0.0 109.178 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -116.87 179.44 4.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 -174.33 2.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.406 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -77.03 -27.22 54.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.438 -0.789 . . . . 0.0 109.176 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -69.13 -44.06 73.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.893 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.75 -39.99 76.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 110.33 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.9 mt -73.88 -24.43 59.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.943 . . . . 0.0 110.042 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -74.57 -26.16 59.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.063 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -53.42 -25.53 16.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' E' ' 20' ' ' CYS . 70.6 m-85 -83.29 -104.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.107 -0.996 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' E' ' 19' ' ' TYR . 0.9 OUTLIER 52.55 171.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.949 -1.094 . . . . 0.0 109.495 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 120.97 -1.081 . . . . 0.0 109.554 -179.879 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.543 ' O ' HG23 ' F' ' 2' ' ' VAL . 17.9 m -79.48 83.42 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -123.44 -26.14 4.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.058 -1.026 . . . . 0.0 109.775 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.97 70.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.487 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -85.59 -28.92 24.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.484 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 27.0 mt -88.71 -72.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.956 . . . . 0.0 109.743 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -45.25 -36.52 4.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 109.811 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.94 -39.05 59.78 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 97.3 p -75.49 0.59 16.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 0.0 109.736 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -97.82 -21.96 16.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.089 -1.007 . . . . 0.0 109.468 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.508 ' N ' HD23 ' F' ' 11' ' ' LEU . 5.3 mt -89.32 -34.7 16.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.211 -0.931 . . . . 0.0 109.417 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.567 HG23 ' N ' ' F' ' 13' ' ' GLU . 22.5 m -49.37 -46.88 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.211 -0.931 . . . . 0.0 109.312 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.567 ' N ' HG23 ' F' ' 12' ' ' VAL . 1.9 pt-20 -66.66 -33.03 74.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.547 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' L' ' 17' ' ' LEU . . . -91.74 17.48 8.91 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.266 -0.896 . . . . 0.0 109.553 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.441 HD11 HD13 ' E' ' 2' ' ' ILE . 0.8 OUTLIER -112.68 -61.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 110.117 -179.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 6.5 p90 -63.37 -33.02 74.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.035 . . . . 0.0 109.633 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.933 HD23 HD23 ' L' ' 17' ' ' LEU . 41.9 tp -64.9 -42.1 95.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.632 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -52.48 -62.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 109.418 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.6 -71.13 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.536 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.37 135.71 0.37 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 50.93 43.18 28.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -1.132 . . . . 0.0 109.603 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -144.03 -66.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.365 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.77 160.22 10.82 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 13.8 p90 -168.85 163.61 11.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -1.067 . . . . 0.0 109.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -126.34 147.94 49.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 109.532 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -127.87 104.63 7.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 109.448 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 86.9 m -138.78 89.16 13.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.681 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.97 85.82 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.57 2.18 . . . . 0.0 110.564 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -130.51 37.52 3.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.286 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 83.8 mt -123.88 -24.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.489 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -78.36 -12.38 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -137.69 34.09 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.228 -0.92 . . . . 0.0 109.696 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -152.64 -37.15 0.11 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.305 -0.872 . . . . 0.0 109.398 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.0 -24.62 10.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -15.02 61.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.319 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 45.9 p -98.46 -2.24 39.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.62 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . 0.54 ' HA ' ' CG1' ' D' ' 2' ' ' VAL . 93.6 p -171.79 135.97 0.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.088 -1.008 . . . . 0.0 109.752 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.46 HG12 ' CB ' ' D' ' 5' ' ' HIS . 2.5 mp -55.01 143.99 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.229 -0.919 . . . . 0.0 108.806 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 m -115.84 177.58 4.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.954 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -104.45 178.19 4.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.43 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.6 -26.36 62.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.267 -0.896 . . . . 0.0 109.745 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -70.6 -40.9 72.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.881 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -72.57 -39.44 67.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.249 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.96 -22.14 58.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.852 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -76.44 -24.46 53.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 109.323 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -55.46 -25.44 36.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.837 . . . . 0.0 109.813 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' G' ' 20' ' ' CYS . 73.9 m-85 -83.65 -103.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.957 . . . . 0.0 109.872 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' G' ' 19' ' ' TYR . 0.9 OUTLIER 51.19 174.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.931 -1.105 . . . . 0.0 109.658 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.554 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 12.1 t80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.471 ' O ' HG23 ' H' ' 2' ' ' VAL . 16.2 m -79.61 81.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -121.87 -28.5 4.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.647 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -39.72 66.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.928 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -89.52 -21.73 22.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 0.0 109.736 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . 0.654 HD21 ' H5 ' ' L' ' 32' ' ' IPH . 31.0 mt -95.8 -70.7 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.5 t -46.52 -35.64 5.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.46 -39.16 57.31 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -77.0 2.92 13.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -1.182 . . . . 0.0 109.663 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -98.94 -23.39 15.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.174 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.523 ' N ' HD23 ' H' ' 11' ' ' LEU . 5.1 mt -87.98 -35.09 17.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.534 HG23 ' N ' ' H' ' 13' ' ' GLU . 18.6 m -49.5 -46.37 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.489 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . 0.534 ' N ' HG23 ' H' ' 12' ' ' VAL . 3.0 pt-20 -67.85 -30.92 70.42 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.317 -0.864 . . . . 0.0 109.418 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.689 ' HA ' HD21 ' B' ' 17' ' ' LEU . . . -95.02 21.63 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.341 -0.85 . . . . 0.0 109.635 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.45 -60.06 1.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 109.639 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.467 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 7.4 p90 -64.58 -32.6 74.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.385 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.791 HD23 HD23 ' B' ' 17' ' ' LEU . 43.8 tp -65.05 -42.52 94.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.912 . . . . 0.0 109.383 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -51.98 -65.83 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.93 . . . . 0.0 109.224 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 58.6 m -64.33 -73.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.331 -0.856 . . . . 0.0 109.53 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.3 136.65 0.84 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 49.87 46.06 24.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.169 -1.195 . . . . 0.0 109.333 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -147.6 -58.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.403 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.06 158.39 14.29 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 9.8 p90 -163.34 174.7 11.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -1.154 . . . . 0.0 109.428 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 15.0 p90 -129.93 157.86 41.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -144.04 91.91 2.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 84.9 m -129.19 90.52 44.82 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -76.75 86.32 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.433 2.089 . . . . 0.0 110.154 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -130.06 35.24 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.912 . . . . 0.0 109.595 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.546 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.418 HD13 HD11 ' J' ' 15' ' ' LEU . 85.3 mt -122.15 -26.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -1.166 . . . . 0.0 109.358 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 14.1 p -75.85 -12.86 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -138.25 43.82 2.16 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.26 -0.9 . . . . 0.0 109.775 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -163.04 -37.45 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.213 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . 0.445 ' SG ' ' O1 ' ' J' ' 32' ' ' IPH . 2.1 t -109.6 -27.05 9.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 109.151 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 52.7 t -72.01 -17.16 62.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 37.1 p -96.38 1.63 51.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.82 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . 0.538 ' HA ' ' CG1' ' B' ' 2' ' ' VAL . 85.8 p -177.24 141.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.543 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' B' ' 5' ' ' HIS . 2.7 mp -60.77 139.93 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 0.0 109.355 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 m -110.04 -174.72 2.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.182 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -110.63 -175.98 2.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.175 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 3.3 mp -75.42 -24.27 57.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.562 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.57 -43.48 63.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.96 . . . . 0.0 109.89 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -70.04 -44.58 68.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.551 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 39.4 mt -68.63 -26.06 65.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.979 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 9.0 mt-10 -74.46 -22.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.048 -1.032 . . . . 0.0 109.731 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.93 -23.2 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.704 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' I' ' 20' ' ' CYS . 71.3 m-85 -83.87 -109.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 0.0 109.114 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' I' ' 19' ' ' TYR . 0.9 OUTLIER 55.61 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.66 -1.275 . . . . 0.0 109.651 179.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.528 179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 t80 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.54 HG23 ' O ' ' J' ' 2' ' ' VAL . 16.9 m -81.48 83.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.345 -0.847 . . . . 0.0 109.568 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.6 -32.2 3.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.75 -39.29 37.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.102 -0.999 . . . . 0.0 109.882 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -88.44 -27.82 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' J' ' 7' ' ' CYS . 33.7 mt -90.96 -71.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.405 ' C ' ' O ' ' J' ' 6' ' ' LEU . 6.4 t -45.01 -38.89 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.05 -39.83 84.08 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . 0.439 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 79.2 p -75.86 1.46 14.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.157 -1.202 . . . . 0.0 109.78 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -97.25 -23.41 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.642 HD22 ' C1 ' ' J' ' 32' ' ' IPH . 3.4 mt -88.43 -36.24 16.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.365 -0.834 . . . . 0.0 109.285 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.54 HG23 ' N ' ' J' ' 13' ' ' GLU . 23.5 m -48.09 -45.64 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.444 -0.785 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.54 ' N ' HG23 ' J' ' 12' ' ' VAL . 0.8 OUTLIER -68.45 -32.17 72.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.63 21.56 6.25 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -0.876 . . . . 0.0 109.438 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . 0.418 HD11 HD13 ' I' ' 2' ' ' ILE . 0.8 OUTLIER -116.05 -60.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.656 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' L' ' 9' ' ' SER . 7.8 p90 -64.66 -32.54 74.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.102 -0.999 . . . . 0.0 109.371 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.682 HD23 HD23 ' D' ' 17' ' ' LEU . 52.8 tp -65.1 -40.8 95.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.31 -61.19 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.495 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 50.8 m -69.6 -69.51 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.382 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.3 133.88 0.17 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 53.62 43.5 31.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -1.109 . . . . 0.0 109.578 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -145.38 -59.0 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.29 155.37 12.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 6.9 p90 -158.88 -179.64 8.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -1.18 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.31 158.86 43.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -144.44 94.89 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.196 -0.94 . . . . 0.0 109.485 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -132.35 91.51 31.03 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.46 -0.775 . . . . 0.0 109.287 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.09 86.62 1.66 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.679 2.253 . . . . 0.0 110.149 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -130.82 36.67 3.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.405 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.07 -24.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.46 HG22 ' O ' ' K' ' 3' ' ' VAL . 14.9 p -78.53 -7.71 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -142.14 34.17 1.53 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.212 -0.93 . . . . 0.0 109.604 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -153.35 -36.49 0.1 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 109.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 t -110.41 -26.12 9.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.208 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -73.28 -13.25 61.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.415 -0.803 . . . . 0.0 109.633 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 43.5 p -99.75 0.26 41.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.598 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 94.7 p -176.31 145.64 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.902 . . . . 0.0 109.306 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.14 139.9 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.147 -0.97 . . . . 0.0 109.393 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 33.7 m -108.8 -176.05 2.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.516 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -109.89 -177.5 3.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 109.16 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 3.3 mp -74.49 -25.64 59.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 0.0 109.74 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -71.24 -42.97 68.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.301 -0.875 . . . . 0.0 109.943 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -70.49 -43.53 69.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.878 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.27 -24.08 62.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 8.3 mt-10 -75.41 -24.09 57.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.391 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -56.94 -23.81 48.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' K' ' 20' ' ' CYS . 73.0 m-85 -85.07 -112.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' K' ' 19' ' ' TYR . 6.1 m 55.46 168.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.733 -1.229 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.381 179.974 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.595 HG23 ' O ' ' L' ' 2' ' ' VAL . 22.3 m -77.1 84.8 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 109.813 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -125.4 -27.1 3.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -37.3 66.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.562 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -91.13 -25.26 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -92.72 -69.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.351 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 4.9 t -48.23 -34.94 11.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.19 -39.1 58.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . 0.494 ' HB2' ' OH ' ' J' ' 16' ' ' TYR . 89.1 p -76.42 1.17 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -1.136 . . . . 0.0 109.717 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . 0.416 ' ND1' HD22 ' H' ' 6' ' ' LEU . 3.1 m-70 -98.28 -24.08 15.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.364 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.492 HD23 ' N ' ' L' ' 11' ' ' LEU . 6.4 mt -86.72 -33.68 19.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.523 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.52 HG23 ' N ' ' L' ' 13' ' ' GLU . 19.0 m -51.83 -45.76 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.52 ' N ' HG23 ' L' ' 12' ' ' VAL . 1.7 pt-20 -67.07 -33.24 75.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -92.11 19.63 6.68 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.7 -61.69 1.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.664 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 7.5 p90 -62.57 -32.96 74.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.6 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.933 HD23 HD23 ' F' ' 17' ' ' LEU . 49.7 tp -65.05 -37.31 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.846 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.6 -59.06 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -67.38 0.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.085 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.46 134.3 0.1 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 53.27 42.41 32.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -1.175 . . . . 0.0 109.516 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -145.32 -60.16 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.018 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.45 162.24 14.83 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 12.2 p90 -165.51 172.09 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -1.2 . . . . 0.0 109.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -127.49 154.18 45.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.447 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -140.43 99.31 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -136.46 91.76 15.95 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 0.0 109.578 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.18 84.41 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.74 2.293 . . . . 0.0 110.663 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -128.8 38.49 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.429 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' IPH . . . . . 0.4 ' H5 ' HD21 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . 0.642 ' C1 ' HD22 ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . 0.654 ' H5 ' HD21 ' H' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.75 3.53 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -1.15 . . . . 0.0 109.721 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 35.9 m -89.52 -11.21 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.86 43.63 2.07 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.301 -0.874 . . . . 0.0 109.356 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.25 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.433 -0.792 . . . . 0.0 109.043 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.4 m -115.15 26.48 10.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 45.6 t -117.64 -24.2 7.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.369 -0.832 . . . . 0.0 109.066 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.1 t -109.0 8.52 26.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.93 120.22 0.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mp -49.11 134.13 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -94.42 -167.47 1.67 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.121 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -110.03 172.18 7.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -27.25 67.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.044 -1.035 . . . . 0.0 109.665 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.71 -46.29 69.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.6 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -33.13 68.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -0.899 . . . . 0.0 109.99 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.79 -8.09 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.212 -0.93 . . . . 0.0 110.184 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -89.69 -23.1 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.57 -8.0 54.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -93.44 4.93 53.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.499 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.72 156.68 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.198 -0.939 . . . . 0.0 109.656 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.35 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.349 0.595 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.667 ' O ' HG13 ' B' ' 2' ' ' VAL . 7.5 p -70.88 91.04 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.885 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.98 -45.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.374 -0.829 . . . . 0.0 109.143 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.36 -32.05 58.4 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.317 -0.864 . . . . 0.0 109.14 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -70.53 -43.2 70.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.34 -0.85 . . . . 0.0 109.273 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 mt -74.24 -32.69 63.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.288 -0.883 . . . . 0.0 108.886 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.09 -31.43 68.99 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.466 -0.771 . . . . 0.0 109.274 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.09 -26.94 61.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.14 -10.35 59.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.25 -1.147 . . . . 0.0 109.456 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -89.59 -24.6 21.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.086 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -87.59 -43.81 11.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.07 -1.019 . . . . 0.0 109.881 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.48 HG23 ' N ' ' B' ' 13' ' ' GLU . 29.0 m -47.31 -42.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.48 ' N ' HG23 ' B' ' 12' ' ' VAL . 5.0 mt-10 -67.35 -39.09 85.72 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 109.752 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.505 ' CB ' ' H5 ' ' B' ' 32' ' ' IPH . . . -92.38 25.59 2.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.183 -0.948 . . . . 0.0 109.555 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.06 -49.21 2.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.399 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 18.3 p90 -79.39 -25.82 42.08 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.506 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.925 HD23 HD23 ' H' ' 17' ' ' LEU . 28.0 tp -74.76 -35.9 62.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.5 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 64.4 t -58.12 -60.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.64 -64.48 0.85 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.579 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.46 -129.29 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.46 82.74 3.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -1.183 . . . . 0.0 109.662 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -148.44 -68.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.48 149.71 7.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 17.3 p90 -158.69 173.27 16.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -1.141 . . . . 0.0 109.312 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.593 ' HB3' ' CD2' ' D' ' 25' ' ' PHE . 23.9 p90 -129.01 146.06 51.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.659 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -124.8 102.7 7.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.458 -0.776 . . . . 0.0 109.025 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 20.6 m -140.72 106.01 6.37 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.922 . . . . 0.0 109.866 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.61 78.41 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.524 2.149 . . . . 0.0 110.278 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -174.29 2.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.634 -179.877 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.39 0.22 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -1.122 . . . . 0.0 109.258 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.418 ' H ' HG22 ' C' ' 3' ' ' VAL . 28.6 m -85.38 -14.14 11.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.229 -0.919 . . . . 0.0 109.805 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.9 42.49 2.01 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.187 -0.946 . . . . 0.0 109.673 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -168.52 -34.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.229 -0.919 . . . . 0.0 109.534 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -120.89 19.7 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 109.151 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.36 -20.31 11.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.504 -0.748 . . . . 0.0 109.205 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -111.53 7.04 20.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . 0.484 ' HA ' ' HB3' ' L' ' 1' ' ' PHE . 85.6 p -175.87 120.12 0.17 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.259 -0.901 . . . . 0.0 109.188 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.414 ' H ' HD12 ' C' ' 10' ' ' ILE . 2.9 mp -48.63 133.98 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.294 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.58 -169.75 2.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.343 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -107.43 172.84 6.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.745 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.29 -27.07 66.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.52 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -69.37 -42.92 74.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -29.23 55.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.306 -0.871 . . . . 0.0 110.028 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.31 -7.15 59.52 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.8 -23.66 21.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.493 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -74.53 -4.35 36.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.938 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -97.38 4.11 50.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.988 . . . . 0.0 109.36 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.17 155.49 18.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.469 179.874 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.597 ' O ' HG13 ' D' ' 2' ' ' VAL . 4.7 p -69.61 94.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.93 -43.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -79.36 -33.79 42.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 109.036 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -68.26 -41.07 81.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 108.919 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.63 -34.56 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.439 -0.788 . . . . 0.0 109.156 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.3 -28.25 67.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.456 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.23 -27.91 50.76 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -78.45 -8.1 58.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 109.211 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -93.65 -20.23 20.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 109.967 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mt -93.18 -44.29 8.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.486 HG23 ' N ' ' D' ' 13' ' ' GLU . 20.2 m -45.89 -42.32 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.425 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.486 ' N ' HG23 ' D' ' 12' ' ' VAL . 4.3 mt-10 -68.12 -43.98 77.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.316 -0.865 . . . . 0.0 109.665 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.435 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -87.8 24.83 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.915 . . . . 0.0 109.862 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 -50.53 2.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.017 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 12.0 p90 -77.92 -24.42 48.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.854 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.532 HD21 ' CB ' ' J' ' 14' ' ' ALA . 35.3 tp -76.86 -36.07 57.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.58 -61.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 9.3 m -66.16 -66.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.743 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.9 -129.41 8.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.57 82.35 3.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -1.159 . . . . 0.0 109.552 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -148.48 -69.9 0.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.587 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.61 143.08 5.65 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 10.9 p90 -150.13 166.58 29.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.292 -1.122 . . . . 0.0 109.289 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' B' ' 25' ' ' PHE . 11.7 m-85 -117.43 143.87 45.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.042 -1.036 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -127.04 104.84 8.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 109.084 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -148.83 105.37 3.42 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.28 83.68 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.397 2.065 . . . . 0.0 110.46 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.86 -179.88 2.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.441 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.393 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 tt -120.41 0.51 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -1.144 . . . . 0.0 109.762 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.38 -8.97 11.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.853 . . . . 0.0 109.927 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.76 37.63 3.73 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.142 -0.974 . . . . 0.0 109.339 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -163.06 -42.2 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 90.3 m -113.85 26.27 10.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 109.228 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 51.1 t -117.24 -23.99 7.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -0.839 . . . . 0.0 109.188 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 8.7 t -109.93 10.97 24.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.19 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' J' ' 1' ' ' PHE . 2.2 p -178.81 119.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -49.41 132.51 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.744 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m -93.27 -169.91 2.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.6 175.45 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -24.59 63.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -71.88 -44.34 63.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -29.74 61.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.438 -0.789 . . . . 0.0 109.889 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -80.87 -10.35 59.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.922 . . . . 0.0 109.819 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -86.27 -25.44 25.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 109.777 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -70.66 -10.01 58.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.9 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -92.38 5.93 48.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.084 -1.01 . . . . 0.0 109.98 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.41 156.71 17.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.746 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.602 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.643 ' O ' HG13 ' F' ' 2' ' ' VAL . 5.9 p -74.21 88.73 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.911 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.74 -44.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.91 . . . . 0.0 109.055 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -77.51 -30.77 53.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -70.46 -45.14 66.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.326 -0.859 . . . . 0.0 109.043 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.48 -30.71 63.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.327 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.414 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 7.1 t -72.36 -29.55 63.88 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.753 . . . . 0.0 109.273 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.73 -25.94 59.59 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 39.2 m -84.23 -2.61 57.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 109.653 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . 0.603 ' ND1' HD22 ' J' ' 6' ' ' LEU . 2.6 m-70 -97.89 -19.16 18.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 15.2 mt -92.22 -43.67 9.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.527 -0.733 . . . . 0.0 109.271 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.477 HG23 ' N ' ' F' ' 13' ' ' GLU . 22.8 m -48.26 -42.1 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.529 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.477 ' N ' HG23 ' F' ' 12' ' ' VAL . 4.7 mt-10 -67.19 -43.07 83.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.749 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.498 ' CB ' ' H5 ' ' E' ' 31' ' ' IPH . . . -87.92 21.79 2.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.283 -0.886 . . . . 0.0 109.875 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.25 -51.91 2.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.882 . . . . 0.0 109.641 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 13.4 p90 -76.37 -25.48 54.68 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.189 -0.944 . . . . 0.0 109.654 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.519 HD23 HD23 ' L' ' 17' ' ' LEU . 31.9 tp -76.21 -35.54 59.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.96 . . . . 0.0 109.769 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.49 -59.23 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.686 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 17.9 m -68.44 -66.72 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.078 -1.014 . . . . 0.0 109.301 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.03 -126.07 7.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -79.44 78.38 5.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.343 -1.092 . . . . 0.0 109.688 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -145.14 -71.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 109.851 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.99 138.84 4.45 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 14.4 p90 -145.94 173.18 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.349 -1.089 . . . . 0.0 109.019 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -125.27 145.52 49.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.032 . . . . 0.0 109.789 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -127.98 104.08 7.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 0.0 109.245 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 53.6 m -147.33 107.1 3.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.9 78.39 3.42 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.539 2.159 . . . . 0.0 110.693 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.52 179.49 5.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.626 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.551 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt -119.29 -1.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -1.091 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.42 -14.4 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.257 -0.902 . . . . 0.0 110.109 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.34 37.47 3.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.069 -1.019 . . . . 0.0 110.018 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -162.05 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.338 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 97.4 m -115.51 21.71 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -23.05 10.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.014 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 11.0 t -108.66 8.77 27.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -177.79 119.2 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.13 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.498 ' H ' HD12 ' G' ' 10' ' ' ILE . 3.3 mp -47.96 137.58 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.372 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 77.9 m -98.22 -168.34 1.64 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.61 169.26 8.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -0.949 . . . . 0.0 109.285 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' G' ' 13' ' ' LEU . 0.3 OUTLIER -64.38 -25.63 68.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.849 . . . . 0.0 109.835 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -70.65 -42.75 70.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -28.16 57.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.42 -4.66 58.7 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.073 -1.017 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -93.29 -21.57 19.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.14 -0.975 . . . . 0.0 109.377 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.07 -9.63 58.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -92.31 1.4 57.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.15 157.82 16.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.002 . . . . 0.0 109.733 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.701 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.621 ' O ' HG13 ' H' ' 2' ' ' VAL . 5.6 p -68.77 91.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.79 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.169 -0.957 . . . . 0.0 109.432 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -77.33 -33.12 55.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.037 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -68.2 -40.7 82.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.248 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . 0.474 HD22 ' ND1' ' L' ' 10' ' ' HIS . 13.8 mt -77.37 -31.83 54.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 108.959 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.11 -28.02 65.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.488 -0.757 . . . . 0.0 109.338 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.98 -29.84 45.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 70.4 m -77.24 -8.35 57.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -1.179 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -93.39 -23.46 18.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.173 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' H' ' 12' ' ' VAL . 12.1 mt -88.93 -44.51 10.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.012 -1.055 . . . . 0.0 109.509 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.525 HG23 ' N ' ' H' ' 13' ' ' GLU . 26.3 m -45.79 -44.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . 0.525 ' N ' HG23 ' H' ' 12' ' ' VAL . 5.3 mt-10 -65.95 -43.86 86.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.784 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.574 ' HA ' HD21 ' B' ' 17' ' ' LEU . . . -86.92 21.11 2.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 110.03 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.45 -51.93 2.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.967 . . . . 0.0 109.684 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 12.4 p90 -76.21 -26.03 55.69 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.925 HD23 HD23 ' B' ' 17' ' ' LEU . 32.2 tp -75.56 -34.93 60.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.44 -60.45 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 0.0 109.954 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 11.5 m -67.55 -63.62 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.69 -130.23 9.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -76.92 81.94 3.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -1.105 . . . . 0.0 109.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -146.94 -68.27 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.03 142.33 5.44 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 18.7 p90 -152.13 174.76 13.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.132 . . . . 0.0 109.511 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.3 162.42 26.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -143.83 92.44 2.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.84 . . . . 0.0 109.588 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 91.3 m -133.76 107.27 11.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.117 -0.989 . . . . 0.0 109.368 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.13 78.25 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.362 2.041 . . . . 0.0 109.959 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.8 -179.22 4.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.697 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.32 179.728 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -119.13 0.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 109.901 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.98 -16.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.055 -1.028 . . . . 0.0 110.075 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.75 42.88 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.804 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -169.96 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -116.91 19.51 14.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.297 -0.877 . . . . 0.0 109.211 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.2 -24.76 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.315 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -105.28 9.38 33.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.633 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . 0.438 ' O ' ' C ' ' I' ' 10' ' ' ILE . 1.9 p 179.67 118.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.453 ' H ' HD12 ' I' ' 10' ' ' ILE . 3.0 mp -43.5 149.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.859 . . . . 0.0 109.21 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -171.76 1.91 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.79 167.55 9.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.158 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' I' ' 13' ' ' LEU . 0.3 OUTLIER -63.39 -27.81 69.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.33 -43.26 77.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.85 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -27.17 56.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.811 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 34.6 mt -84.15 -7.12 59.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 109.864 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -89.78 -24.85 21.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 109.574 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -71.15 -10.83 60.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.695 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -91.45 3.16 55.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 0.0 109.909 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 159.25 15.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 109.378 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.446 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' E' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.261 0.553 . . . . 0.0 109.713 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.624 ' O ' HG13 ' J' ' 2' ' ' VAL . 6.0 p -70.65 91.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.183 -0.948 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.55 -42.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 0.0 109.146 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -79.17 -33.41 44.02 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.004 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -69.06 -40.06 78.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . 0.603 HD22 ' ND1' ' F' ' 10' ' ' HIS . 9.5 mt -78.49 -29.79 46.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.324 -0.86 . . . . 0.0 109.105 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -72.72 -27.71 62.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.333 -0.854 . . . . 0.0 109.465 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.84 -27.0 52.17 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -79.68 -7.57 58.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.568 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -94.5 -20.87 19.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.15 -43.69 9.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 0.0 109.677 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.504 HG23 ' N ' ' J' ' 13' ' ' GLU . 26.1 m -46.95 -44.21 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.504 ' N ' HG23 ' J' ' 12' ' ' VAL . 3.9 mt-10 -65.08 -44.25 89.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.601 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.532 ' CB ' HD21 ' D' ' 17' ' ' LEU . . . -87.6 24.85 1.59 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.271 -0.893 . . . . 0.0 109.809 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.47 -46.34 3.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 109.507 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 14.3 p90 -82.64 -23.25 34.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 30.8 tp -76.98 -37.85 54.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.283 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.0 t -55.7 -61.62 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 m -66.89 -64.77 0.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.55 -129.33 8.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -77.91 85.31 4.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.196 -1.179 . . . . 0.0 109.368 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -150.88 -75.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.358 -0.839 . . . . 0.0 109.07 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.32 141.21 4.42 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 15.5 p90 -149.05 165.69 30.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.307 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -121.79 136.44 54.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -117.37 104.91 11.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.536 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -146.18 108.19 4.23 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.071 -1.018 . . . . 0.0 109.438 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.85 79.57 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.546 2.164 . . . . 0.0 110.994 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.89 179.6 5.2 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 109.337 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.324 179.923 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.6 tt -121.17 1.05 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 30.9 m -86.51 -12.9 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.169 -0.957 . . . . 0.0 109.62 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.89 40.38 2.47 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.688 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -164.93 -42.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.244 -0.91 . . . . 0.0 109.299 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 93.9 m -114.14 23.47 12.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.862 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 40.9 t -112.77 -26.94 8.34 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.447 -0.783 . . . . 0.0 109.238 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 11.2 t -105.48 9.4 33.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.464 -0.773 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.01 118.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.804 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.475 HD12 ' H ' ' K' ' 10' ' ' ILE . 3.1 mp -45.32 135.66 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.298 -0.877 . . . . 0.0 109.597 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.7 m -98.1 -167.73 1.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.46 171.71 7.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.482 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' K' ' 13' ' ' LEU . 0.3 OUTLIER -65.24 -28.06 69.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 109.678 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -69.1 -42.34 76.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.825 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -28.82 56.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 36.9 mt -81.62 -7.28 59.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 109.809 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.59 -25.12 21.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.678 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -72.38 -7.62 50.63 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.245 -0.909 . . . . 0.0 109.825 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -93.55 0.33 56.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.87 158.99 15.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.419 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.519 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' C' ' 9' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.624 ' O ' HG13 ' L' ' 2' ' ' VAL . 5.1 p -70.83 89.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 109.814 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -175.95 -44.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.209 -0.932 . . . . 0.0 109.269 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -78.29 -31.88 49.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -70.63 -39.17 73.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 0.0 109.127 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 13.4 mt -78.21 -31.93 49.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 108.863 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.01 -29.99 67.19 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.12 -27.26 58.43 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -80.37 -6.24 57.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -1.127 . . . . 0.0 109.616 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . 0.474 ' ND1' HD22 ' H' ' 6' ' ' LEU . 4.3 m-70 -95.14 -20.63 19.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.031 -1.043 . . . . 0.0 109.633 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' L' ' 12' ' ' VAL . 11.2 mt -92.68 -44.67 8.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.943 . . . . 0.0 109.515 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.51 HG23 ' N ' ' L' ' 13' ' ' GLU . 23.4 m -45.04 -43.71 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 109.18 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.51 ' N ' HG23 ' L' ' 12' ' ' VAL . 4.7 mt-10 -66.76 -44.83 80.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.554 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.465 ' CB ' ' H5 ' ' L' ' 32' ' ' IPH . . . -86.69 23.53 1.66 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.3 -0.875 . . . . 0.0 109.936 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.62 -49.66 2.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.095 -1.003 . . . . 0.0 109.668 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.526 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 14.4 p90 -79.06 -24.36 43.6 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.162 -0.962 . . . . 0.0 109.663 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.519 HD23 HD23 ' F' ' 17' ' ' LEU . 38.7 tp -76.99 -33.58 57.58 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.75 -59.3 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 12.3 m -69.05 -66.08 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.935 . . . . 0.0 109.568 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.98 -129.95 9.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.17 80.88 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -147.62 -68.22 0.25 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.092 -1.005 . . . . 0.0 109.43 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.59 131.26 3.73 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 9.8 p90 -135.08 -173.21 3.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -1.166 . . . . 0.0 109.317 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -138.2 142.74 39.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.82 108.61 11.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.625 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -150.5 106.64 3.11 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.848 . . . . 0.0 109.451 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.09 79.37 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.508 2.139 . . . . 0.0 110.449 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.3 -179.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.537 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.505 ' H5 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.435 ' H5 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 31' ' ' IPH . . . . . 0.498 ' H5 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 22' ' ' IPH . . . . . 0.486 ' H5 ' ' CB ' ' H' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . 0.508 ' H5 ' ' CB ' ' J' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . 0.465 ' H5 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.7 tt -97.74 -27.34 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' B' ' 28' ' ' PRO . 94.4 t -73.84 -44.11 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.64 52.12 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.35 -0.843 . . . . 0.0 110.151 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -175.38 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.085 -1.01 . . . . 0.0 109.694 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.0 11.05 17.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.8 t -105.57 -23.05 12.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.9 p -67.17 -13.94 62.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.472 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.5 p -175.25 156.52 2.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' F' ' 2' ' ' VAL . 2.1 mp -62.84 130.81 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.255 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -96.32 -167.02 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.504 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -109.72 176.78 4.94 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -42.31 89.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.2 -0.938 . . . . 0.0 109.771 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -66.7 -35.85 81.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.962 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -36.67 77.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.083 -1.011 . . . . 0.0 109.437 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -79.65 -18.45 51.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 109.827 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -85.09 -14.48 47.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.481 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.6 -16.31 15.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.892 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.74 87.27 1.84 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.31 133.07 7.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.461 -0.774 . . . . 0.0 109.485 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.418 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.548 ' HB ' HD12 ' I' ' 10' ' ' ILE . 70.4 t -91.02 -7.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.248 -0.908 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 4' ' ' GLN . 11.3 p30 45.08 -172.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.443 -0.785 . . . . 0.0 109.604 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' B' ' 3' ' ' ASN . 9.4 tt0 83.53 -59.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -89.08 -24.13 22.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 109.191 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -96.78 -50.26 4.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.135 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -57.2 -38.04 73.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.98 -29.46 60.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.489 ' OG ' ' CE1' ' D' ' 16' ' ' TYR . 1.2 m -67.38 -9.08 38.05 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.151 . . . . 0.0 109.424 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -96.25 -36.1 11.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.023 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.0 mt -71.49 -41.44 69.29 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.42 -0.8 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.7 m -48.11 -37.7 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -72.25 -46.12 57.32 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.174 -0.954 . . . . 0.0 109.391 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.12 13.25 4.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 0.0 109.863 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.32 -53.29 3.39 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.003 -1.061 . . . . 0.0 109.537 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 11.3 p90 -73.12 -30.2 63.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.315 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 0.1 OUTLIER -61.93 -52.92 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.384 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.41 -30.75 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.199 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 20' ' ' GLY . 1.3 m -115.45 54.74 0.79 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.016 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' B' ' 22' ' ' ARG . . . -58.72 -119.73 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' B' ' 22' ' ' ARG . 25.8 mt-10 -39.52 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.542 -0.975 . . . . 0.0 109.933 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' B' ' 20' ' ' GLY . 2.9 mtt180 165.37 -51.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 109.657 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 172.48 27.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' D' ' 26' ' ' TYR . 50.9 p90 -170.81 162.74 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.441 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -117.72 141.5 48.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.095 -1.003 . . . . 0.0 109.493 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.86 111.44 17.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.709 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -140.86 98.58 6.92 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.635 ' HB3' HG21 ' A' ' 3' ' ' VAL . 35.7 Cg_endo -77.92 87.73 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.5 2.133 . . . . 0.0 110.662 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -136.1 -123.38 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.98 . . . . 0.0 109.294 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 120.741 -1.225 . . . . 0.0 109.351 179.907 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -100.3 -29.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -1.165 . . . . 0.0 109.457 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.603 HG21 ' HB3' ' D' ' 28' ' ' PRO . 79.2 t -72.81 -40.95 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.408 -0.808 . . . . 0.0 109.66 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 52.54 1.97 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.332 -0.855 . . . . 0.0 110.077 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -175.64 -34.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.82 11.58 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.563 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 t -105.66 -24.4 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.783 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 60.1 p -67.74 -11.94 59.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.0 109.575 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 60.3 p -174.81 155.5 2.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.624 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.673 HD12 ' HB ' ' L' ' 2' ' ' VAL . 1.6 mp -63.7 130.95 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 108.984 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -97.15 -167.61 1.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -107.12 178.8 4.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.332 -0.855 . . . . 0.0 109.289 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -42.29 78.65 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.288 -0.882 . . . . 0.0 109.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -67.04 -34.82 78.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 0.0 109.918 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -32.5 72.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 11.6 mt -83.31 -21.55 33.19 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -13.59 57.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.393 -0.817 . . . . 0.0 109.524 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.96 -15.57 13.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.02 87.94 1.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.57 133.97 7.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.429 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.431 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' G' ' 10' ' ' ILE . 55.8 t -89.58 -9.23 10.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.422 -0.798 . . . . 0.0 109.574 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' D' ' 4' ' ' GLN . 8.6 p30 45.9 -174.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.498 -0.751 . . . . 0.0 109.834 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' D' ' 3' ' ' ASN . 10.2 tt0 84.07 -60.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . 0.454 ' HB3' HG12 ' G' ' 10' ' ' ILE . 32.4 t60 -88.02 -21.99 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.123 -0.986 . . . . 0.0 109.006 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.41 -51.28 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.839 . . . . 0.0 109.188 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 25.6 t -57.31 -37.79 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.29 -33.35 59.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.68 -11.13 32.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -1.105 . . . . 0.0 109.559 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -93.09 -35.28 13.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 15.1 mt -73.52 -39.52 64.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 m -48.15 -35.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -75.63 -44.45 42.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 9.71 11.82 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.02 -56.77 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.711 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 9.1 p90 -71.6 -28.75 64.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.056 -1.027 . . . . 0.0 109.541 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 0.1 OUTLIER -63.15 -52.99 60.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.186 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.1 t -66.27 -33.47 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.303 -0.873 . . . . 0.0 108.866 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' D' ' 20' ' ' GLY . 1.3 m -111.66 55.96 0.66 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.465 -0.772 . . . . 0.0 109.085 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' D' ' 22' ' ' ARG . . . -59.32 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' D' ' 22' ' ' ARG . 23.3 mt-10 -40.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.463 -1.022 . . . . 0.0 110.055 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . 0.483 ' CB ' ' O ' ' D' ' 21' ' ' GLU . 4.2 mtt180 165.07 -53.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.249 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.72 171.61 24.55 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -169.45 172.31 7.17 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -122.16 157.89 30.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.516 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.44 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 79.6 t80 -136.64 100.45 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.47 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -133.83 97.41 15.49 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . 0.603 ' HB3' HG21 ' C' ' 3' ' ' VAL . 34.7 Cg_endo -76.81 86.19 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.447 2.098 . . . . 0.0 110.62 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -134.16 -124.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.153 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.653 -1.28 . . . . 0.0 109.596 -179.886 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.405 HD13 HD11 ' F' ' 15' ' ' LEU . 20.7 tt -101.69 -25.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -1.138 . . . . 0.0 109.135 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' F' ' 28' ' ' PRO . 90.6 t -77.71 -41.47 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.493 -0.754 . . . . 0.0 109.503 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.04 50.75 1.83 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.806 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.58 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.796 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 10.95 15.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.024 . . . . 0.0 109.504 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 33.2 t -105.07 -23.27 12.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 77.1 p -67.01 -14.73 63.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . 0.502 ' HA ' HG21 ' J' ' 2' ' ' VAL . 5.8 p -174.15 155.85 2.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.139 -0.975 . . . . 0.0 109.819 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.567 HD12 ' HB ' ' J' ' 2' ' ' VAL . 2.1 mp -62.0 126.72 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.481 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 2.1 m -94.54 -170.09 2.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -106.91 176.7 5.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 109.615 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.05 -41.04 95.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -68.74 -35.75 77.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 109.9 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -36.63 77.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.448 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 18.9 mt -79.01 -21.28 47.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.905 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -13.44 56.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.953 . . . . 0.0 109.321 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -58.72 -16.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.525 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.1 88.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.161 -0.962 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.65 135.45 8.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.433 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.395 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.365 0.602 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.642 ' HB ' HD12 ' A' ' 10' ' ' ILE . 54.8 t -90.91 -7.45 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' F' ' 4' ' ' GLN . 9.4 p30 45.81 -174.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.77 . . . . 0.0 109.657 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . 0.567 ' CB ' ' O ' ' F' ' 3' ' ' ASN . 9.5 tt0 84.19 -60.54 0.11 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.641 -0.662 . . . . 0.0 109.589 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -87.89 -23.84 23.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mt -97.37 -49.47 4.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 40.1 t -59.01 -37.37 76.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -30.09 58.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.21 -15.21 62.98 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.325 -1.103 . . . . 0.0 109.428 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -89.18 -36.45 15.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 109.546 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 mt -71.87 -38.28 70.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.036 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 m -49.86 -34.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.105 -0.997 . . . . 0.0 109.633 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -76.22 -44.84 35.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.978 . . . . 0.0 109.408 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.09 10.32 6.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.684 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.405 HD11 HD13 ' E' ' 2' ' ' ILE . 1.4 mt -96.06 -57.2 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.085 -1.009 . . . . 0.0 109.831 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 10.9 p90 -69.53 -30.54 68.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.378 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 0.1 OUTLIER -62.57 -53.43 54.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.64 -32.56 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.167 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' F' ' 20' ' ' GLY . 1.3 m -114.21 53.72 0.78 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' F' ' 22' ' ' ARG . . . -57.85 -118.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' F' ' 22' ' ' ARG . 25.4 mt-10 -40.53 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -1.012 . . . . 0.0 109.952 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' F' ' 20' ' ' GLY . 4.3 mtt180 164.56 -49.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 109.559 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.73 27.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -166.92 174.93 8.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -1.125 . . . . 0.0 109.288 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -128.41 152.58 48.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.505 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -130.89 106.98 8.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.463 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -139.25 98.36 8.3 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . 0.485 ' HB3' HG21 ' E' ' 3' ' ' VAL . 33.0 Cg_endo -74.97 86.03 1.46 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.416 2.077 . . . . 0.0 110.554 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -154.48 135.6 13.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.54 -0.725 . . . . 0.0 109.1 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . 0.495 ' C ' ' O ' ' F' ' 29' ' ' LYS . 71.5 p . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt -98.23 -25.58 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -1.156 . . . . 0.0 109.125 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . 0.588 HG21 ' HB3' ' H' ' 28' ' ' PRO . 61.4 t -76.15 -42.94 37.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.461 -0.775 . . . . 0.0 109.417 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 51.64 2.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.336 -0.853 . . . . 0.0 109.684 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.98 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 109.723 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 9.65 19.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.692 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -103.64 -23.15 13.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.179 -0.95 . . . . 0.0 109.818 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 74.5 p -66.92 -14.97 63.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 109.536 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -173.18 160.26 4.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.556 HD12 ' HB ' ' D' ' 2' ' ' VAL . 1.6 mp -66.34 128.46 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.095 -1.003 . . . . 0.0 109.368 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 3.5 m -94.21 -167.97 1.77 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -109.37 179.37 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.465 -0.772 . . . . 0.0 109.305 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.44 -41.32 80.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -68.68 -34.65 76.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.764 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.32 -36.4 80.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.84 -21.28 44.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.243 -0.911 . . . . 0.0 109.56 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -83.63 -9.02 59.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 109.634 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.97 -16.49 59.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.135 -0.978 . . . . 0.0 109.237 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.77 90.91 2.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 0.0 109.413 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -165.16 131.6 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.9 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.464 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.314 0.578 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.632 ' HB ' HD12 ' K' ' 10' ' ' ILE . 54.3 t -92.95 -6.71 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.558 ' O ' ' CB ' ' H' ' 4' ' ' GLN . 9.9 p30 44.92 -173.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.52 -0.738 . . . . 0.0 110.031 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . 0.558 ' CB ' ' O ' ' H' ' 3' ' ' ASN . 9.0 tt0 83.78 -60.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.754 -0.591 . . . . 0.0 109.677 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -87.95 -23.78 23.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.25 -0.906 . . . . 0.0 109.06 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mt -96.3 -50.14 4.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.209 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 37.7 t -58.0 -40.23 80.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.07 -29.97 66.05 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -12.66 55.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -1.131 . . . . 0.0 109.492 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -93.58 -34.03 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.346 -0.846 . . . . 0.0 109.665 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 14.0 mt -74.44 -39.25 62.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 0.0 109.707 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 m -48.21 -37.57 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.129 -0.982 . . . . 0.0 109.387 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.24 -46.26 51.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.09 7.81 10.11 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.384 -0.823 . . . . 0.0 109.634 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -93.36 -55.99 3.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.0 110.096 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' H' ' 17' ' ' LEU . 14.0 p90 -70.45 -31.23 68.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.1 . . . . 0.0 109.624 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' H' ' 16' ' ' TYR . 0.1 OUTLIER -60.82 -53.76 53.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.509 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.19 -30.65 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.423 -0.798 . . . . 0.0 109.748 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 m -111.21 46.66 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.927 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . -66.69 170.27 32.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' H' ' 20' ' ' GLY . 33.8 mt-10 35.5 71.4 0.12 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.661 -0.905 . . . . 0.0 110.078 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 175.32 -48.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.18 -0.95 . . . . 0.0 109.34 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.47 169.74 27.9 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -168.0 169.29 11.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -122.78 145.39 48.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 109.547 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -124.91 105.57 9.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -137.48 98.97 9.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.415 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . 0.588 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.5 Cg_endo -77.84 86.68 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.538 2.159 . . . . 0.0 110.778 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -135.91 -129.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 109.055 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 N--CA 1.49 1.573 0 O-C-N 120.578 -1.327 . . . . 0.0 109.519 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 21.2 tt -99.02 -26.68 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -1.159 . . . . 0.0 109.591 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . 0.558 HG21 ' HB3' ' J' ' 28' ' ' PRO . 87.8 t -75.96 -40.59 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.379 -0.826 . . . . 0.0 109.44 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.64 53.61 2.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -176.28 -32.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.36 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.93 12.3 15.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.011 . . . . 0.0 109.86 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.73 -19.56 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 82.7 p -70.09 -13.48 62.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.031 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . 0.519 ' HA ' ' CG2' ' B' ' 2' ' ' VAL . 52.5 p -174.39 156.89 2.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.478 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.548 HD12 ' HB ' ' B' ' 2' ' ' VAL . 1.8 mp -63.32 128.23 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.248 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 m -93.23 -165.59 1.36 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 109.226 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 3.7 m -110.37 -177.22 3.18 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.248 -0.908 . . . . 0.0 109.042 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -41.21 68.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -68.16 -35.14 77.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -35.79 76.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.2 -0.937 . . . . 0.0 109.636 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.9 mt -81.19 -19.7 42.77 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.99 -10.78 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.487 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.92 -17.61 52.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.944 . . . . 0.0 109.288 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.57 89.29 2.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.37 -0.831 . . . . 0.0 109.53 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.54 134.21 6.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.234 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.377 0.608 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.567 ' HB ' HD12 ' E' ' 10' ' ' ILE . 53.1 t -91.65 -7.34 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' J' ' 4' ' ' GLN . 9.1 p30 45.51 -174.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 0.0 110.011 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' J' ' 3' ' ' ASN . 8.9 tt0 83.61 -61.48 0.11 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.705 -0.622 . . . . 0.0 109.823 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . 0.478 ' CB ' HG12 ' E' ' 10' ' ' ILE . 36.5 t60 -86.83 -21.23 26.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.162 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.02 -52.33 3.58 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.103 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 43.4 t -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.11 -32.33 63.18 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -67.34 -10.55 52.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -1.187 . . . . 0.0 109.543 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -93.7 -34.24 13.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.176 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.91 -41.74 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.455 -0.778 . . . . 0.0 109.711 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 15.3 m -45.88 -38.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.803 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.94 -44.17 61.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.017 -1.052 . . . . 0.0 109.829 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' D' ' 17' ' ' LEU . . . -84.68 13.92 5.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.37 -54.86 2.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.8 p90 -72.62 -29.54 63.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 0.1 OUTLIER -63.79 -52.14 61.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 109.171 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.97 -32.2 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.406 -0.809 . . . . 0.0 109.221 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' J' ' 20' ' ' GLY . 1.1 m -113.72 54.56 0.74 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.078 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . -57.85 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' J' ' 22' ' ' ARG . 26.0 mt-10 -40.76 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -1.15 . . . . 0.0 110.024 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' J' ' 20' ' ' GLY . 3.6 mtt180 165.58 -47.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.848 . . . . 0.0 109.338 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.8 169.42 33.85 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -164.44 172.95 12.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -1.163 . . . . 0.0 109.784 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -122.53 151.75 41.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.166 -0.959 . . . . 0.0 109.251 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -133.59 108.17 8.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 109.199 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 4.7 m -142.41 96.46 6.34 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' I' ' 3' ' ' VAL . 34.4 Cg_endo -76.69 93.96 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.353 2.035 . . . . 0.0 110.593 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -141.03 -119.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.353 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 120.659 -1.275 . . . . 0.0 109.652 -179.768 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 20.1 tt -98.17 -27.6 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -1.111 . . . . 0.0 109.163 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' L' ' 28' ' ' PRO . 94.9 t -74.72 -41.34 47.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.443 -0.786 . . . . 0.0 109.682 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.0 OUTLIER -91.98 56.96 3.02 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.937 -1.102 . . . . 0.0 109.489 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 1.3 tt0 179.94 -32.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 10.85 15.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -107.23 -19.81 13.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 0.0 108.948 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -68.97 -14.23 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.387 -0.821 . . . . 0.0 109.009 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 78.1 p -175.25 156.06 2.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.815 . . . . 0.0 109.31 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.632 HD12 ' HB ' ' H' ' 2' ' ' VAL . 1.4 mp -63.18 129.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 3.6 m -95.02 -170.71 2.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.855 . . . . 0.0 109.455 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -105.85 177.33 4.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.401 -0.812 . . . . 0.0 109.144 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.04 -42.89 88.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.543 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -65.97 -37.57 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.102 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -35.36 73.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.75 -19.85 44.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.211 -0.931 . . . . 0.0 109.769 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.28 -12.11 55.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -18.39 44.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.327 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.55 91.06 2.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.953 . . . . 0.0 109.584 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.4 137.13 5.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.506 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.42 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.42 0.629 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.673 ' HB ' HD12 ' C' ' 10' ' ' ILE . 55.6 t -89.35 -7.45 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.443 -0.786 . . . . 0.0 109.929 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' L' ' 4' ' ' GLN . 10.8 p30 45.22 -173.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . 0.556 ' CB ' ' O ' ' L' ' 3' ' ' ASN . 9.1 tt0 83.84 -59.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.674 -0.641 . . . . 0.0 109.502 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . 0.452 ' HB3' HG12 ' C' ' 10' ' ' ILE . 33.8 t60 -89.14 -20.34 24.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 mt -101.63 -49.33 4.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.431 -0.793 . . . . 0.0 109.431 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -59.03 -32.92 70.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 108.826 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.03 -34.05 34.71 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.58 -11.14 31.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -1.119 . . . . 0.0 109.272 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -93.76 -32.18 14.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.01 -39.33 50.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.476 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -47.82 -36.03 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.561 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.94 -44.51 48.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.187 -0.945 . . . . 0.0 109.293 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.93 15.03 4.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.334 -0.854 . . . . 0.0 109.687 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.42 -53.74 3.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.041 -1.037 . . . . 0.0 109.533 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.555 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 9.4 p90 -73.98 -27.1 60.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.15 -0.969 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 0.1 OUTLIER -66.14 -50.1 65.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.267 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -70.04 -29.04 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.1 49.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.575 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . -70.45 167.91 49.34 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' L' ' 20' ' ' GLY . 31.1 mt-10 39.09 71.39 0.17 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.505 -0.997 . . . . 0.0 109.657 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 173.21 -43.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.826 . . . . 0.0 108.93 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.48 174.23 35.48 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -169.12 172.33 7.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -1.138 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 17.8 p90 -125.0 145.31 49.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.491 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -127.84 109.15 11.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.215 -0.928 . . . . 0.0 109.358 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 9.8 m -142.55 98.22 5.93 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.461 -0.774 . . . . 0.0 109.201 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.4 Cg_endo -78.66 93.9 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.369 2.046 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -139.77 -115.18 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 109.523 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.72 0 O-C-N 120.81 -1.181 . . . . 0.0 109.544 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 22' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.728 ' O ' HG22 ' A' ' 2' ' ' ILE . 49.7 mt -99.42 25.29 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -1.16 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 60.0 t -114.56 -47.43 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 109.851 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -95.47 47.45 1.12 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.239 -0.913 . . . . 0.0 109.538 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -168.23 -35.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.336 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 9' ' ' SER . 99.1 m -108.11 -32.31 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.655 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -69.4 -19.18 63.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.186 -0.946 . . . . 0.0 109.697 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -105.75 -7.31 18.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 5.1 p -168.08 132.35 1.7 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.218 -0.926 . . . . 0.0 109.426 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.445 ' HA ' ' O1 ' ' B' ' 32' ' ' IPH . 2.5 mp -52.49 138.4 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.557 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.7 m -104.39 149.6 25.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.24 158.17 29.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.9 . . . . 0.0 109.517 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -29.51 58.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.782 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -64.97 -43.47 92.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 109.477 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -73.87 -23.55 59.62 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.174 -0.954 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.42 0.4 53.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.238 -0.914 . . . . 0.0 109.967 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -90.86 -26.08 19.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.735 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -83.01 -7.67 59.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.1 -1.0 . . . . 0.0 109.932 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -90.85 15.61 10.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.65 160.16 15.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.484 -179.891 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 11.2 p90 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.414 ' H ' HG12 ' B' ' 2' ' ' VAL . 2.5 p -60.96 123.3 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.27 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 175.55 -36.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.163 -0.96 . . . . 0.0 108.935 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -80.34 -42.32 23.16 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.369 -0.832 . . . . 0.0 109.276 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -58.89 -23.55 61.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.412 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 10.0 mt -101.5 -24.45 14.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 51.1 t -75.26 -17.24 60.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.443 -0.786 . . . . 0.0 109.113 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.75 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -91.41 -21.87 33.53 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -81.01 -18.76 45.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -1.14 . . . . 0.0 109.302 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.445 ' ND1' HD22 ' F' ' 6' ' ' LEU . 20.1 m-70 -85.56 -18.86 32.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.624 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.487 ' CD2' ' C6 ' ' B' ' 32' ' ' IPH . 9.9 mt -93.69 -34.71 13.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.75 HG13 ' O ' ' B' ' 8' ' ' GLY . 34.0 m -60.58 -36.02 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 110.037 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.401 ' N ' HG23 ' B' ' 12' ' ' VAL . 0.8 OUTLIER -73.63 -27.91 61.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.984 . . . . 0.0 109.931 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.33 17.56 17.12 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.163 -0.96 . . . . 0.0 109.864 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 2' ' ' ILE . 1.7 mt -114.98 -56.52 2.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.836 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -64.26 -23.65 67.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.478 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 19.7 tp -74.5 -40.25 61.91 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.2 -0.937 . . . . 0.0 109.306 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 71.4 t -54.69 -72.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.907 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -58.61 -42.6 88.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.08 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.34 -97.68 0.78 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.72 -56.54 20.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -1.143 . . . . 0.0 109.514 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -53.28 154.83 3.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.813 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.72 -167.69 27.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -170.01 169.18 8.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -1.13 . . . . 0.0 109.566 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.648 ' CB ' ' CD2' ' D' ' 25' ' ' PHE . 42.1 p90 -127.78 148.66 50.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.474 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' B' ' 28' ' ' PRO . 30.5 t80 -128.29 113.57 15.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.81 92.11 13.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.482 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' B' ' 26' ' ' TYR . 36.1 Cg_endo -78.96 81.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.909 2.406 . . . . 0.0 110.515 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -133.14 112.25 11.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.089 -1.007 . . . . 0.0 109.946 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.242 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' C' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' C' ' 1' ' ' GLY . 20.4 mt 71.21 -1.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.108 -1.231 . . . . 0.0 110.196 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 61.7 t -106.24 -49.03 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.971 -1.08 . . . . 0.0 108.917 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 44.84 1.03 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.431 -0.793 . . . . 0.0 109.239 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -165.57 -35.68 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' C' ' 9' ' ' SER . 93.1 m -108.27 -30.31 8.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.693 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.3 OUTLIER -71.47 -19.09 62.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 109.388 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -105.59 -6.55 19.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.726 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 6' ' ' CYS . 2.6 p -169.16 130.36 1.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.087 -1.008 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.468 ' HA ' ' O1 ' ' D' ' 32' ' ' IPH . 2.5 mp -50.44 138.08 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.647 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -104.37 149.02 25.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.054 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.67 159.04 29.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.213 -0.929 . . . . 0.0 109.595 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.14 -30.75 60.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.2 -42.2 96.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.134 -0.979 . . . . 0.0 109.702 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -74.69 -23.4 58.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 109.557 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 72.1 mt -96.37 4.67 52.07 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -95.24 -25.85 16.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.269 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -82.78 -9.03 59.53 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.226 -0.921 . . . . 0.0 109.333 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -91.58 19.23 6.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.641 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.27 158.46 17.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.137 -0.977 . . . . 0.0 109.342 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.495 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.1 p90 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.413 ' H ' HG12 ' D' ' 2' ' ' VAL . 2.5 p -59.68 122.7 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.782 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' D' ' 7' ' ' CYS . 0.5 OUTLIER 175.22 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.21 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -82.1 -39.44 23.35 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.244 -0.91 . . . . 0.0 109.131 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -62.17 -22.02 65.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.0 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -102.41 -24.39 13.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.808 . . . . 0.0 109.06 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 42.2 t -74.21 -23.22 59.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.323 -0.86 . . . . 0.0 109.394 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.683 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -87.29 -20.26 52.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 57.6 p -81.45 -15.24 55.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.254 . . . . 0.0 109.434 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -89.68 -21.16 22.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.41 -0.807 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 9.2 mt -90.83 -33.25 15.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.151 -0.968 . . . . 0.0 109.754 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.683 HG13 ' O ' ' D' ' 8' ' ' GLY . 35.5 m -61.85 -35.6 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.798 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.38 -26.94 60.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.066 -1.021 . . . . 0.0 109.812 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.65 19.57 14.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.133 -0.979 . . . . 0.0 109.699 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' C' ' 2' ' ' ILE . 1.6 mt -117.43 -54.75 2.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 109.785 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -66.55 -22.8 66.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.97 . . . . 0.0 109.595 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.678 HD21 ' CB ' ' J' ' 14' ' ' ALA . 22.9 tp -77.62 -33.83 53.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.347 -0.845 . . . . 0.0 109.571 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 66.9 t -60.6 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.342 -0.849 . . . . 0.0 109.885 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -63.35 -42.75 98.93 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 109.701 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.59 -96.93 0.86 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.75 -54.73 41.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.294 -1.121 . . . . 0.0 109.61 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -56.2 156.5 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.894 . . . . 0.0 109.634 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.34 -167.54 26.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -168.13 158.14 10.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -1.113 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . 0.648 ' CD2' ' CB ' ' B' ' 25' ' ' PHE . 19.2 m-85 -113.22 142.99 45.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 109.528 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -125.31 117.0 22.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -0.995 . . . . 0.0 109.465 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.2 92.56 6.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.748 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -79.16 81.61 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.717 2.278 . . . . 0.0 110.39 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -133.68 112.25 11.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.9 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.713 HG22 ' O ' ' E' ' 2' ' ' ILE . 53.2 mt -99.83 22.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.305 -1.115 . . . . 0.0 109.389 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 49.0 t -113.12 -47.42 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.22 -0.925 . . . . 0.0 109.735 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.71 47.88 1.12 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.136 -0.977 . . . . 0.0 109.478 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -169.99 -32.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 109.698 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' E' ' 9' ' ' SER . 99.9 m -111.59 -30.48 7.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.39 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -72.46 -17.08 61.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.173 -0.955 . . . . 0.0 109.321 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -107.3 -7.56 16.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' E' ' 6' ' ' CYS . 3.5 p -168.18 134.07 1.91 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.167 -0.958 . . . . 0.0 109.339 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.467 ' HA ' ' O1 ' ' E' ' 31' ' ' IPH . 2.5 mp -53.73 137.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.131 -0.98 . . . . 0.0 109.736 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 88.0 m -103.3 151.23 22.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.198 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.58 158.25 28.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.851 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.01 -29.91 61.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.221 -0.925 . . . . 0.0 109.106 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -64.62 -45.88 85.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -71.42 -23.05 61.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -0.872 . . . . 0.0 109.698 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.35 -0.62 49.19 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -0.939 . . . . 0.0 110.05 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -89.31 -24.8 21.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.705 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -84.67 -7.04 59.38 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.109 -0.995 . . . . 0.0 109.889 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -92.11 20.14 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.138 -0.976 . . . . 0.0 109.17 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.8 158.28 18.31 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.372 -0.83 . . . . 0.0 109.335 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.595 -179.829 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 10.6 p90 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.04 124.45 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.32 -35.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -80.15 -43.35 21.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.363 -0.836 . . . . 0.0 108.915 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -58.09 -23.03 53.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.664 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.445 HD22 ' ND1' ' B' ' 10' ' ' HIS . 10.4 mt -101.46 -27.27 13.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 108.997 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.485 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 46.8 t -72.65 -20.22 61.29 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.597 -0.689 . . . . 0.0 109.511 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.678 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -88.83 -22.55 38.76 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 27.6 p -80.66 -17.04 52.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -1.123 . . . . 0.0 109.42 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . 0.716 ' ND1' HD22 ' J' ' 6' ' ' LEU . 14.5 m-70 -87.54 -18.18 30.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.933 . . . . 0.0 109.444 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 9.8 mt -94.58 -32.67 13.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.161 -0.962 . . . . 0.0 109.789 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.678 HG13 ' O ' ' F' ' 8' ' ' GLY . 36.0 m -62.83 -35.04 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.856 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -26.59 59.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.935 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.53 18.38 16.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.549 HD11 HD13 ' E' ' 2' ' ' ILE . 1.7 mt -116.15 -55.89 2.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.065 -1.022 . . . . 0.0 109.617 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -64.27 -23.12 67.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.694 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 26.9 tp -77.86 -33.85 52.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.77 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.49 -66.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 109.78 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.21 -44.09 97.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.15 -0.969 . . . . 0.0 109.7 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.93 -96.82 0.88 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.56 -55.71 30.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -1.114 . . . . 0.0 109.575 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -55.12 156.55 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.174 -0.954 . . . . 0.0 109.592 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -166.85 28.57 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -171.62 161.84 6.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -1.093 . . . . 0.0 108.981 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -122.29 151.18 41.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.026 -1.046 . . . . 0.0 109.589 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . 0.422 ' CE2' ' HG3' ' F' ' 28' ' ' PRO . 33.8 t80 -129.66 118.17 21.5 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.216 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.512 HG23 ' HA3' ' H' ' 23' ' ' GLY . 0.3 OUTLIER -142.33 91.27 7.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.366 -0.834 . . . . 0.0 109.352 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . 0.422 ' HG3' ' CE2' ' F' ' 26' ' ' TYR . 35.6 Cg_endo -78.52 82.19 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.646 2.231 . . . . 0.0 110.359 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.67 110.81 10.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 0.0 109.534 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.936 -1.031 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.698 HG22 ' O ' ' G' ' 2' ' ' ILE . 46.3 mt -99.13 23.34 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -1.189 . . . . 0.0 109.523 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' G' ' 7' ' ' CYS . 58.0 t -112.45 -48.76 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.87 46.12 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -167.37 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.503 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' G' ' 9' ' ' SER . 85.6 m -110.07 -27.79 9.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' G' ' 3' ' ' VAL . 22.7 t -72.04 -22.48 61.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.196 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 15.0 t -103.27 -6.16 22.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.455 -0.778 . . . . 0.0 109.695 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' G' ' 6' ' ' CYS . 2.2 p -169.32 132.74 1.3 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -52.22 137.4 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.365 -0.834 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 83.5 m -104.01 150.35 24.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.257 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.39 159.9 30.06 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.311 -0.868 . . . . 0.0 109.405 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -31.82 66.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.075 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -61.6 -46.57 89.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.418 -0.801 . . . . 0.0 109.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -72.33 -20.98 61.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 76.0 mt -96.85 -2.62 43.63 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.103 -0.998 . . . . 0.0 109.792 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -89.02 -24.74 22.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.716 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -82.91 -8.26 59.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 0.0 109.837 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -90.91 12.97 17.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.456 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.01 163.0 12.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.611 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.568 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.423 ' O ' HG13 ' H' ' 2' ' ' VAL . 2.6 p -59.08 121.18 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.22 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.31 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.93 -43.67 29.21 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.284 -0.885 . . . . 0.0 109.181 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -57.14 -23.72 49.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.553 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . 0.553 HD22 ' ND1' ' L' ' 10' ' ' HIS . 10.8 mt -100.86 -26.08 13.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 109.223 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.457 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 15.4 t -73.74 -20.22 60.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.469 -0.769 . . . . 0.0 109.706 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . 0.709 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -88.77 -20.2 48.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 87.9 p -82.04 -16.3 50.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -1.059 . . . . 0.0 109.508 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -89.6 -16.21 31.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.548 ' CD2' ' C6 ' ' G' ' 31' ' ' IPH . 8.0 mt -96.61 -33.42 11.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.473 -0.767 . . . . 0.0 109.547 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.709 HG13 ' O ' ' H' ' 8' ' ' GLY . 35.2 m -62.96 -29.98 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.372 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.98 -25.87 43.41 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.454 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.429 ' CB ' ' H3 ' ' G' ' 31' ' ' IPH . . . -100.7 22.46 11.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.257 -0.902 . . . . 0.0 109.752 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . 0.61 HD11 HD13 ' G' ' 2' ' ' ILE . 1.9 mt -120.15 -54.19 2.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.523 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.58 -24.2 66.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.172 -0.955 . . . . 0.0 109.612 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 20.7 tp -77.22 -36.5 54.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.195 -0.94 . . . . 0.0 109.583 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.32 -67.41 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.932 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' H' ' 22' ' ' ARG . 43.7 m -66.97 -39.99 87.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.985 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.26 -103.37 1.07 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -50.9 -63.55 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -1.221 . . . . 0.0 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' H' ' 19' ' ' CYS . 6.9 mtt-85 -49.08 154.35 0.79 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.361 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.512 ' HA3' HG23 ' F' ' 27' ' ' THR . . . -101.42 -170.57 28.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.57 170.45 15.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -1.176 . . . . 0.0 109.525 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -128.34 150.4 50.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . 0.418 ' CE2' ' HG3' ' H' ' 28' ' ' PRO . 31.8 t80 -131.99 118.55 19.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.296 -0.877 . . . . 0.0 109.397 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.55 89.86 7.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.583 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . 0.418 ' HG3' ' CE2' ' H' ' 26' ' ' TYR . 34.4 Cg_endo -76.47 82.64 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.72 2.28 . . . . 0.0 110.487 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.18 111.78 9.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.368 -0.833 . . . . 0.0 109.194 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.553 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.694 HG22 ' O ' ' I' ' 2' ' ' ILE . 49.6 mt -98.02 24.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -1.194 . . . . 0.0 109.314 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' I' ' 7' ' ' CYS . 57.3 t -113.46 -47.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.146 -0.972 . . . . 0.0 109.57 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.01 50.49 1.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.229 -0.919 . . . . 0.0 109.33 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -172.32 -34.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.475 -0.765 . . . . 0.0 109.252 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 51.3 m -109.06 -32.61 7.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.867 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' I' ' 3' ' ' VAL . 0.5 OUTLIER -71.17 -19.49 62.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.047 . . . . 0.0 109.482 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 15.2 t -103.77 -6.82 21.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 p -169.51 135.66 1.59 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.194 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.84 145.29 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.346 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . 0.45 ' SG ' HD11 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -112.46 150.06 31.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.012 -1.055 . . . . 0.0 109.545 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.57 155.58 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.915 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.77 -30.15 31.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.739 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -63.88 -45.6 88.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -72.03 -23.97 61.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . 0.45 HD11 ' SG ' ' I' ' 11' ' ' CYS . 75.8 mt -94.88 -0.81 53.69 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -91.13 -23.66 20.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.102 -0.998 . . . . 0.0 109.81 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -83.84 -9.03 59.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 109.676 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.54 15.6 10.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.12 156.59 17.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 109.67 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.215 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 9.6 p90 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.41 121.05 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.72 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.382 -0.824 . . . . 0.0 108.868 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -79.26 -40.72 29.84 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.432 -0.793 . . . . 0.0 109.5 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -61.8 -21.65 64.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 109.381 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . 0.716 HD22 ' ND1' ' F' ' 10' ' ' HIS . 8.8 mt -103.14 -22.25 13.78 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.319 -0.863 . . . . 0.0 108.928 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.407 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 46.1 t -77.64 -14.91 59.51 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.405 -0.809 . . . . 0.0 109.099 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.699 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -94.26 -19.2 33.78 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 38.4 p -83.41 -18.04 40.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -1.203 . . . . 0.0 109.179 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -86.02 -20.93 28.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.377 -0.827 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.453 ' CD2' ' C6 ' ' J' ' 32' ' ' IPH . 9.8 mt -92.07 -33.55 14.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.954 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.699 HG13 ' O ' ' J' ' 8' ' ' GLY . 32.5 m -62.2 -36.23 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.739 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.419 ' N ' HG23 ' J' ' 12' ' ' VAL . 1.0 OUTLIER -72.76 -27.11 61.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.957 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.678 ' CB ' HD21 ' D' ' 17' ' ' LEU . . . -99.09 18.35 17.59 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.19 -0.944 . . . . 0.0 109.74 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . 0.595 HD11 HD13 ' I' ' 2' ' ' ILE . 1.4 mt -116.04 -54.15 2.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.984 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -66.19 -23.96 66.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.7 -35.19 58.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.195 -0.94 . . . . 0.0 109.664 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.53 -68.72 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.688 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.08 -44.15 97.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.647 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.92 -94.94 0.8 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.02 -57.83 10.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -1.184 . . . . 0.0 109.519 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -53.23 158.68 1.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.255 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.81 -172.42 25.54 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -163.33 158.24 21.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.246 . . . . 0.0 109.714 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' L' ' 25' ' ' PHE . 42.5 p90 -116.15 147.04 41.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.535 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -131.08 113.07 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.618 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . 0.718 HG23 ' HA3' ' L' ' 23' ' ' GLY . 0.3 OUTLIER -138.0 92.35 12.61 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.585 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.74 81.88 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.6 2.2 . . . . 0.0 110.401 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.3 110.12 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.451 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.715 ' O ' HG22 ' K' ' 2' ' ' ILE . 43.7 mt -97.84 26.67 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -1.195 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 54.5 t -115.18 -49.61 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 109.429 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.02 48.1 1.24 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -169.1 -35.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.334 -0.854 . . . . 0.0 109.684 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' K' ' 9' ' ' SER . 77.5 m -110.0 -27.34 9.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.99 . . . . 0.0 109.327 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 33.6 t -73.82 -19.04 60.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -106.83 -6.04 17.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.34 -0.85 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 2.1 p -167.67 135.43 2.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 109.181 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.414 ' HA ' ' O1 ' ' L' ' 32' ' ' IPH . 2.3 mp -55.89 139.81 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 109.362 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 99.7 m -105.17 147.23 28.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.723 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.17 156.9 36.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.875 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -32.69 60.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 109.501 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -61.36 -44.96 96.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.754 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -72.65 -22.22 60.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.816 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -96.98 2.02 51.02 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.241 -0.912 . . . . 0.0 109.739 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -93.31 -24.73 18.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.396 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -83.14 -9.49 59.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -90.15 15.81 9.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.5 161.99 13.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.446 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.632 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 10.0 p90 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.13 124.4 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.981 . . . . 0.0 109.366 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 174.93 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -80.75 -40.87 24.44 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -61.31 -20.65 63.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 109.356 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.06 -25.03 13.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.05 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.483 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 35.2 t -74.96 -19.72 59.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.566 -0.709 . . . . 0.0 109.381 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.683 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -89.59 -20.97 42.11 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 88.0 p -80.6 -18.48 48.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . 0.553 ' ND1' HD22 ' H' ' 6' ' ' LEU . 21.5 m-70 -87.32 -18.65 29.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.582 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 9.7 mt -94.0 -30.11 14.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.821 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.683 HG13 ' O ' ' L' ' 8' ' ' GLY . 35.3 m -66.61 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -74.34 -25.67 59.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.02 19.69 16.95 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.122 -0.986 . . . . 0.0 109.698 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.584 HD11 HD13 ' K' ' 2' ' ' ILE . 1.4 mt -117.21 -54.16 2.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -65.93 -23.68 66.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.657 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -78.82 -30.37 45.28 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.262 -0.898 . . . . 0.0 109.885 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.52 -68.67 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.23 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -62.2 -44.47 96.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.59 -96.79 0.94 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.73 -59.38 5.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.272 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -51.36 157.89 0.93 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.327 -0.858 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' J' ' 27' ' ' THR . . . -103.14 -166.99 25.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -171.79 155.78 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -1.107 . . . . 0.0 109.3 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' L' ' 25' ' ' PHE . 18.1 p90 -113.88 152.47 30.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.0 109.302 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -132.51 116.64 17.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.404 -0.81 . . . . 0.0 109.247 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.57 91.54 7.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.261 -0.9 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.67 80.23 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.542 2.161 . . . . 0.0 110.202 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.26 111.7 11.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.487 ' C6 ' ' CD2' ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.468 ' O1 ' ' HA ' ' C' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 31' ' ' IPH . . . . . 0.527 ' H5 ' HD21 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 31' ' ' IPH . . . . . 0.548 ' C6 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . 0.453 ' C6 ' ' CD2' ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . 0.441 ' H5 ' HD21 ' H' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' J' J ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' A' ' 2' ' ' ILE . 4.5 tt -118.61 18.52 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -1.166 . . . . 0.0 109.263 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 t -121.45 -7.0 9.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.35 -0.844 . . . . 0.0 109.189 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -102.88 -9.78 19.6 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.356 -0.84 . . . . 0.0 109.612 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -130.96 12.82 5.23 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.307 -0.87 . . . . 0.0 109.644 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -47.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.364 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.93 -15.64 59.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.29 -0.881 . . . . 0.0 109.532 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.3 p -97.74 -34.23 10.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 109.494 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -140.08 145.63 37.91 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 0.0 109.384 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.3 138.13 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.935 . . . . 0.0 109.266 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.3 m -95.81 172.51 7.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 110.037 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.85 167.31 10.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.439 -0.788 . . . . 0.0 108.938 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.22 91.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.334 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -64.67 -33.67 76.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.84 . . . . 0.0 109.689 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -50.62 70.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mt -69.24 -20.13 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.771 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.12 -21.62 61.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.939 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -64.73 -25.04 67.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.071 -1.018 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.457 ' CD2' HD12 ' A' ' 2' ' ' ILE . 40.4 m-85 -100.53 -25.63 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.53 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.85 119.18 8.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.599 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.535 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' I' ' 8' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.36 142.08 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.635 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 168.94 -39.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -76.19 -36.75 58.52 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.409 ' HB2' HD11 ' I' ' 10' ' ' ILE . 85.3 t60 -62.1 -37.79 86.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.185 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.608 HD21 ' H5 ' ' J' ' 32' ' ' IPH . 9.5 mt -84.55 -23.53 29.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.417 -0.802 . . . . 0.0 108.973 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.423 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 38.7 t -69.31 -36.23 76.79 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.93 -21.48 65.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 61.3 p -77.03 -17.13 59.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.486 -1.008 . . . . 0.0 109.494 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -88.07 -24.51 23.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.451 HD22 ' C2 ' ' B' ' 32' ' ' IPH . 10.9 mt -81.14 -39.24 25.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 m -49.99 -40.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -70.07 -40.97 74.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.005 . . . . 0.0 109.24 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.64 27.36 1.77 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.75 -48.29 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 109.312 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.599 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 11.6 p90 -74.38 -17.59 60.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.925 . . . . 0.0 109.086 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.599 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 8.3 mt -78.81 -19.47 52.04 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.408 -0.808 . . . . 0.0 109.483 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 80.3 t -80.3 -50.64 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.87 -69.14 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.372 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.29 -106.29 3.19 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -62.42 -36.36 82.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -1.134 . . . . 0.0 109.551 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -68.5 171.56 7.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.012 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -115.05 178.51 17.89 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.89 159.55 44.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -1.183 . . . . 0.0 109.643 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.581 ' CD1' ' O ' ' B' ' 25' ' ' PHE . 21.5 p90 -113.45 139.42 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 109.599 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -123.13 114.35 20.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.36 87.67 54.6 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.28 79.01 3.42 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.588 2.192 . . . . 0.0 110.509 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 41.7 tttt -132.04 161.42 33.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.202 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.645 -179.811 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.479 HD12 ' CD2' ' C' ' 19' ' ' TYR . 5.1 tt -116.61 13.84 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -1.164 . . . . 0.0 109.491 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -116.61 -5.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.9 -4.49 22.1 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.276 -0.89 . . . . 0.0 109.678 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.98 5.04 3.85 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.061 -1.025 . . . . 0.0 110.222 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -130.06 -42.29 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.043 . . . . 0.0 109.192 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.03 -16.01 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.535 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 71.4 p -96.59 -37.64 10.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.333 -0.854 . . . . 0.0 109.291 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 7.9 m -138.86 144.2 39.1 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.666 HD11 ' HB2' ' L' ' 5' ' ' HIS . 2.6 mp -53.48 138.25 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 m -102.36 159.76 15.13 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 109.622 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 170.98 11.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.349 -0.845 . . . . 0.0 110.329 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.19 -48.93 71.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 109.253 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -61.49 -33.43 73.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.92 . . . . 0.0 109.241 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -47.75 81.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 109.725 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 mt -71.97 -19.88 61.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.224 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.47 -22.75 61.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -63.68 -24.66 67.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.534 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.479 ' CD2' HD12 ' C' ' 2' ' ' ILE . 27.5 m-85 -100.92 -27.24 13.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.519 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -58.5 119.6 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.105 -0.997 . . . . 0.0 109.475 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.6 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.463 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 7.6 p -61.52 144.41 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 0.6 OUTLIER 165.45 -38.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.019 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.07 -34.77 43.34 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.3 -0.875 . . . . 0.0 109.002 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -64.18 -37.69 88.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.384 -0.822 . . . . 0.0 108.928 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -82.39 -30.79 30.01 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.354 -0.841 . . . . 0.0 108.938 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.446 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 16.2 t -63.51 -35.48 80.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.47 -0.769 . . . . 0.0 109.593 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.37 -22.34 65.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . 0.581 ' HB2' ' CZ ' ' B' ' 16' ' ' TYR . 90.7 p -79.43 -17.79 53.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.221 -1.164 . . . . 0.0 109.149 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -83.37 -27.93 29.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 109.342 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 11.1 mt -78.76 -45.05 21.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.464 HG23 ' N ' ' D' ' 13' ' ' GLU . 12.8 m -43.02 -45.3 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.464 ' N ' HG23 ' D' ' 12' ' ' VAL . 11.8 mt-10 -66.08 -40.53 90.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.696 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.29 23.98 2.71 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 109.795 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.33 -48.34 2.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 9.5 p90 -73.72 -18.66 60.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.237 -0.914 . . . . 0.0 109.311 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 8.6 mt -77.51 -20.35 54.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.817 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.62 -50.21 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 45.1 m -74.77 -68.18 0.57 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.93 -109.72 3.87 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -58.59 -37.94 76.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.124 . . . . 0.0 109.316 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -68.42 161.09 28.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.4 -0.812 . . . . 0.0 109.545 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.52 -175.06 25.01 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -158.19 157.66 33.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -1.219 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -111.78 142.62 43.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.331 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.49 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 39.3 t80 -127.76 115.92 19.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.483 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 89.99 47.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . 0.413 ' HD2' ' CA ' ' B' ' 23' ' ' GLY . 35.8 Cg_endo -78.63 74.42 5.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.733 2.289 . . . . 0.0 110.503 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -127.02 159.55 33.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.663 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.486 179.894 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.475 HD12 ' CD2' ' E' ' 19' ' ' TYR . 6.4 tt -118.0 16.32 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -1.102 . . . . 0.0 109.272 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 t -118.47 -10.13 11.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.514 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -100.06 -10.2 21.8 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.343 -0.848 . . . . 0.0 109.851 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -129.03 15.28 6.28 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.35 -50.52 0.68 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.327 -0.858 . . . . 0.0 109.294 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -13.91 25.38 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.696 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 65.2 p -98.74 -34.26 10.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.042 -1.036 . . . . 0.0 109.678 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.3 m -142.72 145.05 32.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.186 -0.946 . . . . 0.0 109.45 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.05 139.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -0.983 . . . . 0.0 109.752 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 87.6 m -97.67 171.42 8.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.775 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.23 167.03 10.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.321 -0.862 . . . . 0.0 109.367 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -47.72 85.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.265 -0.897 . . . . 0.0 109.141 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -63.76 -34.18 77.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.392 -0.818 . . . . 0.0 109.606 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -49.53 76.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.77 -18.65 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 0.0 109.682 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.71 -24.24 60.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.791 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -61.53 -25.41 67.27 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.302 -0.873 . . . . 0.0 109.786 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.475 ' CD2' HD12 ' E' ' 2' ' ' ILE . 24.0 m-85 -100.59 -27.05 13.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.589 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 41.8 t -58.27 118.53 5.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.881 . . . . 0.0 109.584 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.458 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.231 0.539 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 7.6 p -63.91 145.12 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 0.6 OUTLIER 165.21 -38.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.861 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -78.54 -37.54 42.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.311 -0.868 . . . . 0.0 109.102 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -62.47 -36.42 82.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 11.9 mt -84.51 -28.68 26.56 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.014 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 44.0 t -66.0 -33.27 75.43 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.676 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.34 -20.21 62.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . 0.435 ' O ' ' CG2' ' F' ' 12' ' ' VAL . 5.6 p -80.08 -18.02 51.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -1.149 . . . . 0.0 109.047 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -84.13 -26.71 28.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.106 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.5 mt -78.6 -45.8 20.82 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.342 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.473 HG23 ' N ' ' F' ' 13' ' ' GLU . 13.0 m -42.95 -44.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.398 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.473 ' N ' HG23 ' F' ' 12' ' ' VAL . 14.5 mt-10 -65.9 -41.31 91.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.854 . . . . 0.0 109.941 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.81 25.74 2.28 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.191 -0.943 . . . . 0.0 109.888 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.53 -48.23 2.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.3 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.4 p90 -74.0 -17.62 60.97 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 8.4 mt -79.8 -19.53 48.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.874 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.78 -51.2 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.055 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.1 -69.3 0.43 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.367 -0.833 . . . . 0.0 109.276 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.43 -109.17 3.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -58.77 -41.6 86.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.326 -1.102 . . . . 0.0 109.342 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -63.71 163.37 11.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.836 . . . . 0.0 109.733 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.11 -175.86 23.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -161.66 163.51 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -1.074 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.5 p90 -119.85 156.02 31.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.351 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . 0.431 ' O ' ' HD3' ' F' ' 28' ' ' PRO . 31.4 t80 -134.48 105.23 6.45 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.273 -0.892 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.63 87.65 21.96 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . 0.501 ' HD2' ' CA ' ' H' ' 23' ' ' GLY . 35.1 Cg_endo -78.47 73.77 5.71 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.771 2.314 . . . . 0.0 110.713 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -125.88 165.14 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.519 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.494 HD12 ' CD2' ' G' ' 19' ' ' TYR . 5.3 tt -113.16 13.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -1.135 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 t -115.53 -7.51 12.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 109.723 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -102.49 -11.31 18.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -128.59 16.76 6.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.108 -0.995 . . . . 0.0 109.479 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.54 -50.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.436 -0.79 . . . . 0.0 109.255 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.3 -15.66 37.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.428 -0.795 . . . . 0.0 109.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 71.2 p -97.39 -39.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.5 m -136.29 139.77 42.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -50.62 137.8 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 97.1 m -94.97 172.09 8.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 109.514 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . 0.4 ' O ' HD12 ' G' ' 16' ' ' LEU . 0.3 OUTLIER -101.26 170.73 8.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 108.932 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.47 -45.96 85.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.165 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -65.41 -33.28 75.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -49.6 74.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . 0.4 HD12 ' O ' ' G' ' 12' ' ' SER . 2.1 mt -70.47 -19.79 62.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.553 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -71.85 -22.44 61.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -63.53 -29.48 70.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.033 -1.042 . . . . 0.0 109.57 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . 0.494 ' CD2' HD12 ' G' ' 2' ' ' ILE . 29.4 m-85 -94.53 -31.87 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.139 -0.975 . . . . 0.0 109.506 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 121.9 9.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.566 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.3 p -62.63 144.09 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 0.5 OUTLIER 166.09 -42.19 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.192 -0.942 . . . . 0.0 108.964 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.49 -36.61 60.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.228 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.86 -37.48 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 mt -83.3 -28.08 29.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.092 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 16.8 t -66.55 -33.5 75.82 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.681 . . . . 0.0 109.233 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.65 56.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 3.5 p -75.45 -18.0 60.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -1.081 . . . . 0.0 109.571 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -84.52 -24.76 29.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.823 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 11.0 mt -82.54 -42.33 18.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.426 HG23 ' N ' ' H' ' 13' ' ' GLU . 12.0 m -45.68 -43.02 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.333 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . 0.426 ' N ' HG23 ' H' ' 12' ' ' VAL . 12.7 mt-10 -66.66 -42.91 85.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.108 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.4 26.39 1.46 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.887 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.42 -47.25 2.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.045 . . . . 0.0 109.37 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.587 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 8.9 p90 -74.92 -16.68 60.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 7.9 mt -80.33 -19.92 45.42 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.489 -0.757 . . . . 0.0 109.397 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 90.1 t -79.41 -52.29 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.265 -0.897 . . . . 0.0 109.428 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.36 -65.7 0.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.2 -105.66 3.26 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -61.71 -39.73 92.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.154 -1.204 . . . . 0.0 109.405 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.94 165.9 12.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.501 ' CA ' ' HD2' ' F' ' 28' ' ' PRO . . . -109.97 -176.75 21.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -159.05 153.51 24.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.409 -1.054 . . . . 0.0 109.347 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' H' ' 25' ' ' PHE . 37.5 p90 -110.79 141.33 44.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.263 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -119.99 118.88 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.93 . . . . 0.0 109.447 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.5 87.69 49.42 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.611 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.94 77.79 3.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.644 2.23 . . . . 0.0 110.678 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -129.13 160.44 32.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.545 179.915 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.467 HD12 ' CD2' ' I' ' 19' ' ' TYR . 4.2 tt -122.14 15.51 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -1.207 . . . . 0.0 109.38 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 t -118.73 -3.13 9.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.299 -0.875 . . . . 0.0 109.311 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.71 -6.14 17.0 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.245 -0.909 . . . . 0.0 109.496 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -130.92 2.04 4.35 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 109.79 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 50.9 m -127.15 -39.49 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.058 -1.026 . . . . 0.0 109.45 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -69.46 -13.62 62.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.99 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . 0.508 ' O ' ' HB3' ' B' ' 1' ' ' PHE . 67.3 p -102.19 -20.72 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.605 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -153.64 138.09 16.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 109.358 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 5' ' ' HIS . 2.3 mp -50.18 138.08 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 109.014 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.0 m -102.26 161.1 13.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.237 -0.914 . . . . 0.0 109.453 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . 0.422 ' O ' HD12 ' I' ' 16' ' ' LEU . 0.3 OUTLIER -89.55 170.92 10.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.341 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.01 -49.41 72.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.542 -0.724 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -60.42 -35.07 74.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.866 . . . . 0.0 109.405 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.18 -48.69 78.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.577 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . 0.422 HD12 ' O ' ' I' ' 12' ' ' SER . 2.1 mt -72.39 -15.36 61.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.266 -0.896 . . . . 0.0 109.736 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.105 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -61.59 -29.91 70.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . 0.467 ' CD2' HD12 ' I' ' 2' ' ' ILE . 28.3 m-85 -96.21 -30.3 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.705 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.16 118.86 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.255 -0.903 . . . . 0.0 109.651 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.495 179.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.262 0.554 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 7.3 p -64.21 145.3 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 0.6 OUTLIER 165.3 -39.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -77.99 -38.1 45.71 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 109.217 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.32 -35.29 78.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -0.853 . . . . 0.0 108.916 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -85.33 -27.46 25.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.44 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 12.9 t -67.23 -33.95 76.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -0.793 . . . . 0.0 109.42 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.91 -22.67 60.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 93.3 p -77.28 -16.99 58.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.455 -1.026 . . . . 0.0 109.322 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . 0.489 ' CG ' HD22 ' B' ' 6' ' ' LEU . 10.3 m-70 -88.02 -21.65 24.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.892 . . . . 0.0 109.665 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 11.8 mt -84.02 -38.97 20.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.113 -0.992 . . . . 0.0 109.627 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.409 HG23 ' N ' ' J' ' 13' ' ' GLU . 11.8 m -49.67 -40.61 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.409 ' N ' HG23 ' J' ' 12' ' ' VAL . 11.8 mt-10 -69.44 -40.52 77.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.2 27.81 1.8 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.245 -0.909 . . . . 0.0 109.381 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.56 -46.41 2.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.594 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 12.6 p90 -76.22 -16.22 59.87 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.196 -0.94 . . . . 0.0 109.056 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 7.9 mt -80.83 -17.37 51.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.499 -0.75 . . . . 0.0 109.792 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 95.7 t -82.69 -49.42 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.595 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -63.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 109.428 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.74 -105.95 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -61.05 -39.12 88.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -1.138 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -66.63 157.51 32.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 109.936 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.56 -175.87 29.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -161.1 157.9 26.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.058 -1.26 . . . . 0.0 109.726 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -115.97 142.68 46.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.76 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -122.67 119.25 30.16 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.406 -0.809 . . . . 0.0 109.121 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 87.38 53.14 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.72 77.84 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.628 2.218 . . . . 0.0 110.679 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -128.93 160.54 32.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.342 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' K' ' 2' ' ' ILE . 6.2 tt -117.66 17.22 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.316 -1.108 . . . . 0.0 109.718 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 t -119.94 -8.42 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.409 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.63 -10.37 21.0 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.279 -0.888 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -130.94 16.44 5.18 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.56 -47.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.314 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -16.09 56.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.196 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 66.9 p -96.04 -41.33 8.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.823 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 75.3 m -134.35 144.41 48.24 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.142 -0.974 . . . . 0.0 109.721 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.43 137.22 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.29 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.83 169.38 10.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 109.887 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.03 167.49 10.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.38 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -46.44 90.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.387 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.61 -35.0 79.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -49.06 78.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.176 -0.953 . . . . 0.0 109.598 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.23 -18.34 62.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.931 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.45 -23.12 60.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 109.188 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -0.775 . . . . 0.0 109.576 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . 0.431 ' CD2' HD12 ' K' ' 2' ' ' ILE . 24.1 m-85 -99.33 -27.82 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.08 120.94 8.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.486 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' C' ' 8' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.264 0.554 . . . . 0.0 109.587 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 7.3 p -63.14 143.86 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.013 -1.055 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 0.6 OUTLIER 167.27 -39.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.017 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -77.07 -39.89 48.16 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.374 -0.829 . . . . 0.0 108.81 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . 0.666 ' HB2' HD11 ' C' ' 10' ' ' ILE . 86.3 t60 -60.67 -36.61 79.16 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.456 -0.778 . . . . 0.0 109.342 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . 0.425 HD21 ' H5 ' ' D' ' 32' ' ' IPH . 10.8 mt -84.01 -29.34 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.448 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 40.7 t -66.12 -32.68 74.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.578 -0.701 . . . . 0.0 109.595 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.44 -26.7 53.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . 0.41 ' O ' HG22 ' L' ' 12' ' ' VAL . 59.9 p -74.01 -19.74 60.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.48 -1.012 . . . . 0.0 109.329 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -83.78 -23.28 31.56 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.123 -0.986 . . . . 0.0 109.564 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 10.5 mt -82.55 -42.65 18.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 109.566 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.41 HG22 ' O ' ' L' ' 9' ' ' SER . 13.9 m -46.49 -40.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -70.36 -40.21 74.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.89 21.46 3.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.191 -0.943 . . . . 0.0 109.666 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.48 -49.28 2.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.561 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 11.5 p90 -73.05 -17.3 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.962 . . . . 0.0 109.695 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 8.4 mt -79.01 -19.51 51.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.684 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.49 -50.79 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 57.1 m -73.83 -68.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.35 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.82 -108.38 3.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.93 -38.22 85.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -1.169 . . . . 0.0 109.217 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -67.44 160.53 27.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.426 -0.796 . . . . 0.0 109.433 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.62 -175.46 24.91 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -155.33 170.5 21.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -125.57 136.71 53.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.968 -1.083 . . . . 0.0 109.315 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -120.16 117.08 26.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.74 87.16 50.35 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.483 -0.761 . . . . 0.0 109.307 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.99 79.14 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.593 2.196 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -130.07 161.39 31.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 0.0 109.312 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.414 179.872 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.451 ' C2 ' HD22 ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.425 ' H5 ' HD21 ' L' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 31' ' ' IPH . . . . . 0.41 ' C2 ' HD22 ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . 0.608 ' H5 ' HD21 ' B' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' J' J ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_